AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY

FINAL PROGRAM

SAN DIEGO
 Welcome

Dear Colleagues,
Welcome to San Diego, where thousands of allergist/immunologists, allied health and related Table of Contents
healthcare professionals from around the world have gathered for the 2014 AAAAI Annual General Information
Meeting.
Annual Meeting Program Committees.. 2
A five day program of cutting-edge research and the latest advances in the diagnosis and
treatment of allergic and immunologic diseases makes this the premier event in allergy/ Meeting Information............................. 4
immunology. Please join us in recognizing the members of the Annual Meeting Program Business and Committee Meetings...... 8
Subcommittee, who have spent the last 18 months planning the educational program you will
Other Meetings and Events................ 10
experience here.
ARTrust Activities........................... 13
Of special note is this years Presidential Plenary, Immunotherapy: Mechanism, Outcomes
and Markers, which will feature a timely discussion of the latest understanding of allergy Guest/Associate Activities.................. 16
immunotherapy. We invite you to hear more on Saturday, March 1 from 8:15 to 9:45 am. Thanks Lectureships...................................... 17
to Cezmi A. Akdis, MD FAAAAI and Stephen R. Durham, MA MD FRCP for their participation in this
important session. Awards.............................................. 18

Another standout session on immunotherapy is SLIT: Implementation in Your Practice. A review Education Program
of how SLIT works, a discussion of the results of pivotal clinical trials and how to use SLIT in
Continuing Education & Accreditation...22
practice will be covered. To ensure all delegates hear the important information presented,
this Saturday symposium will be recorded onsite and will be available online free of charge to Military Allergy Program..................... 25
registered attendees following the Annual Meeting. More details on how to access the recording Fellows-in-Training Program.............. 25
will be provided once the meeting is over.
Advanced Practice Course................. 26
Other high-profile sessions include two exciting keynotes on Saturday and Monday. Eric J. Topol,
MD will present on genomic and wireless digital innovation, and James R. Baker, Jr., MD FAAAAI Chrysalis Program............................. 26
will talk about nanotechnology in the immune system. Attend both keynotes for the opportunity to Friday Sessions.................................. 25
listen to first-rate speakers cover topics that have the potential to impact the future of medicine.
Saturday Sessions............................. 38
Invest Together in Our Future Sunday Sessions............................... 55
The Annual Meeting has a world-class educational and scientific program, along with
opportunities to network with each other and interact in the Exhibit Hall with our vendor INDANA Course.................................. 61
community. Beyond all of this, you can also use your time in San Diego to invest in the future of Monday Sessions............................... 64
our specialty.
Tuesday Sessions.............................. 73
The Allergy, Asthma & Immunology Education and Research Organization, Inc. (ARTrust) invites
you to join your peers and help raise funds to support allergy, asthma and immunology education Directories
and research. A First Class Event awaits you at the 2014 ARTrust Benefit on Saturday evening at Abstracts........................................... 83
7:00 pm at the San Diego Air & Space Museum. The Skys the Limit as you try on your own set
of wings in the flight simulators, indulge in fine dining and cocktails, and enjoy live entertainment. Late Breaking Abstracts................... 152

On Sunday at 5:30 pm, the ARTrust hosts the Second Annual Race for Allergy and Asthma ACGME Competency Index............... 160
Research 5K Run/Walk: Light Up the Night. Be among the runners and walkers who will loop Exhibits............................................ 161
through the twinkling lights of the San Diego Embarcadero. There is still time to participate in both
Floor Plans....................................... 182
ARTrust events. Visit the ARTrust booth near registration for more details.
Keywords........................................ 186
It is our hope that what you learn here will guide you in providing optimal patient care. On behalf
of the American Academy of Allergy, Asthma & Immunology, thank you for attending the 2014 Faculty Index................................... 188
Annual Meeting! Staff................................................ 194
Sincerely,
AAAAI-1213-225

Linda Cox, MD FAAAAI Stuart L. Abramson, MD PhD FAAAAI

AAAAI President Chair, Annual Meeting Program Subcommittee

The AAAAI Annual Meeting is not a public event. Programs presented at the Annual Meeting are for the education of attendees and purchasers of recorded presentations as authorized by the AAAAI.
Any use of program content, the name of a speaker and/or program title or the name of the AAAAI without the written consent of the AAAAI is prohibited. The program content includes, but is not
limited to, oral presentations, audio visual materials used by the speakers and program handouts. This rule applies before, during and/or after the meeting.
The AAAAI endorses only those activities described in this printed program. Any other events occurring in the city of San Diego, CA, during the AAAAI Annual Meeting are not sanctioned by the AAAAI.

1
 Annual Meeting Program
committees
Annual Meeting Program Subcommittee Symposia Workgroup
Stuart L. Abramson, MD PhD FAAAAI, Chair Wanda Phipatanakul, MD MS FAAAAI, Chair
Paul V. Williams, MD FAAAAI, Vice Chair Mariana C. Castells, MD PhD FAAAAI, Vice Chair
Paula J. Busse, MD FAAAAI, ADT Representative
Interest Section Chairs, Vice Chairs and Michael E. Manning, MD FAAAAI, ADT Vice Representative
Secretaries Christina L. Nance, PhD, BCI Representative
Timothy J. Craig, DO FAAAAI, ADT Chair David D. Chaplin, MD PhD FAAAAI, BCI Vice Representative
Mark F. Sands, MD FAAAAI, ADT Vice Chair Neil Alexis, PhD, EORD Representative
Leonard B. Bacharier, MD FAAAAI, ADT Secretary Jill A. Poole, MD FAAAAI, EORD Vice Representative
Francisco A. Bonilla, MD PhD FAAAAI, BCI Chair Aleena Banerji, MD, FADDA Representative
Gurjit K. Khurana Hershey, MD PhD FAAAAI, BCI Vice Chair Stacie M. Jones, MD, FADDA Vice Representative
Elena E. Perez, MD PhD FAAAAI, BCI Secretary David J. Shulan, MD FAAAAI, HEDQ Representative
Karin A. Pacheco, MD MSPH FAAAAI, EORD Chair Harvey Leo, MD FAAAAI, HEDQ Vice Representative
Jeffrey G. Demain, MD FAAAAI, EORD Vice Chair Christopher W. Calabria, MD, IRSOC Representative
Wanda Phipatanakul, MD MS FAAAAI, EORD Secretary Matthew A. Rank, MD FAAAAI, IRSOC Vice Representative
David A. Khan, MD FAAAAI, FADDA Chair Roma Sehmi, PhD FAAAAI, MAAI Representative
Sarbjit Singh Saini, MD FAAAAI, FADDA Vice Chair Zoulfia Allakhverdi, PhD FAAAAI, MAAI Vice Representative
Lynda C. Schneider, MD FAAAAI, FADDA Secretary Melissa T. Korenblat-Hanin, ACSW LCSW, Allied Health Representative
Giselle Mosnaim, MD MS FAAAAI, HEDQ Chair Pamela H. Steele, MSN CPNP AE-C, Allied Health Vice Representative
Bruce G. Bender, PhD FAAAAI, HEDQ Vice Chair
Tao T. Le, MD MHS FAAAAI, HEDQ Secretary
Dsire E.S. Larenas Linnemann, MD FAAAAI, IRSOC Chair
Martin Wagenmann, MD FAAAAI, IRSOC Vice Chair
Anju T. Peters, MD FAAAAI, IRSOC Secretary
Mitchell H. Grayson, MD FAAAAI, MAAI Chair
Nives Zimmermann, MD FAAAAI, MAAI Vice Chair
Kari C. Nadeau, MD PhD FAAAAI, MAAI Secretary Follow the AAAAI
Plenary Workgroup
Jonathan M. Spergel, MD PhD FAAAAI, Chair
Annual Meeting
Stephen C. Dreskin, MD PhD FAAAAI, Vice Chair on Twitter
Carol A. Saltoun, MD FAAAAI, ADT Representative
Leonard B. Bacharier, MD FAAAAI, ADT Vice Representative
Steve N. Georas, MD, BCI Representative
John W. Steinke, PhD FAAAAI, BCI Vice Representative
Jonathan A. Bernstein, MD FAAAAI, EORD Representative
Christopher Chang, MD PhD FAAAAI, EORD Vice Representative While youre in San Diego,
use #AAAAI when you
Stephen C. Dreskin, MD PhD FAAAAI, FADDA Representative
tweet to participate in
Amal H. Assaad, MD FAAAAI, FADDA Vice Representative
onsite conversations and
Bruce G. Bender, PhD FAAAAI, HEDQ Representative
share what youre learning
Tao T. Le, MD MHS FAAAAI, HEDQ Vice Representative with your colleagues.
Anju T. Peters, MD FAAAAI, IRSOC Representative
Joerg R. Kleine-Tebbe, MD FAAAAI, IRSOC Vice Representative
Cem Akin, MD PhD FAAAAI, MAAI Representative
Paige Lacy, PhD FAAAAI, MAAI Vice Representative
Dee Mallam, RN AE-C, Allied Health Representative
Karen L. Gregory, DNP APRN-BC RRT AE-C, Allied Health Vice
Representative
AAAAI-1213-059
AAAAI-1213-059

2
 Annual Meeting Program
committees
Workshops Workgroup
Christine M. Seroogy, MD FAAAAI, Chair
Angela Haczku, MD PhD FAAAAI, Vice Chair
Ronina A. Covar, MD, ADT Representative
Miles M. Weinberger, MD FAAAAI, ADT Vice Representative
Antonella Cianferoni, MD PhD, BCI Representative
Lisa R. Forbes, MD, BCI Vice Representative
Alisa M. Smith, PhD FAAAAI, EORD Representative
John R. Cohn, MD FAAAAI, EORD Vice Representative
Javed Sheikh, MD FAAAAI, FADDA Representative
Scott P. Commins, MD PhD, FADDA Vice Representative
Asriani M. Chiu, MD FAAAAI, HEDQ Representative
Matthew A. Rank, MD FAAAAI, HEDQ Vice Representative
David W. Hauswirth, MD FAAAAI, IRSOC Representative
Jayant M. Pinto, MD, IRSOC Vice Representative
Monica Vasudev, MD, MAAI Representative
Dorothy S. Cheung, MD FAAAAI, MAAI Vice Representative
Judith C. Taylor-Fishwick, MSc, Allied Health Representative
Janet S. Kamilaris, RN, Allied Health Vice Representative
Allied Health Education Committee
Julie Wang, MD FAAAAI, Co-Chair
Sally A. Noone, RN MSN CCRC, Co-Chair
G. Lynn Christie, MS RD, AAHCP Representative
Teri Holbrook, CRNP, AAHCP Representative
Sheelagh M. Stewart, MPH RN AE-C, AAHCP Represnetative
Anne E. Borgmeyer, RN CPNP AE-C
Marion E. Groetch, MS RD
Stephen J. McGeady, MD FAAAAI
Donna W. Mitchell, RN MSN NP
Debra A. Sedlak, MSN CPNP, Member
Melissa S. Mordecai, MSN RN CRNP, CR Representative
John D. Milewski, MA Representative
William R. Blouin, ARNP, AH Advance Practice Representative
Edward O. Corazalla, MS RPFT, AH Advance Practice Representative
Maria G. Crain, RN MA CPNP, AH Advance Practice Representative
Nina A. Zimmermann, MSN RN ANP-BC AE-C, AH Advance Practice
Representative

Seminars Workgroup
Giselle Mosnaim, MD MS FAAAAI, Chair
Mitchell H. Grayson, MD FAAAAI, Vice Chair
Jonathan Corren, MD, ADT Representative
Faoud Terrence Ishmael, MD PhD FAAAAI, ADT Vice Representative
Rebecca Scherzer, MD FAAAAI, BCI Representative
Douglas R. McDonald, MD PhD, BCI Vice Representative
Charles S. Barnes, PhD, EORD Representative Put your Program
David Elkayam, MD, EORD Vice Representative
Anna H. Nowak-Wegrzyn, MD FAAAAI, FADDA Representative in your Pocket
Miguel A. Park, MD, FADDA Vice Representative Download the
Alton Lee Melton, Jr., MD, HEDQ Representative 2014 Annual Meeting
Alan P. Baptist, MD MPH FAAAAI, HEDQ Vice Representative app to your iPhone, iPad,
Mark C. Glaum, MD PhD FAAAAI, IRSOC Representative Blackberry or Android.
Mark S. La Shell, MD FAAAAI, IRSOC Vice Representative
Easily locate session handouts,
Edward S. Schulman, MD FAAAAI, MAAI Representative
abstracts and evaluations.
Joshua A. Steinberg, MD, MAAI Vice Representative
Research speakers and add their
Maureen C. Damitz, AE-C, Allied Health Representative sessions to your calendar.
Kim E. Mudd, RN MSN CCRP, Allied Health Vice Representative Learn about last minute
program changes.
Navigate with interactive
maps.

http://aaaai.org/AMapp
AAAAI-1213-052

Sponsored by Teva Respiratory.

3
 Meeting Information
Abstracts
Abstracts programmed at the 2014 Annual Meeting were published
as an online supplement to The Journal of Allergy and Clinical
Immunology (JACI) and can be accessed on the JACI website,
jacionline.org. Abstracts are also included with handouts on flash
drives available at the Member Resource Center.
Admission to Sessions
Admission to AAAAI educational sessions is reserved for meeting
registrants and registered members of the press only. Guests and
exhibitors will not be admitted to educational sessions. Ushers will
monitor the name badges of all meeting attendees to control access to
educational sessions.
Some sessions require tickets for entry, which are indicated in this
program with a ticket icon. Ticketed sessions have limited
attendance and may have an additional fee associated with them. The
listing of educational sessions by day includes additional fees, if
applicable. To register for ticketed sessions please visit the Registration
desk. In consideration of state fire codes and as a courtesy to others,
those without tickets will not be allowed into ticketed sessions.
ATMs
An ATM machine can be found in the lobby of the Convention Center on
the Ground Level across from Exhibit Hall B near the Information Center
and escalators.
Business Center
The onsite business center and FedEx office is located in the lobby of
the Convention Center on the Ground Level across from Exhibit Hall
D. The business center offers full-service digital printing, copying and
shipping.
Children and Guests
The AAAAI asks delegates to refrain from taking children, spouses or
guests to any educational session offered at the 2014 Annual Meeting.
Registered guests are welcome to relax in the Hospitality Suite or visit
the Exhibit Hall; however, an adult must accompany children under
the age of 18 at all times. Most San Diego hotels can provide their
guests with a list of independent babysitters and babysitting agencies
frequently used by visitors. For more information, please contact the
concierge at the appropriate hotel.
Emergency/First Aid
Convention Center, Ground Level, Lobby
In the event of an emergency, please dial 5911 at the Convention
Center or 53 at the Marriott Marquis from any house phone. A First Aid
Station is located in the Convention Center lobby. There is a dedicated
room for nursing mothers in the Convention Center behind Exhibit Hall
A, in the show office.
Evaluations
Delegates will be able to provide feedback on their experiences at the
Annual Meeting in three ways:
Participants will be asked to provide input on the educational
program of the 2014 Annual Meeting through the online CME Claim
System when claiming credit for participation.
4
Delegates can provide feedback on Annual Meeting faculty
members and the sessions they attend by using the Annual
Meeting app or on paper evaluation forms.
The Annual Meeting website will include an online comments form
where delegates can record their observations during and after the
meeting.
Exhibits
Convention Center, Ground Level, Exhibit Hall C
The exhibiting companies and organizations will provide you with the
latest information on products and services available to physicians,
researchers and allied health professionals in the field of allergy/
immunology. The directory on page 161 will provide you with the
information you need to take full advantage of the opportunities offered
by the exhibitors.
Please allow adequate time in your daily schedule to visit the exhibits
located in the Exhibit Hall in the Convention Center. Take time to speak
with representatives of companies that provide services or market
products directly to your professional interest.
Exhibit Hours
Saturday, March 1 9:45 am to 3:15 pm
Sunday, March 2 9:45 am to 3:15 pm
Monday, March 3 9:45 am to 3:15 pm
Food Outlets
There are various coffee, food and beverage vendors located on the
ground level of the Convention Center, as well as the Exhibit Hall. There
are also several restaurants within walking distance.
Handouts
Handouts at the 2014 Annual Meeting will be available in two formats:
Online Handouts
The most up-to date versions of the 2014 Annual Meeting handouts are
available to meeting delegates online at annualmeeting.aaaai.org during
and after the Annual Meeting. Delegates are able to view, download and
print available session handouts. Handouts can be searched by session
number, session title or a speakers last name. Login and password are
case-sensitive. Not all handouts are available.
Username: ALLERGY
Password: handouts
Handouts and Abstracts on Flash Drive
Delegates can receive a complimentary copy of the Annual Meeting
handouts and abstracts on a flash drive at the Member Resource
Center. Delegates will be able to search by session number, session
title or a speakers last name to find specific handouts. Not all
handouts are available.
Handout Stations
Convention Center, Ground Level, Lobby
Sponsored by Meda Pharmaceuticals.
Convention Center, Upper Level, Ballroom 6 Foyer
Marriott North Tower, Lobby Level
 Meeting Information
Hospitality Suite
Marriott South Tower, Level 1, Laguna
Attendees with guest badges are welcome to relax in the Hospitality
Suite. Stop in for information on local attractions and shopping, or just
relax and enjoy some friendly conversation.
Hospitality Suite Hours
Friday, February 28 8:00 am to 1:00 pm
Saturday, March 1 8:00 am to 1:00 pm
Sunday, March 2 8:00 am to 1:00 pm
Monday, March 3 8:00 am to 12:00 pm
Internet Stations
Two internet stations are available to check your e-mail and access the
internet.
Convention Center, Ground Level, Lobby
Sponsored by McNeil Consumer Healthcare.
Convention Center, Upper Level, Ballroom 6 Foyer
JACI Journals
Key representatives from The Journal of Allergy and Clinical
Immunology (JACI), the most-cited allergy/immunology journal,
and sister journal JACI: In Practice will be on hand within the
Member Resource Center to answer your questions regarding your
subscriptions and submissions.
Lost and Found
In the event that you have lost a personal belonging, please contact
Guest Services at the San Diego Convention Center at (619) 525-5490
or dial 5490 from any house phone to report your lost item. Found items
can also be turned over to Guest Services or the AAAAI Registration desk.
Member Resource Center
Convention Center, Ground Level, Exhibit Hall B
Visit the AAAAI Member Resource Center to:
Take advantage of Annual Meeting discounts on all public
education products.
View open positions at the AAAAI Career Connections Center kiosk.
Pick up your Annual Meeting abstracts and handouts on flash drive.
Learn how to promote your practice by listing your location in the
AAAAI Find an Allergist/Immunologist Directory.
Obtain guidance about office operations, coding and promoting
your practice with the 2013 Practice Management Resource Guide.
Pay your dues, update your membership information or learn how
to become a member.
Speak with representatives from The Journal of Allergy and
Clinical Immunology (JACI) and The Journal of Allergy and Clinical
Immunology: In Practice about your subscription or submissions.
Member Resource Center Hours
Thursday, February 27 4:00 to 7:00 pm
Friday, February 28 6:45 am to 5:30 pm
Saturday, March 1 6:45 am to 5:30 pm
Sunday, March 2 6:45 am to 5:30 pm
Monday, March 3 6:45 am to 5:30 pm
Tuesday, March 4 6:45 am to 4:00 pm
Mobile Annual Meeting App
Sponsored by Teva Respiratory.
The AAAAI has a mobile application dedicated specifically to the
2014 Annual Meeting. This useful app features tools to search by
speaker or session type, organize your schedule, evaluate educational
sessions, stay current with changes as they occur during the meeting
and navigate the convention center with floor plans and exhibitor
information. Instructions on downloading the app will be provided
onsite near the Registration desk.
Name Badges
All registered attendees at the 2014 Annual Meeting will receive a
name badge as part of their onsite registration package. These badges
have a barcode on the back that is embedded with the attendees
name, mailing address, fax number, NPI number and e-mail address.
Delegates may scan their badges in the Exhibit Hall and give their
contact information to specific exhibitors.
Please note: When you allow an exhibitor to scan your badge, you are
authorizing them to contact you and send you materials via postal mail,
fax and/or e-mail. The AAAAI cannot be responsible for the use of your
contact information once you have given it to an exhibitor.
Networking and Recharging Lounge
Convention Center, Ground Level, Exhibit Hall B
Photography
Due to the distraction to the speakers, personal photography is not
permitted within any educational sessions or in the Poster Hall.
Delegates are welcome to take photographs at all other AAAAI
functions and activities.
Poster Hall
Convention Center, Ground Level, Exhibit Hall B
The poster sessions, featuring presentations of abstracts in thematic
groupings, are open Saturday through Tuesday. Authors will be present
with their posters from 9:45 to 10:45 am daily.
Poster Hall Hours
Saturday, March 1 7:00 am to 6:00 pm
Sunday, March 2 7:00 am to 6:00 pm
Monday, March 3 7:00 am to 6:00 pm
Tuesday, March 4 7:00 am to 5:00 pm
5
 Meeting Information
Press Room
Convention Center, Mezzanine Level, Room 12
Members of the press representing print, broadcast and electronic
consumer media and healthcare trade media are invited to attend
the 2014 AAAAI Annual Meeting if they have pre-registered through
the AAAAI website. To claim a press pass onsite, journalists must
provide media identification or a business card issued by their news
organization. Freelance writers must provide a letter of assignment on
a news organization letterhead or bylined articles from a recognized
news organization. Press passes will only be issued to journalists
representing the editorial staff of print, broadcast or internet media.
Journalists must display their press passes at all times while attending
the meeting for covering meeting-sponsored events.
The AAAAI does not issue press passes to: a publications advertising,
marketing, public relations or sales representatives; publishers,
editors or reporters from manufacturers house organs or promotional
publications, public relations staff of exhibitors or educational
institutions; writers creating analyses or reports sold as a commodity
to customers; or other individuals who are not actually reporting on the
meeting or specific media outlet. Exhibitors may not register as press.
Recording of Sessions
Many of the scientific sessions will be audio recorded and available
for purchase on site, after the meeting or by download as a part of the
Virtual Annual Meeting. Individual audio and/or video recording of
educational sessions is not permitted.
Registration Desk
Convention Center, Ground Level, Exhibit Hall B
Visit the Registration desk to pick up your name badge, tickets and
registration bag. You can also purchase tickets, register onsite and
receive your CME/CE or Attendance Certificates.
Registration Desk Hours
Thursday, February 27 4:00 to 7:00 pm
Friday, February 28 6:45 am to 5:30 pm
Saturday, March 1 6:45 am to 5:30 pm
Sunday, March 2 6:45 am to 5:30 pm
Monday, March 3 6:45 am to 5:30 pm
Tuesday, March 4 6:45 am to 4:00 pm
Ribbons
Ribbons are available at a kiosk located in the lobby area near
registration.
Ticket Exchange
Tickets to available sessions will be sold at the onsite Registration
desk. Please check the session monitor for available sessions. To
exchange or cancel a session ticket, please bring the ticket to the
onsite Registration desk no less than 30 minutes prior to the start of
the session. Refunds for returned tickets will be mailed from the AAAAI
executive office after the meeting.
Smoking
Smoking is prohibited at all 2014 Annual Meeting sessions and events.
6
Speaker Disclosures
Copies of all speakers disclosure information are available at the
Registration desk, the Member Resource Center and the Speaker
Resource Room.
Speaker Resource Room
Convention Center, Mezzanine Level, Room 17A
All speakers are asked to report to the Speaker Resource Room
immediately upon arrival in San Diego to review or upload their
presentation materials. Computers and technical support are available
for speakers to use in this room as well as a rehearsal area. Individuals
will receive their speaker ribbons in the Speaker Resource Room.
Speaker Resource Room Hours
Thursday, February 27 4:00 to 7:00 pm
Friday, February 28 6:45 am to 5:30 pm
Saturday, March 1 6:45 am to 5:30 pm
Sunday, March 2 6:45 am to 5:30 pm
Monday, March 3 6:45 am to 5:30 pm
Tuesday, March 4 6:45 am to 4:00 pm
Special Dietary Requirements
If items on the daily, pre-arranged menu do not meet your special
dietary requirements (e.g., allergies, kosher) an alternative option
can be made available. Please notify an AAAAI staff member at
the Registration desk to ensure arrangements are made. Special
arrangements require at least 24 hours advance notice. If you are
vegetarian, please inform the server assigned to the room at the
beginning of the session that you would like a vegetarian selection.
Training Stations
Convention Center, Ground Level, Exhibit Hall B
Saturday, March 1, 10:00 am to 12:00 pm
Epinephrine Auto-Injector Training
The Anaphylaxis Education Subcommittee will offer training in the
use of epinephrine auto-injectors at the Annual Meeting. This is an
outstanding opportunity to Practice on a Live One. Participation in the
session will be available on a first-come, first-served basis.
Virtual Annual Meeting
Purchase the 2014 Virtual Annual Meeting at the booth located in the
lobby near the Memberh Resource Center. The Virtual Annual Meeting
is available on Data DVD and online. It includes presentation slides
along with video and audio for the plenary and keynote sessions,
presentation slides synchronized with the audio recordings for selected
courses, symposia, interest section forums, workshops, pro/con
debates and allied health sessions. Sessions included in the Virtual
Annual Meeting are indicated with a icon in this program.
Wi-Fi
Complimentary Wi-Fi access is available throughout the San Diego
Convention Center and the Marriott Marquis.
Sponsored by Teva Respiratory.
 Business and Committee
Meetings
AAAAI Business Meeting
Monday, March 3, 12:30 to 1:30 pm
Convention Center, Upper Level, Ballroom 6A
All AAAAI Fellows and members should attend the annual Business
Meeting. Box lunches will be provided. No fee. No pre-registration
required.
Allied Health Professional Assembly Forum
Saturday, March 1, 12:30 to 1:30 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 6
All AAAAI allied health professionals should attend this forum. Box
lunches will be provided. No fee. No pre-registration required.
Allied Health Wine & Cheese Reception
Friday, February 28, 5:15 to 6:15 pm
Marriott South Tower, Level 4, La Costa
All allied health members and their guests are invited to attend. No fee.
No pre-registration required.
Interest Section Forums
Sunday, March 2, 12:30 to 2:30 pm
AAAAI Fellows and members, as well as other delegates, are invited
to attend an Interest Section Forum. Each interest section of the AAAAI
will host a separate forum. Fellows and members may designate their
interest section affiliation, while non-members may inquire about
AAAAI membership opportunities. Continuing education credits are
available for these activities. See page 59 for more information.
International Reception
Friday, February 28, 5:00 to 6:00 pm
Convention Center, Upper Level, Ballroom 6CF
The AAAAI invites all international members and delegates to attend
this reception. No fee. No pre-registration required.
Program Directors Assembly Business Meeting
Friday, February 28, 2:00 to 4:00 pm
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
All Training Program Directors and Co-Directors are invited to attend
this business meeting. No fee. No pre-registration required.
2014 Federation of RSLAAIS Assembly Forum and
Business Meeting
Friday, February 28, 4:45 to 6:30 pm
Convention Center, Upper Level, Room 31AB
The Federation of Regional, State and Local Allergy, Asthma and
Immunology Societies Assembly invites all AAAAI members and
delegates to attend this meeting. No fee. No pre-registration required.
8
Assembly/Board/Division Committee Meetings
If you are a current member of an assembly, Board or division
committee, please plan to attend your committee meeting. Committee
meetings are open to current AAAAI members only. All members of
these committees must be named by the AAAAI President-Elect. If you
are an AAAAI member and you are interested in becoming a member of
any of these committees, please contact the AAAAI executive office at
(414) 272-6071 or info@aaaai.org.
A/I Division Directors Committee
Saturday, March 1, 7:00 to 8:00 am
Marriott North Tower, Lobby Level, Presidio Room 1
Advocacy Committee
Saturday, March 1, 3:00 to 4:00 pm
Marriott South Tower, Level 4, La Mesa
Allied Health Education Committee
Sunday, March 2, 1:45 to 3:00 pm
Marriott South Tower, Level 1, Santa Rosa
Allied Health Professionals Assembly Leadership Team Meeting
Monday, March 3, 7:00 to 8:00 am
Marriott South Tower, Level 4, La Jolla
Annual Meeting Awards Committee
Friday, February 28, 5:15 to 6:15 pm
Marriott South Tower, Level 3, Palomar Room
Annual Meeting Program Subcommittee
Tuesday, March 4, 10:00 am to 12:00 pm
Convention Center, Mezzanine Level, Room 18
Core Curriculum, Education and Residency Review Subcommittee
Friday, February 28, 4:30 to 5:30 pm
Marriott South Tower, Level 3, Carlsbad
Credentials Committee
Monday, March 3, 7:00 to 8:00 am
Convention Center, Mezzanine Level, Room 18
Ethics/Conflict of Interest Committee
Friday, February 28, 5:00 to 6:00 pm
Marriott South Tower, Level 3, Conference Suite 2
Fellows-in-Training Committee
Saturday, March 1, 7:00 to 8:00 am
Marriott North Tower, Lower Level, Rancho Santa Fe 1 and 2
Grant Review Committee
Monday, March 3, 7:00 to 8:00 am
Marriott South Tower, Level 3, Carlsbad
In-Training Exam Committee
Friday, February 28, 11:30 am to 1:30 pm
Marriott South Tower, Level 3, Miramar Room
Joint Meeting of the Interest Section Coordinating Committee and
the Practice, Diagnostics and Therapeutics Committee
Sunday, March 2, 6:45 to 8:00 am
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
 Business and Committee
Meetings
Joint Task Force for Quality Performance Measures Aerobiology Committee
Saturday, March 1, 7:00 to 8:00 am Sunday, March 2, 7:00 to 8:00 am
Marriott South Tower, Level 3, Conference Suite 1 Marriott North Tower, Lobby Level, Rancho Santa Fe 3
Leadership Institute Working Group Allergic Fungal Respiratory Diseases Committee
Saturday, March 1, 2:00 to 3:00 pm Sunday, March 2, 7:00 to 8:00 am
Marriott South Tower, Level 4, La Jolla Marriott South Tower, Level 3, Conference Suite 1
Needs Assessment and Outcomes Subcommittee Allergic Skin Diseases Committee
Monday, March 3, 7:00 to 8:00 am Saturday, March 1, 7:00 to 8:00 am
Marriott South Tower, Level 4, La Mesa Marriott North Tower, Lobby Level, New York and Orlando
New Allergist/Immunologist Assembly Leadership Meeting Altered Immune Response Committee
Sunday, March 2, 7:00 to 8:00 am Saturday, March 1, 12:30 to 1:30 pm
Marriott South Tower, Level 3, Carlsbad Marriott North Tower, Lobby Level, Rancho Santa Fe 3
Plenary Subcommittee Anaphylaxis Committee Meeting
Monday, March 3, 5:00 to 7:00 pm Sunday, March 2, 7:00 to 8:00 am
Marriott North Tower, Lobby Level, Torrey Pines 1 and 2 Marriott North Tower, Lobby Level, Marriott Hall Salon 5
Practice Improvement Subcommittee Asthma and Allergic Diseases in the Elderly Committee
Saturday, March 1, 12:30 to 1:30 pm Sunday, March 2, 7:00 to 8:00 am
Marriott South Tower, Level 4, La Mesa Marriott South Tower, Level 4, Malibu
Practice Management Committee Asthma Diagnosis, Assessment and Treatment Committee
Sunday, March 2, 3:00 to 4:00 pm Saturday, March 1, 12:30 to 1:30 pm
Marriott South Tower, Level 1, Point Loma Marriott North Tower, Lower Level, Marriott Hall Salon 3
Program Directors Assembly Executive Committee Cells and Mediators of Allergic Inflammation Committee
Friday, February 28, 12:30 to 1:30 pm Saturday, March 1, 12:30 to 1:30 pm
Marriott South Tower, Level 3, Cardiff Marriott North Tower, Lobby Level, Marriott Hall Salon 4
Seminar Workgroup Committee on the Underserved
Saturday, March 1, 7:00 to 8:00 am Saturday, March 1, 12:30 to 1:30 pm
Marriott North Tower, Lobby Level, Rancho Santa Fe 3 Marriott North Tower, Lobby Level, San Diego Ballroom Salon C
VAMPSS Investigative Team Wine & Cheese Reception Complementary and Alternative Practices in Allergy Committee
Saturday, March 1, 6:00 to 7:00 pm (After workshop 2804.) Meeting
Convention Center, Upper Level, 11AB Saturday, March 1, 9:45 to 10:45 am
Veterans Health Administration Allergists Committee Marriott North Tower, Lobby Level, Rancho Santa Fe 1
Monday, March 3, 7:00 to 8:00 am Environmental Exposure and Respiratory Health Committee
Marriott North Tower, Lobby Level, Torrey Pines 3 Saturday, March 1, 12:00 to 1:30 pm
Marriott North Tower, Lower Level, Presidio Rooms 1 and 2
Interest Section Committee Meetings Eosinophilic Gastrointestinal Disorders Committee
Committee meetings are held during the Annual Meeting for the
Sunday, March 2, 7:00 to 8:00 am
purpose of conducting AAAAI related business. If you are a current
member of an interest section committee, please plan to attend Marriott North Tower, Lobby Level, Marriott Hall Salon 1
your committee meeting. If you are an AAAAI member and you are Genetics, Molecular Biology and Epidemiology Committee
interested in joining an interest section committee, please attend the Saturday, March 1, 12:30 to 1:30 pm
meeting and notify the chair that you are interested in joining. For more Marriott South Tower, Level 4, Malibu
information on AAAAI committees, please contact the AAAAI executive
Health Informatics, Technology and Education Committee
office at (414) 272-6071 or info@aaaai.org.
Saturday, March 1, 12:30 to 1:30 pm
Adverse Reactions to Drugs, Biologicals and Latex Marriott North Tower, Lobby Level, New York and Orlando
Sunday, March 2, 7:00 to 8:00 am
Immunotherapy, Allergen Standardization and Allergy Diagnostics
Marriott North Tower, Lobby Level, Torrey Pines 3
Committee
Adverse Reactions to Foods Committee Saturday, March 1, 6:30 to 8:00 am
Saturday, March 1, 6:30 to 8:00 am Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
Marriott North Tower, Lobby Level, Marriott Hall Salon 6

9
 Other Meetings and Events
Interest Section Committee Meetings - continued
Infections and Asthma Committee
Monday, March 3, 7:00 to 8:00 am
Marriott North Tower, Lobby Level, Anaheim
Mast Cell Disorders Committee
Saturday, March 1, 7:00 to 8:00 am
Marriott North Tower, Lobby Level, San Diego Ballroom Salon C
Occupational Diseases Committee
Sunday, March 2, 7:00 to 8:00 am
Marriott South Tower, Level 4, La Jolla
Primary Immunodeficiency Disease Committee
Sunday, March 2, 2:45 to 4:00 pm
Marriott North Tower, Lobby Level, San Diego Ballroom Salon B
Quality, Adherence and Outcomes Committee
Monday, March 3, 7:00 to 8:00 am
Marriott North Tower, Lobby Level, Torrey Pines 1 and 2
Rhinitis, Rhinosinusitis and Ocular allergy Committee Meeting
Monday, March 3, 7:00 to 8:00 am
Marriott North Tower, Lobby Level, San Diego Ballroom Salon C
Sports Medicine Committee
Saturday, March 1, 7:00 to 8:00 am
Marriott South Tower, Level 4, Malibu
Vaccines and Biological Threats Committee
Friday, February 28, 5:15 to 6:15 pm
Marriott South Tower, Level 3, Del Mar
Other AAAAI Meetings
JACI Editorial Board Meeting
Saturday, March 1, 6:15 to 7:45 am
Marriott North Tower, Lobby Level, Marriott Hall Salon 5
JACI Associate Editors Meeting
Tuesday, March 4, 6:00 to 8:00 am
Marriott South Tower, Level 3, Del Mar
JACI In Practice Editorial Board Meeting
Monday, March 3, 7:00 to 8:00 am
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
JACI International Advisory Board
Sunday, March 2, 6:45 to 8:00 am
Marriott South Tower, Level 4, Dana Point
JACI Journal Reviewer Workshop
Monday, March 3, 4:45 to 6:00 pm
Marriot North, Lobby Level, Marriott Hall Salon 2
Lay Organization Breakfast
Monday, March 3, 7:30 to 9:00 am
Marriott North Tower, Lobby Level, Rancho Santa Fe 1-3
National Allergy Bureau (NAB) Counters
Friday, February 28, 5:15 to 6:15 pm
Marriott South Tower, Level 4, Malibu
10
RSLAAIS Assembly Governors Meeting
Sunday, March 2, 11:45 am to 1:00 pm
Marriott North Tower, Lobby Level, Rancho Santa Fe 3
Other Meetings and Events
Allergists for Israel Kiddush Reception
Friday, February 28, 6:00 to 11:00 pm
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
American Association of Allergists & Immunologists of Indian
Origin
Friday, February 28, 6:00 to 9:30 pm
Marriott South Tower, Level 3, Marina Ballroom D
Annual Business Meeting of NYSSAAI
Friday, February 28, 3:15 to 4:30 pm
Convention Center, Mezzanine Level, Room 18
Dessert Reception
This program is not sponsored or programmed by the AAAAI.
Advances in Aerosol Therapy for Patients with Allergic Rhinitis
Sunday, March 2, 8:30 to 10:30 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 3
Sponsored by Teva Respiratory.
Join us for the Advances in Aerosol Therapy for Patients with Allergic
Rhinitis program, sponsored by Teva Respiratory. This interactive
presentation will explore an aerosolized therapy alternative for the
treatment of allergic rhinitis. Complimentary beer, wine, desserts
and coffee will be served, and a $50 donation will be made to the
ARTrust for each attendee that participates in the program.
INDANA Committee Meeting
Friday, February 28, 3:00 to 5:30 pm
Marriott South Tower, Level 3, Conference Suite 1
International Asthma Services Authors Reception
Friday, February 28, 5:00 to 6:00 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 6
Joint Council of Allergy, Asthma & Immunology Board of Directors
Meeting
Sunday, March 2, 7:30 am to 12:00 pm
Marriott North Tower, Lobby Level, Presidio 1 & 2
National Jewish Health Faculty and Fellows Reception
Sunday, March 2, 9:00 to 11:00 pm
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
VAMPSS Wine & Cheese Reception
Saturday, March 1 (directly following workshop)
Convention Center, Upper Level, 11AB
 Other Meetings and Events
Non-CME Educational Program
This program is not sponsored or programmed by the AAAAI.
Advances in Aerosol Therapy for Patients with Asthma or Allergic
Rhinitis
Friday, February 28, 6:30 to 8:30 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 1 & 2
Sponsored by Teva Respiratory, LLC.
Phil Lieberman, MD
Ketan Sheth, MD, MBA
William S. Silvers, MD
Steven F. Weinstein, MD
This presentation will highlight the latest studies for patients with
asthma and exercise-induced bronchospasm (EIB). Recent studies
evaluating persistent asthma and how uncontrolled persistent asthma
is often associated with small airway dysfunction will be discussed.
Additionally, recent studies about therapies for patients with asthma,
COPD, and EIB will be discussed. The presentation will then explore
additional information about allergic rhinitis.
Non-CME Educational Program
This program is not sponsored or programmed by the AAAAI.
Treatment for Primary Immunodeficiency (PID): Considerations for
Optimizing Immunoglobulin Replacement
Friday, February 28, 6:30 to 8:30 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 4
Sponsored by Baxter Healthcare Corporation.
Vincent Bonagura, MD
Elena E. Perez, MD
Richard L. Wasserman, MD, PhD (Chair)
This complimentary dinner program will describe the evolution of
current intravenous and subcutaneous immunoglobulin (IgG) treatment
options. The impact of IgG dose and pharmacokinetic parameters such
as trough level and bioavailability on intravenous and subcutaneous
treatment will also be discussed. A case study describing the treatment
of primary immunodeficiency (PID) over the course of a patients life
will illustrate how changing circumstances and treatment options
can affect patients with PID. Overall, this program is designed to
give physicians a practical view of the key attributes that should be
considered when optimizing IgG replacement.
Non-CME Educational Program
This program is not sponsored or programmed by the AAAAI.
Evaluating a Treatment Option for Asthma
Friday, February 28, 8:30 to 10:30 pm
Marriott North Tower, Lobby Level, San Diego Ballroom Salon B
Sponsored by Meda Pharmaceuticals.
Todd Mahr, MD
It is well recognized that poorly controlled asthma remains an
important condition which requires a precise course of therapy.
During this Product Theater, Dr. Todd Mahr, MD, Pediatric Allergy &
Immunology, Gundersen Lutheran Health Systems in La Crosse, WI, will
discuss a treatment option for pediatric and adult patients with asthma.
Non-CME Educational Program
This program is not sponsored or programmed by the AAAAI.
The Clinical Utility of Peanut & Tree Nut Allergen Component
Testing
Sunday, March 2, 6:30 to 8:30 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 4
Sponsored by Thermo Fisher Scientific.
Prof. Dr. med. Barbara Ballmer-Weber
Robert G. Hamilton, PhD, D.ABMLI
Anna Nowak-Wegrzyn, MD
Explore clinical and research applications of peanut and tree nut
allergen component diagnostic testing by leading Allergists during a
non-CME dinner symposium.
Non-CME Educational Program
This program is not sponsored or programmed by the AAAAI.
Targeting IgE in the Management of Allergic Asthma
Sunday, March 2, 6:30 to 8:30 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 5 & 6
Sponsored by Genentech, Inc. and Novartis Pharmaceuticals
Corporation.
Jonathan Corren, MD
Genentech and Novartis will be hosting a non-CME product theater
program on Sunday March 2 in the Marriott Hall Salon 5 and 6. This
program will be presented by Dr. Jonathan Corren and it will feature a
presentation on Targeting IgE in the Management of Allergic Asthma.
Non-CME Educational Program
This program is not sponsored or programmed by the AAAAI.
The Latest Information in Therapy for Asthma, COPD, and Exercise-
Induced Bronchospasm
Monday, March 3, 6:30 to 8:30 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 5 & 6
Sponsored by Teva Respiratory, LLC.
John M. Weiler, MD, MBA
Nancy K. Ostrom, MD, CPI
Christopher Randolph, MD
William W. Storms, MD
This presentation will highlight the latest information in therapy for
patients with asthma, COPD, and exercise-induced bronchospasm (EIB).
The under-recognition and under-treatment of EIB in America will be
reviewed. The presentation will then explore recent evidence about
patients knowledge and tracking of medication in inhalers with a built-
in dose counter.
11
 WISC 2014
WAO International Scientific Conference 2014 and the
XLI Annual Meeting of the Brazilian Association of Allergy and Immunology (ASBAI)
Advancing the borders of allergy: From treatment to prevention by targeting the
environment, infections and the susceptible patient

Rio de Janeiro,
Brazil
WAO-0114-096

6-9 December 2014

www.worldallergy.org/wisc2014

A meeting of in collaboration with

12
 ARTrust Activities

The Allergy, Asthma & Immunology Education and Research

Organization Inc. (ARTrust) is proud to present:
Second Annual 2014 ARTrust 5K Run/Walk: Light
Up the Night!
Sunday, March 2, 2014
San Diego Embarcadero
Onsite Registration: 5:00 pm
The Allergy, Asthma & Immunology Education and Research Organization Warm-up: 5:15 pm
Inc. (ARTrust) is proud to present: Race Start: 5:30 pm
2014 ARTrust Benefit The 2014 ARTrust 5K Run/Walk is sponsored by Teva Respiratory.
A First Class Event: Admission by registration only.
The Skys the Limit!
The first annual ARTrust Race for Allergy & Asthma Research 5K Run/
A Benefit supporting the Allergy, Asthma & Immunology

Saturday, March 1, 2014

Education and Research Organization, Inc. (ARTrustTM)

San Diego Air & Space Museum

Walk was a success. Now we need your help to Light Up the Night
Saturday, March 1, 2014 7:00 pM 10:00 pM

For more information, please visit the ARTrust booth near Registration.
7:00 to 10:00 pm
A Benefit supporting the Allergy, Asthma & Immunology San Diego Air & Space Museum and make the second ARTrust 5K Run/Walk even bigger, as we join
together to bring awareness and raise money to support allergy, asthma
Education and Research Organization, Inc. (ARTrustTM)
ARTrust-0913-406

San Diego Air & Space Museum

Admission by ticket only. Cocktail attire.

Saturday, March 1, 2014 7:00 pM 10:00 pM

For more information, please visit the ARTrust booth near Registration.
& immunology education and research.
Tickets available at the ARTrust booth or at the event.
Serious runners, casual runners, walkers, families and the general public
ARTrust-0913-406

The Skys the Limit at this years ARTrust Benefit event! Mark your
calendar for this themed event benefiting the ARTrust at the San Diego
Air & Space Museum.
Enjoy an adventurous evening exploring aviation and the history of
flight. Try on your own set of wings in the flight simulators, indulge
in fine dining and cocktails, and enjoy live entertainment. Join your
friends and colleagues for an exciting evening and help raise funds
for the ARTrust, which supports funding for allergy, asthma and
immunology education and research.
Doors open at 7:00 pm at the San Diego Air & Space Museum. The
event runs until 10:00 pm. Transportation will be provided to and from
the Marriott Marquis & Marina. For addtional details please visit the
ARTrust booth.
Ticket Information:
are all welcome to participate in this glowing event where runners and
walkers of all ages will loop through the twinkling lights of the San Diego
Embarcadero.
All runners/walkers will receive a race shirt in their registration packet.
Packet pick-up and registration will be available at the ARTrust booth
(Thursday through Sunday) on the Street Level of the San Diego
Convention Center. You may also register onsite Sunday prior to the run.
Onsite registration for the 5K Run/Walk is $35. Children under 12 can be
registered for free with the option to purchase a race shirt for $10.
Friends of the President

und
Patron Table (10 seats): $3,000
Patron Individual: $300
Allied Health/NAIA Individual: $125
Student Individual: $100
Industry Table (10 seats): $12,000
Your donation of $100 or more in support of the
Ticket price, less cost of good and services, may be tax deductible.
Ribbons
Friends of the President Fund
entitles you to wear a Friend of the President
Friend of the President Ribbon at the 2014 Annual Meeting.
Show your support of the current AAAAI President, Linda Cox, MD
FAAAAI, with a $100 donation to the ARTrust. With your contribution This ribbon symbolizes your contribution to increased funding
you will receive a special ribbon to wear throughout the meeting to for education and research in allergy/immunology and honors
demonstrate your support. AAAAI President, Linda Cox, MD, FAAAAI.

NAIA Supports ARTrust

Show the New Allergist/Immunologist Assemblys support of the
ARTrust with a $50 donation.
Pick up or purchase ribbons at the ARTrust Booth near registration.
Purchase or pick up your ribbon at the ARTrust booth near registration.
ARTrust-0114-620

13
 A Benefit supporting the Allergy, Asthma & Immunology
Education and Research Organization, Inc. (ARTrustTM)

San Diego Air & Space Museum

Saturday, March 1, 2014 7:00 pM 10:00 pM

For more information, please visit the ARTrust booth near Registration.
RTrust-0913-406
 Associate & Guest Activities

Associates (Spouses & Friends) to the AAAAI Hospitality Suite

Since 1982, the Associates (Spouses & Friends) to the AAAAI have
provided social events and networking opportunities for the spouses
and friends of the AAAAI.
Full membership in the Associates to the AAAAI is included in each
spouse/guest registration fee. Membership includes volunteer
opportunities, newsletters, a chance to participate in future
programming for the Associates and a networking membership
directory on the AAAAI website.
Associates Breakfast and Business Meeting
Saturday, March 1, 9:00 to 11:00 am
Marriott North Tower, Lobby Level, San Diego Ballroom Salon C
Pre-registration and ticket required.
The Board of Directors of the Associates would like to invite you to
begin your Annual Meeting experience by joining us for the celebration
of the Associates at the San Diego Marriott Marquis & Marina. This
breakfast event is open to registered guests only. For guests interested
in bringing a child under the age of 17, pre-registration and ticket is
required; children under the age of six are complimentary.
Marriott South Tower, Level 1, Laguna Room
Make sure you visit the Hospitality Suite, which is open Friday,
February 28 to Sunday, March 2 from 8:00 am to 1:00 pm and Monday,
March 3 from 8:00 am to 12:00 pm. A host will be on-hand to assist
with restaurant recommendations and to make reservations. Stop by,
have a cup of coffee and learn how you can get involved!
I Support Asthma Camps Fund Drive
The Associates are proud to announce their annual fund drive to
benefit camperships for those children and young adults suffering with
asthma.
Monetary donations (Cash/Check only) will be accepted at both the
Hospitality Suite and the Associates Breakfast Program. Those who
donate will receive an Associates I Support Asthma Camps ribbon to
proudly display on your name badge.
Please consider helping the Associates make the dreams of attending
camp come true!

Associates Committee Meetings

2013-2014 Associates Board of Directors Meeting
Friday, February 28, 1:30 to 2:30 pm Attend the 2014 AAAAI
Annual
Marriott South Tower, Level 1, Laguna Room
2014-2015 Associates Board of Directors Meeting
Sunday, March 2, 10:00 to 11:30 am
Marriott South Tower, Level 1, Laguna Room Business
Meeting AAAAI-0112-176

to include the induction of all

new Fellows and members
Monday, March 3
12:30 to 1:30 pm
Convention Center, Upper Level,
Ballroom 6

16
 Lectureships

Annual Meeting Lectureships

For nearly five decades, members of the American Academy of Allergy, Asthma & Immunology have honored outstanding individuals who have
contributed to this field as leaders and teachers by the establishment of Annual Meeting lectureships. The Annual Meeting Program Committee is
pleased to announce the lectureships and lectureship speakers for the 2014 AAAAI Annual Meeting. Biographies and photographs are available at
annualmeeting.aaaai.org.
The Rebecca Buckley Lectureship: 3rd year The Elliott Middleton Memorial Lectureship: 13th year
Lecturer: Kathleen Sullivan, MD PhD FAAAAI Lecturer: Cezmi Akdis, MD FAAAAI
Award presentation at Symposium Session 2303: The Expanding Award presentation at Plenary Session 2101: Immunotherapy:
Universe of Primary Immunodeficiency on Saturday, March 1, 10:45 am Mechanism, Outcomes and Markers on Saturday, March 1, 8:15 to
to 12:00 pm 9:45 am

The Robert A. Cooke Memorial Lectureship: 52nd year
Lecturer: Donna Davies, BSc PhD
Award presentation at Plenary Session 3101: Integrated Airways on
Sunday, March 2, 8:15 to 9:45 am
The Jerry Dolovich Memorial Lectureship: 16th year
Lecturer: Fernando Martinez, MD
Award presentation at Symposium Session 3304: Wheezing Episodes
in Preschool Children: The Role of Bacterial Pathogens, Treatment of
Acute Exacerbations and Potential for Asthma Prevention on Sunday,
March 2, 10:45 am to 12:00 pm
The Elliot F. Ellis Lectureship: 16 year
th
Lecturer: Mitchell Grayson, MD FAAAAI
Award presentation at Symposium Session 3306: The Relationship
Between Allergies and Infections on Sunday, March 2, 10:45 am to
12:00 pm
The Harold S. Nelson Lectureship: 14th year
Lecturer: Linda Cox, MD FAAAAI
Award presentation at Plenary Session 2101: Immunotherapy:
Mechanism, Outcomes and Markers on Saturday, March 1, 8:15 to
9:45 am
The John E. Salvaggio Memorial Lectureship: 13th year
Lecturer: Jill Poole, MD FAAAAI
Award presentation at Plenary Session 5101: Bioaerosols: When Not to
Take a Deep Breath at Work on Tuesday, March 4, 8:15 to 9:45 am
The Gail G. Shapiro Memorial Lectureship: 8th year
Lecturer: Monica Kraft, MD
Award presentation at Symposium Session 4303: Treatment
Alternatives for Refractory Severe Asthma on Monday, March 3, 10:45
am to 12:00 pm
The Burton Zweiman Memorial Lectureship: 14th year
Lecturer: John Kelso, MD FAAAAI
Award presentation at Symposium Session 4306: Immunosenescence:
Implications of an Aging Immune System on Monday, March 3, 10:45
am to 12:00 pm

ARTrustTM: Investing Together in Our Future Lectureships

Investing Together in Our Future Lectureships are established to recognize substantial contributions of at least $100,000 to the ARTrust through
collaborative contributions of others or individual contributions honoring an individual or entity. The ARTrust Leadership is proud to announce the
lectureships and lectureship speakers for the 2014 AAAAI Annual Meeting. Biographies and photographs are available at annualmeeting.aaaai.org.

ARTrust and Dr. William and Judith H. Busse Lectureship:
Investing Together in Our Future: Inaugural Year
Lecturer: Michael Wechsler, MD
Award presentation at symposia session 2304: NHLBIs Clinical Asthma
Research Networks (AsthmaNet) Approach to Key Asthma Questions
on Saturday, March 1, 10:45 am to 12:00 pm
ARTrustTM and Stephen D. Lockey, Jr., MD Lecture: Investing
Together in Our Future: 2nd year
Lecturer: Thomas B. Casale, MD FAAAAI
Award Presentation at Symposium Session 3302: Pathophysiology and
Management of Urticaria and Angioedema on Sunday, March 2, 10:45
am to 12:00 pm

ARTrustTM and Donald Y.M. Leung, MD PhD FAAAAI-JACI
Lecture: Investing Together in Our Future: 2nd year
Lecturer: Nives Zimmermann, MD FAAAAI
Award Presentation at Symposium Session 4307: Wanted: Eosinophils,
Dead or Alive? Eosinophil Cell Death Subroutines and Implications for
Eosinophil-Targeted Therapy on Monday, March 3, 10:45 am to 12:00 pm
ARTrustTM and Anjuli Seth Nayak, MD FAAAAI Lecture:
Investing Together in Our Future: 2nd year
Lecturer: Luz S. Fonacier, MD FAAAAI
Award Presentation at Symposium Session 3303: Update of the Allergic
Contact Dermatitis Practice Parameter: What's New in 2014? on
Sunday, March 2, 10:45 am to 12:00 pm

17
 Awards
AAAAI Allied Health $750 Travel
Award Recipients
Alcina Lidder, BA
Northwestern University
Chicago, IL
Jaime Ross
Icahn School of Medicine at Mount Sinai
New York, NY
Shannon Seopaul
Johns Hopkins University
Baltimore, MD
2014 Bernard B. Siegel
Memorial Abstract Award
Vered Schichter-Konfino, MD
Haifa, Israel
American Academy of
Pediatrics (AAP) Section on
Allergy and Immunology
Outstanding Pediatric Abstract
Award Recipients
Jacob Daniel Kattan, MD
Icahn School of Medicine at Mount Sinai
Lisa M. Bartnikas, MD
Harvard Medical School
Caroline Y. Kuo
David Geffen School of Medicine at UCLA
Kiran P. Patel, MD MS
University of California, San Francisco
Julia A. Cronin, MD
University of Virginia Allergy, Asthma and Sinus Center
18
AAAAI Interest Section Fellow- 2014 AAAAI Allied Health
in-Training (FIT) Abstract Award Professional Assembly
Recipients Scholarship Travel Award
ADT Recipients
Brian D. Modena, MD Diane Giselle Ananos, RN
University of Pittsburgh Medical Center Mount Sinai Medical Center
BCI New York, NY
Caroline Y. Kuo, MD Helena Azzi, DNP FNP-BC AE-C
David Geffen School of Medicine at UCLA Advance Allergy Asthma Sinus Care
EORD Jupiter, FL
Juan-Carlos Cardet, MD Raquel Z Durban, MS, RD, LDN
Brigham and Womens Hospital Asthma & Allergy Specialists, PA
Charlotte, North Carolina
FADDA
Jessica Rajan, MD Angela Rene Hague, PA-C
Scripps Medical Group DallasAllergyImmunology
Dallas, TX
HEDQ
Adora Lin, MD PhD Edward M Horowitz, BA
Johns Hopkins University, Johns Hopkins
National Institute of Allergy and Infectious
Diseases Asthma and Allergy Center
Baltimore, MD
IRSOC
Margaret J. McCormick, MS RN
Mahboobeh Mahdavinia, MD PhD
Northwestern University Feinberg School of Towson University
Medicine Baltimore, MD
Karen Lynn Meyerson, MSN, APRN, FNP-C,
MAAI
Christina Christianson, PhD AE-C
National Jewish Health Asthma Network of West Michigan
Grand Rapids, MI
Julie A. Kuhn, MSW
APFED Best Oral Abstract Sinai Urban Health Institute
Chicago, IL
on EGIDs
Laura E. Odom, MSN FNP
Member
Paneez Khoury, MD
Knoxville, TN
NIH/NIAID Fallon Schultz, MSW, LCSW, CAM
International Association for Food Protein
Fellow in Training Enterocolitis (IAFFPE)
Jessica Rajan, MD Howell, NJ
Scripps Clinic
Anna Chikovani Sprunger, PA-C
Childrens National Medical Center
Washington, DC
 Awards

2014 International Travel Scholarship Recipients

The following international in-training members have been awarded International Travel Scholarships to attend the Annual Meeting. The 2014
International Travel Scholarships are funded by the AAAAI and selected by an ad hoc panel of International Fellows.

Africa/Middle East Europe South America

Itay Moshkovits, MD Guy Scadding, MD Lucila Camargo Lopes de Oliveira, MD
Tel-Aviv University Imperial College London Federal University of So Paulo
Maresa Botha, MD Pedro Ayuso, MD Fernanda Patini Furlan, MD
University of Cape Town Hospital Infanta Leonor Federal University of So Paulo
Australia Adriana Ariza, MD Kaddy Juliana Beltran Sierra, MD
Eliska Furlong, MD Hospital Regional Universitario de Malaga - Universidad de Antioquia
Princess Margaret Hospital for Children IBIMA
South Asia
Massimo Caruso, MD Komal Agrawal, MD
East Asia University of Catania
Zhihong Chen, MD Institute of Genomics and Integrative Biology
Zhongshan Hospital EAACI FIT Representatives (CSIR-IGIB)

Song-I Yang, MD Mariana Couto, MD PhD Nunthana Siripipattan, MD

Asan Medical Center University of Porto Mahidol University

Atsushi Yamashita, MD Marco Caminati, MD Suparat Sirivimonpan, MD

Institute for Clinical Research, Mie National
Hospital
Verona University Hospital
Mexico
Idalia Vanessa Yanez-Perez, MD
Regional Center of Allergy and Clinical
Immunology, University Hospital
Lorena Rangel, MD
Hospital Universitario, Universidad Autnoma
de Nuevo Len
King Chulalongkorn Memorial Hospital
Wantida Chuenjit, MD
Prince of Songkla University
Anyarat Wanitchakorn, MD
Ramathibodi Hospital, Mahidol University

2014 International Young Investigator Award Recipients

The following young investigators have been awarded International Young Investigator Awards to attend the Annual Meeting. The 2014
International Young Investigator Awards are funded by the AAAAI and selected by an ad hoc panel of International Fellows.
Asia and Pacific Basin Middle East/Africa Latin America
Ji-Won Kwon, MD Mona Hedayat, MD Otavio Marques, MSc, PhD
Seoul National University Bundang Hospital Tehran University of Medical Sciences University of So Paulo
Mentor: Soo-Jong Hong, MD FAAAAI Boston Childrens Hospital, Harvard Medical Mentor: Antonio Condino-Neto, MD PhD
Europe/Commonwealth of Independent School
States Mentor: Nima Rezaei, MD PhD *2013 recipient unable to attend 2013 Annual
Oscar Palomares, PhD Middle East/Africa Meeting.
Complutense University of Madrid Nima Rezaei, MD PhD*
Mentor: Cezmi Akdis, MD FAAAAI Tehran University of Medical Sciences
Mentor: Professor Asghar Aghamohammadi

19
 Awards

2014 FIT Travel Scholarships

The FIT Travel Scholarships for Fellows-In-Training in the United States and Canada allow FIT attendees to supplement their training by attending
the Annual Meeting.
Funded by the AAAAI and in part through grants from Genentech USA, Inc., McNeil Consumer Healthcare, and Sanofi US.
$1,100 Travel Scholarships Manika Girdhar, DO Yong Luo, MD PhD
Jaron Abbott, MD Erica Glancy, MD Jonathan Lyons, MD
Manar Abdalgani, MD Mark Gorelik, MD Solrun Melkorka Maggadottir, MD
Amina Abdeldaim, MD Ritobrata Goswami, PhD Paul Maglione, MD PhD
Colleen Adkins, MD Justin Greiwe, MD Mahboobeh Mahdavinia, MD PhD
Aisha Ahmed, MD Mona Hedayat, MD Rani Maskatia, MD
Stephanie Albin, MD Sandra Ho, MD Ashlei Mathew, MD
Matthew Altman, MD Tetsuya Homma, MD PhD Sara May, MD
Alexander Alvarez, MD Koa Hosoki, MD PhD Emily McGowan, MD
Doerthe Adriana Andreae, MD PhD Brett Hronek, MD Harshna Mehta, MD
Kristyn Anthony, MD Elena Hsieh, MD Javier Mendez, MD
Sara Anvari, MD Chia-Lin Hsu, PhD Ki Milligan, MD
Hiba Bashir, MD Joy Hsu, MD MSCI Jin Young Min, MD PhD
Diana Bayer, DO Joyce Hsu, MD Farheen Mirza, MD
Monica Bhagat, MD Tracy Hwangpo, MD PhD Brian Modena, MD
Mark Biagtan, MD Tammy Jacobs, MD Timothy Moran, MD PhD
Kimberly Blumenthal, MD Amanda Jagdis, MD Megan Morsheimer, MD MPH
Varaz Bozoghlanian, MD David Jara, MD Talal Mousallem, MD
Becky Buelow, MD Devi Jhaveri, DO Adrianne Netterville, MD
Amy CaJacob, MD Qurat Kamili, MD Andrew Nickels, MD
Jennifer Camacho, MD Watcharoot Kanchongkittiphon, MD PhD Sarah Nicolai, MD
Timothy Campbell, MD Lukena Karkhanis, MD Hana Niebur, MD
Juan-Carlos Cardet, MD Eric Karlin, MD Andrew OKeefe, MD
Gang Cheng, MD PhD Anilkumar Katta, MD Eric Oliver, MD
David Chiang, MS Brian Kelly, MD, MA Jennifer Olivier, MD
Niti Chokshi, MD Farah Khan, DO Jonathan Olsen, DO
Kobkul Chotikanatis, MD Dong-Young Kim, MD Andrea Pappalardo, MD
Christina Christianson, PhD Susan Jene Kim, MD Brenda Paquet, MD FRCPC
Amaziah Coleman, MD Erin Klaffky, MD PhD Kiran Patel, MD
Katherine Conner, MD Edward Kleiman Nisha Patel, MD
Gregory Cowan, MD Anastasiya Kleva, MD Reenal Patel, MD
Angelina Crans Yoon, MD Anna Kochin, MD Mary Paul, MD
Julia Cronin, MD Robyn Kreiner, MD Matthieu Picard, MD
Casey Curtis, MD Caroline Kuo, MD Benjamin Prince, MD
Jasmeen Dara, MD Merin Kuruvilla, MD Regan Pyle, DO
Jared Darveaux, MD Nina Lakhani, MD Nashmia Qamar, DO
Beverly Di Giorgi, MD Bruce Lanser, MD Jessica Rajan, MD
Jennifer Diaz, MD Timothy Lax, MD Gita Ram, MD
Tiffany Dy, MD Uyenphuong Le, MD Manish Ramesh, MD PHD
Olajumoke Fadugba, MD Joyce Lee, MD Qura Tul Ain Rashid, MD
Rehan Faridi, PhD Min Lee, MD Whitney Rassbach, MD
Amy Feldman, MD Tricia Lee, MD Anupama Ravi, MD
Matthew Feldman, MD Jinzhu Li, MD PhD Jennifer Regan, MD PhD
Denisa Ferastraoaru, MD Newton Li, MD Karen Robbins, MD
Stacey Galowitz, DO Adora Lin, MD PhD Hector Rodriguez, MD
Rohit Gaurav, PhD Changda Liu, PhD Kelli Rose, MD
Aries Gavino, MD Bradley Locke, DO Frederick Rubner, MD
Moyar Ge Ankmalika Louis, MD Monika Saeedian, MD
Parwinder Gill, MD Margee Louisias, MD Rebecca Saff, MD PhD

20
 Awards

$1,100 Travel Scholarships - continued Adam DeZure, MD Von Ta, MD

Maryam Saifi, MD Nancy Ekeke, MD Matthew Tallar, MD
Carah Santos, MD Charles Feng, MD Charles Thompson, MD PhD
Edan Sarid, MD Charles Filion, MD Bahar Torabi, MD
Nikhila Schroeder, MD Lindsay Finkas, MD Sahana Vishwanath, MD
Nisha Shah, MD Deepthi Gadde, MD Shamim Wadiwalla, MD
Mili Shum, MD Matthew Germinaro, MD Joshua Weitz, MD
Jerome Sigua, MD Asal Gharib, MD Paula Whittington, MD PhD
Jared Silver, MD PhD Malika Gupta, MD Lisa Winterroth, MD
Umesh Singh, MD PhD David Hagin, MD Tiffany Wong, MD
Maria Slack, MD Erin Ham, MD Sharon Yee, MD
Kristin Sokol, MD Corinne Happel, MD Lan Zhou, MD PhD
Collette Spalding, MD Sherwin Hariri, MD
Alison Haynes, MD $650 Travel Scholarships
Robert Sporter, MD
Darren Hirsch, MD Joohee Lee, MD
Ryan Steele, DO
Mark Stevens, MD Kathleen Hise, MD
Whitney Stevens, MD PhD Peter Ho, MD
Patricia Stewart, MD Jillian Hochfelder, MD
Kasey Strothman, MD Junfang Jiao, MD
Qian Sun, PhD Maleewan Kitcharoensakkul, MD
Jessica Tan, MD Fei Li Kuang, MD PhD
Sasipa Tanyaratsrisakul, PhD Catherine Kubiak, MD
Amy OBrian Thomas, MD Christine Lee-Kim, DO
Krista Todoric, MD Kevin Lindgren, MD
Shinji Toki, PhD Stephanie Logsdon, MD
Leticia Tordesillas, PhD Jeanne Lomas, DO
Anubha Tripathi, MD Yuriy Lyubanskyy, MD
Priya Tripathi, PhD Shikha Mane, MD
Yamini Virkud, MD MA David Morris, MD
Hannah Walford, MD Mahta Mortezavi, MD
Brant Ward, MD PhD Ahmad Mourad, MD
Kate Welch, MD Tim Olynych, MD PhD
Aerik Williams, MD Lorena Pereira, MD
Kelli Williams, MD MPH Jennifer Petts, DO
Benjamin Wright, MD Craig Platt, MD PhD
Lakiea Wright, MD Rebecca Pratt, MD
Ting Xu, MD Jaclyn Quirt, MD
Di Xue Juan Ravell, MD
Manisha Relan, MD
$800 Travel Scholarships Caroline Rizk, MD
Rigoberto Acosta, MD Jaime Rosa, MD
Noah Agada, MD Zoe Rosenbaum, MD
Vivek Agarwal, MD Elli Rosenberg, MD PhD
Ashley Altman, DO Alireza Sadegh Nejad, MD PhD
William Anderson, MD Kathryn Samaan, MD
Michael Ansstas, MD Dimple Shah, MD
Ashish Asawa, MD Shaili Shah, MD
Selene Bantz, MD Marissa Shams, MD
Sean Brady, MD Tara Shankar, MD
Kathleen Buchheit, MD Janelle Sher, MD
Vanessa Cavero Chavez, MD Janell Sherr, MD
John Chase, MD Sayantani Sindher, MD
Sheva Chervinskiy, DO Merin Sunny, MD
Andrew Collins, MD Kali Svarczkopf, MD

21
 Continuing Education and
Accreditation
Two types of continuing education credit are available at the 2014
Annual Meeting: AMA PRA Category 1 CME CreditsTM for physicians
and Continuing Education (CE) contact hours for nurses. Not all Annual
Meeting sessions offer credit, and of those that do, not all of them offer
both CME and CE. The types and amount of credit offered for each
session are indicated in the session descriptions beginning on page
XX. Attendance certificates are available to all delegates. Professional
delegates are encouraged to complete the self-report form to receive
their CME/CE or participation certificates. Visit the Registration desk,
complete the self-report form and print your certificate.
If you do not have time to visit the Registration desk before you depart
San Diego, the self-report form will be available online beginning
March 18, 2014 and will be accessible until December 31, 2014 on the
AAAAI website, annualmeeting.aaaai.org.
Physicians Continuing Medical Education (CME)
Credits
Accreditation Statement
The American Academy of Allergy, Asthma & Immunology (AAAAI)
is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
physicians.
Credit Designation
The AAAAI designates this live activity for a maximum of 53.00 AMA
PRA Category 1 Credits. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not
licensed in the U.S. who participate in this CME activity are eligible for
AMA PRA Category 1 Credits.
Target Audience
The Annual Meeting is designed for clinicians, researchers, trainees/
students and allied health professionals involved and/or interested in
the study of allergy, asthma and immunology.
Program Objective
Upon completion of the Annual Meeting, participants should be able to
discuss the latest advances in the research, diagnosis and treatment of
allergic and immunologic disease. Please refer to the individual session
descriptions in this program for session-specific learning objectives.
22
ABAI Continuing Medical Education (CME)
Credits
In 2007 the American Board of Allergy and Immunology (ABAI)
transitioned from a recertification process to a Maintenance of
Certification (MOC) program, which requires board certified physicians
to complete a minimum of 25 AMA PRA Category 1 Credits in
allergy/immunology each year. The educational sessions offered at
the 2014 AAAAI Annual Meeting are linked to the content classification
system used by ABAI to develop its examinations and will help
physicians to meet MOC requirements by enhancing their knowledge
of the specialty for optimal patient care. The Keyword Index on page
186 lists all Annual Meeting sessions by the relevant ABAI topics and
can be used by delegates to tailor their itineraries to meet their needs
when preparing for Certification or Maintenance of Certification. For
more information about Maintenance of Certification, visit the ABAI
website at www.abai.org.
Allied Health Continuing Education (CE) Credits
Nurses Continuing Education (CE) Contact Hours
The American Academy of Allergy, Asthma & Immunology (AAAAI) is
a Provider, approved by the California Board of Registered Nursing,
Provider #10704, for up to 63.50 Contact Hours.
Medical Administrators
Delegates who attend Medical Administrators (MA) sessions at the
2014 Annual Meeting may apply for credit through the American
College of Medical Practice Executives (ACMPE). For additional
information, please contact the Medical Group Management
Association at www.mgma.com.
Advanced Practitioners
The AAPA, ANCC and AANP accept reports of participation in activities
offering AMA PRA Category 1 CreditsTM for continuing education
and credentialing purposes from advanced practitioners. For more
information, please contact the appropriate organization.
Pharmacists
Pharmacists are encouraged to contact their state boards of pharmacy
to determine if reports of participation in the AAAAI Annual Meeting are
accepted for relicensure.
 Continuing Education and
Accreditation
Allied Health Professionals Program Clinical Research (CR) Program
Target Audience Target Audience
Health care professionals who assist with and provide care to persons Physicians, clinical research coordinators, nurses, respiratory
with asthma, allergy and immunologic disease, specifically: RNs, therapists, pharmacists, laboratory research associates, nurse
LPNs, nurse practitioners, physician assistants, respiratory therapists, practitioners, certified medical associates, physician assistants and
medical technologists and medical assistants. other health professionals who are interested in research in clinical,
academic, community, industry or private settings.
Learning Objectives
Upon completion of the Annual Meeting, participants should be able Learning Objectives
to discuss and expand upon the latest advances in medications, Upon completion of the Annual Meeting, participants should be able
equipment and procedures necessary to promote health for their to discuss the various issues in clinical research; Describe diverse
patients; Describe and discuss new therapies, information, patient care aspects of responsible research; Identify new approaches to clinical
and education in the field of allergy, asthma and immunology. Please research which will improve efficiency and effectiveness. Please refer
refer to the individual Allied Health session descriptions in this program to the individual CR session descriptions in this program for session
for session-specific learning objectives. specific learning objectives.

Medical Administrators (MA) Program

Target Audience
Give patients a way to take Administrators, assistants, and office managers directly responsible for
effective office management and development.
your expert advice home
Learning Objectives
Indoor

Healthy Tips
Allergens
A Trusted
The Amer
Reso
Immunologican Academy
urce
Tip
Upon completion of the Annual Meeting, participants should be able to
provide an overview of managed care concepts focusing on local and
of
A Trusted Resource xx Allerg
ic rhinit specialists, y (AAAAI) represAllergy, Asthm

Tip
lungs, throat is symptoms professionalclinical immu ents allergi a &
s and others nologists, allied sts, asthma
Rhinitis The American Academy of Allergy, Asthma &
xx Your
, sinuses, can occur
ears and in the nose, Rhinitis research
and treatm with a specia health Indoor
Immunology (AAAAI) represents
specialists, clinical immunologists, allied
worse.
allergistasthma
allergists,
home, workp
health
can help
you
eyes.
lace or schoo identify things For More
ent of allergi l interest
c diseas
e.
in the Allergens
professionals and others with a special interest in the l that make in your Informatio
xx Allerg
research and treatment of allergic disease. your sympt You depen n
Healthy Tips ens can oms informed d on authoritativ

regional markets; Discuss coding issues and changes; Discuss and

with allergi trigger asthm decisions. e, expert
a sympt
xx There are two forms of rhinitis: allergic and non- For More Informationxx Avoiding c asthma. oms in people Patients
and health
resources
to make
allergic. This distinction is important in order to allergens care profes
You depend on authoritative,effecti expert resources to
ve way that
make
provide the best plan for controlling your symptoms. to treat cause symptoms www.aaasionals alike rely on:
informed decisions. symptoms. is the most
xx The allergic form of rhinitis can be caused by outdoor Feel Bette ai.or g
allergens such as pollen and mold spores. This is Patients and healthcare professionalsr.alike LiverelyBette
on:
referred to as seasonal allergic rhinitis or hay fever.
An allergi
www.aaaai.org st/immunolo r.

develop strategies for dealing with the difficult patient. Please refer
allergist, gist, often
is a pediat referred
xx Allergic rhinitis can also be caused by indoor allergens two additi rician or to
such as dust mites or pets. This is called perennial diagnosis onal years of speciainternist with as an
and
deficiencies treatment lized trainin at least
allergic rhinitis, as symptoms are usually year-round.
and other of allergies, asthmg in the
By visitin immunolog a,
Feel Better. Live Better. g ic diseas immune
accurate the office of an es.
diagn allergist,
An allergist/immunologist, often referred to as an educational osis, a treatm you
information ent plan that can expect an

to the individual MA session descriptions in this program for session-

allergist, is a pediatrician or internist with at least disease works and
and feel to help
better. you manag
two additional years of specialized training in the e your
diagnosis and treatment of allergies, asthma, immune Find an
allergi
deficiencies and other immunologic diseases. www.aaaa st near you at:
i.org
/physref
By visiting the office of an allergist, you can expect an
accurate diagnosis, a treatment plan that works and
educational information to help you manage your

specific learning objectives.

disease and feel better.
Find an allergist near you at:
www.aaaai.org/physref

The conten
only. It ts of this
is brochu
you have not intended to re are for inform
questions replace
allergist/imm or medica evaluation ational purpos
unologist. l concer by es
ns, please a physician. If
AAAAI-101

contact
Allergy

your 2012
Ameri
All rights can Academy
2-572

reserved. of Allergy
May not , Asthm
be duplic a & Immu
Allergy

without ated or nology

The contents of this brochure are for informational purposes permission. appropriated .
AAAAI-1012-572

only. It is not intended to replace evaluation by a physician. If 2012 American Academy of Allergy, Asthma & Immunology.
Allergy

you have questions or medical concerns, please contact your

allergist/immunologist.
All rights reserved. May not be duplicated or appropriated
without permission. A book about asthma for kids.
Allergy

Brochures

Scratchin
g
Surface the
Skin Alle on
Signs rgies
Warning ylaxis
of Anaph
Childrens Books
Skin allerg
but an ies can
allergist/imbe frustrating
has the munologist , An Asthm
exper
which cond tise to diagn
ition you ose Action a
) is
is (an-a
-fi-LAK-sis
ic reac-
provide
relief. have and Plan:
Anaphylax ning allerg
reate anaphy- Eczema
a life-th most common d by
Infants
tion. The ions are cause stings, and peop Helps
lactic react , insect tory of
allerg Your Asthma
le with
a
contr
the long- ol your asthm
to foods more likely ies or asthm his- term a for
allergies ns and latex. to haveAction Plan a are Has zones
scaly
medicatio affect more ally , itchy rash. this red, your symp to help you track
typically and affects Eczema
Symptomspart of the body knees. the face, usu- your asthmtoms and know
Be elbows a is gettin when
than one de: ing or itchinsure to avoid and Expla g worse
may inclu /welts Doing
g the Wellscratch- ins when
rash with hives rash. or go to an to call
red Hives and No coughing, wheezing, emergencythe doctor
GREEN ZONE

Itchy Angioede About Your

ed skin throat Hives are
chest tightness or difficulty room
Flush or tight ma Plan
en that may red, breathing
itchy raise Your
Swoll voice asthma
e breathing be Can work, d areas
play, exercise, per- unique action
Hoars swallowing or lergic react caused by an to your plan
le foods or ion to medi form usual al- activities without Make condition.is
Troub cough
zing or also be
insect bitessymptoms cations, sure your
Whee ess caused Peak . They emer plan inclu
t tightn ng out
triggers by can______ to ______ gency phon
flow des
Ches like heat non-a
ess or passi (80%llergi
to 100%
c of personal best)
Share your e numb
ers.
Dizzin Angioedem or exerc plan with
ting ise. family, friends,
Vomi deep layer a is a swelling teachers
Diarr
hea ping s of the Caution/Getting
in the WorseThen they can or coaches.
ach cram occur s with hives skin
doom and often wheezing, a flare-up. help if
you have
Stom of impending pears on . It Coughing,
g theneyelid typica *This inform
Feelin start withi llytightness
YELLOW ZONE

chest ap- or difficulty ation

typic ally s or mout poses and is for genera
ng in breathing
h.
Symptoms tes of Cont
comi act But in advice of is not intended l pur-
5 to 30
minu
Allerg
allergicen. Dermatitis Symptoms with daily activi- a qualifi to
ed health replace the
with an conta
morect ties, work, play and exercise profes
contact curstake
it may when hy-dermatitis
sional.
some cases to conta
notic e anap
skin comes Nighttimeoc- awakenings
My physi with
ct with cians phon
than an
hour
nicke . l. an allerg in symptoms
direct
e numb
toms Red, bump en such
Peak flow ___________ er is:
lactic symp or swoll an
having y, scaly,(50% as
to ______
_____
you are en skin
the your
use can itchyto 80% of personal best) __________
If you thinktic react pointion,
of conta e ct.
deve
and lop at
________
anaphylac able epinephrin life
autoinject ly. Your Alert!
immediate Difficulty breathing, cough-
call 911 nd on it!
may depe ing, wheezing not helped with
RED ZONE

medications
Pub Ed
Bookm
arks-Sk
Trouble walking or talking due
in-v3.in
dd 1 to asthma symptoms
1/3/201
Not responding 2011,to quick-relief
America
2 4:32:15Immunology n Academ
medication PMPM All rights y of Allergy,
reserve Asthma
1/4/201
Peak flow ______ to ______
2 1:38:10 d. &
(50% of personal best)
dd 2
is-v5.in
aphylax
arks-An
Bookm
Pub Ed
Warning: For extreme difficulty

Mr. Nose-it-All Stickers

breathing, call 911.
Otherwise, if you are in the Red
Zone, contact your physician.

Bookmarks
AAAAI-1112-280

Visit the Member Resource Center at the Annual Meeting

to receive FREE samples and to take advantage
of special discounts.

23
 European Academy of
Allergy and Clinical Immunology
7 11 June 2014
Copenhagen, Denmark

EAACI Congress 2014

Challenging Dogmas

www.eaaci2014.com
 Thursday, February 27 and
friday, February 28
Thursday, February 27 Consultants to the Surgeons General Updates:
3:30 VHA Allergy Committee
Military Allergy Program Joseph S. Yusin, MD FAAAAI
0001 28th Annual Harold S. Nelson Military Allergy/ 3:45 Air Force
Kevin M. White, MD
Immunology Symposium
4:00 Army
7:20 am to 5:00 pm
Michael R. Nelson, MD PhD FAAAAI
Convention Center, Upper Level, Room 3
4:15 Navy
Pre-registration and ticket required. No fee for approved and
Michael R. Kaplan, DO FAAAAI
registered military members. $60 fee for non-military members.
4:30 Business Meeting and Award Presentations
Continental breakfast and box lunch included.
Upon completion of this session, participants should be able to: Discuss the approach to
Credit: 7.00 CME / 8.00 CE identifying allergic skin disorders in the military environment and the role of biopsy in the
Moderator: Kimberly S. Johnson, MD diagnosis and management; Identify the differential diagnosis of chronic urticaria and
7:20 Registration and Breakfast explain the diagnostic approach; Discuss the application of novel therapy in the treatment
7:50 Welcome and Overview of chronic urticaria.
Kimberly S. Johnson, MD Fellows-In-Training and New Allergist/Immunologist
8:00 Morning Address: Dermatology for the Military Allergist
Assembly Joint Reception
Timothy Straight, MD PhD
9:00 Break 7:00 to 8:00 pm
Marriott North Tower, Lobby Level, Rancho Santa Fe 1-3
Fellow Original Research
Reception is open to current Chrysalis participants, FITs and NAIA
9:30 Safety of Cluster Allergen Immunotherapy During Refill Dosing
members.
Tiffany J. Owens, MD
9:50 Demographics and Retention Patterns for 1999-2011 U.S. Air Friday, February 28
Force Allergy Graduates
Michelle Bandino, MD
Fellows-in-Training Program
10:10 Serologic Specific IgE (sIgE) Testing in a Closed Healthcare 1011 FIT Symposium
System 7:00 am to 2:00 pm
Daniel A. Steigelman, MD Marriott North Tower, Lobby Level, San Diego Ballroom Salon B
10:30 Safety and Efficacy of a 12-Week Maintenance Interval in Patients Pre-registration and ticket required. No fee. Continental breakfast and
Treated With Imported Fire Ant Immunotherapy box lunch included.
Karla E. Adams, MD Credit: No CME / No CE
Staff Original Research 7:00 Networking Breakfast
10:50 Vitamin D Supplementation Improve Urticaria Symptoms in Adult 8:00 Introductions
Chronic Urticaria Taylor A. Banks, MD
Tadech Boonpiyathad, MD Mary Beth Fasano, MD FAAAAI
11:10 Increased Respiratory Illness and Transient Immune Alterations 8:05 Networking Organizations
Seen with Multiple Vaccinations Administered in a Stressful 8:15 American Board of Allergy and Immunology
Environment Stephen I. Wasserman, MD FAAAAI
8:20 Allergy Immunotherapy: The Basics
Rachel Umi Lee, MD FAAAAI
Michael R. Nelson, MD PhD FAAAAI
11:30 Lunch and Bruton Lecture: Treatment Options for Refractory
8:50 Immunotherapy Extracts
Urticaria
Robert G. Hamilton, PhD D.ABMLI FAAAAI
David A. Khan, MD FAAAAI
9:20 Break
Fellow Case Reports 9:35 Welcome from the AAAAI President
1:00 Selective IgM Deficiency Presenting as Cryptogenic Organizing Linda Cox, MD FAAAAI
Pneumonia 9:45 Immunotherapy: New and Emerging Issues
Cory A. Lundberg, DO Linda Cox, MD FAAAAI
1:20 A Devastating Outcome in Undiagnosed X-Linked 10:15 Immunomodulation with Immunotherapy
Agammaglobulinemia: A Call for Earlier Screening Joann C. Blessing-Moore, MD FAAAAI
Karen Elizabeth Bruner, MD 10:45 Pearls and Pitfalls of Diagnostic Testing
1:40 Intractable Burkholderia Vietnamiensis and Hemophagocytic Michael S. Blaiss, MD FAAAAI
Lymphohistiocytosis in Homozygous Interleukin-12 Receptor 11:15 Venom Immunotherapy
Beta-1 Deficiency David B.K. Golden, MD FAAAAI
Ki Lee Milligan, MD 11:45 Difficult AIT Cases
2:00 Break David A. Khan, MD FAAAAI
2:30 Vaccine Healthcare Center Update 12:15 Networking Lunch
Limone C. Collins Jr., MD 1:00 AIT Prescription Workshop
Upon completion of this session, participants should be able to: Describe the pathophysi-
3:00 Military Aeroallergen Extract Laboratory Updates ology, initial evaluation and management of patients with allergies to aeroallergens and/or
Susan E. Kosisky, BS MHA venoms; Identify recent advances in the field of immunotherapy, including mechanisms of
immunomodulation; Discuss current and emerging treatment modalities and adjuncts in
the management of aeroallergen and venom allergic patients.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 25
 friday, February 28

Allied Health Course 1101D Differentiating Asthma From COPD: Why is This
So Hard?
1101 Advanced Practice Course
Marriott North Tower, Lobby Level, Atlanta & Chicago
8:00 am to 12:30 pm
Edward O. Corazalla, MS RPFT
Marriott North Tower, Lobby Level, Marriott Hall Salons 1 & 2
Karen L. Gregory, DNP APRN-BC RRT AE-C
Pre-registration and ticket required. No fee.
Upon completion of this session, participants should be able to identify differences and
Credit: 4.50 CME / 5.40 CE similarities in patients with asthma vs. COPD.
Moderators: Nina A. Zimmermann, MSN RN ANP-BC AE-C
Debra A. Sedlak, MSN CPNP Clinical Research Workshop
8:00 Introduction
Debra A. Sedlak, MSN CPNP 1102 The Anatomy of the Clinical Trial Agreement
8:15 Patients Attitudes and Beliefs About Complementary and 8:00 to 9:15 am
Alternative Medicine Use for Asthma Self-Management Marriott North Tower, Lobby Level, Torrey Pines 1 & 2
Maureen George, PhD RN AE-C FAAN Credit: 1.25 CME / 1.50 CE
9:00 Bronchial Thermoplasty for the Treatment of Severe Asthma Moderator: Christopher Chang, MD PhD FAAAAI
Mario Castro, MD MPH The Anatomy of the Clinical Trial Agreement and Negotiating a
9:45 Question & Answer Profitable Budget
Cheryl Koff Bernstein, RN BSN CCRC
10:00 Vitamin D: Sunlight at the End of the Tunnel
Upon completion of this session, participants should be able to: Identify and discuss the
Nicolette De Jong, PhD language used in reciprocal or crossed indemnification and offer alternative indemnifica-
10:45 Food Allergy: New Therapies on the Horizon tion language during contract negotiations; Identify and discuss important sections of the
Beth D. Strong, RN CCRC contract such as liability insurance, language used to describe adherence to the protocol,
payment, study termination and offer alternative language; Discuss successful methods
11:30 Managing Atopic Dermatitis: Itching the Night Away!
and techniques used during contract and budget negotiations with the sponsor.
Karol G. Timmons, RN MS CPNP
12:15 Question & Answer
Chrysalis Project
Upon completion of this session, participants should be able to: Evaluate how patients'
health beliefs impact asthma self-management; Identify asthma patients who may 1111 2014 Chrysalis Project Program
benefit from alternative treatments such as broncial thermoplasty and Vitamin D therapy;
7:30 am to 2:00 pm
Define new and appropriate treatment strategies for common food allergies and atopic
dermatitis. Marriott North Tower, Lobby Level, Rancho Santa Fe 1-3
Pre-registration and ticket required. No fee. Continental breakfast and
box lunch included.
Allied Health Advanced Practice Course Breakout
Credit: No CME / No CE
Sessions 7:30 Breakfast
12:30 to 2:00 pm 8:00 Welcome
Separate pre-registration, ticket and fee from the 1101 Advanced Thomas A. Fleisher, MD FAAAAI
Practice Course. Pre-registration and ticket required. Fee: $20. Kimberly A. Risma, MD PhD FAAAAI
Box lunch included. Sessions and meals are limited to registered
8:05 Welcome from the AAAAI President
attendees.
Linda Cox, MD FAAAAI
Credit: 1.50 CME / 1.80 CE
8:15 Food Allergy
1101A Cough/Chronic Cough A. Wesley Burks, MD FAAAAI
Marriott North Tower, Lobby Level, Marriott Hall Salon 5 8:45 Eosinophilic Disorders
Nina A. Zimmermann, MSN RN ANP-BC AE-C Paneez Khoury, MD
Jeanette L. Arnold, MSN RN C-FNP
9:15 Immunodeficiency
Upon completion of this session, participants should be able to discuss the diagnostic
evaluation and therapeutic options to treat chronic cough. Kathleen E. Sullivan, MD PhD FAAAAI
9:45 Break
1101B Is This Anaphylaxis? 10:00 Asthma
Marriott North Tower, Lobby Level, Marriott Hall Salon 6
Rohit Katial, MD FAAAAI
Gabriel Ortiz, MPAS PA-C DFAAPA
10:30 Atopic Dermatitis
Vivian P. Hernandez-Trujillo, MD FAAAAI
Donald Y.M. Leung, MD PhD FAAAAI
Upon completion of this session, participants should be able to describe anaphylaxis and
the initiation of appropriate treatment. 11:00 Academic Career Paths
Kimberly A. Risma, MD PhD FAAAAI
1101C Opening Pandoras Box: Asking the Right
11:20 Industry Career Paths
Questions Daniel C. Adelman, MD FAAAAI
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2 11:40 Private Practice Career Paths
David Wayne Unkle, MSN APN FCCM Adina Kay Knight, MD FAAAAI
Anthony J. Ricketti, MD FACAI FCCP
12:00 Chrysalis Project Program Luncheon with FIT Mentors
Upon completion of this session, participants should be able to discuss strategies for
interpreting information given by our patients.

26 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 friday, February 28

Program Directors Course Course

1112 How to Develop and Maintain Excellence in 1202 NIAID: Epigenetics in Asthma and Allergy: Basic
Allergy/Immunology Fellowships: Boot Camp for Concepts and Recent Advances
Program Directors and Clinical Faculty 9:00 am to 12:00 pm
8:15 am to 12:00 pm Convention Center, Upper Level, Room 11AB
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A Credit: 2.75 CME / 3.30 CE
Pre-registration and ticket required. No fee. Continental breakfast Moderator: Alkis Togias, MD FAAAAI
included. 9:00 Epigenetics: Basic Concepts
Credit: No CME / No CE Bing Ren, PhD
Moderator: Asriani M. Chiu, MD FAAAAI 9:25 Asthma and Allergy Epigenetics: What Have We Learned So Far?
8:15 Continental Breakfast David A. Schwartz, MD
8:45 The ABCs of Post-Graduate Medical Education (AAAAI, ABAI, 9:50 Environmental Influences on the Epigenome
ACGME) and Beyond Rachel L. Miller, MD FAAAAI
Mary Beth Fasano, MD FAAAAI 10:15 Break
9:15 The Nuts and Bolts of Building an A/I Fellowship Program: 10:30 Epigenetic Regulation of the Immune System in Relation to
Program Requirements in the Era of the Next Accreditation Allergy and Asthma
System Kari C. Nadeau, MD PhD FAAAAI
Jeffrey R. Stokes, MD FAAAAI 10:55 The Epithelial Cell Epigenome and its Relation to Asthma
9:45 Communications and Reference Tools: iPads, iPhones and Carole Ober, PhD
PubMed 11:20 Epigenetic Regulation of Arachidonic Acid Metabolism and its
Thanai Pongdee, MD FAAAAI Clinical Implications
10:15 Break Benjamin A. Raby, MD MPH
10:30 How to Use the Milestones for Effective Learner Assessment 11:45 Question & Answer
Michael R. Nelson, MD PhD FAAAAI Upon completion of this session, participants should be able to: Describe the importance
11:00 Curriculum Design: Tips for Teaching Generation Y of epigenetic changes and their potential impact on our understanding and treatment of
allergic diseases and asthma; Identify specific cells and pathways relevant to allergy and
Fanny Silviu-Dan, MD FAAAAI
asthma where epigenetic changes may influence disease.
11:30 Directing an A/I Fellowship Program: Ask the Expert Panel
Discussion Course
Mariana C. Castells, MD PhD FAAAAI
Lawrence B. Schwartz, MD PhD FAAAAI 1203 Technology in the Clinical Practice Made
Elizabeth A. Secord, MD FAAAAI Ridiculously Simple
Upon completion of this session, participants should be able to: Enhance the teaching 9:00 am to 12:00 pm
skills of upcoming, new and current allergy/immunology fellowship program directors and
Convention Center, Mezzanine Level, Room 14AB
associate program directors, core A/I fellowship faculty and community volunteer clinical
faculty; Provide practical tips for developing and enhancing an A/I fellowship program in Credit: 3.00 CME / 3.40 CE
the context of the next accreditation system; Support the development of allergy/immu- Moderator: Tao T. Le, MD MHS FAAAAI
nology program directors, fellowship core faculty and community volunteer clinical faculty; 9:00 What Can Technology Do for Your Practice
Improve the quality of allergy/immunology fellowship training. Tao T. Le, MD MHS FAAAAI
9:20 EHRs and the Meaningful Use of Life
Course A. Sean McKnight, MD FAAAAI
1201 Advanced Course in Pollen Identification 9:50 Practice Management Systems and Other Office Automation Tools
9:00 am to 12:00 pm Linda D. Green, MD FAAAAI
Marriott North Tower, Lobby Level, Marriott Hall Salon 3 10:20 Break
Pre-registration and ticket required. Fee: $125. 10:30 iPhones, iPads, Androids, Oh My!
Credit: 3.00 CME / 3.60 CE Melinda M. Rathkopf, MD FAAAAI
Moderator: Estelle Levetin, PhD FAAAAI 11:00 Social Media Tools for Marketing and Communications
9:00 Asteraceae Pollen Ves Dimov, MD
Peter Van De Water, PhD 11:30 Making the Technology Work and Pay Off
9:30 Hands-On Instruction; Question & Answer David J. Shulan, MD FAAAAI
10:00 Betulaceae Pollen 11:50 Question & Answer
Richard W. Weber, MD FAAAAI Upon completion of this session, participants should be able to: Describe EHRs, practice
10:30 Hands-On Instruction; Question & Answer management systems and office automation technologies appropriate for the clinical
practice; Explain the role of mobile technologies in the practice; List web and social media
11:00 Other Triporate and Tricolporate Pollen
tools for practice marketing and communications.
Estelle Levetin, PhD FAAAAI
11:30 Hands-On Instruction; Question & Answer
Upon completion of this session, participants should be able to: Differentiate pollen in
the birch family and related tri-porate pollen types; Recognize difficult tricolporate pollen
types; Differentiate asteraceae pollen other than ragweed.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 27
 friday, February 28

Course Course
1204 Endoscopic Evaluation and Management of 1206 Primary Immunodeficiency Diseases: What Do I
Chronic Rhinosinusitis (Pre- and Post-Surgery) Do with My Patient? From Start to Finish
Including Cultures 9:00 am to 12:00 pm
9:00 am to 12:00 pm Convention Center, Upper Level, Ballroom 6CF
Convention Center, Upper Level, Room 3 Credit: 2.75 CME / 3.30 CE
Pre-registration and ticket required. No fee. Moderator: Lisa J. Kobrynski, MD MPH FAAAAI
Credit: 3.00 CME / 3.40 CE 9:00 Who Needs Evaluation for Immunodeficiency?
Moderator: Anju T. Peters, MD FAAAAI M. Teresa De La Morena, MD
9:00 Anatomy of the Sinuses 9:25 Assessing Innate and Adaptive Humoral Immunity
Todd T. Kingdom, MD Francisco A. Bonilla, MD PhD FAAAAI
9:20 Radiology of the Sinuses 9:50 Assessing Innate and Adaptive Cellular Immunity
S. James Zinreich, MD I. Celine Hanson, MD FAAAAI
10:00 Endoscopic Evaluation of the Sinuses Including Cultures: Video 10:15 Question & Answer
and Lecture 10:35 Break
Wellington S. Tichenor, MD FAAAAI 10:50 Therapies for Innate and Adaptive Humoral Immunodeficiency
10:20 Break Vincent R. Bonagura, MD FAAAAI
10:30 Surgical Evaluation 11:15 Therapies for Innate and Adaptive Cellular Immunodeficiency
Robert C. Kern, MD Mark Ballow, MD FAAAAI
10:50 Endoscopic Evaluation of the Sinuses: Post-Surgical 11:40 Question & Answer
Wellington S. Tichenor, MD FAAAAI Upon completion of this session, participants should be able to: Describe a general ap-
11:10 Case Management Studies: Question & Answer proach to a patient with recurrent infections or other presentation consistent with PID;
Daniel L. Hamilos, MD Discuss the stepwise approach to the diagnosis of PID and how to apply advanced and
specialized tests, possibly in conjunction with guidance from a tertiary provider; List
Upon completion of this session, participants should be able to: Describe the anatomy of
the different modalities available for therapy, general principles of their application and
the paranasal sinuses and identify pathology on CT scan; Recall indications for surgery
resources for guidance in unusual or complex situations.
and complications of surgery; Perform endoscopy in patients with CRS as well as cultures
of the middle meatus and/or sinuses and review management of complicated sinusitis.
Course
Course 1207 Drug Hypersensitivity
1205 Difficult Cases (Part 1) 9:00 am to 12:00 pm
9:00 am to 12:00 pm Convention Center, Upper Level, Ballroom 6DE
Convention Center, Mezzanine Level, Room 15AB Credit: 2.75 CME / 3.30 CE
Pre-registration and ticket required. No fee. Moderator: Rebecca S. Gruchalla, MD PhD FAAAAI
Credit: 2.75 CME / 3.20 CE 9:00 Symptoms and Skin Testing for Type I Chemotherapy Drug
Moderators: David W. Hauswirth, MD FAAAAI Hypersensitivity
Joyce E. Yu, MD David E. Sloane, MD
9:00 Hypereosinophilic Disorders (Not EoE) 9:50 Break
Amy D. Klion, MD 10:05 Patch Testing in Drug Allergy
Princess U. Ogbogu, MD FAAAAI Antonino G. Romano, MD
9:35 Itching Without Rash 10:55 Antibiotic Skin Testing
Cem Akin, MD PhD FAAAAI Anahita F. Dioun, MD FAAAAI
Gerald B. Lee, MD 11:45 Question & Answer
10:10 Break Upon completion of this session, participants should be able to: List the symptoms of Type
10:30 Peri-Operative Anaphylaxis I drug hypersensitivity reactions; Identify symptoms of Type IV drug hypersensitivity reac-
tions; Describe diagnostic tools for Type I and Type IV drug hypersensitivity reactions.
Phillip L. Lieberman, MD FAAAAI
Joel M. Hartman, MD
11:05 What the Allergist/Immunologist Sees That is Not Allergy
Dennis K. Ledford, MD FAAAAI
Eugene M. Choo, MD FAAAAI
11:40 Question & Answer
Upon completion of this session, participants should be able to discuss diagnostic and
clinical management challenges encountered in allergy, asthma and immunology practice.

28 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 friday, February 28

Course 1209A/D Hands-On Workshop: Allergy Skin Testing

Convention Center, Upper Level, Room 32AB
1208 Dermatology for the Allergist: Diagnosis and Credit: 1.00 CME / 1.20 CE
Therapeutics Boot Camp Peter S. Creticos, MD FAAAAI
9:00 am to 12:00 pm Jay A. Lieberman, MD
Convention Center, Mezzanine Level, Room 16AB John Oppenheimer, MD FAAAAI
Pre-registration and ticket required. No fee. Anita Trikha, MD
Credit: 3.00 CME / 3.40 CE Upon completion of this session, participants should be able to: Compare the different
Moderator: Lynda C. Schneider, MD FAAAAI devices and other equipment and their characteristics; Explain the importance of stan-
9:00 Common Dermatologic Diseases with Mimics and Crossovers in dardized allergen extracts for the test result; Demonstrate the importance of standardized
testing technique and its control by proficiency testing.
Allergy: Overview from a Dermatology Perspective
Peter A. Lio, MD 1209B/C Coding and Regulatory Issues Related to
9:30 Therapies for Dermatitis Allergy Diagnosis and Treatment
Lawrence F. Eichenfield, MD Convention Center, Upper Level, Room 33AB
10:00 Question & Answer Credit: 1.00 CME / 1.20 CE
10:10 Break Donald W. Aaronson, MD FAAAAI
10:20 Video Demonstration: Biopsies, Scrapings and Patent Testing David A. Brown, MD
Lawrence F. Eichenfield, MD Gary N. Gross, MD FAAAAI
Upon completion of this session, participants should be able to apply adequately the cod-
11:00 Hands-On Learning
ing, documentation and regulatory guidelines for immunotherapy.
Lawrence F. Eichenfield, MD
Luz S. Fonacier, MD FAAAAI
Peter A. Lio, MD
Course
Upon completion of this session, participants should be able to: Discuss common diag- 1210 Principles of Healthy Homes: What to Look for
nostic tests applicable to eczemas; Outline basic skin care for allergic skin diseases and
avoidance of pitfalls.
and How to Help Your Patients or Evaluation and
Mitigation
Course 9:00 am to 12:00 pm
1209 Allergen Immunotherapy: The Nuts and the Bolts Convention Center, Upper Level, Room 33C
Pre-registration and ticket required. No fee.
(Part 1) Credit: 2.75 CME / 3.30 CE
9:00 to 10:00 am Moderator: Jay M. Portnoy, MD FAAAAI
Convention Center, Upper Level, Room 30CDE
9:00 The Indoor Biome and Healthy Housing
Pre-registration and ticket required. No fee.
Christina E. Ciaccio, MD FAAAAI
Credit: 1.00 CME / 1.20 CE
9:30 How to Evaluate a Problem Home: Tools You Can Use
Moderator: Matthew A. Rank, MD FAAAAI
Kevin Kennedy, MPH CIEC
9:00 Advances in Allergy Diagnostic Testing: Component Resolved
10:00 Break
Diagnosis to Identify Specific Allergens
Joerg R. Kleine-Tebbe, MD FAAAAI 10:15 Working With Patients: Taking an Environmental Healthy History
James L. Sublett, MD FAAAAI
9:30 Food Immunotherapy: Baked, Shaken or Stirred: Is it Ready to be
Served? 10:45 Remediating and Maintaining a Healthy Home
Robert A. Wood, MD FAAAAI Paul J. Dowling, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss how diagnosis 11:15 What Works, What Doesnt and What Needs to be Done
might improve with in vitro techniques to come; Discuss clinical readiness of food im- Wanda Phipatanakul, MD MS FAAAAI
munotherapy. 11:45 Question & Answer
Upon completion of this session, participants should be able to: Identify the principles of
Course Breakout Sessions healthy homes and the relative importance of each; Identify the basic steps in taking an
Attendees will rotate between the following two workshops. environmental history about a patients home environment; Describe the essential steps to
Pre-registration and ticket required. Fee: $25. Sessions are limited to assess home environmental hazards and conditions and mitigation.
registered attendees.
10:00 am to 12:00 pm

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 29
 friday, February 28

Allied Health Workshop Allied Health Workshop

1301 Psychosocial Well-Being: Living with Food 1501 Ask the Expert: Roundtable Discussion
Allergies 12:30 to 1:30 pm
9:30 to 10:45 am Marriott North Tower, Lobby Level, Presidio Rooms 1 & 2
Marriott North Tower, Lobby Level, Marriott Hall Salon 5 Pre-registration and ticket required. Fee: $40. Box lunch included.
Credit: 1.25 CME / 1.50 CE Credit: 1.00 CME / 1.20 CE
Panelists: Moderator: John D. Milewski, Med. Admin.
Jennifer M. Darr, MSW LCSW Joan E. Hawkins
Melissa T. Korenblat-Hanin, ACSW LCSW Teresa Thompson, CPC CMSCS CCC
Upon completion of this session, participants should be able to: Describe the psychoso- 11:30 Question & Answer
cial dynamics of living with food allergies: challenges, emotions and accomplishments; Upon completion of this session, participants should be able to: Identify coding and ICD10
Discuss approaches that build and enhance stability, security and sensibility using chal- challenges in 2014; Discuss best practices for motivating employees; Identify how to
lenging case scenarios; Identify successful resources for assisting the food allergic patient assess your clinical practices.
and family.
Program Directors Business Meeting
Allied Health Workshop 2:00 to 4:00 pm
1302 The Asthma Action Plan: Use of Simulation to Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
All Program Directors and Co-Directors are invited to attend this
Teach and Reinforce business meeting.
9:30 to 10:45 am
Marriott North Tower, Lobby Level, Atlanta & Chicago
Credit: 1.25 CME / 1.50 CE Course
Moderator: Maureen George, PhD RN AE-C FAAN 1601 Advanced Course in Fungal Spore Identification
Using Simulation to Improve Patient Education About the Asthma 2:00 to 5:00 pm
Action Plan Marriott North Tower, Lobby Level, Marriott Hall Salon 3
Anne E. Borgmeyer, MSN RN CPNP AE-C Pre-registration and ticket required. Fee: $125.
Upon completion of this session, participants should be able to: Describe principles of Credit: 3.00 CME / 3.60 CE
patient and family-focused education; Review the use of simulation to teach patient
Moderator: Estelle Levetin, PhD FAAAAI
communication strategies to providers; List the key principles of the Asthma Action Plan to
improve self-management and asthma control. 2:00 Basidiospore Identification
Estelle Levetin, PhD FAAAAI
Allied Health Workshop 2:30 Hands-On Instruction; Question & Answer
3:00 Ascospore Identification
1401 Developing and Maintaining a Successful W. Elliott Horner, PhD LEED AP FAAAAI
Research Center: Secrets of a Trade 3:30 Hands-On Instruction; Question & Answer
11:00 am to 12:15 pm 4:00 Challenging Spore Types
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2 James Scott, PhD
Credit: 1.25 CME / 1.50 CE
4:30 Hands-On Instruction; Question & Answer
Moderator: Craig F. LaForce, MD FAAAAI
Upon completion of this session, participants should be able to: Interpret common basid-
Cheryl Koff Bernstein, RN BSN CCRC iospores; Interpret common ascospores; Describe Fusarium, Penicillium/Aspergillus and
David I. Bernstein, MD FAAAAI other difficult spore types.
Upon completion of this session, participants should be able to: Discuss the infrastruc-
ture necessary to establish a successful and productive research center; Discuss the
challenges of maintaining a successful research center while competing in global clinical
trials; Identify strategies for promoting your research center and enhancing your chances
for clinical trial selection.

Allied Health Workshop

1402 The Food Allergy Spectrum: Not Just Peanuts,
Eggs and Milk
11:00 am to 12:15 pm
Marriott North Tower, Lobby Level, Torrey Pines 3
Credit: 1.25 CME / 1.50 CE
Panelists:
Pinkus Goldberg, MD FAAAAI
Karen S. Rance, DNP RN CPNP AE-C
Upon completion of this session, participants should be able to: Identify an evidence-
based approach to managing food allergy patients with less common allergens; Discuss
how to screen for possible sensitivity to food additives and preservatives; Describe a
management approach for patients with multiple food allergies.

30 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 friday, February 28

Course Course
1602 NIAID: Recent Advances in Biomarkers of Allergy 1604 Difficult Cases (Part 2)
and Asthma 2:00 to 5:00 pm
2:00 to 5:00 pm Convention Center, Mezzanine Level, Room 15AB
Convention Center, Upper Level, Room 11AB Pre-registration and ticket required. No fee.
Credit: 2.75 CME / 3.30 CE Credit: 2.75 CME / 3.20 CE
Moderator: Marshall Plaut, MD FAAAAI Moderators: Jason W. Caldwell, DO FAAAAI
2:00 Allergen Challenge as a Biomarker of Disease Severity and of the Michael H. Land, MD FAAAAI
Effects of Treatment 2:00 COPD vs. Asthma
Stephen R. Durham, MA MD FRCP William W. Busse, MD FAAAAI
2:25 Transcriptomic Changes After Allergen Exposure Matthew C. Bell, MD
Sunil K. Ahuja, MD 2:35 Implant Allergy
2:50 Basophil Activation as a Predictor of Food Allergen Severity Luz S. Fonacier, MD FAAAAI
Alexandra F. Santos, MD MSc Haejin Kim, MD
3:15 Break 3:10 Break
3:30 Basophil Activation as a Biomarker of Food Allergy and Asthma 3:30 New Immune Deficiencies
Wayne G. Shreffler, MD PhD FAAAAI Gulbu Uzel, MD
Monica G. Lawrence, MD
3:55 T Regulatory Cells as Markers of Allergen Immunotherapy
Andrew D. Luster, MD PhD 4:05 Mystery Rashes
Lisa A. Beck, MD FAAAAI
4:20 CD27 Effector Cell Depletion During Allergen Immunotherapy
Anne Marie Singh, MD
Erik R. Wambre, PhD
4:40 Question & Answer
4:45 Question & Answer
Upon completion of this session, participants should be able to discuss diagnostic and
Upon completion of this session, participants should be able to: Explain how mediators clinical management challenges encountered in allergy, asthma and immunology practice.
produced following allergen challenge predict the status of allergic diseases; Describe the
relationship of successful allergen immunotherapy to effects on circulating T cell subsets
and antibody responses; Appreciate the value of measuring peripheral blood basophil Course
activation in allergic diseases and asthma.
1605 Mast Cell Activation Syndromes: From
Course Anaphylaxis to Mastocytosis
2:00 to 5:00 pm
1603 Finding a Job and Getting Started in Practice Convention Center, Upper Level, Room 6A
2:00 to 5:00 pm Credit: 2.75 CME / 3.30 CE
Convention Center, Upper Level, Room 2 Moderator: Luis Escribano, MD PhD FAAAAI
Credit: 3.00 CME / 3.40 CE 2:00 Anaphylaxis to Hymenoptera Venom
Moderator: Tao T. Le, MD MHS FAAAAI Patrizia Bonadonna, MD PhD
2:00 Overview and Introductions 2:30 Mastocytosis: Role of Tryptase and C-Kit Mutations
Tao T. Le, MD MHS FAAAAI Cem Akin, MD PhD FAAAAI
2:05 Finding a Job and Negotiating the Agreement 3:00 Break
Tao T. Le, MD MHS FAAAAI
3:15 Non-Clonal Mast Cell Activation Syndrome
2:40 Getting Licensed and Transitioning into Practice Mariana C. Castells, MD PhD FAAAAI
Brian A. Smart, MD FAAAAI
3:45 When and How to Perform a Bone Marrow Study in MCAS:
2:55 Break Practical Recommendations
3:05 Secrets of an Efficient Allergy Practice Luis Escribano, MD PhD FAAAAI
David L. Patterson, MD MS MBA FAAAAI 4:15 Idiopathic Anaphylaxis
3:40 Practice Finances 101 Paul A. Greenberger, MD FAAAAI
Marshall P. Grodofsky, MD FAAAAI 4:45 Question & Answer
4:15 Marketing Your Practice and Referral Development Upon completion of this session, participants should be able to: Discuss the symptoms
Stanley M. Fineman, MD MBA FAAAAI and presentation of mast cell activation syndromes (MCAS); Outline the role of tryptase
4:50 Question & Answer and c-kit mutations in MCAS; Describe management options for MCAS.
Upon completion of this session, participants should be able to: Outline how to identify
and join the right practice opportunity; Discuss the fundamentals of office management;
Identify strategies for marketing a practice and building a patient base.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 31
 friday, February 28

Course Upon completion of this session, participants should be able to: Discuss ethnic and
geographical differences in PID prevalence and clinical presentation around the world;
1606 Review of Systemic Autoimmune Disease and Discuss international vaccine programs and challenges posed for the PID community;
Review clinical scenarios of PID management in different settings around the world.
Treatment
2:00 to 5:00 pm
Convention Center, Upper Level, Ballroom 6B
Course
Credit: 3.00 CME / 3.60 CE 1608 NIEHS: Exposure to Indoor Allergens and
Moderator: Arnold I. Levinson, MD FAAAAI Endotoxin in Relation to Allergic Disease: Results
2:00 Update on Laboratory Diagnosis of Systemic Autoimmune
from NHANES 2005-2006
Disease
2:00 to 5:00 pm
David P. Huston, MD FAAAAI
Convention Center, Upper Level, Ballroom 6DE
2:30 ACR Updated Recommendations for Disease-Modifying Credit: 2.75 CME / 3.20 CE
Antirheumatic Drugs and Biologic Agents in the Treatment of RA Moderators: Paivi M. Salo, PhD
Arthur Kavanaugh, MD FAAAAI Darryl C. Zeldin, MD
3:00 Question & Answer 2:00 Overview of the NHANES 2005-2006 Allergy Component
3:15 The Spectrum of Vasculitis: New Insights into Pathogenesis and Darryl C. Zeldin, MD
Treatment 2:20 Multiplexed Allergen Measurements: New Standards and
Richard Keating, MD Performance Parameters
3:45 New Treatment Modalities for Lupus Eva-Maria King, PhD
Mary Anne Dooley, MD 2:40 NHANES 2005-2006: Getting to Grips with the Big Data
4:15 Susceptibility to Infections in Autoimmune Disease: Is it the Agustin Calatroni, MA MS
Disease or the Treatment? 3:00 Break
John J. Cush, MD
3:20 IgE Sensitization and Current Allergen Exposure: Implications for
4:45 Question & Answer Environmental Intervention
Upon completion of this session, participants should be able to: Interpret screening and
Herman Mitchell, PhD
follow-up reflex testing in the diagnosis of autoimmune disease; Review the latest treat-
ment guidelines for rheumatoid arthritis; Describe the organ systems lupus can affect and 3:40 Environmental Exposures and Allergy Symptoms
the downstream sequelae of complement activation. Paivi M. Salo, PhD
4:00 Which Combinations of IgE Clusters and Exposures Have the
Course Greatest Impact on Asthma?
Peter J. Gergen, MD MPH
1607 Primary Immune Deficiency: A Global Perspective
4:20 Endotoxin Exposure Assessment and Respiratory Disease
2:00 to 5:00 pm
Peter S. Thorne, PhD
Convention Center, Upper Level, Ballroom 6CF
Credit: 3.00 CME / 3.40 CE 4:40 Question & Answer
Upon completion of this session, participants should be able to: Interpret the role that
Moderator: Motohiro Ebisawa, MD PhD FAAAAI
allergen/endotoxin exposures and allergic sensitization play in allergic diseases; Apply
2:00 An Overview of Primary Immunodeficiency Diseases Around the new, standardized methods in indoor allergen assessment; Review strategic objectives of
World NHANES and the allergy component.
Fred Modell
2:25 Vaccine-Associated Paralytic Polio and Other Live Attenuated Course
Vaccine-Associated Disease in Immunodeficient Infants
Antonio Condino-Neto, MD PhD
1609 Allergen Immunotherapy: The Nuts and the Bolts
2:50 Clinical Cases: Diagnosis and Management of Primary (Part 2)
Immunodeficency Around the World 2:00 to 3:00 pm
Elham M. Hossny, MD PhD FAAAAI Convention Center, Upper Level, Room 30CDE
Pre-registration and ticket required. No fee.
3:15 Question & Answer
Credit: 1.00 CME / 1.20 CE
3:25 Break
Moderator: Michael R. Nelson, MD PhD FAAAAI
Moderators: Elham M. Hossny, MD PhD FAAAAI 2:00 SCIT and SLIT: Optimal Dosing, Regimen and Duration
Mona I. Kidon, MD FAAAAI Harold S. Nelson, MD FAAAAI
3:35 Defects of Human Immunity and Mycobacterium Diseases Around 2:30 Allergen Immunotherapy: Practical Considerations, Cost-
the World Effectiveness, Adherence and Quality of Life
Stephanie Boisson-Dupuis, MD Cheryl S. Hankin, PhD
4:00 Molecular Mechanisms of Hyper IgE Syndromes Upon completion of this session, participants should be able to: Describe how immuno-
Speaker to be announced. therapy can easily be dosed and the knowledge gaps we still have in this field; Discuss
4:25 Malnutrition, Vitamin Deficiencies, the Immune System and when doses might need to be adjusted for SCIT and for SLIT.
Infections: Time to Revisit Our Knowledge
Raz Somech, MD PhD
4:50 Question & Answer

32 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 friday, February 28

Course Breakout Sessions Course

Attendees may attend one of the following sessions. 1611 Career Building for the Junior Investigator
Pre-registration and ticket required. Fee: $25. Sessions are limited to 2:00 to 5:00 pm
registered attendees. Convention Center, Upper Level, Room 1AB
3:00 to 5:00 pm Credit: 2.75 CME / 3.20 CE
1609A/D Hands-On Workshop: Media Fill Test and Moderator: Laura B. Fanning, MD
Extract Preparation Management 2:00 Panel Discussion: Career Advice from Established Investigators:
Convention Center, Upper Level, Room 32AB Strategies to Establish Scientific/Clinical Expertise
Credit: 1.00 CME / 1.20 CE Effective Time Management
Donald W. Aaronson, MD FAAAAI Effective Lab Management
Michael S. Blaiss, MD FAAAAI Andrea J. Apter, MD MA MSc FAAAAI
Susan E. Kosisky, BS MHA Kathleen C. Barnes, PhD FAAAAI
Cecilia Mikita, MD MPH FAAAAI Joshua A. Boyce, MD FAAAAI
Michael R. Nelson, MD PhD FAAAAI James E. Gern, MD FAAAAI
Upon completion of this session, participants should be able to demonstrate the ability to Mitchell H. Grayson, MD FAAAAI
make a sterile immunotherapy vial.
3:05 Question & Answer
1609B/C Allergen Immunotherapy Prescription Writing: 3:20 Break
Cross-Reactivity, Proteolytic Enzymes, Diluents 3:40 Panel Discussion: Career Advice from Junior Investigators:
and Other Factors Time Management Strategies
Convention Center, Upper Level, Room 33AB Strategies for Work and Family Life Balance
Credit: 1.00 CME / 1.20 CE Data Management
Rohit Katial, MD FAAAAI Grant Writing
Bryan L. Martin, DO FAAAAI Nora A. Barrett, MD FAAAAI
Michael S. Tankersley, MD FAAAAI Patrick J. Brennan, MD PhD
Upon completion of this session, participants should be able to demonstrate the proper Taylor A. Doherty, MD FAAAAI
method for writing immunotherapy prescriptions for optimal efficacy and safety.
Tanya M. Laidlaw, MD FAAAAI
Brian P. Vickery, MD FAAAAI
Course 4:45 Question & Answer
1610 Personalized Medicine Approaches in Asthma Upon completion of this session, participants should be able to: Discuss how to develop a
specific clinical and scientific expertise; Discuss how to manage their time effectively and
and Allergy how to choose roles and projects wisely; Describe benchmarks of success.
2:00 to 5:00 pm
Convention Center, Upper Level, Room 8 Course
Credit: 2.75 CME / 3.20 CE
Moderator: Antonella Cianferoni, MD PhD 1612 Hands-On Rhinolaryngoscopy
2:00 CyTOF Flow: The New Frontier 2:00 to 5:00 pm
Jonathan M. Irish, PhD Convention Center, Upper Level, Room 30AB
Pre-registration and ticket required. Fee: $50.
2:30 Lessons Learned from Genetic Diseases of Allergy
Credit: 2.75 CME / 3.30 CE
Joshua D. Milner, MD
Moderator: Jerald W. Koepke, MD FAAAAI
3:10 Break
2:00 Intro to Rhinolaryngoscopy
3:30 Using Biomarkers and Genomics to Personalize Therapeutics for
Jerald W. Koepke, MD FAAAAI
Allergy and Asthma
3:15 Break
Stanley J. Szefler, MD FAAAAI
3:30 Hands-On Instruction
4:05 Establishing a Personalized Medicine Program: The Harvard
Allen D. Adinoff, MD FAAAAI
Experience
Kevin R. Murphy, MD
Scott T. Weiss, MD MS
Grant C. Olson, MD
4:40 Question & Answer
Donald W. Pulver, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the availability
C. Ross Westley, MD FAAAAI
for genetic variation in disease risk, progression and therapy; Describe readily available
predictive tests (genetic and non-genetic); Describe the use and cost effectiveness of a Upon completion of this session, participants should be able to: Describe the surgical
personalized medicine approach in clinical practice. anatomy of the upper airway, including the nasal cavity, pharynx and larynx; Identify
examples of normal and abnormal anatomy, as well as disease presentations and
post-operative changes found with endoscopic examination of the upper airway; Identify
indications for and the use of the fiberoptic rhinoscope in the allergists office.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 33
 friday, February 28

Course Problem-Based Learning Workshop

1613 Interpretation of Pulmonary Function Tests (PFTs) 1801 Diagnosis of Patients with Defects in Innate
2:00 to 5:00 pm Immunity Including TLR Pathway Defects
Convention Center, Upper Level, Room 33C 5:00 to 6:15 pm
Pre-registration and ticket required. No fee. Convention Center, Upper Level, Room 3
Credit: 3.00 CME / 3.50 CE Pre-registration and ticket required. Fee: $50.
Moderator: Mark F. Sands, MD FAAAAI Credit: 1.25 CME / 1.50 CE
2:00 Introductory Remarks PBL Facilitator: Richard L. Wasserman, MD PhD FAAAAI
2:05 Pathophysiology and the PFT Content Lecturer: Dinakantha Kumararatne, MD PhD
Mark F. Sands, MD FAAAAI Upon completion of this session, participants should be able to: Describe the currently
2:30 Performing PFT: Video Demonstration known causes of defective innate immunity; Describe the clinical presentation of defects
John M. Weiler, MD FAAAAI in innate immunity; Discuss the selection and interpretation of laboratory tests to diagnose
defects in innate immunity.
2:40 Interpretation of the PFT: Putting it All Together
Donald P. Tashkin, MD
Q & A Workshop
3:10 Question & Answer
3:25 Break 1802 Difficult to Manage Asthma: The Very Young, the
3:30 Hands-On Workshop Very Old and the Obese
Donald W. Cockcroft, MD FAAAAI 5:00 to 6:15 pm
Meredith C. McCormack, MD Convention Center, Mezzanine Level, Room 14AB
Riccardo Polosa, MD PhD FAAAAI Credit: 1.25 CME / 1.50 CE
Mark F. Sands, MD FAAAAI Moderator: Timothy J. Craig, DO FAAAAI
Donald P. Tashkin, MD 5:00 What to Do When Your Patient Cant Tell You Whats Wrong:
John M. Weiler, MD FAAAAI Challenges in the Diagnosis and Management of Asthma in
Upon completion of this session, participants should be able to: Describe the components Children Under Age Five
of pulmonary function testing; Recognize simple and complex obstructive and restrictive Joseph D. Spahn, MD
pulmonary abnormalities; Interpret PFTs from asthma and COPD to fixed and variable
obstructive abnormalities, as well as interstitial and other restrictive diseases. 5:15 Pitfalls in the Diagnosis and Management of Asthma in Older
Adults: An Evidence-Based Update
Tolly Epstein, MD MS
Clinical Research Symposium
5:30 New Insights into the Obese Asthma Phenotype: Diagnostic and
1621 Tools of the Trade Therapeutic Challenges in Obese Asthmatics
2:00 to 3:15 pm Juan C. Celedon, MD DrPH FAAAAI
Marriott North Tower, Lobby Level, Torrey Pines 3 5:45 Question & Answer
Credit: 1.25 CME / 1.50 CE Upon completion of this session, participants should be able to: Identify emerging diag-
Moderator: Jaime E. Ross, RN nostic modalities for asthma that may be useful in children under age 5 years; Develop
2:00 What You Need to Know to Prepare for an FDA Audit strategies to distinguish asthma from other potential comorbid conditions in elderly
asthmatics and implement age-appropriate management strategies in older asthmatics;
Kim E. Mudd, RN MSN CCRP
Summarize recent data regarding the obese asthmatic phenotype and critically assess
2:30 Developing Your Monitoring Plan: Improving the Quality of the current management strategies in this subgroup of asthmatics.
Research
Janet S. Kamilaris, RN Q & A Workshop
3:00 Question & Answer
Upon completion of this session, participants should be able to: Describe the components 1803 What are Damp Buildings and How Do They
of a monitoring plan; List the methods to keep a clinical trial site ready for an audit; Cause Problems?
Identify the proper use of a note to file and describe its limitations. 5:00 to 6:15 pm
Convention Center, Upper Level, Room 5AB
Allied Health Plenary Credit: 1.25 CME / 1.50 CE
1701 Cybersecurity: Technology in Practice Moderator: Jay M.Portnoy, MD FAAAAI
4:00 to 5:15 pm 5:00 Innate Immunity Factors from Fungi
Marriott North Tower, Lobby Level, Marriott Hall Salon 5 Anthony A. Horner, MD FAAAAI
Credit: 1.25 CME / 1.50 CE 5:15 Damp Buildings, Respiratory Disease and Asthma
Moderator: Sally A. Noone, RN MSN CCRC Kari E. Reijula, MD PhD FAAAAI
Larry Thompson 5:30 Allergens from Damp Housing
Upon completion of this session, participants should be able to: Identify actions to protect Eva-Maria King, PhD
hardware and software; Describe how to implement security measures to protect a 5:45 Question & Answer
practice; Identify how to set up emergency plans in case of a breach.
Upon completion of this session, participants should be able to: Review the multiple expert
panels/reports and Position Statements concluding that there is adequate evidence for
respiratory health impacts, including new onset asthma, due to damp buildings; Describe
the challenges of quantifying dampness and establishing acceptable moisture levels;
Recognize the several plausible mechanisms that underlie the adverse respiratory impacts
of the damp building effect.

34 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 friday, February 28

Q & A Workshop Seminars

1804 The Science Behind Complementary and 5:15 to 6:15 pm
Alternative Medicine Pre-registration and ticket required. Fee: $40. Refreshments included.
Sessions and refreshments are limited to 30 people.
5:00 to 6:15 pm
Credit: 1.00 CME / 1.20 CE
Convention Center, Upper Level, Room 7AB
Credit: 1.25 CME / 1.50 CE 1901 Allergen Immunotherapy or Omalizumab in
Moderator: William S. Silvers, MD FAAAAI Asthma: When to Use Which?
5:00 Role of Vitamin D in Allergic Inflammation Thomas B. Casale, MD FAAAAI
Katrina Jane Allen, MD PhD FAAAAI Jonathan Corren, MD
5:15 Immunomodulation by Chinese Herbal Medicine in Food Allergy Marriott South Tower, Level 3, Balboa
Julie Wang, MD FAAAAI Upon completion of this session, participants should be able to: Review efficacy of AIT in
asthma and safety of AIT in moderate to severe asthma; Review studies of omalizumab
5:30 Probiotics, Prebiotics and Synbiotics For Prevention and
alone and in combination with AIT in asthma; Make recommendations on individual use of
Treatment of Allergic Disease these drugs and in combination for asthma.
Mimi L.K. Tang, MD PhD FAAAAI
5:45 Question & Answer 1902 When is an Elevated IgE Level a Sign of
Upon completion of this session, participants should be able to: Explain the role of vitamin Immunodeficiency?
D in allergic inflammation; Discuss the immunomodulatory effects of Chinese herbal Alexandra F. Freeman, MD
medicine for food allergy; Describe the role of prebiotics and probiotics in the prevention Hans D. Ochs, MD
and treatment of allergy. Marriott South Tower, Level 3, Mission Hills
Upon completion of this session, participants should be able to: Review the differential di-
Q & A Workshop agnosis of an elevated IgE level; Discuss the work up necessary in patients with elevated
IgE levels; Review the Hyper IgE syndromes.
1805 Difficult Situations in Practice Management
5:00 to 6:15 pm 1903 How to Assess and Manage a Child with Multiple
Convention Center, Mezzanine Level, Room 16AB Positive Environmental and Food Allergy Tests
Credit: 1.25 CME / 1.50 CE Sami L. Bahna, MD DrPH FAAAAI
Moderator: Tao T. Le, MD MHS FAAAAI Anna H. Nowak-Wegrzyn, MD FAAAAI
5:00 Employment Agreements and Partnerships Marriott South Tower, Level 3, Cardiff
Adhuna C. Mathuria, MD Upon completion of this session, participants should be able to: Explain the prevalence
Robert J. Holzhauer, MD MBA FAAAAI and difference between classic food allergies and pollen-food allergy syndrome; Describe
the utility of skin prick, fresh food skin prick, serum specific IgE testing, component
5:15 Hiring and Firing resolved diagnostics and oral food challenge in assessment of complex patients with mul-
Vinay Mehta, MD FAAAAI tiple food and environmental sensitizations; Discuss the management of complex patients
Weily Soong, MD FAAAAI with multiple food and environmental sensitivities and/or allergies.
5:30 Marketing and Referral Development
1904 So the Patient Has Eosinophilia: What Next?
Sakina S. Bajowala, MD FAAAAI
Amy D. Klion, MD
Stanley M. Fineman, MD MBA FAAAAI
Catherine R. Weiler, MD PhD FAAAAI
5:45 Question & Answer Marriott South Tower, Level 1, Point Loma
Upon completion of this session, participants should be able to: Identify and address Upon completion of this session, participants should be able to: Review diagnosis of
difficult situations regarding employment and partnership contracts; Evaluate difficult various hypereosinophilic syndromes; Describe identification of secondary eosinophilia;
situations in hiring and firing; Investigate difficult situations in marketing. Discuss therapeutic approaches to hypereosinophilic syndrome.

International Reception 1905 Mechanisms and Biomarkers Related to

5:00 to 6:00 pm Sublingual and Subcutaneous Immunotherapy
Convention Center, Upper Level, Ballroom 6CF Giovanni Passalacqua, MD
All international members and delegates are invited to attend this Mohamed H. Shamji, BSc MSc PhD
reception. Marriott South Tower, Level 1, Solana
Upon completion of this session, participants should be able to: Discuss humoral mecha-
Allied Health Wine and Cheese Reception nisms of SCIT and SLIT; Discuss cellular mechanisms of SCIT and SLIT; Discuss novel
biomarkers of successful SCIT and SLIT.
5:15 to 6:15 pm
Marriott South Tower, Level 4, La Costa
All allied health members and their guests are invited to attend
this reception for an evening of networking with other allied health Annual Meeting Seminars and Workshops
professionals. Programmed by the AAAAI. Annual Meeting Seminars and
Workshops funded through an educational grant from Merck.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 35
 friday, February 28

2014 Federation of RSLAAIS Assembly Forum, Business

Meeting and Reception
4:45 to 6:30 pm
San Diego Convention Center, Upper Level, Room 31AB
4:45 Wine and Cheese Welcome Reception
5:10 RSLAAIS Assembly Business Meeting
Moderator: Sharon B. Markovics, MD FAAAAI, RSLAAIS Chair
5:20 ACOs: Will they really be accountable?
Co-Moderators: Marshall P. Grodofsky, MD FAAAAI, RSL Governor
Jody T. Inglefield, MD FAAAAI, RSL Governor
Speakers:
Jonathan L. Bayuk, DO FAAAAI
Hampden County Physician Associates
Springfield, MA
Warner W. Carr, MD FAAAAI
Allergy and Asthma Associates of Southern California
6:10 Joint Council of Allergy, Asthma and Immunology (JCAAI) Update
Richard W. Honsinger, MD MACP FAAAAI
President, JCAAI
6:15 American Board of Allergy and Immunology (ABAI) Update
Stephen I. Wasserman, MD FAAAAI
President, ABAI
6:20 Whats Next With RSLs
6:30 Adjourn

36 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

Seminars or scheduled splenectomy.

7:00 to 8:00 am 2006 An Update on the Diagnosis and Treatment of

Pre-registration and ticket required. Fee: $40. Continental breakfast Chronic Granulomatous Disease (CGD)
included. Sessions and meals are limited to 30 people. Alexandra F. Freeman, MD
Credit: 1.00 CME / 1.20 CE Peter J. Mustillo, MD FAAAAI
2001 Microbiota and Asthma Marriott South Tower, Level 3, Mission Hills
Yvonne Huang, MD Upon completion of this session, participants should be able to: Describe current diagnos-
Marriott South Tower, Level 3, Marina Ballroom Salon D tic tests for CGD; Review treatment options for patients with CGD including consideration
for bone marrow transplant.
Upon completion of this session, participants should be able to: Review the importance
of the microbiota in asthma and allergic disorders; Discuss the dangers of inappropriate 2007 How to Be a Mold Sleuth
antibiotic use on the microbiota; Describe fostering a healthy microbiota.
Anupma B. Dixit, PhD
2002 Provocative Testing for Exercise-Induced Asthma: H. James Wedner, MD FAAAAI
Methacholine vs. Mannitol vs. Exercise Marriott South Tower, Level 3, Cardiff
Donald W. Cockcroft, MD FAAAAI Upon completion of this session, participants should be able to: Discern the quality of
building inspection reports regarding water damage and mold colonization in housing;
John M. Weiler, MD FAAAAI Describe mold sampling data to assess the significance of occupant exposure to molds
Marriott South Tower, Level 3, Marina Ballroom Salon E indoors.
Upon completion of this session, participants should be able to: Discuss indications/
contraindications for bronchoprovocation challenges in patients with EIB; Describe the 2008 Pathogenic Bacteria and Viral Illness: Are They
strengths and weaknesses of each in the evaluation of hyper-reactivity; Identify metha- Associated? What the Microbiome Tells Us
choline and mannitol challenge as potential tests for monitoring asthma treatment.
James E. Gern, MD FAAAAI
2003 Monitoring and Managing Non-Infectious Kirsten Kloepfer, MD
Complications of Common Variable Immune Marriott South Tower, Level 3, Del Mar
Upon completion of this session, participants should be able to: Describe the association
Deficiency between pathogenic bacteria and asthma exacerbations; Discuss potential mechanisms
Charlotte Cunningham-Rundles, MD PhD FAAAAI for viral infections to promote infections with pathogenic airway bacteria; Discuss
Rima A. Rachid, MD FAAAAI potential treatment implications related to bacterial infections, wheezing illnesses and
Marriott South Tower, Level 3, Marina Ballroom Salon F exacerbations of asthma.
Upon completion of this session, participants should be able to: Review the non-infectious 2009 Aspirin and Antibiotic Desensitization
complications of CVID; Discuss how to monitor and treat these complications.
Anahita F. Dioun, MD FAAAAI
2004 Theres an App for That: Using Smart Phones, Catherine R. Weiler, MD PhD FAAAAI
Tablets and Web Tools for Clinical Practice Marriott South Tower, Level 3, Miramar
Tao T. Le, MD MHS FAAAAI Upon completion of this session, participants should be able to: Describe what is needed
to perform a desensitization in the office; Discuss the desensitization of aspirin allergic
Melinda M. Rathkopf, MD FAAAAI
patients; Describe the desensitization of antibiotic allergic patients.
Marriott South Tower, Level 3, Marina Ballroom Salon G
Upon completion of this session, participants should be able to: Describe the various 2010 Fifty Shades of Eosinophilic Esophagitis:
device options and platforms available to the clinician; Discuss the various apps available Identifying the Phenotypes
for the various devices and how to maximize their use; Identify web tools useful in the
allergy practice. Juan Pablo Abonia, MD
Mirna Chehade, MD MPH
2005 Immunizing the Immunodeficient Patient Marriott South Tower, Level 1, Point Loma
Francisco A. Bonilla, MD PhD FAAAAI Upon completion of this session, participants should be able to: Demonstrate the ability
M. Louise Markert, MD PhD FAAAAI to identify EoE co-morbidities; Recognize when to suspect EoE given the medical history,
Marriott South Tower, Level 3, Balboa whenever esophageal eosinophilia is found; Discuss how to investigate for other poten-
Upon completion of this session, participants should be able to: Identify laboratory findings tially associated diseases with EoE that require medical attention.
that may predict when live viral vaccinations may be administered to patients with cellular 2011 Getting Ready for ICD-10: Cracking the Code
immunodeficiency; Describe factors involved in timing of live viral vaccinations after im-
munosuppressive medications; Discuss vaccinations and timing for patients with asplenia Priya J. Bansal, MD FAAAAI
Marshall P. Grodofsky, MD FAAAAI
Marriott South Tower, Level 1, Solana
Upon completion of this session, participants should be able to: Describe the differences
between ICD-10 and ICD-9-CM; Discuss the impact of ICD-10 on billing and coding;
Identify strategies for implementing ICD-10 in clinical practice.

2012 Component-Resolved Diagnosis for Inhalant

Annual Meeting Seminars Allergies
Programmed by the AAAAI. Annual Meeting Seminars funded Reto Crameri, PhD
through an educational grant from Merck. Peter Schmid-Grendelmeier, MD PhD
Marriott South Tower, Level 1, Santa Rosa
Upon completion of this session, participants should be able to: Describe cross-reactivity
between various inhalant allergens and food allergens; Define predictive value of CRD for
disease outcome; Identify better selection criteria for allergen-specific immunotherapy.

38 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

2013 Cockroach Immunotherapy Allied Health Workshop

Luisa Karla P. Arruda, MD PhD FAAAAI
William W. Busse, MD FAAAAI
2023 Management of Atopic Dermatitis
6:45 to 8:00 am
Marriott South Tower, Level 4, La Costa
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2
Upon completion of this session, participants should be able to: Discuss epidemiologic
studies on cockroach allergy, including outcomes of abatement procedures; Describe Pre-registration and ticket required. No fee.
characteristics of cockroach allergens and composition of cockroach extracts currently Credit: 1.25 CME / 1.50 CE
available; Discuss ongoing and published studies on cockroach immunotherapy and new Moderator: William R. Blouin, ARNP
perspectives for treatment of cockroach allergy. Instructors:
2014 Alternative Pathways of Antigen-Mediated Carla M. Duff, CPNP MSN
Sally A. Noone, RN MSN CCRC
Anaphylaxis Karol G. Timmons, RN MS CPNP
Mary Beth Hogan, MD FAAAAI Upon completion of this session, participants should be able to: Identify and differentiate
Wei Zhao, MD PhD FAAAAI atopic dermatitis from other skin conditions; Demonstrate appropriate skin care including
Marriott South Tower, Level 4, Catalina wet to dry dressings; Discuss how to teach patients and families about proper skin care.
Upon completion of this session, participants should be able to: Review the traditional
pathway of anaphylaxis; Discuss the role of basophils and neutrophils in the pathogenesis Allied Health Workshop
of anaphylaxis; Distinguish IgE (mast cell) mediated anaphylaxis from IgG/Platelet Activat-
ing Factor as an alternative mechanism of anaphylaxis. 2024 Bring Your Own Pediatric Food Challenge
2015 Interpreting Anti-IL5 Trial Data: Implications for Experience
Asthma, EoE and HES Pathophysiology 6:45 to 8:00 am
Steven J. Ackerman, PhD Marriott North Tower, Lobby Level, Torrey Pines 3
Sameer K. Mathur, MD PhD FAAAAI Credit: 1.25 CME / 1.50 CE
Marriott South Tower, Level 4, Coronado Moderator: Suzanne K. Carlisle, RN BSN CCRP
Upon completion of this session, participants should be able to: Discuss the different types Elisabeth S. Stieb, RN BSN AE-C
of anti-IL-5 therapy in use in clinical trials; Review the outcomes of anti-IL-5 therapy for Anne M. Hiegel, RN CRC
asthma, eosinophilic esophagitis and hypereosinophilic syndrome. Upon completion of this session, participants should be able to: Discuss solutions to
common problems encountered when conducting oral food challenges; Develop access to
Allied Health Workshop a network of health care providers conducting food challenges and interact with them as
needed throughout the year.
2021 The Ins and Outs of Management of Chronic
Eosinophilic Esophagitis Allied Health Workshop
6:45 to 8:00 am 2025 Exploring the Spectrum of Gluten-Related
Marriott North Tower, Lobby Level, Marriott Hall Salon 1
Credit: 1.25 CME / 1.50 CE
Disorders
Moderator: Debra A. Sedlak, MSN CPNP 6:45 to 8:00 am
Marriott North Tower, Lobby Level, Atlanta
6:45 Are You Missing the EoE Patient? It Starts with the History
Credit: 1.25 CME / 1.50 CE
Katie J. Atkinson, RN CFNP
Isabel J. Skypala, PhD
7:00 Diagnosis and Treatment Options: Diet or Steroids? Berber Vlieg-Boerstra, PhD RD
Seema Sharma Aceves, MD PhD FAAAAI Upon completion of this session, participants should be able to: Discuss the various
7:15 Meeting the Patients Needs: Nutrition and Quality of Life gluten-related disorders; Discuss strategies based on the individual patients gluten-
Marion E. Groetch, MS RD related disorder.
7:30 Question & Answer
Upon completion of this session, participants should be able to: List the common symp- Allied Health Workshop
toms of esosinophilic esophagitis (EoE) and the history that may trigger suspicion of EoE;
Identify appropriate treatment options; Define how to guide patients on elimination diets 2026 Pharmacology of Tobacco Cessation Medications
to meet nutritional needs and maintain quality of life. 6:45 to 8:00 am
Marriott North Tower, Lobby Level, Chicago
Allied Health Workshop Credit: 1.25 CME / 1.50 CE
Beth A. Allison, NP
2022 What Allied Health Professionals Need to Know Upon completion of this session, participants should be able to: Describe nicotine
About Drug Sensitivity dependence and nicotine withdrawal; Discuss evidence-based use of smoking cessation
6:45 to 8:00 am medications.
Marriott North Tower, Lobby Level, Marriott Hall Salon 2
Credit: 1.25 CME / 1.50 CE
Moderator: Kim E. Mudd, RN MSN CCRP
Miguel A. Park, MD
Upon completion of this session, participants should be able to: Define the key compo-
nents of the drug allergy history; Discuss diagnostic tests and work-up for drug allergies;
Review the treatment options for drug allergies.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 39
 saturday, March 1

Plenary Hands-On Workshop

2101 Immunotherapy: Mechanism, 2251 Adolecent Allergy/Asthma Simulation
Outcomes and Markers 10:00 am to 2:15 pm
8:15 to 9:45 am Convention Center, Ground Level, Exhibit Hall B
Convention Center, Ground Level, Exhibit Hall A Pre-registration and ticket required. No fee.
Credit: 1.50 CME / 1.80 CE Credit: 0.50 CME / 0.60 CE
Moderator: Linda Cox, MD FAAAAI Participate in a live simulation of treating an adolescent patient
experiencing allergies and asthma, working with faculty and
8:15 Tolerance to Allergens: How it Develops and How it Can be
standardized patients from the University of San Diego.
Induced
Upon completion of this session, participants should be able to demonstrate appropriate
Cezmi A. Akdis, MD FAAAAI clinical skills to be used when treating an adolescent patient at risk of, or experiencing,
8:45 Biomarker Predictors of Effective Immunotherapy allergies or asthma.
Stephen R. Durham, MA MD FRCP
9:15 SIT Outcomes: Examining the Data for Efficacy, Safety, Adherence Hands-On Workshop
and Costs
Linda Cox, MD FAAAAI 2252 Adult Anaphylaxis Simulation
Upon completion of this session, participants should be able to: Discuss the benefits of 10:00 am to 2:15 pm
specific immunotherapy; Describe factors affecting safety of specific allergy immunother- Convention Center, Ground Level, Exhibit Hall B
apy; Discuss the use of biomarkers to predict the response to immunotherapy to pollens. Pre-registration and ticket required. No fee.
Credit: 0.50 CME / 0.60 CE
Posters Participate in a live simulation of treating an adolescent patient
experiencing allergies and asthma, working with faculty and
7:00 am to 6:00 pm
standardized patients from the University of San Diego.
Convention Center, Ground Level, Exhibit Hall B
Upon completion of this session, participants should be able to demonstrate appropri-
Posters on display from 7:00 am to 6:00 pm. Authors present from ate clinical skills to be used when treating an adult patient at risk of, or experiencing
9:45 to 10:45 am. anaphylaxis.
Credit: No CME / No CE
Refer to pages 83 158 for abstracts and authors. Symposium
2201 Asthma Therapeutics: Advances in Biologics and
2301 Oral Immunotherapy (OIT)
Drugs 10:45 am to 12:00 pm
2202 Asthma Epidemiology Convention Center, Ground Level, Exhibit Hall A
2203 Primary Antibody Deficiencies Credit: 1.25 CME / 1.50 CE
Moderator: J. Andrew Bird, MD FAAAAI
2204 Asthma Epidemiology, Risk Factors, and Public 10:45 Current Protocols for Oral Immunotherapy
Health I Kari C. Nadeau, MD PhD FAAAAI
2205 Aerobiology I 11:05 Oral Immunotherapy: Native or Modified Allergen?
Hugh A. Sampson, MD FAAAAI
2206 Insect Hypersensitivity/Anaphylaxis
11:25 When Should We Stop Oral Immunotherapy? When Should it be
2207 HAE and Angioedema Restarted?
2208 Population Health in Asthma Giovanni B. Pajno, MD FAAAAI
2209 Healthcare Delivery in Primary 11:45 Question & Answer
Upon completion of this session, participants should be able to: Identify patients with
Immunodeficiency IgE-mediated food allergy who represent a target for OIT; Examine different protocols for
2210 Diagnostics different foods; Outline the risk-benefit ratio of OIT.

2211 Oral Immunotherapy

2212 Mechanisms of Cytokines and Chemokines
2213 Role of Granulocytes and Mast Cells in
Mechanisms of Allergic Disease
2214 Allied Health Poster Session

40 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

Symposium Symposium
2302 World Allergy Forum: Anaphylaxis: 2304 NHLBIs Clinical Asthma Research Networks
From Mechanisms to Novel (AsthmaNet) Approach to Key Asthma Questions
Therapeutics 10:45 am to 12:00 pm
10:45 am to 12:00 pm Convention Center, Upper Level, Ballroom 6A
Convention Center, Upper Level, Ballroom 6B Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE Moderators: William W. Busse, MD FAAAAI
Moderators: Linda Cox, MD FAAAAI James P. Kiley, PhD
Lanny J. Rosenwasser, MD FAAAAI 10:45 What Roles Do Novel and Not-So Novel Medications Have in
10:45 Diagnosis and Prevention of IgE and Non-IgE-Mediated Treating Preschool Wheezers?
Anaphylaxis Leonard B. Bacharier, MD FAAAAI
Fred D. Finkelman, MD 11:05 Is LABA or Increased Dose of ICS the Best Step-Up Therapy for
11:05 Causes of Anaphylaxis African Americans: Do Children Respond Differently Than Adults?
Motohiro Ebisawa, MD PhD FAAAAI Michael E. Wechsler, MD
11:25 Treatment of Anaphylaxis: Recent Advances 11:25 Does Vitamin D Have a Role in Clinical Asthma?
F. Estelle R. Simons, MD FAAAAI Mario Castro, MD MPH
11:45 Question & Answer 11:45 Question & Answer
Upon completion of this session, participants should be able to: Outline therapeutic
Upon completion of this session, participants should be able to: List the etiology and
options to optimize asthma treatment early in life; Describe the unique therapeutic ap-
mechanisms of anaphylaxis; Recognize the most common triggers in anaphylaxis; Discuss
proaches that produce improved outcomes in African-American patients; Discuss the use
the management of anaphylaxis including an action plan for prevention.
of Vitamin D as a therapeutic agent for treating asthma.

Symposium Symposium
2303 The Expanding Universe of Primary 2305 The Indoor Air Exposome in Work, School and
Immunodeficiency Home: Taking in the Whole Picture
10:45 am to 12:00 pm
10:45 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6CF
Convention Center, Mezzanine Level, Room 14AB
Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE
Moderator: M. Teresa De La Morena, MD
Moderator: Jill A. Poole, MD FAAAAI
10:45 The Ever-Expanding Spectrum of PID
10:45 Exposure Assessments and Risk of Disease in Multiple Settings
Troy R. Torgerson, MD PhD
Wanda Phipatanakul, MD MS FAAAAI
11:05 Diagnosing PID in 2014
11:05 Pesticides, Chemicals and Other Exposures Matter in Allergic
Kathleen E. Sullivan, MD PhD FAAAAI
Disorders
11:25 Supporting and Reconstituting Immune Function Rachel L. Miller, MD FAAAAI
M. Louise Markert, MD PhD FAAAAI
11:25 Evaluation and Management of Patients Presenting with
11:45 Question & Answer Suspected Building-Related Illness
Upon completion of this session, participants should be able to: Describe how discovery Karin A. Pacheco, MD MSPH FAAAAI
of new immunodeficiencies leads to new insights into immune system biology; Develop
a stepwise approach to diagnosing the broad range of immunodeficiencies; Discuss the 11:45 Question & Answer
latest developments in the therapy of immunodeficiency. Upon completion of this session, participants should be able to: Describe the most com-
mon indoor air quality issues that cause negative health effects; Identify the emerging
role of pesticides, chemicals and other exposures in modulating allergic sensitization,
epigenetic markers and health outcomes; Outline best practices for clinical assessment of
susceptible workers exposed to poor office indoor air quality and remediation strategies to
create a healthy office indoor air quality environment.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 41
 saturday, March 1

Symposium Symposium
2306 Mechanisms of Virus-Induced Asthma 2308 The Relevance of Microbes and Their Diversity in
10:45 am to 12:00 pm Chronic Rhinosinusitis and Asthma
Convention Center, Mezzanine Level, Room 15AB 10:45 am to 12:00 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Upper Level, Room 30ABCDE
Moderator: Mitchell H. Grayson, MD FAAAAI Credit: 1.25 CME / 1.50 CE
10:45 Local Interactions Betweens Dendritic Cells and T Cells in the Moderator: Martin Wagenmann, MD FAAAAI
Antiviral Immune Response 10:45 Asthma and the Relevance of the Microbiome
Kevin Legge, PhD Trevor ThomasHansel, MD PhD
11:05 The Neutrophilic Antiviral Response: Is There More Than Meets 11:05 Biofilms in Chronic Rhinosinusitis
the Eye? James Palmer, MD
Dorothy S. Cheung, MD FAAAAI 11:25 Dont Underestimate Viruses as Relevant Factors in the
11:25 The Chronic NKT-Macrophage Axis in Asthma Development of Chronic Airway Disease
Michael J. Holtzman, MD FAAAAI Daniel J. Jackson, MD
11:45 Question & Answer 11:45 Question & Answer
Upon completion of this session, participants should be able to: Discuss how innate Upon completion of this session, participants should be able to: Discuss the relevance of
lymphoid cells contribute to airway inflammation in response to viral infections; Discuss microbial diversity in the development of asthma; Define alterations in resident microbiota
new understanding of the neutrophilic response during viral infections; Describe how NKT relevant for chronic rhinosinusitis presentation and treatment; Recognize the importance
cells and macrophages drive a chronic post-viral asthma phenotype. of viral infections in the development of chronic lower airway disease.

Symposium Allied Health Workshop

2307 Innovative Methods for Reducing Asthma 2311 Anaphylaxis Recognition and Management:
Disparities What People Need to Know
10:45 am to 12:00 pm 10:45 am to 12:00 pm
Convention Center, Mezzanine Level, Room 16AB Marriott North Tower, Lobby Level, Marriott Hall Salon 1
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Mary E. Bollinger, DO Moderator: Debra A. Sedlak, MSN CPNP
10:45 Reaching Kids Where They Are: School-Based Asthma Panelists
Interventions William R. Blouin, ARNP
Minal R. Patel, PhD MPH Vivian P. Hernandez-Trujillo, MD FAAAAI
11:05 Telemedicine: How Can it be Utilized to Decrease Barriers to Gabriel Ortiz, MPAS PA-C
Asthma Healthcare? Upon completion of this session, participants should be able to: Discuss how patients,
Tamara T. Perry, MD teachers and members of the lay community can recognize the signs and symptoms of
anaphylaxis; Discuss how to plan and use appropriate treatment.
11:25 Can Web-Based and Mobile Applications Improve Asthma
Outcomes?
Giselle Mosnaim, MD MS FAAAAI
Allied Health Workshop
11:45 Question & Answer 2312 Atopic Dermatitis: Advancing Proficiency in
Upon completion of this session, participants should be able to: Describe the impact of Management
web and mobile-based interventions for asthma healthcare delivery; Discuss the impact
and cost-effectiveness of school-based asthma interventions on health outcomes; Discuss
10:45 am to 12:00 pm
the impact of asthma subspecialty care via telemedicine on health outcomes. Marriott North Tower, Lobby Level, Marriott Hall Salon 2
Pre-registration and ticket required. No fee.
Credit: 1.25 CME / 1.50 CE
Moderator: Pooja Varshney, MD
10:45 Atopic Dermatitis: Immune Dysregulation
Gregory M. Metz, MD
11:00 Atopic Dermatitis: Management Strategies
Karen L. Gregory, DNP APRN-BC RRT AE-C
11:15 Hands-On Instruction
Upon completion of this session, participants should be able to: Discuss the complex
immune dysregulation that occurs in atopic dermatitis; Describe the general concepts of
managing atopic dermatitis; Identify signs and symptoms that warrant further investiga-
tion (food allergy, immune deficiency, secondary infections).

42 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

Allied Health Workshop Allied Health Workshop

2313 Immune Replacement Therapy: The Route to 2316 Using Technology to Improve Patient Adherence
Travel 10:45 am to 12:00 pm
10:45 am to 12:00 pm Marriott North Tower, Lobby Level, Atlanta
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2 Credit: 1.25 CME / 1.50 CE
Pre-registration and ticket required. No fee. Moderator: John D. Milewski, Med. Admin.
Credit: 1.25 CME / 1.50 CE David R. Stukus, MD FAAAAI
Moderator: Ginger S. LaBelle, CPNP 11:30 Question & Answer
10:45 SCIG Upon completion of this session, participants should be able to: Discuss the recognition of
Kristin Epland, NP health literacy in patients and its impact on adherence to treatment plans; Review tools
available for use in clinical practice; Discuss ways to utilize both social media and mobile
11:00 IVIG devices to improve office and provider efficiency, patient engagement and overall care in
M. Elizabeth M. Younger, CRNP PhD the clinical setting.
11:15 Hands-On Instruction
Upon completion of this session, participants should be able to: Describe the pros and Allied Health Professional Assembly Forum
cons of both IV and SC therapy; Identify the supplies and devices used for SC infusions.
12:30 to 1:30 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 6
Allied Health Symposium All allied health professionals are invited to attend this forum. Box
2314 The Contribution of Aerobiology Towards Asthma lunches included.
Morbidity
Seminars
10:45 am to 12:00 pm
Marriott North Tower, Lobby Level, Torrey Pines 3 12:30 to 1:30 pm
Credit: 1.25 CME / 1.50 CE Pre-registration and ticket required. Fee: $40. Box lunch included.
Moderator: David L. Rosenstreich, MD FAAAAI Sessions and meals are limited to 30 people.
10:45 Association Between Tree Pollen Counts and Asthma ER Visits in Credit: 1.00 CME / 1.20 CE
a High-Density Urban Center 2501 The Evolution of Childhood Wheezing to Asthma
Sunit Jariwala, MD Leonard B. Bacharier, MD FAAAAI
11:05 The Impact of Mouse Allergen on Asthma Bradley E. Chipps, MD FAAAAI
Susan L. Balcer-Whaley, MPH Marriott South Tower, Level 3, Marina Ballroom Salon D
11:25 Neighborhood Differences in Asthma Prevalence and Persistence Upon completion of this session, participants should be able to: Determine the diagnostic
criteria for varied phenotypic expression of childhood asthma; Examine the progression of
Matthew S. Perzanowski, PhD
immunopathologic events in the development of childhood asthma; Examine the implica-
11:45 Question & Answer tion for treatment given the varied immunopathologic and phenotypic expressions.
Upon completion of this session, participants should be able to: Describe the relationship
between outdoor air quality components and asthma-related morbidities; Identify the 2502 Performing and Interpreting Spirometry:
effect mouse allergen contributes to asthma in an urban environment. Understanding and Implementing the ATS/ERS
Guidelines
Allied Health Workshop James M. Quinn, MD FAAAAI
2315 Revenue Management with Correct Coding Kevin M. White, MD
10:45 am to 12:00 pm Marriott South Tower, Level 3, Marina Ballroom Salon E
Marriott North Tower, Lobby Level, Chicago Upon completion of this session, participants should be able to: Identify the source and
relevance of the ATS/ERS guidelines for lung function testing; Discuss the ATS/ERS recom-
Credit: 1.25 CME / 1.50 CE
mendations for correct performance of spirometry; Identfy ATS/ERS guidelines to interpret
Moderator: Joan E. Hawkins spirometry and classify the severity of identified abnormalities.
Teresa Thompson, CPC CMSCS CCC
11:30 Question & Answer
2503 Hereditary Angioedema: Diagnosis and
Upon completion of this session, participants should be able to: List the current CPT Management
guidelines; Describe the current information to code correctly to third party payer guide- Mark S. Dykewicz, MD FAAAAI
lines; Discuss the current information regarding reviews from CMS, OIG, RAC and third Andrew J. MacGinnitie, MD PhD
party payers. Marriott South Tower, Level 3, Marina Ballroom Salon F
Upon completion of this session, participants should be able to: Review the mechanism of
HAE; Discuss how and when to use the new therapies for HAE; Describe how to improve
outcomes of your patients with HAE.

Annual Meeting Seminars

Programmed by the AAAAI. Annual Meeting Seminars funded
through an educational grant from Merck.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 43
 saturday, March 1

2504 Making the Most of Your EMR: Meeting 2510 Quality Improvement and Patient Safety in
Meaningful Use Allergy Practice
Priya J. Bansal, MD FAAAAI Brad J. McClimon, MD
A. Sean McKnight, MD FAAAAI Matthew A. Rank, MD FAAAAI
Marriott South Tower, Level 3, Marina Ballroom Salon G Marriott South Tower, Level 1, Point Loma
Upon completion of this session, participants should be able to: Discuss tips for optimizing Upon completion of this session, participants should be able to: Discuss the need for
your current EMR; Discuss current state of Meaningful Use government incentive pay- allergists to consider, plan and perform quality projects; Discuss fundamental principles
ments; Discuss clinical quality measures and PQRI reporting with your EMR. guiding quality improvement of allergic/immunologic diseases in the United States;
Discuss potential quality improvement opportunities that could positively influence the
2505 When Should Bone Marrow Transplantation be outcomes of allergy, asthma and immunology education, research and patient care at the
Considered in Primary Immunodeficiency? local and national level.
Rebecca A. Marsh, MD 2511 Biologics Targeting the Immune Responses in
Elena E. Perez, MD PhD FAAAAI
Marriott South Tower, Level 3, Balboa
Chronic Rhinosinusitis and Nasal Polyps
Claus Bachert, MD PhD
Upon completion of this session, participants should be able to: Review the primary immu-
nodeficiency diseases for which BMT can be a curative treatment; Discuss how soon after Daniel L. Hamilos, MD
diagnosis a patient with certain immunodeficiency disorders should be referred to a BMT Marriott South Tower, Level 1, Solana
center; Describe any therapies to be avoided prior to a patient going to transplant. Upon completion of this session, participants should be able to describe biologic treat-
ments under consideration for treatment of chronic rhinosinusitis.
2506 Viral Infections in the Allergic Host: What Factors
May Be Synergistic? 2512 Immunotherapy with Immunomodulator
Josh L. Kennedy, MD Therapy: Which Work and Which Do Not?
Eva Kathryn Miller, MD Peter S. Creticos, MD FAAAAI
Marriott South Tower, Level 3, Mission Hills Mohamed H. Shamji, BSc MSc PhD
Upon completion of this session, participants should be able to: Evaluate the innate im- Marriott South Tower, Level 1, Santa Rosa
mune response to viral infection in the exacerbating asthmatic, particularly the evidence Upon completion of this session, participants should be able to: Review new data on the
of a deficient or overactive response; Discuss the role of the epithelium in asthmatic combination of immunotherapy and certain immunomodulators; Discuss the the possible
responses to viral infection; Evaluate the role of allergy by examining the evidence that IgE mechanisms that might account for these findings, analyzing the mechanisms of im-
responses are important predictors of asthma exacerbations. munotherapy in a new light.

2507 Biomass Smoke: Alternative Energy or Pollutant 2513 Evaluating Experimental Models of Allergic
Source? Rhinitis
Patricia Mason Fritz Anne K. Ellis, MD MSc FAAAAI
Alisa M. Smith, PhD FAAAAI Martin Wagenmann, MD FAAAAI
Marriott South Tower, Level 3, Cardiff Marriott South Tower, Level 4, La Costa
Upon completion of this session, participants should be able to: Recognize the emergence Upon completion of this session, participants should be able to: Describe the most com-
of a potentially significant source of community (neighborhood) air pollution; Discuss monly used methodologies for experimental nasal allergen challenge in the investigation
the continuum and coherence of health effects from exposure to combustion emissions; of allergic rhinitis; Describe the commonly used methodologies utilized in environmental
Analyze the role of ambient air pollution on the health of non-urban populations. exposure unit-type studies of allergic rhinitis; Describe the advantages and disadvantages
of both experimental models pertaining to the study of allergic rhinitis.
2508 The Intricacy of Penicillin Allergy Evaluation
Eric M. Macy, MD FAAAAI 2514 Food Allergy and the Mucosal B Cell
Miguel A. Park, MD Cathryn R. Nagler, PhD
Marriott South Tower, Level 3, Del Mar Duane R. Wesemann, MD PhD
Upon completion of this session, participants should be able to: Discuss the different Marriott South Tower, Level 4, Catalina
components of the penicillin skin test; Discuss how the different components of the Upon completion of this session, participants should be able to: Discuss how commensal
penicillin skin test affect the negative predictive value; Discuss the role of oral challenges organisms and dietary antigens may shape the pre-immune antibody repertoire; Review
to penicillin and/or amoxicillin in the evaluation of penicillin allergy. the known mechanisms underlying immune tolerance to gut luminal antigens; Describe
the mechanisms regulating antibody affinity maturation and IgH class switch recombina-
2509 Performance of Oral Food Challenges in the tion to IgE.
Office Setting 2515 Prostaglandins: Regulatory Lipid Mediators
S. Allan Bock, MD FAAAAI
Darryl C. Zeldin, MD
Justin M. Skripak, MD
Weisong Zhou, PhD
Marriott South Tower, Level 3, Miramar
Marriott South Tower, Level 4, Coronado
Upon completion of this session, participants should be able to: Describe and perform
Upon completion of this session, participants should be able to: Define the role of
food challenges in their own practices; Review the practical aspects of how to carry out a
prostaglandins in vascular remodeling and allergic lung inflammation; Describe the role
typical food challenge in the office; Discuss how to select patients for extensively heated
of prostaglandins in regulating T cell differentiation and function; Describe the role of
milk and egg challenges and how to perform those challenges.
prostaglandins on allergen-induced immune tolerance.

Annual Meeting Seminars

Programmed by the AAAAI. Annual Meeting Seminars funded
through an educational grant from Merck.

44 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

Pro/Con Debate Pro/Con Debate

2521 NHLBI Guideline Adherence Leads to 2524 The Microbiome is Important in Asthma
Improvements in Asthma Outcomes in Medical 12:30 to 1:30 pm
Center Homes Convention Center, Upper Level, Ballroom 6CF
Credit: 1.00 CME / 1.20 CE
Programmed by the AAAAI and JCAAI. Honored through an educational
Moderator: R. Stokes Peebles, Jr., MD FAAAAI
grant from Robert J. Becker, MD, Joint Council of Allergy, Asthma and
Immunology Memorial Lectureship Fund. Pro
12:30 to 1:30 pm Homer A. Boushey, MD FAAAAI
Convention Center, Mezzanine Level, Room 15AB Con
Credit: 1.00 CME / 1.20 CE Thomas A.E. Platts-Mills, MD PhD FAAAAI
Moderator: Tao T. Le, MD MHS FAAAAI Upon completion of this session, participants should be able to: Define the human micro-
biome; Discuss the relevance of the human microbiome to allergic disease, particularly as
Pro it relates to asthma; Discuss possible alterations to the microbiome that might be useful
Richard W. Honsinger, MD MACP FAAAAI in asthma therapy.
Con
Harvey L. Leo, MD FAAAAI Pro/Con Debate
Upon completion of this session, participants should be able to: Describe the role of quality
measures in the development of ACA parameters; Identify limitations in guideline develop- 2525 Biopsy is Necessary for Follow-up of EoE
ments for chronic diseases like asthma; Develop novel ideas to promote the expertise of 12:30 to 1:30 pm
allergy/immunologys role in active population based management of an important chronic Convention Center, Upper Level, Ballroom 6DE
disease.
Credit: 1.00 CME / 1.20 CE
Moderator: Katrina Jane Allen, MD PhD FAAAAI
Pro/Con Debate Pro
2522 Bronchial Thermoplasty Has a Role in Severe Jonathan M. Spergel, MD PhD FAAAAI
Asthma Management Con
12:30 to 1:30 pm Mirna Chehade, MD MPH
Convention Center, Upper Level, Ballroom 6A Upon completion of this session, participants should be able to: List the arguments sup-
porting the assertion that endoscopy is necessary for monitoring EoE; Discuss the argu-
Credit: 1.00 CME / 1.20 CE
ments suggesting that you can follow EoE patients by symptoms; Discuss the relevance of
Moderator: Mark F. Sands, MD FAAAAI endoscopies and symptom scores in evaluating and managing patients with esophageal
Pro eosinophilia.
Mario Castro, MD MPH
Con Pro/Con Debate
William J. Calhoun, MD FAAAAI
Upon completion of this session, participants should be able to: Recognize the risk and
2526 Bone Marrow Biopsy is Indicated in Idiopathic
benefit of bronchial thermoplasty (BT) in asthma management; Describe the indications Anaphylaxis
and contraindications for BT; Describe the outcomes of major clinical trials for BT. 12:30 to 1:30 pm
Convention Center, Upper Level, Room 11AB
Pro/Con Debate Credit: 1.00 CME / 1.20 CE
Moderator: Phillip L. Lieberman, MD FAAAAI
2523 Component Resolved Diagnosis Can Predict
Pro
Anaphylactic Reactions to Peanut Mariana C. Castells, MD PhD FAAAAI
12:30 to 1:30 pm
Con
Convention Center, Upper Level, Ballroom 6B
Paul A. Greenberger, MD FAAAAI
Credit: 1.00 CME / 1.20 CE
Upon completion of this session, participants should be able to: Name the current informa-
Moderator: Stacie M. Jones, MD tion related to mast cell activation syndrome and idiopathic anaphylaxis; Discuss the
Pro primary and secondary triggers of mast cell activation syndrome and anaphylaxis; List the
Joerg R. Kleine-Tebbe, MD FAAAAI current treatment guidelines of mast cell activation syndrome and idiopathic anaphylaxis.
Con
Anna H. Nowak-Wegrzyn, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the significance
of molecular testing as an indicator for food allergen challenge.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 45
 saturday, March 1

Pro/Con Debate Oral Abstract

2527 All Patients with Recurrent Sinus Infections 2602 Mechanisms and Immunotherapy
Should be Screened for Immunodeficiencies 2:00 to 3:15 pm
12:30 to 1:30 pm Convention Center, Upper Level, Ballroom 6CF
Convention Center, Upper Level, Room 30ABCDE Credit: 1.25 CME / 1.50 CE
Credit: 1.00 CME / 1.20 CE Moderator: Ricardo U. Sorensen, MD
Moderator: John M. Routes, MD FAAAAI 2:00 The Utility Of Anti-Pneumococcal Antibody Measurement
Pro In Patients With Primary Immunodeficiency Receiving
Vincent R. Bonagura, MD FAAAAI Immunoglobulin
Con Stephen Jolles
Todd T. Kingdom, MD 2:15 Diagnostic Immunization With Bacteriophage X 174
Upon completion of this session, participants should be able to: List the differential In Patients With Common Variable Immunodeficiency/
diagnosis of recurrent or chronic sinusitis in adults; Identify appropriate immunodeficiency Hypogammaglobulinemia
screening measures in recurrent/chronic sinusitis and patients that would benefit from Lauren Smith, MD
screening. 2:30 Immunochip Study Reveals Regions On Chromosomes 2 and 6
May Contribute To The Spectrum Of CVID
Oral Abstract Tracy Hwangpo, MD PhD
2601 Novel Genetic Factors in Asthma 2:45 Rule Of Different Memory Cells In Common Variable
2:00 to 3:15 pm Immunodeficiency and Specific Antibody Deficiency
Convention Center, Upper Level, Ballroom 6A Amer M. Khojah, MD
Credit: 1.25 CME / 1.50 CE 3:00 Evaluation of a Novel Missense Activation-Induced Deaminase
Moderator: Paula L. Busse, MD FAAAAI AID Mutation in a Child with Hyper IgM Syndrome: Is it a
2:00 IL-33 and IL1RL1 Single Nucleotide Polymorphisms and Their Pathogenic Mutation?
Association With Asthma Among Puerto Ricans Ottavia M. Delmonte, MD
Javier A. Mendez, MD Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.
2:15 Genetic Effect Of Single-Nucleotide Polymorphisms In The
PPARGC1B Gene On Airway Hyperreactivity In Asthmatic Patients
Jong-Sook Park, MD
Oral Abstract
2:30 Polymorphisms In IL10, TGFB, TLR4, TLR8 and ADBR2 Genes 2603 Asthma Environmental Risk Factors and
Resulted Associated To Asthma In Brazilian Family Trio Study Infections
Isabel Rugu Genov, MD 2:00 to 3:15 pm
2:45 Genetic Variation Along The Histamine Pathway In Children With Convention Center, Mezzanine Level, Room 14AB
Allergic Vs. Non-Allergic Asthma Credit: 1.25 CME / 1.50 CE
Sara Anvari, MD Moderator: Daniel Elkayam, MD
3:00 Association Of Polymorphism At The CD14 Promoter (CD14- 2:00 Surfactant Protein A (SP-A) Reduces Human Rhinovirus 16
C159T) With Atopic and Non-Atopic Asthma In Adults From (RV16)-Induced Inflammatory Responses In Bronchial Epithelial
Crimea, Ukraine Cells and Inhibits Viral Replication In H1-HeLa Cells
Yuri Bisyuk Sasipa Tanyaratsrisakul, PhD
Upon completion of this session, participants should be able to discuss recent research 2:15 The Home Microbiome and Childhood Asthma
developments in the field of allergy/immunology.
Christina E. Ciaccio, MD FAAAAI
2:30 Effect Of Prenatal Antioxidant Intake On Infants Respiratory
Infection
Eun Lee
2:45 Epidermal Growth Factor Receptor (EGFR) Mediates Cell Fusion
and Infectivity Of Respiratory Syncytial Virus (RSV)
Sujin Lee
3:00 Cluster Analysis Of An Inner-City Cohort Of Infant Wheezers
Monica B. Reddy, MD
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.

46 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

Oral Abstract Oral Abstract

2604 Atopic Dermatitis 2606 Local Allergic Rhinitis and Non-Allergic Rhinitis
2:00 to 3:15 pm 2:00 to 3:15 pm
Convention Center, Upper Level, Ballroom 6B Convention Center, Upper Level, Ballroom 6DE
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderators: Lisa A. Beck, MD FAAAAI Moderator: Joaquim Mullol, MD PhD FAAAAI
Peck G. Ong, MD FAAAAI 2:00 The Nasal NO Response To External Acoustic Energy: A Pilot
2:00 A Randomized, Multi-Center, NIH/NIAID Funded Study To Assess Study
The Immunogenicity Of Fluzone Intradermal and Intramuscular Dennis Shusterman, MD MPH
Vaccines In Atopic Dermatitis 2:15 Flagellin/Toll-Like Receptor 5 Induces Interleukin-17C In Human
Donald Y.M. Leung, MD PhD FAAAAI Nasal Epithelia
2:15 Which Infants With Eczema Are At Risk Of Food Allergy? Results Hyun Jin Min
From A Population Based Study 2:30 Phenotyping Non-Allergic and Local Allergic Rhinitis
Jana K. Eckert, PhD Carmen Rondon, MD PhD
2:30 Exome Chip Genotyping Reveals Association With PDE4C and 2:45 Role Of Basophil Activation Test For Identifying Subjects With
Atopic Dermatitis In Populations Of European and African Descent Local Allergic Rhinitis
Nicholas M. Rafaels Paloma Campo, MD PhD
2:45 Exploring a Role for Laminin Proteins in the Pathogenesis of 3:00 Does Serum Leptin Differ Between Patients With Rhinitis Of
Atopic Dermatitis Allergic Vs Nonallergic Aetiology?
Erin J. Klaffky, MD PhD Ayse Fusun Kalpaklioglu, MD
3:00 Thymic Stromal Lymphopoietin and Interleukin-33 Promote Skin Upon completion of this session, participants should be able to discuss recent research
Inflammation and Containment Of Vaccinia Virus In A Mouse developments in the field of allergy/immunology.
Model Of Atopic Dermatitis
Michiko K. Oyoshi, PhD MSc Oral Abstract
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.
2607 Mechanisms of Steroid and Arachidonic Acid
Pathways in Allergic Disease
Oral Abstract 2:00 to 3:15 pm
Convention Center, Mezzanine Level, Room 16AB
2605 Health Disparities Credit: 1.25 CME / 1.50 CE
2:00 to 3:15 pm Moderators: Larry Borish, MD FAAAAI
Convention Center, Upper Level, Room 1AB Dawn C. Newcomb Baker, PhD
Credit: 1.25 CME / 1.50 CE 2:00 LTC4, But Not LTD4 Or LTE4, Activates Platelets Through a
Moderators: Melody C. Carter, MD CysLT2R and P2Y12 Receptor-Dependent Pathway
Princess U. Ogbogu, MD FAAAAI Joshua A. Boyce, MD FAAAAI
2:00 What Really Happens In The Home: The Medication Environment 2:15 Predictors Of Response To Glucocorticoids In Hypereosinophilic
Of Urban, Minority Youth Syndromes
Molly Martin, MD MAPP Paneez Khoury, MD
2:15 Young, African American Adults With Asthma: What Matters To 2:30 Differential Proteomic Analysis Of Eosinophils From Patients
Them? With Glucocorticoid Responsive Or Resistant Hypereosinophilic
Aimee L. Speck, MD Syndrome
2:30 Language Disparities Among Minority Patients with Poor Asthma Konrad Pazdrak, MD PhD
Control 2:45 Glucocorticoid Receptor- Up-Regulation In C57BL/6 Diet-
Jose R. Zaragoza-Buxo, MD Induced Obese Mice With House Dust Mite-Mediated Asthma
2:45 Race/Ethnicity and SES Are Predictors Of Allergic Sensitization To Jennifer Diaz, MD
Environmental and Food Allergens 3:00 Reduced EP2 Receptor Expression Accounts For Prostaglandin E2
Amina Abdeldaim, MD Resistance In Nasal Polyp Fibroblasts From Patients With Aspirin
3:00 Unrecognized Allergic Rhinoconjunctivitis and Allergic Exacerbated Respiratory Disease; Possible Role For Histone
Sensitization Among Latino Youth (GALA II Study) Acetylation In Control Of EP2 Receptor Expression
Ulysses Burley, MPH Katherine N. Cahill, MD
Upon completion of this session, participants should be able to discuss recent research Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology. developments in the field of allergy/immunology.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 47
 saturday, March 1

Symposium Allied Health Workshop

2611 SLIT: Implementation in Your Practice 2623 ICD-10CM: Dispelling the Fear
2:00 to 3:15 pm 2:00 to 3:15 pm
Convention Center, Ground Level, Exhibit Hall A Marriott North Tower, Lobby Level, Torrey Pines 1 & 2
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
A recording of this session will be available online free of charge to Moderator: Joan E. Hawkins
registered attendees following the Annual Meeting. Teresa Thompson, CPC CMSCS CCC
Moderators: Dsire E.S. Larenas Linnemann, MD FAAAAI 2:45 Question & Answer
Michael S. Tankersley, MD FAAAAI Upon completion of this session, participants should be able to: Identify the documentation
2:00 Therapeutic Mechanisms of SLIT requirements for the ICD-10CM system; Review the guidelines for choosing the correct
Stephen R. Durham, MA MD FRCP diagnosis code for ICD-10; Discuss the timelines and the effects on the entire allergy
practice.
2:20 SLIT Approval Trials in the U.S.
Thomas B. Casale, MD FAAAAI
2:40 SLIT in Practice: The Nuts and the Bolts of Using it
Allied Health Symposium
Linda Cox, MD FAAAAI 2624 Data Management: Taking Your Data from
3:00 Question & Answer Collection to Analysis
Upon completion of this session, participants should be able to: Review how SLIT works; 2:00 to 3:15 pm
Discuss the results of pivotal SLIT clinical trials; Describe how to use SLIT in practice.
Marriott North Tower, Lobby Level, Torrey Pines 3
Credit: 1.25 CME / 1.50 CE
Allied Health Workshop Moderator: Patrick J. Lenehan, MD
2621 Patient Safety in Allergy Practices: Is it an Issue? 2:00 Data Collection: The First Part of a Long Process
2:00 to 3:15 pm Patrick J. Lenehan, MD
Marriott North Tower, Lobby Level, Marriott Hall Salon 1 2:20 Data Cleaning: Reviewing and Reflecting on Study Variables
Credit: 1.25 CME / 1.50 CE Charles Aloe, MPH
Moderator: John D. Milewski, Med. Admin. 2:40 Data Analysis: Identifying the True Message
2:00 Malpractice: Risk Assessment Jean Curtin-Brosnan, MA
Donald W. Aaronson, MD FAAAAI 3:00 Question & Answer
2:30 Question & Answer Upon completion of this session, participants should be able to: Discuss strategies for col-
Upon completion of this session, participants should be able to: Identify potential causes of lecting and storing data completely and accurately; Describe the process of cleaning data
patient injury due to allergy care; List actions that can prevent patient injury in an allergy and preparing it for analysis; Identify how changes in data can affect analytical results.
practice; Discuss the risks of allergy immunotherapy and how to design practices that will
reduce medical errors related to allergen immunotherapy that result in patient injury.

Allied Health Symposium

2622 Taking a Food Allergy History for the Advanced
Practice Provider: The Key to Diagnosis
2:00 to 3:15 pm
Marriott North Tower, Lobby Level, Marriott Hall Salon 2
Credit: 1.25 CME / 1.50 CE
Moderator: Pamela H. Steele, MSN CPNP AE-C
2:00 Obtaining a Complete and Concise Food Allergy History from Your
Patients
Maria G. Crain, CPNP AE-C
2:30 Interpreting the History to Guide Your Use of Diagnostic Testing
Katie J. Atkinson, RN CFNP
3:00 Question & Answer
Upon completion of this session, participants should be able to: Describe a complete food
allergy history; Discuss a concise diet history; Interpret patient information to guide testing.

48 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

Allied Health Workshop Keynote

2625 Allied Health Workshop: Travel Scholarship 2701 Genomic and Wireless Digital Innovation:
Award Recipients Reshaping the Future of Medicine
2:00 to 3:15 pm 3:30 to 4:30 pm
Marriott North Tower, Lobby Level, Atlanta Convention Center, Ground Level, Exhibit Hall A
Credit: 1.25 CME / 1.50 CE Credit: 1.00 CME / 1.20 CE
Moderator: Stephen J. McGeady, MD FAAAAI Moderator: Stuart L. Abramson, MD PhD FAAAAI
2:00 Case Study of a Successful Asthma Network Eric J. Topol, MD
Karen L. Meyerson, MSN FNP-C AE-C Cardiologist, Scripps La Jolla, California; Professor of Genomics at
2:05 AsthmaCare Partners Program the Scripps Research Institute and Chief Academic Officer of Scripps
Julie A. Kuhn, MSW Health; and Editor-in-Chief at Medscape
2:10 Patient Satisfaction Surveys (Research) Upon completion of this session, participants should be able to describe how genomics
Diane G. Ananos, RN and digital technologies can be utilized in the development and implementation of medical
management plans.
2:15 Five Years of FOIT (Food Oral Immunotherapy) in Private Practice
Angela Hague, PA-C
Q & A Workshop
2:20 Developing Support Groups for Patients with EGID
Raquel Z. Durban, MS RD LDN 2801 The Influence of Bisphenol A and Phthalates
2:25 Bridging the Gap: Gaps in the World of Food Protein Entercolitis (Xenoestrogens) on the Development of Asthma
Fallon Schultz, MSW LCSW CAM and Allergy in Children and Adults: Whats Known
2:30 Understanding Barriers and Support in Asthma Management in
and Whats Real?
School Age Children
4:45 to 6:00 pm
Helena Azzi, DNP FNP-BC AE-C
Convention Center, Upper Level, Room 1AB
2:35 Indentifying Dietary Interventions in EoE Credit: 1.25 CME / 1.50 CE
Anna C. Sprunger, PA-C Moderator: Leslie C. Grammer, MD FAAAAI
2:40 Strengthening Physicians' Ability to Convey Information to 4:45 How Are We Exposed to Bisphenol A and Phthalates in Our
Patients Immediate and Regional Environments?
Edward M. Horowitz, BA Randall M. Goldblum, MD
2:45 Effietive Program Planning Program Workshop for Asthma 5:00 What Can Basic Research Teach Us About the Effects of
Educators Xenoestrogens on Allergy and Asthma?
Margaret J. McCormick, MS RN Terumi Midoro-Horiuti, MD PhD FAAAAI
2:50 Surprising Benefits of Omalizumab in a Patient with Mixed 5:15 What Have We Observed About the Effects of Xenoestrogens on
Disease Asthma/COPD A Case Study in Knoxville, Tennessee the Development of Childhood and Adult Asthma and Allergy?
Laura E. Odom, MSN FNP Rachel L. Miller, MD FAAAAI
2:55 Question & Answer 5:30 Question & Answer
Upon completion of this session, participants should be able to: Develop an appreciation Upon completion of this session, participants should be able to: Define the environmen-
for the activities of Allied Health members that contribute to the care of patients; Identify tal sources of chemicals with estrogen properties such as bisphenol A and phthalates;
effective patient care strategies that can be implemented into the allergy/immunology Summarize the research demonstrating the effects of xenoestrogens on the allergic and
practice; Develop professional networks within Allied Health. asthmatic phenotype; Describe the epidemiology that associates xenoestrogen exposures
and the development of asthma and allergy in children and adults.

Annual Meeting Workshops

Programmed by the AAAAI. Annual Meeting Workshops funded
through an educational grant from Merck.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 49
 saturday, March 1

Hands-On Workshop Q & A Workshop

2802 EMR Roundtable: What Are Allergists Using? 2804 The Safety of Asthma Medications During
4:45 to 6:00 pm Pregnancy: An Update
Convention Center, Upper Level, Room 2 4:45 to 6:00 pm
Pre-registration and ticket required. Fee: $50. Convention Center, Upper Level, Room 11AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Tao T. Le, MD MHS FAAAAI Moderator: Michael Schatz, MD MS FAAAAI
Practice Fusion 4:45 The Safety of Asthma Medications During Pregnancy: VAMPSS
Dana V. Wallace, MD FAAAAI Prospective Cohort Data
GE Centricity Christina Chambers, PhD MPH
A. Sean McKnight, MD FAAAAI 5:00 The Safety of Asthma Medications During Pregnancy: VAMPSS
Allscripts Case-Control Data
Melinda M. Rathkopf, MD FAAAAI Allen A. Mitchell, MD
EPIC 5:15 A Synthesis of Data on the Safety of Asthma Medications During
Ves Dimov, MD Pregnancy
Meditab-IMS Jennifer A. Namazy, MD FAAAAI
Richard L. Wasserman, MD PhD FAAAAI 5:30 Question & Answer
NextGen Upon completion of this session, participants should be able to: Evaluate the recent
Robert Anolik, MD FAAAAI VAMPSS prospective cohort data on the safety of asthma medications in pregnancy;
Review the recent VAMPSS case-control data on the safety of asthma medications in
ModuleMD pregnancy; Discuss current information on the gestational safety of asthma medications
Instructor to be announced. to the clinical care of pregnant patients with asthma.
eClinical Works Reception immediately following the session with the VAMPSS Investigative
Hugh H. Windom, MD FAAAAI Team.
Rosch
Nathaniel D. Hare, MD FAAAAI Q & A Workshop
Upon completion of this session, participants should be able to: Discuss the challenges al-
lergists face in EMR selection; Discuss tips on EMR selection and implementation specific 2805 AAP: Hot Topics in Pediatric Allergy and
to the practicing allergist; Review specific EMRs with allergists using them in practice. Immunology
4:45 to 6:00 pm
Problem-Based Learning Workshop Convention Center, Upper Level, Ballroom 6A
Credit: 1.25 CME / 1.50 CE
2803 A Child with Severe Atopic Dermatitis Moderator: Todd A. Mahr, MD FAAAAI
4:45 to 6:00 pm
4:45 Allergic Respiratory Disease
Convention Center, Upper Level, Room 3
Chitra Dinakar, MD FAAAAI
Pre-registration and ticket required. Fee: $50.
Credit: 1.25 CME / 1.50 CE 5:00 Food and Drug Allergies
PBL Facilitator: Stanley M. Fineman, MD MBA FAAAAI Brian P. Vickery, MD FAAAAI
Content Lecturer: Mark Boguniewicz, MD FAAAAI 5:15 Immunologic Disorders
Upon completion of this session, participants should be able to: Discuss the differential Thomas A. Fleisher, MD FAAAAI
diagnosis of severe atopic dermatitis; Assess food allergy as a co-morbid condition in this 5:30 Question & Answer
patient; Summarize cutting-edge literature on state of the art skin therapy in refractory Upon completion of this session, participants should be able to: Describe the latest devel-
atopic dermatitis. opments in pediatric allergy and immunology; Discuss how these might impact the care of
pediatric patients with respiratory allergic disease, food and drug allergy and immunologic
disorders.

Annual Meeting Workshops

Programmed by the AAAAI. Annual Meeting Workshops funded
through an educational grant from Merck.

50 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

Q & A Workshop Q & A Workshop

2806 Whos on First? Primary Immunodeficiency, 2809 Update in Occupational Allergy: A Focus on the
Autoimmune Disease or Immune Modulation Skin, Nose, and the Young Worker
4:45 to 6:00 pm 4:45 to 6:00 pm
Convention Center, Upper Level, Ballroom 6B Convention Center, Upper Level, Room 7AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Ramsay L. Fuleihan, MD Moderator: Susan M. Tarlo, MBBS FAAAAI
4:45 Autoimmune Disease with Primary and Secondary Failure of 4:45 Skin Prick Testing in the Diagnosis of Occupational Type I
Tolerance Allergies
Speaker to be announced. Joaquin Sastre, MD PhD FAAAAI
5:00 Infectious Complications of Immune Modulation 5:00 Occupational Rhinitis
Christina C. Price, MD Santiago Quirce, MD PhD
5:15 Monitoring and Supporting Immune Function After 5:15 Prevention of Work-Related Respiratory Allergies in Young
Immunomodulation Workers
Vibeke Strand, MD Andr Cartier, MD FAAAAI
5:30 Question & Answer 5:30 Question & Answer
Upon completion of this session, participants should be able to: Discuss how autoimmu- Upon completion of this session, participants should be able to: Review the pros and
nity arises in the setting of primary and secondary immunodeficiency; Review potential cons of skin testing for occupational allergens and recent advances in occupational skin
infectious sequelae arising from immunomodulation; Describe how to monitor and support allergy; Identify the range of exposures causing occupational rhinitis and tools for inves-
immune function after immune compromise due to immunomodulator therapy. tigation; Discuss how to approach adolescents and young adults at risk of work-related
allergic responses.
Q & A Workshop
Q & A Workshop
2807 Difficult Drug Allergy Cases: Case-Based
Discussions 2810 Molecular Pathogenesis of Aspirin Intolerance
4:45 to 6:00 pm 4:45 to 6:00 pm
Convention Center, Upper Level, Ballroom 6CF Convention Center, Upper Level, Room 8
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Rebecca S. Gruchalla, MD PhD FAAAAI Moderator: Robert P. Schleimer, PhD FAAAAI
4:45 Management of Patients with Multiple Drug Allergies 4:45 Prostaglandin E2 Resistance: An Explanation for Dysregulation of
Roland Solensky, MD FAAAAI Leukotrienes in AERD
Tanya M. Laidlaw, MD FAAAAI
5:00 Perioperative Anaphylaxis and Advice for Patients Needing
Further Surgery 5:00 Chronic Rhinosinusitis and Disturbed Microbial Homeostasis
Aleena Banerji, MD Susan V. Lynch, PhD
5:15 Determine When Skin Testing, Test Doses and Desensitization are 5:15 The Surprising Role of Interferon Gamma in AERD
Appropriate Larry Borish, MD FAAAAI
David A. Khan, MD FAAAAI 5:30 Question & Answer
Upon completion of this session, participants should be able to: Identify the molecular
5:30 Question & Answer
control mechanisms of the 5-lipoxygenase enzyme; Identify the potential contribution
Upon completion of this session, participants should be able to: Explain management of from the perturbed microbiome; Discuss the potential role of inteferon gamma in AERD.
patients with multiple drug allergies; Describe perioperative anaphylaxis: diagnosis, evalu-
ation and management; Identify the role for skin testing, test dose and desensitization.
Panel Discussion Workshop
Panel Discussion Workshop 2811 Experimental Models of Allergic Rhinitis:
2808 Thriving and Surviving in the Evolving Healthcare Evaluation and Utilization
System: 2014 JCAAI Update 4:45 to 6:00 pm
4:45 to 6:00 pm Convention Center, Upper Level, Room 5AB
Convention Center, Upper Level, Ballroom 6DE Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE Moderator: Fuad M. Baroody, MD FAAAAI
Moderator: J. Allen Meadows, MD FAAAAI Panelists:
Panelists: Anne K. Ellis, MD MSc FAAAAI
Donald W. Aaronson, MD FAAAAI Robert M. Naclerio, MD FAAAAI
Gary N. Gross, MD FAAAAI Martin Wagenmann, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the commonly
Richard W. Honsinger, MD MACP FAAAAI
used methodologies utilized in environmental exposure unit-type studies of allergic
Upon completion of this session, participants should be able to: List strategies for rhinitis; Describe the most commonly used methodologies for experimental nasal allergen
positioning their practices for success in the changing healthcare arena; Describe the challenge in the investigation of allergic rhinitis; List the advantages and disadvantages of
changing allergy CPT codes, ICD-10 changes and other new coding developments; both experimental models pertaining to the study of allergic rhinitis.
Discuss the requirements for compliance with federal regulations, including penalties for
non-compliance.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 51
 saturday, March 1

Q & A Workshop Q & A Workshop

2812 Safety Challenges with Allergen Immunotherapy 2814 ABAI: Help Me Help You Meet MOC Requirements
4:45 to 6:00 pm 4:45 to 6:00 pm
Convention Center, Mezzanine Level, Room 14AB Convention Center, Mezzanine Level, Room 16AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Matthew A. Rank, MD FAAAAI Moderator: Stephen I. Wasserman, MD FAAAAI
4:45 Allergen Immunotherapy in Patients with Other Special Medical 4:45 Whats New and What Do I Have to Do to Meet MOC
Conditions Requirements?
Dsire E.S. Larenas Linnemann, MD FAAAAI Rayn Harrison
5:00 Immunotherapy and Medication: Lessons Learned from 5:00 Roadblocks to Meeting MOC Requirements
Experience on How to Approach these Patients Sarah Johnson
Christopher W. Calabria, MD 5:15 How I Survived Meeting MOC Requirements
5:15 Which Factors Might Enhance Safety of Immunotherapy in Your James M. Tracy, DO FAAAAI
Clinic? 5:30 Question & Answer
David I. Bernstein, MD FAAAAI Upon completion of this session, participants should be able to: Review the MOC require-
5:30 Question & Answer ments and how to successfully complete them; Demonstrate tips and tricks to completing
Upon completion of this session, participants should be able to: Discuss safety experience MOC requirements; Reflect upon the personal experience of a peer who completed MOC
with allergen immunotherapy given to patients with a history of cancer, HIV positivity, requirements.
hypertension and other underlying medical conditions; Describe problems that might arise
theoretically and problems that have been reported with AIT in patients taking certain Q & A Workshop
medications (beta-blockers, ACE inhibitors, immunosuppressive drugs, etc.); Recognize
factors in an allergy clinic associated with a higher rate of adverse events with AIT and 2815 The Next Step After ICS/LABA
recommend actions in their clinics that might augment safety of AIT. 4:45 to 6:00 pm
Convention Center, Upper Level, Room 30ABCDE
Q & A Workshop Credit: 1.25 CME / 1.50 CE
Moderator: Harold S. Nelson, MD FAAAAI
2813 The Epithelium in Control
4:45 The Case for Anti-Cholinergics
4:45 to 6:00 pm
Brian J. Lipworth, MD
Convention Center, Mezzanine Level, Room 15AB
Credit: 1.25 CME / 1.50 CE 5:00 The Case for Fine Particle ICS
Moderator: Angela Haczku, MD PhD FAAAAI Richard J. Martin, MD
4:45 TSLP, Here We Go Again! 5:15 The Case for Omalizumab
Steven Ziegler, PhD Thomas B. Casale, MD FAAAAI
5:00 The Importance of IL-25 5:30 Question & Answer
Hirohito Kita, MD Upon completion of this session, participants should be able to: List the evidence sup-
porting the use of anticholinergic therapy in refractory asthma; Review the evidence
5:15 Epithelial and Dendritic Cell-Derived IL-33 in Control of Allergic supporting the use of a small particle ICS over conventional ICS molecules; Discuss recent
Disease evidence supporting the use of omalizumab treatment in difficult asthma.
Anne Sperling, PhD
5:30 Question & Answer Problem-Based Learning Workshop
Upon completion of this session, participants should be able to: Describe novel mecha-
nisms through which epithelial TSLP drives allergic disease; Discuss the mechanism 2816 Controversies in a Patient with Insect Sting
through which epithelial derived IL-25 drives allergic disease; Discuss how the epithelium Anaphylaxis
through IL-1a is able to drive allergic disease.
4:45 to 6:00 pm
Convention Center, Upper Level, Room 31C
Pre-registration and ticket required. Fee: $50.
Credit: 1.25 CME / 1.50 CE
PBL Facilitator: Ray S. Davis, MD FAAAAI
Annual Meeting Workshops Content Lecturer: David B.K. Golden, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss a case vignette
Programmed by the AAAAI. Annual Meeting Workshops funded of a patient with stinging insect anaphylaxis; Apply the latest Practice Parameters in the
through an educational grant from Merck. management of a challenging patient with insect venom anaphylaxis; Determine criteria
for when to discontinue venom immunotherapy.

52 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 saturday, March 1

Allied Health Workshop Allied Health Workshop

2821 Anaphylaxis: Advancing Proficiency in 2824 Myth Busters: Using Evidence-Based Medicine
Recognition, Management and Risk Reduction to Dispel Your Patients Allergy-Related Urban
4:45 to 6:00 pm Myths
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2 4:45 to 6:00 pm
Pre-registration and ticket required. No fee. Marriott North Tower, Lobby Level, Torrey Pines 3
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Dee Mallam, RN AE-C Moderator: Jeanette L. Arnold, MSN RN C-FNP
4:45 Anaphylaxis: Recognition and Treatment David R. Stukus, MD FAAAAI
Gregory M. Metz, MD 5:30 Question & Answer
5:00 Anaphylaxis: Risk Reduction Strategies Upon completion of this session, participants should be able to: Discuss commonly held
Karen L. Gregory, DNP APRN-BC RRT AE-C misconceptions in the field of allergy/immunology; Analyze the evidence that refutes these
5:15 Hands-On Instruction commonly held misconceptions; Describe information that can be utilized in clinical prac-
tice to address frequently asked questions received from referring providers and patients.
Upon completion of this session, participants should be able to: Discuss the criteria for
anaphylaxis; Identify signs and symptoms of anaphylaxis and understand appropriate
treatment; Describe risk factors for anaphylaxis and implement risk reduction strategies. Allied Health Workshop
2825 Managing the Complexities of the Food Protein-
Allied Health Workshop
Induced Enterocolitis Syndrome Diet
2822 Paths to Empowerment: Motivation and 4:45 to 6:00 pm
Cost-Effective Incentives in an Economically Marriott North Tower, Lobby Level, Atlanta
Challenging Environment Credit: 1.25 CME / 1.50 CE
Moderator: G. Lynn Christie, MS RD
4:45 to 6:00 pm
Kathryn E. Grimshaw, PhD RD
Marriott North Tower, Lobby Level, Marriott Hall Salon 2
Carina Venter, PhD RD
Credit: 1.25 CME / 1.50 CE
Moderator: John D. Milewski, Med. Admin. 5:25 Question & Answer
Jeanette Booker Upon completion of this session, participants should be able to: Identify foods commonly
associated with FPIES; Describe the typical feeding progression in infancy and how to
5:30 Question & Answer provide appropriate foods to promote feeding skill development with a very limited diet;
Upon completion of this session, participants should be able to: Identify how to assess Discuss specific nutritional risks associated with a limited solid foods diet in infancy and
level of motivation in current employees; Discuss how to improve motivation and increase how to prevent/correct deficiencies in these diets.
productivity; Outline how to change the culture in their practices and look at alternative
incentives that are cost effective and reap positive results.
New Allergist/Immunologist Assembly Business Meeting
Allied Health Workshop and Reception
4:45 to 6:15 pm
2823 Performing a Practice Assessment Convention Center, Upper Level, Room 31AB
4:45 to 6:00 pm The AAAAI invites all new allergy/immunology specialists to attend this
Marriott North Tower, Lobby Level, Marriott Hall Salon 1 business meeting and reception.
Credit: 1.25 CME / 1.50 CE
Moderator: Joan E. Hawkins Chrysalis Project Reception
Thomas J. Derrico
6:00 to 7:00 pm
5:30 Question & Answer Marriott North Tower, Lobby Level, Rancho Santa Fe 1-3
Upon completion of this session, participants should be able to: Discuss the importance
Private reception open to Chrysalis project participants, mentors,
of a periodic assessment of their practices operational and financial performance; Identify
key areas for consideration in performing an assessment; Describe sources of data from faculty, and the Program Directors Assembly.
within their practices and how to obtain the data.
The Allergy, Asthma & Immunology Education and
Research Organization (ARTrust) First Class Event

7:00 to 10:00 pm
San Diego Air & Space Museum
All AAAAI members, delegates and guests are invited to attend this
Saturday evening event. See page 13 for more information.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 53
Save the Date

AAAAI-0913-505

2015 AAAAI Annual Meeting

February 20-24

Houston Texas
American Academy of Allergy, Asthma & Immunology
 sunday, March 2

Seminars 3007 Environmental Microbiomes

7:00 to 8:00 am
Pre-registration and ticket required. Fee: $40. Continental breakfast
included. Sessions and meals are limited to 30 people.
Credit: 1.00 CME / 1.20 CE
3001 Treating the Patient with Difficult to Treat
Exercise-Induced Asthma: Novel Therapies for
Exercise-Induced Bronchoconstriction
Matteo W. Bonini, MD
William W. Storms, MD FAAAAI
Marriott South Tower, Level 3, Marina Ballroom Salon D
Upon completion of this session, participants should be able to: Outline current therapies
for exercise-induced bronchoconstriction and acknowledge that some patients do not re-
spond to them; Describe novel therapies for exercise-induced bronchoconstriction; Explain
why beta agonists do not work for all patients with exercise-induced bronchoconstriction.
3002 Use of Cytokine Inhibitors in Severe Asthma
Jonathan Corren, MD
Sally E. Wenzel, MD FAAAAI
Marriott South Tower, Level 3, Marina Ballroom Salon E
Upon completion of this session, participants should be able to: Review and understand
the roles that specific cytokines play in asthma; Review trials of various agents (anti-TNF,
anti-IL4, anti-IL13, anti-IL5, anti-IL17, anti-IL9) in asthma; Explore subtypes of asthma
where these agents might best be used.
3003 How Many Eosinophils are Too Many?
Paneez Khoury, MD
Princess U. Ogbogu, MD FAAAAI
Marriott South Tower, Level 3, Marina Ballroom Salon F
Upon completion of this session, participants should be able to: Review the criteria for
eosinophilia; Discuss the differential diagnosis of eosinophilia; Review the work-up for an
increased eosinophil count.
3004 Social Media for Allergy/Immunology Practice:
Lets Do It!
Sakina S. Bajowala, MD FAAAAI
Nathaniel D. Hare, MD FAAAAI
Marriott South Tower, Level 3, Marina Ballroom Salon G
Upon completion of this session, participants should be able to: Discuss how to set up a
Twitter account and how to use it to connect with patients and colleagues; Discuss how to
set up a Facebook professional page; Describe how to use YouTube to embed and record
videos to maintain an interactive website for your practice.
3005 Update on Testing for Primary Immunodeficiency
Diseases
John M. Routes, MD FAAAAI
Kathleen E. Sullivan, MD PhD FAAAAI
Marriott South Tower, Level 3, Balboa
Upon completion of this session, participants should be able to: Review novel testing for
recurrent or unusual infections; Discuss genetic testing for primary immunodeficiency
diseases; Discuss future testing for primary immunodeficiency.
3006 Lets Take the Myth-stery Out of Mold
James J. Anderson, MLT
Peter J. Pityn, PhD
Marriott South Tower, Level 3, Mission Hills
Upon completion of this session, participants should be able to: Provide evidence that
the risk of mold is often overstated, misstated or misunderstood; Learn of the true risk
presented by mold; Explore issues with mold assessments and everyday mold exposure.
Annual Meeting Seminars
Programmed by the AAAAI. Annual Meeting Seminars funded
through an educational grant from Merck.
Christina E. Ciaccio, MD FAAAAI
Brett J. Green, PhD
Marriott South Tower, Level 3, Cardiff
Upon completion of this session, participants should be able to: Explore the human micro-
biome and allergic disease; Discuss the normal indoor microbiome and factors that cause
alterations in the typical structure.
3008 Medical Management of Eosinophilic Esophagitis
in Adults
Mark Holbreich, MD FAAAAI
Javed Sheikh, MD FAAAAI
Marriott South Tower, Level 3, Del Mar
Upon completion of this session, participants should be able to: Show the appropriate use
of diet in EoE management in adults; Demonstrate the different medications and become
familiar with dose and delivery; Describe the pros and cons of esophegeal dilation in EoE.
3009 Mastocytosis Mimics: Cutting Through the Clutter
Joseph H. Butterfield, MD FAAAAI
Melody C. Carter, MD
Marriott South Tower, Level 3, Miramar
Upon completion of this session, participants should be able to: List the criteria for
diagnosing systemic mastocytosis; Recognize the variety of mast cell activation disorders
and the criteria needed for a true diagnosis of mast cell activation syndrome; Describe the
differential diagnostic possibilities when faced with a patient with symptoms suggestive of
systemic mastocytosis or mast cell activation syndrome.
3010 Optimizing the Allergists Expertise in Asthma
Adherence
Bruce G. Bender, PhD FAAAAI
L. Keoki Williams, MD MPH FAAAAI
Marriott South Tower, Level 1, Point Loma
Upon completion of this session, participants should be able to: Discuss an appreciation
for the prevalence and implications of suboptimal adherence in asthma; Develop clues
which may suggest suboptimal adherence; Discuss strategies to facilitate optimal control-
ler use in specific asthmatic patients.
3011 Is Immunotherapy Getting Safer? Updated
Information on Various Forms of Immunotherapy
and How to Improve
Tolly Epstein, MD MS
Michael S. Tankersley, MD FAAAAI
Marriott South Tower, Level 1, Solana
Upon completion of this session, participants should be able to: Summarize current
evidence regarding the incidence of fatal reactions to SCIT; Critically assess new evidence
characterizing risk factors associated with SCIT anaphylaxis that may be applied to
optimize safety protocols; Discuss the necessity of the thirty minute waiting period after
SCIT injections.
3012 Clinical Conundrums in Chronic Rhinosinusitis
Rakesh Chandra, MD
Raymond G. Slavin, MD MS FAAAAI
Marriott South Tower, Level 1, Santa Rosa
Upon completion of this session, participants should be able to: Utilize an evidence-based
approach to the diagnosis and treatment of chronic rhinosinusitis.
3013 Understanding How Allergic Responses End:
The Allergy Resolvome
Koichiro Asano, MD
Ariel Munitz, PhD
Marriott South Tower, Level 4, La Costa
Upon completion of this session, participants should be able to: Identify factors involved
in resolution of inflammation; Review lipid mediators, IL-10 and endocannabinoids
mechanism of action in the resolution of inflammation.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 55
 sunday, March 2

3014 Inhibitory Receptors on Allergy Effector Cells: 3044 Tips on Training School Personnel about Food
New Therapeutic Targets Allergies and Anaphylaxis
Bruce S. Bochner, MD FAAAAI Sonia C. Mancia, RN
Francesca Levi-Schaffer, PhD FAAAAI Humaira Robinson, BSN RN
Marriott South Tower, Level 4, Catalina Marriott North Tower, Lobby Level, New York & Orlando
Upon completion of this session, participants should be able to: Discuss the mechanisms Upon completion of this session, participants should be able to: Discuss tips on how to
of three different inhibitory receptors pertinent for asthma; Describe efforts to therapeuti- train school personnel to recognize and treat anaphylaxis; Review evidence regarding the
cally target these receptors. content to include training and the efficacy of such training.

3015 Parasites, Allergy and Asthma

Luisa Karla P. Arruda, MD PhD FAAAAI
Plenary
Thomas A.E. Platts-Mills, MD PhD FAAAAI 3101 Integrated Airways
Marriott South Tower, Level 4, Coronado 8:15 to 9:45 am
Upon completion of this session, participants should be able to: Review outcomes of Convention Center, Ground Level, Exhibit Hall A
clinical trials conducted with parasites to treat patients with asthma or rhinitis; Discuss Credit: 1.50 CME / 1.80 CE
epidemiologic studies on parasites, allergy and asthma carried out in different areas of
the world and with different populations; Discuss mechanisms by which parasite infection
Moderator: Steve N. Georas, MD
may influence immune responses underlying allergy and asthma and the role of parasite 8:15 Host Defense, Inflammation and Remodeling in the Upper Airway
infections in total and specific IgE. Robert P. Schleimer, PhD FAAAAI
8:45 Barrier Dysfunction in the Lower Airway
Allied Health Seminars Donna Davies, BSc PhD
7:00 to 8:00 am 9:15 Asthma Endotypes: The Next Step Towards Personalized Asthma
Pre-registration and ticket required. Fee: $10. Sessions are limited to Care
30 people. Sally E. Wenzel, MD FAAAAI
Credit: 1.00 CME / 1.20 CE Upon completion of this session, participants should be able to: Discuss the immuno-
pathogenesis of barrier dysfunction in chronic rhinosinusitis; Describe the relationship be-
3041 PFT Interpretation: Beyond the FVC tween barrier dysfunction and the immunopathogenesis of asthma; Discuss how asthma
Edward O. Corazalla, MS RPFT endotypes are influencing the development of personalized asthma therapy.
Marriott North Tower, Lobby Level, Rancho Santa Fe 1 & 2
Upon completion of this session, participants should be able to: Review the effect clinical Posters
status has on PFT testing; Develop the ability to interpret difficult spirometry tracings;
Interpret PFTs and develop options to modify the asthma care plan. 7:00 am to 6:00 pm
Convention Center, Ground Level, Exhibit Hall B
3042 Recurrent Infections: When is a Little Cold More Posters on display from 7:00 am to 6:00 pm. Authors present from
Than a Little Cold 9:45 to 10:45 am.
Joseph L. Roberts, MD PhD Credit: No CME / No CE
Debra A. Sedlak, MSN CPNP Refer to pages 83 158 for abstracts and authors.
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2 3201 Bronchoprovocation and Asthma Comorbidities
Upon completion of this session, participants should be able to: Develop an appreciation
of the multiple presentations of the patient with recurrent infections; Discuss the selection 3202 Biomarkers and Asthma Control I
of appropriate testing to determine if the patient has or is evolving to a primary im-
munodeficiency diagnosis; Review the appropriate screening test for non-PIDD diagnosis
3203 Atopic Disease Basic Science
(autoimmune, endocrine). 3204 T Cell Mediated Immunity
3043 Complementary and Alternative Medicine (CAM): 3205 Asthma Epidemiology, Risk Factors and Public
Whats New and What We Need to Know: Taking a Health II
History and Providing Guidance on Patients Use 3206 Aerobiology II
of CAM in Allergy and Asthma 3207 Food Allergy I
Maureen George, PhD RN AE-C
William S. Silvers, MD FAAAAI 3208 Urticaria
Marriott North Tower, Lobby Level, Atlanta & Chicago 3209 Pediatric Population Health
Upon completion of this session, participants should be able to: Discuss commonly used
CAM for seasonal allergies and asthma; Describe the evidence for saline nasal irriga-
3210 Health Information Technology
tion, acupuncture, butterbur, honey and other CAM in a clinical case; Investigate online 3211 Chronic Rhinosinusitis and Polyps
resources for reference, e.g. NCCAM (NIH National Center for Complementary and Alterna-
tive Medicine), Natural Medicines Comprehensive Database, etc. 3212 Rhinitis
3213 Mechanisms of Lymphocyte Function
3214 Role of Structural Cells in Mechanisms in Health
and Disease
Annual Meeting Seminars
Programmed by the AAAAI. Annual Meeting Seminars funded
through an educational grant from Merck.

56 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 sunday, March 2

Symposium Symposium
3301 EAACI: Novel Developments 3303 Update of the Allergic Contact Dermatitis Practice
in Asthma Exacerbations Parameter: Whats New in 2014?
10:45 am to 12:00 pm 10:45 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6A Convention Center, Upper Level, Ballroom 6CF
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderators: Cezmi A. Akdis, MD FAAAAI Moderator: H. Henry Li, MD PhD
Nikolaos G. Papadopoulos, MD FAAAAI 10:45 Clinical Pearls and Clues in the Assessment of the Patient
10:45 Molecular Mechanisms of Asthma Exacerbations Referred for Evaluation of Contact Dermatitis and Patch Testing
Evangelos Andreakos, PhD David I. Bernstein, MD FAAAAI
11:05 Immune Response to Rhinoviruses and Their Link to Asthma 11:05 What are the Most Common Chemical Sensitizers at Home and in
Exacerbations the Workplace?
Mubeccel Akdis, MD PhD Luz S. Fonacier, MD FAAAAI
11:25 Eicosanoids and Asthma Exacerbations 11:25 Metal Allergy and Implantable Devices
Marek Sanak, MD Karin A. Pacheco, MD MSPH FAAAAI
11:45 Question & Answer 11:45 Question & Answer
Upon completion of this session, participants should be able to: List mechanisms underly- Upon completion of this session, participants should be able to: Identify key factors in
ing asthma exacerbations; Describe the interaction of respiratory viruses with epithelium, clinical history and patch testing in suspected allergic contact dermatitis; Identify the
the immune system and how eicosanoids play a role in the pathogenesis of asthma most frequent contact sensitizers encountered at home and in the workplace; Discuss the
exacerbations. relationship between metal hypersensitivity and prosthetic joint failure.

Symposium Symposium
3302 Pathophysiology and Management of Urticaria 3304 Wheezing Episodes in Preschool Children: The
and Angioedema Role of Bacterial Pathogens, Treatment of
10:45 am to 12:00 pm Acute Exacerbations and Potential for Asthma
Convention Center, Upper Level, Ballroom 6B
Prevention
Credit: 1.25 CME / 1.50 CE
10:45 am to 12:00 pm
Moderator: David R. Weldon, MD FAAAAI
Convention Center, Upper Level, Ballroom 6DE
10:45 Pathophysiology of Chronic Urticaria Credit: 1.25 CME / 1.50 CE
Thomas B. Casale, MD FAAAAI Moderator: Leonard B. Bacharier, MD FAAAAI
11:05 Diagnostic Evaluation of Patients with Chronic Urticaria/ 10:45 Wheezing Episodes in Preschool Children: Beyond Viral Infections
Angioedema: What Does the Evidence Tell Us? Daniel J. Jackson, MD
David M. Lang, MD FAAAAI
11:05 Oral Corticosteroids as a Treatment of Acute Wheezing Episodes
11:25 Therapy Options for Patients with Anti-Histamine Resistant in Preschool Children: What is the Evidence for the Efficacy of
Chronic Urticaria This Treatment?
Javed Sheikh, MD FAAAAI Avraham Beigelman, MD MSCI
11:45 Question & Answer 11:25 The Utility of Oral Bacterial Extracts as a Prevention Modality for
Upon completion of this session, participants should be able to: Describe updates of
Wheezing Episodes and Asthma
the pathophysiology of chronic urticaria; Describe cost-effective and evidence-based
diagnostic evaluation of patients with chronic urticaria/angioedema; Relate evidence sup- Fernando D. Martinez, MD
porting use of therapeutic interventions for patients with antihistamine-resistant urticaria/ 11:45 Question & Answer
angioedema. Upon completion of this session, participants should be able to: Discuss the current
evidence of the role of bacterial pathogens in the pathogenesis of wheezing episodes
in preschool children; Evaluate whether the current evidence supports the utility of oral
corticosteroids as a treatment for acute wheezing episodes in preschool children; Discuss
emerging concepts on the utility of immunostimulants for the prevention of wheezing
episodes and potentially asthma.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 57
 sunday, March 2

Symposium Symposium
3305 Molecular Allergy: From Bench to Bedside 3307 The Emergence of Innate Lymphocyte
10:45 am to 12:00 pm Populations Driving Allergic Disease
Convention Center, Upper Level, Room 11AB 10:45 am to 12:00 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Mezzanine Level, Room 15AB
Moderator: Robert G. Hamilton, PhD D.ABMLI FAAAAI Credit: 1.25 CME / 1.50 CE
10:45 Improved Diagnostics for Food Allergy: Higher Analytical Moderator: Larry Borish, MD FAAAAI
Sensitivity and Better Risk Assessment Using Single Molecules 10:45 Innate Properties of IL-5+ Super-Effector Th2 Cells
Kirsten Beyer, MD Calman Prussin, MD FAAAAI
11:05 Improved Diagnostics for Inhalant Allergy: Addressing Plant 11:05 Type 2 Innate Lymphoid Cell Activation by CysLTs
Related Crossreactivity and Multisensitizations with Single Taylor A. Doherty, MD FAAAAI
Molecules 11:25 Innate Lymphoid Cells and Invariant Natural Killer T Cells in
Joerg R. Kleine-Tebbe, MD FAAAAI Asthma
11:25 Allergenic Molecules in Anaphylactic Reactions: Improved Dale T. Umetsu, MD PhD FAAAAI
Differentiation and Analytical Sensitivity 11:45 Question & Answer
Markus W. Ollert, MD Upon completion of this session, participants should be able to: Discuss the various innate
11:45 Question & Answer cell populations and their contributions to allergic inflammation and pathogenesis; Identify
Upon completion of this session, participants should be able to: Discuss the diagnostic the role of lipid mediators in regulation of adaptive Th2 immunity; Identify the potential
value of food components and how they can lead to improved diagnostic answers and roles of innate lymphocytes in allergic disease.
advice to the patient; Describe the diagnostic value of inhalant allergen components and
how they can lead to improved diagnostic answers and advice to the multi- sensitized Symposium
patient; Identify recently identified components from bee and wasp venom, latex and other
protein allergens that facilitate definitive answers in cases of presumed sensitizations and 3308 Closing the Outcome Gap for Women with
enhance analytical sensitivity.
Asthma : A Tribute to Noreen M. Clark, PhD
10:45 am to 12:00 pm
Symposium Convention Center, Mezzanine Level, Room 16AB
3306 The Relationship Between Allergies and Credit: 1.25 CME / 1.50 CE
Infections Moderator: Georgiana M. Sanders, MD MS FAAAAI
10:45 am to 12:00 pm 10:45 Clinical, Social, and Cultural Factors in Asthma Management
Convention Center, Room 14AB by Women and Potential Outcomes from Gender Focused
Credit: 1.25 CME / 1.50 CE Interventions
Moderator: Dorothy S. Cheung, MD FAAAAI Georgiana M. Sanders, MD MS FAAAAI
10:45 Basophils: Initiators of the Immune Response 11:05 Asthma Management in Women with Multiple Morbidities
Caroline L. Sokol, MD PhD Mary Janevic, MPH PhD
11:05 Mast Cells in the Immune Response Against Bacteria 11:25 Special Challenges in Treatment and Self Management for Older
Soman N. Abraham, PhD Women with Asthma
Alan P. Baptist, MD MPH FAAAAI
11:25 Role of IgE in the Anti-Viral Immune Response
Mitchell H. Grayson, MD FAAAAI 11:45 Question & Answer
Upon completion of this session, participants should be able to: Describe the range of
11:45 Question & Answer
treatment and management challenges and solutions particular to their female asthma
Upon completion of this session, participants should be able to: Discuss the ability of patients; Recognize elements of education for female patients that are associated with
basophils to present antigen and start an immune response; Describe the data suggesting reduced health care use and symptom burden.
that the production of IgE is part of the antiviral immune response; Discuss how mast cells
play a role in the clearance of bacterial and viral infections.
Allied Health Symposium
3311 Update on Experience Performing Baked Egg and
Baked Milk Food Challenges
10:45 am to 12:00 pm
Marriott North Tower, Lobby Level, Marriott Hall Salons 1 & 2
Credit: 1.25 CME / 1.50 CE
Moderator: Kim E. Mudd, RN MSN CCRP
Teri Holbrook, RN CRNP
Hemant P. Sharma, MD MHS FAAAAI
Elisabeth S. Stieb, RN BSN AE-C
11:45 Question & Answer
Upon completion of this session, participants should be able to: Identify which children
can be considered for a food challenge to baked milk and baked egg; Describe the ap-
propriate protocol to use in your practice to conduct a baked milk and baked egg food
challenge; Discuss how children who pass a baked milk and baked egg food challenge
can increase the foods in their diets.

58 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 sunday, March 2

Allied Health Workshop Allied Health Oral Abstract Session

3312 Motivational Interviewing Strategies 3520 Allied Health Oral Abstract Luncheon
10:45 am to 12:00 pm 12:15 to 1:30 pm
Marriott North Tower, Lobby Level, Rancho Santa Fe 1 & 2 Marriott North Tower, Lobby Level, San Diego Ballroom Salon C
Credit: 1.25 CME / 1.50 CE Pre-registration and ticket required. Fee: $40. Box lunch included.
Moderator: Michael S. Tankersley, MD FAAAAI Credit: 1.25 CME / 1.50 CE
Beth A. Allison, NP Moderator: Debra A. Sedlak, MSN CPNP
11:30 Question & Answer 12:15 Clinical Efficacy Of Subcutaneous and Sublingual Immunotherapy
Upon completion of this session, participants should be able to: Discuss the role of In Asthma and Rhinitis Children Sensitized To House Dust Mite
ambivalence in behavior change; Describe strategies for dealing with patient resistance; Min-Ju Kim
Review brief motivational interviewing strategies to incorporate into practice.
12:30 A Patient-Reported Symptom-Based Predictor Of Objective Sinus
Inflammation
Allied Health Workshop Alcina K. Lidder, BA
3313 Immunotherapy Guideline Update: Third Edition 12:45 Healthcare Providers Perception vs. Reality In Patient Concerns
and USP 797 Compliance About Starting Subcutaneous Immunoglobulin
10:45 am to 12:00 pm Carla M. Duff, CPNP MSN
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2 1:00 Anaphylaxis During Obstetric Surgery In Latex Allergic Patients
Credit: 1.25 CME / 1.50 CE Nana Jinjolava, MD
Panelists 1:15 The Impact Of Legislation On Illinois School Nurses
Cheryl Koff Bernstein, RN BSN CCRC Christine Szychlinski, APN CPNP
Michael R. Nelson, MD PhD FAAAAI Upon completion of this session, participants should be able to discuss the diversity in
Upon completion of this session, participants should be able to: Discuss the requirements care provided to the allergy and immunology patient population.
and importance of becoming compliant with USP chapter 797; Describe the compliance
requirements for allergen extract preparation according to the USP chapter 797 and Interest Section Forum
immunotherapy Practice Parameters Guidelines Third Edition Update; Identify practical
approaches for implementation of the guidelines. 3521 ADT: Hot Issues in Asthma
12:30 to 2:30 pm
Allied Health Workshop Convention Center, Upper Level, Room 5AB
Pre-registration and ticket required. No fee. Box lunch included. Bring
3314 Childhood Asthma and Obesity: What Do We your mobile device to participate.
Know? What Can We Do? Credit: 1.25 CME / 1.50 CE
10:45 am to 12:00 pm Moderator: Timothy J. Craig, DO FAAAAI
Marriott North Tower, Lobby Level, Atlanta & Chicago 12:30 Lunch
Credit: 1.25 CME / 1.50 CE 12:35 Business Meeting
Moderator: Stephen J. McGeady, MD FAAAAI Timothy J. Craig, DO FAAAAI
Anne E. Borgmeyer, MSN RN CPNP AE-C
1:05 Question & Answer
Carina Venter, PhD RD
1:15 Why are Microbiomes Important in Asthma?
11:25 Question & Answer
Homer A. Boushey, MD FAAAAI
Upon completion of this session, participants should be able to: Outline the relationship
between asthma and obesity; Review current guidelines for the management of childhood 1:45 Update on Newer Approved Therapies and New Uses of Old Drugs
obesity and asthma; Discuss barriers to adherence for obese children with asthma and for Asthma
their families. William W. Busse, MD FAAAAI
2:15 Question & Answer
Allied Health Workshop Upon completion of this session, participants should be able to: Discuss the importance of
microbiomes in asthma; Discuss the introduction of new therapies into the present care of
3315 Team Approach to Providing Interdisciplinary asthma; Describe how biologicals can affect asthma care.
Care of Atopic Dermatitis
10:45 am to 12:00 pm
Marriott North Tower, Lobby Level, New York & Orlando
Credit: 1.25 CME / 1.50 CE
Moderator: Jennifer S. LeBovidge, PhD
Karol G. Timmons, RN MS CPNP
Wendy Elverson, RD LDN
11:15 Question & Answer
Upon completion of this session, participants should be able to: Describe the formation
of a multidisciplinary team to care for children with atopic dermatitis; Discuss the role of
a psychologist/mental health professional in an interdisciplinary clinic for children with
atopic dermatitis; Describe the role of a nutritionist in an interdisciplinary clinic to optimize
nutritional care for patients with atopic dermatitis.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 59
 sunday, March 2

Interest Section Forum Interest Section Forum

3522 BCI: Cutting-Edge Research from Members of the 3524 FADDA: Practice Parameter Updates on Allergic
Basic and Clinical Immunology Interest Section Skin Diseases
12:30 to 2:30 pm 12:30 to 2:30 pm
Convention Center, Upper Level, Room 11AB Convention Center, Upper Level, Ballroom 6A
Pre-registration and ticket required. No fee. Box lunch included. Pre-registration and ticket required. No fee. Box lunch included. Bring
Credit: 1.25 CME / 1.50 CE your mobile device to participate.
Moderator: Francisco A. Bonilla, MD PhD FAAAAI Credit: 1.25 CME / 1.50 CE
12:30 Lunch Moderator: David A. Khan, MD FAAAAI
12:35 Business Meeting 12:30 Lunch
Francisco A. Bonilla, MD PhD FAAAAI 12:35 Business Meeting
1:05 Question & Answer David A. Khan, MD FAAAAI
1:15 Nanotechnology Meets Allergy: The Yin and Yang of Nanoscale 1:05 Question & Answer
Toxicity and Therapy 1:15 Atopic Dermatitis: Updates on Evaluation and Management from
James R. Baker, Jr., MD FAAAAI the Practice Parameter
1:45 Genome Safari: Navigating the Nucleotides to Find the Origins of Lynda C. Schneider, MD FAAAAI
Asthma 1:45 Chronic Urticaria: Updates on Diagnostic Testing and Therapy
Kathleen C. Barnes, PhD FAAAAI from the Practice Parameter
2:15 Question & Answer Jonathan A. Bernstein, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss nanotechnol- 2:15 Question & Answer
ogy applications in medicine generally; Identify nanotechnology applications specific to Upon completion of this session, participants should be able to: Describe recent updates
allergy and immunology; Describe the most recent advances in genomic approaches to to the practice parameter on atopic dermatitis focusing on evaluation and management of
understanding the origins of asthma and allergy. atopic dermatitis; Discuss recent updates to the practice parameter on urticaria focusing
on evaluation and management of chronic urticaria.
Interest Section Forum
Interest Section Forum
3523 EORD: Metals, Cements and Glues: Assessing the
Exposure: Diagnosing the Disease 3525 HEDQ: Bringing Added Value to Accountable
12:30 to 2:30 pm Care Organizations (ACOs) Through Asthma
Convention Center, Mezzanine Level, Room 14AB Population Management
Pre-registration and ticket required. No fee. Box lunch included. 12:30 to 2:30 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Mezzanine Level, Room 15AB
Moderator: Jeffrey G. Demain, MD FAAAAI Pre-registration and ticket required. No fee. Box lunch included. Bring
12:30 Lunch your mobile device to participate.
12:35 Business Meeting Credit: 1.25 CME / 1.50 CE
Karin A. Pacheco, MD MSPH FAAAAI Moderators: Bruce G. Bender, PhD FAAAAI
1:05 Question & Answer Giselle Mosnaim, MD MS FAAAAI
1:15 Metals: Source Exposures, Disease Outcomes, and Making the 12:30 Lunch
Association Between the Two 12:35 Tribute to Dr. Noreen Clark
James S. Taylor, MD 12:40 Business Meeting
1:45 Cements and Glues: Common and Overlooked Causes of Allergic Giselle Mosnaim, MD MS FAAAAI
Disease 1:05 Question & Answer
Karin A. Pacheco, MD MSPH FAAAAI 1:15 Asthma Population Management (Part 1): Identifying Persistent
2:15 Question & Answer Asthma, Defining High Risk Asthma, and Measuring Quality of
Upon completion of this session, participants should be able to: Recognize common oc- Asthma Care
cupational and procedure-related exposures to metals, cements and glues; Identify which Michael Schatz, MD MS FAAAAI
of these to suspect in adverse reactions in the workplace or the surgical suite; Describe
how best to establish the diagnosis of sensitization to these agents. 1:45 Asthma Population Management (Part 2): Strategies for
Improving Clinical Outcomes and Improving Quality of Care
William W. Crawford, MD
Robert J. Becker, MD, Memorial Lectureship Recipient
2:15 Question & Answer
Upon completion of this session, participants should be able to: Define the administra-
tive data elements necessary for effective management of large populations of asthma
patients; Describe the barriers to reducing emerengy room asthma visits at the level of
a large population of asthma patients; Identify strategies for improving performance on
publicly reported asthma quality of care measures.

60 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 sunday, March 2

Interest Section Forum Allied Health Course

3526 IRSOC: Make Sublingual Immunotherapy One of 3551 The International Network for Diet and Nutrition
Your Tools in Your Practice in Allergy (INDANA): Add Nutrition Management
12:30 to 2:30 pm to Your Practice Toolkit
Convention Center, Upper Level, Ballroom 6B 12:30 to 5:00 pm
Pre-registration and ticket required. No fee. Box lunch included. Marriott North Tower, Lobby Level, Marriott Hall Salons 1 & 2
Credit: 1.25 CME / 1.50 CE Pre-registration and ticket required. Fee: $30.
Moderator: Dsire E.S. Larenas Linnemann, MD FAAAAI Credit: 4.25 CME / 5.10 CE
12:30 Lunch Moderator: Marion E. Groetch, MS RD
12:35 Business Meeting 12:30 Diet History: Making the Right Connections
Dsire E.S. Larenas Linnemann, MD FAAAAI Isabel J. Skypala, PhD
1:05 Question & Answer 1:10 Whats in a Label?
1:15 How to Select and Administer Grass SLIT Among the Patients of Berber Vlieg-Boerstra, PhD RD
Your Practice 1:45 Food Triggers: The Degree of Avoidance
Michael S. Blaiss, MD FAAAAI Marion E. Groetch, MS RD
1:45 How to Select and Administer House Dust Mite SLIT Among the 2:20 A Day in the Life
Patients of Your Practice in the Future Jamie L. Kabourek, MS RD
Giovanni Passalacqua, MD 2:55 Break
2:15 Question & Answer 3:10 Oops...Frequently Made Mistakes in Nutrition and Allergy
Upon completion of this session, participants should be able to: Comment on which G. Lynn Christie, MS RD
patients would make good and which would make bad candidates for SLIT; Discuss safety
issues concerning SLIT with grass pollen extracts, especially focused on practical similari- 3:45 Prevention and Weaning
ties and differences in Europe and U.S.; Give an overview of innovative formula of house Carina Venter, PhD RD
dust mite SLIT, as are the tablets and use of adjuvants and argue how molecular diagnosis 4:20 What is a Healthy Diet Anyway?
might have implications for immunotherapy. Kathryn E. Grimshaw, PhD RD
Upon completion of this session, participants should be able to: Recognize how to take
Interest Section Forum a dietary history and link symptoms to food ingredients; Identify the implications (social,
emotional, financial and nutritional) of allergen elimination diets and how to minimize the
3527 MAAI: Novel Mechanisms in Turning impact on patients and families; Describe the nutritional implications of various avoidance
Inflammation On and Off diets and how to advise patients on substitutes to meet nutrient needs.
12:30 to 2:30 pm
Convention Center, Mezzanine Level, Room 16AB Oral Abstract
Pre-registration and ticket required. No fee. Box lunch included. 3601 Biomarkers
Credit: 1.25 CME / 1.50 CE
2:45 to 4:00 pm
Moderator: Mitchell H. Grayson, MD FAAAAI
Convention Center, Upper Level, Ballroom 6A
12:30 Lunch Credit: 1.25 CME / 1.50 CE
12:35 Tribute to Dr. Redwan Moqbel Moderators: Faoud T. Ishmael, MD PhD FAAAAI
12:50 Business Meeting Leonard B. Bacharier, MD FAAAAI
Mitchell H. Grayson, MD FAAAAI 2:45 Socio-Demographic and Environmental Correlates Of Exhaled
1:10 Question & Answer Nitric Oxide Levels
1:15 Epithelial Cell Apoptosis Protects Against Inflammation Lakiea S. Wright, MD MAT
Larry Borish, MD FAAAAI 3:00 Relationships Between The New Biomarkers Induced By
1:45 Eicosanoid Storm: The Role of the Inflammasome Interleukin-13 and Bronchial Hyperresponsiveness In Asthmatic
Karsten Gronert, PhD Children: Periostin and Squamous Cell Carcinoma-Related
2:15 Question & Answer Antigens
Upon completion of this session, participants should be able to: Describe how epithelial Heysung Baek, MD PhD
cells control inflammation through ingestion of apoptotic cells; Describe how the inflam- 3:15 Exhaled Nitric Oxide Performance Compared To Methacholine
masome contributes to inflammation through the rapid release of eicosanoids. Challenge In Asthma
Andrew Nickels, MD
3:30 Serum Interleukin 13 (IL-13) and Surfactant Protein D (SP-D)
Expression Is Differentially Associated With Disease Status In
Pediatric Asthma Patients
Vasiliki Gemou-Engesaeth, MD PhD
3:45 Correlation Of Exhaled Breath Temperature With Age In Chronic
Respiratory Diseases
Radoslaw Gawlik, MD
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 61
 sunday, March 2

Oral Abstract Oral Abstract

3602 Immune Mechanisms in Atopy 3604 Drug Allergy
2:45 to 4:00 pm 2:45 to 4:00 pm
Convention Center, Upper Level, Room 1AB Convention Center, Upper Level, Ballroom 6CF
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderators: Antonella Cianferoni, MD PhD Moderators: Mariana C. Castells, MD PhD FAAAAI
Hans C. Oettgen, MD PhD FAAAAI Miguel A. Park, MD
2:45 Peripherally Induced Foxp3+ Regulatory T Cells Mediates The 2:45 Safety Of Propofol Use In Patients With Food Allergies
Immunomodulatory Effect Of Intravenous Immunoglobulin In An Harshna Mehta, MD
Experimental Model Of Allergic Airway Disease 3:00 Risk Stratification Protocol For Carboplatin and Oxaliplatin
Amir Hossein Massoud, PhD Hypersensitivity Reactions With Repeat Skin Testing Improves
3:00 Differential DNA Methylation In Mothers Increases The Prevalence Care
Of Atopic Dermatitis In Their Offspring Alberta L. Wang, MD
Pia J. Hauk, MD 3:15 Added Value Of Skin Testing In Hypersensitivity Reactions To
3:15 Hypereosinophilia In Children and Adults: A Retrospective Taxanes
Comparison Matthieu Picard, MD
Kelli Williams, MD MPH 3:30 Risk Stratification For Paclitaxel-Induced Hypersensitivity
3:30 Interleukin 35 Modulates TSLP, IL-25 and IL-33 Primed Dendritic Reactions Improves Quality Of Care
Cells and Inhibits Naive T Cell Differentiation and Grass Pollen- Timothy P. Lax, MD
Specific T Cell Proliferation 3:45 Healthcare Utilization and Serious Infection Prevalence
Natalia C. Couto-Francisco Associated With Penicillin Allergy In Hospitalized Patients: A
3:45 Fc-Gamma-Receptor-IIb Is Required For The Immunomodulatory Cohort Study
Actions Of Intravenous Immune Globulin In An Antigen-Driven Eric M. Macy, MD FAAAAI
Murine Model Of Allergic Airways Disease Upon completion of this session, participants should be able to discuss recent research
Gabriel N. Kaufman, MSc developments in the field of allergy/immunology.
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology. Oral Abstract
Oral Abstract 3605 Oral Immunotherapy for Food Allergy
2:45 to 4:00 pm
3603 I. Leonard Bernstein Session on Occupational Convention Center, Upper Level, Ballroom 6B
Allergic Diseases Credit: 1.25 CME / 1.50 CE
2:45 to 4:00 pm Moderators: J. Andrew Bird, MD FAAAAI
Convention Center, Upper Level, Room 11AB Amy M. Scurlock, MD
Credit: 1.25 CME / 1.50 CE 2:45 Length Of Avoidance Period Following Peanut Oral
Moderator: Jonathan A. Bernstein, MD FAAAAI Immunotherapy Influences Effector Cell Suppression and Clinical
2:45 Endotoxin In Size-Specific Airborne Particles Induces Differential Outcomes
Nitrative Stress In Human Bronchoepithelial Cells Michael D. Kulis Jr., PhD
Umesh Singh 3:00 Basophil Hyporesponsiveness To Peanut Following
3:00 High Rates Of Sensitization To Selected Metals and Bone Immunotherapy May Be Transient and Correlates With Clinical
Cement In Joint Replacement Failure Patients and Preoperative Response
Evaluations Mark Gorelik, MD
Karin A. Pacheco, MD MSPH FAAAAI 3:15 Safety Of Pediatric Peanut Oral Immunotherapy Is Complicated By
3:15 Component Resolved Diagnosis In Bakers Asthma High Adverse Event Rates
Cristina Gmez-Casado Yamini Virkud, MD MA
3:30 Endotoxin Exposure May Protect Against The Development Of 3:30 Course and Outcome Of Patients With Asthma During Oral
Rhinoconjunctivitis and Respiratory Symptoms In Non-Atopic Immunotherapy To Cows Milk Protein
Individuals With Occupational Exposure To Mice Arnon Elizur, MD
Sharon K. Ahluwalia, MD 3:45 B-Fahf-2 Pretreatment Reduces OIT Adverse Reactions and
3:45 Sensitization To Occupational Allergens and Allergic Diseases In Improves Outcomes In a Murine Model Of Multiple Nut Allergy
Workers Of 5 Havana Bakeries Xiu-Min Li, MD
Mirta Alvarez, MD Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.

62 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 sunday, March 2

Oral Abstract Oral Abstract

3606 Adherence 3608 Mechanisms of Eosinophil-Driven Disease
2:45 to 4:00 pm 2:45 to 4:00 pm
Convention Center, Upper Level, Room 2 Convention Center, Upper Level, Room 7AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderators: Eugene M. Choo, MD FAAAAI Moderators: Paige Lacy, PhD FAAAAI
Sujani Kakumanu, MD Hans-Uwe Simon, MD PhD FAAAAI
2:45 Adherence Documentation During Asthma Encounters At a 2:45 IL-4 and IL-13 Differentially Regulate TLR-Induced Eosinophil-
Pediatric Tertiary Care Referral Center Basophil Differentiation Of Cord Blood CD34+ Progenitor Cells
Kara J. Wada, MD Pia Reece, PhD
3:00 High-Risk Asthma Multidisciplinary Care Clinic Adherence Linked 3:00 Basophils Act As a Cellular Switch to Drive Eosinophilic
To Asthma Control Test (ACT) Score Improvement Inflammation after IgE Activation
Bradley A. Locke, DO Laurence E. Cheng, MD PhD
3:15 Understanding Asthma Medical Nonadherence In Adult and 3:15 The SNARE VAMP-7 Contributes To Eosinophil Degranulation, In
Pediatric Populations Vivo
Joyce Xiang Wu Lee, MD Paige Lacy, PhD FAAAAI
3:30 Improved Education and Self-Management In Children and 3:30 Microbiota Regulates Eosinophils In The Small Intestine
Adolescents With Asthma Using a Personalized Smartphone Rodrigo Jimenez-Saiz, PhD
Application 3:45 The Airway Mucins Muc5b and Muc4 Are Endogenous Ligands
David R. Stukus, MD FAAAAI For Siglec-F and Induce Mouse Eosinophil Death
3:45 Misuse Of Medical Devices Among Patients In a Tertiary Care Takumi Kiwamoto, MD PhD
Allergy/Immunology Practice Upon completion of this session, participants should be able to discuss recent research
Rana S. Bonds, MD FAAAAI developments in the field of allergy/immunology.
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology. Featured Poster Session and Reception
4:00 to 6:00 pm
Oral Abstract Convention Center, Upper Level, Ballroom 6 Lobby
3607 Mechanisms of Immunotherapy All Annnual Meeting delegates and their guests are invited to attend
2:45 to 4:00 pm this event. No fee and no pre-registration required.
Convention Center, Upper Level, Ballroom 6DE Credit: No CME / No CE
Credit: 1.25 CME / 1.50 CE Featured Posters highlight the highest quality abstracts submitted
Moderator: Mark Larch, PhD for presentation at the Annual Meeting. During the Featured Poster
Session and Reception on Sunday evening, authors will be present
2:45 B Cells and Plasma Cells Populations Suffer Changes Along
with their posters to discuss their research. Take this opportunity to
The Time After Dermatophagoides Pteronyssinus Specific
talk with these authors and network with other meeting delegates.
Immunotherapy
Enrique Gmez, PhD 3801 Best of ADT
3:00 A Subset Of Novel Timothy Grass Antigens Is Associated With 3802 Advances in Primary Immunodeficiencies
Marked Th1/Th2 Shifts Following Specific Immunotherapy
3803 Best of EORD
Veronique M. Schulten
3:15 Interleukin IL-27+ Dendritic Cells Modulate Ex-Vivo Th2 3804 Best of FADDA
Responses In a Pdl-1-Dependent Manner and Increase In-Vivo 3805 Best of HEDQ
Following Grass Pollen Immunotherapy
3806 Chronic Rhinosinusitis and Polyps
Tomokazu Matsuoka
3:30 Local Protective IgG4 Antibodies In Nasal Fluid Are Elevated 3807 The Redwan Moqbel Memorial MAAI Featured
Following Grass Pollen Immunotherapy Poster Session
Jinjin Zhang 3811 Allied Health Featured Poster
3:45 Grass Pollen Immunotherapy: Impaired Allergen-Induced Nasal
and Cutaneous Responses Correlate With Overall Seasonal Second Annual ARTrust 5K Run/Walk: Light Up
Symptom Scores and Are Associated With Suppressed Local Th2
the Night
Cytokines In Nasal Fluid
Guy W. Scadding, MD 5:30 pm
Upon completion of this session, participants should be able to discuss recent research Embarcadero
developments in the field of allergy/immunology. This event is open to everyone: serious runners, casual runners,
walkers, families and the general public. Registration required. See
page 13 for more information.
Sponsored by Teva Respiratory.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 63
 Monday, March 3

Seminars 4007 Occupational Disease: New Agents, New

7:00 to 8:00 am Diseases, Prevention and Epidemiology
Pre-registration and ticket required. Fee: $40. Continental breakfast Leslie C. Grammer, MD FAAAAI
included. Sessions and meals are limited to 30 people. Santiago Quirce, MD PhD
Credit: 1.00 CME / 1.20 CE Marriott South Tower, Level 3, Cardiff
4001 Asthma and the Older Adult Upon completion of this session, participants should be able to: Discuss new and updated
knowledge in the areas discussed; Describe updated strategies for diagnosis and treat-
Alan P. Baptist, MD MPH FAAAAI ment of occupational diseases.
Paula L. Busse, MD FAAAAI
Marriott South Tower, Level 3, Marina Ballroom Salon D 4008 Diagnosing an Allergy to Galactose Alpha 1,3
Upon completion of this session, participants should be able to: Compare how asthma Galactose
symptoms and spirometry may differ in older adults compared to younger populations; Scott P. Commins, MD PhD
Identify unique factors associated with poor asthma control and quality of life in older
Maya R. Jerath, MD PhD
adults; Discuss the optimal pharmacologic and non-pharmacologic management strate-
gies for older adults with asthma. Marriott South Tower, Level 3, Del Mar
Upon completion of this session, participants should be able to: Describe the clinical
4002 Use of Biomarkers in Severe Asthma presentation of alpha gal food allergy; Discuss how to diagnose and manage alpha gal
Jonathan Corren, MD food allergy.
Faoud T. Ishmael, MD PhD FAAAAI 4009 Non-IgE-Mediated Food Allergies
Marriott South Tower, Level 3, Marina Ballroom Salon E
Jean-Christoph Caubet, MD
Upon completion of this session, participants should be able to: Review and understand
Anna H. Nowak-Wegrzyn, MD FAAAAI
specific markers (blood and sputum eosinophils, FeNO, periostin, urine leukotrienes, EBT);
Describe the relationship of these markers to specific asthma phenotypes and endotypes; Marriott South Tower, Level 3, Miramar
Describe the use of these markers as predictors of efficacies of specific therapies. Upon completion of this session, participants should be able to: Discuss a variety of
patient cases posing diagnostic dilemmas in non-IgE food allergy; Describe the utility of
4003 Evaluation of Autoinflammatory Disorders in feeding history, skin prick, serum specific IgE testing and oral food challenge in diagnos-
Children ing complex patients with possible GI food allergies.
Ronit Herzog, MD FAAAAI 4010 Outcomes and Quality Measures in Allergy
Lu Yao, MD Practice and Research
Marriott South Tower, Level 3, Marina Ballroom Salon F
Chitra Dinakar, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the clinical
Kaiser G. Lim, MD FAAAAI
and laboratory presentation of children with auto-inflammatory disorder; Describe the
pathophysiology of auto-inflammatory disorder in children; Discuss the workup and Marriott South Tower, Level 1, Point Loma
management of children with suspected auto-inflammatory disorder. Upon completion of this session, participants should be able to: Describe the most appro-
priate outcomes measures for assessment of quality practice in asthma and other allergic
4004 Selection and Implementation of an Electronic diseases; Discuss how to design an outcomes study for asthma.
Medical Record 4011 Proactive Management of Food Allergies in
David J. Shulan, MD FAAAAI
Richard L. Wasserman, MD PhD FAAAAI
Schools
Alton Lee Melton, MD
Marriott South Tower, Level 3, Marina Ballroom Salon G
Michael C. Young, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss why one would
choose an EHR; Describe how to pick an EHR; Identify the needed procedures in imple- Marriott South Tower, Level 1, Solana
menting an EHR. Upon completion of this session, participants should be able to: Identify activities and situ-
ations in the school setting that place allergic students at risk for accidental food allergen
4005 The Spectrum of Presentations in Patients with exposures; Discuss recommendations for schools and parents regarding best practices
Auto-Immune Lymphoproliferative Syndrome for treating reactions that do occur and proactively reducing the risk for accidental food
allergen exposures.
(ALPS)
Jack J.H. Bleesing, MD PhD 4012 New Aspects of the Involvement of B and T Cells in
V. Koneti U. Rao, MD the Mechanisms of Immunotherapy
Marriott South Tower, Level 3, Balboa Mubeccel Akdis, MD PhD
Upon completion of this session, participants should be able to: Discuss common findings Mark Larche, PhD
in patients with ALPS; Review current laboratory testing for the disease; Discuss treat- Marriott South Tower, Level 1, Santa Rosa
ment options for ALPS. Upon completion of this session, participants should be able to: Review new data of
4006 How to Get Your K Award Applications by a Mock regulatory T cell involvement in the immunologic reactions documented after immuno-
therapy; Review new data of regulatory B cell involvement in the immunologic reactions
Study Section documented after immunotherapy; Discuss the interactions between both these systems.
Nora A. Barrett, MD FAAAAI
Lawrence J. Prograis, MD
Joshua A. Boyce, MD FAAAAI
Marriott South Tower, Level 3, Mission Hills Annual Meeting Seminars
Upon completion of this session, participants should be able to: Describe the peer review
process for K award applications; Describe common strengths and weaknesses in K
Programmed by the AAAAI. Annual Meeting Seminars funded
award applications as identified by reviewers; Apply knowledge of common review through an educational grant from Merck.
concerns to the preparation of a competitive K award application.

64 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 Monday, March 3

4013 Chronic Rhinosinusitis Subtypes and Treatment Plenary

Implications 4101 Drug Allergy in the 21st Century
Amber U. Luong, MD PhD
8:15 to 9:45 am
Rodney J. Schlosser, MD
Convention Center, Ground Level, Exhibit Hall A
Marriott South Tower, Level 4, La Costa
Credit: 1.50 CME / 1.80 CE
Upon completion of this session, participants should be able to: Describe the classification
of sinusitis; Describe the clinical subtypes of chronic rhinosinusitis; Explain the different
Moderator: David A. Khan, MD FAAAAI
non-surgical treatment options for the different chronic rhinosinusitis subtypes. 8:15 HLA and Drug Hypersensitivity
David A. Ostrov, PhD
4014 How Do Antigens Become Allergens?
8:45 Exanthematous Drug Eruptions
Angela Haczku, MD PhD FAAAAI
Werner J. Pichler, MD
Anne Sperling, PhD
Marriott South Tower, Level 4, Catalina 9:15 New Challenges and Outcomes for Drug Desensitization
Upon completion of this session, participants should be able to: Describe how the immune
Mariana C. Castells, MD PhD FAAAAI
system recognizes innocuous allergens; Discuss dendritic cells, important sentinel cells in Upon completion of this session, participants should be able to: Discuss the genetic
allergy; Identify the development of therapeutic agents that could fine tune the dendritic basis for selected drug reactions; Recognize and interpret erythematous drug eruptions;
cell response. Develop expertise in the management of hypersensitivity reactions to chemotherapy,
monoclonals, new biologicals and antibiotics.
4015 Th17 Cells, Neutrophils and Severe Asthma
Dawn C. Newcomb Baker, PhD Posters
R. Stokes Peebles, Jr., MD FAAAAI
7:00 am to 6:00 pm
Marriott South Tower, Level 4, Coronado
Convention Center, Ground Level, Exhibit Hall B
Upon completion of this session, participants should be able to: Describe the role of STAT
Posters on display from 7:00 am to 6:00 pm. Authors present from
signaling in Th17 cell development and cytokine expression; Define the role of gender in
Th17 cell differentiation and cytokine expression in patients with severe asthma; Discuss 9:45 to 10:45 am.
the role of IL-17A on structural cells in the airway. Credit: No CME / No CE
Refer to pages 83 158 for abstracts and authors.
Allied Health Course 4201 Epidemiology: Asthma Control
4051 Primer on Primary Immune Deficiency (PIDD) 4202 Biomarkers and Asthma Control II
8:00 am to 2:15 pm 4203 IVIG and Other Therapeutics
Marriott North Tower, Lobby Level, Marriott Hall Salon 1
Pre-registration and ticket required. Fee: $85. Box lunch included. 4204 Autoinflammatory Disorders
Credit: 5.50 CME / 6.60 CE 4205 Airborne Allergen Exposures
Moderator: Debra A. Sedlak, MSN CPNP 4206 Infections, Asthma and Allergies
8:00 Overview of PIDD: Disease Characteristics and Presentation
M. Elizabeth M. Younger, CRNP PhD 4207 Immune Mediated Skin Diseases
8:45 Basics of Diagnostic Testing 4208 Food Allergy II
William R. Blouin, ARNP 4209 Health Care Delivery
9:30 Non-Immune Replacement Therapies
Kristin Epland, NP
4210 Allergen Extracts and Immunotherapy
10:15 Break 4211 Outcome Measures and Challenge Testing with
10:30 Immune Replacement: Is There a Right Way? Immunotherapy
Debra A. Sedlak, MSN CPNP 4212 Mechanistic Insight into Pollens and Other
11:15 Transplantation in PIDD Antigens
M. Louise Markert, MD PhD FAAAAI
12:00 Lunch Break
12:30 Panel Discussion
Moderator:
M. Elizabeth M. Younger, CRNP PhD
Panelists:
M. Elizabeth M. Younger, CRNP PhD
William R. Blouin, ARNP
Kristin Epland, NP
Debra A. Sedlak, MSN CPNP
M. Louise Markert, MD PhD FAAAAI
1:30 Hands-On Instruction: SCIG
Carla M. Duff, CPNP MSN
Kristin Epland, NP
Upon completion of this session, participants should be able to: Identify and develop
understanding of the multiple presentations of PIDD; Describe the various laboratory tests
and appropriate application of these tests in the evaluation for PIDD; Develop an under-
standing of the treatments utilized in the management and treatment of PIDD.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 65
 Monday, March 3

Symposium Symposium
4301 American Lung Association Clinical Trials 4304 How Close are We to Preventing Asthma by
Network: Recent Advances Vaccination?
10:45 am to 12:00 pm 10:45 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6B Convention Center, Upper Level, Room 11AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Stephen P. Peters, MD PhD FAAAAI Moderator: R. Stokes Peebles, Jr., MD FAAAAI
10:45 Validation Studies of Asthma Outcomes for Clinical Research 10:45 The Role of Rhinovirus and RSV in Asthma Incepton
Speaker to be announced. Tina V. Hartert, MD MPH
11:05 Pharmacogenomic Studies of Asthma from the ALA ACRC 11:05 The Current State of Rhinovirus Vaccine Development
Network Sebastian L. Johnston, MD PhD
John Lima, MD 11:25 The Current State of RSV Vaccine Development
11:25 SOYA: Effect of Soy Isoflavones on Asthma Barney S. Graham, MD PhD
Lewis J. Smith, MD 11:45 Question & Answer
11:45 Question & Answer Upon completion of this session, participants should be able to: Define the data that link
Upon completion of this session, participants should be able to: List newly defined asthma severe lower respiratory tract infection with rhinovirus and respiratory syncytial virus in
outcome measures; Describe the effect of new therapeutic options in asthma; Discuss infancy and the subsequent development of childhood asthma; Describe the current state
new information on pharmacogenomics in asthma. of vaccine development for respiratory syncytial virus; Describe the current state of vac-
cine development for rhinovirus.
Symposium
Symposium
4302 Primary Immunodeficiency at the Molecular
4305 B Cell and Antibody Biology in Upper and Lower
Level: The Wave of the Future
10:45 am to 12:00 pm Airways
Convention Center, Upper Level, Ballroom 6CF 10:45 am to 12:00 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Mezzanine Level, Room 14AB
Moderator: Elena E. Perez, MD PhD FAAAAI Credit: 1.25 CME / 1.50 CE
Moderator: Patricia A. Takach, MD FAAAAI
10:45 Update on Newborn Screening for PID
Jennifer M. Puck, MD 10:45 Epidemiology and Burden of Antibody Deficiency in Chronic
Rhinosinusitis
11:05 New Immunodeficiencies Defined by Genomic Methods
Anju T. Peters, MD FAAAAI
Janet S. Chou, MD
11:05 B Cell Responses in Chronic Rhinosinusitis
11:25 Gene Therapy for PID: Quo Vadis?
Kathryn E. Hulse, PhD
Fabio Candotti, MD
11:25 Regulation of B Cell Activation and Antibody Production
11:45 Question & Answer
Mubeccel Akdis, MD PhD
Upon completion of this session, participants should be able to: Discuss what progress
has been made in the diagnosis of immunodeficiency at birth via newborn screening; 11:45 Question & Answer
Describe how genomic analysis is leading to an explosion in the discovery of new forms Upon completion of this session, participants should be able to: Describe the epidemiol-
of immunodeficiency; Identify what advances are being made in gene therapy for im- ogy of antibody deficiency in chronic rhinosinusitis; Discuss the role of B cells in chronic
munodeficiency. rhinosinusitis; Identify the role of IgA in mucosal immunity in allergic diseases.

Symposium Symposium
4303 Treatment Alternatives for Refractory Severe 4306 Immunosenescence: Implications of an Aging
Asthma Immune System
10:45 am to 12:00 pm 10:45 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6DE Convention Center, Mezzanine Level, Room 15AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Paula L. Busse, MD FAAAAI Moderator: Sharmilee M. Nyenhuis, MD FAAAAI
10:45 The Role of Anti-Cholinergics, Vitamin D Replacement and Fine 10:45 Effects of Aging on Immune Function
Particle ICS Jorg Goronzy, MD PhD
Reynold A. Panettieri, MD 11:05 Vaccine Responses in the Elderly
11:05 The Role of Bronchial Thermoplasty John M. Kelso, MD FAAAAI
Monica Kraft, MD 11:25 Effect of Aging on Asthma and Allergic Diseases
11:25 Novel Approaches to Steroid Resistance Sameer K. Mathur, MD PhD FAAAAI
Stanley J. Szefler, MD FAAAAI 11:45 Question & Answer
11:45 Question & Answer Upon completion of this session, participants should be able to: Describe changes in im-
Upon completion of this session, participants should be able to: Describe the risks and mune function with aging; Describe changes in vaccine response and current recommen-
benefits of bronchial thermoplasty in severe asthma; Outline novel approaches to therapy dations for vaccination in the elderly; Discuss the effect of aging on allergic diseases.
of steroid resistant asthma; Discuss the evidence supporting the use of vitamin D replace-
ment, anti-cholinergics and small particle inhaled corticosteroids.

66 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 Monday, March 3

Symposium Oral Abstract

4307 Wanted: Eosinophils, Dead or Alive? Eosinophil 4602 Bone Marrow Transplantation in Primary
Cell Death Subroutines and Implications for Immunodeficiencies
Eosinophil-Targeted Therapy 2:00 to 3:15 pm
10:45 am to 12:00 pm Convention Center, Upper Level, Room 11AB
Convention Center, Mezzanine Level, Room 16AB Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE Moderator to be announced.
Moderator: Gerald J. Gleich, MD FAAAAI 2:00 G Protein-Coupled Receptor Kinase-3 (GRK-3) In Bone Marrow
10:45 Eosinophil Extracellular DNA Trap Cell Death (ETosis) Mediates Niche Interactions and Transplantation
Lytic Release of Free Secretion-Competent Eosinophil Granules Jaime M. Brozowski
Lisa A. Spencer, PhD FAAAAI 2:15 Allogeneic Hematopoietic Stem Cell Transplantation For Immune
11:05 Siglec-8 Engagement Induces Apoptotic or Lytic Eosinophil Cell Dysregulation, Polyendocrinopathy, X-Linked (IPEX) Syndrome
Death, Depending on Cell Activation Status Resolves Enteropathy and Autoimmunity: A Single Institution
Nives Zimmermann, MD FAAAAI Experience
11:25 Targeting Eosinophils in Disease Zeynep Yesim Yesim Kucuk, MD
Parameswaran K. Nair, MD PhD FRCP 2:30 Natural Killer Cell Immunoglobulin Like Receptor (KIR) Genetic
11:45 Question & Answer Profile Is a Strong Predictor Of Allogeneic Hematopoietic Cell
Upon completion of this session, participants should be able to: Identify cell death
Transplant Outcomes
subroutines; Discuss consequences of eosinophils dying by different subroutines; Discuss Rehan M. Faridi, PhD
consequences of cell death subroutines on efficacy and safety of eosinophil-targeting 2:45 Transient Lymphopenia Of Infancy: A Previously Unrecognized
agents. Entity
Robert Sporter, MD
AAAAI Business Meeting Upon completion of this session, participants should be able to discuss recent research
12:30 to 1:30 pm developments in the field of allergy/immunology.
Convention Center, Upper Level, Ballroom 6A
All AAAAI Fellows and members should attend this annual business Oral Abstract
meeting. Box lunches included. No fee. No pre-registration required. 4603 Air Pollution/Allergens/Air Quality
2:00 to 3:15 pm
Oral Abstract Convention Center, Upper Level, Room 5AB
Credit: 1.25 CME / 1.50 CE
4601 Adherence Moderator: Neil Alexis, PhD
2:00 to 3:15 pm
2:00 Associations Among Volatile Organic Compounds, Allergic
Convention Center, Upper Level, Ballroom 6B
Sensitization, and Respiratory Illness In Children With Asthma
Credit: 1.25 CME / 1.50 CE
Enrolled In a Study Of Low-Income, Green Eco-Friendly Housing
Moderator: Mark F. Sands, MD FAAAAI
(The Green Housing Study)
2:00 Poor Asthma Control In Older Adults Is Associated With Reduced
Joy Hsu, MD MSCI
Adherence To Controller Therapies and Inability To Afford
2:15 A Systematic Analysis Of Pollen Transcriptomes From Plant
Medications
Allergens Reveals Conserved Targets Of Immune Responses
Jessica Tan, MD MPH
Bjoern Peters
2:15 Texting Medication Reminders For Better Asthma Control In
2:30 Urinary Polycyclic Aromatic Hydrocarbon Metabolites and Th2
Children and Teens
Immunity In Children
Humaa M. Bhatta, DO
Kinjal M. Hew, PhD
2:30 Adherence To Prescribed Controller Therapy and Effects On
2:45 Impact Of BMI On Ozone-Induced IL-1 In The Airways Of Human
Asthma Control In The Hispanic Population Of a Pediatric Disease
Volunteers
Management Program
Michelle L. Hernandez, MD
Lyne G. Scott, MD
3:00 Group-2 Innate Lymphoid Cells Promote Air-Pollutant Induced
2:45 Correlation Between Emergency Department Visits For Asthma
Airway Inflammation and Hyperresponsiveness (AHR)
Exacerbation and No Show Visits To Primary Care Provider In a
Qi Yang, PhD
Pediatric Population
Upon completion of this session, participants should be able to discuss recent research
Margaret Redmond, MD
developments in the field of allergy/immunology.
3:00 Choosing Wisely: Adherence By Allergists To Recommended Use
Of Spirometry In The Diagnosis and Management Of Adult Asthma
Kristin C. Sokol, MD MPH
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 67
 Monday, March 3

Oral Abstract Oral Abstract

4604 Food Allergy 4606 Chronic Rhinosinusitis
2:00 to 3:15 pm 2:00 to 3:15 pm
Convention Center, Upper Level, Ballroom 6CF Convention Center, Upper Level, Ballroom 6DE
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Rima A. Rachid, MD FAAAAI Moderator: Anju T. Peters, MD FAAAAI
2:00 Peanut T Cell Epitope Discovery: Ara h1 and Ara h3 2:00 The Clinical Significance Of Specific Antibody Deficiency (SAD)
Manish Ramesh, MD PhD Severity In Chronic Rhinosinusitis (CRS)
2:15 Microparticles Encapsulated With Antigen Protect Against Anjeni Keswani, MD
Sensitization and Reduce Anaphylactic Reactivity In a Food 2:15 Meta-Analysis Of Gene Expression Microarrays Reveals Novel
Allergy Model Biomarkers Consistent With Altered Functionality Of Mucosal
Karen B. Chien, PhD Barrier In Patients With Chronic Rhinosinusitis
2:30 Over-The-Counter Dietary Supplements Genistein and Ipriflavone Sergejs Berdnikovs, PhD
Suppress Peanut Allergy Symptoms 2:30 Evidence For Immunoglobulin D In Patients With Chronic
Lisa Chang, BS Rhinosinusitis
2:45 Analyzing Casein-Specific IL-4 and IL-13 Secreting T-Cells: A Jin Young Min, MD PhD
Reliable Tool For Diagnosis Of Cows Milk Allergy 2:45 Oncostatin M Is Elevated In Chronic Rhinosinusitis and Decreases
Benedicte Michaud, MD PhD Barrier Function In Human Airway Epithelium
3:00 Growth Of Children Aged 2-17 With Cows Milk, Peanut, and Egg Kathryn L. Pothoven
Allergy In NHANES 3:00 Immunologic Changes During Chronic Rhinosinusitis
Karin Robbins, MD Exacerbations Compared To Controls
Upon completion of this session, participants should be able to discuss recent research Shefali Samant, MD
developments in the field of allergy/immunology. Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.
Oral Abstract
Oral Abstract
4605 Epidemiology
2:00 to 3:15 pm 4607 Mechanisms of Asthma and Allergic Disease
Convention Center, Upper Level, Room 7AB 2:00 to 3:15 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Upper Level, Room 1AB
Moderator: Chitra Dinakar, MD FAAAAI Credit: 1.25 CME / 1.50 CE
2:00 Allergic Causes Of Death In The United States Moderator: Nora A. Barrett, MD FAAAAI
Susan J. Kim, MD 2:00 Allergen Challenge Increases Peripheral Blood CD84+ ILC2 In
2:15 Death From Anaphylaxis Is a Reassuringly Unusual Outcome Allergic Rhinitis
Larry Borish, MD FAAAAI David R. Scott, MD
2:30 Allergic Rhinitis, Asthma and Cardiovascular Disease 2:15 Asthma Susceptibility Due To Environmental Programming Of
Angela M. Crans Yoon, MD Innate Immunity In Utero
2:45 Pre-Natal and Early Life Predictors Of Atopy In Canadian Children: Sarah Manners, BS
Results Of The Family Study 2:30 Rhinovirus Challenge Augments Allergen Responsiveness In
Tahira Batool, MBBS Basophils Of Atopic Asthmatics
3:00 Association Between Antibiotic Treatment In The First Six Months Rachana Agrawal, PhD
Of Life and Clinical Allergic Outcomes At Ages 2 To 3 Years 2:45 Der p 3 Allergen Activated Ano-1 Channel On Afferent Airway
Kyra Jones, MEd Nerves Regulates Th2 Cell Responses
Upon completion of this session, participants should be able to discuss recent research Mayur Patil, MS
developments in the field of allergy/immunology. 3:00 Increased Serum Soluble ST2 In Asthmatic Children and
Recurrent Early Wheezers
Hai Lee Chung, MD PhD
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.

68 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 Monday, March 3

Late Breaking Oral Abstract Session Q & A Workshop

4611 Basic Translational Sciences 4802 Social Media: The Future is Here
2:00 to 3:15 pm 4:45 to 6:00 pm
Convention Center, Mezzanine Level, Room 15AB Convention Center, Upper Level, Room 2
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderators: Francisco A. Bonilla, MD FAAAAI Moderator: Melinda M. Rathkopf, MD FAAAAI
Mitchell H. Grayson, MD FAAAAI 4:45 Using Twitter
2:00 Human TNFR2 Exhibits Bi-Directional Control over Regulatory Nathaniel D. Hare, MD FAAAAI
T Cells 5:00 Using Facebook
Denise L. Faustman, MD Gerald B. Lee, MD
2:15 Contribution of Sequential and Conformational IgE-Binding 5:15 Creating a Blog/Website
Epitopes to the Allergenicity of Major Peanut Allergen Ara h 2 Ves Dimov, MD
Stephane Hazebrouck, PhD 5:30 Question & Answer
2:30 Immunocap Cellulose Displays Cross-Reactive Carbohydrate Upon completion of this session, participants should be able to: Discuss how the utilization
Epitopes and Can Cause False-Positive Test Results in Patients of social media in allergy and immunology practices can lead to improved patient educa-
with Anti-CCD IgE Antibodies tion and satisfaction; Identify a step-wise plan for the implementation and maintenance
Wolfgang Hemmer, PhD of a social media strategy; Identify and implement processes designed to protect PHI and
prevent HIPAA violations when using healthcare social media.
2:45 The RNA-Binding Protein Hur Is Required to Control Cytokine
Expression in CD4+ T Cells
Ulus Atasoy, MD FAAAAI
Problem-Based Learning Workshop
3:00 Whole-Exome Sequencing Reveals IKBKB As a Cause of 4803 Making the Practice Parameters Work for You:
Combined Immunodeficiency Using a Quality Improvement Approach
Talal Mousallem, MD 4:45 to 6:00 pm
Upon completion of this session, participants should be able to discuss recent research Convention Center, Upper Level, Room 3
developments in the field of allergy/immunology.
Pre-registration and ticket required. Fee: $50.
Credit: 1.25 CME / 1.50 CE
Cutting-Edge Research Keynote PBL Facilitator: Jay M. Portney, MD FAAAAI
4701 Nanotechnology Applications in Content Lecturer: Marcus S. Shaker, MD MS FAAAAI
Upon completion of this session, participants should be able to: Describe how quality im-
Immunology and Allergy provement initiatives can be used to implement practice parameters in the clinical setting;
3:30 to 4:30 pm Define fundamentals of quality improvement; Define how quality improvement initiatives
Convention Center, Ground Level, Exhibit Hall A can be applied in maintenance of certification requirements.
Credit: 1.00 CME / 1.20 CE
Moderator: Paul V. Williams, MD FAAAAI Panel Discussion Workshop
James R. Baker, Jr., MD FAAAAI
Ruth Dow Doan Professor, Director, Michigan Nanotechnology Institute
4804 Use of Gamma Globulin in Clinical Practice:
for Medicine and Biological Sciences Indications, Challenges, Adverse Reactions and
Upon completion of this session, participants should be able to describe how nanotechnol- Monitoring
ogy can be utilized in drug delivery and disease management. 4:45 to 6:00 pm
Convention Center, Upper Level, Room 5AB
Panel Discussion Workshop Credit: 1.25 CME / 1.50 CE
Moderator: Elena E. Perez, MD PhD FAAAAI
4801 Mast Cell Activation Disorders: A Plan of Attack Panelists:
4:45 to 6:00 pm Mark Ballow, MD FAAAAI
Convention Center, Upper Level, Room 1AB Vivian P. Hernandez-Trujillo, MD FAAAAI
Credit: 1.25 CME / 1.50 CE Rima A. Rachid, MD FAAAAI
Moderator: Melody C. Carter, MD Upon completion of this session, participants should be able to: Discuss the relative
Panelists: virtues of intravenous and subcutaneous IgG therapy; Review common approaches to
Cem Akin, MD PhD FAAAAI reducing the systemic side effects of IGIV and managing adverse reactions; Discuss how
Lawrence B. Schwartz, MD PhD FAAAAI to optimize IgG replacement therapy in immunodeficiency patients to minimize infections
Catherine R. Weiler, MD PhD FAAAAI and maintain appropriate levels of Ig with maximal benefit.
Upon completion of this session, participants should be able to: Differentiate between
mast cell activation disorder, monoclonal mast cell activation syndrome and mastocytosis;
Determine which objective data is useful in defining the diagnosis of each entity.
Annual Meeting Workshops
Programmed by the AAAAI. Annual Meeting Workshops funded
through an educational grant from Merck.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 69
 Monday, March 3

Q & A Workshop Q & A Workshop

4805 Influenza and Pneumococcal Vaccines in 4808 FDA: Update from the U.S. Food and Drug
Asthmatic Patients Administration
4:45 to 6:00 pm 4:45 to 6:00 pm
Convention Center, Upper Level, Ballroom 6B Convention Center, Upper Level, Ballroom 6A
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Pedro C. Avila, MD FAAAAI Moderator: F. Estelle R. Simons, MD FAAAAI
4:45 Burden of Influenza and Invasive Pneumococcal Disease in 4:45 Year-in-Review: An Update from the U.S. Food and Drug
Asthmatic Patients Administration
Tina V. Hartert, MD MPH Badrul A. Chowdhury, MD PhD FAAAAI
5:00 Influenza and Pneumococcal Vaccines in Asthmatic Patients: 5:00 Over-the-Counter (OTC) Marketing of Allergy Drug Products
Benefits and Risks Sofia A. Chaudhry, MD
John M. Kelso, MD FAAAAI 5:15 Eosinophilic Asthma: Considerations for Drug Product
5:15 New Influenza Vaccines for the 21st Century Development
Speaker to be announced. Susan Lee Limb, MD FAAAAI
5:30 Question & Answer 5:30 Question & Answer
Upon completion of this session, participants should be able to: Discuss the burden of Upon completion of this session, participants should be able to: Review recent issues of
influenza and invasive pneumococcal disease in asthmatic patients; Describe the types, scientific importance at FDA and their regulatory implications; Identify issues related to
benefits and risks of influenza and pneumococcal vaccines for asthmatic patients. the over-the-counter (OTC) marketing of allergy drug products; Recognize issues in the
clinical development of drug products for eosinophilic asthma.
Year-in-Review Workshop
Q & A Workshop
4806 Practical Aspects of SCID Newborn Screening
4:45 to 6:00 pm 4809 Innate Immunity Modulators in the Lung
Convention Center, Upper Level, Ballroom 6CF 4:45 to 6:00 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Upper Level, Room 7AB
Moderator: Kathleen E. Sullivan, MD PhD FAAAAI Credit: 1.25 CME / 1.50 CE
4:45 Secondary Evaluation of SCID Screen-Positive Infants Moderator: Harald E. Renz, MD
Jolan E. Walter, MD PhD 4:45 Anionic Pulmonary Surfactant Phospholipids Act as a Regulator
5:00 PID Diagnosed Using TRECs for Newborn Screening of Inflammation and Viral Infection in the Lung
John M. Routes, MD FAAAAI Dennis R. Voelker, PhD
5:15 PID Cases Missed Using TRECs for Newborn Screening 5:00 Surfactant Protein-A and D in Airway Inflamation
Jennifer M. Puck, MD Angela Haczku, MD PhD FAAAAI
5:30 Question & Answer 5:15 Antagonism of Toll-Like Receptor Activation in Lung Disease
Upon completion of this session, participants should be able to: Review secondary Anthony A. Horner, MD FAAAAI
evaluation of SCID screen positive infants; Identify the cases that are detected via TRECs 5:30 Question & Answer
screening; Identify PID that can be potentially missed via TRECs screening. Upon completion of this session, participants should be able to: Recognize the capacity
of surfactant phospholipids in suppression of lung inflammation due to aeroallergen,
Q & A Workshop bacterial infection and viral infection; Describe how surfactant protein-A suppresses
lung inflammation and damage due to bacterial infection; Discuss the specificity and
4807 Standardization of Oral Food Challenges: How mechanisms of immune regulation regulated by pulmonary surfactant phospholipids and
Protein-A.
Golden is the Gold Standard?
4:45 to 6:00 pm
Convention Center, Upper Level, Ballroom 6DE
Credit: 1.25 CME / 1.50 CE Annual Meeting Workshops
Moderator: Scott H. Sicherer, MD FAAAAI Programmed by the AAAAI. Annual Meeting Workshops funded
4:45 The Food Challenge PRACTALL Guidelines: What are They and through an educational grant from Merck.
When Should they be Used?
Hugh A. Sampson, MD FAAAAI
5:00 Why do We Need to Standardize OFC Stopping Criteria: What are
the Controversies?
David Mark Fleischer, MD FAAAAI
5:15 What is the Role of OFC in Oral Immunotherapy Trials?
Kirsten Beyer, MD
5:30 Question & Answer
Upon completion of this session, participants should be able to: Discuss the different
methodologies for oral food challenges; Describe the controversies around objective stop-
ping criteria and the evidence base for this; Describe how and when to use different types
of challenge methodologies.

70 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 Monday, March 3

Q & A Workshop Q & A Workshop

4810 Allergic Inflammation: New Advances in 4813 Stepping Down Asthma Medications: Benefits
Chemokines and Cell Signaling and Risks
4:45 to 6:00 pm 4:45 to 6:00 pm
Convention Center, Upper Level, Room 11AB Convention Center, Mezzanine Level, Room 15AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: David H. Broide, MB ChB FAAAAI Moderator: Chitra Dinakar, MD FAAAAI
4:45 The Role of CCL18 in Chronic Allergic Inflammation 4:45 Which Patients May Be Good Candidates for Stepping Down
Andrew D. Luster, MD PhD Asthma Medications?
5:00 Eosinophilic Esophagitis: The Role of Eotaxins and Other Fernando D. Martinez, MD
Chemokines 5:00 Understanding the Risks and Benefits of Stepping Down Asthma
Amal H. Assaad, MD FAAAAI Medication
5:15 Mast Cells in Chronic Allergic Inflammation John B. Hagan, MD FAAAAI
Stephen J. Galli, MD 5:15 Comparing Asthma Step-Down Strategies: Is Dynamic Dosing
5:30 Question & Answer Ready for Prime Time?
Upon completion of this session, participants should be able to: Discuss how chemokines Paul M. OByrne, MD FAAAAI
such as CCL18 are important in allergic inflammation, particularly in atopic dermatitis; 5:30 Question & Answer
Identify how cytokines such as eotaxins play an important role in eosinophilic esophagitis; Upon completion of this session, participants should be able to: Identify asthma patients
Describe the role of mast cells in chronic allergic inflammation and how innate mediators who may be good candidates for stepping down their asthma medication; Describe the
and Th2 inflammation exacerbate allergic disease. risks associated with stepping down asthma medication with the best currently available
evidence; Compare and contrast different types of step down strategies.
Panel Discussion Workshop
4811 Dilemmas in the Management of Allergic Q & A Workshop
Bronchopulmonary Mycosis 4814 Chronic Rhinosinusitis in Children
4:45 to 6:00 pm 4:45 to 6:00 pm
Convention Center, Upper Level, Room 8 Convention Center, Mezzanine Level, Room 16AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Andrew J. Wardlaw, MD PhD Moderator: Martin Wagenmann, MD FAAAAI
Panelists: 4:45 Pathophysiology of Chronic Rhinosinusitis in Children
Leslie C. Grammer, MD FAAAAI Daniel L. Hamilos, MD
Catherine A. Pashley, PhD 5:00 Medical Workup and Treatment of Chronic Rhinosinusitis in
Raymond G. Slavin, MD MS FAAAAI Children
Upon completion of this session, participants should be able to: Describe which fungi can David W. Hauswirth, MD FAAAAI
cause ABPM and how they might cause lung damage; Review the clinical spectrum of
how ABPM presents; Discuss how to optimally manage ABPM.
5:15 Surgical Treatment of Chronic Rhinosinusitis in Children
Fuad M. Baroody, MD FAAAAI
Q & A Workshop 5:30 Question & Answer
Upon completion of this session, participants should be able to: Discuss the pathophysi-
4812 Utility of FeNO in the Diagnosis and Management ology of CRS in children; List the workup and medical treatment of children with CRS;
Review the surgical approach to CRS in children after failure of medical therapy.
of Asthma: Comparison to Other Measures
4:45 to 6:00 pm
Convention Center, Mezzanine Level, Room 14AB
Problem-Based Learning Workshop
Credit: 1.25 CME / 1.50 CE 4815 Aspirin Desensitization for Aspirin-Exacerbated
Moderator: Harold S. Nelson, MD FAAAAI Respiratory Disease: Indications, Protocols and
4:45 The Use of FeNO in Adult Asthma
Pitfalls
Miguel J. Lanz, MD FAAAAI
4:45 to 6:00 pm
5:00 The Use of FeNO in Pediatric Asthma
Convention Center, Upper Level, Room 31C
Stanley J. Szefler, MD FAAAAI
Pre-registration and ticket required. Fee: $50.
5:15 Practical Implications of Implementing FeNO in Clinical Practice Credit: 1.25 CME / 1.50 CE
Joseph D. Spahn, MD PBL Facilitator: Richard W. Weber, MD FAAAAI
5:30 Question & Answer Content Lecturer: Donald D. Stevenson, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the appropriate Upon completion of this session, participants should be able to: Describe indications for
uses of FeNO in adults; Review the appropriate uses of FeNO in children; Discuss the aspirin desensitization for aspirin exacerbated respiratory disease; Identify problems that
practical implications of implementing FeNO in clinical practice. can occur with aspirin desensitization and develop strategies for how to deal with these
problems.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 71
 Monday, March 3

Seminars 4826 Exercise-Induced Anaphylaxis and Food-

4:45 to 5:45 pm Dependent Exercise-Induced Anaphylaxis
Pre-registration and ticket required. Fee: $40. Refreshments included. Anna M. Feldweg, MD
Sessions and refreshments are limited to 30 people. Kirsi M. Jarvinen-Seppo, MD PhD
Credit: 1.00 CME / 1.20 CE Marriott South Tower, Level 1, Point Loma
4821 From Urticaria to Toxic Epidermal Necrolysis: Upon completion of this session, participants should be able to: Review the most common
clinical presentations of EIAn and typical foods that can trigger FD-EIAn; Identify recent
Cutaneous Drug Eruptions for the Clinician publications relevant to EIAn and FD-EIAn; Increase understanding of treatment options for
Jennifer S. Kim, MD FAAAAI EIAn and FD-EIAn.
Peter A. Lio, MD
Marriott South Tower, Level 3, Marina Ballroom Salon G
4827 Physical Urticarias
Upon completion of this session, participants should be able to: Evaluate cutaneous drug
Mario Geller, MD FAAAAI
eruptions and render a diagnosis with confidence; Analyze evidence-based medicine to Karen S. Hsu Blatman, MD
current therapeutic options for these conditions. Marriott South Tower, Level 1, Solana
Upon completion of this session, participants should be able to: Identify physical urticarias;
4822 Smoking and Asthma: Not Just Blowing Smoke Evaluate and educate patients with physical uticarias; Manage and treat physical urticarias
Riccardo Polosa, MD PhD FAAAAI with the recent data.
Mark F. Sands, MD FAAAAI
Marriott South Tower, Level 3, Balboa
4828 Advanced Coding for the Allergist
Upon completion of this session, participants should be able to: Describe the pathophysio-
Noga Askenazi, MD FAAAAI
logic consequences of tobacco smoking upon the asthmatic; Discuss the effect of tobacco Gary N. Gross, MD FAAAAI
smoke on the lung from fetus through adult life; Describe effective smoking cessation Marriott South Tower, Level 1, Santa Rosa
interventions. Upon completion of this session, participants should be able to: Discuss the use of codes
pertinent to allergy/immunology practice; Describe details of coding for patients allergy
4823 Gene Therapy for Primary Immunodeficiency testing and immunotherapy.
Disorders: Where are We in 2014?
4829 Immunodeficiencies Discovered in the Last Five
Fabio Candotti, MD
Matthew Porteus, MD PhD Years
Marriott South Tower, Level 3, Mission Hills Francisco J. Espinosa-Rosales, MD
Upon completion of this session, participants should be able to: Review the primary Gulbu Uzel, MD
immunodeficiency disorders for which gene therapy is a treatment option; Discuss the Marriott South Tower, Level 4, La Costa
mechanism of gene therapy; Discuss limitations and risks associated with gene therapy. Upon completion of this session, participants should be able to: Discuss the new primary
immunodeficiency diseases with a focus on those described during the past five years;
4824 Occupational Respiratory Diseases Describe the newer technologies used for discovery of these and future disorders; Identify
Andr Cartier, MD FAAAAI the expanding overlap between immunodeficiency and inflammatory disorders.
Susan M. Tarlo, MBBS FAAAAI
Marriott South Tower, Level 3, Cardiff
4830 Management of Children and Adult Patients with
Upon completion of this session, participants should be able to: Recognize the history Atopic Dermatitis
clues pointing to potential work-related asthma; Develop familiarity with the approach Jon M. Hanifin, MD FAAAAI
needed to establish the diagnosis of occupational asthma; Compare the strengths and Dagmar Simon, MD
weaknesses of the tools available to establish work-relatedness. Marriott South Tower, Level 4, Catalina
4825 Asthma Management Among Minority Upon completion of this session, participants should be able to: Describe the presenta-
tion, pathophysiology and complications of atopic dermatitis; Discuss the management of
Populations: Practical Insights for Clinicians, these patients, including their education; Discuss possible therapeutic consequences due
Researchers and Public Health Planners to new insights into the pathogenesis of atopic dermatitis.
Alan P. Baptist, MD MPH FAAAAI
Christine L.M. Joseph, PhD
Marriott South Tower, Level 3, Del Mar
Upon completion of this session, participants should be able to: Identify the healthcare
disparities that exist in asthma care; Discuss reasons why these disparities exist; Discuss
effective strategies to treat minority populations, thereby decreasing health disparities in
asthma.

Annual Meeting Seminars

Programmed by the AAAAI. Annual Meeting Seminars funded
through an educational grant from Merck.

72 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 tuesday, March 4

Seminars 5008 Challenges of Managing Multiple Food Allergies

7:00 to 8:00 am
Pre-registration and ticket required. Fee: $40. Continental breakfast
included. Sessions and meals are limited to 30 people.
Credit: 1.00 CME / 1.20 CE
5001 Corticosteroid Resistance in Asthma
Elena Goleva, PhD
Faoud T. Ishmael, MD PhD FAAAAI
Marriott South Tower, Level 3, Balboa
Upon completion of this session, participants should be able to: Discuss current ap-
proaches for clinical evaluation of potential insensitivity to oral and inhaled CS; Describe
glucocorticoid receptor function and current understanding of the molecular pathways
that lead to CS insensitivity; Explain the interaction of the glucocorticoid receptor with
other steroid receptor regulated pathways, i.e. vitamin D, sex hormones, etc.; Discuss
management of patients with suspected CS insensitivity and alternative therapeutic
strategies for these patients.
Julie Wang, MD FAAAAI
Michael C. Young, MD FAAAAI
Marriott South Tower, Level 4, Catalina
Upon completion of this session, participants should be able to: Identify the diagnostic and
management challenges of multiple food allergies; Recognize the nutritional, feeding and
social risk factors; Develop and implement a feeding plan for adequate nutrition, feeding
skill and social development of children with multiple food allergies.
5009 SLIT vs. SCIT in Children
Giovanni Passalacqua, MD
David P. Skoner, MD
Marriott South Tower, Level 4, Coronado
Upon completion of this session, participants should be able to: Summarize experience
with SLIT and compare and contrast its safety/efficacy vs. SCIT; Appreciate recent data
describing SLIT; Appreciate methodologic variation in SLIT.

5002 Rethinking Allergen Avoidance Q & A Workshop

Elizabeth Matsui, MD 5051 Glycobiology and Glycoimmunology: From
Euan R. Tovey, PhD
Concepts to Clinical Relevance
Marriott South Tower, Level 3, Mission Hills
6:45 to 8:00 am
Upon completion of this session, participants should be able to: Define current guidelines
for allergen avoidance in asthma management; Describe methods of reducing allergen Convention Center, Upper Level, Room 2
exposure and evidence based studies of their effectiveness; Discuss new strategies for Credit: 1.25 CME / 1.50 CE
allergen avoidance that take into account the complex interactions between allergens, the Moderator: Nives Zimmermann, MD FAAAAI
innate immune system and genetic markers. 6:45 Cell Surface Sialic Acids: The Dark Matter of Immune Regulation
5003 Role of Allergy in Atopic Dermatitis Ronald L. Schnaar, PhD
Johannes Ring, MD PhD FAAAAI 7:00 Induction of Tolerance by Targeting B Cell Siglecs
Marriott South Tower, Level 3, Cardiff James C. Paulson, PhD
Upon completion of this session, participants should be able to: Review practical relevance 7:15 Sialic Acid Recognition is Key to Immune Regulation-Role of
of aero-food and contact allergic reactions in triggering flairs of AD; List practical tips for Siglecs
management with regard to restoring disturbed barrier function in AD. Bruce S. Bochner, MD FAAAAI
5004 Cases of Patients with Chronic Cough 7:30 Question & Answer
Mandel R. Sher, MD FAAAAI Upon completion of this session, participants should be able to: Explain sialic acid
Gary J. Stadtmauer, MD FAAAAI biosynthesis and its role in human biology; Define the role that glycans play in immune
recognition and regulation.
Marriott South Tower, Level 1, Point Loma
Upon completion of this session, participants should be able to describe various diagnostic
and treatment techniques for patients with chronic cough. Problem-Based Learning Workshop
5005 New Insights into IgE Biology 5052 An Allergists' Vision of Ocular Diseases: A Case-
Hannah J. Gould, PhD Based Approach
Marriott South Tower, Level 1, Solana 6:45 to 8:00 am
Upon completion of this session, participants should be able to: Identify the regulation of Convention Center, Upper Level, Room 3
IgE production in B cells; Describe the acquisition of IgE by tissue mast cells; Identify the Pre-registration and ticket required. Fee: $50.
effects of IgE activation on tissue mast cells in inflammation.
Credit: 1.25 CME / 1.50 CE
5006 Exhaled NO: Time to Clear the Air! PBL Facilitator: Andrew M. Smith, MD FAAAAI
Chitra Dinakar, MD FAAAAI Content Lecturer: Neal P. Barney, MD
Stanley J. Szefler, MD FAAAAI Upon completion of this session, participants should be able to: Describe the pathophysiol-
Marriott South Tower, Level 1, Santa Rosa ogy of ocular conditions commonly encountered in the allergy clinic; Facilitate interaction
Upon completion of this session, participants should be able to: Discuss the application of between allergists and ophthalmologists and explain how each plays a complementary
eNO in the context of ATS guidelines and AAAAI/ACAAI position statements; Recognize the role in the management of ocular allergy; Discuss allergic diseases which present in
relationship between the levels of evidence and practice guidelines for clinical eNO use; different age groups (children, young adults and elderly) and how their diagnoses and
Explain potential weaknesses/strengths of eNO for managing asthmatics. management are different.

5007 Perioperative Anaphylaxis: Which Tests and How

to Interpret Annual Meeting Workshops
Gerald W. Volcheck, MD FAAAAI
Marriott South Tower, Level 4, La Costa Programmed by the AAAAI. Annual Meeting Workshops funded
Upon completion of this session, participants should be able to explain to patients the through an educational grant from Merck.
meaning of allergy tests performed for perioperative anaphylaxis.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 73
 tuesday, March 4

Q & A Workshop Plenary

5053 Impact of Climate Change on Indoor and Outdoor 5101 Bioaerosols: When Not to Take a Deep Breath at
Aeroallergens Work
6:45 to 8:00 am 8:15 to 9:45 am
Convention Center, Upper Level, Room 5AB Convention Center, Ground Level, Exhibit Hall A
Credit: 1.25 CME / 1.50 CE Credit: 1.50 CME / 1.80 CE
Moderator: Estelle Levetin, PhD FAAAAI Moderator: Leslie C. Grammer, MD FAAAAI
6:45 Overview of the Impact of Climate Change 8:15 Office: Building-Related Illness
Charles S. Barnes, PhD Jean M. Cox-Ganser, PhD
7:00 Changing Patterns of Aeroallergens and Pollens Around the World 8:45 Agriculture: Respiratory Illness in Large Animal Farming
John R. Cohn, MD FAAAAI Environments
7:15 Impacts On the Indoor Environment Jill A. Poole, MD FAAAAI
Jonathan A. Bernstein, MD FAAAAI 9:15 Factory: Occupational Illness in the Textile Industry
7:30 Question & Answer David C. Christiani, MD
Upon completion of this session, participants should be able to: Identify two recent reports Upon completion of this session, participants should be able to: State the health effects
on the impact of climate change on environmental exposures; Describe changes docu- of bioaerosol exposure on health in office building workers; Discuss the immunologic
mented to date on indoor and outdoor allergen exposures that have been related to cli- mechanisms of respiratory disease associated with working in large animal confinement
mate change adaptation factors; Discuss future factors that might be directly or indirectly feeding operations; Describe bioaerosol sampling methods and exposure risk for health
related to climate change and changes in environmental exposures; Discuss appropriate effects in textile manufacturing workers.
changes in allergy practice in response to changing environmental exposures.
Posters
Q & A Workshop 7:00 am to 5:00 pm
5054 Teaching Allergy and Immunology to Residents Convention Center, Ground Level, Exhibit Hall B
Posters on display from 7:00 am to 5:00 pm. Authors present from
and Medical Students: An Achievable Goal for the
9:45 to 10:45 am.
Clinical Allergist Credit: No CME / No CE
6:45 to 8:00 am Refer to pages 83 158 for abstracts and authors.
Convention Center, Upper Level, Room 8
Credit: 1.25 CME / 1.50 CE
5201 The Impact of Environmental Factors on Asthma
Moderator: Mark H. Moss, MD 5202 Diagnostic Modalities of Asthma
6:45 The Six Core Compentencies 5203 Basic and Translational Immunology
Asriani M. Chiu, MD FAAAAI
5204 Innate Immunity and Primary
7:00 Designing a Clinical Rotation
Lily Pien, MD FAAAAI Immunodeficiencies
7:15 Teaching from a Practitioners Perspective: What Works 5205 Epidemiology and Risk Factors of Asthma
Stephen A. Tilles, MD FAAAAI 5206 Eosinophilic Gastrointestinal Diseases
7:30 Question & Answer
Upon completion of this session, participants should be able to: Identify the six core
5207 Drug Allergy
competencies of postgraduate medical training; Describe resources to enhance teaching 5208 Ocular Allergy
of trainees in the office setting; Discuss qualities of a clinical rotation that lend value to a
medical training program. 5209 Allergen Immunotherapy
5211 Late Breaking Poster Session

Annual Meeting Workshops

Programmed by the AAAAI. Annual Meeting Workshops funded
through an educational grant from Merck.

74 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 tuesday, March 4

Symposium Symposium
5301 The Road to Allergy: Soluble Instructions to 5304 Angioedema with Negative Family History
Dendritic Cells 10:45 am to 12:00 pm
10:45 am to 12:00 pm Convention Center, Upper Level, Room 11AB
Convention Center, Upper Level, Room 5AB Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE Moderator: Michael M. Frank, MD FAAAAI
Moderator: Dawn C. Newcomb Baker, PhD 10:45 New Developments in Angioedema Caused by Angiotensin-
10:45 Cysteinyl Leukotrienes are Endogenous Signaling Molecules Converting Enzyme Inhibitors
Nora A. Barrett, MD FAAAAI Marco Cicardi, MD PhD
11:05 Inhibition of Th2 Priming by the UDP Receptor P2Y6 11:05 Diagnosis of Idiopathic Angioedema
Joshua A. Boyce, MD FAAAAI Marc A. Riedl, MD MS
11:25 Platelets Dictate Th2 Sensitization: The Role of Serotonin 11:25 Management of Idiopathic Angioedema
Marco Idzko, MD Aleena Banerji, MD
11:45 Question & Answer 11:45 Question & Answer
Upon completion of this session, participants should be able to: Recognize the role cyste- Upon completion of this session, participants should be able to: Discuss mechanisms and
inyl leuktrienes play as signaling molecules in dendritic cells; Identify the counterregula- clinical aspects of recurrent angioedema caused by angiotensin-converting enzyme inhibi-
tory role of the purinergic 6 receptor; Identify the role of serotonin in Th2 priming. tors; Review the differential diagnosis and management issues of idiopathic angioedema;
Describe the management of idiopathic angioedema.

Symposium
Symposium
5302 What to Do When Everything Fails: Treatment
5305 Innate Cytokines and the Regulation of Allergy
Options for Severe Chronic Rhinosinusitis 10:45 am to 12:00 pm
10:45 am to 12:00 pm Convention Center, Mezzanine Level, Room 14AB
Convention Center, Upper Level, Room 7AB Credit: 1.25 CME / 1.50 CE
Credit: 1.25 CME / 1.50 CE Moderator: Zoulfia Allakhverdi, PhD FAAAAI
Moderator: Anju T. Peters, MD FAAAAI
10:45 Role of Epithelial-Derived Cytokines in the Initiation and
10:45 Is More and Longer Better? Long-Term and High-Dose Pathogenesis of Allergy
Glucocorticosteroids Clare M. Lloyd, PhD
Joaquim Mullol, MD PhD FAAAAI
11:05 Cross-Regulatory Mechanisms of Interferon and Allergic
11:05 Treating With the Cause of Trouble: ASA-Desensitization Stimulation
Katharine M. Woessner, MD FAAAAI J. David Farrar, PhD
11:25 The Road to Future: Will Biologics Improve Treatment? 11:25 Modulation of Innate Cytokines by TLR Agonists to Achieve
Claus Bachert, MD PhD Tolerance
11:45 Question & Answer Speaker to be announced.
Upon completion of this session, participants should be able to: Contrast the limitations
11:45 Question & Answer
and possibilities of high-dose or long-lasting glucocorticosteroid treatment in recurrent
chronic rhinosinusitis with nasal polyps; Identify suitable patient subgroups, success rates Upon completion of this session, participants should be able to: Identify the key cytokines
and limitations of aspirin desensitization; Outline the pathophysiological basis and current secreted by lung epithelial cells in response to infections and the role of these cytokines in
knowledge about anti-IgE and anti-IL-5 treatment in nasal polyposis. priming of the allergic condition; Describe the role of type I and III interferons in the sup-
pression of Th2 and Th17 responses and the inhibition of interferon secretion by allergic
stimulation through the high affinity IgE Fc receptor; Discuss how TLR ligands, such as
Symposium CpG oligonucleotides, are being used to mediate allergic suppression through the induc-
tion of cross-regulatory cytokines.
5303 Atopic Dermatitis
10:45 am to 12:00 pm
Convention Center, Upper Level, Room 2
Credit: 1.25 CME / 1.50 CE
Moderator: Lynda C. Schneider, MD FAAAAI
10:45 Barrier Defects in Atopic Dermatitis
Anna De Benedetto, MD
11:05 Atopic Dermatitis as a Global Burden
Peter Schmid-Grendelmeier, MD PhD
11:25 New Treatment Modalities
Mark Boguniewicz, MD FAAAAI
11:45 Question & Answer
Upon completion of this session, participants should be able to: Discuss atopic dermatitis;
Identify and use appropriate diagnostic tools; Demonstrate efficient, safe and state-of-the-
art treatment.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 75
 tuesday, March 4

Symposium Course
5306 B Cells and Mucosal Immune Responses in Health 5311 Mechanisms of Allergic Inflammation
and Disease 10:45 am to 1:45 pm
10:45 am to 12:00 pm Convention Center, Upper Level, Room 4
Convention Center, Mezzanine Level, Room 15AB Pre-registration and ticket required. Fee: $40. Box lunch included.
Credit: 1.25 CME / 1.50 CE Credit: 2.75 CME / 3.20 CE
Moderator: Atsushi Kato, PhD Moderator: Mitchell H. Grayson, MD FAAAAI
10:45 Mucosal Immunity: Balancing Immune Responses at the 10:45 Introduction: Control of Type 2 Immunity
Forefront of Microbial Exposure Mitchell H. Grayson, MD FAAAAI
Andrea Cerutti, MD 10:50 Transcriptional Cross-Regulation of Th1 and Th2 Cell
11:05 Immunity and B Cells in the Gut: From Immune Exclusion to Food Differentiation
Allergy Jinfang Zhu, PhD
Cecilia Berin, PhD 11:15 Question & Answer
11:25 B Cells and Respiratory Immunity 11:20 Location, Location, Location: Dendritic Cells, B Cells and Th2
Kathryn E. Hulse, PhD Development
11:45 Question & Answer Frances E. Lund, PhD
Upon completion of this session, participants should be able to: Outline how the mucosal 11:45 Question & Answer
immune system balances responses to commensal and pathogenic microbes; Describe 11:50 From Friend to Foe: T Regs Acting Th2
the unique role of B cells and their antibodies in maintaining tolerance and homeostasis
at mucosal sites; Identify how mucosal B cell responses may be dysregulated in allergic
Prabir Ray, PhD
disease as a strategy for the development of more targeted therapeutic interventions. 12:15 Question & Answer
12:20 Break
Symposium 12:40 Introduction: Novel Concepts in Immunoglobulin E and its
Receptors
5307 Inflammasome Disorders: Here and Now
Mitchell H. Grayson, MD FAAAAI
10:45 am to 12:00 pm
12:45 Breaking Up is Hard to Do: Disassembly of IgE and FceRI
Convention Center, Mezzanine Level, Room 16AB
Theodore S. Jardetzky, PhD
Credit: 1.25 CME / 1.50 CE
Moderator: John W. Steinke, PhD FAAAAI 1:10 Question & Answer
10:45 Nuts and Bolts of Inflammasome Biology 1:15 Exclusivity: IgE Binding to CD23 or FceRI
Daniel L. Kastner, MD Hannah J. Gould, PhD
Brian Sutton, MA DPhil
11:05 Inflammasome Associated Diseases: The Old and New
Monica G. Lawrence, MD 1:40 Question & Answer
Upon completion of this session, participants should be able to: Describe mechanisms
11:25 Treatment Options for Inflammasome Disorders
through which t-bet is able to suppress Th2 responses and discuss how dendritic cells
Hal M. Hoffman, MD FAAAAI and B cells drive Th2 development outside of the T cell zone; Review how a viral respira-
11:45 Question & Answer tory infection can induce Th2 cytokine production from regulatory T cells; Discuss how
Upon completion of this session, participants should be able to: Describe the basics of macromolecules can disrupt IgE-FcRI complexes and how IgE interacts with CD23 and
how the inflammasome works; Outline the current state of inflammasome disorders and how this prevents binding to FcRI and vice versa.
what is new in the field; Discuss novel therapeutic approaches to treating inflammasome
disorders.

76 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 tuesday, March 4

Course Course
5312 Developing Clinical Skills to Promote Adherence 5314 Owning the Bone: How to Minimize
and Maximize Asthma Outcomes Glucocorticoid-Induced Osteoporosis Risk
10:45 am to 1:45 pm 10:45 am to 1:45 pm
Convention Center, Upper Level, Room 3 Convention Center, Upper Level, Room 8
Pre-registration and ticket required. Fee: $40. Box lunch included. Pre-registration and ticket required. Fee: $40. Box lunch included.
Credit: 2.75 CME / 3.30 CE Credit: 2.75 CME / 3.30 CE
Moderator: Marcus S. Shaker, MD MS FAAAAI Moderator: Joshua A. Steinberg, MD
11:15 Clinical Management Strategies to Promote Adherence of 10:45 Cellular Mechanisms of Glucocorticoid Action in Bone
Pediatric Asthma Patients and Families Ernesto Canalis, MD
Cynthia S. Rand, PhD 11:15 Bone Biomechanics and Glucocorticoid Effects
11:45 Methods to Diagnose Adherence Status Bjoern Buehring, MD
Andrew G. Weinstein, MD FAAAAI 11:45 Break
12:15 Break 12:00 Corticosteroids and Bone Accretion
12:30 Shared Decision Making: A Communication Practice Proven to Kelan Tantisira, MD MPH
Enhance Adult Asthma Patients Adherence and Outcomes 12:30 Influence of Diet and Lifestyle on Glucocorticoid-Induced
Sandra R. Wilson, PhD Osteoporosis
1:00 The Role of Motivational Interviewing to Help Guide Patients to Mary C. Tobin, MD FAAAAI
Favorable Asthma Management Actions 1:00 Incorporating Best Bone Health Care into Allergy Practice
Belinda Borrelli, PhD Andrea J. Apter, MD MA MSc FAAAAI
1:30 Question & Answer 1:30 Question & Answer
Upon completion of this session, participants should be able to: Identify the reasons why Upon completion of this session, participants should be able to: Identify known bone
patients are non-adherent with health care providers plans; Discuss objective means to health risks of acute and chronic exposure to inhaled and oral glucocorticoids; Recognize
diagnose adherence status; Demonstrate motivational interviewing and other patient- differences between GIOP and post-menopausal osteoporosis pathophysiology, risk factors
centered techniques to help patients and families follow asthma treatment plans. and screening tools; Discuss present and emerging guidelines and pharmacotherapy in the
prevention and management of GIOP.
Course
Pro/Con Debate
5313 Mechanisms and Treatment of Exacerbations of
Asthma 5502 Adaptive Immune Responses are Essential
10:45 am to 1:45 pm 12:30 to 1:30 pm
Convention Center, Upper Level, Room 1AB Convention Center, Upper Level, Room 5AB
Pre-registration and ticket required. Fee: $40. Box lunch included. Credit: 1.00 CME / 1.20 CE
Credit: 2.75 CME / 3.30 CE Moderator: Larry Borish, MD FAAAAI
Moderators: James E. Gern, MD FAAAAI Pro
Daniel J. Jackson, MD Erwin W. Gelfand, MD FAAAAI
10:45 Role of Viruses Con
Eva Kathryn Miller, MD Hirohito Kita, MD
11:10 Role of Bacteria Upon completion of this session, participants should be able to discuss the increasingly
important role of ILC2 lymphocytes in generating allergic airway inflammation.
Hans Bisgaard, MD DMSci
11:35 How Does Allergic Inflammation Alter the Immune Response to
Viruses?
Pro/Con Debate
Peter W. Heymann, MD 5503 Anti-Fungals are Effective in Treating Allergic
12:00 Break Fungal Airway Disease
12:15 Etiology of Exacerbations in Different Populations 12:30 to 1:30 pm
Malcolm R. Sears, MD FAAAAI Convention Center, Upper Level, Room 11AB
12:40 Identifying the Exacerbation-Prone Patient Credit: 1.00 CME / 1.20 CE
Ronina A. Covar, MD Moderator: Jeffrey G. Demain, MD FAAAAI
1:05 Approaches to the Prevention and Treatment of Exacerbations Pro
Daniel Jackson, MD Daniel L. Hamilos, MD FAAAAI
1:30 Question & Answer Con
Upon completion of this session, participants should be able to: List the most common Andrew J. Wardlaw, MD PhD
viruses and bacteria associated with asthma exacerbations; Discuss mechanisms of Upon completion of this session, participants should be able to: Identify the clinical trials
virus-allergen interactions that promote exacerbations; List major risk factors for exacer- and case series that have described the use of anti-fungals in fungal associated asthma;
bations of asthma. List the pros and cons of using anti-fungal agents in ABPA and related conditions.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 77
 tuesday, March 4

Pro/Con Debate Seminars

5504 The Diagnosis of Asthma vs. COPD Does Not 12:30 to 1:30 pm
Affect Treatment Pre-registration and ticket required. Fee: $40. Box lunch included.
Sessions and meals are limited to 30 people.
12:30 to 1:30 pm
Credit: 1.00 CME / 1.20 CE
Convention Center, Mezzanine Level, Room 14AB
Credit: 1.00 CME / 1.20 CE 5521 Approach to the Evaluation of Immunodeficiency
Moderator: Michael E. Manning, MD FAAAAI in Adults
Pro Adina Kay Knight, MD FAAAAI
Stephen P. Peters, MD PhD FAAAAI Joyce E. Yu, MD
Con Marriott South Tower, Level 1, Point Loma
Nicola A. Hanania, MD Upon completion of this session, participants should be able to: Discuss the workup and
Upon completion of this session, participants should be able to: Describe how COPD and management of adults with suspected immunodeficiency; Compare and contrast the dif-
asthma can be differentiated; Compare and contrast treatment options and treatment ferential diagnosis for hypogammaglobulinemia in adult patients; List key differences be-
expectations in COPD vs. asthma. tween the immunodeficiency diagnostic spectrum in adults vs. adolescents and children.

5522 Office Evaluation of Patients with Multiple

Pro/Con Debate Antibiotic Allergies
5505 Epinephrine Should be Prescribed to All Allergen Roland Solensky, MD FAAAAI
Immunotherapy Patients (SLIT and SCIT) Marriott South Tower, Level 1, Solana
Upon completion of this session, participants should be able to describe how to approach
12:30 to 1:30 pm patients with multiple antibiotic allergies with appropriate diagnostic testing and challenge
Convention Center, Mezzanine Level, Room 15AB procedures.
Credit: 1.00 CME / 1.20 CE
Moderator: Linda Cox, MD FAAAAI 5523 Novel Therapies for Chronic Urticaria and
Pro Angioedema
Dana V. Wallace, MD FAAAAI David H. Dreyfus, MD PhD FAAAAI
Con Marriott South Tower, Level 1, Santa Rosa
John Oppenheimer, MD FAAAAI Upon completion of this session, participants should be able to: Discuss novel therapy for
chronic urticaria and angioedema; Describe novel diagnostic testing for chronic urticaria
Upon completion of this session, participants should be able to: Discuss the safety of SCIT
and angioedema; Review practical considerations for application of novel therapy and
with emphasis on timing and severity of reactions; Discuss safety of SLIT in the reported
diagnosis.
studies and surveys.
5524 Tree Nut and Peanut: Complexity in Cross-
Pro/Con Debate Reactivity
5506 Androgens are the Best Option for Prophylactic Soheila J. Maleki, PhD
Suzanne S. Teuber, MD FAAAAI
Treatment of Hereditary Angioedema Marriott South Tower, Level 4, La Costa
12:30 to 1:30 pm Upon completion of this session, participants should be able to: Distinguish between
Convention Center, Mezzanine Level, Room 16AB clinical cross-reactivity and in vitro cross-reactivity; List the main seed storage proteins
Credit: 1.00 CME / 1.20 CE involved in cross-reactivity; Review the closely related tree nuts that are often clinically
Moderator: Bruce L. Zuraw, MD cross-reactive.
Pro 5525 Chronic Rhinosinusitis Subtypes and Implications
Marco Cicardi, MD PhD
for Treatment
Con
Joseph K. Han, MD
Marc A. Riedl, MD MS
Amber U. Luong, MD PhD
Upon completion of this session, participants should be able to: List the benefits and risks
Marriott South Tower, Level 4, Catalina
of androgens for prophylaxis in HAE; Discuss the risks and benefits of C1 inhibitor therapy
for prophylaxis in HAE; Compare and contrast the use of androgens vs. C1 inhibitor Upon completion of this session, participants should be able to: Describe the classification
therapy for prophylaxis in HAE. of sinusitis; Describe the clinical subtypes of chronic rhinosinusitis; Explain the different
non-surgical treatment options for the different chronic rhinosinusitis subtypes.

Annual Meeting Seminars

Programmed by the AAAAI. Annual Meeting Seminars funded
through an educational grant from Merck.

78 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 tuesday, March 4

Oral Abstract Oral Abstract

5601 Asthma Epidemiology and Risk Factors 5603 Environmental Risk Factors and Disease
2:00 to 3:15 pm Outcomes
Convention Center, Upper Level, Room 5AB 2:00 to 3:15 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Upper Level, Room 1AB
Moderators: Ronina A. Covar, MD Credit: 1.25 CME / 1.50 CE
Timothy J. Craig, DO FAAAAI Jonathan A. Bernstein, MD FAAAAI
2:00 Exposures That Alter The Early Life Microbiome and The Risk Of Moderator: James. L. Sublett, MD FAAAAI
Asthma 2:00 Effect Of Prenatal Exposure To Indoor PM2.5 and Environmental
Amy S. Feldman, MD Tobacco Smoke Affecting Lower Respiratory Tract Infection Was
2:15 Ethnic Differences Of Reported Asthma Symptoms In Urban Modified By ROS Genes: Cocoa Study
School-Based Screening Surveys Song I. Yang, MD
Margee Louisias, MD 2:15 IgE Anti-Respiratory Syncytial Virus Antibodies In Older
2:30 Year One Daycare Attendance Predicts Asthma At Age Seven: The Asthmatic Children
Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS) Mira Mandal
Gang Cheng, MD PhD 2:30 Asthma Symptoms and Rhinovirus In A Longitudinal Childrens
2:45 Determining Risk Levels Of The Composite Asthma Severity Index Cohort
(CASI) Euan R. Tovey, PhD
Rebecca A. Zabel 2:45 Maternal Transfer Of Der p 1 and Blo t 5 Allergens and Their
3:00 BMI and Asthma Severity In An Elementary and Middle School Respective Specific Antibodies Trough Placenta and Colostrum
Inner City Population Patricia Macchiaverni
Christina G. Kwong, MD 3:00 Rhinovirus Infection Is Associated With Changes In The Airway
Upon completion of this session, participants should be able to discuss recent research Microbiome
developments in the field of allergy/immunology.
Kirsten Kloepfer, MD
Upon completion of this session, participants should be able to discuss recent research
Oral Abstract developments in the field of allergy/immunology.
5602 Basic and Translational Immunology
2:00 to 3:15 pm
Oral Abstract
Convention Center, Upper Level, Room 7AB 5604 Eosinophilic Gastrointestinal Diseases
Credit: 1.25 CME / 1.50 CE 2:00 to 3:15 pm
Moderator: TBA Convention Center, Upper Level, Room 2
2:00 Novel NK Cytotoxicity Assay Enables Drug Discovery For Credit: 1.25 CME / 1.50 CE
Hemophagocytic Lymphohistiocytosis Moderator: Antonella Cianferoni, MD PhD
Jinzhu Li, MD PhD 2:00 Natural History Of Esophageal Remodeling In Pediatric
2:15 Exploitation Of The Host Ubiquitin System By Respiratory Eosinophilic Esophagitis Treated For Four Years
Syncytial Virus Nonstructural Protein 2 Jessica Rajan, MD
Jillian N. Whelan 2:15 Diagnostic Inaccuracy Of Biopsy Evaluations In Eosinophilic
2:30 Epigenetic Regulation Of Dendritic Cell Migration Esophagitis Underscores The Value Of a Secondary Review
Timothy P. Moran, MD PhD Process
2:45 LRBA Subcellular Localization: Evidence Of The LRBAs Role Emily Stucke, BA
In Vesicle Trafficking From The Golgi To Cell Membrane and 2:30 Development Of Eosinophilic Esophagitis To Food After
Endocytosis Development Of IgE Tolerance To The Same Food
Michelle A. Reiser, MS Solrun Melkorka Maggadottir, MD
3:00 Differential Role Of Dendritic Cell Subsets In Shaping T-Cell 2:45 Mast Cells, Eosinophils and Eosinophilic Esophagitis
Responses To Respiratory Viruses Jay Jin, MD PhD
Meera Rani Gupta, MD 3:00 CD3 and CD8 Cells Produce IL-9 In Pediatric Eosinophilic
Upon completion of this session, participants should be able to discuss recent research Esophagitis
developments in the field of allergy/immunology.
Arjun Andrew Anilkumar, BS
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 79
 tuesday, March 4

Oral Abstract Oral Abstract

5605 Population Health and Food Allergy 5607 Mechanisms of T Cell-Mediated Allergic Disease
2:00 to 3:15 pm 2:00 to 3:15 pm
Convention Center, Upper Level, Room 11AB Convention Center, Mezzanine Level, Room 15AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Marcus S. Shaker, MD MS FAAAAI Moderator: Taylor A. Doherty, MD FAAAAI
2:00 Longitudinal Effect Of Food Allergy Education On Epinephrine 2:00 TSLP Induces Corticosteroid Resistance In Natural Helper Cells
Availability In Public Schools Via STAT5 Pathway
Dipika Patel, MD Hiroki Kabata
2:15 Population Response To Change In Infant Feeding Guidelines For 2:15 Impairment Of IL-27s Differential Effect On CD4+T Cells In
Allergy Prevention Asthma
Dean Tey, MD Zhihong Chen
2:30 Teasing and Bullying Among Adolescents With Food Allergy 2:30 Profile Of Food Allergen-Specific T Cells In Allergic and Clinically
Adora Lin, MD PhD Tolerant Individuals
2:45 Differences In Food Allergy Quality Of Life Between Caregivers In David Chiang, MS
a Clinic-Based and a Caregiver-Reported Food Allergic Population 2:45 Follicular Helper T Cells Mediate IgE Antibody Production and
Matthew J. Greenhawt, MD MBA MSc Allergic Immune Responses in Mice
3:00 Food Allergy Management In An Urban Pediatric Population Takao Kobayashi, PhD
Jennifer M. Camacho, MD 3:00 Analysis Of Circulating Rhinovirus-Specific CD4+ T Cells Using
Upon completion of this session, participants should be able to discuss recent research Novel MHC Class II Tetramers Reveals Marked Expansion Of
developments in the field of allergy/immunology. Effector Memory Cells In Infected Subjects
Lyndsley Muehling
Oral Abstract Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.
5606 New Forms of Immunotherapy
2:00 to 3:15 pm Late Breaking Oral Abstract Session
Convention Center, Mezzanine Level, Room 14AB
Credit: 1.25 CME / 1.50 CE 5611 Clinical Sciences
Moderator: Dsire E.S. Larenas Linnemann, MD FAAAAI 2:00 to 3:15 pm
2:00 Persistent Treatment Effect Achieved At One Year After Four Convention Center, Upper Level, Room 8
Doses Of Der p Derived Synthetic Peptide Immuno-Regulatory Credit: 1.25 CME / 1.50 CE
Epitopes In An Exposure Chamber Model Of House Dust Mite Moderator: Jeffrey G. Demain, MD FAAAAI
Allergy Giselle Mosnaim, MD MS FAAAAI
Rod Hafner, PhD 2:00 Efficacy and Safety of Lebrikizumab in Severe Uncontrolled
2:15 Treatment With Synthetic Peptide Immuno-Regulatory Epitopes Asthma: Results from the Lute and Verse Phase II Randomized,
Derived From Grass Allergens Leads To a Substantial Reduction Double-Blind, Placebo-Controlled Trials
In Grass Allergy Symptoms In The Environmental Exposure Unit Nicola A. Hanania, MD
Anne K. Ellis, MD MSc FAAAAI 2:15 Dose-Finding Efficacy and Safety Trial of House Dust Mite
2:30 Epicutaneous Immunotherapy Induces Epigenetic Changes In Sublingual Immunotherapy Tablet, MK-8237, Using an
Sensitized Mice Environmental Exposure Chamber
Lucie Mondoulet, PhD Hendrik Nolte, MD, PhD
2:45 Ultra-Fast Hypoallergenic Birch Pollen Allergy Vaccine Allert Is 2:30 Long-Lasting Egg Consumption in Egg Allergic Children Treated
Efficient and Safe: Results Of a Phase IIb Study with Oral Immunotherapy (OIT): Follow-up from the Consortium of
Francois Spertini, MD Food Allergy Research (CoFAR) Study
3:00 Stable Conjugates Between A Novel Toll-Like Receptor 7 Ligand Stacie M. Jones, MD
and Protein Allergens As Modulators Of Th2 Responses In Vitro 2:45 A Randomized, Double-Blind, Placebo-Controlled Trial of
and In Vivo Omalizumab Combined with Oral Immunotherapy (OIT) in the
Lucia Fili Treatment of Cow's Milk Allergy (CMA): Safety of Dosing
Upon completion of this session, participants should be able to discuss recent research Jennifer S. Kim, MD
developments in the field of allergy/immunology. 3:00 Dupilumab Monotherapy in Adults with Moderate-to-Severe
Atopic Dermatitis: A 12-Week, Randomized, Double-Blind,
Placebo-Controlled Study
Thomas R.M. Bieber, MD PhD FAAAAI
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.

80 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
 tuesday, March 4

Panel Discussion Workshop Q & A Workshop

5801 Improving Inpatient Asthma Outcomes in 5804 Challenges and Interventions to Improve
Pediatrics Adherence in Urban Minority Populations with
3:30 to 4:45 pm Asthma
Convention Center, Upper Level, Room 5AB 3:30 to 4:45 pm
Credit: 1.25 CME / 1.50 CE Convention Center, Upper Level, Room 4
Moderator: Miles M. Weinberger, MD FAAAAI Credit: 1.25 CME / 1.50 CE
Panelists: Moderator: Cynthia S. Rand, PhD
Amal H. Assaad, MD FAAAAI 3:30 Brief-Interval Telephone Surveys of Medication Adherence and
Karen M. McDowell, MD Asthma Symptoms In the Chilhood Asthma Management Program
Joseph D. Spahn, MD Continuation Study
Upon completion of this session, participants should be able to: Utilize questionnaires that Bruce G. Bender, PhD FAAAAI
identify need in inpatient asthma care; Identify opportunities to improve outcomes for
children with recurrent asthma admissions. 3:45 Problem Solving to Improve Adherence and Asthma Outcomes in
Urban Adults with Asthma
Panel Discussion Workshop Andrea J. Apter, MD MA MSc FAAAAI
4:00 Use of Mobile Technology to Improve Adherence in Low-Income
5802 The Ins and Outs of Managing Dietary and Minority Adolescents with Asthma
Corticosteroid Therapy in Eosinophilic Giselle Mosnaim, MD MS FAAAAI
Esophagitis 4:15 Question & Answer
3:30 to 4:45 pm Upon completion of this session, participants should be able to: Discuss barriers to adher-
Convention Center, Upper Level, Room 2 ence in urban minority populations with asthma; Discuss the efficacy of a problem solving
intervention to improve adherence in urban adults with asthma; Evaluate the efficacy
Credit: 1.25 CME / 1.50 CE of an MP3 player and peer support intervention to improve adherence in urban minority
Moderator: Dan Atkins, MD FAAAAI adolescents with asthma.
Panelists:
Juan Pablo Abonia, MD Q & A Workshop
Seema Sharma Aceves, MD PhD FAAAAI
Katrinia Jane Allen, MD PhD FAAAAI 5805 Allergic Inflammation: New Insights into Key
Upon completion of this session, participants should be able to: Identify and discuss is- Innate Mediators
sues in the dietary treatment and management of EoE, including the use of an elimination
3:30 to 4:45 pm
diet and how to reintroduce foods into the diet; Identify and discuss issues in the use of
swallowed topical steroids in the treatment of EoE. Convention Center, Upper Level, Room 1AB
Credit: 1.25 CME / 1.50 CE
Moderator: Steve N. Georas, MD
Problem-Based Learning Workshop
3:30 IL33 Dependent Allergic Inflammation via FcgRIII Signalling
5803 Evaluation and Management of Patients with Anne Sperling, PhD
Recurrent Infections 3:45 Epithelial Cell-Derived Exosomes in Allergic Airway Inflammation
3:30 to 4:45 pm Nirav Bhakta, MD PhD
Convention Center, Upper Level, Room 3 4:00 Innate Type 2 Cytokines and their Receptors in Human Asthma
Pre-registration and ticket required. Fee: $50. Morris Ling, MD
Credit: 1.25 CME / 1.50 CE 4:15 Question & Answer
PBL Facilitator: Vincent R. Bonagura, MD FAAAAI Upon completion of this session, participants should be able to: Explain the importance of
Content Lecturer: Mark R. Stein, MD FAAAAI type 2 innate lymphoid cells in mediating the initial steps of allergic inflammation; Review
Upon completion of this session, participants should be able to: List the susceptibility the importance of airway epithelial cells and the effect of stress on production of inflam-
factors for recurrent infection (immunodeficiency, rhinitis, structural defects, CF); Discuss matory exosomes in allergic airway inflammation; Recognize the importance of innate
the role of the diagnostic modalities relevant to the evaluation of patients with recurrent type 2 cytokines and their receptors in human asthma.
infection; Outline IgG therapy for immunodeficiency patients.

Annual Meeting Workshops

Programmed by the AAAAI. Annual Meeting Workshops funded
through an educational grant from Merck.

Allied Health Session ticket required fee required included in the Virtual Annual Meeting 81
 tuesday, March 4

Year-in-Review Workshop Q & A Workshop

5806 Mechanistic Basis of Food Allergy: New Frontiers 5808 Follicular Helper T Cells in Health and Disease
3:30 to 4:45 pm 3:30 to 4:45 pm
Convention Center, Upper Level, Room 11AB Convention Center, Mezzanine Level, Room 16AB
Credit: 1.25 CME / 1.50 CE Credit: 1.25 CME / 1.50 CE
Moderator: Kari C. Nadeau, MD PhD FAAAAI Moderator: John W. Steinke, PhD FAAAAI
3:30 Environmental Sanitizers as a Potential Cause of Epidemic Food 3:30 Development of Follicular Helper T Cells
Allergy Shane Crotty, PhD
Jessica R. Savage, MD 3:45 Vaccines and Follicular Helper T Cells
3:45 Novel iNKT Ligands in Foods: Potential Role in the Development of Michael G. McHeyzer-Williams, PhD
Allergy 4:00 The Role of Follicular Helper T Cells in Autoimmunity
Patrick J. Brennan, MD PhD Eric Meffre, PhD
4:00 Role of B Cells in Food Allergy Therapy 4:15 Question & Answer
Duane R. Wesemann, MD PhD Upon completion of this session, participants should be able to: Discuss how follicular
4:15 Question & Answer helper T cells develop; Describe how vaccines can be used to modulate follicular helper T
Upon completion of this session, participants should be able to: Identify the possible role cell function; Describe the mechanisms through which follicular helper T cells participate
of sanitizing agents in the pathogenesis of food allergy; Review the importance of innate in the development of autoimmunity.
iNKT cell ligands in food allergy; List the principle of B cell receptor editing in the periph-
ery and its potential relevance to the control of IgE responses. Problem-Based Learning Workshop
Panel Discussion Workshop 5809 A Case of Chronic Severe Urticaria
3:30 to 4:45 pm
5807 Rapid Desensitizations: Protocols and Convention Center, Upper Level, Room 31C
Management of Reactions Pre-registration and ticket required. Fee: $50.
3:30 to 4:45 pm Credit: 1.25 CME / 1.50 CE
Convention Center, Mezzanine Level, Room 15AB PBL Facilitator: Don A. Bukstein, MD
Credit: 1.25 CME / 1.50 CE Content Lecturer: Allen P. Kaplan, MD FAAAAI
Moderator: Karen S. Hsu Blatman, MD Upon completion of this session, participants should be able to: Discuss the differential
diagnosis of a patient with chronic severe urticaria; Debate the evaluation of urticaria,
David E. Sloane, MD
including serological, prick skin testing and biopsy interpretation; Discuss novel medical
Timothy J. Sullivan, MD and immunomodulatory therapy.
Katharine M. Woessner, MD FAAAAI
Upon completion of this session, participants should be able to: Identify the safety and
efficacy of drug desensitization protocols; Discuss the build up and progression of the
available protocols for desensitization; Describe management tools for reactions during
drug desensitizations.

Annual Meeting Workshops

Programmed by the AAAAI. Annual Meeting Workshops funded
through an educational grant from Merck.

82 Allied Health Session ticket required fee required included in the Virtual Annual Meeting
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Scientific Abstract Sessions
Asthma Therapeutics: Advances in Biologics and
Drugs
2201
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
1 A Rare Presentation Of Surfactant Deficiency In a Term Neo-
nate
Dr. Nisha N. Shah, MD, LSU Health Sciences Center New Or-
leans, New Orleans, LA, Dr. Heena Shah, MD, Louisiana State
University, New Orleans, LA and Dr. Kenneth Paris, MD, MPH,
LSU Health Sciences Center, New Orleans, New Orleans, LA
2 Relapse Of Severe Asthma Exacerbations After Cessation Of
Omalizumab Treatment Real Life Data
Dr. Izabela R. Kuprys-Lipinska, MD, PhD and Prof. Piotr Kuna,
MD, PhD, Dept. of Internal Medicine, Asthma and Allergy, Med-
ical University in Lodz, Poland
3 Therapeutic Equivalence Of Budesonide/Formoterol (BUD/
FM) Breath-Actuated Inhaler (BAI) Compared With Bud/FM
Pressurized Metered-Dose Inhaler (pMDI) In Adults and Ado-
lescents With Moderate To Severe Asthma
Kevin R. Murphy, MD1, Rajiv Dhand, MD2, Frank Trudo, MD3,
Tom Uryniak, MS3 and Ajay Aggarwal, MD3, 1Boys Town Na-
tional Research Hospital, Boys Town, NE, 2Department of Medi-
cine, University of Tennessee Graduate School of Medicine,
3 vere Asthma Patients
AstraZeneca LP
4 Effects of Budesonide/Formoterol (BUD/FM) Deliverd By Pres-
surized Metered-Dose Inhaler (pMDI) on Symptoms In African
Americans and Caucasians With Moderate and Severe Asthma
With and Without Fixed Airway Obstruction (FAO)
Donald P. Tashkin, MD, David Geffen School of Medicine at
UCLA, Los Angeles, CA, Bradley E. Chipps, MD, Capital Allergy
& Respiratory Disease Center, Sacramento, CA and Frank Trudo,
MD, AstraZeneca, Wilmington, DE
5 Long-Term Effectiveness Of Omalizumab Treatment In Thai
Severe Asthmatic Patients: A Real-Life Experience
Dr. Orapan Poachanukoon, MD, Thammasat University, Pathum-
tani, Thailand, Dr. Theerasak Kawamatawong, Ramathibodi Hos-
paital, Mahidol University, Taiwan, Dr. Atik Saengasapaviriya,
Phramonkutklao hospital, Thailand, Dr. Chanchai Sittipunt, Chula-
longkorn University, Thailand, Dr. Hiroshi Chantaphakul, MD,
FAAAAI, Chutuchak District, Chulalongkorn University Hospital,
Bangkok, Thailand, Prof. Kittipong Maneechotesuwan, Siriraj hos-
pital, Mahidol university, Bangkok, Thailand, Dr. Pintip Ngamcha-
nyaporn, Ramathibodi Hospital, Mahidol University, Thailand, Dr.
Kunchit Piyavechviratana, Pramongkut Hospital, Sathorn, Thai-
land, Dr. Apichart Khanisap, Thammasat University Hospital,
Thailand, Dr. Siwasak Juthong, Faculty of Medicine, Songklanak-
rin University, Thailand, Dr. Warangkana Rithirak, Songklanakar-
ind University, Thailand, Dr. Chaicharn Pothirat, Chiangmai
University, Thailand and Dr. Watchara Boonsawat, Srinagarind
Hospital, Thailand
6 Role Of Monoclonal Antibody In Sickle Cell Disease Patients
With Allergic Rhinitis and Asthma Along With Raised IgE
Level
Dr. Abdul Rehman Syed, MD, King Fahad University Hospital
Khobar, Dammam, Saudi Arabia
7 Effects Of Long-Term Treatment With Budesonide/Formoterol
(BUD/FM) Delivered By Pressurized Metered-Dose Inhaler
(pMDI) On Symptoms In African-American and Caucasian
Abstracts AB293
SATURDAY
Patients With Moderate To Severe Asthma With and Without
Fixed Airway Obstruction (FAO)
Randall Brown, MD, MPH, Center for Managing Chronic Disease,
University of Michigan School of Public Health, Bradley E. Chipps,
MD, Capitol Allergy and Respiratory Disease Center, Donald P.
Tashkin, MD, David Geffen School of Medicine at UCLA, Los An-
geles, CA and Frank Trudo, MD, AstraZeneca, Wilmington, DE
8 Retrospective Observational Assessment Of Nasal Polyposis In
Asthmatic Patients Treated With Omalizumab
Dr. Ana Anton-Laiseca, MD, Dr. Silvia Martnez Blanco, MD, Dr.
Gabriel Gonzalez Salazar, MD, Dr. Maria Carmen Dieguez Pastor,
MD, Dr. Ruth Mielgo Ballesteros, MD and Dr. Consuelo Fernandez
Rodrguez, MD, PhD, Hospital Universitario 12 de Octubre, Spain
9 FDA Guidance-Designed Study Of The Effects Of Intranasal
Triamcinolone Acetonide Aqueous (TAA-AQ) On Growth Ve-
locity (GV) Of Children With Perennial Allergic Rhinitis (PAR)
Dr. David P. Skoner, MD, Temple University School of Medicine,
Allegheny General Hospital, Pittsburgh, PA; West Penn Allegheny
Health System, Pittsburgh, PA
10 Extended Omalizumab Dosage Intervals and Efficacy
Dr. Saraleen Benouni, MD1, Dr. Lee E. Sheinkopf, MD,
FAAAAI2, Dr. LanAnh T. Do, MD, FAAAAI3, Dr. Asif Rafi,
MD2 and Dr. Roger M. Katz, MD, FAAAAI2, 1UCLA, Los An-
geles, CA, 2ucla, los angeles, CA, 3ucla, Los Angeles, CA
11 Effect Of Roflumilast On Asthma Control In Moderate and Se-
Prof. V.A. Beloglazov1, Dr. Yuri Popenko1 and Prof. Lawrence M.
DuBuske, MD, FAAAAI2, 1Crimean State Medical University, Uk-
raine, 2George Washington University School of Medicine, DC
12 The Potent and Selective CRTH2 Antagonist OC000459 Is Ef-
fective In The Treatment Of Eosinophilic Asthma When Given
Once Daily
Dr. Roy Pettipher1, Dr. Michael Perkins1, Dr. Lisa Pearce Collins1,
Dr. Mark Baillet2, Dr. Trevor Lewis3, Dr. Jan Steiner4, Prof. John
Bell5, Dr. Mark Payton1 and Dr. Michael Hunter1, 1Atopix Thera-
peutics, Abingdon, United Kingdom, 2S-Cubed, Abingdon, United
Kingdom, 3TL-Wise Consulting, Cambridge, United Kingdom,
4
Oxford Therapeutics Consulting, Brightwell-cum-Sotwell, United
Kingdom, 5Medical Sciences Division, Oxford, United Kingdom
13 Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral
CRTh2 Antagonist, In Patients With Mild To Moderate Th2-
Driven Asthma
Sally E. Wenzel, MD, FAAAAI1, Robert Hopkins, Director of
Clinical Operations2, Dr. Michael Saunders, MD, Senior Director
of Drug Safety2, David Chantry, Senior Director of Translational
Medicine and Cell Biology2, Lisa Anderson, Clinical Research
Manager2, Roger Aitchison, Senior BioStatistician2, Christine
Eberhardt, Research Investigator2, Stacie Bell, Director of Clinical
Pharmacology2, Dr. Jeremy Cole, MD, Principal Investigator3, Dr.
James Wolfe, MD, Physician/Research Investigator4, Dr. Sheldon
L. Spector, MD, FAAAAI5, Dr. Lawrence D. Sher, MD, FAAAAI6,
Dr. Edward M. Kerwin, MD, FAAAAI7 and Dr. Larry Burgess,
PhD, Executive Director of Medicinal Chemistry2, 1University of
Pittsburgh Medical Center NW, Pittsburgh, PA, 2Array BioPharma
Inc., Boulder, CO, 3IPS Research Company, Oklahoma City, OK,
4
Allergy & Asthma Associates of Santa Clara County Research
Center, San Jose, CA, 5California Allergy & Asthma Medical
Group, Los Angeles, CA, 6Peninsula Research Associates, Rolling
Hills Estates, CA, 7Allergy and Asthma Center of Southern OR,
Medford, OR
83
 AB294 Abstracts
SATURDAY
14 A Phase I Assessment Of Safety and Tolerability Of RNS60, a
Novel Therapeutic Containing Charge-Stabilized Nanostruc-
tures In Asthma
Supurna Ghosh, PhD, Andreas Kalmes, PhD, Jarrad Mock, Jocelyn
Sutherland and Richard Watson, MD, Revalesio Corporation, WA
15 Tiotropium Respimat Add-On To Inhaled Corticosteroids Im-
proves Lung Function In Patients With Symptomatic Mild
Asthma: Results From A Phase III Trial
Pierluigi Paggiaro1, Dr. David M.G. Halpin, MD2, Roland Buhl3,
Dr. Michael Engel, MD4, Valentina Zubek5, Zuzana Blahova6, Dr.
Petra Moroni-Zentgraf4 and Dr. Emilio Pizzichini7, 1University of
Pisa, Pisa, Italy, 2Royal Devon & Exeter Hospital, Exeter, United
Kingdom, 3Mainz University Hospital, Mainz, Germany, 4Boeh-
ringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein,
Germany, 5Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield,
CT, 6Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Aus-
tria, 7NUPAIVA (Asthma Research Centre), Universidade Federal
de Santa Catarina, Florianopolis, Brazil
16 Tiotropium Respimat Add-On Therapy Reduces Airflow Ob-
struction In Patients With Symptomatic Moderate Asthma, In-
dependent Of TH2 Inflammatory Status
Dr. Thomas B. Casale, MD, FAAAAI1, Dr. Eric Donn Bateman,
MD2, Prof. Ronald Dahl, MD3, Dr. Emilio Pizzichini4, Dr. Mark
L. Vandewalker, MD5, Dr. Johann Christian Virchow6, Dr. Michael
Engel, MD7, Dr. Petra Moroni-Zentgraf7, Dr. Hendrik Schmidt8 and
Huib A.M. Kerstjens9, 1Univeristy Of South Florida Morsani Col-
lege Of Medicine, Tampa, FL, 2University of Cape Town Lung In-
stitute, Cape Town, South Africa, 3Odense University Hospital,
Odense, Denmark, 4NUPAIVA (Asthma Research Centre), Univer-
sidade Federal de Santa Catarina, Florianopolis, Brazil, 5Clinical
Research of the Ozarks, Columbia, MO, 6University Clinic Ro-
stock, Rostock, Germany, 7Boehringer Ingelheim Pharma GmbH
& Co. KG, Ingelheim Am Rhein, Germany, 8Boehringer Ingelheim
Pharma GmbH & Co. KG, Biberach an der Riss, Germany, 9Uni-
versity Medical Center Groningen, University of Groningen, Gro-
ningen, Netherlands
17 Once-Daily Tiotropium Respimat Improves Lung Function In
Patients With Severe Symptomatic Asthma Independent Of
Leukotriene Modifier Use
Prof. Ronald Dahl, MD1, Prof. Dennis E. Doherty2, Jonathan Cor-
ren, MD3, Dr. Jill Karpel4, Huib A. M. Kerstjens5, Dr. Michael En-
gel, MD6, Dr. Petra Moroni-Zentgraf6, Dr. Hendrik Schmidt7 and
Dr. Shu Hashimoto, MD, PhD8, 1Odense University Hospital,
Odense, Denmark, 2Lexington VA Medical Center, University of
Kentucky, Lexington, KY, 3University of California, Los Angeles,
CA, 4North Shore Medical Arts LLP, Great Neck, NY, 5University
Medical Center Groningen, University of Groningen, Groningen,
Netherlands, 6Boehringer Ingelheim Pharma GmbH & Co. KG, In-
gelheim Am Rhein, Germany, 7Boehringer Ingelheim Pharma
GmbH & Co. KG, Biberach an der Riss, Germany, 8Nihon Univer-
sity School of Medicine, Tokyo, Japan
Asthma Epidemiology
2202
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
18 Close Correlation Between Month Of Birth and The Prevalence
Of Bronchial Asthma In Schoolchildren In a Taiwanese Popula-
tion
Prof. Ho-Chang Kuo, Kaohsiung Chang Gung Memorial Hospital
and Chang Gung University, Kaohsiung, Taiwan, Prof. Wei-Chiao
Chang, Taipei Medical University, Prof. Kuender D. Yang, Show
Chwan Memorial Hospital in Chang Bing, Changhua, Taiwan
and Prof. Wei-Pin Chang, Yuanpei University, Taiwan
84
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
19 Test-Retest Reliability Of The ISAAC Questionnaire For a
Web-Based Study
Dr. Koichi Yoshida, MD1, Dr. Yuichi Adachi, MD, PhD2, Dr. Mari
Sasaki, MD1, Dr. Mayumi Furukawa, MD1, Dr. Toshiko Itazawa,
MD, PhD2, Dr. Koji Hashimoto, MD, PhD3, Dr. Hiroshi Odajima4
and Dr. Akira Akasawa, MD, PhD1, 1Division of Allergy, Tokyo
Metropolitan Childrens Medical Center, Tokyo, Japan, 2Depart-
ment of Pediatrics, University of Toyama, Toyama, Japan, 3Depart-
ment of Pediatrics and Child Health, Nihon University School of
Medicine, Tokyo, Japan, 4Fukuoka National Hospital, Fukuoka,
Japan
20 Characteristics Of Adolescents With Undiagnosed Asthma In
Rural Counties In Georgia
Dr. Poneh Davoodi, MD1, Dr. Dennis Ownby, M.D. FAAAAI2,
Ms. Suzanne Havstad, M.A.3, Dr. Jennifer Waller, PhD4, Dr. Chris-
tine L.M. Joseph, PhD3 and Dr. Martha Tingen, PhD4, 1Georgia Re-
gents University, 2Division of Allergy-Immunology and
Rheumatology, Georgia Regents University, Augusta, GA, 3Depart-
ment of Public Health Sciences, Henry Ford Hospital, Detroit, MI,
4
Georgia Regents University, Augusta, GA
21 Trends In Prevalence Of Asthma and Allergies In 13-14 Year
Old Children Between Two ISAAC Studies In Birjand City,
Iran
Dr. Mohammad Fereidouni, MD, PhD, Asthma, Allergy & Im-
munology Research Center,Birjand University of Medical Sciences,
Iran and Mrs. Shaghayeghsadat Nourani hassankiadeh, birjand uni-
versity of medical sciences
22 An Evaluation Of The Thai-Translated Version Of The Child-
hood Asthma Control Questionnaire (C- ACT) and The Com-
posite Asthma Severity Index (CASI) Among Thai Asthmatic
Children
Dr. Benjarat Dardaranonda, MD, Department of Pediatrics, Fac-
ulty of Medicine, Siriraj Hospital, Mahidol University, Bangkok,
THAILAND, Bangkok, Thailand
23 Impact Of Change In Inhaled Corticosteroids/Long-Acting
Beta Agonist Combination (ICS/LABA) Use On The Risk Of
Asthma Exacerbations In Asthma Patients Within a Medical
Group
Dr. Richard H. Stanford, PharmD, MS1, Saurabh Nagar, MS1,
Dr. Xiwu Lin, PhD1 and Dr. Dick OConnor, MD2,
1
GlaxoSmithKline, 2Sharp Rees-Stealy Medical Group, San
Diego, CA
24 HLA-DRB1 Alleles, Levels Of Total IgE and IL-13 In Patients
Of Bronchial Asthma From A Local Tertiary Care Hospital In
Lahore, Pakistan Mr. Khursheed Javaid, M.Phil., University of
Health Sciences, Lahore, Pakistan
25 Infectious Asthma Trigger, Acq Score and Minirqlq Score Cor-
relations Support The One Airway Hypothesis
Dr. Amy Virojanapa, MD1, Ms. Phoebe Shah2, Mr. Arthur
Omondi1 and Dr. Efren L. Rael, MD, FAAAAI3, 1Penn State, Her-
shey Medical Center, Hershey, PA, 2UC San Diego, Vista, CA, 3Al-
lergy/Immunology, Penn State University College of Medicine,
Hershey, PA
Primary Antibody Deficiencies
2203
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
26 Comprehensive Immunological and Clinical Features Of Com-
mon Variable Immunodeficiency (CVID)
Dr. Varaz Bozoghlanian, MD1, Sudhanshu Agrawal, MS2 and
Sudhir Gupta, MD, PhD, FAAAAI1, 1University of California, Ir-
vine, Irvine, CA, 2University of California, Irvine
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
27 Clinical, Immunological and Genetic Spectrum Of Novel BTK
Gene Mutations In X-Linked Agammaglobulinemia Patients
and Female Carriers
Dr. Regan Pyle, DO1, Dr. John B. Hagan, MD, FAAAAI1, Amanda
Martinez, MS1, Dr. Avni Y. Joshi, MD1, Dr. Thomas Boyce, MD1,
Dr. Gerald W. Volcheck, MD, FAAAAI2, Dr. Yesim Yilmaz-Demirdag,
MD3, Prof. Sami L. Bahna, MD DrPH FAAAAI4 and Dr. Roshini S.
Abraham, PhD FAAAAI1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic
and Foundation, Rochester, MN, 3Columbia University, New York, NY,
4
LA State University Health Sciences Center, Shreveport, LA
28 CD19+CD27+CD43+CD70-CD5- B-1b Cells In Children With
Specific Antibody Deficiency, Specific Antibody Deficiency
With Decreased IgG, and Common Variable Immunodeficiency
Dr. Kathryn D. Convers, MD1,2, Barbara Kariuki, MPH1 and Dr.
Alan Knutsen, MD, FAAAAI1,2, 1Saint Louis University School of
Medicine, Saint Louis, MO, 2Cardinal Glennon Childrens Medical
Center, Saint Louis, MO
29 A Devastating Outcome In Undiagnosed X-Linked Agamma-
globulinemia A Call For Earlier Screening
Dr. Karen Elizaeth Bruner, MD, Wilford Hall Ambulatory Surgi-
cal Center, Lackland AFB, TX and Dr. Anthony Infante, MD, PhD,
UT Health Science Center San Antonio, San Antonio, TX
30 Genetic Basis Of CVID-Like Disease
Dr. Kate Welch, MD, Mt. Sinai Medical Center, Dr. Elena Re-
snick, MD, Mount Sinai School of Medicine, New York, NY and
Dr. Charlotte Cunningham-Rundles, MD, PhD, FAAAAI, Mt. Sinai
Medical Center, New York, NY
31 A Case Of A CVID Patient and Rabies Exposure
Dr. Hassan Nasir, DO, Nova Southeastern University College of
Osteopathic Medicine, Davie, FL; Larkin Community Hospital,
Miami, FL and Dr. Shahnaz Fatteh, Larkin Community Hospital,
South Miami, FL
32 Common Variable Immunodeficiency In The Very Old
Dr. Katherine E. Gundling, MD, UCSF, San Francisco, CA
33 Clinical Predictors Of Granulomatous Disease In Common
Variable Immunodeficiency
Dr. Anna R. Wolfson and Dr. Anna Kovalszki, Beth Israel Deacon-
ess Medical Center, Boston, MA
34 Jacobsen Syndrome With Combined Variable Immunoddefi-
ciency (CIVD)
Dr. Arnaldo C. Porto Neto, MD, PhD, FAAAAI, Dr. Julio Mella
Pierezan, Student, Dr. Joao Paulo Bordin, Student, Dr. Julia Noschang,
Dr. Juliana Gotardo, Student, Dr. Juliana Moro, Student, Dr. Jorge
Luigi Orso, Student, Dr. Jamile Pedroni, Student and Dr. Jessica Zan-
dona, Student, School of Medicine UPF, PASSO FUNDO, Brazil
35 Factors Predicting Long-Term Hypogammaglobulinemia In
Lymphoma Survivors
Dr. Huifang Lu, MD, PhD, UT MD Anderson Cancer Center,
Houston, TX and Dr. Xerxes Pundole, UT MD Anderson Cancer
Center
36 Assessment Of Benefits Of Scig Valued By Healthcare Pro-
viders and Patients: Survey Results
Ms. Annette R. Zampelli, NP1, Ms. Carla M. Duff, CPNP MSN2
and Dr. Ann Bullinger, PharmD1, 1CSL Behring, LLC, King of
Prussia, PA, 2University of South Florida, Tampa, FL
37 Pneumococcal Titer Levels: Comparison Of Patients Receiving
Intravenous Immunoglobulin Vs. Subcutaneous Immunoglobulin
Dr. Pamella Abghari, MD1,2, Dr. Elizabeth A. Secord, MD,
FAAAAI1,2 and Dr. Pavadee Poowuttikul, MD1,3, 1Childrens Hospital
of Michigan Department of Allergy Immunology, Detroit,
MI, 2Wayne State University, Detroit, MI, 3Pediatrics- Allergy/Immu-
nology Division, Wayne State University School of Medicine, Detroit,
MI
38 Hypogammaglobulinemia, Multiple Sclerosis, and Treatment
With Intravenous Gammaglobulin
Dr. Tiffany Dy, MD, Montefiore Medical Center at Albert
Einstein College of Medicine, Bronx, NY and Dr. Arye
Abstracts AB295
SATURDAY
Rubinstein, MD, FAAAAI, Albert Einstein College of Medicine,
Bronx, NY
39 Selective IgM Deficiency Presenting As Cryptogenic Organiz-
ing Pneumonia
Dr. Cory A. Lundberg, DO1, Dr. Taylor A. Banks, MD1, Dr. Ce-
cilia Mikita, MD, MPH FAAAAI2 and Dr. Jeffrey Mikita, MD1,
1
Walter Reed National Military Medical Center, Bethesda, MD,
2
Walter Reed Army Medical Center, Bethesda, MD
42 High Prevalence Of Bronchiolitis In Children With Primary
Immunodeficies
Dr. Celia Pinto Fernandez1, Dr. Mara Dolores Gurbindo Gutier-
rez1, Dr. Jose Manuel Zubeldia Ortuno, MD, PhD2 and Dr. Mara
Elena Seoane Reula1, 1Gregorio Mara~ n
on Universitary Hospital,
Madrid, Spain, 2Hospital Gregorio Maranon, Madrid, Spain
43 Three Cases Of Goods Syndrome
Dr. Whitney M. Rassbach, MD, Mount Sinai School of Medicine,
New York, NY and Dr. Charlotte Cunningham-Rundles, MD, PhD,
FAAAAI, Mt. Sinai Medical Center, New York, NY
44 Immunological Analysis Of Primary Selective IgM Deficiency
In Adults
Ankmalika Louis, MD, UNIVERSITY OF CALIFORNIA, IR-
VINE, CA, Sudhanshu Agrawal, MS, University of California, Ir-
vine and Sudhir Gupta, MD, UNIVERSITY OF CALIFORNIA,
IRVINE
45 A Rare Case Of Helicobacter Cellulitis In a Patient With X-
Linked Agammaglobulinemia
Dr. Nina Lakhani, MD1, Dr. Linda R. Taggart2, Dr. Henry Jaku-
bovic3, Dr. Stephen D. Betschel, MD1 and Dr. Zafir Hussain4,
1
University of Toronto, Division of Clinical Immunology and Al-
lergy, Toronto, ON, Canada, 2University of Toronto, Divison of In-
fectious Diseases, Toronto, 3University of Toronto, Division
of Laboratory Medicine and Pathology, Toronto, ON, Canada,
4
University of Toronto, Division of Microbiology, Toronto, ON,
Canada
46 Neuropathy In Patients With Underlying Immunodeficiency
Syndrome
Dr. Robyn Kreiner, MD and Dr. Arye Rubinstein, MD, FAAAAI,
Albert Einstein College of Medicine, Bronx, NY
Asthma Epidemiology, Risk Factors, and Public
Health I
2204
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
47 Allergic Sensitization and Enviromental Exposures In Amish
and Hutterite Children
Dr. Mark Holbreich, MD, FAAAAI1, Ms. Michelle Stein, MS2,
Ms. Rebecca Anderson, MS3, Dr. Nervana Metwali, PhD4, Dr.
Peter S. Thorne, PhD4, Dr. Donata Vercelli, MD5, Dr. Erika
Von Mutius, MD, MSc6 and Dr. Carole Ober, PhD3, 1Allergy
and Asthma Consultants, Indianapolis, IN, 2The University of
Chicago, Chicago, IL, 3University of Chicago, Chicago, IL,
4
University of Iowa, Iowa City, IA, 5The University of
Arizona, Tucson, AZ, 6University Childrens Hospital, Munich,
Germany
48 Association Between Asthma-Related Emergency Department
Visits, Tree Pollen, Pollution and Humidity In The Bronx,
2001 - 2008
Dr. Jennifer Toh, MD1, Dr. Mili Shum, MD2,3, Dr. Gabriele De
Vos, MD4, Tulsi Desai4, Priyank Patel4, Dr. Sunit Jariwala, MD1
and Dr. David L. Rosenstreich, MD, FAAAAI5, 1Albert Einstein/
Montefiore Medical Center, New York, NY, 2Montefiore Medical
Center, Bronx, NY, 3Weill Cornell Medical College, New York,
85
 AB296 Abstracts
SATURDAY
NY, 4Albert Einstein College of Medicine, Bronx, NY, 5Albert Ein-
stein/Montefiore Medical Center, Bronx, NY
49 Association Of Wheezing Illness With Respiratory Viruses In
Hospitalized Jordanian Children
Olajumoke Fadugba, MD1, Eva Kathryn Miller, MD2, Najwa
Khuri-Bulos, MD, FIDSA, CIC3, Samir Faouri, MD3, Asem She-
habi, PhD4, Christopher Fonnesbeck, PhD1, Li Wang, MS1, John
V. Williams, MD1 and Natasha Halasa, MD, MPH1, 1Vanderbilt
University Medical Center, Nashville, TN, 2Pediatric Allergy, Im-
munology, and Pulmonary Medicine, Vanderbilt University Medi-
cal Center, Nashville, TN, 3Jordan University Hospital, Jordan,
4
University of Jordan, Jordan
50 The Effect Of Obesity On Asthma Control As Measured By
The Asthma Control Test
Dr. Aerik A. Williams, MD, MPH1, Dr. Mark S. Dykewicz, MD,
FAAAAI2 and Dr. Jason W. Caldwell, DO, FAAAAI1, 1Wake For-
est University Baptist Medical Center, Winston Salem, NC, 2Saint
Louis University School of Medicine, St. Louis, MO
51 Perception Of Asthma Control Is Not Consistent With Re-
ported Symptom Frequency In Urban Adolescents
Emily C. Ledford, Johns Hopkins School of Medicine, Ms. Jean
Curtin-Brosnan, MA, Johns Hopkins University, Baltimore, MD,
Dr. Meredith C. McCormack, MD, The Johns Hopkins Pulmonary,
Baltimore, MD and Dr. Elizabeth Matsui, MD, The Johns Hopkins
University School of Medicine, Baltimore, MD
52 Urban Residence Modifies The Association Between Atopy and
Wheeze
Dr. Pablo F. Endara1, Dr. Phil J. Cooper2,3, Thomas A.E. Platts-
Mills, MD, PhD, FAAAAI4, Lisa J. Workman, BA4, Maritza
Vaca5, Dr. Martha Chico6, Mauricio L Barreto, PhD7 and Prof.
Laura Rodrigues8, 1Universidad San Francisco de Quito, 2St.
Georges University, London, United Kingdom, 3Pontificia Univer-
sidad Catolica del Ecuador, 4Division of Asthma, Allergy & Immu-
nology, University of Virginia Health System, Charlottesville, VA,
5
Laboratorio de FEPIS, Quininde, Esmeraldas Province, Ecuador,
6
Laboratorio de Investigacion FEPIS, 7Instituto de Saude Coletiva,
UFBa, Salvador, BA, Brazil, 8London School of Hygiene and Trop-
ical Medicine
53 Allergic Inflammation and Health Outcomes Of Comorbid
Asthma and Obesity In Inner-City Black and Hispanic School-
children
Dr. Perdita Permaul, MD1,2, Dr. William J. Sheehan, MD2,3, Mr.
Carter Petty, MA3, Dr. Sachin N. Baxi, MD2,3, Dr. Jonathan M.
Gaffin, MD, MMSc2,3, Dr. Lianne S. Kopel, MD2,3, Dr. Watcharoot
Kanchongkittiphon, MD, PhD3, Mrs. Chunxia Fu, MS4, Dr. Diane
R. Gold, MD, MPH2,4 and Dr. Wanda Phipatanakul, MD, MS,
FAAAAI2,3, 1Division of Pediatric Allergy/Immunology, Massa-
chusetts General Hospital, Boston, MA, 2Harvard Medical School,
Boston, MA, 3Boston Childrens Hospital, Boston, MA, 4Channing
Laboratory, Brigham and Womens Hospital, Boston, MA
54 Targeted Education Of Adult Patients From An Inner City
Population At Risk For Non-Adherence With Asthma Therapy
Dr. Edan Sarid, MD, SUNY Downstate Medical Center, Center
for Allergy and Asthma Research, Brooklyn, NY and Dr. Rauno
Joks, MD, Center for Allergy and Asthma Research at SUNY
Downstate, Brooklyn, NY
55 Maternal Allergy and Asthma and Their Association With
Breastfeeding In Inner-City Mothers In a Birth Cohort Study
(URECA)
Katy F. Jaffee, MS1, Dr. Cynthia Visness, PhD1, Dr. George T.
OConnor, MD2, Dr. Gordon R. Bloomberg, MD, FAAAAI3, Dr.
Meyer Kattan, MD4, Robert A. Wood, MD, FAAAAI5, Dr. Peter
J. Gergen, MD, MPH6 and Dr. James E. Gern, MD, FAAAAI7,
1
Rho, Inc., Chapel Hill, NC, 2Boston University School of Medi-
cine, Boston, MA, 3Campus Box 8116, St. Louis Childrens Hospi-
tal, Saint Louis, MO, 4NewYork-Presbyterian/Columbia, New
York, NY, 5Johns Hopkins University Medical Center, Baltimore,
86
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
MD, 6AAIB\DAIT\NIH, Bethesda, MD, 7University of Wisconsin
School of Medicine and Public Health, Madison, WI
56 Genetic Determinants Of Allergic Sensitization To Cockroach
Allergen In Children
Priya Tripathi, PhD1, Xiumei Hong, PhD2, Deanna Caruso, MS2,
Peisong Gao, MD, PhD1 and Dr. Xiaobin Wang, MD, MPH ScD2,
1
Division of Allergy & Clinical Immunology, Johns Hopkins Uni-
versity School of Medicine, Baltimore, MD, 2Johns Hopkins Uni-
versity School of Public Health, Baltimore, MD
57 Exhaled Nitric Oxide (FeNO) and Dust Mite (Der p1) Exposure
Are Significantly Higher In Asthmatic Children Living In Hu-
mid Environments
Dr. Miguel J. Lanz, MD, FAAAAI1, Benjamin Efaw2, Mirna Gon-
zalez1 and Dr. Ronald J. Harbeck, PhD2, 1AAADRS Clinical Re-
search Center, Coral Gables, FL, 2National Jewish Health,
Denver, CO
Aerobiology I
2205
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
58 Extraordinary Alternaria Mold Counts During a Severe
Drought
Mr. James J. Anderson, MLT, Environmental Allergy/Oshtech,
London, ON, Canada and Dr. Linda B. Ford, MD, FAAAAI, The
Asthma & Allergy Center, P.C., Bellevue, NE
59 Culture Of The House Dust Mite Euroglyphus Maynei To Pro-
duce Allergen Material
Dr. Larry G. Arlian, PhD FAAAAI, DiAnn L. Vyszenski-Moher,
MS, Dr. Marjorie S. Morgan, PhD and Jacqueline Neal, MS, Wright
State University, Dayton, OH
60 Emergency Department Visits For Asthma As a Function Of
Pollen and Mold Spore Counts
Dr. Stacey Galowitz, DO1,2, Dr. Christopher Chang, MD, PhD,
FAAAAI1 and Mr. Michael R. McDowell3, 1Alfred I duPont Hospital
for Children, Wilmington, DE, 2Thomas Jefferson University Hospi-
tal, Philadelphia, PA, 3Air Quality Management, New Castle, DE
61 Daily Ragweed Pollen Forecasting
Estelle Levetin, PhD FAAAAI1 and Lauren Howard, B.S.1,2, 1Uni-
versity of Tulsa, Tulsa, OK, 2University of Oklahoma, Oklahoma
City, OK
62 Conditions Affect Dust Mite Infestation Of Flour Samples In
Tropical Area
Dr. Theerapan Songnuy, Allergy and Immunology Division, Chu-
lalongkorn University Medical School, Bangkok, Thailand
63 Airborne Alternaria Spore Levels In Kansas City Is Associated
With Climatic Changes
Dr. David A. Jara, MD1, Dr. Charles Barnes, PhD2, Dr. Jay M.
Portnoy, MD, FAAAAI2 and Dr. Minati Dhar, Ph.D3, 1Childrens
Mercy Hospital, 2Childrens Mercy Hospital, Kansas City, MO,
3
Childrens Mercy Hospital & Clinics, Kansas City, MO
64 Influence Of Meteorological Conditions On Mountain Cedar
Pollen
Landon Bunderson, PhD1,2, Peter Van De Water, PhD3, Jeffrey
Luvall, PhD4 and Estelle Levetin, PhD FAAAAI2, 1Iowa State Uni-
versity, Ames, IA, 2University of Tulsa, Tulsa, OK, 3California
State University, Fresno, Fresno, CA, 4NASA Marshall Space
Flight Center, Huntsville, AL
65 A Post-Hoc Qualitative Analysis Of Real Time Heads-Up Pollen
Counting Versus Traditional Microscopic Counting In The En-
vironmental Exposure Unit (EEU)
Ms. Lisa Steacy, BSc1, Mr. Terry Walker, BA1, Mr. Barnaby Hobs-
bawn1, Mrs. Jenny Thiele, MSc2 and Dr. Anne K. Ellis, MD, MSc
FAAAAI1,3, 1Allergy Research Unit, Kingston General Hospital,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Kingston, ON, Canada, 2Queens University, Kingston, ON, Canada,
3
Departments of Medicine and Biomedical & Molecular Science,
Queens University, Kingston, ON, Canada
66 Real-Time PCR Quantification Of Virginia Live Oak (Quercus
virginiana) Pollen
Dr. Mark C. Glaum, MD, PhD, FAAAAI1,2, Ms. Eileen Rifkin1,
Dr. Jia-Wang Wang, PhD1, Dr. Richard F. Lockey, MD1,2 and Dr.
Dennis K. Ledford, MD, FAAAAI1,2, 1Division of Allergy and Im-
munology, Department of Internal Medicine, University of South
Florida, Morsani College of Medicine, Tampa, FL, 2James A. Haley
Veterans Affairs Hospital, Tampa, FL
67 Unusual Timing For The Ragweed Ambrosia Pollen Peak In
Vinnitsa, Ukraine
Ms. Viktoria Rodinkova1, Ms. I Motruk1, Ms. L. Slobodianiuk1,
Ms. O. Mazur1, Ms. O. Palamarchuk1 and Prof. Lawrence M. Du-
Buske, MD, FAAAAI2, 1Vinnitsa National Pirogov Memorial Med-
ical University, Ukraine, 2George Washington University School of
Medicine, DC
Insect Hypersensitivity/Anaphylaxis
2206
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
68 Safety and Efficacy Of a 12-Week Maintenance Interval In Pa-
tients Treated With Imported Fire Ant Immunotherapy
Dr. Karla E. Adams, MD1, Dr. Shayne Stokes, MD2, Dr. Kevin M.
White, MD1, Dr. Kirk H. Waibel, MD, FAAAAI3 and Dr.
Michael S. Tankersley, MD, FAAAAI4, 1Wilford Hall Ambulatory
Surgical Center, Joint Base San Antonio, Lackland AFB, TX,
2
Luke AFB, Glendale, AZ, 3Landstuhl RMC, 4Wilford
Hall Ambulatory Surgical Center, Joint Base San Antonio, San
Antonio, TX
69 Epidemiology and Clinical Predictors Of Biphasic Reactions In
Children With Anaphylaxis Waleed
D. Alqurashi1, Ian Stiell2, Kevin Chan3, Gina Neto1 and George
Wells4, 1Childrens Hospital of Eastern Ontario, Ottawa, ON, Can-
ada, 2Ottawa Hospital Research Institute, Ottawa, ON, Canada,
3
Hospital for Sick Children, Toronto, ON, Canada, 4University of
Ottawa Heart Institute, Ottawa, ON, Canada
70 Age As a Risk Factor For Fatal Food-Induced Anaphylaxis: An
Analysis Of UK and Australian Fatal Food Anaphylaxis Data
Dr. Paul J. Turner, FRACP PhD1,2, Dr. Vibha Sharma, FRCPCH3,
Prof. Mimi L. K. Tang, MD, PhD, FAAAAI4, Ms. M. Hazel Gow-
land, BA5, Dr. Nigel Harper, MBChB FRCA3, Dr. Tomaz Garcez,
MRCP FRCPath3, Dr. Richard Pumphrey, FRCPath3 and Dr. Robert
J. Boyle, MBChB PhD1, 1Imperial College London, United King-
dom, 2University of Sydney, Australia, 3Central Manchester Uni-
versity Hospitals NHS Foundation Trust, United Kingdom, 4The
University of Melbourne, Melbourne, Australia, 5Allergy Action,
United Kingdom
71 Dying From Allergies: A Profile Of Fatal Anaphylaxis In The
United States: 1999-2010
Dr. Elina Jerschow, MD, M.Sc.1, Dr. Robert Yao-Wen Lin,
FAAAAI2,3, Ms. Moira Scaperotti, Medical Student4 and Dr.
Aileen McGinn, PhD4, 1Albert Einstein College of Medicine/Mon-
tefiore Medical Center, Bronx, NY, 2New York Downtown Hospi-
tal, New York, NY, 3New York Medical College, Valhalla, NY,
4
Albert Einstein College of Medicine, Bronx, NY
72 Prospective Study To Determine Risk Factors and Severity Of
Food-Induced Allergic Reactions In Children
Dr. Angela Tsuang, MD1, Mr. Nikhil Menon, Medical student1,
Ms. Natasha Setia, Medical student1, Mr. Larry Geyman, Medical
student1, Ms. Christina Cherny2 and Dr. Anna H. Nowak-Wegrzyn,
MD, FAAAAI3, 1Mount Sinai School of Medicine, New York, NY,
Abstracts AB297
SATURDAY
2
Cornell University, 3Icahn School of Medicine at Mount Sinai,
New York, NY
73 Factors Associated With Increased Risk Of Anaphylaxis
Aylin Altan Riedel, PhD1, Erin Buysman, MS1, Dr. Ray A. Wolf,
PharmD2, Paul Cavanaugh, Jr, PhD3, Jerald Seare, MD1 and Tim
Bancroft, PhD1, 1OPTUM, Prairie Eden, MN, 2Mylan Specialty
L.P., New Hope, PA, 3Mylan Specialty, Basking Ridge, NJ
74 A Face-To-Face Educational Program By Allergists Can Im-
prove Knowledge, Attitudes, and Behaviors (KAB) Of Internal
Medicine, Pediatric, and Emergency Medicine Residents
Dr. Artemio M. Jongco III, MD, PhD MPH, Feinstein Institute
for Medical Research, Manhasset, NY; Cohen Childrens Medical
Center of New York, Great Neck, NY, Dr. Sheila Bina, MD, Stony
Brook University Hospital, Stony Brook, NY, Dr. Robert Sporter,
MD, Division of Allergy/Immunology, Departments of Medicine
and Pediatrics, Hofstra North Shore-LIJ School of Medicine, Dr.
Marie A. Cavuoto Petrizzo, MD, FAAAAI, ProHealth Care Asso-
ciates LLP, Lake Success, NY, Dr. Blanka M. Kaplan, MD,
FAAAAI, Department of Pediatrics, Division of Allergy & Im-
munology, Hofstra-North Shore-LIJ School of Medicine, Great
Neck, NY and Dr. Susan Schuval, MD, FAAAAI, Stony Brook
U Medical Cente, Stony Brook University Medical Center, Stony
Brook, NY
75 Anaphylaxis Management Before and After Implementation Of
Guidelines In The Pediatric Emergency Department
Dr. Shilpa Desai1, Dr. Rhett Lieberman1, Stephen Wisniewski,
PhD2 and Dr. Todd David Green, MD, FAAAAI1, 1Childrens Hos-
pital of Pittsburgh of UPMC, Pittsburgh, PA, 2University of
Pittsburgh
76 Managing Anaphylaxis In Adults: A Review Of All Cases Pre-
senting In A Single Year At An Emergency Department
Dr. Yarden Yanishevsky, MD1, Dr. Ann Elaine Clarke, MD, MSc2,3,
Dr. Sebastian La Vieille, MD4, Dr. Scott Delaney, MD5, Dr. Reza Ali-
zadehfar, MD1, Mr. Christopher Mill, BSc3, Dr. Lawrence Joseph,
PhD3, Dr. Judy Morris, MD, MSc6, Dr. Yuka Asai, MD3,7 and Dr.
Moshe Ben-Shoshan, MD, MSc1, 1Division of Paediatric Allergy
and Clinical Immunology, Department of Paediatrics, McGill Uni-
versity Health Center, Montreal, QC, Canada, 2Division of Allergy
and Clinical Immunology, Department of Medicine, McGill Univer-
sity Health Centre, Montreal, QC, Canada, 3Division of Clinical Ep-
idemiology, Department of Medicine, McGill University Health
Centre, Montreal, QC, Canada, 4Food Directorate, Health Canada,
Ottawa, ON, Canada, 5Department of Emergency Medicine, McGill
University Health Center, Montreal, QC, Canada, 6Department of
Emergency Medicine, H^ opital du Sacre-Cur, Montreal, QC, Can-
ada, 7Division of Dermatology, Department of Medicine, McGill
University Health Centre, Montreal, QC, Canada
77 Anaphylaxis Cases Presenting To Primary Care Paramedics In
Quebec
Ms. Nofar Kimchi1, Dr. Ann Elaine Clarke, MD, MSc2,3, Jocelyn
Moisan4, Colette Lachaine5, Dr. Sebastian La Vieille, MD6, Dr.
Yuka Asai, MD3,7, Dr. Lawrence Joseph, PhD3,8, Mr. Christopher
Mill, BSc3 and Dr. Moshe Ben-Shoshan, MD, MSc9,10, 1Technion
American Medical Students Program, Israel, 2McGill University
Health Centre, Montreal, Canada, 3Division of Clinical Epidemiol-
ogy, Department of Medicine, McGill University Health Centre,
Montreal, QC, Canada, 4Services prehospitaliers durgence de
lOutaouais, Quebec, Canada, QC, Canada, 5Direction adjointe
de services prehospitaliers durgence, MSSS, Quebec, Canada,
QC, Canada, 6Food Directorate, Health Canada, Ottawa, ON, Can-
ada, 7Division of Dermatology, Department of Medicine, McGill
University Health Centre, Montreal, QC, Canada, 8Departments
of Epidemiology and Biostatistics, McGill University, Montreal,
Canada, 9Division of Paediatric Allergy and Clinical Immunology,
Department of Paediatrics, McGill University Health Center, Mon-
treal, QC, Canada, 10Montreal Childrens Hospital, Montreal,
Canada
87
 AB298 Abstracts
SATURDAY
78 Anaphylaxis Management In A Pediatric Emergency Depart-
ment
Natasha Sidhu, MD1,2, Stacie M. Jones, MD3,4, Elizabeth Storm,
MD1,2, Maria Melguizo castro1,5, Todd Nick1,2 and Tonya Thomp-
son, MD1,2, 1University of Arkansas for Medical Sciences, Little
Rock, AR, 2Arkansas Childrens Hospital, 3University of Arkansas
for Medical Sciences and Arkansas Childrens Hospital, Little
Rock, AR, 4Arkansas Childrens Hospital Research Institute, Little
Rock, AR, 5Arkansas Childrens Hospital, Little Rock, AR
79 Characteristics Of Anaphylaxis In a Pediatric Emergency Unit
Beatriz Ameiro, M.D.1, Blanca Noguerado, M.D.1, Gabriela Zam-
brano, M.D.1, Cristina Morales, M.D.1, Miguel Guzman, M.D.1,
Mara L. Baeza, MD, PhD2 and Alberto Alvarez-Perea, MD3,
1
Hospital General Universitario Gregorio Mara~non, Allergy De-
partmen, Madrid, Spain, 2Hospital General Universitario Gregorio
Mara~ on, Allergy Department, Madrid, Spain, 3Hospital Materno
n TUM, Prairie Eden, MN, 2Mylan Specialty L.P., New Hope, PA,
Infantil Gregorio Mara~non, Pediatric Allergy Department, Madrid,
Spain
80 Characteristics Of Anaphylaxis and Angioedema In Pediatric
Emergency Center
Dr. Jung Hyun Kwon, Departments of Pediatrics Ewha Womans
University School of Medicine, Korea, Seoul, South Korea and
Dr. Hyun Sup Keum, Departments of Pediatrics Ewha Womans
University School of Medicine, Korea, South Korea
81 Anaphylaxis: Epidemiology and Treatment In The Emergency
Department
Dr. Judy Morris, MD, MSc1,2, Dr. Julie Lapointe1, Dr. Sebastien
La Vieille, MD3, Dr. Harley Eisman, MD4,5, Dr. Reza Alizadeh-
far, MD6, Ms. Emma Perkins, BSc7, Mr. Christopher Mill, BSc7,
Dr. Lawrence Joseph, PhD5,7, Dr. Ann Elaine Clarke, MD, MSc7,8
and Dr. Moshe Ben-Shoshan, MD, MSc5,6, 1Department of Emer-
gency Medicine, H^opital du Sacre-Cur, Montreal, QC, Canada,
2
University of Montreal, Montreal, QC, Canada, 3Food Director-
ate, Health Canada, Ottawa, ON, Canada, 4Montreal Childrens
Hospital, Montreal, QC, Canada, 5McGill University, Montreal,
QC, Canada, 6Division of Paediatric Allergy and Clinical Immu-
nology, Department of Paediatrics, McGill University Health
Center, Montreal, QC, Canada, 7Division of Clinical Epidemiol-
ogy, Department of Medicine, McGill University Health Centre,
Montreal, QC, Canada, 8Division of Allergy and Clinical Immu-
nology, Department of Medicine, McGill University Health Cen-
tre, Montreal, QC, Canada
82 Anaphylaxis In An Upstate New York Emergency Department:
Triggers and Treatments
Dr. Britta Sundquist, Dr. Jaison Jose, Dr. John Paige, Keith Swee-
ney, Michael Lavelle, Dr. Daniel Pauze, Dr. Denis Pauze and Dr.
Kirsi M. Jarvinen, Albany Medical College, Albany, NY
83 The Clinical Characteristics Of Children and Adolescents With
Anaphylaxis Who Visited 139 ERs In Korea In 2012
Dr. Mi-Hee Lee, Department of Pediatrics, Seoul Womens Hospi-
tal, Incheon, South Korea, Dr. Eun-Hee Chung, Department of Pe-
diatrics,National Medical Center, Seoul, South Korea and Dr.
Young-Shil Lim, Division of Chronic Disease Surveillance, Korea
Centers for Disease Control and Prevention, Osong, South Korea
84 Pattern Of Epinephrine Use and Referral Of Emergency De-
partment Personnel In A Korean Hospital
Dr. Jae Won Jeong, Inje University Ilsan PAIK Hospital, Goyang-
si, South Korea, Dr. Chansun PARK, Haeunda PAIK Hospital,
South Korea and Mi Young KIM, Busan PAIK Hospital, South
Korea
85 Characterisation Of Anaphylaxis In a Large UK City With An
Ethnically Diverse Population
Richard J. Buka1, Richard J. Crossman2, Cathryn Derbridge1,
Aarnoud P. Huissoon1, Scott Hackett1, Matthew W. Cooke1,2, Susan
Dorrian1 and Mamidipudi T. Krishna1, 1Birmingham Heartlands
Hospital, Birmingham, United Kingdom, 2University of Warwick,
United Kingdom
88
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
86 Ten Years Experience Of Anaphylaxis In a Single University
Hospital In Korea
Dr. Cheol-Woo Kim, Inha University Hospital, Incheon, South Ko-
rea and Jae Hwa Cho, Inha University Hospital, South Korea
87 Incidence Of Anaphylaxis In a Vilnius Lithuania Hospital Ap-
plying WAO Criteria
Prof. Audra Blaziene1, Dr. Neringa Buterleviciute1, Viktorija Pal-
tarackiene2 and Prof. Lawrence M. DuBuske, MD, FAAAAI3, 1Vil-
nius University Medical School, Lithuania, 2Vilnius university
Medical School, Lithuania, 3George Washington University School
of Medicine, Washington, DC
88 Factors Associated With a Lower Probability Of Refilling An
Epipen Auto-Injector In a Timely Manner
Erin Buysman, MS1, Dr. Ray A. Wolf, PharmD2, Paul Cavanaugh,
Jr, PhD3, Aylin Altan Riedel, PhD1 and Tim Bancroft, PhD1, 1OP-
3
Mylan Specialty, Basking Ridge, NJ
89 Food-Induced Anaphylaxis: Recognition and Response In Ohio
Schools
Dr. Erica Glancy, MD1, Dr. Peter J. Mustillo, MD, FAAAAI2, Dr.
Christine B. Cho, MD3, Dr. Rekha Raveendran, MD4 and Dr. Dan-
iel Scherzer, MD2, 1Cleveland Clinic, Cleveland, OH, 2Nationwide
Childrens Hospital, Columbus, OH, 3National Jewish Health, Den-
ver, CO, 4Asthma and Allergy Center LLC, Washington, DC
90 Availability and Utilization Of Epinephrine In Utah Schools
For The Management Of Anaphylaxis
Benjamin L. Wright, MD1, Michelle Fogg, BS2, Catherine
Sparks, MSN, RN, NCSN3, Brian P. Vickery, MD, FAAAAI4, Dr.
Joseph L. Roberts, MD, PhD5, Yamini Virkud, MD, MA1 and
Mandy Allison, MD, MSPH, M.Ed.6, 1Duke University, Durham,
NC, 2Utah Food Allergy Network, Salt Lake City, UT, 3Utah De-
partment of Health, Salt Lake City, UT, 4University of North Car-
olina, Chapel Hill, NC, 5Duke University Medical Center, Durham,
NC, 6University of Colorado Denver, Denver, CO
91 Induction Of Remission Of Frequent Idiopathic Anaphylaxis
With Rituximab
Dr. Arturo Borzutzky, MD, Division of Pediatrics, School of Med-
icine, Pontificia Universidad Catolica de Chile, Santiago, Chile, Dr.
Pamela S. Morales, MD, Pediatric Rheumatology, Allergy and Im-
munology Unit, Division of Pediatrics, School of Medicine, Pontifi-
cia Universidad Catolica de Chile, Santiago, Chile, Dr. Veronica
Mezzano, MD, Department of Rheumatology and
Clinical Immunology, School of Medicine, Pontificia Universidad
Catolica de Chile, Santiago, Chile, Ms. Sofia Nussbaum,
Universidad de San Sebastian, Santiago, Chile and A. Wesley Burks,
MD, FAAAAI, University of North Carolina, Chapel Hill, NC
92 Evaluation Of a Diagnostic Protocol For Perioperative Anaphy-
laxis Due To Isosulfan Blue Dye Allergy
Ms. Mary Grace Baker, University of Virginia School of Medicine,
Charlottesville, VA, Julia A. Cronin, MD, University of Virginia, Di-
vision of Asthma, Allergy and Immunology, Charlottesville, VA, Dr.
Larry Borish, MD, FAAAAI, Asthma and Allergic Diseases Center,
Carter Center for Immunology Research, University of Virginia,
Charlottesville, VA and Dr. Monica G. Lawrence, MD, University
of Virginia Department of Medicine, Division of Asthma, Allergy
and Immunology, Charlottesville, VA
93 Acute Serum Tryptase Elevation In ALTE - An Atypical Man-
ifestation Of Bullous Mastocytosis
Dr. Alexander Alvarez, MD, Virginia Commonwealth University,
Dr. Anne-Marie A. Irani, MD, FAAAAI, Virginia Commonwealth
University Health Systems, Richmond, VA and Dr. Lawrence B.
Schwartz, MD, PhD, FAAAAI, Virginia Commonwealth Univer-
sity, Richmond, VA
94 Methodology For Identifying Patients Presenting With Anaphy-
laxis Using Administrative Claims Data
Jerald Seare, MD1, Erin Buysman, MS1, Dr. Ray A. Wolf,
PharmD2, Paul Cavanaugh, Jr, PhD3, Aylin Altan Riedel, PhD1
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
and Tim Bancroft, PhD1, 1OPTUM, Prairie Eden, MN, 2Mylan Spe-
cialty L.P., New Hope, PA, 3Mylan Specialty, Basking Ridge, NJ
95 Epicare (Epinephrine Pen Investigation: Compliance and Rec-
ommendations)
Dr. Nisha S. Patel, MD, Thomas Jefferson University, Philadel-
phia, PA, Dr. Christopher Chang, MD, PhD, FAAAAI, Alfred I du-
Pont Hospital for Children, Wilmington, DE and Dr. Gang Ye, PhD,
Nemours, Orlando, FL
96 Confusion With Substituting Epinephrine Auto-Injectors: A
Focus On Medication Counseling, Dispensing, and Patient Ed-
ucation
Sonia Dhanjal, PharmD and Stacie Lampkin, PharmD, BCACP,
AE-C, DYouville College School of Pharmacy, Buffalo, NY
97 Omalizumab For a Case Of Monoclonal Mast Cell Activation
Syndrome With Recurrent Anaphylaxis
Dr. Amanda Jagdis, University of Toronto, Faculty of Medicine,
Toronto, ON, Canada and Dr. Peter Vadas, MD, PhD, St. Michaels
Hospital, Toronto, ON, Canada
98 Chlorhexidine Impregnated Central Venous Lines: A Poten-
tially Avoidable Cause Of Severe Perioperative Anaphylaxis
Dr. Aisha Ahmed, MD and Dr. Katherine E. Gundling, MD,
UCSF, San Francisco, CA
99 Food Dependent Exercise Induced Anaphylaxis Treatment
With Specific Oral Tolerance Induction Using IFN-Gamma
Dr. Jae Ho Lee, MD, PhD, Department of Pediatrics, Chungnam
National University, Taejeon, South Korea, Dr. Sun Young
You, MD, Department of Pediatrics, Taejeon, South Korea
and Dr. Hye Young Han, MD, Department of Pediatrics,
School of Medicine, Chungnam National University, Taejeon,
South Korea
100 Food Associated Exercise Induced Anaphylaxis Associated
With Late Phase Skin Test Reactivity To Shrimp
Dr. Marisol Nardi, New York Downtown Hospital, New York and
Dr. Robert Yao-Wen Lin, FAAAAI, New York Downtown Hospital,
New York, NY; Weill Cornell Medical College, New York, NY
101 Idiopathic Capillary Leak Syndrome
Dr. Carl B. Lauter, MD, FAAAAI, William Beaumont Hospital
102 Comprehensive Metabolomic Analysis Identifies Uric Acid As a
Critical Mediator Of Peanut Sensitization
Mr. Joshua Kong1, Dr. Kenneth Chalcraft, PhD2, Dr. Rodrigo Ji-
menez-Saiz, PhD1, Mrs. Tina Walker-Fattouh2, Dr. Susanna Gon-
charova, MD, PhD2, Dr. Brian McCarry, PhD2 and Dr. Manel
Jordana, MD, PhD1, 1McMaster Immunology Research Centre
(MIRC), McMaster University, Hamilton, ON, Canada, 2McMaster
University, Hamilton, ON, Canada
103 Pharmacokinetics Of Berberine, a Bioactive Compound In Bu-
tanol Purified Food Allergy Herbal Formula-2
Dr. Nan Yang, PhD, MS1, Dr. Ying Song, MD1, Dr. Changda Liu,
PhD1, Sool Yeon Cho, PhD2 and Dr. Xiu-Min Li, MD1, 1Pediatrics,
Icahn School of Medicine at Mount Sinai, New York, NY, 2Hema-
tology, Icahn School of Medicine at Mount Sinai, New York
City, NY
104 Anaphylaxis After Bitten By Domestic Hamster: A Case Report
Dr. Leila Borges, MD1, Dr. Danielle Bichueti Silva, MD2, Dr. Tessa
Rachel Tranquilini Goncalves, MD3, Dr. Rafael Rota, MD3, Camila
Gonzaga da Silva4, Dr. Danieli Hirari, MD4, Dr. Marcia Mallozi,
MD5 and Prof. Dirceu Sole, MD, PhD3, 1UNIFESP, Brazil, 2Univer-
sidade Federal de S~ao Paulo, S~ao Paulo, Brazil, 3Federal University
of Sao Paulo, Sao Paulo, Brazil, 4Federal University of S~ao Paulo,
S~ao Paulo, Brazil, 5Federal University of S~ao Paulo, Brazil
105 Gene Expression Profiling Of Food-Induced Anaphylaxis Asso-
ciated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Dr. Rosa M. Munoz-Cano, MD, PhD1,2, Dr. Joan Bartra, MD, PhD2,
Dr. Jorg Scheffel, PhD1, Dr. Mariona Pascal, PhD3, Dr. Barbara Dema,
PhD1, Dr. Antonio Valero, MD, PhD2, Dr. Ana Olivera, PhD1, Prof.
Cesar Picado, MD, PhD2 and Dr. Juan Rivera, PhD1, 1National Insti-
tute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),
Abstracts AB299
SATURDAY
National Institutes of Health, Bethesda, MD, 2Unitat dAl.lergia. Ser-
vei de Neumologia i Al.lergia Respiratoria. Hospital Clinic. Barce-
lona. Institut dInvestigacions Biomediques August Pi i Sunyer
(IDIBAPS)., Barcelona, Spain, 3Servei dImmunologia, Centre de Di-
agnostic Biomedic. Hospital Clinic., Barcelona, Spain
106 Recurrence Rates Of Anaphylaxis In Children
Dr. Andrew OKeefe, MD1,2, Dr. Yuka Asai, MD3,4, Mr. Christo-
pher Mill, BSc3, Dr. Harley Eisman, MD5, Dr. Sebastian La Vieille,
MD6, Dr. Reza Alizadehfar, MD5,7, Ms. Emma Perkins, BSc3, Dr.
Lawrence Joseph, PhD3, Dr. Ann Elaine Clarke, MD, MSc3,8 and
Dr. Moshe Ben-Shoshan, MD, MSc5,9, 1McGill University, Mon-
treal, Canada, QC, Canada, 2Division of Pediatric Allergy and Clin-
ical Immunology, Montreal Childrens Hospital, Canada, 3Division
of Clinical Epidemiology, Department of Medicine, McGill Univer-
sity Health Centre, Montreal, QC, Canada, 4Division of Dermatol-
ogy, Department of Medicine, McGill University Health Centre,
Montreal, QC, Canada, 5McGill University, Montreal, QC, Canada,
6
Food Directorate, Health Canada, Ottawa, ON, Canada, 7Division
of Paediatric Allergy and Clinical Immunology, Department of Pae-
diatrics, McGill University Health Center, Montreal, QC, Canada,
8
Montreal General Hospital, 9Montreal Childrens Hospital, Mon-
treal, Canada
107 Sensitization To Recombinant Allergens Of Hevea Brasilensis
In Patients With Latex Anaphylaxis
Dr. J.M. Escobar Montalvo, MD1, Ms. A. G omez Infante, MD1,
Dr. Silvia Martnez Blanco, MD2 and Dr. R. Vives Conesa, MD1,
1
Hospital Universitario 12 de Octubre, Madrid, Spain, 2Hospital
Universitario 12 de Octubre, Spain
108 Patients Monosensitised To Hev b 8 Performs Surgery Without
Avoidance The Latex and Without Complications
Dr. Adriano Sa, MD, Federal University of S~ao Paulo, S~ao Paulo,
Brazil, Dr. Leila Borges, MD, UNIFESP, Brazil, Dr. Nathalia Bar-
roso, Federal University of Sao Paulo, Dr. Luis Felipe C. Ensina,
MD, Universidade Federal de S~ao Paulo, S~ao Paulo, Brazil, Ines
Nunes, Federal University of S~ao P~aulo and Prof. Dirceu Sole,
MD, PhD, Federal University of Sao Paulo, Sao Paulo, Brazil
HAE and Angioedema
2207
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
109 Home Treatment With Conestat Alfa In Attacks Of Hereditary
Angioedema Due To C1-Inhibitor Deficiency
Henriette Farkas, MD, PhD DSc1, Dr. Erika Szabo1, Dr. Dorottya
Csuka, PhD2, Dr. Kinga, Vikt
oria Kohalmi1, Dr. Zsuzsanna Zotter1
and Dr. Lilian Varga, PhD1, 1Semmelweis University, Budapest,
Hungary, 2Hungarian HAE Center, 3rd Department of Internal
Medicine, Semmelweis University, Budapest, Hungary
110 Comparison Of Plasma Kallikrein Inhibition By The Monoclo-
nal Antibody Inhibitor DX-2930 To Endogenous C1-INH
Daniel Sexton, Jon Kenniston, Ryan Faucette, Andrew Nixon,
Christopher TenHoor, Yung H. Chyung and Burt Adelman, Dyax
Corp.
111 The Prophylactic Use Of C1 Esterase Inhibitor (Berinert) In
HAE Patients Undergoing Invasive Procedures
Rachel Harrison, BSc1, Stephanie Santucci, RN1, Genevieve Gav-
igan, MASc, MD2 and William H. Yang, MD1,2, 1Allergy and
Asthma Research Corp., Ottawa, ON, Canada, 2University of Ot-
tawa Medical School, Ottawa, ON, Canada
112 Self-Administration Of a Novel Subcutaneous Bradykinin B2 Re-
ceptor Antagonist, Icatibant (Firazyr), As An Effective Treat-
ment Option In Patients With Hereditary Angioedema (HAE)
Stephanie Santucci, RN1, Hoang Pham, MD 2016, BSc, BA2, Ra-
chel Harrison, BSc1 and William H. Yang, MD1,2, 1Allergy and
89
 AB300 Abstracts
SATURDAY
Asthma Research Corp., Ottawa, ON, Canada, 2University of Ottawa
Medical School, Ottawa, ON, Canada
113 Current Medical Management Of Hereditary Angioedema
(HAE): Follow-Up To a Large Survey Of US Physicians
Dr. Marc A. Riedl, MD, MS, University of California, San Diego,
La Jolla, CA, Dr. Richard G. Gower, MD, FAAAAI, Marycliff Al-
lergy Specialists, Spokane, WA and Dr. Aleena Banerji, MD, Divi-
sion of Rheumatology, Allergy, and Immunology, Department of
Medicine, Massachusetts General Hospital, Harvard Medical
School, Boston, MA
114 HAE In a Southern Louisiana Kindred: Novel Gene Mutations
Dr. Adrian Casillas, MD, FAAAAI, Baylor College of Medicine,
Houston, TX
115 Hereditary Angioedema Without C1 Inhibitor Deficiency: Ob-
servation Of Patients Homozygous For FXII GENE Mutation
Christiane Stieber1, Camila Veronez2, Nathalia Cagini2, Elisabete
Cordeiro3, Dr. Anete S. Grumach3, Rosemeire Constantino-Silva3,
Joao Bosco Pesquero2 and Sven Cichon4, 1Life & Brain Center
and Institute of Human Genetics, University of Bonn, Germany,
2
Federal University of S~ao Paulo, Brazil, 3Faculty of Medicine
ABC, Brazil, 4Division of Medical Genetics, Department of Bio-
medicine, University of Basel, Switzerland
116 Hereditary Angioedema Without C1 Inhibitor Deficiency: Clin-
ical Evaluation Of 67 Brazilian Patients
Elisabete Cordeiro1, Camila Veronez2, Christiane Stieber3, Natha-
lia Cagini2, Rosemeire Constantino-Silva1, Rozana Goncalves4,
Gustavo Fusaro4, Neusa Wandalsen1, Sven Cichon5, Joao Bosco
Pesquero2 and Dr. Anete S. Grumach1, 1Faculty of Medicine
ABC, Brazil, 2Federal University of S~ao Paulo, Brazil, 3Life &
Brain Center and Institute of Human Genetics, University of
Bonn, Germany, 4Federal University of Minas Gerais, Brazil, 5Di-
vision of Medical Genetics, Department of Biomedicine, University
of Basel, Switzerland
117 Circulating Extracellular Micrornas In Hereditary Angioe-
dema
Peisong Gao, MD, PhD1, Kenneth Witwer, PhD2, Melissa McA-
lexander2, Priya Tripathi, PhD1, Tamara Johnson3 and Dr. Huamin
Henry Li, MD, PhD, FAAAAI3, 1Division of Allergy & Clinical
Immunology, Johns Hopkins University School of Medicine,
Baltimore, MD, 2Johns Hopkins Institute for NanoBioTechnol-
ogy, Baltimore, MD, 3Institute for Asthma and Allergy, Chevy
Chase, MD
118 Hereditary Angioedema In The Pediatric Patient
Dr. Gregory H. Bennett, DO, Penn State Childrens Hospital, Her-
shey, PA and Dr. Timothy J. Craig, DO, FAAAAI, Penn State Uni-
versity College of Medicine, Hershey, PA
119 Clinical Features Of Pediatric Hereditary Angioedema
Shelby N. Elenburg, MD1, Amal H. Assaad, MD, FAAAAI2, Dr.
Jonathan A. Bernstein, MD, FAAAAI3 and Maya Nanda, MD2,
1
University of Tennessee Health Science Center, Memphis, TN,
2
Cincinnati Childrens Hospital Medical Center, Cincinnati, OH,
3
Division of Immunology Allergy & Rheumatology, University of
Cincinnati Medical Center, Cincinnati, OH
120 A Case Series Of Seven Pediatric Patients Successfully Treated
With Ecallantide and Icatibant For Hereditary Angioedema
Heather Minto, MD1,2 and Kelly M. Maples, MD1,2, 1Eastern Vir-
ginia Medical School, Norfolk, VA, 2Childrens Hospital of The
Kings Daughters, Norfolk, VA
121 IHAE-Qol: Specific Health-Related Quality Of Life (HRQoL)
Questionnaire In Hereditary Angioedema Due To C1 Inhibitor
Deficiency (HAE-C1INH)
Dr. Nieves Prior, MD1, Prof. Eduardo Remor2, Elia Perez-Fernan-
dez, MSc3, Dr. Carmen G omez-Traseira, MD4, Dr. Magdalena Julia
Caminoa, MD4, Francisco Gaya5, Prof. Werner Aberer, MD6, Dr.
Olga Melcina Barrera, MD7, Dr. Stephen D. Betschel, MD8,
Prof. Laurence Bouillet, MD, PhD9, Prof. Anette Bygum, MD10,
Henriette Farkas, MD, PhD DSc11, Dr. Anete S. Grumach12, Dr.
90
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Vesna Grivcheva- Panovska, MD, PhD13, Dr. Marcel Levi, MD14,
Dr. Hilary Longhurst, MD15, Dr. Alejandro Malbran, MD16, Dr.
Dumitru Moldovan, MD, PhD17, Dr. Gregor Porebski, MD18, Dr.
Avner Reshef, MD19, Dr. Petra Staubach, MD20, Dr. Andrea Zani-
chelli, MD21, Dr. Yu-xiang Zhi, MD22 and Dr. Teresa Caballero,
MD, PhD4,23, 1Hospital Universitario Severo Ochoa, Madrid,
Spain, 2Psychology Faculty, Universidad Autonoma, Madrid,
Spain, 3Hospital Universitario Fundacion Alcorcon, Madrid, Spain,
4
Allergy Department, Hospital La Paz Institute for Health Research
(IdiPaz), Madrid, Spain, 5Research Unit, Hospital La Paz Institute
for Health Research (IdiPaz), Madrid, Spain, 6Department of Der-
matology and Venereology, Medical University of Graz, Graz, Aus-
tria, 7Institute of Pneumology and Allergy. San Fernandos
Hospital, Panama City, Panama, 8University of Toronto, Division
of Clinical Immunology and Allergy, Toronto, ON, Canada, 9Na-
tional Reference Centre for Angioedema, Internal Medicine De-
partment, Grenoble University Hospital, Grenoble, France,
10
Denmark HAE Centre, Department of Dermatology and Allergy
Centre, Odense University Hospital, Odense, Denmark, 11Hungar-
ian HAE Center, 3rd Department of Internal Medicine, Semmel-
weis University, Budapest, Hungary, 12Department of
Dermatology, School of Medicine, University of Sao Paulo, Sao
Paulo, Brazil, 13Unit of Allergology and Clinical Immunology. De-
partment of Dermatology. Medicine School University Sts Cyril
and Methodius, Skopje, Macedonia, 14Department of Internal Med-
icine,Academic Medical Center,University of Amsterdam., Amster-
dam, Netherlands, 15Barts Health NHS Trust, London, United
Kingdom, 16British Hospital of Buenos Aires, Buenos Aires, Ar-
gentina, 17Department of AllergologyImmunology, Mures County
Hospital, Tirgu-Mures, Romania, 18Department of Clinical and En-
vironmental Allergology, Jagiellonian University,, Krakow, Poland,
19
Allergy, Clinical Immunology & Angioedema Unit, Chaim Sheba
Medical Center, Tel Hashomer, Israel, 20Department of Dermatol-
ogy, University Medical Center, University of Mainz, Mainz, Ger-
many, 21Internal Medicine Department, Luigi Sacco Hospital,
Milan, Italy, 22Peking Union Medical College Hospital, Beijing,
China, 23Biomedical Research Network on Rare Diseases (CI-
BERER, U754), Madrid, Spain
122 Relationship Between Angioedema Attacks and Health-Related
Quality Of Life Outcomes In Patients With Hereditary Angio-
edema (HAE)
Dr. Jeff Dayno, MD1, Dave P. Miller2, Ms. Emily Hautamaki,
MPH3, Scott Newcomer1, David Fitts1 and Dr. William R. Lumry,
MD, FAAAAI4,5, 1ViroPharma Incorporated, 2ICON Clinical Re-
search, 3Oxford Outcomes, an ICON plc company, 4AARA Re-
search Center, Dallas, TX, 5Allergy and Asthma Specialists,
Dallas, TX
123 Health-Related Quality Of Life (HRQoL) In Adult Patients
With Hereditary Angioedema Due To C1 Inhibitor Deficiency
(HAE-C1-INH) Assessed By SF-36v2
Dr. Teresa Caballero, MD, PhD1,2, Dr. Magdalena Julia Cami-
noa, MD1, Elia Perez-Fernandez, MSc3, Dr. Carmen Gomez-Tra-
seira, MD1, Dr. Anne Aabom, MD4, Prof. Werner Aberer, MD5,
Dr. Stephen D. Betschel, MD6, Prof. Anette Bygum, MD4, Dr.
Dorottya Csuka, PhD7, Henriette Farkas, MD, PhD DSc7, Dr. Ma-
ria Gomide, MD8, Dr. Adriane Groffik, MD9, Dr. Anete S. Grum-
ach8, Mrs. Iris Leivobich10, Dr. Alejandro Malbran, MD11, Dr.
Eniko Mihaly, MD12, Dr. Dumitru Moldovan, MD, PhD13, Dr.
Krystyna Obtulowicz, MD14, Dr. Gregor Porebski, MD15, Mrs.
Celina Rayonne16, Dr. Avner Reshef, MD10, Dr. Petra Staubach,
MD9, Dr. Michaela Wiednig, MD5, Maria Joao Forjaz17,18 and
Dr. Nieves Prior, MD19, 1Allergy Department, Hospital La Paz In-
stitute for Health Research (IdiPaz), Madrid, Spain, 2Biomedical
Research Network on Rare Diseases (CIBERER, U754), Madrid,
Spain, 3Hospital Universitario Fundacion Alcorcon, Madrid,
Spain, 4Denmark HAE Centre, Department of Dermatology and
Allergy Centre, Odense University Hospital, Odense, Denmark,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
5
Department of Dermatology and Venereology, Medical Univer-
sity of Graz, Graz, Austria, 6University of Toronto, Division of
Clinical Immunology and Allergy, Toronto, ON, Canada, 7Hun-
garian HAE Center, 3rd Department of Internal Medicine, Sem-
melweis University, Budapest, Hungary, 8Department of
Dermatology, School of Medicine, University of Sao Paulo, Sao
Paulo, Brazil, 9Department of Dermatology, University Medical
Center, University of Mainz, Mainz, Germany, 10Allergy, Clinical
Immunology & Angioedema Unit, Chaim Sheba Medical Center,
Tel Hashomer, Israel, 11British Hospital of Buenos Aires, Buenos
Aires, Argentina, 12Department of AllergologyImmunology,
Mures County Hospital, Trgu-Mures, Romania, 13Department
of AllergologyImmunology, Mures County Hospital, Tirgu-
Mures, Romania, Tirgu-Mures, Romania, 14Department of Clini-
cal and Enviromental Medicine, Jagiellonian University, Krakow,
Poland, 15Department of Clinical and Environmental Allergology,
Jagiellonian University, Krakow, Poland, 16ReSolve Research So-
lutions Inc., Whitby, Ontario, Canada, 17National School of Pub-
lic Health, Carlos III Institute of Public Health, Madrid, Spain,
18
REDISSEC, Madrid, Spain, 19Hospital Universitario Severo
Ochoa, Madrid, Spain
124 The Icatibant Outcome Survey: Characteristics Of Patients
With Hereditary Angioedema Requiring Reinjection
Dr. Hilary Longhurst, MD, Barts Health NHS Trust, London,
United Kingdom, Prof. Marcus Maurer, MD, Department of Der-
matology and Allergy, Charite Universitatsmedizin, Berlin, Ger-
many, Dr. Vincent Fabien, PhD, Shire, Eysins, Switzerland, Prof.
Werner Aberer, MD, Department of Dermatology and Venereology,
Medical University of Graz, Graz, Austria, Prof. Laurence Bouillet,
MD, PhD, National Reference Centre for Angioedema, Internal
Medicine Department, Grenoble University Hospital, Grenoble,
France, Dr. Andrea Zanichelli, MD, Dipartimento di Scienze Bio-
mediche e Cliniche, Ospedale Luigi Sacco, Universita degli Studi
di Milano, Milan, Italy and Dr. Teresa Caballero, MD, PhD, Allergy
Department, Hospital La Paz Institute for Health Research (IdiPaz),
Madrid, Spain
125 The Icatibant Outcome Survey: Characterizing Breakthrough
Hereditary Angioedema Attacks In Patients Receiving Long-
Term Prophylaxis
Prof. Werner Aberer, MD, Department of Dermatology and Vene-
reology, Medical University of Graz, Graz, Austria, Prof. Marcus
Maurer, MD, Department of Dermatology and Allergy, Charite
Universitatsmedizin, Berlin, Germany, Prof. Laurence Bouillet,
MD, PhD, National Reference Centre for Angioedema, Internal
Medicine Department, Grenoble University Hospital, Grenoble,
France, Amandine Perrin, Shire, Eysins, Switzerland, Dr. Andrea
Zanichelli, MD, Dipartimento di Scienze Biomediche e Cliniche,
Ospedale Luigi Sacco, Universita degli Studi di Milano, Milan,
Italy, Dr. Teresa Caballero, MD, PhD, Allergy Department, Hospi-
tal La Paz Institute for Health Research (IdiPaz), Madrid, Spain and
Dr. Hilary Longhurst, MD, Barts Health NHS Trust, London,
United Kingdom
126 The Icatibant Outcome Survey: Rate and Impact Of Treatment
By Self-Administration
Dr. Dolores Hernandez Fernandez de Rojas, MD1, Dr. Ethel
nez, MD1, Dr. Hilary Longhurst, MD2, Prof. Marcus Maurer,
Iba~
MD3, Dr. Vincent Fabien, PhD4, Prof. Werner Aberer, MD5, Prof.
Laurence Bouillet, MD, PhD6, Dr. Andrea Zanichelli, MD7 and
Dr. Teresa Caballero, MD, PhD8, 1IIS Hospital Universitario La
Fe, Valencia, Spain, 2Barts Health NHS Trust, London, United
Kingdom, 3Department of Dermatology and Allergy, Charite Uni-
versitatsmedizin, Berlin, Germany, 4Shire, Eysins, Switzerland,
5
Department of Dermatology and Venereology, Medical University
of Graz, Graz, Austria, 6National Reference Centre for Angioe-
dema, Internal Medicine Department, Grenoble University Hospi-
tal, Grenoble, France, 7Dipartimento di Scienze Biomediche e
Cliniche, Ospedale Luigi Sacco, Universita degli Studi di Milano,
Abstracts AB301
SATURDAY
Milan, Italy, 8Allergy Department, Hospital La Paz Institute for
Health Research (IdiPaz), Madrid, Spain
127 Most Hereditary Angioedema (HAE) Attacks Resolved After
One Icatibant Injection: Analysis Of FAST-3 Open-Label Ex-
tension Study
Dr. William R. Lumry, MD, FAAAAI, Allergy and Asthma Spe-
cialists, Dallas, TX, Jovanna Baptista, MS, Shire, Lexington, MA,
Dr. Marc A. Riedl, MD, MS, University of California, San Diego,
La Jolla, CA and Dr. Timothy J. Craig, DO, FAAAAI, Penn State
University College of Medicine, Hershey, PA
128 Evaluation Of Icatibant Reinjection Of Laryngeal Hereditary
Angioedema Attacks: A Pooled Analysis Of Three Phase III
Open-Label Extension Studies
Jovanna Baptista, MS, Shire, Lexington, MA, Dr. Jonathan A.
Bernstein, MD, FAAAAI, Division of Immunology Allergy &
Rheumatology, University of Cincinnati Medical Center, Cincin-
nati, OH, Dr. William R. Lumry, MD, FAAAAI, Allergy and
Asthma Specialists, Dallas, TX and Dr. Marc A. Riedl, MD, MS,
University of California, San Diego, La Jolla, CA
129 Successful and Safe Use Of Icatibant For Life-Threatening An-
gioedema Attack During Pregnancy In a Patient With Heredi-
tary Angioedema Type I
Dr. Karine Boufleur, MD1, Ms. Luana Delcaro1, Dr. Daniel L.
Cordeiro, MD1, Dr. Priscila B. Botelho Palhas, MD1, Dr. Janaina
Fernandes de Melo Sousa, MD1, Dr. Thas Mendonca, MD1, Dr. Ja-
naina Michele de Lima Melo, MD1, Dr. Gustavo Neppelenbroek,
MD1, Prof. Wlly Sarti1, Dr. Adriana S. Moreno, PhD1 and Dr. Luisa
Karla P. Arruda, MD, PhD, FAAAAI2, 1Ribeirao Preto Medical
School, University of Sao Paulo, Ribeirao Preto, Brazil, 2School
of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil
130 Recombinant Human C1 Inhibitor Treatment Does Not Affect
D-Dimer Levels and Is Not Associated With Thromboembolic
Events In HAE Patients
Dr. Avner Reshef, MD, Allergy, Clinical Immunology & Angioe-
dema Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel, Dr.
Andrea Zanichelli, MD, Dipartimento di Scienze Biomediche e
Cliniche, Ospedale Luigi Sacco, Universita degli Studi di Milano,
Milan, Italy, Dr. Hilary Longhurst, MD, Barts Health NHS Trust,
London, United Kingdom, Yun Hardiman, MS, Santarus Inc., San
Diego, CA, Anurag Relan, MD, Pharming Technologies BV, Lei-
den, Netherlands and C. Erik Hack, MD, University Medical Center
Utrecht, Utrecht, Netherlands
131 C1-Esterase Inhibitor Concentrate For Acute Attacks Of La-
ryngeal Edema In Hereditary Angioedema (HAE): Fixed Dos-
ing Vs Body Weight-Adjusted Dosing
Konrad Bork, MD1, Dr. Jonathan A. Bernstein, MD, FAAAAI2,
Henrike Feuersenger3, Thomas Machnig3 and Dr. Timothy J. Craig,
DO, FAAAAI4, 1University of Mainz, Mainz, Germany, 2Division
of Immunology Allergy & Rheumatology, University of Cincinnati
Medical Center, Cincinnati, OH, 3CSL Behring GmbH, Marburg,
Germany, 4Penn State University College of Medicine, Hershey, PA
132 Sustained Response Following Acute Treatment Of Hereditary
Angioedema Attacks With Recombinant Human C1 Esterase
Inhibitor
H.Henry Li, MD, PhD, Institute for Asthma and Allergy, Chevy
Chase, MD, Dr. Marc A. Riedl, MD, MS, University of California,
San Diego, La Jolla, CA, Dr. Jonathan A. Bernstein, MD, FAAAAI,
Division of Immunology Allergy & Rheumatology, University of
Cincinnati Medical Center, Cincinnati, OH, Dr. William R. Lumry,
MD, FAAAAI, AARA Research Center, Dallas, TX, Dr. Avner Re-
shef, MD, Allergy, Clinical Immunology & Angioedema Unit,
Chaim Sheba Medical Center, Tel Hashomer, Israel, Dr. Dumitru
Moldovan, MD, PhD, Department of AllergologyImmunology,
Mures County Hospital, Tirgu-Mures, Romania, Tirgu-Mures, Ro-
mania, Henriette Farkas, MD, PhD DSc, Semmelweis University,
Budapest, Hungary, Dr. Gregor Porebski, MD, Department of Clin-
ical and Environmental Allergology, Jagiellonian University,
91
 AB302 Abstracts
SATURDAY
Krakow, Poland, Marcin Stobiecki, MD, Jagiellonian University
College, Krakow, Poland, Yun Hardiman, MS, Santarus Inc., San
Diego, CA, Anurag Relan, MD, Pharming Technologies BV, Lei-
den, Netherlands and Prof. Marco Cicardi, MD, PhD, Department
of Internal Medicine, Luigi Sacco Hospital, Milan, Italy, Milan,
Italy
133 Efficacy Of C1Inhibitor Concentrate (Berinert) For Severe An-
gioedema Attacks Induced By Drugs Targeting The Renin-An-
giotensin Aldosterone System
Prof. Laurence Bouillet, Grenoble university hospital, Grenoble,
France, Dr. Bernard Floccard, Lyon university hospital, Lyon,
France, Dr. Isabelle Boccon-Gibod, Grenoble University Hospital,
Grenoble, France, Dr. Sebastien Trouiller, Centre hospitalierd
Aurillac, Aurillac, France, Dr. Anne Du-Than, Montpellier univer-
sity hospital, Montpellier, France and Prof. Olivier Fain, Jean Ver-
dier universty hospital, Bondy, France
134 Professional Administration Costs In The US For On-Demand
Therapy Of Hereditary Angioedema
Thomas Machnig, CSL Behring GmbH, Marburg, Germany and
Mr. Art Zbrozek, RPh, MSc, MBA, CSL Behring LLC, King of
Prussia, PA
135 Successful Administration Of C1Esterase Inhibitor (C1inh) In
An Individual Anaphylactic To It
Dr. Arthur B. Vegh, MD, FAAAAI1, Ms. Marni Sellers2, Ms.
Nancy Boyden2 and Ms. Jennifer Vegh2, 1University of Washing-
ton, Tacoma, WA, 2none, Tacoma, WA
136 Evaluation Of DX-88 (Ecallantide) For Treatment Of Angioten-
sin Enzyme Inhibitor Induced Angioedema In The Emergency
Department
Dr. Joseph Moellman, MD1, Dr. Jonathan A. Bernstein, MD,
FAAAAI2, Ms. Kimberly Hart1, Dr. Sean Collins3 and Dr. Christo-
pher Lindsell1, 1University of Cincinnati, Cincinnati, OH, 2Division
of Immunology Allergy & Rheumatology, University of Cincinnati
Medical Center, Cincinnati, OH, 3Vanderbilt University, Nashville,
TN
137 Ecallantide In Treatment Of Type III Hereditary Angioedema
Dr. Anil Nanda, MD, Asthma and Allergy Center, Lewisville, TX;
UT Southwestern Medical Center, Dallas, TX and Dr. Anita N. Wa-
san, MD, Allergy and Asthma Center, Lansdowne, VA
138 BCX4161, An Oral Kallikrein Inhibitor: Safety and Pharmaco-
kinetic Results Of a Phase 1 Study In Healthy Volunteers
Dr. Phil Collis1, Dr. Melanie Cornpropst1, Dr. Jo Collier2 and Dr.
William Sheridan1, 1BioCryst Pharmaceuticals, Durham, NC,
2
Quotient Clinical, Nottingham, United Kingdom
139 Treatment Of Hereditary Angioedema At The Time Of Prodro-
mal Symptoms: International Survey Of Physicians
Dr. Neelu Kalra, MD, Penn State Hershey Medical Center, Her-
shey, PA and Dr. Timothy J. Craig, DO, FAAAAI, Penn State Uni-
versity College of Medicine, Hershey, PA
141 Structural and Molecular Changes Caused By Mutations
Thr328Lys and Thr328Arg In FXII Associated With Hereditary
Angioedema With Normal C1 Inhibitor
Dr. Adriana S. Moreno, PhD, Ribeirao Preto Medical School,
University of Sao Paulo, Ribeirao Preto, Brazil, Dr. Helen Arcuri,
PhD, Institute of Investigation in Immunology iii, School of Medi-
cine of the University of Sao Paulo, S~ao Paulo, Brazil, Prof. Mario
Palma, PhD, Biosciences Institute, State University of S~ao Paulo,
Rio Claro, Brazil and Dr. Luisa Karla P. Arruda, MD, PhD,
FAAAAI, School of Medicine of Ribeirao Preto, Ribeirao Preto,
Brazil
142 Ludwigs Angina Masquerading As Angioedema
Dr. Lynn A. Wiens, MD, FAAAAI, Warren Clinic, Tulsa, OK
143 A Simple, Sensitive and Selective Fluorogenic Assay To Monitor
Plasma Kallikrein Inhibitory Activity Of BCX4161 In Activated
Plasma
Dr. YS Babu1, Ms. Ramanda Wilson1, Dr. Jianwen Zhang1, Dr.
Melanie Cornpropst2, Dr. Phil Collis2 and Dr. William Sheridan2,
92
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
1
BioCryst Pharmaceuticals, Inc, Birmingham, AL, 2BioCryst Phar-
maceuticals, Durham, NC
144 Incidence and Treatment Of Angioedema In a Third Level
Spanish Hospital
Marta Seoane, MD, Maria Elisa Caralli, MD, Sarah Micozzi, MD,
Marta Elena Rodriguez-Mazariego, MD and Mara L. Baeza, MD,
PhD, Hospital General Universitario Gregorio Mara~non, Allergy
Department, Madrid, Spain
145 Seasonal Increase In Angioedema In An Inner City Hospital
Center
Helen Zhou, BS, Dr. Ashlei Mathew, MD and Dr. Rauno Joks, MD,
Center for Allergy and Asthma Research, State University of New
York Downstate Medical Center, Brooklyn, NY
146 Seeming Tongue Swelling Responding To Nebulized Ipratro-
pium In An Individual With A Diagnosis Of Type III HAE (He-
reditary Angioedema)
Ms. Jennifer Vegh1, Dr. Arthur B. Vegh, MD, FAAAAI2 and Ms.
Nicholette Butler1, 1none, Tacoma, WA, 2University of Washington,
Tacoma, WA
147 Cytokine Expression In a Case Of Cutaneous Mastocytosis
With An Unusual Presentation
Prof. Young Min Ahn, MD, Department of Pediatrics, South Ko-
rea, Prof. sang-Hoon Kim, Department of Internal Medicine, South
Korea, Prof. Ho-jung Lee, Department of Pathology,Eulji Univer-
sity School of Medicine, South Korea and Prof. Jai Youl Ro,
PhD, Sungkyunkwan University School of Medicine, South
Korea
Population, Health in Asthma
2208
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
148 Aerochambers and Asthmatics: Do No Harm?
Dr. Jack Leon-Max Mutnick, MD, Stevens Community Medical
Center, Morris, MN
149 Characterizing The Severe Asthma Population In The United
States: Claims-Based Analysis Of Three Treatment Cohorts
In The Year Prior To Treatment Escalation
Dr. Patrick W. Sullivan, PhD1, Dr. Jon Campbell, PhD2, Dr. Vah-
ram Ghushchyan, PhD2, Dr. Gary Globe, PhD3, Dr. Jeff Lange,
PhD3 and Dr. J Michael Woolley, PhD3, 1Regis University, 2Univer-
sity of Colorado Denver, 3Amgen, Inc., Thousand Oaks, CA
150 Impact Of Asthma On Child and Family Activities Among a
Rural Cohort
Dr. Allison J. Burbank1,2, Mallikarjuna Rettiganti, PhD1,2, Paige
Fisher, BA3 and Tamara T. Perry, MD1,2, 1University of Arkansas
for Medical Sciences, Little Rock, AR, 2Arkansas Childrens Hos-
pital, Little Rock, AR, 3Drexel University School of Public Health,
Philadelphia, PA
151 Inhaled Asthma Medications: Highlighting The Differences In
Formulations and Use
Dr. Lachara Lvingston Livingston, University of South Florida
Morsoni College of Medicine, Dr. Gregory Michael Cowan, MD,
University of South Florida Morsani College of Medicine and Dr.
Richard F. Lockey, MD, Division of Allergy and Immunology, De-
partment of Internal Medicine, University of South Florida Morsani
College of Medicine and James A. Haley Veterans Affairs Hospi-
tal, Tampa, FL
152 Rhinitis and Asthma Exacerbation Revealing Large Pulmonary
Effusion and Pelvic Mass
Dr. Jennifer Olivier, MD, Tulane University School of Medicine,
New Orleans, LA and Dr. Laurianne G. Wild, MD, FAAAAI, Tu-
lane University, New Orleans, LA
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
153 Deprivation Is Longitudinally Associated With Incident Child-
hood Asthma
Dr. Elinor Simons, MD, MS, FAAAAI1,2, Dr. Sharon Dell, MD2,3,
Dr. Rahim Moineddin, PhD4,5 and Dr. Teresa To, PhD1,5, 1Child
Health Evaluative Sciences, Hospital for Sick Children, Toronto,
ON, Canada, 2Clinical Epidemiology, Department of Health Policy,
Management and Evaluation, University of Toronto, Toronto, ON,
Canada, 3Respiratory Medicine and Child Health Evaluative Sci-
ences, Hospital for Sick Children, Toronto, ON, Canada, 4Depart-
ment of Family and Community Medicine, University of Toronto,
Toronto, ON, Canada, 5Institute for Clinical Evaluative Sciences,
Toronto, ON, Canada
154 Use Of Asthma Control Indicators In Measuring Efficacy Of In-
haled Corticosteroids In Asthmatic Smokers: A Systematic Re-
view
Ms. Claire E. Hayes, MPH, CHES, AE-C and Mr. Henry Nuss,
PhD, Louisiana State University Health Sciences Center School
of Public Health, New Orleans, LA
155 Evaluation Of a Medication Adherence Estimator Survey Com-
pared To Exhaled Nitric Oxide (FeNO) Levels and Asthma Con-
trol Test In Difficult-To-Treat/Severe Pediatric Asthma Patients
Jigar Patel1, Vanessa Y. Cavero, MD2, Amy Perkins, MS2,
Heather Minto, MD2 and Maripaz B. Morales, MD2,
1
Department of Pediatrics, Eastern Virginia Medical School,
Norfolk, VA, 2Childrens Hospital of The Kings Daughters,
Norfolk, VA
Healthcare Delivery in Primary
Immunodeficiency
2209
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
156 An Assessment Of Infection Rates and Health Resource Use
Among Primary Immunodeficiency Disorder (PIDD) Patients
Prior To Diagnosis
Dr. Chris Rabbat, PhD, Ms. Diane Ito, MA, Ms. Yan Xiong, MS
and Dr. Josephine Li-McLeod, PhD, Baxter Healthcare Corpora-
tion, Westlake Village, CA
157 A Comparison Of Costs Between Outpatient Hospital, Clinic and
Home Settings For Intravenous Immunoglobulin (IVIG) Infusions
Dr. Xiaolan Ye, PhD, Ms. Diane Ito, MA, Ms. Yan Xiong, MS and Dr.
Josephine Li-McLeod, PhD, Baxter Healthcare Corporation, Westlake
Village, CA
158 Differences In Infection Rates Between Outpatient Hospital,
Clinic and Home Infusion Settings For Patients With Primary
Immunodeficiency Disorder (PIDD)
Ms. Diane Ito, MA, Ms. Yan Xiong, MS, Dr. Xiaolan Ye, PhD and
Dr. Josephine Li-McLeod, PhD, Baxter Healthcare Corporation,
Westlake Village, CA
159 Assessment Of The Quality Of Life and Health Resource Utili-
zation Burden Among Patients With Primary Immunodefi-
ciency Disorder (PIDD) Prior To Treatment
Dr. John M. Routes, MD, FAAAAI1, Dr. Beatriz Tavares Costa-
Carvalho, MD2, Prof. Bodo Grimbacher, MD3, Dr. Kenneth Paris,
MD, MPH4, Dr. Hans D. Ochs, MD5, Ms. Diane Ito, MA6, Ms.
Yan Xiong, MS6, Dr. Josephine Li-McLeod, PhD6 and Dr. Ri-
chard I. Schiff, MD, PhD7, 1Medical College of Wisconsin, Mil-
waukee, WI, 2Federal University of Sao Paulo, Brazil, 3Royal
Free Hospital & University College, London, United Kingdom,
4 1
LSU Health Sciences Center, New Orleans, New Orleans, LA,
5
University of Washington, Seattle, WA, 6Baxter Healthcare Cor-
poration, Westlake Village, CA, 7Baxter BioScience, Westlake
Village, CA
Abstracts AB303
SATURDAY
Diagnostics
2210
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
160 Phadiatop - An Atopy Test With Optimal Allergen Composition
Relevant For Most Geographical Regions
Kerstin M. Wall1, Monica Noren1 and Dr. Cathy Van Rooyen2,
1
Thermo Fisher Scientific, ImmunoDiagnostics, Uppsala, Sweden,
2
Ampath National Reference Laboratory, Immunology, Pretoria,
South Africa
161 Histamine Skin Reactivity Increased With Body Mass Index In
Korean Children
Dr. Jeon Mi Lee, Dr. Ju Wan Kang and Dr. Hyung Ju Cho, Yonsei
University College of Medicine
162 The Impact Of Component Resolved Diagnosis On Allergen-
Specific Immunotherapy Prescription In Children With Pol-
len-Related Allergic Rhinitis
Dr. Paolo Matricardi, MD1, Dr. Giovanna Stringari2, Prof. Carlo
Caffarelli2, Dr. Riccardo Asero, MD3, Dr. Arianna Dondi4, Dr. Sal-
vatore Tripodi5 and The Italian Pediatric Allergy Network6,
1
Charite, Berlin, Germany, 2Pediatric Department, University of
Parma, Parma, Italy, 3Clinica San Carlo, Paderno Dugnano, Italy,
4
Department of Pediatrics, University of Bologna, Bologna, Italy,
5
Pediatric Department, Ospedale Sandro Pertini, Roma, Italy, 6.
163 Randomized Evaluation Of Ten Allergy Skin Prick Test Devices
Dr. Yohalakshmi Chelladurai, MD, MPH1, Prof. Robert G. Ham-
ilton, PhD D.ABMLI FAAAAI2 and Dr. Jody R. Tversky, MD2,
1
Johns Hopkins University Bloomberg School of Public Health,
2
Johns Hopkins University School of Medicine, Baltimore, MD
164 Phenotypic Classification Of Allergen Polysensitization In Ger-
iatric Adults
Dr. Rohit Divekar, MBBS, PhD1, Dr. John B. Hagan, MD,
FAAAAI2 and Hirohito Kita, MD2, 1Division of Allergic Diseases,
Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN
165 Analysis Of The Discordance Between Immunocap and Skin
Prick Test For Common Allergens In Patients With Allergic
Rhinitis Symptoms
Dr. Do Yang Park1, Prof. Hyun Jun Kim1, Dr. Ju Wan Kang2, Prof.
Yoo Suk Kim1 and Prof. Chang-Hoon Kim3, 1Ajou University
School of Medicine, 2Yonsei University College of Medicine, 3De-
partment of Otorhinolaryngology, Yonsei University College of
Medicine, Seoul, South Korea
166 Role Of House Dust Mites In Allergic and Non Allergic Nasal
Diseases
Prof. Maged Refaat, MD1, Prof. Tarek Mansour1, Prof. Talaat
Samny2, Prof. Ahmed Zaki3, Prof. Eman Osman1, Dr. Eman Ez-
zat1 and Dr. Eman Ahmed1, 1Department of Allergy and
Clinical immunology,Ain Shams university, Cairo, Egypt, 2De-
partment of ear,nose and throat diseases,Ain Shams university,
Cairo, Egypt, 3Department of pathology,Ain Shams university,
Cairo, Egypt
167 Immunogenicity and IgE Blocking Capacity Of a Mixture Of
Depigmented and Chemically Modified Allergens From Differ-
ent Homologous Groups
Dr. Victor Miguel Iraola, Mr. Jose Ramon Leonor, Dr. Mara Mo-
rales, Dr. Raquel Moya, Dr. M. Angeles Lopez Matas, Dr. Ma Ter-
esa Gallego and Dr. Jeronimo Carnes, Laboratorios LETI, Tres
Cantos, Spain
168 Modified Shuffled Blo t 5 Recombinant Allergen From Blomia
Tropicalis Produces a Shift Of Antigenicity For Binding To
IgG4 Isotype
Dr. Ernesto Taketomi, MD, PhD1, Mrs. Barbara Avila, MSc1,
1
Mrs. Karine Almeida, PhD , Mrs. Deise Silva, PhD , Prof. Odonrio
Abrah~ao Junior, PhD2 and Prof. Jair Cunha-Junior, PhD1, 1Federal
University of Uberl^andia, Uberlandia, Brazil, 2Federal University of
Triangulo Mineiro, Uberaba, Brazil
93
 AB304 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
SATURDAY

Oral Immunotherapy Fernandez-Rivas, MD, PhD5 and Javier Martnez-Botas, PhD1,6,

1
Hospital Universitario Ramon y Cajal. Instituto Ramon y Cajal
2211 para la Investigacion Sanitaria, Madrid, Spain, 2Hospital del Sure-
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM ste, Arganda del Rey, Spain, 3Hospital Clnico San Carlos, Spain,
4
Hospital Universitario 12 de Octubre, Spain, 5Hospital Clnico
169 Induction Of Arah2-Specific Memory B Cells Identified Using a San Carlos, Madrid, Spain, 6CIBER de Fisiopatologa de la Obesi-
Novel Tetramer-Based Approach Occurs Early and Transiently dad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Ma-
During Peanut Oral Immunotherapy drid, Spain
Dr. Sarita U. Patil, MD1,2, Dr. Adebola Ogunniyi, PhD3, Mr. Alex
Ma4, Ms. Alisa K. Brennan, B.S.5, Ms. Theadora Swenson, BA6,
Mr. Agustin Calatroni, MA MS7, Dr. James Moon, PhD8, Dr.
J.Christopher Love, PhD3 and Wayne G. Shreffler, MD, PhD, Mechanisms of Cytokines and Chemokines
FAAAAI1,6, 1Harvard Medical School, Boston, MA, 2Allergy and
Immunology, Massachusetts General Hospital, Boston, MA, 3Mas- 2212
sachusetts Institute of Technology, Cambridge, MA, 4Massachusetts Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
General Hospital, Charlestown, MA, 5Rush Medical College, Chi-
176 IL-33 and TSLP Mediate Chronic Eosinophilic Airway Inflam-
cago, IL, 6Massachusetts General Hospital, Boston, MA, 7Rho,
mation and IgE Antibody Production Induced by Multiple Air-
Inc., Chapel Hill, NC, 8Harvard Medical School, Charlestown, MA
borne Allergens
170 De Novo Generation Of Gastrointestinal Regulatory T Cells In
Koji Iijima, PhD1, Takao Kobayashi, PhD1, Kenichiro Hara,
Response To OIT and EPIT
MD1,2, Gail Kephart1 and Hirohito Kita, MD1, 1Mayo Clinic, Ro-
Leticia Tordesillas, PhD1, Lucie Mondoulet, PhD2, Pierre Henri
chester, MN, 2Gunma University Graduate School of Medicine,
Benhamou, MD2, Hugh A. Sampson, MD, FAAAAI3 and M. Ceci-
Maebashi, Gunma, Japan
lia Berin, PhD1, 1Icahn School of Medicine at Mount Sinai, New
177 IL-17 Enhances TNF-a-Induced, But Not IL-1b-Induced, Ex-
York, NY, 2DBV Technologies, Bagneux, France, 3Pediatrics, Icahn
pression Of Neutrophil-Associated Cytokines By Human Lung
School of Medicine at Mount Sinai, New York, NY
Tissue Cells
171 Long Term Protection Against New Sensitization After Milk-
Dr. Akio Matsuda, PhD, Dr. Kenichiro Motomura, MD, Dr. Tetsuo
Epit In Mice Sensitized To Milk Is Mediated By Tregs
Shoda, MD, Dr. Kyoko Futamura, MD, PhD, Dr. Hirohisa Saito,
Pierre Henri Benhamou, MD1, Dr. Vincent Dioszeghy, PhD1,
MD., PhD. and Dr. Kenji Matsumoto, MD, PhD, Department of Al-
Mrs. Emilie Puteaux1, Mrs. Melanie Ligouis1, Mrs. Veronique
lergy and Immunology, National Research Institute for Child
Dhelft1, Mrs. Camille Plaquet1, Prof. Christophe Dupont, MD,
Health and Development, Tokyo, Japan
PhD2 and Lucie Mondoulet, PhD1, 1DBV Technologies, Bagneux,
178 Prostaglandin I2Receptor (IP) Signaling Inhibits Alternaria-In-
France, 2Hopital Necker Enfants Malades, Paris, France
duced IL-5 and IL-13 Expression Through Group 2 Innate
172 Epicutaneous Immunotherapy-Induced Regulatory T Cells
Lymphoid Cells (ILC2)
Could Migrate To More Various Sites Of Allergen Exposure
Dr. Shinji Toki, PhD, Kasia Goleniewska, Sara Reiss, MS, Dr.
Compared To Sublingual Or Subcutaneous Immunotherapy
Weisong Zhou, PhD and Dr. R. Stokes Peebles Jr., MD, FAAAAI,
In Mice Sensitized To Peanut
Vanderbilt University School of Medicine, Nashville, TN
Dr. Vincent Dioszeghy, PhD1, Lucie Mondoulet, PhD1, Mrs.
179 Local Administration Of CCL28 Is Sufficient To Drive Airway
Veronique Dhelft1, Mrs. Melanie Ligouis1, Mrs. Emilie Puteaux1,
Hyper-Responsiveness and Mucous Cell Metaplasia
Mrs. Camille Plaquet1, Prof. Christophe Dupont, MD, PhD2 and
Dr. Becky Buelow, MD, Mrs. Desire Hunter and Dr. Mitchell H. Gray-
Pierre Henri Benhamou, MD1, 1DBV Technologies, Bagneux,
son, MD, FAAAAI, Medical College of Wisconsin, Milwaukee, WI
France, 2Hopital Necker Enfants Malades, Paris, France
180 Mucosal Uric Acid Induces Interleukin 33 and Initiates Type 2
173 Anaphylactic Reactions After Peanut Oral Immunotherapy
Immune Responses To Inhaled Protease Allergens
Noam Berlin1, Dr. Amanda Jagdis1, Carly Barron2, Sean Macla-
Kenichiro Hara, MD1, Koji Iijima, PhD2, Takao Kobayashi, PhD2,
chlan3, Mohana Giruparajah2, Nathan Leader4, Dennis Penn5 and
Dr. Satoshi Seno3, Dr. Ichiro Tojima3, Gail Kephart2, Dr. Manabu
Dr. Gordon L. Sussman, FAAAAI1, 1University of Toronto, Faculty
Ueno1, Dr. Toshitaka Maeno1, Dr. Masahiko Kurabayashi1 and Hir-
of Medicine, Toronto, ON, Canada, 2Gordon Sussman Clinical Re-
ohito Kita, MD2, 1Gunma University Graduate School of Medicine,
search Inc., Toronto, ON, Canada, 3University of Ottawa, Faculty of
Maebashi, Gunma, Japan, 2Mayo Clinic, Rochester, MN, 3Shiga
Medicine, Ottawa, ON, Canada, 4University of Melbourne, Faculty
University of Medical Science, Otsu, Shiga, Japan
of Medicine, Melbourne, Australia, 5MastCell Pharmaceuticals,
181 Surrogate Biomarkers Of Eosinophilic Airway Inflammation In
Inc., Raleigh, NC
Asthma: Quantitation Of Major Basic Protein-1 and Charcot-
174 Evaluation Of The Immunological Mechanisms Involved In The
Leyden Crystal Protein/Galectin-10 In Induced Sputum
Efficacy Of Sublingual Immunotherapy With Ltp (Pru p 3) In
Dr. Sharmilee M. Nyenhuis, MD, FAAAAI1,2, Mr. Preeth Alum-
Allergic Patients Sensitized To Food By Ltps
kal, BS3, Dr. Jian Du, MD3, Brian Maybruck, PhD3, Mr. Mark Vin-
Dr. Francisca Gomez, MD, PhD1, Dr. Enrique Gomez, MD, PhD2,
icky, BS3, Ms. Melissa Morales-Perez, BS3, Dr. Jerry A. Krishnan,
Dr. Maria J Torres, MD, PhD3, Mrs. Luisa Galindo, RN3, Ms. Maria
MD, PhD4 and Dr. Steven J. Ackerman, PhD3, 1Jesse Brown VA
Dolores Ruiz3, Dr. Inmaculada Do~na, MD, PhD3, Mrs. Gador Bo-
Medical Center, Chicago, IL, 2MC 719, University of Illinois at
gas1, Dr. Paloma Campo, MD, PhD3, Dr. Teresa Posadas3, Dr. Mi-
Chicago, Chicago, IL, 3University of Illinois at Chicago, Chicago,
guel Blanca, MD, PhD3 and Dr. Cristobalina Mayorga, PhD4,
1 IL, 4University of Illinois at Chicag, Chicago, IL
Allergy Service, Carlos Haya Hospital, Spain, 2Research Labora-
182 IL-35-Producing T Cells (iTR35) Inhibit Th2 Effector Function,
tory, Carlos Haya Hospital-FIMABIS, Spain, 3Allergy Service, Car-
Induce Infectious Tolerance and Are Elevated Following Grass
los Haya Hospital, Malaga, Spain, 4Research Laboratory, Carlos
Pollen Sublingual Immunotherapy
Haya Hospital-FIMABIS, Malaga, Spain
Dr. Mohamed H. Shamji, BSc MSc PhD1, Ms. Janice Layhadi,
175 Changes In IgE and IgG4 Epitopes After Milk Oral Immuno-
BSc( Hons)2, Mr. Alan Perera-web, BSc( Hons)2,3, Ms. Rachel
therapy (OIT)
Yan, RN4 and Prof. Stephen R. Durham, MA MD FRCP5, 1Imperial
Belen de la Hoz Caballer, MD, PhD1, Mrs. Cristina Vlaicu1, In-
College London, South Kensington, United Kingdom, 2Imperial
maculada Cerecedo Carballo, MD, PhD2, Monica Rodrguez-
College London, 3Medical Research Council and Asthma UK Cen-
Alvarez, MD3, Dr. Maria Carmen Dieguez Pastor, MD4, Montserrat

94
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
tre for Allergic Mechanisms of Asthma, UK, 4Imperial College
London, United Kingdom, 5Imperial College London, London,
United Kingdom
183 Th2 Cytokines Inhibit Toll-Like Receptor 2 Mediated Epider-
mal Barrier Repair
Takeshi Yoshida, PhD1, I-Hsin Kuo, PhD1, Anna De Benedetto,
MD, FAAAAI1, Donald Y.M. Leung, MD, PhD, FAAAAI2 and
Lisa A. Beck, MD, FAAAAI1, 1University of Rochester Medical
Center, Rochester, NY, 2National Jewish Health, Denver, CO
184 Epicutaneous Sensitization To Food Allergens Induce IL-4-Pro-
ducing Cells and T Follicular Helper (Tfh) Cells In An IL-6 and
IL-1-Dependent Manner
Ritobrata Goswami, PhD, Leticia Tordesillas, PhD and M. Cecilia
Berin, PhD, Icahn School of Medicine at Mount Sinai, New York, NY
185 Enhanced Thymic Stromal Lymphopoietin-Induced Eosinophil-
Basophil Lineage Commitment In Atopic Individuals
Claudia C.K. Hui, MSc1, Sina Rusta-Sallehy, BSc1, Dr. Ilan
Asher, MD1, Delia Heroux, BSC1 and Judah Aryeh Denburg,
MD, FRCPC, FAAAAI2, 1McMaster University, Hamilton, ON,
Canada, 2Division of Clinical Immunology and Allergy, Depart-
ment of Medicine, McMaster University, ON, Canada
186 CMRF35-Like Molecule 1 (CLM-1) Is Required For IL-33-In-
duced Eosinophil Activation
Dr. Ariel Munitz, PhD1, Mrs. Dana Shik1, Mr. Itay Moshkovits2
and Mrs. Danielle Karo-Atar1, 1Department of Clinical Microbiol-
ogy and Immunology, The Sackler School of Medicine, Tel-Aviv
University, Tel Aviv, Israel, 2Tel-Aviv University, Israel
187 Role Of Interleukine-33 In Rhinovirus-Induced Allergic
Asthma Exacerbation
Dr. Marie Toussaint, DMV, PhD, Dr. Aran Singanayagam, MD,
Prof. Sebastian L. Johnston, MD, PhD and Dr. Nathan Bartlett,
PhD, Imperial College London, London, United Kingdom
188 TGF-beta1 Mobilizes Mesenchymal Stem Cells In Allergic
Asthma
Ting Xu, MD1,2, Ling-Ling Xian, MD, PhD3, Yufeng Zhou, MD,
PhD1, Beverly Plunkett, MS1, Xu Cao, PhD3, Mei Wan, MD,
PhD3 and Peisong Gao, MD, PhD1, 1Division of Allergy & Clinical
Immunology, Johns Hopkins University School of Medicine, Balti-
more, MD, 2Department of Respiratory Medicine, Southern Medi-
cal University, Guangzhou, China, 3Department of Orthopedics
Surgery, Johns Hopkins University School of Medicine, Baltimore,
MD
189 IL-10-Producing B Cells Are Increased After Grass Pollen Im-
munotherapy Compared To Untreated Grass Pollen Allergic
Controls: A Blinded Cross-Sectional Study
Mr. James E G Charlesworth1,2, Dr. Guy W Scadding, MD1,2, Dr.
Aarif Eifan, MD2, Ms. Rachel Yan, RN2, Ms. Andrea Goldstone,
RN2, Dr. Moises A. Calderon, MD, PhD1,2, Prof. Stephen R. Durham,
MA MD FRCP3,4 and Dr. Mohamed H. Shamji, BSc MSc PhD5,
1
Medical Research Council and Asthma UK Centre for Allergic Mech-
anisms of Asthma, United Kingdom, 2Imperial College London,
United Kingdom, 3Imperial College London, London, United King-
dom, 4Medical Research Council and Asthma UK Centre for Allergic
Mechanisms of Asthma, London, United Kingdom, 5Imperial College
London, South Kensington, United Kingdom
190 Respiratory Syncytial Virus Induces IL-25 and IL-33 Produc-
tion In The Lungs
Matthew T. Stier1, Kasia Goleniewska2 and R. Stokes Peebles1,2,
1
Department of Pathology, Microbiology, and Immunology, Van-
derbilt University School of Medicine, Nashville, TN, 2Allergy,
Pulmonary, and Critical Care Medicine, Department of Medicine,
Vanderbilt University School of Medicine, Nashville, TN
191 Small-Molecule Inhibition Of Stat3 Prevents House-Dust-Mite
(HDM)-Induced Airway Inflammation By Blocking Lung Pro-
duction Of Th17 and Th2 Cytokines
Dr. Aries C. Gavino, MD and Dr. David J. Tweardy, MD, Baylor
College of Medicine, Houston, TX
Abstracts AB305
SATURDAY
192 Differential Promoter Usage and Regulation Of The Human In-
terleukin-5 Receptor a (IL-5Ra) Gene In Developing Eosino-
phil Progenitors
Kimberly G. Laffey, BSc, Dr. Jian Du, MD and Dr. Steven J. Ac-
kerman, PhD, University of Illinois at Chicago, Chicago, IL
193 Multiplex Cytokine Analysis Of Cord Blood Non-Adherent
Mononuclear Cells From Infants With Attributable Atopic
Risk Following Il-5 Stimulation
Mrs. Jenny Thiele, MSc, Queens University, Kingston, ON, Can-
ada, Ms. Vanessa N. Omana, MSc, Queens University, ON, Canada
and Dr. Anne K. Ellis, MD, MSc FAAAAI, Allergy Research Unit,
Kingston General Hospital, Kingston, ON, Canada; Departments of
Medicine and Biomedical & Molecular Science, Queens Univer-
sity, Kingston, ON, Canada
194 Association Of IL-33 With Atherogenic Cytokines: A Link Be-
tween Allergic Disease and Atherosclerosis
Dr. Misu Paul, MD1, Dr. Allison B. Reiss, MD2, Dr. Steven Carsons,
MD3, Dr. Luz S. Fonacier, MD, FAAAAI4 and Dr. Iryna Voloshyna,
PhD2, 1Section of Allergy and Clinical Immunology, Department of
Medicine, Winthrop University Hospital, mineola, NY, 2Winthrop Re-
search Institute, Department of Medicine, Winthrop University Hospi-
tal, Mineola, NY, 3Division of Rheumatology, Allergy and
Immunology, Department of Medicine, Winthrop University Hospital,
Mineola, NY, 4Section of Allergy and Clinical Immunology, Depart-
ment of Medicine, Winthrop University Hospital, Mineola, NY
195 Modulation Of Human Basophil Degranulation By Geranylger-
anyl Compounds
Dr. Yuko Nakase1, Dr. Masao Yamaguchi1, Dr. Naoya Sugimoto1,
Dr. Maho Suzukawa, MD2, Dr. Hiroyuki Tamiya1, Dr. Yasuhiro Ko-
jima1, Dr. Hisanao Yoshihara1, Dr. Michio Kuramochi1, Dr. Hide-
nori Arai1, Dr. Hiroyuki Nagase1 and Dr. Ken Ohta1,2, 1Teikyo
University School of Medicine, Tokyo, Japan, 2National Hospital
Organization Tokyo National Hospital, Tokyo, Japan
196 Variation In mRNA Expresion Of GATA1 and PRG2 In Umbil-
ical Cord Blood Following IL-5 Stimulation
Ms. Vanessa N. Omana, MSc, Queens University, ON, Canada,
Mrs. Jenny Thiele, MSc, Queens University, Kingston, ON, Canada
and Dr. Anne K. Ellis, MD, MSc FAAAAI, Departments of Medi-
cine and Biomedical & Molecular Science, Queens University,
Kingston, ON, Canada
197 Mast Cells Drive Tissue Inflammation By Producing IL-33 That
Orchestrates a Unique Basophil Phenotype
Dr. Chia-Lin Hsu, PhD and Dr. Paul Bryce, PhD, Division of Al-
lergy-Immunology, Department of Medicine, Feinberg School of
Medicine, Northwestern University, Chicago, IL
198 Differential Regulation Of Pro-Inflammatory Cytokine Expres-
sion Of Airway Smooth Muscle Cells (ASM) By Insulin, Glu-
cose, and Rosiglitazone
Dr. Qura-Tul-Ain Rashid, MD, Allergy and Immunology, Univer-
sity of Texas Medical Branch, Dr. Lata Kaphalia, PhD, University
of Texas Medical Branch, Galveston and Dr. William J. Calhoun,
MD, FAAAAI, Allergy And Immunology, University of Texas
Medical Branch, Galveston, TX
Role of Granulocytes and Mast Cells in
Mechanisms of Allergic Disease
2213
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
199 An Association Between Disease Severity and Levels Of Low-
Density Granulocytes In The Peripheral Blood Mononuclear
Cell Fraction Of Asthma Subjects
Dr. Mary C. Tobin, M.D.1,2, Dr. Jun Fu, PhD1, Ms. Paige Adeli,
RN1 and Dr. Larry L. Thomas, PhD1, 1Rush University Medical
95
 AB306 Abstracts
SATURDAY
Center, Chicago, IL, 2University Consultants in Asthma and Al-
lergy, Chicago, IL
200 Asthma Severity and Expression Of CLC3 On Human Periph-
eral Blood and Nasal Lavage Eosinophils
Devendra K. Agrawal, Rohit Gaurav and Againdra K. Bewtra, De-
partments of Biomedical Sciences and Internal Medicine, and Cen-
ter for Clinical and Translational Science, Creighton University
School of Medicine, Omaha, NE
201 The Interaction Of Bifidobacteria With Human Blood Leuko-
cytes
Dr. Leonid P. Titov, MD, PhD1, Dr. A.S. Murashko2, Dr. Andrei
Y. Hancharou3, Dr. N.A. Golovnyova3, Dr. E.I. Kolomiets3 and
Prof. Lawrence M. DuBuske, MD, FAAAAI4, 1Republican Scien-
tific and Practical Center for Epidemiology and Microbiology,
Minsk, Belarus, 2Republican Scientific And Practical Center for
Epidemiology and Microbiology, Minsk, Belarus, 3Republican Sci-
entific and Practical Center for Epidemiology and Microbiology,-
Minsk, Belarus, 4George Washington University School of
Medicine, DC
202 Worldwide Impact Of LAD2 Mast Cell Line On Mast Cell Bi-
ology Research
Arnold S. Kirshenbaum, MD, FAAAAI1, Amy Petrik, PhD2,
Rosemary Walsh, PhD2, Sury Vepa, PhD JD3 and Dean D. Met-
calfe, MD, FAAAAI1, 1Laboratory of Allergic Diseases, NIAID,
NIH, Bethesda, MD, 2Technology Transfer and Intellectual Prop-
erty Office, NIAID, NIH, Bethesda, MD, 3Office of Technology
Transfer, NIH, Rockville, MD
203 Non c-Kit Tyrosine Kinase Expression In Mast Cell Leukemia
Dr. Joseph H. Butterfield, MD, FAAAAI, Mayo Clinic, Roches-
ter, MN
204 Characterization Of Systemic Mastocytosis Patients Based
Solely On The Minor Criteria
Dr. Anupama Ravi, MD and Dr. Joseph H. Butterfield, MD,
FAAAAI, Mayo Clinic, Rochester, MN
205 Basophil Activation Is a Reliable Biomarker Of Allergic Bron-
chopulmonary Aspergillosis (ABPA) In CF: One Year Results
Of a Longitudinal Cohort Study
Dr. Yael Gernez, MD, PhD1,2, Mr. Jeffrey Waters2, Mrs. Colleen
Dunn2, Zoe Davies2, Dr. Rabindra Tirouvanziam3, Mrs. Cassie
Everson2, Dr. John Tamaresis2, Prof. Leonore Herzenberg4 and
Dr. Richard B. Moss, MD5, 1Highland Hospital, San Francisco,
2
Stanford University School of Medicine, Stanford, CA, 3Emory
University School of Medicine, Department of Pediatrics, Atlanta,
GA, 4stanford, School of Medicine, stanford, 5Stanford University
School of Medicine, Palo Alto, CA
206 Exosomes Secretion By Eosinophils: A Possible Role In Asthma
Pathogenesis
Victoria Del Pozo, PhD1, Carla Mazzeo1, Ainara Rodriguez
Marco2, Mar Del Mar fERNANDEZ-NIETO3, Maria Paz Zafra4,
Veronica Sanz1 and Prof. Joaquin Sastre, MD, PhD, FAAAAI3,
1
IIS-FJD and CIBERES, 2IIS-FJD, 3Fundacion Jimenez Diaz, Ma-
drid, Spain, 4IIS-Fundaci
on Jimenez Daz
207 CD49d-Expressing Neutrophils Are Found In The Nasal Lavage
During An Acute Upper Respiratory Illness
Dr. Jerome Sigua, MD, Dr. Mitchell H. Grayson, MD, FAAAAI,
Dr. Pippa Simpson, PhD, Ms. Erika Buell, Mrs. Desire Hunter
and Dr. Dorothy S. Cheung, MD, FAAAAI, Medical College of
Wisconsin, Milwaukee, WI
208 Estradiol Has a Negative Impact On The Anaphylactic Re-
sponse In Mice, Independent From Mast Cell Degranulation
Valerie Hox, MD, PhD1,2, Avanti Desai1, Geethani Bandara, PhD1,
Alasdair M. Gilfillan, PhD1, Dr. Michael Beaven, PhD3, Dr. Ana
Olivera, PhD1 and Dean D. Metcalfe, MD, FAAAAI1, 1Laboratory
of Allergic Diseases, NIAID, NIH, Bethesda, MD, 2Laboratory of
Clinical Immunology, Department of Microbiology and Immunol-
ogy, KULeuven, Leuven, Belgium, 3Laboratory of Molecular Im-
munology, NHLBI, NIH, Bethesda, MD
96
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
209 Regulation Of Reactive Oxygen Species Production Involving
Src Family Kinase In Siglec-8 Induced Eosinophil Cell Death
Dr. Gen Kano, MD, PhD, Kyoto Prefectural University of Medi-
cine, Kyoto, Japan, Bruce S. Bochner, MD, FAAAAI, Division of
Allergy and Clinical Immunology, Northwestern University School
of Medicine, Chicago, IL and Dr. Nives Zimmermann, MD,
FAAAAI, Childrens Hospital Medical Center, Cincinnati, OH
210 Ragweed Pollen Extract (RWPE)-Induces TLR4-Dependent
Neutrophil Recruitment That Augments Allergic Airway In-
flammation
Dr. Koa Hosoki, MD, PhD, Dr. Leopoldo Aguilera-Aguirre, PhD,
Prof. Istvan Boldogh, PhD, Dr. Qian Sun, PhD and Prof. Sanjiv Sur,
MD, University of Texas Medical Branch, Galveston, TX
211 LAMP1 and CD63 Expression In Mouse Mast Cells and Human
Basophils Rendered Hyporesponsive By Antigen/IgE-Mediated
Activation and Desensitization
Prof. Pedro Giavina-Bianchi, MD, PhD, FAAAAI1, Dr. Matthieu
Picard, MD2, Dr. Joana Caiado, MD2, Dr. Veronica Mezzano, MD2
and Dr. Mariana C. Castells, MD, PhD, FAAAAI2, 1Clinical Imun-
nology and Allergy Division, University of Sao Paulo, Boston, MA,
2
Division of Rheumatology, Allergy and Immunology, Department
of Medicine, Brigham and Womens Hospital, Harvard Medical
School, Boston, MA
212 Vectorial Exposure and Fusion Of Secretory Granule Content
At The Mast Cell Degranulatory Synapse
Dr. Nicolas Gaudenzio1, Mr. Regis Joulia2, Prof. Salvatore Vali-
tutti2 and Dr. Eric Espinosa2, 1Stanford University, Stanford, CA,
2
INSERM U1043, Toulouse, France
213 Airway Tissue, But Not Luminal, Eosinophilia Is Related To
The Magnitude Of Airway Hyperresponsiveness In a Trans-
genic Murine Model Of Cat Allergy
Mr. Daniel M. Moldaver1, Dr. Mantej S. Bharhani1, Ms. Jennifer
Wattie1, Ms. Tarandeep Singh1, Ms. Melissa Babra1, Dr. Marianne
van Hage, MD2, Dr. Mark D. Inman, MD, PhD1 and Dr. Mark
Larche, PhD1, 1McMaster University, Hamilton, ON, Canada, 2Kar-
olinska Institutet, Department of Medicina Solna, Clinical Immu-
nology and Allergy Unit, Stockholm, Sweden
214 IgEMediated Mast Cell Responses Are Inhibited By Thymol-
Mediated Activation-Induced Cell Death
Dr. Joshua B. Wechsler, MD1, Dr. Chia-Lin Hsu, PhD2 and Dr.
Paul Bryce, PhD2, 1Ann & Robert H. Lurie Childrens Hospital
of Chicago, Chicago, IL, 2Division of Allergy-Immunology, De-
partment of Medicine, Feinberg School of Medicine, Northwestern
University, Chicago, IL
215 Mechanisms Of Non-IgE-Mediated Uptake Of Antigen By Hu-
man Mast Cells
Dr. Brant Ward, MD, PhD, Ms. Sahar Lotfi-Emran and Dr. Law-
rence B. Schwartz, MD, PhD, FAAAAI, Virginia Commonwealth
University, Richmond, VA
216 Human EMR1, An Eosinophil-Specific Surface Receptor Of
Unknown Function, Is Modulated In Vivo and In Vitro
Dr. Fanny Legrand1, Dr. Nenad Tomasevic2, Mrs. Michelle Ma-
kiya1, Dr. Christopher Bebbington2 and Dr. Amy D. Klion, MD1,
1
National Institutes of Health, Bethesda, MD, 2Allakos
217 Cyclo-Oxygenase Inhibition Increases The Frequency Of
CD49d+ Neutrophils In The Bronchoalveolar Lavage (BAL)
During a Respiratory Viral Infection
Ms. Jennifer A. Hass, Ms. Erika Buell, Mrs. Desire Hunter, Dr.
Dorothy S. Cheung, MD, FAAAAI and Dr. Mitchell H. Grayson,
MD, FAAAAI, Medical College of Wisconsin, Milwaukee, WI
218 High Blood Eosinophils Predict Reductions In Sputum Mast
Cells and Lung Function In Response To Triamcinolone In
Asthma
Dr. Merritt L. Fajt, MD1, Ms. Crystal Uvalle, BS1, Mr. John Tru-
deau, BA1 and Sally E. Wenzel, MD, FAAAAI2, 1The University of
Pittsburgh Asthma Institute at UPMC and the University of Pitts-
burgh School of Medicine, Department of Pulmonary, Allergy
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
and Critical Care Medicine, 2The University of Pittsburgh Asthma
Institute at UPMC and the University of Pittsburgh School of Med-
icine, Department of Pulmonary, Allergy and Critical Care Medi-
cine, Pittsburgh, PA
219 Analyses Of IL-33-Producing Cells During Multiple Antigen
Challenges In Murine Asthma
Dr. Takeshi Nabe1, Mr. Hiroki Wakamori1, Ms. Anna Takiguchi1, Mrs.
Haruka Kida1, Prof. Susumu Ohya1, Dr. Nobuaki Mizutani2, Prof. Shin
Yoshino2 and Prof. David Chaplin3, 1Kyoto Pharmaceutical University,
Kyoto, Japan, 2Kobe Pharmaceutical University, Kobe, Japan, 3Univer-
sity of Alabama at Birmingham, Birmingham, AL
220 Repeat Lipopolysaccharide Exposure Is Sufficient To Impair
Viral Induced Pro-Atopic, CD49d Expressing Neutrophil Re-
cruitment To The Lung
Dr. Wei An, MD1,2, Ms. Jennifer A. Hass2, Ms. Erika Buell2, Mrs.
Desire Hunter2, Dr. Dorothy S. Cheung, MD, FAAAAI2 and Dr.
Mitchell H. Grayson, MD, FAAAAI2, 1Froedtert Hospital, Milwau-
kee, WI, 2Medical College of Wisconsin, Milwaukee, WI
221 Important Role For Mast Cells But Not Basophils In An Adju-
vant-Free Model Of Active Anaphylaxis In Mice
Dr. Laurent L. Reber, PhD1, Dr. Hajime Karasuyama, MD, PhD2,
Dr. Mindy Tsai, DMSc1 and Dr. Stephen J. Galli, MD1, 1Stanford
University School of Medicine, Stanford, CA, 2Tokyo Medical
and Dentistry Graduate School, Tokyo, Japan
222 Functional Phenotype Of CD49d-Expressing Neutrophils Dif-
fers Between Viral Infection and TLR Stimulation
Dr. Dorothy S. Cheung, MD, FAAAAI, Erika Buell, Mrs. Desire
Hunter and Dr. Mitchell H. Grayson, MD, FAAAAI, Medical Col-
lege of Wisconsin, Milwaukee, WI
223 Mast Cells Preferentially Migrate To Denatured Collagens
Compared To Native Collagens
Thomas Kaido1, Robert T. Reid1, Anthony Montgomery2 and Ri-
chard Reid1, 1The Banck Center, San Diego, CA, 2University of
California San Diego, San Diego, CA
224 Expression Of The Transcription Factor E4BP4 In Human Ba-
sophils
Dr. Bettina M. Jensen, Mrs. Maria Gohr and Prof. Lars K. Poulsen,
PhD FAAAAI, Allergy Clinic, Copenhagen University Hospital -
Gentofte, Hellerup, Denmark
225 Cross-Talk Between Human Mast Cells and Bronchial Epithe-
lial Cells In The Production Of Plasminogen Activator Inhibi-
tor-1 Via TGF-b1
Dr. Seong Ho Cho, MD1, Dr. Sun Hye Lee, PhD1, Dr. Atsushi
Kato, PhD2, Dr. Tetsuji Takabayashi, MD1, Dr. Soon Shin1 and
Dr. Robert P. Schleimer, PhD FAAAAI1, 1Division of Allergy-Im-
munology, Department of Medicine, Northwestern University Fein-
berg School of Medicine, Chicago, IL, 2Department of Medicine,
Division of Allergy-Immunology, Northwestern University Fein-
berg School of Medicine, Chicago, IL
Allied Health Saturday Poster Session
2214
Saturday, March 1st, 2014, 9:45 AM - 10:45 AM
226 Tolerability Of Two Different Immunoglobulin Intravenous
Product In Patients With Primary Immunodeficiency Disease
Amanda Skoskiewicz, MSN, CPNP, Ann & Robert H. Lurie Chil-
drens Hospital of Chicago, Chicago, IL, Melanie M. Makhija, MD,
Division of Allergy & Immunology, Department of Pediatrics,-
Northwestern University Feinberg School of Medicine, Chicago,
IL; Ann and Robert H. Lurie Childrens Hospital of Chicago, Chi-
cago, IL and Ramsay L. Fuleihan, MD, Division of Allergy & Im-
munology, Department of Pediatrics, Northwestern University
Feinberg School of Medicine, Ann & Robert H. Lurie Childrens
Abstracts AB307
SATURDAY
Hospital of Chicago, Chicago, IL; Division of Allergy & Immunol-
ogy, Department of Pediatrics, Northwestern University Feinberg
School of Medicine, Chicago, IL
227 Epinephrine Use In Positive Oral Food Challenges Performed
As Screening For Food Allergy Therapeutic Trials
Ms. Sally A. Noone, RN MSN CCRC1, Jaime Ross, RN2, Hugh A.
Sampson, MD, FAAAAI3 and Dr. Julie Wang, MD, FAAAAI2,
1
Icahn School of Medicine at Mount Sinai, New York, NY, 2The
Icahn School of Medicine at Mount Sinai, New York, NY, 3Pediat-
rics, Icahn School of Medicine at Mount Sinai, New York, NY
228 School Experience With Food Allergy Reactions Highlight The
Need For Training and Availability Of Epinephrine
Mrs. Katherine A. Schmeissing, MS, R.N.1, Christine Szychlin-
ski, APN, CPNP2, Dr. Jacqueline Pongracic, MD, FAAAAI1,3 and
Dr. Anne Marie Singh, MD4, 1Ann & Robert H. Lurie Childrens
Hospital of Chicago, Chicago, IL, 2Division of Allergy & Immunol-
ogy, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi-
cago, IL, 3Division of Allergy & Immunology, Department of
Pediatrics,Northwestern University Feinberg School of Medicine,
4
Division of Allergy & Immunology, Department of Pediatrics,
Northwestern University Feinberg School of Medicine, Ann & Rob-
ert H. Lurie Childrens Hospital of Chicago, Chicago, IL
229 Early and Significant Improvement In The Intensity Of Allergic
Rhinitis Symptoms After Treatment With Intranasal Cicleso-
nide 200 Mcg Qd: Open Trial In Mexican Population
Francisco Javier Saynes-Marin1, Araceli Arellano-Plancarte2,
Jazmin Chiu-Ugalde2, Estefania Torres-Medina2, Jose Antonio Var-
gas-Romero2 and Juan Carlos Lopez-Alvarenga2,3, 1Hospital An-
geles Metropolitano, Mexico City, Mexico, 2Medical Department,
Takeda Mexico S.A. de C.V., Edo. de Mex., Mexico, 3Direccion
de Investigacion, Hospital General de Mexico Eduardo Liceaga,
Mexico City, Mexico
230 Viral Induced Ibuprofen Sensitivity Leading To Anaphylaxis In
Preschool Aged Children
Mrs. Jodi A. Shroba, RN MSN CPNP and Ms. Kathryn Choj-
nacki, Childrens Mercy Hospital
231 Anthropomorphic Variations According To Clinical Pattern In
Cows Milk Allergic Children
Ms. Diana Colson1, Prof. Nicolas Kalach, MD, Ph D2, Ms. Pascale
Soulaines3 and Prof. Christophe Dupont, MD, PhD3,4, 1Nutricia
Nutrition Clinique, Saint Ouen, France, 2H^opital Saint Vincent de
Paul, Groupement des Hospitaux de lInstitut Catholique de Lille
(GH-ICL), Lille, France, 3Hopital Necker Enfants Malades, Paris,
France, 4DBV Technologies, Paris, France
232 Development and Piloting Of a Food Allergy Education Pro-
gram For Parents Of Young Children
Ms. Catherine Gillespie, RN MN CAE1, Ms. Nancy Ross, RN
CAE1, Dr. Nestor F. Cisneros, MD FRCPC2 and Dr. Allan Becker,
MD FRCPC3, 1Childrens Hospital, Winnipeg, MB, Canada, 2Uni-
versity of Manitoba, Winnipeg, MB, Canada, 3University Of Man-
itoba, Winnipeg, MB, Canada
233 The Proficiency Status In The Use Of Inhaler and The Effect Of
Education On Inhaler Technique
Eun-Jung Jo, MD1, Jung-Ha Mok, MD1, Seung-Eun Lee, MD2,
Mi-Hyun Kim, MD1, Kwangha Lee, MD, PhD1, Ki-Uk Kim,
MD, PhD1, Min-Ki Lee, MD, PhD1 and Hye-Kyung Park, MD,
PhD1, 1Department of Internal Medicine, Pusan National University
School of Medicine, Busan, South Korea, 2Department of Internal
Medicine, Pusan National University Yangsan Hospital, Yangsan,
South Korea
234 The Natural History Of Wheat Hypersensitivity In Thai Chil-
dren
Dr. Nunthana Siripipattanamongkol, MD, Mahidol university,
Bangkok, Thailand
235 Development Of a Multidisciplinary Clinic To Improve Care Of
Adolescent Asthmatic Patients Ms. Lila C. Kertz, MSN RN
CPNP AE-C, Washington University, St. Louis, MO
97
 AB308 Abstracts
SATURDAY
236 Food Allergy Herbal Formula-2 (FAHF-2) Adherence To
Treatment
Jaime Ross, RN1, Suzanne K. Carlisle, RN BSN CCRP2, Maripaz
Vazquez, RN, BSN, CDE3, Stacie M. Jones, MD4, Dr. Jacqueline Pon-
gracic, MD, FAAAAI5 and Dr. Julie Wang, MD, FAAAAI1, 1The
Icahn School of Medicine at Mount Sinai, New York, NY, 2University
of Arkansas for Medical Sciences, Little Rock, AR, 3Division of Al-
lergy and Immunology, Ann & Robert H. Lurie Childrens Hospital
of Chicago, Chicago, IL, Chicago, IL, 4Slot 512-13, University of Ar-
kansas for Medical Sciences, Little Rock, AR, 5Ann & Robert H. Lurie
Childrens Hospital of Chicago, Chicago, IL
237 Adapting Waiting-List For Allergy By Health Care On-Line: Co-
ordination Between Providers and Allergist In The Public System
Dr. Inmaculada S anchez-Machn, MD1, Dr. Paloma Poza Guedes2,
Dr. Ruperto gonzalez Perez1, Dr. Yvelise Barrios, MD, PhD3 and Dr.
Victor Matheu, MD1, 1Hospital del T orax-Ofra, Sta Cruz de Tenerife,
Spain, 2Hospital Ofra-Torax, santa cruz de tenerife, Spain, 3Hospital
Universitario de Canarias, Tenerife, Spain
238 Aerobiology Of Texas Panhandle and Efficiency Of AHPCO
Technology As Air Purifier, Surface Sterilizer In Food Processing
Dr. Nabarun K. Ghosh, PhD1, Dr. Constantine K. Saadeh, MD,
FAAAAI2, Dr. Jeff Bennert, PhD CTN3 and Ms. Griselda Estrada,
BS1, 1West Texas A&M University, Canyon, TX, 2Allergy ARTS
ACCR, Amarillo, TX, 3AIR OASIS, Amarillo, TX
Novel Genetic Factors in Asthma
2601
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
239 IL-33 and IL1RL1 Single Nucleotide Polymorphisms and Their
Association With Asthma Among Puerto Ricans
Dr. Javier A. Mendez, MD, Dr. Sylvette Nazario, MD, Dr. Angel
Laureano, MD, Dr. Adriana Baez, PhD and Ms. Bianca Rivera,
PhDc, University of Puerto Rico School of Medicine, San Juan, PR
240 Genetic Effect Of Single-Nucleotide Polymorphisms In The
PPARGC1B Gene On Airway Hyperreactivity In Asthmatic Pa-
tients
Dr. Jong-Sook Park, MD, Dr. Myung-Sin Kim, Dr. Sung-Woo
Park, Dr. An-Soo Jang and Dr. Choon-Sik Park, MD, Soonchun-
hyang University Bucheon Hospital, Bucheon, South Korea
241 Polymorphisms In IL10, TGFB, TLR4, TLR8 and ADBR2 Genes
Resulted Associated To Asthma In Brazilian Family Trio Study
Mrs. Isabel Rugu^e Genov, MD, Federal University of S~ao Paulo,
S~ao Paulo, Brazil, Mrs. Angela Falcai, PhD, ICB USP, S~ao Paulo,
Brazil, Dr. Lucila Camargo, MD, UNIFESP, S~ao Paulo, Brazil, Dr.
Marcia Mallozi, MD, Federal University of S~ao Paulo, Brazil, Dr.
Virginia Ferriani, MD, PhD, School of Medicine of Ribeirao Preto-
University of Sao Paulo, Brazil, Prof. Alessandra Pontillo, PhD, Uni-
versity of S~ao Paulo, Brazil, Prof. Antonio Condino-Neto, MD, PhD,
Institute of Biomedical Sciences, Department of Immunology, Uni-
versity of S~ao Paulo, Sao Paulo, Brazil and Prof. Dirceu Sole, MD,
PhD, Federal University of Sao Paulo, Sao Paulo, Brazil
242 Genetic Variation Along The Histamine Pathway In Children
With Allergic Vs. Non-Allergic Asthma
Dr. Sara Anvari, MD1, Dr. Carrie A. Vyhlidal, PhD2, Mo Rezaie-
khaligh, MS2, Dr. Hongying Dai, PhD2 and Dr. Bridgette L. Jones,
MD, FAAAAI1,2, 1Childrens Mercy Hospital & Clinics, Division
of Allergy, Asthma and Immunology, Kansas City, MO, 2Childrens
Mercy Hospital & Clinics, Division of Pediatric Clinical Pharma-
cology, Kansas City, MO
243 Association Of Polymorphism At The CD14 Promoter (CD14-
C159T) With Atopic and Non-Atopic Asthma In Adults From
Crimea, Ukraine
Dr. Yuri Bisyuk1, Prof. V.A. Beloglazov1, Dr. A.I. Dubovyi1, Dr.
98
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
L.K. Znamenska1 and Prof. Lawrence M. DuBuske, MD,
FAAAAI2, 1Crimean State Medical University, Ukraine, 2George
Washington University School of Medicine, DC
Mechanisms and Immunotherapy
2602
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
244 The Utility Of Anti-Pneumococcal Antibody Measurement In Pa-
tients With Primary Immunodeficiency Receiving Immunoglobulin
Dr. Stephen Jolles, Dr. Adrian Heaps, Dr. Mo Moody and Dr. Rachel
Jones, University Hospital of Wales, Cardiff, United Kingdom
245 Diagnostic Immunization With Bacteriophage FX 174 In Pa-
tients With Common Variable Immunodeficiency/Hypogamma-
globulinemia
Dr. Lauren Smith, MD1, Dr. Rebecca H. Buckley, MD, FAAAAI1
and Dr. Patricia L. Lugar, MD, MS2, 1Department of Pediatrics,
Duke University Medical Center, Durham, NC, 2Duke University
Medical Center, Durham, NC
246 Immunochip Study Reveals Regions On Chromosomes 2 and 6
May Contribute To The Spectrum Of CVID
Dr. Tracy Hwangpo, MD/PhD1, Ewa Szymanksa, PhD1, Mrs.
Marsha Brand1, Dr. Peter Gregerson, MD2, Dr. Peter Burrows, PhD3,
Dr. Elizabeth Brown, PhD4, Dr. Richard Reynolds, PhD5 and Dr. Harry
Schroeder, MD/PhD6, 1UAB, 2The Feinstein Institute for Medical Re-
search, 3UAB, Department of Microbiology, 4UAB,Department of Ep-
idemiology, 5UAB, Department of Medicine, 6UAB, Department of
Medicine and Department of Microbiology, AL
247 Rule Of Different Memory Cells In Common Variable Immuno-
deficiency and Specific Antibody Deficiency
Amer M. Khojah, MD, Umm Al Qura Univirsity, Makkah, Saudi
Arabia; Inova Fairfax Hospital for children, Fall Church, VA, Oral
Alpan, MD, Amerimmune, LLC, VA; O&O ALPAN, LLC and
Ameera Bukhari, MS, Taif University, Saudi Arabia
248 Evaluation of a Novel Missense Activation-Induced Deaminase
AID Mutation in a Child with Hyper IgM Syndrome: Is it a
Pathogenic Mutation?
Dr. Ottavia M. Delmonte, M.D., Pediatric Residency Program, Boston
Childrens Hospital, Harvard Medical School, Boston, MA, Dr. Feilong
Meng, PhD, Howard Hughes Medical Institute, Program in Cellular and
Molecular Medicine and Immune Disease Institute, Boston Childrens
Hospital, Department of Genetcis, Harvard Medical School, Boston,
MA, Dr. Frederick Alt, PhD, Howard Hughes Medical Institute, Pro-
gram in Cellular and Molecular Medicine and Immune Disease Insti-
tute, Boston Childrens Hospital, Department of Genetics, Harvard
Medical School, Boston, MA, Dr. Luigi D. Notarangelo, MD, Division
of Immunology, Boston Childrens Hospital, Harvard Medical School,
Boston, MA; The Manton Center for Orphan Disease Research, Boston
Childrens Hospital, Boston, MA and Dr. Jolan E. Walter, MD, PhD, Di-
vision of Allergy/Immunology, Massachusetts General Hospital for
Children, Harvard Medical School, Boston, MA
Asthma Environmental Risk Factors and
Infections
2603
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
249 Surfactant Protein A (SP-A) Reduces Human Rhinovirus 16
(RV16)-Induced Inflammatory Responses In Bronchial Epithe-
lial Cells and Inhibits Viral Replication In H1-HeLa Cells
Sasipa Tanyaratsrisakul, PhD1, Ying Wang, MD2, Monica Kraft,
MD2, Mari Nakamura, MD1 and Prof. Dennis R. Voelker, PhD1,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
1
Department of medicine, National Jewish Health, Denver, CO, 2De-
partment of Medicine, Duke University Medical Center, Durham, NC
250 The Home Microbiome and Childhood Asthma
Dr. Christina E. Ciaccio, MD, FAAAAI, Mr. Kevin Kennedy,
MPH CIEC, Prof. Charles S. Barnes, PhD, Dr. Jay M. Portnoy,
MD, FAAAAI and Dr. Lanny J. Rosenwasser, MD, FAAAAI, Chil-
drens Mercy Hospital, Kansas City, MO
251 Effect Of Prenatal Antioxidant Intake On Infants Respiratory
Infection
Dr. Eun Lee1, Seo Ah Hong2, Dr. Song I Yang, MD1, Prof. Kyung
Won Kim, MD, PhD3, Prof. Youn Ho Shin4, Kang Mo Ahn5, Dr.
Soo-Jong Hong, MD, PhD1 and And the COCOA study group, 1De-
partment of Pediatrics, Childhood Asthma Atopy Center, Research
Center for Standization of Allergic Diseases, Asan Medical Center,
University of Ulsan College of Medicine, Seoul, Korea, 2Asan Insti-
tute for Life Sciences, University of Ulsan College of Medicine,
Seoul, Korea, 3Department of Pediatrics, Severance Childrens Hos-
pital, College of Medicine, Yonsei University, Seoul, Korea, Seoul,
South Korea, 4Department of Pediatrics, CHA Medical Center,
CHA University School of Medicine, Seoul, Korea, South Korea,
5
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, Korea, South Korea
252 Epidermal Growth Factor Receptor (EGFR) Mediates Cell Fu-
sion and Infectivity Of Respiratory Syncytial Virus (RSV)
Sujin Lee1,2, Michael G. Currier1,2, Anne L. Hotard1,2, Jia Meng1,2,
Carla Pretto1,2, Ultan F. Power3, Remi Villenave3, Michael D.
Shields3,4, Michael H. Chi5, R. Stokes Peebles6 and Martin L.
Moore1,2, 1Department of Pediatrics, Emory University, GA, 2Chil-
drens Healthcare of Atlanta, GA, 3Centre for Infection and Immu-
nity, School of Medicine, Dentistry and Biomedical Science,
Queens University Belfast, Northern Ireland, 4The Royal Belfast
Hospital for Sick Children, Northern Ireland, 5Allergy, Pulmonary,
and Critical Care Medicine; Department of Medicine; Vanderbilt
University School of Medicine, TN, 6Allergy, Pulmonary, and Crit-
ical Care Medicine, Department of Medicine, Vanderbilt University
School of Medicine, Nashville, TN
253 Cluster Analysis Of An Inner-City Cohort Of Infant Wheezers
Dr. Monica B. Reddy, MD1, Andrew H. Liu, MD2, Allison
Schiltz1,2, Mrs. Anna Forssen, MS2 and Dr. Mary D. Klinnert,
PhD1,2, 1University of Colorado School of Medicine, 2National
Jewish Health, Denver, CO
Atopic Dermatitis
2604
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
254 A Randomized, Multi-Center, NIH/NIAID Funded Study To As-
sess The Immunogenicity Of Fluzone Intradermal and Intra-
muscular Vaccines In Atopic Dermatitis
Donald Y.M. Leung, MD, PhD, FAAAAI1, Lisa A. Beck, MD,
FAAAAI2, Dr. Jon M. Hanifin, MD, FAAAAI3, Dr. Lynda C.
Schneider, MD, FAAAAI4, Dr. Amy Paller, MD5, Dr. Gloria David,
PhD6, Ms. Katherine Monti6, Mr. Brett Jepson6 and Dr. Adriana
Weinberg, MD7, 1National Jewish Health, Denver, CO, 2University
of Rochester Medical Center, Rochester, NY, 3Oregon Health &
Science University, Portland, OR, 4Boston Childrens Hospital,
Boston, MA, 5Northwestern University Feinberg School of Medi-
cine, Chicago, IL, 6Rho, Inc., Chapel Hill, NC, 7University of Col-
orado Heath Sci Ctr., Denver, CO
255 Which Infants With Eczema Are At Risk Of Food Allergy? Re-
sults From A Population Based Study
Dr. Jana K. Eckert, PhD1, Dr. Pamela Martin, PhD1, Dr. Adrian
Lowe, PhD1,3, Dr. Jennifer Koplin, PhD1, Prof. Shyamali Dharmage,
MD, PhD1,3, Prof. Lyle Gurrin, PhD1,3, Prof. Mimi L. K. Tang, MD,
Abstracts AB309
SATURDAY
PhD, FAAAAI4, Prof. Anne-Louise Ponsonby, PhD1, Dr. Melanie
Matheson, PhD3, Dr. David Hill, MBBD, FRACP1 and Prof. Katrina
Jane Allen, MD, PhD, FAAAAI1,5, 1Murdoch Childrens Research
Institute, Victoria, Australia, 3University of Melbourne, Victoria, Aus-
tralia, 4The University of Melbourne, Melbourne, Australia, 5Royal
Childrens Hospital, Victoria, Australia
256 Exome Chip Genotyping Reveals Association With PDE4C and
Atopic Dermatitis In Populations Of European and African De-
scent
Nicholas M. Rafaels1, Lili Huang, MPH1, Donald Y.M. Leung, MD,
PhD, FAAAAI2, Lisa A. Beck, MD, FAAAAI3, Dr. Candelaria I. Ver-
gara, MD, PhD1, Dr. Mark Boguniewicz, MD, FAAAAI2, Dr. Tissa
Hata, MD4, Dr. Lynda C. Schneider, MD, FAAAAI5, Dr. Jon M. Ha-
nifin, MD, FAAAAI6, Dr. Richard Gallo, MD, PhD7, Dr. Li Gao, MD,
PhD1, Dr. Ingo Ruczinski, PhD8, Dr. Rasika A. Mathias, ScD1 and Dr.
Kathleen C. Barnes, PhD FAAAAI1, 1Division of Allergy and Clini-
cal Immunology, Department of Medicine, Johns Hopkins Univer-
sity, Baltimore, MD, 2National Jewish Health, Denver, CO,
3
University of Rochester Medical Center, Rochester, NY, 4University
of California, San Diego, San Diego, CA, 5Boston Childrens Hospi-
tal, Boston, MA, 6Oregon Health & Science University, Portland,
OR, 7Division of Dermatology, University of California, San Diego,
San Diego, CA, 8Johns Hopkins University School of Public Health,
Baltimore, MD
257 Exploring a Role for Laminin Proteins in the Pathogenesis of
Atopic Dermatitis
Erin J. Klaffky, MD, PhD, Rachana Agrawal, PhD and Judith A.
Woodfolk, MBChB, PhD, FAAAAI, University of Virginia, Char-
lottesville, VA
258 Thymic Stromal Lymphopoietin and Interleukin-33 Promote
Skin Inflammation and Containment Of Vaccinia Virus In A
Mouse Model Of Atopic Dermatitis
Dr. Michiko K. Oyoshi, PhD, MSc, Ms. Jacqueline Beaupre, Mr. Nich-
olas Venturelli and Raif S. Geha, MD, Division of Immunology, Boston
Childrens Hospital, Harvard Medical School, Boston, MA
Health Disparities
2605
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
259 What Really Happens In The Home: The Medication Environ-
ment Of Urban, Minority Youth
Dr. Molly Martin, MD, MAPP and Andrea A Pappalardo, MD,
Rush University Medical Center, Chicago, IL
260 Young, African American Adults With Asthma: What Matters
To Them?
Dr. Aimee L. Speck, M.D.1, Dr. Belinda Nelson, PhD2, Mrs. S. Olivia
Jefferson, MSW3 and Dr. Alan P. Baptist, MD, MPH FAAAAI1, 1Uni-
versity of Michigan, Division of Allergy and Clinical Immunology,
Ann Arbor, MI, 2University of Michigan, Health Behavior and Health
Education, School of Public Health, Ann Arbor, MI, 3University of
Michigan, Department of Health Behavior and Health Education,
School of Public Health, Ann Arbor, MI
261 Language Disparities Among Minority Patients with Poor
Asthma Control
Dr. Jose R. Zaragoza-Buxo, MD, Penn State University College of
Medicine, Hershey, PA and Dr. Efren L. Rael, MD, FAAAAI, Al-
lergy/Immunology, Penn State University College of Medicine,
Hershey, PA
262 Race/Ethnicity and SES Are Predictors Of Allergic Sensitiza-
tion To Environmental and Food Allergens
Dr. Amina Abdeldaim, MD1, Dr. Supinda Bunyavanich, MD,
MPH2, Ms. Sheryl Rifas-Shiman, MPH3, Thomas A.E. Platts-Mills,
MD, PhD, FAAAAI4, Dr. Diane R. Gold, MD, MPH5, Dr. Carlos
99
 AB310 Abstracts
SATURDAY
Camargo Jr., MD, DrPH6, Dr. Emily Oken, MD7, Dr. Matthew Gill-
man, MD, SM3 and Dr. Augusto A. Litonjua, MD, MPH8, 1Channing
Division of Network Medicine, Brigham and Womens Hospital,
MA, 2Division of Pediatric Allergy & Immunology, Department of
Pediatrics, Icahn School of Medicine at Mount Sinai, New York,
NY, 3Harvard Medical School, Boston, MA, 4Division of Asthma, Al-
lergy & Immunology, University of Virginia Health System, Charlot-
tesville, VA, 5Channing Laboratory, Brigham and Womens Hospital,
Boston, MA, 6Department of Emergency Medicine, Massachusetts
General Hospital, Harvard Medical School, Boston, MA, 7Harvard
Medical School, 8Channing Division of Network Medicine, Brigham
and Womens Hospital, Boston, MA
263 Unrecognized Allergic Rhinoconjunctivitis and Allergic Sensiti-
zation Among Latino Youth (GALA II Study)
Ulysses Burley, MPH1, Dr. Joy Hsu, MD, MSCI2, Duanny Alva,
MD-IMG, MPH1, Ms. Elizabeth Nguyen, BS3, Ms. Lindsey Roth,
MA4, Dr. Joshua Galanter, MD4, Dr. Sam Oh, PhD, MPH4, Ms. Ce-
leste Eng, BS4, Mr. Fred Lurmann, MS5, Dr. Rajesh Kumar, MD,
MS, FAAAAI6, Dr. Harold J. Farber, MD, MSPH7, Dr. Denise Ser-
ebrisky, MD8, Dr. Luisa Borrell, DDS, PhD9, Dr. Saunak Sen,
PhD10, Dr. William Rodriguez-Cintron, MD11, Dr. Jose Rodriguez-
Santana, MD12, Dr. Esteban Gonza Burchard, MD, MPH4 and Prof.
Pedro C. Avila, MD, FAAAAI1, 1Feinberg School of Medicine,
Northwestern University, Chicago, IL, 2Department of Medicine, Di-
vision of Allergy-Immunology, Northwestern University Feinberg
School of Medicine, Chicago, IL, 3Department of Medicine, Univer-
sity of California, San Francisco, California, San Francisco, CA, 4De-
partment of Medicine, University of California, San Francisco, San
Francisco, CA, 5Sonoma Technology, Inc., Petaluma, CA, 6Pediatric
allergy, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi-
cago, IL, 7Baylor College of Medicine and Texas Childrens Hospital,
Houston, TX, 8Pediatric Pulmonary Division, Jacobi Medical Center,
Bronx, NY, 9Department of Health Sciences, Graduate Program in
Public Health, Lehman College, City University of New York, Bronx,
NY, 10Department of Epidemiology and Biostatistics, University of
California, San Francisco, San Francisco, CA, 11Veterans Caribbean
Health Care System, San Juan, PR, 12Centro de Neumologia Pedia-
trica, San Juan, PR
Local Allergic Rhinitis and Non-Allergic Rhinitis
2606
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
264 The Nasal NO Response To External Acoustic Energy: A Pilot
Study
Dennis Shusterman, MD, MPH, University of California, San
Francisco, Richmond, CA
265 Flagellin/Toll-Like Receptor 5 Induces Interleukin-17C In Hu-
man Nasal Epithelia
Dr. Hyun Jin Min1, Dr. Tae-Hoon Kim2, Su-Yeon Choi2, Prof. Joo-
Heon Yoon1,2 and Prof. Chang-Hoon Kim1,3, 1Department of Oto-
rhinolaryngology, Yonsei University College of Medicine, Seoul,
South Korea, 2Research Center for Human Natural Defense System,
Yonsei University College of Medicine, Seoul, South Korea, 3The
Airway Mucus Institute, Yonsei University College of Medicine,
Seoul, South Korea
266 Phenotyping Non-Allergic and Local Allergic Rhinitis
Dr. Carmen Rondon, MD, PhD1, Dr. Paloma Campo, MD, PhD1,
Dr. Esther Barrionuevo Sanchez, MD1, Ms. Cristina De Leiva Mo-
lina1, Dr. Leticia Herrero Lifona, MD, PhD1, Ms. Maria Auxiliadora
Guerrero1, Dr. Francisca Gomez, MD, PhD1, Dr. Natalia Blanca-
Lopez, MD, PhD2, Dr. Gabriela Canto, MD, PhD2 and Dr. Miguel
Blanca, MD, PhD1, 1Allergy Service, Carlos Haya Hospital, Malaga,
Spain, 2Allergy Service, Infanta Leonor Hospital, Madrid, Spain
100
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
267 Role Of Basophil Activation Test For Identifying Subjects With
Local Allergic Rhinitis
Dr. Paloma Campo, MD, PhD1, Dr. Carmen Rondon, MD, PhD1,
Dr. Enrique Gomez, PhD2, Dr. Esther Barrionuevo Sanchez1, Mrs.
Luisa Galindo, RN1, Mr. JA Huertas1, Dr. Cristobalina Mayorga,
PhD2 and Dr. Miguel Blanca, MD, PhD1, 1Allergy Service, Carlos
Haya Hospital, Malaga, Spain, 2Research Laboratory for Allergic
Diseases, Hospital Regional Universitario de Malaga - IBIMA,
Malaga, Spain
268 Does Serum Leptin Differ Between Patients With Rhinitis Of
Allergic Vs Nonallergic Aetiology?
Prof. Ayse Fusun Kalpaklioglu, MD and Dr. Ayse Baccioglu, MD,
Kirikkale University Faculty of Medicine Department of Allergic
Diseases
Mechanisms of Steroid and Arachidonic Acid
Pathways in Allergic Disease
2607
Saturday, March 1st, 2014, 2:00 PM - 3:15 PM
269 LTC4, But Not LTD4 Or LTE4, Activates Platelets Through a
CysLT2R and P2Y12 Receptor-Dependent Pathway
Dr. Joshua A. Boyce, MD, FAAAAI1,2, Dr. Tao Liu, PhD1,2 and
Dr. Hannah Cummings, PhD1,2, 1Harvard Medical School, Boston,
MA, 2Brigham and Womens Hospital, Division of Rheumatology,
Immunology and Allergy, Boston, MA
270 Predictors Of Response To Glucocorticoids In Hypereosino-
philic Syndromes
Paneez Khoury, MD1, Annalise Abiodun, RN1, Kelli Williams,
MD, M.P.H.1, JeanAnne Ware, CRNP1, Nicole Holland-Thomas,
MSN, RN2 and Dr. Amy D. Klion, MD1, 1National Institutes of
Health, Bethesda, MD, 2SAIC-Frederick Inc., Bethesda, MD
271 Differential Proteomic Analysis Of Eosinophils From Patients
With Glucocorticoid Responsive Or Resistant Hypereosino-
philic Syndrome
Konrad Pazdrak, MD, PhD1, Paneez Khoury, MD2, Kizhake V.
Soman, PhD1, Nicole Holland-Thomas, MSN, RN3, Mrs. Michelle
Makiya2, Christof Straub, PhD1, Zheng Wu, PhD1, Dr. Amy D.
Klion, MD2 and Alexander Kurosky, PhD1, 1University of Texas
Medical Branch, Galveston, TX, 2National Institutes of Health, Be-
thesda, MD, 3SAIC-Frederick Inc., Bethesda, MD
272 Glucocorticoid Receptor-^a Up-Regulation In C57BL/6 Diet-In-
duced Obese Mice With House Dust Mite-Mediated Asthma
Dr. Jennifer Diaz, MD1,2, Dr. Malvika Solanki, MBBS, MPH3, Dr.
Xiangying Xue, MD3, Prodyot Chatterjee, PhD3, Dr. Madhu Gupta,
MBBS3, Dr. Vincent R. Bonagura, MD, FAAAAI4 and Christine
Metz, PhD3, 1Feinstein Institute for Medical Research, Manhasset,
NY, 2Allergy and Immunology, North Shore-LIJ Health System,
Great Neck, NY, 3Feinstein Institute for Medical Research, NY,
4
Division of Allergy/Immunology, Departments of Medicine and
Pediatrics, Hofstra North Shore-LIJ School of Medicine, Great
Neck, NY
273 Reduced EP2 Receptor Expression Accounts For Prostaglandin
E2 Resistance In Nasal Polyp Fibroblasts From Patients With
Aspirin Exacerbated Respiratory Disease; Possible Role For
Histone Acetylation In Control Of EP2 Receptor Expression
Dr. Katherine N. Cahill, MD1,2, Mr. Derek Thibault3, Dr. Benja-
min A. Raby, MD, MPH3, Dr. Andrea Baccarelli, MD, MPH
PhD4, Dr. Neil Bhattacharyya, MD2,3, Dr. Joshua A. Boyce, MD,
FAAAAI1,2 and Dr. Tanya M. Laidlaw, MD, FAAAAI1,2, 1Brigham
and Womens Hospital, Division of Rheumatology, Immunology
and Allergy, Boston, MA, 2Harvard Medical School, Boston, MA,
3
Brigham and Womens Hospital, Boston, MA, 4Harvard School
of Public Health, Boston, MA
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Bronchoprovocation and Asthma Comorbidities
3201
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
274 Association Between Body Mass Index (BMI) and Fraction Of
Exhaled Nitric Oxide (FeNO) Levels In The National Health
and Nutrition Examination Survey (NHANES) 2007-2010
Dr. Sindhura Gogineni, MD, Dr. Joseph Espiritu and Dr. Aditya
Uppalapati, MD, St. Louis University, St. Louis, MO 275 Daily
Global Stress Is Associated With Nocturnal Awakenings Due
To Asthma In School-Age Children
Dr. Caroline C. Horner, MD, FAAAAI1, Courtney Dula, MS1, Dr.
Leonard B. Bacharier, MD, FAAAAI2, Dr. Jane Garbutt, MBChB1,
Dr. Robert C. Strunk IV, MD, FAAAAI1, Mr. Carlos Gonzalez,
MS1, Ms. Elena Deych, MS1 and Dr. William Shannon, PhD1,
1
Washington University School of Medicine, Saint Louis, MO, 2De-
partment of Pediatrics, Washington University School of Medicine
and St. Louis Childrens Hospital, Saint Louis, MO
276 A Seven Minute High Intensity Workout Is Well Tolerated In
Adults With Asthma and Results In Decreased Salivary Leuko-
trienes
Dr. Katherine G. Conner, MD1, Dr. Meaghan Misiasz, M.D.1, Dr.
Maria Talamo2, Ms. Caitlin Campion1, Julie McDaniel1, Dr. Jun Fu,
PhD1 and James N Moy, MD1,2, 1Rush University Medical Center, Chi-
cago, IL, 2John H. Stroger Hospital of Cook County, Chicago, IL
277 Obesity and Depression Affecting Asthma Morbidity: An Anal-
ysis Of Montefiore Asthma Centers Poorly Controlled Asth-
matics
Dr. Sunit Jariwala, MD1, Dr. Jennifer Toh, MD1 and Dr. Sumita Si-
nha, MD2, 1Albert Einstein/Montefiore Medical Center, New York,
NY, 2Albert Einstein/Montefiore Medical Center, Bronx, NY
278 Psycho Social Stresses and Asthma Morbidity In Children
Dr. Ejaz Yousef, MD FAAAI, Marshfield Clinic, Marshfield, WI;
Marshfield Clinic, Marshfield, WI
279 Does The Sinusitis Affect Bronchial Hyperresponsiveness In
Asthmatic Children ?
Chikako Motomura, Dr. Hiroshi Odajima, Yuko Amimoto, Rin-
taro Ono, Keisuke Watanuki, Yoko Murakami, Naohiko Taba, Sa-
toshi Honjho and Sankei Nishima, Fukuoka National Hospital,
Fukuoka, Japan
280 Allergic Bronchopulmonary Mycosis. Are We Overdiagnosing
In Cape Town, South Africa?
Dr. Tamara Kerbelker, MBChB, Red Cross War Memorial Chil-
drens Hospital, Cape Town, South Africa
281 Risk Factors For Postoperative Pulmonary Complications After
Noncardiothoracic Surgery In Adult Asthma Patients
Seung-Eun Lee, MD1,2, Eun-Jung Jo, MD2, Hye-Kyung Park, MD2,
Woo-Hyeon Cho, MD1,2, Doo-Soo Jeon, MD1,2 and Prof. Yun-Seong
Kim, MD1,2, 1Respiratory and allergy clinic, Pusan National University
Yangsan Hospital, South Korea, 2Department of Internal Medicine, Pu-
san National University School of Medicine, South Korea
282 Rates Of Comorbidities Are Related To Level Of Asthma Con-
trol
Dr. Mark Stevens, MD1, Dr. Jeffrey R. Stokes, MD, FAAAAI1,
Ryan Walters, M.S.2, Dr. Michael Schatz, MD, MS, FAAAAI3
and Dr. Thomas B. Casale, MD, FAAAAI4, 1Creighton University
Medical Center, Omaha, NE, 2Creighton University, 3Kaiser Perma-
nente Southern California, San Diego, CA, 4Univeristy Of South
Florida Morsani College Of Medicine, Tampa, FL
283 Rates Of Co-Morbidities Are Related To Asthma Severity
Dr. Jeffrey R. Stokes, MD, FAAAAI1, Dr. Mark Stevens, MD1,
Ryan Walters, M.S.2, Dr. Michael Schatz, MD, MS, FAAAAI3
and Dr. Thomas B. Casale, MD, FAAAAI4, 1Creighton University
Medical Center, Omaha, NE, 2Creighton University, 3Kaiser Perma-
nente Southern California, San Diego, CA, 4Univeristy Of South
Florida Morsani College Of Medicine, Tampa, FL
Abstracts AB311
284 Exercise-Induced Bronchospasm In Adolescents: Characteris-
tics Of Lung Function and Accuracy Of Symptoms
Mr. Daniel Andrade Hygidio1, Ms. Beatriz Schwinden1, Dr. Paulo
Freitas1 and Dr. Jane Da Silva1,2, 1University of Southern Santa
Catarina - UNISUL, Tubar~ao - SC, Brazil, 2Hospital Universitario
Polydoro Ernani de S~ao Thiago - HU/UFSC, Florianopolis - SC,
Brazil
285 Variation Of Bronchial Hyperresponsiveness According To Age
and Gender In Pediatric Population
Dr. Young Ho Kim, MD1, Dr. Eun Lee, MD2, Dr. Song I Yang,
MD2, Dr. Young Ho Jung, MD2, Dr. Hyung Young Kim, MD3,
Dr. Ju-Hee Seo, MD4, Dr. Byoung-Ju Kim, MD, PhD5, Dr. Hyo-
Bin Kim, MD, PhD6, Prof. So Yeon Lee, MD, PhD7, Prof. Dae
Jin Song, MD, PhD8, Prof. Woo Kyung Kim, MD, PhD9, Dr.
Gwang Cheon Jang, MD, PhD10, Prof. Jung Yeon Shim, MD,
PhD11, Prof. Jinho Yu, MD, PhD2, Prof. Soo-Jong Hong, MD.
PhD12 and Dr. Ji-Won Kwon, MD13, 1Department of Pediatrics,
Seoul National University Bundang Hospital, Seongnam, South Ko-
SUNDAY
rea, South Korea, 2Childhood Asthma Atopy Center, Department of
Pediatrics, Asan Medical Center, University of Ulsan College of
Medicine, Seoul, South Korea, 3Department of Pediatrics, Kosin
University Gospel Hospital, Kosin University College of Medicine,
Seoul, South Korea, 4Department of Pediatrics, Korea Cancer Cen-
ter Hospital, Seoul, South Korea, 5Department of Pediatrics, Hae-
undae Paik Hospital, Inje University College of Medicine, Busan,
South Korea, 6Department of Pediatrics,Inje University Sanggye
Paik Hospital, Seoul, South Korea, 7Department of Pediatrics, Hal-
lym University College of Medicine, Seoul, South Korea, 8Depart-
ment of Pediatrics, Korea University Guro Hospital, Seoul, South
Korea, 9Department of Pediatrics, Seoul Paik Hospital, Inje Univer-
sity College of Medicine, Seoul, South Korea, 10Department of Pe-
diatrics, National Health Insurance Corporation Ilsan Hospital,
Seoul, South Korea, 11Department of Pediatrics, Kangbuk Samsung
Hospital, Sungkyunkwan University College of Medicine, Seoul,
South Korea, 12Research Center for Standardization of Allergic
Disease, University of Ulsan College of Medicine, Seoul, Korea,
13
Department of Pediatrics, Seoul National University Bundang
Hospital, Seoul National University College of Medicine, Seong-
nam, South Korea
286 Nasal Provocation Test In The Diagnosis Of Mite Allergic Rhi-
nitis : Standard Or Rapid ?
Prof. Frederic de BLAY, Dr. Celine Lutz, Dr. Mael Bellier, Prof.
Jean Jacques Braun and Mrs. Brigitte Sbinne, CHRU Strasbourg,
France
287 Nocturnal Asthma In Latino Children Is Associated With Se-
vere Disease and Allergenic Triggers (GALA II Study)
Dr. Geeta Bhargave, MD1, Dr. Joy Hsu, MD, MSCI1, Ms. Eliza-
beth Nguyen, BS2, Ms. Lindsey Roth, MA3, Dr. Joshua Galanter,
MD3, Dr. Sam Oh, PhD, MPH3, Ms. Celeste Eng, BS3, Mr. Fred
Lurmann, MS4, Dr. Harold J. Farber, MD, MSPH5, Dr. Denise Ser-
ebrisky, MD6, Dr. Luisa Borrell, DDS, PhD7, Dr. Saunak Sen,
PhD8, Dr. William Rodriguez-Cintron, MD9, Dr. Jose Rodriguez-
Santana, MD10, Dr. Esteban Gonza Burchard, MD, MPH3 and
Prof. Pedro C. Avila, MD, FAAAAI1, 1Feinberg School of Medi-
cine, Northwestern University, Chicago, IL, 2Department of Medi-
cine, University of California, San Francisco, California, San
Francisco, CA, 3Department of Medicine, University of California,
San Francisco, San Francisco, CA, 4Sonoma Technology, Inc., Pet-
aluma, CA, 5Baylor College of Medicine and Texas Childrens Hos-
pital, Houston, TX, 6Pediatric Pulmonary Division, Jacobi Medical
Center, Bronx, NY, 7Department of Health Sciences, Graduate Pro-
gram in Public Health, Lehman College, City University of New
York, Bronx, NY, 8Department of Epidemiology and Biostatistics,
University of California, San Francisco, San Francisco, CA, 9Vet-
erans Caribbean Health Care System, San Juan, PR, 10Centro de
Neumologia Pediatrica, San Juan, PR
101
 AB312 Abstracts
Biomarkers and Asthma Control I
3202
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
288 Nasal Challenge With 50mgs Of L-Aspirin For Diagnosis Of
ASA Exacerbated Respiratory Disease
Dr. Jose Manuel Reyna Guerra, MD, National Institute Of Respi-
ratory Diseases, Distrito Federal, Mexico
289 Clinical Usefulness Of Bronchial Mannitol Provocation Test In
Children With Asthma Symptoms
Dr. Young A. Park, MD1, Hyun Bin Park, MD1, Dr. Yoon Hee Kim,
MD1, Dr. Hee Seon Lee, MD1, Dr. Yoon Ki Han, MD1, Dr. Min Jung
Kim, MD1, Hye Mi Jee, MD2, Prof. Kyung Won Kim, MD, PhD1,
Prof. Myung Hyun Sohn, MD, PhD1 and Prof. Kyu-Earn Kim, MD,
PhD1, 1Department of Pediatrics, Severance Children s Hospital,
College of Medicine, Yonsei University, Seoul, Korea, Seoul, South
Korea, 2Department of Pediatrics, CHA University School of Medi-
SUNDAY
cine, Seongnam, Korea, South Korea
290 Salivary Alpha Amylase Activity Is a Potential Surrogate Bio-
marker For Inhaled Beta-2 Agonist Responsiveness
Andrea A Pappalardo, MD1,2, Jamie H Kiehm, MD1, Caitlin M
Campion1, Dr. Larry L. Thomas, PhD1 and James N Moy, MD1,2,
1
Rush University Medical Center, Chicago, IL, 2John H. Stroger
Hospital of Cook County, Chicago, IL
291 Feno Decreases Significantly During Improved Symptom Con-
trol In Pediatric Patients After Acute Asthma Exacerbations
Necessitating Emergency Department Care
Dr. Eric M. Karlin, MD, Division of Allergy, Pulmonary, and Crit-
ical Care Medicine, Department of Medicine, Vanderbilt University
School of Medicine, Nashville, TN, Tebeb Gebretsadik, MPH, De-
partment of Biostatistics, Vanderbilt University School of Medi-
cine, Nashville, TN; Division of Allergy, Pulmonary, and Critical
Care Medicine, Department of Medicine, and Center for Asthma
and Environmental Sciences Research, Vanderbilt University
School of Medicine, Nashville, TN, Dr. Emily W. Langley, MD, Di-
vision of Allergy, Pulmonary, and Critical Care Medicine, Depart-
ment of Medicine, Vanderbilt University School of Medicine,
Nashville, Tennessee, Dr. Tina V. Hartert, MD, MPH, Vanderbilt
University School of Medicine, Nashville, TN, Dr. R. Stokes Pee-
bles Jr., MD, FAAAAI, Division of Allergy, Pulmonary and Critical
Care Medicine, Vanderbilt University School of Medicine, Nash-
ville, TN and Dr. Donald H. Arnold, MD, MPH, Center for Asthma
and Environmental Health Sciences Research, Vanderbilt Univer-
sity School of Medicine, Nashville, TN; Departments of Pediatrics
and Emergency Medicine, Vanderbilt University School of Medi-
cine, Nashville, Tennessee
292 Risk Factors Of High Feno Levels & Cut-Off Value Of Feno In
Elementary School Children With Asthma
Dr. Hyun Ju Cho, MD1, Dr. Young-Ho Ho Jung, MD1,2, Dr. Eun
Lee, MD1,3, Dr. Song I Yang, MD1,4, Dr. Hyung Young Kim,
MD4,5, Dr. Ju-Hee Seo, MD6,7, Dr. Ji-Won Kwon, MD4,8, Dr. By-
oung-Ju Kim, MD, PhD9,10, Dr. Hyo-Bin Kim, MD, PhD11,12,
Prof. So Yeon Lee, MD, PhD12,13, Prof. Dae Jin Song, MD,
PhD4,14, Prof. Woo-Kyung Kim, MD, PhD2,15, Dr. Gwang Cheon
Jang, MD, PhD4,16, Prof. Jung Yeon Shim, MD, PhD4,17 and Dr.
Soo-Jong Hong, MD, PhD1,2, 1Childhood Asthma Atopy Center,
Department of Pediatrics, Asan Medical Center, University of Ul-
san College of Medicine, Seoul, South Korea, 2Research Center
for Standardization of Allergic Disease, Seoul, South Korea, 3child-
hood Asthma atopy center , asan medical center, University of Ul-
san College of Medicine, South Korea, 4Research Center for
Standardization of Allergic Diseases, Seoul, South Korea, 5Depart-
ment of Pediatrics, Kosin University Gospel Hospital, Kosin Uni-
versity College of Medicine, Seoul, South Korea, 6Department of
Pediatrics, Korea Cancer Center Hospital, Seoul, South Korea, 7De-
partment of pediatrics, Korea Cancer Center Hospital, South Korea,
102
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
8
Department of Pediatrics, Seoul National University Bundang
Hospital, Seoul National University College of Medicine, Seong-
nam, South Korea, 9Department of Pediatrics, Hae-undae Paik Hos-
pital, Inje University College of Medicine, Busan, South Korea,
10
Department of Pediatrics, Hae-undae Paik Hospital, Inje Univer-
sity College of Medicine, 11Department of Pediatrics,Inje Univer-
sity Sanggye Paik Hospital, Seoul, South Korea, 12Research
Center for Standardization of Allergic Diseases, Seoul, South Ko-
rea, South Korea, 13Department of Pediatrics, Hallym University
College of Medicine, Seoul, South Korea, 14Department of Pediat-
rics, Korea University Guro Hospital, Seoul, South Korea, 15Depart-
ment of Pediatrics, Seoul Paik Hospital, Inje University College of
Medicine, Seoul, South Korea, 16Department of Pediatrics, National
Health Insurance Corporation Ilsan Hospital, Seoul, South Korea,
17
Department of Pediatrics, Kangbuk Samsung Hospital, Sung-
kyunkwan University College of Medicine, Seoul, South Korea
293 Metabolomic Profiles Of Exhaled Breath Condensate In Asth-
matics
Dr. Sandra Ho, MD1, Dr. Bruce Luxon, PhD1, Dr. Wendy Baker,
PhD1, Dr. Heidi Spratt, PhD1, Dr. Rohit Divekar, MBBS, PhD2,
Emily Aaron1 and Dr. William J. Calhoun, MD, FAAAAI1, 1Insti-
tute of Translational Sciences, University of Texas Medical Branch,
Galveston, TX, 2Division of Allergic Diseases, Mayo Clinic, Ro-
chester, MN
294 Extended Nitric Oxide Analysis and Bronchial Hyperrespon-
siveness In Children With Asthma According To Atopy
Dr. Yoon Hee Kim, MD, Dr. Min Jung Kim, MD, Dr. Hee Seon
Lee, MD, Dr. Yoon Ki Han, MD, Dr. Young A. Park, MD, Prof.
Kyu-Earn Kim, MD, PhD, Prof. Kyung Won Kim, MD, PhD and
Prof. Myung Hyun Sohn, MD, PhD, Department of Pediatrics, Sev-
erance Childrens Hospital, College of Medicine, Yonsei University,
Seoul, Korea, Seoul, South Korea
295 Reference Values and Determinants Of Fractional Concentra-
tion Of Exhaled Nitric Oxide (FeNO) In Healthy Children
Dr. Young Ho Jung, MD1,2, Dr. Hyun Ju Cho, MD1, Dr. Ji-Won
Kwon, MD2,3, Dr. Song I Yang, MD1,2, Dr. Eun Lee, MD1,4, Dr.
Hyung Young Kim, MD2,5, Dr. Ju-Hee Seo, MD6,7, Dr. Byoung-
Ju Kim, MD, PhD8,9, Dr. Hyo-Bin Kim, MD, PhD9,10, Prof. So
Yeon Lee, MD, PhD9,11, Prof. Dae Jin Song, MD, PhD2,12, Prof.
Woo Kyung Kim, MD, PhD2,13, Dr. Gwang Cheon Jang, MD,
PhD2,14, Prof. Jung Yeon Shim, MD, PhD2,15 and Prof. Soo-Jong
Hong, MD. PhD2,16, 1Childhood Asthma Atopy Center, Department
of Pediatrics, Asan Medical Center, University of Ulsan College of
Medicine, Seoul, South Korea, 2Research Center for Standardiza-
tion of Allergic Diseases, Seoul, South Korea, 3Seoul National Uni-
versity Bundang Hospital, Seoul National University College of
Medicine, 4childhood Asthma atopy center , asan medical center,
University of Ulsan College of Medicine, South Korea, 5Depart-
ment of Pediatrics, Kosin University Gospel Hospital, Kosin Uni-
versity College of Medicine, Seoul, South Korea, 6Department of
Pediatrics, Korea Cancer Center Hospital, Seoul, South Korea, 7De-
partment of pediatrics, Korea Cancer Center Hospital, South Korea,
8
Department of Pediatrics, Hae-undae Paik Hospital, Inje Univer-
sity College of Medicine, Busan, South Korea, 9Research Center
for Standardization of Allergic Diseases, Seoul, South Korea, South
Korea, 10Department of Pediatrics,Inje University Sanggye Paik
Hospital, Seoul, South Korea, 11Department of Pediatrics, Hallym
University College of Medicine, Seoul, South Korea, 12Department
of Pediatrics, Korea University Guro Hospital, Seoul, South Korea,
13
Department of Pediatrics, Seoul Paik Hospital, Inje University
College of Medicine, Seoul, South Korea, 14Department of Pediat-
rics, National Health Insurance Corporation Ilsan Hospital, Seoul,
South Korea, 15Department of Pediatrics, Kangbuk Samsung Hospi-
tal, Sungkyunkwan University College of Medicine, Seoul, South
Korea, 16Childhood Asthma Atopy Center, Department of Pediat-
rics, Asan Medical Center, University of Ulsan College of Medi-
cine, South Korea
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
296 Improvement Of FENO In Youth With Asthma After Attending
An Asthma Summer Camp
Dr. Jonathan A. Olsen, DO1, Dr. Mark Stevens, MD1, Mr. Patrick
Foster, B.S.2 and Dr. Russell Hopp, DO, FAAAAI3, 1Creighton
University Medical Center, Omaha, NE, 2American Lung Associa-
tion, Omaha, NE, 3Creighton University School Medicine, Omaha,
NE
297 Exhaled Nitric Oxide (FeNO) and T-Helper 2 Cell Biomarkers:
Can They Predict Treatment Response To Dupilumab, An IL-
4Ra Antibody, In An Eosinophilic Asthma Population?
Brian N. Swanson, PhD1, Lin Wang, PhD1, Jeffrey Ming, MD1,
Jennifer D. Hamilton, PhD2, Ariel Teper, MD1, Thomas Dicioccio,
PhD2, Yongtao Li, PhD1, Dr. Neil Graham, MD2, Dr. Gianluca Pir-
ozzi, MD, PhD1 and Sally E. Wenzel, MD, FAAAAI3, 1Sanofi,
Bridgewater, NJ, 2Regeneron Pharmaceuticals, Inc., Tarrytown,
NY, 3University of Pittsburgh Medical Center NW, Pittsburgh, PA
298 Asthma Management Costs With Feno In Addition To Standard
Guidelines
Dr. Glenn Crater, MD1, Dr. Craig F. LaForce, MD, FAAAAI2, Ms.
Nancy Herje, BSN, RN, MBA1, Dr. Elizabeth Brooks, PhD3 and Dr.
Kathy Rickard, M.D.1, 1Aerocrine, Inc., Morrisville, NC, 2North
Carolina Clinical Research, Raleigh, NC, 3Reimbursement Princi-
ples, Highlands Ranch, CO
299 Developmental Assessment Of Serum Periostin As An Asthma
Biomarker In Children
Dr. Halie M. Anderson1, Dr. Robert F. Lemanske Jr., MD,
FAAAAI2, Joseph R. Arron3, Cecile Holweg4, Ms. Victoria Raja-
manickam5, Dr. James E. Gern, MD, FAAAAI2 and Dr. Daniel J.
Jackson, MD6, 1University of Wisconsin, Madison, WI, 2University
of Wisconsin School of Medicine and Public Health, Madison, WI,
3
Genentech, Inc., South San Francisco, CA, 4Genentech, Inc, South
San Francisco, CA, 5University of Wisconsin Hospitals and Clinics,
6
Pediatrics, University of Wisconsin School of Medicine and Public
Health, Madison, WI
Atopic Disease Basic Science
3203
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
300 T-Cell Profiles In Bronchoalveolar Lavage (BAL) Of Wheezing
Children With and Without A History Of Respiratory Syncytial
Virus (RSV) Lower Respiratory Tract Infection
Dr. Chang-Kuen Kim, MD, FAAAAI, Asthma & Allergy Center,
Inje University Sanggye Paik Hospital, Seoul, South Korea, Dr. Jin-
Tack Kim, MD, PhD, Department of Pediatrics, Uijeongbu St.
Marys Hospital, The Catholic University of Korea, College of
Medicine, Uijeongbu, Gyeonggi-Do, South Korea, Sally E. Wenzel,
MD, FAAAAI, University of Pittsburgh Medical Center NW, Pitts-
burgh, PA and Dr. Marzena E. Krawiec, MD, National Jewish Med-
ical and Research Center, Denver, CO
301 Increased Blood Th2-Like Invariant Natural Killer T Cells In
Patients With Asthma
Prof. Young-Il Koh, MD and Jae-Uoong Shim, Chonnam National
University Medical School
302 Establishment and Treatment Of a Steroid Resistant Asthma
Model By Adoptive Transfer Of Helper T Cell Clones
Dr. Akio Mori, MD, PhD1, Mr. Satoshi Kouyama, MSc1, Ms.
Miyako Yamaguchi1, Ms. Yo Iijima1, Dr. Jun Itoh, MD1, Dr. Hir-
oaki Hayashi, MD1, Dr. Takafumi Minami, MD1, Dr. Kentaro Wa-
tarai, MD1, Dr. Chihiro Mitsui, MD1, Dr. Chiyako Oshikata, MD1,
Dr. Hidenori Tanimoto, MD1, Dr. Yuma Fukutomi, MD1, Dr.
Kiyoshi Sekiya, MD1, Dr. Takahiro Tsuburai, MD, PhD1, Dr. Ma-
sami Taniguchi, MD, PhD1, Dr. Yuji Maeda, MD1, Dr. Mamoru Oh-
tomo, MD1, Dr. Maki Hasegawa, MD, PhD1, Dr. Kazuo Akiyama,
Abstracts AB313
MD1 and Dr. Osamu Kaminuma, PhD2, 1National Hospital Organi-
zation, Sagamihara National Hospital, Sagamihara, Japan, 2Tokyo
Metropolitan Institute of Medical Science, Tokyo, Japan
303 CD4+ T Cells From Nasal Polyp Explants Contain Abundant
Th2 Cells Expressing Functional Interleukin-25 Receptors To-
gether With Th17 Cells
Mrs. Emily Lam, MSc1, Dr. Harsha H. Kariyawasam, MD, PhD2,
Prof. Stephen R. Durham, MA MD FRCP3, Ms. Joanne Rimmer,
FRCS(ORL-HNS)2, Dr. Valerie J. Lund, MD2, Dr. David Cousins,
PhD1 and Dr. Stephen Till, MD, PhD1, 1Kings College London,
London, United Kingdom, 2Royal National Throat, Nose & Ear
Hospital London, University College London, London, United
Kingdom, 3Imperial College London, London, United Kingdom
304 Successful Desensitization To Paclitaxel For Stage 4 Ovarian
Cancer
Dr. Erica T. Gastelum, MD, UCSF Fresno, Madera, CA, Kush
Das, Baz Allergy, Asthma & Sinus Center, Fresno, CA, Dr. Praveen
Buddiga, MD, FAAAAI, University of California San Francisco-
SUNDAY
Fresno, Fresno, CA; Baz Allergy Asthma & Sinus Center, Fresno,
CA and Dr. Malik N. Baz, MD, UCSF-Fresno, Fresno, CA; Baz Al-
lergy Asthma and Sinus Center, Fresno, CA
305 IL-17 Plays a Major Role In Driving The Recruitment Of B
Cells Into Bronchial Tissue Of Asthmatic Patients
Dr. S Al-Muhsen, MD, King Saud University, College of Medi-
cine, Riyadh, Saudi Arabia, Mrs. Mary -Angeline Pureza, King
Saud University, Riyadh, Saudi Arabia, Dr. Qutayba Hamid, MD,
PhD, FAAAAI, McGill University Health Centre, Montreal, QC,
Canada and Dr. Rabih Halwani, PhD, King Saud University, college
of Medicine, Riyadh, Saudi Arabia
306 A Comparison Of Asthma Prevalence and Severity Among Ur-
ban and Rural African American Teenage Youth
Dr. Dennis Ownby, M.D. FAAAAI1, Dr. Martha Tingen, PhD2,
Ms. Suzanne Havstad, M.A.3, Dr. Jennifer Waller, PhD2, Dr. Chris-
tine Cole Johnson, PhD MPH FAAAAI3 and Dr. Christine L.M. Jo-
seph, PhD3, 1Division of Allergy-Immunology and Rheumatology,
Georgia Health Sciences University, Augusta, GA, 2Georgia Re-
gents University, Augusta, GA, 3Department of Public Health Sci-
ences, Henry Ford Hospital, Detroit, MI
307 Interleukin-4 and Transforming Growth Factor-Beta Single Nu-
cleotide Genes Polymorphisms Confer Susceptibility To Atopic
Dermatitis
Dr. Nima Rezaei, MD, PhD1,2, Ms. Zahra Aryan2,3, Dr. Nasrin
Behniafard, MD4, Ms. Elham Farhadi, MSc5, Dr. Soheila Sotoudeh,
MD4, Dr. Mojdeh Khaledi, MD6, Dr. Maryam Mahmoudi, MD7,
Prof. Asghar Aghamohammadi8, Prof. Ali Akbar Amirzargar,
PhD2 and Dr. Mohammad Gharagozlou, MD4, 1Research Center
for Immunodeficiencies, Childrens Medical Center, Tehran Univer-
sity of Medical Sciences, Tehran, Tehran, Iran, 2Molecular Immu-
nology Research Center; and Department of Immunology, School
of Medicine, Tehran University of Medical Sciences, Tehran,
Iran, 3Student Scientific Research Center (SSRC), School of Med-
icine, Tehran University of Medical Sciences, Tehran, Iran, 4Chil-
drens Medical Center, Tehran University of Medical Sciences,
Tehran, Tehran, Iran, 5Hematology Department, School of Allied
Medical Science, Tehran University of Medical Sciences, Tehran,
Tehran, Iran, 6Growth and Development Research Center, Tehran
University of Medical Sciences, Tehran, Tehran, Iran, 7School of
Nutrition and Dietetics, Tehran University of Medical Sciences,
Tehran, Tehran, Iran, 8Research Center for Immunodeficiencies,
Childrens Medical Center, Tehran University of Medical Sciences,
Tehran, Iran
308 A Comparison Of Regulatory T-Cell Receptor Vb (3,5) Expres-
sion In Patients With Food Allergy and Atopic Dermatitis
Benjamin Prince, MD1,2, Kristin A. Erickson1, Christine Szychlin-
ski, APN, CPNP2, Miao Cai, MS2 and Dr. Anne Marie Singh,
MD1,3, 1Northwestern University Feinberg School of Medicine,
Chicago, IL, 2Division of Allergy & Immunology, Ann & Robert
103
 AB314 Abstracts
H. Lurie Childrens Hospital of Chicago, Chicago, IL, 3Division of
Allergy & Immunology, Department of Pediatrics, Northwestern
University Feinberg School of Medicine, Ann & Robert H. Lurie
Childrens Hospital of Chicago, Chicago, IL
309 Correlation Between Fractional Exhaled Nitric Oxide and
Asthma Exacerbation
Dr. Nawinda Mahawichit, MD, Mahidol University, Bangkok,
Thailand
310 IL17RB+ Granulocytes In Asthma Patients
Dr. Lin Li, MD1, Dr. Matthew A. Schaller, PhD2, Dr. Alan P. Bap-
tist, MD, MPH FAAAAI1 and Dr. Nicholas W. Lukacs, PhD3, 1Uni-
versity of Michigan, Division of Allergy and Clinical Immunology,
Ann Arbor, MI, 2University of Michigan, Department of Pathology,
Ann Arbor, MI, 3University of Michigan, Ann Arbor, MI
311 Pollen From Genetically Modified Bt Maize Does Not Promote
Allergic Responses In Mice
Mrs. Monica Andreassen1,2, Dr. Elena Rocca3, Dr. Thomas
Bhn3,4, Dr. Odd-Gunnar Wikmark3, Prof. Johnnie Van den
SUNDAY
Berg5, Prof. Martinus Lovik2, Prof. Terje Traavik3,4 and Dr. Unni
C. Nygaard2, 1Genk - Centre for Biosafety, Tromso, Norway,
2
Norwegian Institute of Public Health, Oslo, Norway, 3Genk -
Centre for Biosafety, Norway, 4University of Troms, Norway,
5
North-West University, Potchefstroom, South Africa
312 Effects Of rs3744262 On DNA Methylation and Symptoms In
Participants With Allergic Rhinitis During Grass Pollen Expo-
sure In The Environmental Exposure Unit (EEU)
Dr. Michelle North, PhD1, Ms. Sarah Mah, BSc.2, Mr. Andrew G.
Day, MSc3, Dr. Michael Kobor, PhD2,4 and Dr. Anne K. Ellis, MD,
MSc FAAAAI1,5, 1Departments of Medicine and Biomedical &
Molecular Science, Queens University, Kingston, ON, Canada,
2
Centre for Molecular Medicine & Therapeutics, Child & Family
Research Institute, Vancouver, BC, Canada, 3Clinical Research
Centre, Kingston General Hospital, Kingston, ON, Canada, 4Uni-
versity of British Columbia, Vancouver, BC, Canada, 5Allergy Re-
search Unit, Kingston General Hospital, Kingston, ON, Canada
313 Chronic Spontaneous Urticaria An Evaluation Of An Indirect
Immunofluorescence Method For Detecting Anti-Mast Cell IgG
Antibodies
Bahar Bahrani, Natasha Gattey and Peter Hull, University of Sas-
katchewan, Canada
314 Protease Activity Of Per a 10 Causes CD 40 Cleavage On Den-
dritic Cells and Th2 Polarization
Ms. Komal Agrawal, MSc, CSIR-IGIB, DELHI, India and Dr.
Naveen Arora, Ph.D, CSIR Institute of Genomics and Integrative
Biology, New Delhi, India
315 Type 2 Immunity Can Have a Protective Role In Host Defense
Against Venoms In Mice
Dr. Thomas Marichal, DVM PhD1, Dr. Philipp Starkl, PhD1, Dr.
Laurent Reber, PhD1, Dr. Janet Kalesnikoff, PhD1, Dr. Hans C.
Oettgen, MD, PhD, FAAAAI2, Dr. Mindy Tsai, DMSc1, Dr. Martin
Metz, MD, PhD3 and Dr. Stephen J. Galli, MD1, 1Stanford Univer-
sity School of Medicine, Stanford, CA, 2Boston Childrens Hospi-
tal, Boston, MA, 3Charite Campus Mitte, Berlin, Germany
316 CD4+ and CD8+ T Cells Bearing Nave and Memory Markers
In Blood Of Immigrants To Brooklyn Who Develop Asthma and
Allergic Disease
Dr. Ashlei Mathew, MD1,2, Dr. Irina Katayeva, MD1,3, Seto Chice,
MS1,4, Dr. Stephan Kohlhoff, MD1,5, Dr. Rauno O. Joks, MD,
FAAAAI1,2, Dr. Helen G. Durkin, PhD1,4 and Dr. Maria-Anna Vast-
ardi, MD1,3, 1Center for Allergy and Asthma Research, State Uni-
versity of New York Downstate Medical Center, Brooklyn, NY,
2
Department of Medicine, State University of New York Downstate
Medical Center, Brooklyn, NY, 3Lutheran Medical Center, Brook-
lyn, NY, 4Department of Pathology, State University of New York
Downstate Medical Center, Brooklyn, NY, 5Department of Pediat-
rics, State University of New York Downstate Medical Center,
Brooklyn, NY
104
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
317 17b-Estradiol Increases IL-17A Protein Expression From
Mouse CD4+ Th17 Differentiated Cells
Jacqueline-Yvonne Cephus, BS1, Dr. Dawn C. Newcomb Baker,
PhD2, Madison Boswell1, Kasia Goleniewska3 and Dr. Ray Peebles,
MD1, 1Allergy, Pulmonary, and Critical Care Medicine; Depart-
ment of Medicine; Vanderbilt University School of Medicine, Nash-
ville, TN, 2Division of Allergy, Pulmonary and Critical Care
Medicine, Vanderbilt University School of Medicine, Nashville,
TN, Nashville, TN, 3Allergy, Pulmonary, and Critical Care Medi-
cine, Department of Medicine, Vanderbilt University School of
Medicine, Nashville, TN
318 17-b Estradiol Positively Correlates With IL-17A+ CCR6+
Memory CD4+ T Cells In Patients With Severe Asthma
Dr. Dawn C. Newcomb Baker, PhD1,2, Jacqueline-Yvonne Ce-
phus, BS3, Dr. Emily W. Langley, MD4, Amy S. Feldman, MD5,
Mrs. Nanalene Frey6, Ms. Kristen Cooper6, Dr. John M. Fahren-
holz, MD, FAAAAI7 and R. Stokes Peebles8, 1Vanderbilt Univer-
sity School of Medicine, Nashville, TN, 2Medicine, Vanderbilt
University Medical Center, Nashville, TN, 3Allergy, Pulmonary,
and Critical Care Medicine; Department of Medicine; Vanderbilt
University School of Medicine, Nashville, TN, 4Division of Al-
lergy, Pulmonary, and Critical Care Medicine, Department of Med-
icine, Vanderbilt University School of Medicine, Nashville,
Tennessee, 5Division of Allergy, Pulmonary, and Critical Care Med-
icine, Department of Medicine, and Center for Asthma and Envi-
ronmental Sciences Research, Vanderbilt University School of
Medicine, Nashville, TN, 6Vanderbilt University Medical Center,
7
Vanderbilt University Medical Center, Nashville, TN, 8Allergy,
Pulmonary, and Critical Care Medicine, Department of Medicine,
Vanderbilt University School of Medicine, Nashville, TN
319 Allergic Sensitization and Determination Of Serum Eosinophil
Cationic Protein and Triptase In Preschool Population In Her-
mosillo, Sonora, Mexico
Dr. Claudia Gallego-Corella1, Dr. Guadalupe Corella2, Ms. An-
drea Romo3, Prof. Antonio Rascon4 and Mr. Pablo Martnez3,
1
Medicine Faculty, Xochicalco University, Tijuana, Mexico,
2
Health, Nutrition and Environment, Department of Chemical and
Biological Sciences, University of Sonora, Mexico, Hermosillo,
Mexico, 3Department of Chemical and Biological Sciences, Univer-
sity of Sonora, Mexico, Hermosillo, Mexico, 4Health, Nutrition and
Environment, Department of Chemical and Biological Sciences,U-
niversity of Sonora, Mexico, Hermosillo, Mexico
320 Fungal Cross-Allergenicity In Specific Ige Testing
Dr. Mercedes C. Amado, MD, FAAAAI1, Dr. Jay M. Portnoy,
MD, FAAAAI2 and Dr. Charles Barnes, PhD2, 1Childrens Mercy
Hospital, Shawnee Mission, KS, 2Childrens Mercy Hospital, Kan-
sas City, MO
321 Monocytes From Peanut-Allergic Patients Express Higher
Levels Of RALDH2 In Response To Peanut Protein Than Mon-
ocytes From Tolerant Subjects
Elizabeth Fleming, BS1, Bert Ruiter, PhD1, Barry K. Hurlburt,
PhD2, Soheila J. Maleki, PhD2 and Wayne G. Shreffler, MD,
PhD, FAAAAI1, 1Massachusetts General Hospital, Boston, MA,
2
USDA-ARS-SRRC, New Orleans, LA
322 Peanut Protein Induces Expression Of RALDH2 In Human
Dendritic Cells In a TLR2-Dependent Manner
Bert Ruiter, PhD1, Elizabeth Fleming, BS1, Barry K. Hurlburt,
PhD2, Soheila J. Maleki, PhD2 and Wayne G. Shreffler, MD,
PhD, FAAAAI1, 1Massachusetts General Hospital, Boston, MA,
2
USDA-ARS-SRRC, New Orleans, LA
323 IL-4 Receptor Alpha and STAT6 Single Nucleotide Polymor-
phisms Are Associated With Increased Risk Of Asthma In a
Saudi Arabian Population
Dr. Rabih Halwani, PhD1, Dr. Alejandro Vazquez-Tello2, Mr. Amer
Jamhawi2, Dr. Hamdan Jahdali3 and Dr. Saleh Al-Muhsen, MD4,
1
King Saud University, college of Medicine, Riyadh, Saudi Arabia,
2
King Saud University, Riyadh, Saudi Arabia, 3King Saud University
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
for Health Sciences, Riyadh, Saudi Arabia, 4King Saud University,
College of Medicine, Riyadh, Saudi Arabia
T Cell Mediated Immunity
3204
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
324 Infants With Idiopathic T Cell Lymphopenia Identified On New
York State Newborn Screen: A Follow Up Report
Dr. Stephanie Albin, MD1, Dr. Harshna Mehta, MD1 and Dr. Char-
lotte Cunningham-Rundles, MD, PhD, FAAAAI2, 1The Icahn
School of Medicine at Mount Sinai, New York, NY, 2Mt. Sinai
Medical Center, New York, NY
325 Frequency Of Cellular and Humoral Immunodeficiencies In Di-
george Syndrome Patients Seen At New York Presbyterian Co-
lumbia Between 2006-2012
Dr. Collette Spalding, MD1, Dr. Kyung Hwa Jung, PhD1, Dr. Ra-
chel L. Miller, MD, FAAAAI1 and Dr. Yesim Demirdag, MD2, 1Di-
vision of Pulmonary, Allergy and Critical Care Medicine, Columbia
University, New York, NY, 2Department of Pediatric Allergy/Im-
munology, Columbia University, New York, NY
326 A Novel ORAI1 Mutation Resulting In T+B+NK+ SCID With
Normal Lymphocyte Proliferation
Janet S. Chou, MD1, Christina S.K. Yee, MD, PhD1, Mr. Wayne
Bainter, BS1, Dr. Luigi D. Notarangelo, M.D.2, Dr. Suleiman M.
S. E. Al-Hammadi, MD, FAAAAI3 and Raif S. Geha, MD1, 1Divi-
sion of Immunology, Boston Childrens Hospital, Harvard Medical
School, Boston, MA, 2Stem Cell Institute, Boston, MA, 3FMHS,
UAE University, Al-Ain, United Arab Emirates
327 Coronin-1A Oligomerization Is Critical For Host Defense
Against Viral Pathogens
Christina S.K. Yee, MD, PhD1, Ozden Sanal, MD2, Janet S. Chou,
MD1, Raif S. Geha, MD1, Deniz Ayvaz, MD3, Caner Aytekin, MD3
and A. Nurten Akarsu, MD, PhD4, 1Division of Immunology, Boston
Childrens Hospital, Harvard Medical School, Boston, MA, 2Depart-
ment of Pediatrics, Hacettepe University Ihsan Dogramaci Childrens
Hospital, Ankara, Turkey, 3Department of Pediatric Immunology, Dr
Sami Ulus Maternity and Childrens Research and Educational Hos-
pital, Ankara, Turkey, 4Department of Medical Genetics, Hacettepe
University Ihsan Dogramaci Childrens Hospital, Ankara, Turkey
328 Newborn Screening For Severe Combined Immunodeficiency In
Iowa: TREC Assay Results and Characteristics Of SCID and T-
Cell Lymphopenic Patients
Farheen Mirza, MD1, Emily Phillips, RN BSN CCRC1, Travis
Henry, PhD1 and Dr. Mary Beth Fasano, MD, FAAAAI2, 1Univer-
sity of Iowa, 2C42-E6 GH, University of Iowa College Medicine,
Iowa City, IA
329 Thymus Graft Factors Critical For Negative Selection Of Direct
Allospecific T Cells
Dr. Ivan K. Chinn, MD, Dr. Ivo D. Shterev, PhD, Kristina J. Riebe
and Dr. Douglas C. Rouse, DVM, Duke University Medical Center,
Durham, NC
330 Successful Hematopoietic Stem Cell Transplant For CD40 Defi-
ciency Manifesting As Hyper-IgM Syndrome With Absent
CD40 Expression and Marked Lymphocytosis
Dr. Joyce Hsu, MD, Medicine, Boston Childrens Hospital, Boston,
MA, Dr. Michel Massaad, PhD, Boston Childrens Hospital and Dr.
Luigi D. Notarangelo, MD, Stem Cell Institute, Boston, MA
331 IL-2 Receptor Gamma-Chain(IL2RG) Defect Can Present With
Features Other Than Increased Susceptibility To Infection
Dr. Bob Geng, MD1, Dr. Maria Garcia-Lloret, MD, FAAAAI2, Dr.
Yen Tun Wang, MD3, Dr. Ki-Young Yoo, MD3, Dr. Raymond Barn-
hill, MD3, Dr. Derek Wong, MD3 and Dr. E. Richard Stiehm, MD,
FAAAAI2, 1UCLA, Los Angeles, CA, 2Division of Allergy and
Abstracts AB315
Immunology, Department of Pediatrics, David Geffen School of
Medicine at UCLA, Los Angeles, CA, 3UCLA, CA
332 Studies On Cohort Of Infants With Di-George Syndrome De-
tected By New York State Newborn Screening For Severe Com-
bined Immunodeficiency (SCID)
Dr. Doerthe A. Andreae, MD1, Dr. Stephanie Albin, MD1, Dr.
Harshna Mehta, MD1 and Dr. Charlotte Cunningham-Rundles,
MD, PhD, FAAAAI2, 1The Icahn School of Medicine at Mount Si-
nai, New York, NY, 2Mt. Sinai Medical Center, New York, NY
333 Immunologic Profile Of Single Ventricle Survivorship Partici-
pants: Risk Factors For Clinically Significant Immunologic
Dysfunction
Dr. Megan Morsheimer, MD, MPH, Dr. Jack Rychik, MD, FACC,
Ms. Katie Dodds, RN, MSN, CRNP and Dr. Jennifer Heimall, MD,
Childrens Hospital of Philadelphia, Philadelphia, PA
334 Chronic Non-Iatrogenic Lymphatic Loss Syndromes Identified
Though Abnormal TREC Analysis From The Texas Newborn
Screening Program (NBS)
SUNDAY
Dr. Qurat U. Kamili, MD1, Niti Y. Chokshi, MD2, Dr. Jordan Or-
ange, MD, PhD, FAAAAI3, Dr. I. Celine Hanson, MD, FAAAAI4
and Dr. Lisa R. Forbes, MD4, 1Baylor College of Medicine and Texas
Childrens Hospital, Section of Immunology, Allergy and Rheuma-
tology, Houston, TX, 2Baylor College of Medicine and Texas Chil-
drens Hospital, Section of Immunology, Allergy and
Rheumatology, Houston, TX, 3Baylor College of Medicine and Texas
Childrens Hospital, Section of Immunology, Allergy and Rheuma-
tology, 4Baylor College of Medicine-Texas Childrens Hospital, Sec-
tion of Immunology, Allergy, and Rheumatology, Houston, TX
335 An Adult With Disseminated Herpes Zoster Infection Found To
Have Rare Combined CD4, CD8 T-Cell and NK-Cell Deficiency
Neil Parikh, MD, UCLA-VA Greater Los Angeles Healthcare Sys-
tem, Los Angeles, CA and Joseph S. Yusin, MD, FAAAAI, VA
Greater Los Angeles Health Care System, Los Angeles, CA
336 Clinical and Virological Characteristics Of HIV-Associated
Lymphomas In Patients With Perinatally-Acquired HIV In
The Era Of Antiretroviral Therapy
Dr. Jasmeen S. Dara, MD, Montefiore Medical Center/Albert Ein-
stein College of Medicine, Dr. Stefan Barta, Montefiore Medical
Center and Dr. Jenny Shliozberg, MD, FAAAAI, Montefiore Med-
ical Center, Bronx, NY
Asthma Epidemiology, Risk Factors and Public
Health II
3205
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
337 Study On Air Pollution and Respiratory Health Of Children In
Delhi, India
Ms. Jincy Mathew, M.Tech, CSIR- Institute of Genomics and In-
tegrative Biology, Delhi, India, Dr. Radha Goyal, Ph.D, CSIR- Na-
tional Environmental Engineering Research Institute, Delhi, India,
Dr. Krinshna K Taneja, Ph.D, CSIR- Istitute of Genomics and Inte-
grative Biology,, Delhi, India and Dr. Naveen Arora, Ph.D, CSIR
Institute of Genomics and Integrative Biology, New Delhi, India
338 Trans-Generational Transmission Of Ozone Induced Airway
Dysfunction
Prof. Park Choon Sik, Mr. Bae Da-Jeong, Dr. Park Jong-Sook and
Dr. Jang An Soo, Soonchunhyang University Bucheon Hospital,
Gyeonggi-Do, South Korea
339 Dust Mite Allergen In Bed Dust Predicts Rhinitis Symptom Per-
sistence In Urban Pre-Adolescent Children With Higher Ele-
mental Carbon Particulate Matter Exposure
Dr. Young Yoo, MD, PhD1,2, Dr. Luis M. Acosta, MD1, Prof. Inge
Goldstein, DrPH3, Prof. Andrew Rundle, DrPH4, Omar Olmedo1,
105
 AB316 Abstracts
Adnan Divjan1, Dr. Beihzhan Yan5, Prof. Judith Jacobson, DrPH4,
Dr. Rachel L. Miller, MD, FAAAAI6, Dr. Steven Chillrud5 and
Prof. Matthew S. Perzanowski, PhD1, 1Department of Environmen-
tal Health Sciences, Mailman School of Public Health, Columbia
University, New York, NY, 2Department of Pediatrics, College of
Medicine, Korea University, Seoul, South Korea, 3Department of
Epidemiology, Mailman School of Public Health, Columbia Uni-
versity, New York, NY, 4Department of Epidemiology, Mailman
School of Public Health, Columbia University, New York, NY, 5La-
mont-Doherty Earth Observatory, Columbia University, Palisades,
NY, 6Division of Pulmonary, Allergy and Critical Care Medicine,
Columbia University, New York, NY
340 Associations Between Outdoor Of PM2.5 With Cough and
Wheeze Symptoms In Asthmatic Children In Korea
Prof. Woo Kyung Kim, MD, PhD1,2, Mrs. Young Wook Lee1 and
Dr. Hae-Sun Yoon1, 1Allergy & respiratory research laboratory, Inje
University College of Medicine, Seoul, South Korea, 2Department
of Pediatrics, Seoul Paik Hospital, Inje University College of Med-
SUNDAY
icine, Seoul, South Korea
341 Effect Of Duration Of Residence In Brooklyn On IgE Re-
sponses Of Immigrants
Dr. Edward Kleiman, MD1, Dr. Maria-Anna Vastardi, MD2,3, Dr.
Irina Katayeva, MD2,3, Dr. Helen G. Durkin, PhD2 and Dr. Rauno
O. Joks, MD, FAAAAI1, 1SUNY Downstate Medical Center, Center
for Allergy and Asthma Research, Brooklyn, NY, 2Center for Allergy
and Asthma Research, State University of New York Downstate Med-
ical Center, Brooklyn, NY, 3Lutheran Medical Center, Brooklyn, NY
342 Impact Of Energy Expenditure On Ozone-Induced Inflamma-
tion
Dr. Krista Todoric, MD1, Dr. Michelle L. Hernandez, MD1, Dr.
Haibo Zhou, PhD2 and Dr. David B. Peden, MD, MS, FAAAAI1,
1
University of North Carolina at Chapel Hill School of Medicine,
Chapel Hill, NC, 2University of North Carolina at Chapel Hill,
School of Public Health
343 Exposure Of Mice To Silica Crystals and Poly I:C Synergisti-
cally Enhances Neutrophil Infiltration and Epithelial Damage
In The Airway
Dr. Hirotoshi Unno, M.D., Dr. Hideaki Morita, MD., PhD., Dr. Hir-
ohisa Saito, MD., PhD., Dr. Kenji Matsumoto, MD, PhD and Dr. Akio
Matsuda, PhD, Department of Allergy and Immunology, National
Research Institute for Child Health and Development, Tokyo, Japan
344 Modest Effects Of Bisphenol A Exposure In Mouse Models Of
Respiratory Allergy and Food Allergy
Dr. Unni C. Nygaard1, Dr. Mari Samuelsen1, Dr. Nina Vinje1, Mrs.
Monica Andreassen1,2, Prof. Martinus Lovik1 and Dr. Johanna
Bodin1, 1Norwegian Institute of Public Health, Oslo, Norway,
2
Genk - Centre for Biosafety, Tromso, Norway
Aerobiology II
3206
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
345 In Vitro Allergy Testing: Relationship Patterns Between Aller-
gen Pairs
Dr. John S. Kaptein, PhD1, C.K. Lin, PhD1 and Dr. Bruce J. Gold-
berg, MD, PhD, FAAAAI2, 1Southern California Permanente
Medical Group, Los Angeles, CA, 2Kaiser Permanente, Los An-
geles, CA
346 Comparison Of Total Protein Profile Of Alternaria Alternata
Extract Obtained From Various U.S. Allergenic Extract Manu-
facturers
Dr. Jay E. Slater, MD1, Ms. Allison Zoch2, Ms. Shoshana New-
man-Gerhardt2 and Dr. Taruna Khurana, PhD3, 1FDA/CBER/
OVRR/DBPAP, Rockville, MD, 2FDA/CBER, 3CBER FDA
106
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
347 IgE Antibodies To Cat and Cat Components In Relation To
Asthma In a Population Study Of 963 18 Year Olds From Six
Schools In Northern Sweden
Ms. Hayley James, BS1, Prof. Matthew S. Perzanowski, PhD2, Eva
Ronmark, PhD3, Bo Lundback, MD, PhD3, Jillian Roper1 and
Thomas A.E. Platts-Mills, MD, PhD, FAAAAI4, 1University of Vir-
ginia, Charlottesville, VA, 2Department of Environmental Health
Sciences, Mailman School of Public Health, Columbia University,
New York, NY, 3Karolinska Institutet, Stockholm, Sweden, 4Divi-
sion of Asthma, Allergy & Immunology, University of Virginia
Health System, Charlottesville, VA
348 Epitope Mapping Of An Anti-Bla g 1 ScFv Used For Cockroach
Allergen Quantitation
Dr. Geoffrey Mueller, PhD1, Mr. John Ankney2, Dr. Lars Peder-
sen1, Dr. Taruna Khurana, PhD3, Dr. Jay E. Slater, MD4, Ms. Jill
Glesner5, Dr. Anna Pomes, PhD FAAAAI5 and Dr. Robert London1,
1
National Institute of Environmental Health Sciences, NIH, Re-
search Triangle Park, NC, 2National Intstitute of Environmental
Health Sciences, NIH, 3FDA Center for Biologics Evaluation and
Research, 4FDA/CBER/OVRR/DBPAP, Rockville, MD, 5Indoor Bi-
otechnologies, Inc., Charlottesville, VA
349 Antigenic Analysis Of The Major Cockroach Allergen Bla g 5
and Its Dust Mite Homolog Der p 8
Ms. Jill Glesner1, Dr. Geoffrey Mueller, PhD2, Dr. Lars Pedersen2,
Dr. Martin D. Chapman, PhD FAAAAI1 and Dr. Anna Pomes, PhD
FAAAAI1, 1Indoor Biotechnologies, Inc., Charlottesville, VA, 2Na-
tional Institute of Environmental Health Sciences, NIH, Research
Triangle Park, NC
350 Immunomodulatory Effects Of Rye Grass Pollen Allergen Lol p
5 On The Prostaglandin E2 Pathway and Kallikrein-Kinin Sys-
tem Of Respiratory Epithelial Cells
Cecilia Tong, Alice Vrielink, Martha Ludwig and Geoffrey Stew-
art, University of Western Australia
351 Development and Characterization Of a Murine Model Of Re-
peated Dry Exposure To Aerosolized Fungal Conidia
Dr. Ajay Nayak, PhD1, Dr. Amanda Buskirk, PhD1,2, Mr. W.Travis
Goldsmith3, Ms. Angela Lemons1, Dr. Justin Hettick, PhD1, Dr. Mi-
chael Kashon, PhD4, Ms. Amy Cumpston3, Mr. Jared Cumpston3,
Mr. Howard Leonard3, Mr. Walter McKinney3, Dr. David Frazer,
PhD3, Dr. Donald H. Beezhold, PhD FAAAAI1 and Dr. Brett J.
Green, PhD1, 1CDC/NIOSH/ACIB, Morgantown, WV, 2West Vir-
ginia University, Morgantown, WV, 3CDC/NIOSH/PPRB, Morgan-
town, WV, 4CDC/NIOSH/BEB, Morgantown, WV
352 Cross-Reactivity Between Recombinant Tropomyosin From
Chortoglyphus and Natural Tropomyosin Of Other Extracts
Dr. Jer onimo Carnes1, Dr. M. Angeles Lopez Matas1, Dr. Manuel
Boquete, MD2, Dr. Raquel Moya1 and Dr. Victor Miguel Iraola1,
1
Laboratorios LETI, Tres Cantos, Spain, 2Hospital Xeral de Calde,
Lugo, Spain
353 Identification Of The Cysteine Protease Amb a x As A Novel
Major Allergen From Short Ragweed Pollen (Ambrosia artemi-
siifolia)
Dr. Philippe Moingeon, PhD1, Julien Bouley, PhD2, Maxime Le
Mignon, PhD2, Veronique Baron-Bodo, PhD2, Veronique Bordas,
PhD2, Laetitia Bussieres2, Marie-Noelle Couret3, Aurelie Lautr-
ette, PhD2, Thierry Batard, PhD4, Rachel Groeme2, Henri Chabre,
PhD2 and Emmanuel Nony2, 1Stallergenes SA, Antony, France,
2
Stallergenes, France, 3Stallergenes, 4Stallergenes, Antony,
France
354 Characterization Of The Allergenic Activity Of Tropomyosin
From Aedes Aegypti
Mr. Jose F. Cantillo, Complutense University of Madrid, Spain; In-
munotek S.L., Alcala de Henares, Spain, Prof. Leonardo Puerta, In-
stitute for Immunological Research/University of Cartagena,
Cartagena, Colombia, Dr. Enrique Fernandez-Caldas, Inmunotek,
S.L, Spain and Dr. Sylvie Lafosse-Marin, Cabinet de Inmunoaller-
gology, Fort de France, Martinique
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
355 Allergy To Ferret
Mr. Ignacio Esteban Gorgojo1, Javier Cuesta Herranz1, Carlos
Pastor2, Aroa Sanz Maroto2, Mr. David Gonzalez3 and Dr. Manuel
De Las Heras1, 1Department of Allergy, Fundacion Jimenez Daz,
Madrid, Spain, 2Department of Immunology, Fundaci on Jimenez
Daz, Spain, 3Allergy unit, Hospital de Fuenlabrada, Spain
356 Do Residual Wheal Skin Prick Test Responses To Perennial and
Seasonal Allergens Correlate With Their Specific IgE Levels In
Allergic Subjects?
Dr. AnneMarie Salapatek, PhD, Victoria Nelson, M.Sc and Dr.
Piyush Patel, MD, FRCP, Inflamax Research, Mississauga, ON,
Canada
Food Allergy I
3207
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
357 Peanut Epicutaneous Immunotherapy (EPIT) In Peanut-Aller-
gic Children: 18 Months Treatment In The Arachild Study
Prof. Christophe Dupont, MD, PhD1, Dr. Thierry Bourrier2, Prof.
Frederic de BLAY3, Dr. Lydie Guenard-Bilbault3, Dr. Christine
Sauvage4, Dr. Marie-Odile Cousin4, Dr. Gisele Kanny, MD,
PhD5, Dr. Sophie Jarlot5 and Dr. Chantal Karila, MD6, 1Hopital
Necker Enfants Malades, Paris, France, 2Lenval Hospital, Nice,
France, 3CHRU Strasbourg, France, 4Saint Vincent de Paul Hospi-
tal, Lille, France, 5CHU Nancy Hopital Central, Nancy, France,
6
Hopital Necker, Paris, France
358 Predictors For Allergic Symptoms During Build-Up and Main-
tenance Phases Of Oral Immunotherapy To Peanut
Dr. Marie M. de Alwis, MD1,2, Dr. Jason Lee, MD, FAAAAI1, Dr.
Mitchell R. Lester, MD, FAAAAI1, Dr. Louis M. Mendelson, MD,
FAAAAI1, Dr. Glenda Nouman, MD1 and Dr. Jeffrey M. Factor,
FAAAAI1, 1New England Food Allergy Treatment Center, West Hart-
ford, CT, 2Connecticut Childrens Medical Center, Hartford, CT
359 Quality Of Life With Sublingual Immunotherapy For Peanut
Nicole Leung1, Yamini Virkud, MD, MA2, Pamela H. Steele, MSN
CPNP AE-C3, Janet S. Kamilaris, RN4, Edwin Kim, MD, MS5, Brian
P. Vickery, MD, FAAAAI3, Dr. Audrey Dunn Galvin6 and A. Wesley
Burks, MD, FAAAAI3, 1Duke University, 2Duke University, Durham,
NC, 3University of North Carolina, Chapel Hill, NC, 4Carolinas Health
Care System, Charlotte, NC, 5University of North Carolina at Chapel
Hill, Chapel Hill, NC, 6University College Cork, Cork, Ireland
360 Low Dose Maintenance Peanut Oral Immunotherapy Can Pro-
duce Sustained Unresponsiveness
Julia A. Cronin, MD, University of Virginia, Division of Asthma,
Allergy and Immunology, Charlottesville, VA, Julia Wisniewski,
MD, University of Virginia, Division of Pediatric Respiratory Med-
icine and Allergy, Charlottesville, VA and Scott P. Commins, MD,
PhD, University of Virginia Health System, Charlottesville, VA
361 Increases In Peanut-Specific IgA1 and IgA2 During Peanut Im-
munotherapy Do Not Correlate With Clinical Tolerance
Adrienne L. Yancey1, Michael D. Kulis Jr., PhD1, Pamela H.
Steele, MSN CPNP AE-C1, Edwin Kim, MD, MS1, Brian P. Vick-
ery, MD, FAAAAI2 and A. Wesley Burks, MD, FAAAAI1, 1Univer-
sity of North Carolina School of Medicine, Chapel Hill, NC,
2
University of North Carolina, Chapel Hill, NC
362 Peanut OIT-Induced IgG Suppresses Ex Vivo Activation Of Al-
lergic Donor Basophils Via a Combination Of Antigen Intercep-
tion and Receptor-Bound Inhibition
Caitlin Burk, Michael D. Kulis Jr., PhD, Edwin Kim, MD, MS, Brian
P. Vickery, MD, FAAAAI and A. Wesley Burks, MD, FAAAAI, Uni-
versity of North Carolina at Chapel Hill, Chapel Hill, NC
363 Omalizumab Pretreatment Does Not Protect Against Peanut
Oral Immunotherapy-Related Adverse Gastrointestinal Events
Uyenphuong Le, MD1, Yamini Virkud, MD, MA2, Brian P. Vick-
ery, MD, FAAAAI1, Pamela H. Steele, MSN CPNP AE-C1, Janet S.
Abstracts AB317
Kamilaris, RN3, Michael D. Kulis Jr., PhD1, Jelena Berglund, PhD,
RAC2 and A. Wesley Burks, MD, FAAAAI1, 1University of North
Carolina, Chapel Hill, NC, 2Duke University, Durham, NC, 3Caro-
linas Health Care System, Charlotte, NC
364 Single Practice Five-Year Experience Treating Food Allergy
With Oral Immunotherapy: Efficacy and Epinephrine Treated
Reactions
Mrs. Angela R. Hague, PA-C, Dr. Richard L. Wasserman, MD,
PhD, FAAAAI, Dr. Stacy K. Silvers, MD and Dr. Robert W. Suger-
man, MD, FAAAAI, DallasAllergyImmunology, Dallas, TX
365 Single Practice, Five-Year Experience Treating Food Allergy
With Oral Immunotherapy (FOIT): Successes and Failures
Ms. Dena M. Pence, RT, Mrs. Angela R. Hague, PA-C, Dr. Ri-
chard L. Wasserman, MD, PhD, FAAAAI, Dr. Robert W. Suger-
man, MD, FAAAAI and Dr. Stacy K. Silvers, MD,
DallasAllergyImmunology, Dallas, TX
366 Single Practice Five Year Experience Treating Food Allergy
With Oral Immunotherapy (FOIT): Effect On Antigen Specific
SUNDAY
IgE (asIgE)
Dr. Stacy K. Silvers, MD, Mrs. Angela R. Hague, PA-C, Ms. Dena
M. Pence, RT, Dr. Robert W. Sugerman, MD, FAAAAI and Dr. Ri-
chard L. Wasserman, MD, PhD, FAAAAI, DallasAllergyImmunol-
ogy, Dallas, TX
367 Secondary Eosinophilic Reactions During ORAL Immunother-
apy
Prof. Yitzhak Katz, MD, FAAAAI1,2, Dr. Michael Goldberg, MD,
PhD2, Dr. Liat Nachshon, MD2, Dr. Marc E. Rothenberg, MD,
PhD, FAAAAI3,4, Dr. Miguel Leon Stein, MD, FAAAAI5, Dr. Efrat
Broide6,7, Dr. Gratiana Hermann6, Dr. Arnon Elizur, MD1,2 and Dr.
Michael B. Levy, MD, FAAAAI2, 1Tel Aviv University, Tel Aviv, Is-
rael, 2Assaf Harofeh, Zerifin, Israel, 3Cincinnati Childrens Hospital
Medical Center, Cincinnati, OH, 4Childrens Hospital Medical Cen-
ter, Cincinnati, OH, 5Assaf Harofeh Medical Center, Rehovot, Israel,
6
Assaf Hrofeh Meducal center, Israel, 7Tel-Aviv university
368 Rate Of Anaphylaxis Caused By Oral Immunotherapy In Chil-
dren With Cows Milk Allergy
Prof. Giovanni B. Pajno, MD, FAAAAI1, Dr. Giuseppe Crisa-
fulli1,2, Dr. Giuseppina Salzano1,2, Dr. Roberta Vadala1,2, Dr. Stefa-
nia Arasi1,2, Dr. Salvatore Barberi3 and Dr. Lucia Caminiti1,2,
1
University of Messina, Messina, Italy, 2Dept of Pediatrics, Allergy
Unit, University of Messina, 3Pediatric Clinic, San Paolo Hospital,
University of Milan, Milan, Italy
369 Long-Term Follow Up In Cows Milk Anaphylaxis After Suc-
cessful Rush Oral Immunotherapy
Mrs. Paloma Poza-Guedes, Dr. Ruperto Gonzalez-Perez, Dr. In-
maculada Sanchez-Machn, MD and Dr. Victor Matheu, MD, Hos-
pital del Torax-Ofra, Sta Cruz de Tenerife, Spain
370 Milk Oral Immunotherapy. Standard Versus Personalized Pro-
tocols: Efficiency and Safety
Alberto Alvarez-Perea, MD, Dr. Elena Alonso-Lebrero, PhD, Fer-
nanda Freire, MD, Dr. Sonsoles Infante, MD, Victoria Fuentes-
Aparicio, MD and Lydia Zapatero, MD, Hospital Materno Infantil
Gregorio Mara~non, Pediatric Allergy Department, Madrid, Spain
371 Cross-Desensitization To Goat and Sheep Milk Protein In Cows
Milk Protein Desensitized Patients
Dr. Michael Levy, MD, FAAAAI1, Dr. Liat Nachshon, MD1, Dr.
Michael Goldberg, MD, PhD1, Dr. Arnon Elizur, MD1,2 and Prof.
Yitzhak Katz, MD, FAAAAI1,2, 1Assaf Harofeh, Zerifin, Israel,
2
Tel Aviv University, Tel Aviv, Israel
372 Long Term Follow Up Of Children Who Incorporated Exten-
sively Heated (baked milk) In The Diet
Dr. Anna H. Nowak-Wegrzyn, MD, FAAAAI1, Mrs. Beth D.
Strong, RN CCRC2, Ms. Diane Ananos1 and Hugh A. Sampson,
MD, FAAAAI3, 1Icahn School of Medicine at Mount Sinai, New
York, NY, 2Icahn School of medicine at Mount Sinia, New York,
NY, 3Pediatrics, Icahn School of Medicine at Mount Sinai, New
York, NY
107
 AB318 Abstracts
373 Baked Milk Oral Immunotherapy For Severe IgE-Mediated
Cows Milk Protein (CMP) Allergic Patients: Interim Results
Dr. Michael Goldberg, MD, PhD1, Dr. Liat Nachshon, MD1, Dr.
Arnon Elizur, MD2, Dr. Moshe Appel3, Dr. Michael B. Levy,
MD, FAAAAI1 and Prof. Yitzhak Katz, MD, FAAAAI1,2, 1Assaf
Harofeh, Zerifin, Israel, 2Department of Pediatrics, Sackler School
of Medicine, Tel Aviv, Israel, 3Assaf Harofeh, Israel
374 Progression Towards Increasing Tolerance To Less Extensively
Heat-Denatured Milk Products
Hugh A. Sampson, MD, FAAAAI1, Dr. George N. Konstantinou,
MD, PhD, MSc2,3, Jacob Daniel Kattan, MD4, Madhan Masilamani,
PhD4, Mrs. Beth D. Strong, RN CCRC5, Mr. Tee Bahnson, BS,
MPH6, Ms. Kaitie Fernandez7 and Dr. Anna H. Nowak-Wegrzyn,
MD, FAAAAI4, 1Pediatrics, Icahn School of Medicine at Mount Si-
nai, New York, NY, 2424 General Military Training Hospital, The-
ssaloniki, Greece, 3First Pediatric Department, Aristotle University
of Thessaloniki, Hippokration General Hospital, Thessaloniki,
Greece, 4Icahn School of Medicine at Mount Sinai, New York,
SUNDAY
NY, 5Icahn School of medicine at Mount Sinia, New York, NY,
6
Rho Federal Systems Division, Inc., Chapel Hill, NC, 7Rho Fed-
eral Systems Division, Inc., Chapel Hill, NC, Chapel Hill, NC
375 Cows Milk Allergen Specific CD4+ T Cell Responses In Pa-
tients With Persistent Cows Milk Allergy
Dr. Fatima S. Khan, MD, Altru, Grand Forks, ND, Nupur Bhatna-
gar, PhD, Benaroya Research Institute, Seattle, WA, Dr. David Rob-
inson, Virginia Mason Medical Center and William W. Kwok, PhD,
Benaroya Research Institute at Virginia Mason, Seattle, WA
376 The Role Of Skin Prick Testing and Specific IgE To Boiled Ver-
sus Unheated Cow Milk In Cow Milk Allergic Children
Dr. Anilkumar Katta, MD, Saint Louis University, Saint Louis,
MO, Dr. Julie Hong, MD, St. Louis University, Portland, OR and
Dr. Alan Knutsen, MD, FAAAAI, Saint Louis University School
of Medicine, Saint Louis, MO
378 Comparing The Utility Of Skin Prick Testing Using Commer-
cial Extracts and Fresh Food In Diagnosing Peanut Allergy
Dr. Carah Santos, MD, Dr. Matthew Strand, PhD, Pearlanne Zelar-
ney, MS and David Mark Fleischer, MD, FAAAAI, National Jewish
Health, Denver, CO
379 Variability Of Major Allergens In Commercially Available Pea-
nut Extracts For Skin Prick Testing
Dr. Yong Luo, MD, PhD, Dr. Vincent R. Bonagura, MD, FAAAAI
and Dr. David Rosenthal, DO, Division of Allergy/Immunology,
Departments of Medicine and Pediatrics, Hofstra North Shore-LIJ
School of Medicine, Great Neck, NY
380 Ara h 2 and The Relative Risk Of Other Sensitizations
Dr. James Thompson, Fellow-In-Training, ., Evans, GA, Dr. Dan-
iel Duquette, PhD, UW La Crosse, La Crosse, WI and Dr. Brock
Williams, PhD, U. of Missouri Medical School, Olathe, KS
381 Variability Of Repeat Peanut Serum IgE Levels
Tricia D. Lee, MD, Icahn School of Medicine at Mount Sinai, Ja-
cob Daniel Kattan, MD, Icahn School of Medicine at Mount Sinai,
New York, NY, Dr. Manish Ramesh, MD, PhD, Mount Sinai School
of Medicine, New York, NY and Dr. Julie Wang, MD, FAAAAI,
The Icahn School of Medicine at Mount Sinai, New York, NY
382 Does Peanut Allergen Conjunctival Provocation Test Reflect
Specific IgE Levels To Peanut?
Helene Lindvik, MD1, Petter Mowinckel, M.Sc.2, Jesintha Navar-
atnam, MD3, Prof. Karin Cecilie Ldrup Carlsen, MD, PhD1,4, Prof.
Magnus Borres, Md, Phd, FAAAAI5, Dr. Bente Kvenshagen, MD2
and Prof. Kai Hakon Carlsen, MD, PhD1,4, 1Department of Paedi-
atrics, Oslo University Hospital, Oslo, Norway, 2Oslo University
Hospital, Oslo, Norway, 3Department of Ophthalmology, Oslo Uni-
versity Hospital, Oslo, Norway, 4The Faculty of Medicine, Univer-
sity of Oslo, Oslo, Norway, 5Department of Womens and Childrens
Health, Uppsala Univerisity, and Thermo Fisher Scientific, Uppsala,
Sweden
108
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
383 The Use Of The ISAC Mircroarray Platform In Food Allergic
Patients
Jacob Daniel Kattan, MD1, Gustavo Gimenez, BA1, Jay A. Lie-
berman, MD2 and Hugh A. Sampson, MD, FAAAAI3, 1Icahn
School of Medicine at Mount Sinai, New York, NY, 2University
of Tennessee, Memphis, TN, 3Pediatrics, Icahn School of Medicine
at Mount Sinai, New York, NY
384 IgE Antibodies To Ara h 2 and Ara h 6 By Immunocap ISAC
Distinguish Peanut Anaphylaxis Children From Asymptomatic
Peanut Sensitization
Dr. Rumiko Shibata, MD, PhD1, Dr. Youko Murakami, MD1 and
Dr. Hiroshi Odajima2, 1Department of Pediatrics, Fukuoka National
Hospital, Fukuoka, Japan, 2Fukuoka National Hospital, Fukuoka,
Japan
385 Molecular Component Testing For Peanut Allergy Reactivity
Differs Based On Age
Dr. Michelle L. Altrich, PhD, Viracor-IBT Laboratories, Lees
Summitt, MO
386 CD-Sens and Component Resolved Diagnostics In Diagnosing
Hazelnut Allergy
Dr. Josef Brandstrom, MD1, Prof. Magnus Borres, Md, Phd,
FAAAAI2, Prof. S. G. O. Johansson, MD, PhD, FAAAAI3, Ms. Ag-
neta Jansson Roth1, Ms. Ann-Charlotte Sundqvist1, Dr. Gunnar
Lilja, MD, PhD1, Dr. Anna Nopp, PhD3 and Dr. Caroline Nilsson,
MD, PhD1, 1Department of Clinical Science and Education,
Sodersjukhuset, Karolinska Institutet and SachsChildrens Hospital,
Sodersjukhuset, Stockholm, Sweden, 2Department of Womens and
Childrens Health, Uppsala Univerisity, and Thermo Fisher Scien-
tific, Uppsala, Sweden, 3Department of Medicine, Clinical Immu-
nology and Allergy Unit, Karolinska Institutet, Stockholm, Sweden
387 Effect Of Oleic Acid On The Allergenic Properties Of Peanut
and Cashew Allergens
Si-Yin Chung, PhD1, Christopher P. Mattison, PhD1, Shawndrika
Reed1, Dr. Richard L. Wasserman, MD, PhD, FAAAAI2 and Wendy
A. Desormeaux1, 1USDA-ARS-SRRC, New Orleans, LA, 2Allergy/
Immunology Research Center of North Texas, Dallas, TX
388 Identification Of Conformational IgE Epitopes Of Ara h 2 and
Ara h 6
Dr. Xueni Chen, University of Colorado, Aurora, CO and Dr. Ste-
phen C. Dreskin, MD, PhD, FAAAAI, University of Colorado Den-
ver, Aurora, CO
389 Basophil Response To Storage Proteins and Oleosins From Sun-
flower Seed
Maria Luisa Macias1, Dr. Francisca Gomez, MD, PhD2, Araceli
Diaz3, Dr. Cristobalina Mayorga, PhD1, Dr. Ana Aranda, PhD1, Mi-
guel Gonzalez1, Dr. Natalia Blanca-Lopez, MD, PhD4, Dr. Gabriela
Canto, MD, PhD4, Ms. Miriam Osorio1, Dr. Maria Garrido, PhD3,
Dr. Maria J Torres, MD, PhD2 and Dr. Miguel Blanca, MD,
PhD2, 1Research Laboratory, Carlos Haya Hospital-FIMABIS,
Malaga, Spain, 2Allergy Service, Carlos Haya Hospital, Malaga,
Spain, 3Plant Biotechnology Institute (UPM-INIA), Madrid, Spain,
4
Allergy Service, Infanta Leonor Hospital, Madrid, Spain
390 Utility Of Ovomucoid Specific IgE In Predicting Unheated Egg
Food Challenge Outcomes
Dr. Katherine S. Larabee, MD1, Dr. William J. Sheehan, MD2,3,
Dr. Lisa M. Bartnikas, MD2,3, Mr. Carter Petty, MA3, Dr. Lynda
C. Schneider, MD, FAAAAI2,3 and Dr. Wanda Phipatanakul, MD,
MS, FAAAAI2,3, 1Massachusetts General Hospital for Children,
Boston, MA, 2Harvard Medical School, Boston, MA, 3Boston Chil-
drens Hospital, Boston, MA
391 Allergy Testing In Childhood: Agreement Between Skin Prick
Test and Specific IgE In Preschool Children
Ann-Marie M. Schoos, MD, Bo Chawes, MD, Nilofar Flsgaard,
MD, Nasim Samandari, MD, Klaus Bnnelykke, MD and Dr. Hans
Bisgaard, MD DMSci, Danish Pediatric Asthma Center, Gentofte,
Denmark
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
392 Measurement Of Allergenic Components For Predicting Clin-
ically Relevant Shrimp Allergy In House Dust Mite Sensitized
Children Prof. Man-Yong Han, MD, PhD, Department of Pedi-
atrics, CHA University School of Medicine, Seongnam,
South Korea, Prof. Heysung Baek, MD, PhD, Department of Pe-
diatrics, Hallym University College of Medicine, Seoul, South
Korea and Prof. Ha-Baik Lee, MD, PhD, Department of
Pediatrics, Hanyang University School of Medicine, Seoul, South
Korea
393 Cross Reactivity Of Alpha Gal Allergy With An Extended Red
Meat Panel
Dr. Linda Flebbe-Rehwaldt, PhD, Viracor-IBT Laboratories,
Lees Summit, MO and Dr. Michelle L. Altrich, PhD, Viracor-
IBT Laboratories, Lees Summitt, MO
394 Prediction Of Tolerance To Food Allergens By The Allergen-
Specific IgE/Total IgE Ratio
Ms. Claudia Lau1, Dr. Ruchi Gupta, MD, MPH1,2, Dr. Aaron Don-
nell, MD3, Prof. Robert G. Hamilton, PhD D.ABMLI FAAAAI4
and Dr. Kelly Newhall, MD3, 1Ann and Robert H. Lurie Childrens
Hospital of Chicago, Chicago, IL, 2Northwestern University Fein-
berg School of Medicine, Chicago, IL, 3Chicago Family Asthma
& Allergy, Chicago, IL, 4Johns Hopkins University School of Med-
icine, Baltimore, MD
395 T Regulatory Cells and Food Specific Responses In Peanut and
Egg Allergic Children
Nashmia Qamar, DO, Anna B. Fishbein, Kristin A. Erickson,
Miao Cai, MS, Christine Szychlinski, MS, APN, CPNP, Ramsay
L. Fuleihan, MD and Dr. Anne Marie Singh, MD, Division of Al-
lergy & Immunology, Department of Pediatrics, Northwestern Uni-
versity Feinberg School of Medicine, Ann & Robert H. Lurie
Childrens Hospital of Chicago, Chicago, IL
396 Surveillance Of Persistent Nut Allergy Including The Use Of
Basophil Activation Test In Pediatric Patients
Dr. Ashleigh A. Olson, MD1, Kristin A. Erickson2, Miao Cai, MS2,
Ms. Christine Szychlinski, APN, CPNP3 and Dr. Anne Marie Singh,
MD2, 1Department of Pediatrics, Northwestern University Feinberg
School of Medicine, Ann & Robert H. Lurie Childrens Hospital of
Chicago, Chicago, IL, 2Division of Allergy & Immunology, Depart-
ment of Pediatrics, Northwestern University Feinberg School of
Medicine, Ann & Robert H. Lurie Childrens Hospital of Chicago,
Chicago, IL, 3Northwestern University Feinberg School of Medi-
cine, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi-
cago, IL
397 Assessment Of a Modified Basophil Activation Test In The Di-
agnosis Of Peanut Allergy
Dr. Monika Saeedian, MD, University of California, Los Angeles
and Dr. Maria Garcia-Lloret, MD, UCLA
398 Utility Of Probability Curves Using 3gAllergy For Diagnosis Of
Wheat Allergy
Sakura Sato1, Kiyotake Ogura1, Yasunori Sato2 and Motohiro Ebi-
sawa, MD, PhD, FAAAAI1, 1Clinical Research Center for Allergy
and Rheumatology, Sagamihara National Hospital, Kanagawa, Ja-
pan, 2Department of Biostatistics, Clinical Research Center Chiba
University
399 Skin Prick Test and Specific IgE To Purified Peanut Allergens
Are Related To The Age Of Onset Of Sympstons
Dr. Maria Salas, MD, PhD1, Dr. Francisca Gomez, MD, PhD2, Dr.
Ana Aranda, PhD3, Dr. Carmen Rondon, MD, PhD1, Dr. Natalia
Blanca-L opez, MD, PhD4, Dr. Gabriela Canto, MD, PhD4, Dr. Ma-
ria J Torres, MD, PhD1, Dr. Cristobalina Mayorga, PhD3, Dr. Mi-
guel Blanca, MD, PhD1 and Maria Isabel Sanchez Rivas5,
1
Allergy Service, Carlos Haya Hospital, Malaga, Spain, 2Allergy
Service, Carlos Haya Hospital, Spain, 3Research Laboratory, Carlos
Haya Hospital-FIMABIS, Malaga, Spain, 4Allergy Service, Infanta
Leonor Hospital, Madrid, Spain, 5Allergy Service Carlos Haya
Hospital, Malaga, Spain
Abstracts AB319
400 The Relationship Between Mitochondrial Haplogroups Variant
on Children with Cow Milk Allergy Expressed As Atopic Der-
matitis and Gastrointestinal Disease
Dr. Juan Carlos Muino, MD, PhD, FAAAAI1, Dr. Raul Boudet1,
Dr. Maria Chaig1, Dr. Roberto Chaig1, Prof. Nelida Gerez2 and
Prof. Juan Carlos Copioli1, 1FAC CS MED UNC, Cordoba, Argen-
tina, 2FAC CS MED UNC, Cordoba, Argentina
401 Detection Of Peanut Allergens In Breast Milk and Saliva
Dr. Kelli M. Rose, MD1, Christian Plaisance2, Casey C. Grimm,
PhD2, Hsiaopo Cheng, M.S.2, Tysheena Charles, MS2, Saeed A.
Jortani3 and Soheila J. Maleki, PhD2, 1Tulane University, New Or-
leans, LA, 2USDA-ARS-SRRC, New Orleans, LA, 3University of
Louisville, Louisville, KY
402 Importance Of High Molecular Weight Proteins In Walnut Al-
lergy
Melanie L. Downs, M.S.1,2, Dr. Aida Semic-Jusufagic, MD2, Dr.
Angela Simpson, MD2, Prof. Adnan Custovic, MD, PhD,
FAAAAI2, Dr. Savas Savatianos, MD3, Dr. Nikolaos G. Papadopou-
SUNDAY
los, MD, FAAAAI3, Dr. Joan Bartra, MD, PhD4, Dr. Montserrat
Fernandez-Rivas5, Joe L. Baumert1, Steve L. Taylor, PhD1 and
Prof. E.N. Clare Mills, BSc PhD2, 1Food Allergy Research and Re-
source Program, University of Nebraska-Lincoln, Lincoln, NE, 2In-
stitute of Inflammation and Repair, University of Manchester,
Manchester, United Kingdom, 3Allergy Department, 2nd Pediatric
Clinic, University of Athens, Athens, Greece, 4Allergy Unit, Ser-
vice of Pneumology and Respiratory Allergy, Hospital Clinic
(ICT), Barcelona, Spain, 5Allergy Department, Hospital Clinico
San Carlos, IdISSC, Madrid, Spain
403 Characterizing The Effect Of Sodium Sulfite On Cashew Aller-
gens
Christopher P. Mattison, PhD1, Wendy A. Desormeaux1, Dr. Ri-
chard L. Wasserman, MD, PhD, FAAAAI2 and Casey C. Grimm,
PhD1, 1USDA-ARS-SRRC, New Orleans, LA, 2Allergy/Immunol-
ogy Research Center of North Texas, Dallas, TX
404 Cross-Sensitization To Rosaceae Fruits and Their Molecular
Components In Japanese School Children
Dr. Junya Hirayama1, Dr. Atsushi Yamashita1, Dr. Mizuho Nagao,
MD1, Dr. Reiko Tokuda1,2, Dr. Keigo Kainuma, MD1 and Dr. Takao
Fujisawa, MD, FAAAAI1, 1Institute for Clinical Research, Mie Na-
tional Hospital, 2Tokuda Family Clinic
405 Food-Specific IgE Panel Testing Commonly Results In Misdiag-
nosis and Inappropriate Dietary Exclusion
Dr. Maryam Saifi, MD, University of Texas Southwestern Medical
Center, Dallas, Mrs. Maria G. Crain, CPNP AE-C, Childrens Medical
Center Dallas, Dallas, TX, Dr. Pooja Varshney, MD, Dell Childrens
Medical Center, Specially for Children, Austin, TX and Dr. J. Andrew
Bird, MD, FAAAAI, UT Southwestern Medical Center, Dallas, TX
406 Epitope Mapping The Peanut Panallergen Ara h 8
Barry K. Hurlburt, PhD1, Hsiaopo Cheng, M.S.1, Dr. Lesa Offer-
mann2, Dr. Maksymilian Chruszcz, PhD3, Dr. Alexandra F. Santos,
MD, MSc4, Prof. Gideon Lack, MD FRCPCH5 and Soheila J. Mal-
eki, PhD1, 1USDA-ARS-SRRC, New Orleans, LA, 2university of
south carolina, columbia, SC, 3University of South Carolina, Co-
lumbia, SC, 4Kings College London, London, United Kingdom,
5
St Thomas Hospital, St Thomas Hospital, London, United
Kingdom
407 Simulated Roasting Affects Patient IgE Binding To Ara h 2
Tysheena Charles, MS1,2, Casey C. Grimm, PhD2, Jane McBride2,
Samuel Landry, PhD1 and Soheila J. Maleki, PhD2, 1Tulane Univer-
sity Health Sciences Center, New Orleans, LA, 2USDA-ARS-
SRRC, New Orleans, LA
408 Transfer Of Peanut IgE Sensitization Following Kidney and
Pancreas Transplant
Alalia Berry, M.D., University of Utah, Department of Medicine,
Salt Lake City, UT, Dr. Rafael Firszt, MD, MBA, Pediatrics, Uni-
versity of Utah, Salt Lake City, UT, Dr. Fuad Shihab, MD,
109
 AB320 Abstracts
University of Utah,Division of Nephrology, Salt Lake City, UT, Dr.
Jeffrey Campsen, M.D. FACS, University of Utah, Division of
Transplant Surgery, Salt Lake City, UT and Craig Myrick, R.N., In-
termountain Donor Services, Salt Lake City, UT
Urticaria
3208
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
409 Outcome Measures Of Challenge Testing In Patients With
Physically Induced-Urticaria
Dr. Dean D. Metcalfe, MD1, Sarah Arceo, RN1, Michael L. Young,
RN MPH2, Celeste Nelson, NP1 and Dr. Hirsh D. Komarow, MD3,
1
NIH/NIAID/Laboratory of Allergic Diseases, Bethesda, MD,
2
2Clinical Research Directorate/CMRP, SAIC-Frederick Inc, Fred-
erick National Laboratory for Clinic Research, Frederick, MD,
SUNDAY
3
Laboratory of Allergic Diseases, NIAID/NIH, Bethesda, MD
410 Whole Blood Histamine Concentration Response To Omalizu-
mab In Patients With Chronic Idiopathic/Spontaneous Urti-
caria: Post Hoc Analysis Of Asteria I, Asteria II and Glacial
Studies
Dr. Sarbjit S. Saini, MD, FAAAAI1, Dr. Karin Rosen, MD, PhD2,
Dr. Hsin-Ju Hsieh, PhD2, Ms. Patricia M. Sterba, MS1, Mr. John-
Paul Courneya, MS1, Dr. Henry Hulter2 and Dr. Hubert Chen2,
1
Johns Hopkins University, Baltimore, MD, 2Genentech, Inc., South
San Francisco, CA
411 Efficacy Of Omalizumab In Patients With Chronic Idiopathic/
Spontaneous Urticaria With Different Background Therapy:
Post Hoc Analysis Of Asteria I, Asteria II, and Glacial Studies
Dr. Jonathan A. Bernstein, MD, FAAAAI1, Dr. Sarbjit S. Saini,
MD, FAAAAI2, Prof. Marcus Maurer, MD3, Dr. Hsin-Ju Hsieh,
PhD4, Dr. Hubert Chen4, Dr. Janice Canvin, MD, FRCPC5, Dr.
Thomas B. Casale, MD, FAAAAI6, Dr. Allen P. Kaplan, MD,
FAAAAI7 and Dr. Karin Rosen, MD, PhD4, 1Division of Immunol-
ogy Allergy & Rheumatology, University of Cincinnati Medical
Center, Cincinnati, OH, 2Johns Hopkins University, Baltimore,
MD, 3Department of Dermatology and Allergy, Charite Univer-
sitatsmedizin, Berlin, Germany, 4Genentech, Inc., South San Fran-
cisco, CA, 5Novartis Pharmaceuticals UK Limited, Horsham, West
Sussex, United Kingdom, 6Univeristy Of South Florida Morsani
College Of Medicine, Tampa, FL, 7Medical University of South
Carolina, Charleston, SC
412 Angioedema and Angioedema Management From Asteria I and
Asteria II: Phase III Studies To Evaluate The Efficacy and
Safety Of Omalizumab In Patients With Chronic Idiopathic/
Spontaneous Urticaria Who Remain Symptomatic Despite H1
Antihistamine Treatment
Dr. James Zazzali, PhD, Dr. Karin Rosen, MD, PhD, Mary S.
Bradley, MS and Karina Raimundo, BPharm, MS, Genentech,
Inc., South San Francisco, CA
413 Improvements In Health-Related Quality Of Life From Asteria
I & II: Phase III Studies To Evaluate The Efficacy and Safety
Of Omalizumab In Patients With Chronic Idiopathic/Spontane-
ous Urticaria Who Remain Symptomatic Despite H1 Antihista-
mine Treatment
Karina Raimundo, BPharm, MS, Dr. James Zazzali, PhD, Benja-
min Trzaskoma and Dr. Karin Rosen, MD, PhD, Genentech, Inc.,
South San Francisco, CA
414 Estimating The Minimal Important Difference (MID) Of The
Measures In The Urticaria Patient Daily Diary (UPDD): Up-
dated Findings Using Data From The Asteria I, Asteria II,
and Glacial Studies Of Omalizumab In Chronic Idiopathic/
Spontaneous Urticaria
Susan Mathias1, Dr. Ross D. Crosby2, Dr. Karin Rosen, MD, PhD3
and Dr. James Zazzali, PhD3, 1Health Outcomes Solutions,
110
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
2
Neuropsychiatric Research Institute, Fargo, 3Genentech, Inc.,
South San Francisco, CA
415 Treatment With Off-Label Omalizumab In Chronic Idiopathic
Histaminergic Urticaria - Angioedema Resistant To Conven-
tional Treatment
Dr. Y. V. Rijo, MD1, Dr. P. Palao, MD1, Dr. N. Prior, MD2, Dr. A.
Fiandor, MD1, Dr. M.C. Lopez-serrano, MD, PhD1, Dr. S. Olalde,
MD1, Mrs. M.C. Torres1, Dr. S. Quirce, MD, PhD1 and Dr. T. Ca-
ballero, MD, PhD1, 1Hospital La Paz Institute for Health Research
(IdiPaz), Allergy department., Madrid, Spain, 2Hospital Severo
Ochoa, Madrid, Spain
416 Real-Life Experiences With Omalizumab For The Treatment
Of Severe Refractory Chronic Urticaria (SRCIU)
Carly Barron1, Dr. Gordon L. Sussman, FAAAAI1,2, Dr. Jacques
Hebert, MD3,4, Jiayi Bian1, Rose-Marie Caron-Guay4, Stephanie
Laflamme4 and Simon Stern1, 1Gordon Sussman Clinical Research
Inc., Toronto, ON, Canada, 2University of Toronto, Faculty of Med-
icine, Toronto, ON, Canada, 3University Laval Center Hospital,
Quebec City, QC, Canada, 4Centre de Recherche Appliquee en Al-
lergie de Quebec, Quebec City, QC, Canada
417 Outcomes Of Chronic Urticaria Patients Treated With Hydrox-
ychloroquine
Dr. Jacqueline Eastman, Dr. Nicole Wilde and Dr. Maya R. Jerath,
MD, PhD, University of North Carolina, Chapel Hill, NC
418 Polymorphisms Of Genes Encoding Interleukin-4 and Its Re-
ceptor Are Associated With Chronic Idiopathic Urticaria
Ms. Zahra Aryan1,2, Dr. Marzieh Tavakol3,4, Prof. Ali Akbar
Amirzargar, PhD1, Prof. Masoud Movahedi3, Dr. Alireza Zare bi-
doki3, Dr. Mohammad Gharagozlou, MD3, Prof. Asghar Aghamo-
hammadi5, Dr. Mohammad Nabavi6, Mr. Alireza Ahmadvand3,
Dr. Nasrin Behniafard, MD3, Ms. Kimia Heidari3, Ms. Samaneh
Soltani3 and Dr. Nima Rezaei, MD, PhD1, 1Molecular Immunology
Research Center; and Department of Immunology, School of Med-
icine, Tehran University of Medical Sciences, Tehran, Iran, 2Na-
tional elites foundation, Iran., 3Molecular Immunology Research
Center; and Department of Immunology, School of Medicine, Teh-
ran University of Medical Sciences, Tehran, Iran, Iran, 4Student
Scientific Research Center (SSRC), School of Medicine, Tehran
University of Medical Sciences, Tehran, Iran, 5Research Center
for Immunodeficiencies, Childrens Medical Center, Tehran Univer-
sity of Medical Sciences, Tehran, Iran, 6Department of Allergy and
Immunology, Rasool-e-Akram Hospital, Tehran University of Med-
ical Sciences, Tehran, Iran, Iran
419 Chronic Idiopathic Urticaria Index (CIUI) As a Tool For Pre-
dicting Response To Cyclosporine In Pediatric Patients With
Refractory Autoimmune Urticaria
Dr. Moira E. Breslin, MD, MSc, Pediatrics, UCLA Medical Cen-
ter, Los Angeles, CA, Dr. Bob Geng, MD, UCLA, Los Angeles, CA
and Dr. Robert Roberts, MD, PhD, UCLA
420 Cholinergic Urticaria: Case Report Of Urticaria Induced By
Acquired Seasonal Hypohidrosis
Dr. Yuriy Zgherea, MD, Dr. Muhammad Imran, MD, Dr. Jaron T.
Abbott, MD, Dr. Aaron K. Pinion, DO, Dr. Selina Gierer, DO and
Dr. John D. Martinez, MD, University of Kansas Medical Center
421 Relation Between Environmental Allergen Exposure and
Chronic Urticaria
Dr. Denisa Ferastraoaru, MD, MSc, Allergy - Immunology, Al-
bert Einstein College of Medicine / Montefiore Medical Center,
Bronx, NY, Dr. Sunit Jariwala, MD, Albert Einstein/Montefiore
Medical Center, New York, NY, Dr. Golda Hudes, MD, PhD, Albert
Einstein/ Montefiore Medical Center, New York, NY and Dr. David
L. Rosenstreich, MD, FAAAAI, Albert Einstein/Montefiore Medi-
cal Center, Bronx, NY
422 Relationship Of Clinical Characteristics Of Chronic Urticaria
In Children To Treatment Outcome
Lisa Neverman, B.S. and Prof. Miles M. Weinberger, MD,
FAAAAI, University of Iowa, Iowa City, IA
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
423 Clinical Characteristics Of Elderly Chronic Urticaria
Dr. Ga Young Ban, MD1, Ji Hye Kim, MD2, Mi-Yea Kim, MD1,
Dr. Hye-Soo Yoo, MD1, Dong-Ho Nahm, MD, PhD1, Dr. Young
Min Min Ye, MD1, Yoo Seob Shin, MD, PhD1 and Prof. Hae-
Sim Park, MD, PhD1, 1Department of Allergy & Clinical Immunol-
ogy, Ajou University School of Medicine, Suwon, South Korea,
2
Department of Internal medicine, Konyang University College of
Medicine, Daejeon, South Korea
424 Decreased Serum Vitamin D Level In Patients With Chronic
Spontaneous Urticaria
Dr. Tadech Boonpiyathad, MD, Dr. Panitan Pradappongsa and Dr.
Atik Sangasapaviriya, Phramonkutklao Hospital, Bangkok, Thailand
425 Supplementation With Vitamin D In a Cohort Of Patients With
Chronic Urticaria Results In Clinical Improvement
Dr. Anastasiya Kleva, MD, Dr. Sherry Farzan, MD and Dr. Blanka
M. Kaplan, MD, FAAAAI, Department of Pediatrics, Division of
Allergy & Immunology, Hofstra-North Shore-LIJ School of Medi-
cine, Great Neck, NY
426 Clinical and Laboratory Features Of Chronic Urticaria
Dr. Koji Masuda, Kyoto Prefectural University of Medicine,
Kyoto, Japan
427 Serum Specific IgE Response To Thyroid Autoantigens In Aspi-
rin Intolerant Urticaria Patients
Dr. Yoo Seob Seob Shin, MD, PhD, Dr. Hye-Soo Yoo, MD, Dr.
Ga Young Ban, MD, Dr. Young Min Min Ye, MD and Prof. Hae-
Sim Park, MD, PhD, Department of Allergy & Clinical Immu-
nology, Ajou University School of Medicine, Suwon, South
Korea
428 Basophil Receptor Profiles In Chronic Idiopathic Urticaria
Dr. Eric Oliver, MD, Ms. Patricia M. Sterba, MS and Dr. Sarbjit S.
Saini, MD, FAAAAI, Department of Medicine, Division of Allergy
and Clinical Immunology, Johns Hopkins University School of
Medicine, Baltimore, MD
429 Altered Systemic Adipokine Levels In Patients With Chronic
Idiopathic Urticaria
Dr. Young Min Ye, MD, Dr. Ga Young Ban, MD, Eun-Mi Yang,
Dr. Hye-Soo Yoo, MD, Yoo Seob Shin, MD, PhD and Prof. Hae-
Sim Park, MD, PhD, Department of Allergy & Clinical Immu-
nology, Ajou University School of Medicine, Suwon, South
Korea
430 Predicting Clinical Responsiveness To Dapsone In The Treat-
ment Of Chronic Idiopathic Urticaria (CIU)
Dr. Ryan A. Steele, DO, MS1, Dr. Janelle Sher, MD2, Dr. Mark
Davis-Lorton, MD, FAAAAI2, Dr. Marcella R. Aquino, MD,
FAAAAI2 and Dr. Luz S. Fonacier, MD, FAAAAI3, 1Allergy & Im-
munology, Winthrop University Hospital, Mineola, NY, 2Winthrop
University Hospital, Allergy & Immunology, Mineola, NY, 3Section
of Allergy and Clinical Immunology, Department of Medicine,
Winthrop University Hospital, Mineola, NY
431 Chronic Urticaria/Angioedema and Auto-Immunity: Diagnostic
Profile Among Patients Attending a Reference Clinic In Brazil
Dr. Daniel L. Cordeiro, MD1, Dr. Janaina Fernandes de Melo
Sousa, MD1, Dr. Karine Boufleur, MD1, Dr. Priscila Botelho Palhas,
MD1, Dr. Thas Mendonca, MD1, Dr. Janaina Michele de Lima
Melo, MD1 and Dr. Luisa Karla P. Arruda, MD, PhD, FAAAAI2,
1
Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao
Preto, Brazil, 2School of Medicine of Ribeirao Preto, Ribeirao
Preto, Brazil
432 Chronic Spontaneous Urticaria-The Saskatchewan Experience
and Questionnaire Survey
Ms. Natasha Gattey, University of Saskatchewan, Saskatoon, SK,
Canada
433 A Case Of Incontinentia Pigmenti Masquerading As Urticaria
Pigmentosa
Dr. Erin C. Donahue, MD and Dr. Sonal R. Patel, MD, White Me-
morial Medical Center, Los Angeles, CA
Abstracts AB321
434 Acute Urticaria Caused By Infection In 72 Chinese Patients
Prof. Ting Xiao, The First Affiliated Hospital, China Medical Uni-
versity, Shenyang, China and Dr. Lin Zhu, The First Affiliated Hos-
pital, China Medical University
435 Assessment Of Acute Urticaria In Pediatric Emergency Depart-
ment
Dr. Raquel Reis Pitchon, Clinical Research1, Mr. Daniel Reis,
Medical Student2, Ms. Adriana Reis, Medical Student3, Mr. Andre
Chuster, Medical Student3, Prof. Teresa Mohallen, Professor2, Dr.
Jose Ribeiro, Pediatrician4, Dr. Nvea Claret, Pediatrician4, Dr.
Giane Chaves, Pediatrician4, Dr. Virgilio Aleixo, Pediatrician4,
Dr. Maria do Socorro Fernandes, Pediatrician4 and Dr. Fausto Pa-
checo, Pediatrician4, 1Mater Dei Hospital, BELO HORIZONTE,
Brazil, 2Universidade Federal de Minas Gerais, BELO HORI-
ZONTE, Brazil, 3Faculdade de Ciencias Medicas, BELO HORI-
ZONTE, Brazil, 4Hospital Mater Dei, BELO HORIZONTE, Brazil
436 OTC Pills and Severe Urticaria
Ivan Cherrez1, Enrique Loayza2, Leonardo Greiding3, Jose M. Vi-
SUNDAY
lema4, Juan Calderon4, Erick Calero4 and Gabriela Martinetti4,
1
Respiralab - Hospital Kennedy, Guayaquil, Ecuador, 2Respiralab
- Hospital Luis Vernaza, Guayaquil, Ecuador, 3Instituto Argentino
de Alergia e Inmunologia, Buenos Aires, Argentina, 4Respiralab,
Guayaquil, Ecuador
437 Hypocomplementemic Urticarial Vasculitis With Elevated Im-
mune Complexes and Nasal Polyposis
Dr. Khrystyna Lishchuk-Yakymovych, MD, Medical University,
Lviv, Ukraine, Dr. Roman Pukalyak, Danylo Halytskyy Lviv Na-
tional Medical University, Ukraine and Prof. Lawrence M. Du-
Buske, MD, FAAAAI, George Washington University School of
Medicine, DC
Pediatric Population Health
3209
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
438 Nannies Knowledge, Attitude and Management Of Food Aller-
gies In Children; An Online Survey
Dr. Justin C. Greiwe, MD1, Dr. Lisanne P. Newton, MD2, Dr. Fou-
seena Pazheri, MD3 and Dr. Brian C. Schroer, MD2, 1Cleveland
Clinic, Cleveland, OH, 2Cleveland Clinic Foundation, Cleveland,
OH, 3Cleveland Clinic
439 Does Omega-3 Fatty Acid Supplementation During Pregnancy
Prevent Childhood Atopic Disease?
Dr. Manika Girdhar, DO, Childrens Mercy Hospital & Clinics,
Kansas City, MO and Dr. Christina E. Ciaccio, MD, FAAAAI, Chil-
drens Mercy Hospital, Kansas City, MO
440 Helping Children Cope With Discomfort Associated With Skin
Prick Testing In a Pediatric Setting: A Quality Improvement
Report
Ms. Amanda Troger, BSN, RN1, Ms. Humaira Robinson, BSN
RN1, Ms. Sonia C. Mancia, RN2, Dr. Hemant P. Sharma, MD
MHS FAAAAI3 and Dr. Katherine Kelly, PhD, RN1, 1Childrens
National Medical Center, Washington, DC, 2Childrens National
Medical Center, Fairfax, VA, 3Childrens National Medical Center
441 Are Total Serum IgE Levels Good Predictors Of Allergies In
Children?
Dr. Stephanie Barnes-Mercado1, Dr. Vylma Velazquez, MD2 and
Dr. Annette Pietri-Ramirez1, 1Hospital Episcopal San Lucas-Ponce,
2
Hospital Episcopal San Lucas, Ponce, PR
442 Relationship Between Maternal Fat During Pregnancy and
Risks Of Allergic and Respiratory Diseases In Early Childhood:
The Mothers and Childrens Environmental Health Study
Prof. Ja Hyeong Kim, MD1, Prof. Eun-Hee Ha, MD2, Prof. Hye
sook Park, MD2, Prof. Mina Ha, MD3, Prof. Yun-Chul Hong,
111
 AB322 Abstracts
MD4, Prof. Yangho Kim, MD5, Mr. Min-ho Kim, PhD6, Prof. Jin-A
Jung, MD7 and Prof. NamSoo Chang, PhD8, 1Ulsan University
Hospital, Ulsan, South Korea, 2Department of Preventive Medicine,
School of Medicine, Ewha Womans University, South Korea, 3De-
partment of Preventive Medicine, Dankook University College of
Medicine, 4Department of Preventive Medicine, Seoul National
University College of Medicine, South Korea, 5Department of Oc-
cupational and Environmental Medicine, University of Ulsan, Col-
lage of Medicine, Ulsan University Hospital, South Korea, 6Ulsan
University Hospital, South Korea, 7Dong-A University College of
Medicine, Busan, 8Department of Nutritional Science and Food
Management, Ewha Womans University, Seoul, Korea, South
Korea
443 The Efficacy Of Training School and Nursery Personnel On Ep-
inephrine Autoinjector Use
Dr. Mari Sasaki, MD, Dr. Mayumi Furukawa, MD, Dr. Koichi
Yoshida, MD and Dr. Akira Akasawa, MD, PhD, Division of Al-
lergy, Tokyo Metropolitan Childrens Medical Center, Tokyo, Japan
SUNDAY
444 Referral Patterns To An Outpatient Allergy/Immunology Clinic
At a Tertiary Care Pediatric Academic Center
Kasey Strothman, MD1,2, David R. Stukus, MD, FAAAAI1 and
Rebecca Scherzer, MD, FAAAAI1, 1Nationwide Childrens Hospi-
tal, Columbus, OH, 2Wexner Medical Center at The Ohio State Uni-
versity, Columbus, OH
445 Food Allergy Education Significantly Improves School Person-
nel Food Allergy Knowledge and Bullying Attitudes
Niti Y. Chokshi, MD1, Kristin H. Dillard, MD1, Danielle Guffey,
MS2, Charles Minard, PhD2 and Carla M. Davis, MD1, 1Baylor
College of Medicine and Texas Childrens Hospital, Section of Im-
munology, Allergy and Rheumatology, Houston, TX, 2Baylor Col-
lege of Medicine, Houston, TX
Health Information Technology
3210
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
446 How Patients Rate Their Allergists Online: Analysis Of Physi-
cian-Review Websites
Xiao C. Wan, M.D., University of Chicago, Department of Internal
Medicine, Chicago, IL and Ves Dimov, MD, Section of Allergy,
Asthma and Immunology, Department of Pediatrics, Department
of Medicine, University of Chicago, Chicago, IL
447 Improving Allergy and Immunology Education For The Internal
Medicine Resident Through Internet-Based Learning Modules
Dr. Michelle C. Fox, MD1,2, Dr. Paige G. Wickner, MD3 and Dr. Ma-
riana C. Castells, MD, PhD, FAAAAI4, 1Brigham and Womens Hos-
pital, 2Harvard Medical School, 3Brigham & Womens Hospital,
Chestnut Hill, MA, 4Division of Rheumatology, Allergy and Immu-
nology, Department of Medicine, Brigham and Womens Hospital,
Harvard Medical School, Boston, MA
448 Electronic Patient Data Acquisition Tablet (ePDAT) Provides
Customized, Flexible Scheduling For Collecting Patient Re-
ported Outcomes (ePRO) With High Usability and Compliance
Ideal For Use In Single and Multicenter Environmental Expo-
sure Chamber Studies
Mr. Dan Wilson, Dr. Piyush Patel, MD, FRCP, Konrad Boczula
and Dr. AnneMarie Salapatek, PhD, Inflamax Research, Missis-
sauga, ON, Canada
449 Feasibility and Acceptability Of a Novel Asthma Self-Manage-
ment Smartphone Application For Children and Adolescents
Nabeel Farooqui, MD1,2, Gary Phillips, M.A.S.2 and David R. Stu-
kus, MD, FAAAAI1,2, 1Nationwide Childrens Hospital, Columbus,
OH, 2Wexner Medical Center at The Ohio State University, Colum-
bus, OH
112
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
450 Experience In The Development Of a Mobile Diagnosis Support
System For Asthma: Intelimed
Prof. Silvia Wanick Sarinho Sr., Prof.Dr.1, Prof. Julio Ven^ancio
Menezes Junior1, Prof. Cristine Gusm~ao1 and Nilza R S Lyra,
MD2, 1Universidade Federal de Pernambuco, 2Universidade Federal
de Pernambuco, Recife PE, Brazil
451 An Assessment Of Food Allergy Knowledge Among Parents Of
Children With Food Allergy and The Role Of An Educational
Website
Jamee Castillo, MD1, Neha Mehrotra, MD1, Raoul L. Wolf, MD,
FAAAAI2 and Ves Dimov, MD3, 1Internal Medicine Residency Pro-
gram, Department of Medicine, University of Chicago, Chicago, IL,
2
Section of Allergy, Asthma and Immunology, Department of Pedi-
atrics, Department of Medicine, University of Chicago, Chicago,
IL, 3University of Chicago Medicine, Chicago, IL
Chronic Rhinosinusitis and Polyps
3211
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
452 The Differences Of TNF-a, Rantes, Interleukin-5 Levels In Na-
sal Polyps With Allergic, Local Allergic, and Non-Allergic Rhi-
nitis
Prof. Jae-Won Oh, MD, PhD, FAAAAI, Hanyang University Guri
Hospital, Seoul, Dr. Joo-Hwa Kim, MD, Hanyang University Guri
Hospital, Seoul, South Korea and Dr. JIn-Hyuk Cheong, Hanygang
University Guri Hospital, Guri, South Korea
453 Cigarette Smoke Promotes Eosinophilic Inflammation, Airway
Remodeling and Nasal Polyps In a Murine Polyp Model
Dr. Ji-Hun Mo, Department of Otorhinolaryngology, Dankook
University College of Medicine, Cheonan, South Korea and Ki-Il
Lee, Dankook university, South Korea
454 Evaluation Of Oral Antibiotics Versus Placebo For The Treat-
ment Of Rhinosinusitits With Neutrophilia On Nasal Cytology
Manar Abdalgani, MD1, Dr. Joud Hajjar, MD2, Krista Edelman,
MD1 and Dr. Lawrence B. Schwartz, MD, PhD, FAAAAI1, 1Vir-
ginia Commonwealth University, Richmond, VA, 2Baylor Colleage
of Medicine, Houston, TX
455 Pediatric Allergic Fungal Otomastoiditis Improved With Anti-
IgE Therapy
Dr. Diana K. Bayer, DO1, Dr. Ankhi Dutta, MD, MPH2,3, Dr. Rob-
ert Williamson, MD4, Dr. Andrew deJong, MD3,5, Dr. Keith Paull,
MD3,6, Dr. I. Celine Hanson, MD, FAAAAI1 and Dr. Lisa R. For-
bes, MD1, 1Baylor College of Medicine-Texas Childrens Hospital,
Section of Immunology, Allergy, and Rheumatology, Houston, TX,
2
Health Point ABC Clinic, College Station, TX, 3Texas A&M
Health Science Center, Bryan, TX, 4Texas Childrens Hospital-Bay-
lor College of Medicine, Department of Surgery, Otolaryngology,
Houston, TX, 5Texas ENT and Allergy, Bryan, TX, 6The Paull Al-
lergy and Asthma Clinic, Bryan, TX
456 Measurement Of Nasal and Exhaled Nitric Oxide In Chronic
Rhinosinusitis and Its Comparison According To The Presence
Of Nasal Polyps
Dr. Woo Yong Bae, MD, Department of Otorhinolaryngology, Col-
lege of Medicine, Dong-A University, Busan, South Korea, Prof.
Jin-A Jung, MD, Dong-A University College of Medicine, Busan
and Dr. Young-Hee Nam, MD, Department of Internal Medicine,
College of Medicine, Dong-A University, Busan, South Korea
457 Post-Translational Modification By Serine Proteases Controls
The CCL23 Activity In Nasal Polyps Of Chronic Rhinosinusitis
Dr. Atsushi Kato, PhD1, Dr. Anjeni Keswani, MD1, Dr. Julie Kim,
M.D.1, Ms. Julie Poposki, MS1, Dr. Sarah Peterson, MD1, Ms. Ly-
dia Suh, BSc1, Mr. James Norton, MS1, Dr. Anju T. Peters, MD,
FAAAAI1, Dr. Kathryn E. Hulse, PhD2, Dr. Leslie C. Grammer,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
MD, FAAAAI1, Dr. Bruce K. Tan, MD3, Dr. Rakesh Chandra,
MD2, Dr. David Conley, MD3, Dr. Juan Jaen, PhD4, Dr. Thomas
Schall, PhD4, Dr. Robert C. Kern, MD1,3 and Dr. Robert P.
Schleimer, PhD FAAAAI5, 1Department of Medicine, Division of
Allergy-Immunology, Northwestern University Feinberg School
of Medicine, Chicago, IL, 2Northwestern University, Chicago, IL,
3
Department of Otolaryngology, Northwestern University Feinberg
School of Medicine, Chicago, IL, 4Chemocentryx Inc, Mountain
View, CA, 5Division of Allergy-Immunology, Department of Med-
icine, Northwestern University Feinberg School of Medicine, Chi-
cago, IL
458 Sinusitis In Latino Children Is Associated With Allergic Respi-
ratory Diseases and Inversely Related To Native American An-
cestry (GALA II Study)
Dr. Jennifer A. Regan, MD, PhD1, Dr. Joy Hsu, MD, MSCI2, Ms.
Elizabeth Nguyen, BS3, Ms. Lindsey Roth, MA4, Dr. Joshua Gal-
anter, MD4, Dr. Sam Oh, PhD, MPH4, Ms. Celeste Eng, BS4, Mr.
Fred Lurmann, MS5, Dr. Rajesh Kumar, MD, MS, FAAAAI6, Dr.
Harold J. Farber, MD, MSPH7, Dr. Denise Serebrisky, MD8, Dr.
Luisa Borrell, DDS, PhD9, Dr. Saunak Sen, PhD10, Dr. William Ro-
driguez-Cintron, MD11, Dr. Jose Rodriguez-Santana, MD12, Dr. Es-
teban Gonza Burchard, MD, MPH4 and Prof. Pedro C. Avila, MD,
FAAAAI1, 1Feinberg School of Medicine, Northwestern University,
Chicago, IL, 2Department of Medicine, Division of Allergy-Immu-
nology, Northwestern University Feinberg School of Medicine,
Chicago, IL, 3Department of Medicine, University of California,
San Francisco, California, San Francisco, CA, 4Department of
Medicine, University of California, San Francisco, San Francisco,
CA, 5Sonoma Technology, Inc., Petaluma, CA, 6Pediatric allergy,
Ann & Robert H. Lurie Childrens Hospital of Chicago, Chicago,
IL, 7Baylor College of Medicine and Texas Childrens Hospital,
Houston, TX, 8Pediatric Pulmonary Division, Jacobi Medical Cen-
ter, Bronx, NY, 9Department of Health Sciences, Graduate Program
in Public Health, Lehman College, City University of New York,
Bronx, NY, 10Department of Epidemiology and Biostatistics, Uni-
versity of California, San Francisco, San Francisco, CA, 11Veterans
Caribbean Health Care System, San Juan, PR, 12Centro de Neumo-
logia Pediatrica, San Juan, PR
459 Evaluation Of Olfactory Function In Patients With Chronic
Rhinitis
Dr. Idalia V. Yanez-Perez, MD, Dr. Sandra N. Gonzalez-Diaz,
MD, PhD, FAAAAI, Dr. Alejandra Macias-Weinmann, Dr. Alfredo
Arias-Cruz, Dr. Lorena Rangel-Garza, Dr. Hilda Hernandez-San-
chez, MD, Dr. Rafael Perez-Vanzzini and Dr. Karla Mejia-Salas,
Regional Center of Allergy and Clinical Immunology. University
Hospital Dr. Jose Eleuterio Gonzalez., Monterrey, Mexico
460 A Method For Assessing Regional Determinants Of Eosino-
philia In Chronic Rhinosinusitis
Dr. Bruce K. Tan, MD1, Ms. Erin Rocci, BS2, Dr. Kent Lam, MD1,
Ms. He Huang, MS1, Ms. Lydia Suh, BSc3, Mr. Avesh Thuluvath,
BA4, Ms. Alcina K. Lidder, BA1, Dr. Rakesh Chandra, MD5, Dr.
David Conley, MD1, Dr. Stephanie Shintani-Smith, MD1, Dr. Ka-
thryn E. Hulse, PhD5, Dr. Atsushi Kato, PhD3, Dr. Anju T. Peters,
MD, FAAAAI3, Dr. Leslie C. Grammer, MD, FAAAAI3, Dr. Robert
C. Kern, MD1 and Dr. Robert P. Schleimer, PhD FAAAAI6, 1De-
partment of Otolaryngology, Northwestern University Feinberg
School of Medicine, Chicago, IL, 2Loyola University Stritch School
of Medicine, Chicago, IL, 3Department of Medicine, Division of
Allergy-Immunology, Northwestern University Feinberg School
of Medicine, Chicago, IL, 4Northwestern University- Feinberg
School of Medicine, Chicago, IL, 5Northwestern University, Chi-
cago, IL, 6Division of Allergy-Immunology, Department of Medi-
cine, Northwestern University Feinberg School of Medicine,
Chicago, IL
461 The Prevalence Of AERD In a Tertiary Care Center
Dr. Whitney Wyatt Stevens, MD, PhD1, Dr. Anju T. Peters, MD,
FAAAAI1, Dr. Kathryn E. Hulse, PhD2, Dr. Leslie C. Grammer,
Abstracts AB323
MD, FAAAAI1, Dr. Joy Hsu, MD, MSCI1, Prof. Pedro C. Avila,
MD, FAAAAI1, Mr. James Norton, MS1, Ms. Lydia Suh, BSc1,
Dr. Rakesh Chandra, MD2, Dr. David Conley, MD3, Dr. Robert
C. Kern, MD3, Dr. Bruce K. Tan, MD3 and Dr. Robert P. Schleimer,
PhD FAAAAI4, 1Department of Medicine, Division of Allergy-Im-
munology, Northwestern University Feinberg School of Medicine,
Chicago, IL, 2Northwestern University, Chicago, IL, 3Department
of Otolaryngology, Northwestern University Feinberg School of
Medicine, Chicago, IL, 4Division of Allergy-Immunology, Depart-
ment of Medicine, Northwestern University Feinberg School of
Medicine, Chicago, IL
462 Expression Of Hypoxia-Inducible Factor 1alpha In Regulatory
T Cells Is Associated With Nasal Polypogenesis
Prof. Yong Min Kim1, Dr. Jun Jin2, Dr. Dong-Yeop Chang3, Sung
Ha Kim4 and Ki-Sang Rha4, 1Chungnam National University
School of Medicine, Daejeon, South Korea, 2Chungnam National
University School of Medicine, 3Laboratory of Immunology and In-
fectious Diseases, Graduate School of Medical Science and Engi-
SUNDAY
neering, KAIST, Daejeon, South Korea, 4Chungnam National
University School of Medicine, South Korea
463 Prognoistic Factors For Olfaction After Endoscopic Sinus Sur-
gery In Chronic Sinusitis With Or Without Allergy
Dr. Byung Guk KIM1, Jihyun SHIN2, Chan Soon PARK2, Dr. Soo
Whan Kim3, JUN Myung Kang2 and So Young PARK2, 1The Catholic
University Of Korea, Seoul, Korea, South Korea, 2The Catholic Univer-
sity Of Korea, Seoul, Korea, 3The Catholic University of Korea
Rhinitis
3212
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
464 The Association Between Two SNPs GATA3 (rs1269486,
rs2229360) Gene and Allergic Rhinitis
Prof. Reza Farid, MD, FAAAAI, Allergy Research Center, Mash-
had University of Medical Sciences, Iran, Prof. mohammad Raza
Abbaszadegan, 1. Genetic Research Center,Mashhsd University of
Medical Science, mashhad, Iran, Prof. Farahzad Jabbari, Allergy re-
search center, Mashhsd University of Medical Science, Mashhad,
Iran, Prof. Mehran Gholamin, Immunology Research Center,1.
Mashhsd University of Medical Science, mashhad, Iran, Dr. Afshin
Shirkani, MD, Bushehr University of Medical Science, Mashhad,
Iran, Mrs. Hadis Yousefzadeh, allergy Research Center. Mashhsd
University of Medical Science, mashhad, Iran and Ms. Atena Man-
souri, buoshar university, Iran
465 Impacts Of Adolescents Allergic Rhinitis On School Achieve-
ment and Quality Of Life
Prof. Sun-Hee Choi, MD, PhD1, Dr. Kyung Suk Lee, MD, PhD2
and Prof. Yeong-Ho Rha, MD, PhD2, 1Gangdong Kyung Hee Uni-
versity Hospital, Seoul, South Korea, 2Kyung Hee University
Hospital
466 Allergic Rhinitis (AR) Is Sub-Optimally Controlled: The Need
For a More Effective Treatment Option
Dr. Phillip L. Lieberman, MD, FAAAAI, Allergy and Asthma As-
sociates, Germantown, TN and Prof. David Price, FRCGP, MRCGP,
DRCOG, Research In Real Life, Cambridge, United Kingdom
467 Short and Long-Term Safety Of MP29-02 In The Treatment Of
Allergic Rhinitis
Dr. William Berger, MD, Allergy & Asthma Associates of South-
ern California, Mission Viejo, CA, Dr. Jonathan A. Bernstein, MD,
FAAAAI, Division of Immunology Allergy & Rheumatology, Uni-
versity of Cincinnati Medical Center, Cincinnati, OH, Dr. Nancy
Ruiz, MD, MEDA Pharmaceuticals, Somerset, NJ and Dr. Warner
W. Carr, MD, FAAAAI, Allergy and Asthma Associates of SCs,
Mission Viejo, CA
113
 AB324 Abstracts
468 Anti-Allergic Effect Of Intranasal 1,25-Dihydroxyvitamin D3
Treatment In Allergic Rhinitis Mouse Model
Dr. Dong-Young Kim, Division of Allergy-Immunology, Depart-
ment of Medicine, Northwestern University Feinberg School of
Medicine, Chicago, IL; Department of otorhinolaryngology, Seoul
national university college of medicine, Seoul, Korea and Dr. Jae-
Min Shin, Department of Otorhinolaryngology-Head and Neck Sur-
gery, Soon Chun Hyang University Hospital, Seoul, South Korea
469 B-Cells In Allergic Airways Disease: Inhibition Of Epsilon
Transcription By Omalizumab
Dr. Marylin Desjardins, MD1,2, Dr. Jean-Philippe Drolet, MD3,
Ms. Marianne Beland2, Dr. Sam Daniel, MD1 and Dr. Bruce D. Ma-
zer, MD, FAAAAI1,4, 1Montreal Childrens Hospital, Montreal,
QC, Canada, 2Meakins-Christie Laboratories, Montreal, QC, Can-
ada, 3Centre Hospitalier Universitaire de Quebec, Quebec, QC,
Canada, 4Meakins-Christie Laboratories, Research Institute -
McGill University Health Centre, Montreal, QC, Canada
470 Early Childhood Allergic Phenotypes Are Associated With In-
SUNDAY
ternalizing Disorders
Maya Nanda, MD1, Linda Levin, PhD2, Grace K. LeMasters, PhD2,
Amal H. Assaad, MD, FAAAAI1, Nicholas Newman, DO, MS1 and
Patrick Ryan, PhD1, 1Cincinnati Childrens Hospital Medical Center,
Cincinnati, OH, 2University of Cincinnati, Cincinnati, OH
471 Allergic Rhinitis In Puerto Rican Children: Under-Diagnosis
and Risk Factors
Dr. Tammy S. Jacobs, MD, MA, Dr. Erick Forno, MD, MPH, Dr.
John M. Brehm, MD, MPH, Dr. Yueh-Ying Han, PhD, MS and Dr.
Juan C. Celedon, MD, DrPH, FAAAAI, Childrens Hospital of
Pittsburgh of UPMC, Pittsburgh, PA
472 Hematopoietic Prostaglandin D Synthase Is a Useful Target For
Treating Nasal Obstruction In Guinea Pigs With Allergic Rhi-
nitis
Daisuke Kajiwara, Hiroki Aoyagi, Kazuhiko Shigeno, Katsunao
Tanaka, Eiji Sasaki and Teruhiro Utsugi, Tsukuba Research Center,
TAIHO PHARMACEUTICAL CO.,LTD.
473 Efficacy Of MP29-02 In The Treatment Of Nasal and Ocular
Symptoms Of Seasonal Allergic Rhinitis (SAR)
Dr. Paul H. Ratner, MD, FAAAAI, Sylvana Research, San Antonio,
TX, Dr. Frank Hampel, MD, Central Texas Health Research, Dr. Julius
Van Bavel, MD, Allergy and Asthma Research Associates, Austin, TX
and Dr. Nancy Ruiz, MD, MEDA Pharmaceuticals, Somerset, NJ
474 Atypical Symptoms Of Chronic Rhinitis and The Impact On
Quality Of Life
Jettanong Klaewsongkram, Chulalongkorn University, Bangkok,
Thailand and Pungjai Mongkolpathumrat, King Chulalongkorn Me-
morial Hospital, Bangkok, Thailand
475 Clinical Characteristics Of Allergic and Nonallergic Rhinitis In
Children
Dr. Yong Ju Lee, MD1, Prof. Kyung Won Kim, MD, PhD2, Prof.
Myung Hyun Sohn, MD, PhD2, Prof. Kyu-Earn Kim, MD, PhD2
and Prof. Hae-Ran Lee, MD, PhD3, 1Hallym University Kangnam
Sacred Heart Hospital, Seoul, South Korea, 2Department of Pediat-
rics, Severance Childrens Hospital, College of Medicine, Yonsei
University, Seoul, Korea, Seoul, South Korea, 3Hallym University
Sacred Heart Hospital, Anyang-si, Gyeonggi-do, South Korea
Mechanisms of Lymphocyte Function
3213
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
476 GATA3-Expressing ILC2 Are Selectively Enriched In Allergic
Eosinophilic Nasal Polyposis
Dr. Hannah H. Walford, MD1, Dr. Andrew A. White, MD,
FAAAAI2, Dr. Christopher Bergeron, MD3, Dr. Jacob Husseman,
114
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
MD4, Dr. Kelly Bethel5, Ms. Rachel Baum, B.S.4, Mr. Sean
Lund, B.S.6, Naseem Khorram, M.S.6, Dr. David R. Scott, M.D.7,
Dr. David H. Broide, MB ChB FAAAAI8 and Dr. Taylor A. Doh-
erty, MD, FAAAAI9, 1University of California, San Diego, San
Diego, CA, 2Scripps Clinic Medical Group, San Diego, CA,
3
Scripps Clinic, San Diego, CA, 4University of California, San
Diego, 5Scripps Green Hospital, 6University of California, San
Diego, La Jolla, CA, 7Allergy and Asthma Center of Western Col-
orado, 8Department of Medicine, San Diego, CA, 9Medicine, Uni-
versity of California, San Diego, San Diego, CA
477 Innate and Adaptive Lymphocyte Responses In a Mouse Model
Of Rhinovirus-Induced Asthma Exacerbation
Dr. Annabelle Jayaraman, PhD, Dr. Nathan Bartlett, PhD and
Prof. Sebastian L. Johnston, MD, PhD, Imperial College London,
London, United Kingdom
478 Aspergillus Fumigatus May Promote Th2 Activation By Sup-
pression Of Interferon Signaling
Dr. Tetsuya Homma, MD1,2, Mr. Bharat Bhushan1,3, Dr. Atsushi
Kato, PhD1, Mr. James Norton, MS1, Ms. Lydia Suh, BSc1, Dr.
Quan Sha, MD, PhD4, Dr. Dave S. Gupta, MD5 and Dr. Robert P.
Schleimer, PhD FAAAAI6, 1Department of Medicine, Division of
Allergy-Immunology, Northwestern University Feinberg School
of Medicine, Chicago, IL, 2Department of Internal Medicine, Divi-
sion of Respiratory Medicine and Allergology, Showa University
School of Medicine, Tokyo, Japan, 3Division of Otolaryngology-
Head and Neck Surgery, Ann & Robert H. Lurie Childrens Hospi-
tal of Chicago, 4Allergy and Immunology research center, Anhui
Medical University, China, 5Department of Allergy Immunology,
National Jewish Health, Denver, CO, 6Division of Allergy-Immu-
nology, Department of Medicine, Northwestern University Feinberg
School of Medicine, Chicago, IL
479 Heterogeneity Of Specific CD4+ T Cell Responses To Peanut Al-
lergic Components: Prospects For Specific Immunotherapy
Dr. Erik R. Wambre, PhD, Benaroya Research Institute, Seattle,
WA, William W. Kwok, PhD, Benaroya Research Institute at Vir-
ginia Mason, Seattle, WA and Dr. David Robinson, Virginia Mason
Medical Center
480 Vitamin D Supplementation Reduces Th17 Cells In The Lung
and Spleen Of CRA-Sensitized and Challenged Mice
Ankita Aggarwal1, Greg Perry1, Vikash Kansal2, Min-Jung Kim1
and Devendra K. Agrawal1, 1Department of Medical Microbiology
& Immunology and Center for Clinical & Translational Science,
Creighton University School of Medicine, Omaha, NE, 2Center
for Clinical and Translational Science and Department of Biomed-
ical Sciences, Creighton University School of Medicine, Omaha,
NE
481 Distinct Patterns and Magnitude Of T Cell Responses Are Asso-
ciated With Seasonal Exposure To Timothy Grass Allergens
Dr. Pearl Bakhru1, Carla Oseroff1, Dr. Veronique M. Schulten1,
Dr. Denise Hinz1, Victoria Tripple1, Rafeul Alam, MD, PhD,
FAAAAI2, Dr. David H. Broide, MB ChB FAAAAI3, Dr. April
Frazier1, John Sidney1, Dr. Bjoern Peters1, Dr. Howard Grey1 and
Dr. Alessandro Sette, Dr. Biol. Sci.1, 1La Jolla Institute for Allergy
and Immunology, La Jolla, CA, 2National Jewish Health, Denver,
CO, 3Department of Medicine, San Diego, CA
482 IgE Production In B Cells Through Up-Regulating CD40L Ex-
pression and Mediator Release Via CD1d Expressed In Surface
Of Mast Cells Related To Allergic Asthma In Mice
Jai Youl Ro1, Gwan Ui Hong1, Nam Goo Kim1 and Young Min
Ahn2, 1Sungkyunkwan University School of Medicine, 2Eulji Uni-
versity School of Medicine
483 FOXP3 Epigenetic Signature To Distinguish Between Thymic-
and Peripherally-Derived Regulatory T Cells During In Vivo
Induction Of Immune Tolerance
Dr. Philippe Begin, MD, MSc FRCPC1,2, Dr. Udo Baron, PhD3,
Dr. Sven Olek, PhD3, Dr. Rosa Bacchetta, MD, PhD1,4 and Dr.
Kari C. Nadeau, MD, PhD, FAAAAI5, 1Stanford University,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Pediatric Allergy and Immunology, 2Centre Hospitalier Universi-
taire Ste-Justine, Montreal, QC, Canada, 3Epiontis GmbH, Berlin,
Germany, 4San Raffaele Telethon Institute for Gene Therapy
(HSR-TIGET), Milan, Italy, 5Pediatric Allergy Immunology, Stan-
ford University, Stanford, CA
484 CD4+ and CD8+ T Cells Of Allergic Humans Express Increased
Phosphorylated p38 MAP Kinase (p38MAPK), Substance P
Suppresses T Cell Expression Of p38MAPK and Memory IgE
Responses
Bryan McCarthy, BS1, Jonathan I Silverberg, MD, PhD, MPH1, Seto
M Chice, MS1, Ankuri Desai, BS1, Dr. Tamar A. Smith-Norowitz, PhD1,
Mark Stewart, MD, PhD1, Dr. Rauno Joks, MD2 and Helen G Durkin,
PhD1, 1Center for Allergy and Asthma Research at SUNY Downstate,
Brooklyn, NY, 2Center for Allergy and Asthma Research, State Univer-
sity of New York Downstate Medical Center, Brooklyn, NY
485 Novel Mechanisms Of Immune Modulation By Alpha-1-Anti-
trypsin
Louise V. Rice1, Sarah Dimeloe1, Mun Peak Nyon2, Imran Haq3,
James Irving3, James McDonnell4, Bibek Gooptu2,5, Claudia Kem-
per6 and Catherine M. Hawrylowicz4, 1MRC and Asthma UK Centre
for Allergic Mechanisms of Asthma, Kings College London, Lon-
don, United Kingdom, 2Institute of Structural and Molecular Biol-
ogy/Crystallography, London, United Kingdom, 3Cambridge
Institute for Medical Research, University of Cambridge, Cambridge,
United Kingdom, 4MRC and Asthma UK Centre for Allergic Mech-
anisms of Asthma, Kings College London, London, United King-
dom, 5Division of Asthma, Allergy and Lung Biology, Kings
College London, London, United Kingdom, 6MRC Centre for Trans-
plantation, Division of Transplantation Immunology and Mucosal Bi-
ology, Kings College London, london, United Kingdom
486 Prevalence Of Allergic Diseases and/Or Allergic Sensitization
In Children and Adolescents With Type 1 Diabetes Mellitus
Dr. Hadley Vila-Nova, MD1, Prof. Angela Spinola-Castro, MD,
PhD1, Dr. Fabola E. Garcia, MD2 and Prof. Dirceu Sole, MD,
PhD3, 1Federal University of S~ao Paulo, S~ao Paulo, Brazil, 2Federal
UNiversity of S~ao Paulo, S~ao Paulo, Brazil, 3Federal University of
Sao Paulo, Sao Paulo, Brazil
487 Microcytosis: A Risk Factor For Asthma and Pulmonary In-
flammation?
Dr. Emily Brigham, MD, Dr. Meredith C. McCormack, MD, Dr.
Clifford Takemoto, MD and Dr. Elizabeth Matsui, MD, The Johns
Hopkins University School of Medicine, Baltimore, MD
488 Identification and Cloning Of Active CLC3 Promoter
Rohit Gaurav and Devendra K. Agrawal, Department of Biomed-
ical Sciences and Center for Clinical and Translational Science,
Creighton University School of Medicine, Omaha, NE
Role of Structural Cells in Mechanisms in Health
and Disease
3214
Sunday, March 2nd, 2014, 9:45 AM - 10:45 AM
489 Airway Epithelial Cells Exposed To Alternaria Release IL-18
Independent Of NALP3/Caspase-1 Pathway By Inducing Au-
tophagy and Nf-Kb Activation
Hiroki Murai, MD, PhD1, Shintaro Okazaki, MD1, Hisako Haya-
shi, MD1, Akiko Kawakita, MD1, Motoko Yasutomi, MD, PhD1,
Mitsufumi Mayumi, MD, PhD1, Prof. Sanjiv Sur, MD2 and Yusei
Ohshima, MD, PhD1, 1University of Fukui, Fukui, Japan, 2Univer-
sity of Texas Medical Branch, Galveston, TX
490 Generation Of Human Hybridomas Secreting Naturally-Occur-
ring IgE MAbs Using Memory B-Cells From Atopic and Asth-
matic Patients
Dr. Scott A. Smith, MD, PhD1, Dr. Dennis Horvath, PhD1, Dr.
Charles Steven Smith, MD, FAAAAI2, Dr. Dawn C. Newcomb
Abstracts AB325
Baker, PhD3 and Dr. Ray Peebles, MD4, 1Infectious Diseases; De-
partment of Medicine; Vanderbilt University School of Medicine,
Nashville, TN, 2Accredited Asthma and Allergy Care, PCS, Louis-
ville, KY, 3Division of Allergy, Pulmonary and Critical Care Med-
icine, Vanderbilt University School of Medicine, Nashville, TN,
Nashville, TN, 4Allergy, Pulmonary, and Critical Care Medicine;
Department of Medicine; Vanderbilt University School of Medi-
cine, Nashville, TN
491 Anti-Viral Innate Immunity Varies Across Different Asthma In-
flammatory Phenotypes
Prof. John W. Upham, MD, PhD, FAAAAI1, Mrs. Melanie Car-
roll, BSc1, Prof. Peter Gibson, MD/PhD2,3, Prof. Ian A. Yang,
MBBS (Hons) PhD4 and Dr. Jodie Simpson, PhD2, 1University of
Queensland, Brisbane, Australia, 2University of Newcastle, New-
castle, Australia, 3John Hunter Hospital, Newcastle, Australia,
4
The University of Queensland
492 Effect Of siRNA Inhibition Of Sialyltransferases and Fucosyl-
transferases On Siglec-F Ligand Expression By Epithelial Cells
SUNDAY
In Vitro
Dr. Maho Suzukawa, MD, National Hospital Oranization, Tokyo
Hospital, Dr. Ken Ohta, National Hospital Organization Tokyo Na-
tional Hospital, Tokyo, Japan and David Broide, MB ChB, Univer-
sity of California San Diego, Department of Medicine, Division of
Allergy and Immunology
493 Allergic Airway Inflammation Can Be Regulated By Sema-
phorin 4C Through Controlling B-Cell Migration
Ms. Di Xue, Mcgill university, Montreal, QC, Canada, Dr. Mar-
ylin Desjardins, MD, Division of Allergy and Clinical Immunol-
ogy, Department of Paediatrics, McGill University Health Centre,
Montreal, QC, Canada, Dr. Bruce D. Mazer, MD, FAAAAI, Mon-
treal Childrens Hospital, Montreal, QC, Canada, Dr. Amir Hos-
sein Massoud, PhD, McGill University Health Centre, Montreal,
QC, Canada and Ms. Marianne Beland, MUHC, Montreal, QC,
Canada
494 Mouse Bone Marrow Derived Mesenchymal Stem Cells Supress
Airway Inflammation In Both Chronic and Acute Murine
Asthma Model
Dr. Tunc Akkoc, PhD1, Mr. Ismail Ogulur, MSc.1, Ms. Gulben
Gurhan1, Ms. Ayca Aksoy, MSc.2, Dr. Gokhan Duruksu, PhD2,
Dr. Deniz Filinte, MD3, Dr. Erdem Kombak3, Prof. Isil B. Barlan,
MD1 and Prof. Erdal Karaoz, PhD2, 1Marmara University Division
of Pediatric Allergy-Immunology, 2Kocaeli University Center for
Stem Cell and Gene Therapies Research and Practise, 3Marmara
University Department of Pathology
495 Profiling Eicosanoids In Breath Condensates Of Asthmatic and
Healthy Children
Dr. Li-chen Chen1,2, Prof. Jing-Long Huang1,2, Mrs. AI-Hsuan
Wu1, Prof. Ming-ling Kuo3 and Prof. Shau-ku Huang4,5, 1Chang-
Gung Memorial Hospital, Taoyuan, Taiwan, 2Chang-Gung Univer-
sity, Taoyuan, Taiwan, 3Department of Microbiology and Immunol-
ogy, Institute of Basic Medical Science, Taoyuan, Taiwan,
4
Division of Environmental Health and Occupational Medicine,
National Health Research Institutes, Miaoli, Taiwan, 5Johns Hop-
kins Asthma and Allergy Center, Baltimore, MD
496 Increased IP-10 Expressions In Nasal Fibroblasts From Patients
With Refractory Chronic Rhinosinusitis and Asthma
Dr. Mamoru Yoshikawa, MD1, Dr. Kota Wada, MD1, Dr. Tsuyoshi
Yoshimura, MD2, Dr. Daiya Asaka, MD2 and Prof. Hiroshi Mor-
iyama, MD2, 1Department of Otorhinolaryngology, Toho University
School of Medicine, Tokyo, Japan, 2Department of Otorhinolaryn-
gology, Jikei University School of Medicine, Tokyo, Japan
497 Vitamin D Regulating TGF-b Induced Epithelial-Mesenchymal
Transition
Ms. Kimberly Fischer, Creighton University, Omaha and Deven-
dra K. Agrawal, Department of Biomedical Sciences and Center
for Clinical and Translational Science, Creighton University School
of Medicine, Omaha, NE
115
 AB326 Abstracts
498 Macrophage-Derived Chemokine In Nasal Washes Is Associ-
ated With Asthma Exacerbations and Infections With Rhinovi-
rus In Children
Carolyn R. Word, MD1, Holliday T. Carper, BS1, Patricia Jorge,
MD1, Joshua L. Kennedy, MD2, Deborah D. Murphy, RN1, Thomas
A.E. Platts-Mills, MD, PhD, FAAAAI3 and Peter W. Heymann,
MD1, 1University of Virginia, Charlottesville, VA, 2Arkansas Chil-
drens Hospital Research Institute, Little Rock, AR, 3Division of
Asthma, Allergy & Immunology, University of Virginia Health Sys-
tem, Charlottesville, VA
499 Application Of Isoraft Single Cell Isolation For Analysis Of Pe-
diatric Bal Macrophages
Dr. Neil Alexis, PhD1, Ms. Heather Wells2, Dr. Yogesh Saini,
PhD3, Ms. Louisa Brighton2, Dr. Nancy Allbritton, MD, PhD4
and Dr. Marianne Muhlebach, MD2, 1Center Environmental Med.
Asthma/Lung Biology, Chapel Hill, NC, 2Center for Environmental
Medicine Asthma and Lung Biology, Chapel Hill, NC, 3CF Center
UNC Chapel Hill, Chapel Hill, NC, 4Department of Chemistry
SUNDAY
UNC Chapel Hill, Chapel Hill, NC
500 7, 4-Dihydroxyflavone Isolated From Glycyrrhiza Uralensis a
Constituent Of ASHMITM Prevents Dexamethasone Enhance-
ment Of Eotaxin-1 Secretion By Human Lung Fibroblasts
Dr. Changda Liu, PhD1, Dr. Nan Yang, PhD, MS1, Mr. Ryan P.
Robalino2, Dana Greene2, Janaki Patel2, Jiachen Zi3, Shuwei
Zhang3, Dr. Joseph Goldfarb2, Hugh A. Sampson, MD, FAAAAI1,
Dr. Jixun Zhan3 and Dr. Xiu-Min Li, MD1, 1Pediatrics, Icahn
School of Medicine at Mount Sinai, New York, NY, 2Icahn School
of Medicine at Mount Sinai, New York, NY, 3Utah State University
501 Allergen Sensitivities and Obstruction Indices Among Inner
City Asthmatic Patients with High IgE (30-700 IU/ml) Vs Ul-
tra-High IgE Levels (>700 IU/ml)
Jamie Zacharias, MD1, Dr. Edward S. Schulman, MD, FAAAAI2,
Rebanta Chakraborty, MD2, Rozina Ali, DO1 and Natasha Mehta,
MD1, 1Division of Internal Medicine, Drexel University College
of Medicine, Philadelphia, PA, 2Division of Pulmonary, Critical
Care and Sleep Medicine, Drexel University College of Medicine,
Philadelphia, PA
502 Alcohol Exposure and Airway Hyperresponsiveness
Dr. Christina Cruz, MD1, Dr. Thomas B. Casale, MD, FAAAAI2
and Peter Oldenburg, PhD1, 1Creighton University School of Med-
icine, Omaha, NE, 2Univeristy Of South Florida Morsani College
Of Medicine, Tampa, FL
503 Ragweed Or Dust Mite Antigen-Stimulated Human Primary
Bronchial Epithelial Cells Differentially Express Cytokines In
Response To Formoterol Or Mometasone Or Their Combina-
tion
Dr. Anthony Szema, MD, FAAAAI, SUNY Stony Brook School
of Medicine, East Setauket, NY; Stony Brook University, Stony
Brook, NY, Dr. Sayyed Hamidi, Stony Brook University School
of Medicine, Stony Brook, NY, Dr. Ken-Ichi Takemaru, State Uni-
veristy of New York @ Stony Brook, Stony Brook, NY and Ma-
rianne Frieri, MD, PhD, FAAAAI, Medicine and Pediatrics,
Nassau University Medical Center, East Meadow, NY; State Uni-
versity of NY @ Stony brook, Stony Brook, NY
504 Release Kinetics Of Soluble ST2 and Proinflammatory Cyto-
kines In Allergic Rhinits
Mr. Igor Stenin1, Mr. Ralf Baumann1, Mr. Matthaeus Rabaszow-
ski1, Dr. Kathrin I. M. Scheckenbach, MD1, Mr. Pascal Werming-
haus1 and Dr. Martin Wagenmann, MD, FAAAAI2, 1Department
of Otorhinolaryngology, Head and Neck Surgery, Heinrich-Heine-
University Duesseldorf, Germany, 2Henrich Heine University,
Dusseldorf, Germany
505 Interaction Between Dietary Antioxidants and Passive Smoking
On The Risk Of Asthma Modified By GSTP1(rs1695) Polymor-
phism
Dr. Young-Hwa Song, MD, MPH Candidate1, Hye Lim Shin2,
Seo Ah Hong3, Sung-Ok Kwon4, Dr. Young Ho Jung, MD5, Dr.
116
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Eun Lee, MD6, Dr. Song I Yang, MD7, Dr. Ji-Won Kwon, MD8,
Dr. Hyung Young Kim, MD9, Dr. Ju-Hee Seo, MD10, Dr. By-
oung-Ju Kim, MD, PhD11, Dr. Hyo-Bin Kim, MD, PhD12, Se-
Young Oh4, Dr. Soo-Jong Hong, MD, PhD7 and Dr. Bong-Seong
Kim, MD13, 1Johns Hopkins Bloomberg School of Public Health,
2
Research Center for Standardization of Allergic Diseases, Asan
Institute for Life Sciences, University of ulsan College of Medi-
cine, 3Research Center for Standardization of Allergic Diseases,
Asan Institute for Life Sciences, University of ulsan College of
Medicine, South Korea, 4Department of Food and Nutrition, Col-
lege of Human Ecology, Kyung Hee University, 5Childhood
Asthma Atopy Center, Department of Pediatrics, Asan Medical
Center, University of Ulsan College of Medicine, South Korea,
6
Department of Pediatrics, Childhood Asthma Atopy Center,
Asan Medical Center, University of Ulsan College of Medicine,
Seoul, South Korea, 7Department of Pediatrics, Childhood
Asthma Atopy Center, Research Center for Standization of Aller-
gic Diseases, Asan Medical Center, University of Ulsan College
of Medicine, Seoul, Korea, 8Department of Pediatrics, Seoul Na-
tional University Bundang Hospital, Seoul National University
College of Medicine, Seongnam, South Korea, 9Department of
Pediatrics, Kosin University Gospel Hospital, Kosin University
College of Medicine, Seoul, South Korea, 10Department of Pedi-
atrics, Korea Cancer Center Hospital, 11Department of Pediatrics,
Hae-undae Paik Hospital, Inje University College of Medicine,
Busan, South Korea, 12Department of Pediatrics,Inje University
Sanggye Paik Hospital, Seoul, South Korea, 13Department of Pe-
diatrics, Gangneung Asan Hospital, University of Ulsan College
of Medicine
506 Longitudinal Trends Of Food and Environmental Allergen-Spe-
cific IgE In Asthmatic Inner-City Children < 4 Years Of Age
Dr. Keshav Achar, M.B.B.S1, Yikania Pichardo2, Margaret A.
Chin, NP3, Dr. Ramin Nazari, MD4, Dr. Andrew A. Wiznia,
MD4 and Dr. Gabriele De Vos, MD5, 1Albert Einstein
College of Medicine, NY, 2Jacobi Medical Center, New York,
NY, 3Jacobi Medical Center, NY, 4Albert Einstein College of
Medicine, 5Albert Einstein College of Medicine, Bronx, NY
507 The Effect Of Human Placental Extract In a Mouse Model Of
Allergic Rhinitis
Dr. Soo Whan Kim and Dr. Suk-Woo Yang, The Catholic Univer-
sity of Korea
508 Induced Long-Lived Mucosal Mast Cells In The Airways Arise
From Circulating Mast Cell Progenitors
Dr. Lora Georgieva Bankova, Rheumatology/Immunology/Al-
lergy, Brigham and Womens Hospital, Boston, MA, Daniel Dwyer,
Brigham and Womens Hospital, Dr. Anne Y. Liu, MD, Stanford
University School of Medicine, Palo Alto, CA, Dr. Tatiana Jones,
College of Health Science University of Massachusetts, Lowell,
MA, Dr. K. Frank Austen, MD, FAAAAI, Brigham and Womens
Hospital, Harvard Medical School, Boston, MA and Dr. Michael
Gurish, Brigham and Womens Hospital/Harvard Medical School,
Boston, MA
509 Despite Inflammation, No Structural Upper Airway Remodel-
ling In Severe Allergic Rhinitis
Dr. Aarif Eifan, MD1, Dr. Nara Orban, MD2, Dr. Mikila Jacobson,
PhD2 and Prof. Stephen R. Durham, MA MD FRCP2, 1Imperial
College London, United Kingdom, 2Imperial College London, Lon-
don, United Kingdom
510 Ozone Inhalation Induces Epithelial IL-33 and Thymic Stromal
Lymphopoietin (TSLP) and Leads To Eosinophilic Airway In-
flammation
Stephanie Kubala1,2, Moyar Q. Ge2, Imre Redai2, Monica Soni2,3,
Dr. Bei Chen, MD2, Dr. Qi Yang, PhD2, Dr. Avinash Bhandoola,
MBBS PhD2, Dr. Noam A. Cohen, MD, PhD2 and Dr. Angela
Haczku, MD, PhD, FAAAAI2, 1Temple University School of Med-
icine, Philadelphia, PA, 2University of Pennsylvania, Philadelphia,
PA, 3Georgetown University
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Allied Health Oral Abstract Luncheon
3520
Sunday, March 2nd, 2014, 12:15 PM - 1:30 PM
511 Clinical Efficacy Of Subcutaneous and Sublingual Immunother-
apy In Asthma and Rhinitis Children Sensitized To House Dust
Mite Min-Ju Kim1,2, Eun Lee1,3, Keun-Mi Park1, Keum-Hee
Hwang1, Young-Ho Jung1,3, Song-Yi Yang1,4, Jae-Eun Lee2, Hee-
Kyeong Kim2, Hye-yeong Lee2, Jin-ho Yu1 and Prof. Soo-Jong
Hong, MD. PhD1,3, 1Childhood Asthma Atopy Center, Department
of Pediatrics, Asan Medical Center, University of Ulsan College of
Medicine, South Korea, 2Department of Childrens Hospital Nurs-
ing, Asan Medical Center, South Korea, 3Research Center for Stan-
dardization of Allergic Disease, University of Ulsan College of
Medicine, Seoul, Korea, 4Research Center for Standardization of
Allergic Disease, University of Ulsan College of Medicine, Seoul,
Korea, South Korea
512 A Patient-Reported Symptom-Based Predictor Of Objective Si-
nus Inflammation
Ms. Alcina K. Lidder, BA1, Dr. Rakesh Chandra, MD2, Dr. David
Conley, MD1, Dr. Stephanie Shintani-Smith, MD1, Dr. Anju T. Pe-
ters, MD, FAAAAI3, Dr. Leslie C. Grammer, MD, FAAAAI3, Dr.
Robert C. Kern, MD1, Dr. Brian Schwartz, MD4,5 and Dr. Bruce
K. Tan, MD1, 1Department of Otolaryngology, Northwestern Uni-
versity Feinberg School of Medicine, Chicago, IL, 2Northwestern
University, Chicago, IL, 3Department of Medicine, Division of Al-
lergy-Immunology, Northwestern University Feinberg School of
Medicine, Chicago, IL, 4Center for Health Research, Geisinger
Clinic, Danville, PA, 5Johns Hopkins Bloomberg School of Public
Health, Baltimore, MD
513 Healthcare Providers Perception Versus Reality In Patient
Concerns About Starting Subcutaneous Immunoglobulin
Ms. Carla M. Duff, CPNP MSN1, Ms. Annette R. Zampelli, NP2
and Dr. Ann Bullinger, PharmD2, 1University of South Florida,
Tampa, FL, 2CSL Behring, LLC, King of Prussia, PA
514 Anaphylaxis During Obstetric Surgery In Latex Allergic Pa-
tients
Dr. Nana Jinjolava, MD1, Dr. *Mili Shum, MD2, Dr. Keshav
Achar1, Dr. Ren Zhen1 and Dr. Elina Jerschow, MD, M.Sc.3, 1Albert
Einstein College of Medicinen, 2Montefiore Medical Center, Bronx,
NY, 3Albert Einstein College of Medicine/Montefiore Medical Cen-
ter, Bronx, NY
515 The Impact Of Legislation On Illinois School Nurses
Ms. Christine Szychlinski, APN, CPNP1, Mrs. Katherine A.
Schmeissing, MS, R.N.2, Dr. Jacqueline Pongracic, MD, FAAAAI2
and Dr. Anne Marie Singh, MD3, 1Northwestern University Fein-
berg School of Medicine, Ann & Robert H. Lurie Childrens Hos-
pital of Chicago, Chicago, IL, 2Ann & Robert H. Lurie Childrens
Hospital of Chicago, Chicago, IL, 3Division of Allergy & Immunol-
ogy, Department of Pediatrics, Northwestern University Feinberg
School of Medicine, Ann & Robert H. Lurie Childrens Hospital
of Chicago, Chicago, IL
Biomarkers
3601
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
516 Socio-Demographic and Environmental Correlates Of Exhaled
Nitric Oxide Levels
Dr. Lakiea S Wright, MD MAT, Brigham and Womens Hospital
Division of Rhematology, Immunology & Allergy, Boston, MA;
Boston Childrens Hospital Division of Allergy and Immunology,
Boston, MA, Dr. Wanda Phipatanakul, MD, MS, FAAAAI, Boston
Childrens Hospital, Boston, MA and Jessica Rabe Savage, MD ,
Abstracts AB327
Brigham and Womens Hospital, Division of Rheumatology, Immu-
nology and Allergy, Boston, MA
517 Relationships Between The New Biomarkers Induced By Inter-
leukin-13 and Bronchial Hyperresponsiveness In Asthmatic
Children: Periostin and Squamous Cell Carcinoma-Related An-
tigens
Prof. Heysung Baek, MD, PhD1, Prof. Kenji Izuhara, MD, PhD2
and Dr. Jeong-Sub Yoo1, 1Department of Pediatrics, Hallym Uni-
versity College of Medicine, Seoul, South Korea, 2Saga Medical
School, Saga, Japan
518 Exhaled Nitric Oxide Performance Compared To Methacholine
Challenge In Asthma
Andrew Nickels, MD, Dr. Kaiser G. Lim, MD, FAAAAI, Dr. Paul
Scanlon, MD and Kenneth Parker, Mayo Clinic, Rochester, MN
519 Serum Interleukin 13 (IL-13) and Surfactant Protein D (SP-D)
Expression Is Differentially Associated With Disease Status In
Pediatric Asthma Patients
Dr. Vasiliki Gemou-Engesaeth, MD, PhD1, Dr. N Laliotou, MD1,
SUNDAY
Prof. Chris J. Corrigan, MD, PhD, FAAAAI2, Prof. George P.
Chrousos, MD, PhD1 and Dr. Angela Haczku, MD, PhD, FAAAAI3,
1
National & Kapodistrian University of Athens, Greece, 2Kings
College London School of Medicine, London, United Kingdom,
3
University of Pennsylvania, Philadelphia, PA
520 Correlation Of Exhaled Breath Temperature With Age In
Chronic Respiratory Diseases
Dr. Radoslaw Gawlik, MD1, Dr. Malgorzata Rajzer-Wrobel2, Dr.
Dariusz Ziora2 and Prof. Lawrence M. DuBuske, MD, FAAAAI3,
1
Silesian Medical University, Katowice, Poland, 2Silesian Medical
University, Poland, 3George Washington University School of Med-
icine, Washington, DC
Immune Mechanisms in Atopy
3602
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
521 Peripherally Induced Foxp3+ Regulatory T Cells Mediates The
Immunomodulatory Effect Of Intravenous Immunoglobulin In
An Experimental Model Of Allergic Airway Disease
Dr. Amir Hossein Massoud, PhD1,2, Mr. Gabriel N. Kaufman,
MSc1,2, Dr. Ciriaco Piccirillo, PhD2 and Dr. Bruce D. Mazer,
MD, FAAAAI1,3, 1Meakins-Christie Laboratories, Research Insti-
tute - McGill University Health Centre, Montreal, QC, Canada,
2
McGill University Health Centre, Montreal, QC, Canada, 3Mon-
treal Childrens Hospital, Montreal, QC, Canada
522 Differential DNA Methylation In Mothers Increases The Prev-
alence Of Atopic Dermatitis In Their Offspring
Dr. Pia J. Hauk, MD1, Mrs. Anna Forssen, MS1, Dr. Brent Peder-
sen, PhD2, Dr. Matthew Strand, PhD1, Mrs. Lindsay Munoz, BA1,
Dr. Michaela Schedel, PhD1, Dr. Anne Lynch, MD, MSPH2, Dr.
Virginia Winn, MD, PhD2, David A. Schwartz, MD3 and Dr. Erwin
W. Gelfand, MD, FAAAAI1, 1National Jewish Health, Denver, CO,
2
University of Colorado Denver, Aurora, CO, 3University of Colo-
rado Denver School of Medicine, Aurora, CO
523 Hypereosinophilia In Children and Adults: A Retrospective
Comparison
Kelli Williams, MD, M.P.H., JeanAnne Ware, CRNP, Annalise
Abiodun, RN, Paneez Khoury, MD and Dr. Amy D. Klion, MD, Na-
tional Institutes of Health, Bethesda, MD
524 Interleukin 35 Modulates TSLP, IL-25 and IL-33 Primed Den-
dritic Cells and Inhibits Naive T Cell Differentiation and Grass
Pollen-Specific T Cell Proliferation
Natalia C Couto-Francisco1, Dr. Tomokazu Matsuoka2,3, Ms. Ra-
chel Yan, RN3, Prof. Stephen R. Durham, MA MD FRCP1 and Dr.
Mohamed H. Shamji, BSc MSc PhD4, 1Imperial College London,
117
 AB328 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014

London, United Kingdom, 2Medical Research Council and Asthma
UK Centre for Allergic Mechanisms of Asthma, UK, United King-
dom, 3Imperial College London, United Kingdom, 4Imperial Col-
lege London, South Kensington, United Kingdom
525 Fc-Gamma-Receptor-IIb Is Required For The Immunomodula-
tory Actions Of Intravenous Immune Globulin In An Antigen-
Driven Murine Model Of Allergic Airways Disease
Mr. Gabriel N. Kaufman, MSc1, Dr. Amir Hossein Massoud,
PhD1, Dr. Ciriaco A. Piccirillo, PhD2 and Dr. Bruce D. Mazer,
MD, FAAAAI1,3, 1Meakins-Christie Laboratories, Research Insti-
tute - McGill University Health Centre, Montreal, QC, Canada,
2
Centre for the Study of Host Resistance, Research Institute -
McGill University Health Centre, Montreal, QC, Canada, 3Montreal
Childrens Hospital, Montreal, QC, Canada
Leonard Bernstein Session on Occupational
SUNDAY
530 Sensitization To Occupational Allergens and Allergic Diseases
In Workers Of 5 Havana Bakeries
Dr. Mirta Alvarez, MD1, Dr. Alexis Labrada, PhD2, Raul Lazaro
Castro Almarales, MD3, Mrs. Yaqueln Leyva1, Mr. Victor R
Meli4, Dr. Humberto Barata4 and Dr. Miguel Hinojosa5, 1Calixto
Garca University Hospital, Cuba, 2National Center of Bioproducts,
Havana, Cuba, 3National Center of Bioproducts, Cuba, 4Diater Lab-
oratories, Argentina, 5Ramon y Cajal Hospital, Spain
Drug Allergy
3604
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
531 Safety Of Propofol Use In Patients With Food Allergies
Dr. Harshna Mehta, MD, The Icahn School of Medicine at Mount

Sinai, New York, NY and Dr. Mirna Chehade, MD, MPH, Icahn
Allergic Diseases School of Medicine at Mount Sinai, New York, NY; Mount Sinai
Center of Eosinophilic Disorders, Jaffe Food Allergy Institute,
3603 Mount Sinai School of Medicine, New York, NY
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM 532 Risk Stratification Protocol For Carboplatin and Oxaliplatin
Hypersensitivity Reactions With Repeat Skin Testing Improves
526 Endotoxin In Size-Specific Airborne Particles Induces Differen-
Care
tial Nitrative Stress In Human Bronchoepithelial Cells
Dr. Alberta L. Wang, MD1, Dr. Sarita U. Patil, MD2, Dr. Aidan
Umesh Singh1, Dr. Jonathan A. Bernstein, MD, FAAAAI1, Kristin
Long, MD, FAAAAI2 and Dr. Aleena Banerji, MD2, 1Department
Luther2, Lauren Haar2 and Dr. W. Keith Jones, PhD2, 1Division of
of Medicine, Massachusetts General Hospital, Harvard Medical
Immunology Allergy & Rheumatology, University of Cincinnati
School, Boston, MA, 2Division of Rheumatology, Allergy, and Im-
Medical Center, Cincinnati, OH, 2Department of Medicine and
munology, Department of Medicine, Massachusetts General Hospi-
Pharmacology & Cell Biophysics, University of Cincinnati Medical
tal, Harvard Medical School, Boston, MA
Center, Cincinnati, OH
533 Added Value Of Skin Testing In Hypersensitivity Reactions To
527 High Rates Of Sensitization To Selected Metals and Bone Ce-
Taxanes
ment In Joint Replacement Failure Patients and Preoperative
Dr. Matthieu Picard, MD1, Dr. Leyla Pur, MD1, Dr. Joana Caiado,
Evaluations
MD1, Prof. Pedro Giavina-Bianchi, MD, PhD, FAAAAI2, Dr. Vio-
Dr. Karin A. Pacheco, MD, MSPH FAAAAI, Dr. Annyce Mayer,
leta Galv~ao, MD1 and Dr. Mariana C. Castells, MD, PhD,
MD, MSPH, Ms. Samantha Erb, MS, Dr. Lata Shirname-More, PhD
FAAAAI1, 1Division of Rheumatology, Allergy and Immunology,
and Dr. Lisa A. Maier, MD, MSPH FCCP, National Jewish Health,
Department of Medicine, Brigham and Womens Hospital, Harvard
Denver, CO
Medical School, Boston, MA, 2Clinical Imunnology and Allergy
528 Component Resolved Diagnosis In Bakers Asthma
Division, University of Sao Paulo, Boston, MA
Ms. Cristina Gomez-Casado1, Dr. Paloma Campo, MD, PhD2, Dr.
534 Risk Stratification For Paclitaxel-Induced Hypersensitivity Re-
Maria Garrido, PhD3, Ms. C Pereira4, Dr. Arantxa Palacin, PhD1,
actions Improves Quality Of Care
Dr. La Rivas4, Dr. M Catarino5, Dr. Ana Aranda, PhD6, Maria Luisa
Dr. Timothy P. Lax, MD, Dr. Aleena Banerji, MD, Dr. Johnson T.
Macias6, Dr. Alicia Armentia, MD, PhD7, Dr. S. Quirce, MD, PhD8,
Wong, MD, FAAAAI, Dr. Michael T. Wilson, MD, PhD and Dr. Ai-
Dr. Miguel Blanca, MD, PhD2 and Araceli Diaz Perales1, 1Centre
dan Long, MD, FAAAAI, Division of Rheumatology, Allergy, and
for Plant Biotechnology and Genomics (UPM-INIA), Madrid,
Immunology, Department of Medicine, Massachusetts General
Spain, 2Allergy Service, Carlos Haya Hospital, Malaga, Spain,
3 Hospital, Harvard Medical School, Boston, MA
Plant Biotechnology Institute (UPM-INIA), Madrid, Spain, 4Mo-
535 Healthcare Utilization and Serious Infection Prevalence Associ-
lecular Evolution Laboratory, Astrobiology Centre (INTA-CSIC),
ated With Penicillin Allergy In Hospitalized Patients: A Co-
Madrid, Spain, 5Faculty of Pharmacy, University of Lisbon, Lisbon,
hort Study
Portugal, 6Research Laboratory, Carlos Haya Hospital-FIMABIS,
Dr. Eric M. Macy, MD, FAAAAI, 5th Floor, SCPMG-Kaiser Per-
Malaga, Spain, 7Valladolid University, Valladolid, Spain, 8Hospital
manente San Diego, San Diego, CA and Richard Contreras, MS,
La Paz Institute for Health Research (IdiPaz), Allergy department.,
Kaiser Permanente Health Care Program, Department of Research
Madrid, Spain
and Evaluation, Pasadena, CA
529 Endotoxin Exposure May Protect Against The Development Of
Rhinoconjunctivitis and Respiratory Symptoms In Non-Atopic
Individuals With Occupational Exposure To Mice
Dr. Sharon K. Ahluwalia, MD1,2, Dr. Roger Peng, PhD3, Mr.
Charles Aloe, MPH2, Wayne G. Shreffler, MD, PhD, FAAAAI4,5,
Oral Immunotherapy for Food Allergy
Mary Krevans, RN6, Karol A. Hagberg, BSN FNP6, Dr. Peter S.
Thorne, PhD7, Kenneth Walsh8 and Dr. Elizabeth Matsui, MD9, 3605
1
Childrens National Medical Center, Washington, DC, 2Johns Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
Hopkins University School of Medicine, Baltimore, MD, 3Johns 536 Length Of Avoidance Period Following Peanut Oral Immuno-
Hopkins School of Public Health, Baltimore, MD, 4Massachusetts therapy Influences Effector Cell Suppression and Clinical Out-
General Hospital, Boston, MA, 5Harvard Medical School, Boston, comes Michael D. Kulis Jr., PhD, Dr. Rishu Guo, PhD, Brian P.
MA, 6The Jackson Laboratory, Bar Harbor, ME, 7 University of Vickery, MD, FAAAAI, Pamela H. Steele, MSN CPNP AE-C, Ed-
Iowa, Iowa City, IA, 8The Jackson Laboratories, ME, 9The Johns win Kim, MD, MS and A. Wesley Burks, MD, FAAAAI, University
Hopkins University School of Medicine, Baltimore, MD of North Carolina at Chapel Hill, Chapel Hill, NC

118
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
537 Basophil Hyporesponsiveness To Peanut Following Immuno-
therapy May Be Transient and Correlates With Clinical Re-
sponse
Dr. Mark Gorelik, MD1, Dr. Satya Narisety, MD1, Kristin Chiches-
ter, MS1, Anja Bieneman, BS1, Corinne Keet, MD, MS2, Robert A.
Wood, MD, FAAAAI2, Dr. John T. Schroeder, PhD1 and Pamela
Frischmeyer Guerrerio1, 1Johns Hopkins University School of Med-
icine, 2Johns Hopkins University Medical Center, Baltimore, MD
538 Safety Of Pediatric Peanut Oral Immunotherapy Is Compli-
cated By High Adverse Event Rates
Yamini Virkud, MD, MA1, Brian P. Vickery, MD, FAAAAI2, Pa-
mela H. Steele, MSN CPNP AE-C2, Janet S. Kamilaris, RN3 and A.
Wesley Burks, MD, FAAAAI2, 1Duke University, Durham, NC,
2
University of North Carolina, Chapel Hill, NC, 3Carolinas Health
Care System, Charlotte, NC
539 Course and Outcome Of Patients With Asthma During Oral
Immunotherapy To Cows Milk Protein
Dr. Arnon Elizur, MD1,2, Dr. Michael Goldberg, MD, PhD1, Dr.
Michael Levy, MD, FAAAAI1, Dr. Liat Nachshon, MD1 and Prof.
Yitzhak Katz, MD, FAAAAI1,2, 1Assaf Harofeh, Zerifin, Israel,
2
Tel Aviv University, Tel Aviv, Israel
540 B-Fahf-2 Pretreatment Reduces OIT Adverse Reactions and
Improves Outcomes In a Murine Model Of Multiple Nut Al-
lergy
Dr. Xiu-Min Li, MD, Dr. Ying Song, MD, Dr. Changda Liu, PhD,
Mr. Ilan Goldberg, Hugh A. Sampson, MD, FAAAAI and Dr. Ka-
mal D. Srivastava, PhD, Pediatrics, Icahn School of Medicine at
Mount Sinai, New York, NY
Adherence
3606
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
541 Adherence Documentation During Asthma Encounters At a Pe-
diatric Tertiary Care Referral Center
Kara J. Wada, MD, Nationwide Childrens Hospital and The Ohio
State University, Columbus and David R. Stukus, MD, FAAAAI,
Nationwide Childrens Hospital, Columbus, OH
542 High-Risk Asthma Multidisciplinary Care Clinic Adherence
Linked To Asthma Control Test (ACT) Score Improvement
Dr. Bradley A. Locke, DO1, Dr. Pippa Simpson, PhD1, Mrs. Tina
Bromberger, RN, BSN, AE-C2, Mrs. Melodee Nugent, MA1, Mrs.
Sara A. Lowe, NP1, Dr. Juan Ruiz, MD1, Dr. Patricia Marik,
PsyD2, Dr. Jacquelyn Smith, PhD2, Dr. Joshua A. Steinberg, MD1
and Dr. Dorothy S. Cheung, MD, FAAAAI1, 1Medical College of
Wisconsin, Milwaukee, WI, 2Childrens Hospital of Wisconsin,
Milwaukee, WI
543 Understanding Asthma Medical Nonadherence In Adult and
Pediatric Populations
Joyce Xiang Wu Lee, MD1, Henry Wojtczak, MD2, Allan M.
Wachter, MD3, Martin Lee, PhD4, Lisa Burns, RN3, Diana Chen3
and Joseph S. Yusin, MD, FAAAAI5, 1Allergy/Immunology, VA
Greater Los Angeles Health Care System, Los Angeles, CA, 2Naval
Medical Center San Diego, San Diego, CA, 3Foundation for
Asthma Research and Intervention, Phoenix, AZ, 4UCLA School
of Public Health, Los Angeles, CA, 5VA Greater Los Angeles
Health Care System, Los Angeles, CA
544 Improved Education and Self-Management In Children and
Adolescents With Asthma Using a Personalized Smartphone
Application
David R. Stukus, MD, FAAAAI1,2, Gary Phillips, M.A.S.1 and Na-
beel Farooqui, MD1,2, 1Wexner Medical Center at The Ohio State
University, Columbus, OH, 2Nationwide Childrens Hospital, Co-
lumbus, OH
Abstracts AB329
545 Misuse Of Medical Devices Among Patients In a Tertiary Care
Allergy/Immunology Practice
Dr. Rana S. Bonds, MD, FAAAAI, University of Texas Medical
Branch, Galveston, TX and Dr. Aasia I. Ghazi, MD, Allergy and
Asthma Specialists, Plano, TX
Mechanisms of Immunotherapy
3607
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
546 B Cells and Plasma Cells Populations Suffer Changes Along
The Time After Dermatophagoides Pteronyssinus Specific Im-
munotherapy
Dr. Enrique Gomez, PhD1, Dr. Taha Fernandez, PhD2, Dr. Inmacu-
lada Do~na, MD, PhD3, Dr. Francisca Gomez, MD, PhD3, Mrs. Luisa
SUNDAY
Galindo, RN3, Ms. Lidia Melendez, Lab. Tech.4, Dr. Miguel Blanca,
MD, PhD3, Dr. Cristobalina Mayorga, PhD5 and Dr. Maria Jose Jose
Torres, MD, PhD3, 1Research Laboratory for Allergic Diseases, Hos-
pital Regional Universitario de Malaga - IBIMA, Malaga, Spain, 2Re-
search Laboratory - FIMABIS Foundation, Malaga, Spain, 3Allergy
Service, Carlos Haya Hospital, Malaga, Spain, 4Research Labora-
tory, Carlos Haya Hospital-FIMABIS, Malaga, Spain, 5Research
Laboratory, Carlos Haya Hospital-FIMABIS, Malaga, Spain
547 A Subset Of Novel Timothy Grass Antigens Is Associated With
Marked Th1/Th2 Shifts Following Specific Immunotherapy
Dr. Veronique M. Schulten1, Victoria Tripple1, John Sidney1, Dr.
Jason Greenbaum1, Dr. April Frazier1, Rafeul Alam, MD, PhD,
FAAAAI2, Dr. David H. Broide, MB ChB FAAAAI3, Dr. Howard
Grey1, Dr. Bjoern Peters1 and Dr. Alessandro Sette, Dr. Biol.
Sci.1, 1La Jolla Institute for Allergy and Immunology, La Jolla,
CA, 2National Jewish Health, Denver, CO, 3Department of Medi-
cine, San Diego, CA
548 Interleukin IL-27+ Dendritic Cells Modulate Ex-Vivo Th2 Re-
sponses In a Pdl-1-Dependent Manner and Increase In-Vivo
Following Grass Pollen Immunotherapy
Dr. Tomokazu Matsuoka1, Ms. Rachel Yan, RN2, Dr. Guy W
Scadding, MD2, Prof. Stephen R. Durham, MA MD FRCP3 and
Dr. Mohamed H. Shamji, BSc MSc PhD4, 1Medical Research
Council and Asthma UK Centre for Allergic Mechanisms of
Asthma, UK, United Kingdom, 2Imperial College London, United
Kingdom, 3Imperial College London, London, United Kingdom,
4
Imperial College London, South Kensington, United Kingdom
549 Local Protective IgG4 Antibodies In Nasal Fluid Are Elevated
Following Grass Pollen Immunotherapy
Jinjin Zhang1, Dr. Esther Steveling2, Ms. Rachel Yan, RN2, Dr.
Aarif Eifan, MD2, Rebecca Parkin3, Dr. Guy W Scadding, MD2,
Dr. Mohamed H. Shamji, BSc MSc PhD4 and Prof. Stephen R. Dur-
ham, MA MD FRCP1, 1Imperial College London, London, United
Kingdom, 2Imperial College London, United Kingdom, 3Imperial
College London, London, 4Imperial College London, South Ken-
sington, United Kingdom
550 Grass Pollen Immunotherapy: Impaired Allergen-Induced Na-
sal and Cutaneous Responses Correlate With Overall Seasonal
Symptom Scores and Are Associated With Suppressed Local
Th2 Cytokines In Nasal Fluid
Dr. Guy W Scadding, MD1, Dr. Aarif Eifan, MD1, Dr. Mongkol
Lao-Araya, MD1, Dr. Martin J. Penagos Paniagua, MD1, Ms.
Shun Yan Poon1, Dr. Esther Steveling1, Ms. Andrea Goldstone,
RN1, Ms. Rachel Yan, RN1, Ms. Amy Switzer1, Dr. Deborah Phip-
pard2, Dr. Mohamed H. Shamji, BSc MSc PhD3 and Prof. Stephen
R. Durham, MA MD FRCP4, 1Imperial College London, United
Kingdom, 2Immune Tolerance Network, 3Imperial College London,
South Kensington, United Kingdom, 4Imperial College London,
London, United Kingdom
119
 AB330 Abstracts
Mechanisms of Eosinophil-Driven Disease
3608
Sunday, March 2nd, 2014, 2:45 PM - 4:00 PM
551 IL-4 and IL-13 Differentially Regulate TLR-Induced Eosino-
phil-Basophil Differentiation Of Cord Blood CD34+ Progenitor
Cells
Dr. Pia Reece, PhD1, Dr. Roma Sehmi, PhD FAAAAI1 and Ju-
dah Aryeh Denburg, MD, FRCPC, FAAAAI2, 1McMaster Univer-
sity, Hamilton, ON, Canada, 2Division of Clinical Immunology
and Allergy, Department of Medicine, McMaster University,
ON, Canada
552 Basophils Act As a Cellular Switch to Drive Eosinophilic In-
flammation after IgE Activation
Dr. Laurence E. Cheng, MD, PhD, University of California, San
Francisco Medical Center, San Francisco, CA and Prof. Richard
M. Locksley, MD, University of California, San Francisco,
SUNDAY
HHMI, San Francisco, CA
553 The SNARE VAMP-7 Contributes To Eosinophil Degranula-
tion, In Vivo
Dr. Paige Lacy, PhD FAAAAI1, Dr. Lian Willetts, PhD1, Dr. Eliza-
beth Jacobsen, PhD2, Dr. Rachel Condjella, PhD2, Ms. Katie Zellner2,
Dr. Sergei Ochkur, PhD2, Mr. Hui Lou2, Mr. Will LeSuer2, Mr. John
Kim, MSc1, Ms. Cheryl Protheroe2, Mr. Ralph Pero2, Dr. James J.
Lee, PhD3, Dr. Nancy A. Lee, PhD2 and Dr. Redwan Moqbel, PhD
FRCPath FAAAAI4, 1University of Alberta, Edmonton, AB, Canada,
2
Mayo Clinic Arizona, Scottsdale, AZ, 3Mayo Clinic of Arizona,
Scottsdale, AZ, 4University of Manitoba, Winnipeg, MB, Canada
554 Microbiota Regulates Eosinophils In The Small Intestine
Dr. Rodrigo Jimenez-Saiz, PhD1, Mrs. Tina Walker-Fattouh1,
Mrs. Melissa E. Gordon, MSc1, Mr. Waleed S. Ahmed1, Ms.
Breanne Dale1, Mr. Talveer S. Mandur1, Mr. Joshua Kong1,
Mr. Derek K. Chu1, Dr. Roland Kolbeck, PhD2, Dr. Alison A.
Humbles, PhD2, Dr. Elena F. Verdu, MD, PhD3 and Dr. Manel
Jordana, MD, PhD1, 1McMaster Immunology Research Centre
(MIRC), McMaster University, Hamilton, ON, Canada, 2Medi-
mmune LCC, Gaithersburg, MD, 3Farcombe Family Digestive
Health Research Institute, McMaster University, Hamilton, ON,
Canada
555 The Airway Mucins Muc5b and Muc4 Are Endogenous Ligands
For Siglec-F and Induce Mouse Eosinophil Death
Takumi Kiwamoto, MD, PhD1, Toshihiko Katoh, PhD2, Christo-
pher Evans, PhD3, Mary E. Brummet, MS1, Sherry Hudson, MS1,
Zhou Zhu, MD, PhD1, Michael Tiemeyer, PhD2 and Bruce S. Boch-
ner, MD, FAAAAI1, 1Division of Allergy and Clinical Immunology,
Johns Hopkins University School of Medicine, Baltimore, MD,
2
Complex Carbohydrate Research Center, University of Georgia,
Athens, GA, 3Division of Pulmonary Medicine, University of Col-
orado School of Medicine, Denver, CO
Featured Poster Session
Best of ADT
3801
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
556 Impact Of Asthma Exacerbations On Lung Function In a Large
Cohort Of Patients With Severe Or Difficult-To-Treat Asthma
Dr. Theodore A. Omachi1, Dr. Tmirah Haselkorn1, Dave P. Miller2
and Dr. William J. Calhoun, MD, FAAAAI3, 1Genentech, Inc., South
San Francisco, CA, 2ICON Clinical Research, 3Allergy And Immunol-
ogy, University of Texas Medical Branch, Galveston, TX
120
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
557 Analysis Of Severe Asthma Phenotypes By Using High-Resolu-
tion Computed Tomography: Relation To Clinical Assessment
Sujeong Kim1, Kwang-Nam Jin2, Chang Hyun Lee2, Prof. So-Hee
Lee3, Jae-Won Jung4, Prof. Woo-Jung Song, M.D.1, Prof. Hye-
Ryun Kang1, Kyung-Up Min1 and Prof. Sang Heon Cho, MD,
PhD3, 1Department of Allergy and Clinical Immunology, Seoul Na-
tional University College of Medicine, Seoul, South Korea, 2De-
partment of Radiology, Seoul National University College of
Medicine, Seoul, South Korea, 3Department of Internal Medicine,
Seoul National University College of Medicine, Seoul, South Ko-
rea, 4Inje university ilsan paik hospital, Seoul, South Korea
558 Associations Between The Expression Of Corticosteroid Regu-
lated Genes By Peripheral Blood Mononuclear Cells (PBMCs)
In Children From The NIH/NIAID Sponsored Asthma Pheno-
types In The Inner City (APIC) Study
Dr. Elena Goleva, PhD1, Leisa P. Jackson, BS1, Baomei Shao, BS2,
Zheng Hu, BS2, Dr. Michelle A. Gill, MD, PhD2, Andrew H. Liu,
MD1 and Donald Y.M. Leung, MD, PhD, FAAAAI1, 1National
Jewish Health, Denver, CO, 2UT Southwestern Medical Center,
Dallas, TX
559 Bronchial Mast Cell Markers and Clinical Asthma Severity In
Steroid Refractory Asthmatics
Dr. Mandeep Hundal, M.D.1, Dr. Katherine N. Cahill, MD2, Rob-
ert Pedicini1, Allison Crosby-Thompson1, Stefanie Dutile1, Usha
Govindarajulu, PhD2, Dr. Kartik Shenoy, M.D.3, Dr. Mark Drans-
field4, Dr. Emily DiMango5, Dr. Serpil C. Erzurum, M.D.6, Dr.
Mario Castro, MD, MPH7, Dr. Nizar N. Jarjour, MD8, Dr. Howard
Katz, PhD2, Dr. Joshua A. Boyce, MD, FAAAAI2 and Dr. Elliot Is-
rael, MD, FAAAAI1, 1Brigham and Womens Hospital, Boston,
MA, 2Brigham and Womens Hospital, Division of Rheumatology,
Immunology and Allergy, Boston, MA, 3Temple University School
of Medicine, 4University of Alabama School of Medicine, AL, 5Co-
lumbia University, New York, NY, 6Department of Pathobiology,
Cleveland Clinic, 7Washington University School of Medicine, St.
Louis, MO, 8University of Wisconsin School of Medicine and Pub-
lic Health, Madison, WI
560 Antagonistic Effects Of Ozone (O3) Exposure and Glucocorti-
coid Treatment On Airway Hyperresponsiveness (AHR) and
Surfactant Protein D (SP-D) Production In Mice
Moyar Q. Ge1,2, Monica Soni1, Imre Redai1, Blerina Kokalari1, Dr.
Angela Haczku, MD, PhD, FAAAAI1 and Zhilong Jiang1, 1Univer-
sity of Pennsylvania, Philadelphia, PA, 2National University of Sin-
gapore, Singapore, Singapore
Advances in Primary Immunodeficiencies
3802
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
561 Impaired Glycosylation Due To Autosomal Recessive PGM3
Mutations Results In Atopy, Immune Deficiency, Autoimmu-
nity, and Neurocognitive Impairment
Dr. Joshua D. Milner, MD1, Dr. Jonathan J. Lyons, MD1, Dr. Yu
Zhang, PhD2, Dr. Xiaomin Yu, PhD1, Dr. Shrimati Datta, PhD1,
Ian T. Lamborn, BSc2, Matthew R. Biancalana, BSc3, Lynne A.
Wolfe, CRNP4, Thomas DiMaggio, BSN2, Helen F. Matthews,
BSN3, Dr. Sarah M. Kranick, MD5, Dr. Kelly D. Stone, MD,
PhD, FAAAAI1, Dr. Steven M. Holland, MD6, Dr. Daniel S. Reich,
MD, PhD7, Dr. Jason D. Hughes, PhD8, Dr. Huseyin Mehmet,
PhD8, Dr. Joshua McElwee, PhD8, Dr. Hudson H. Freeze, PhD9,
Dr. Alexandra F. F. Freeman, MD6 and Dr. Helen C. Su, MD,
PhD2, 1Laboratory of Allergic Diseases, NIAID/NIH, Bethesda,
MD, 2Laboratory of Host Defenses, NIAID/NIH, Bethesda, MD,
3
Laboratory of Immunology, NIAID/NIH, Bethesda, MD, 4Undiag-
nosed Diseases Program, NHGRI/NHI, Bethesda, MD, 5Medical
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Neurology Branch, NINDS/NIH, Bethesda, MD, 6Laboratory of
Clinical Infectious Diseases, NIAID/NIH, Bethesda, MD, 7Neuro-
immunology Branch, NINDS/NIH, Bethesda, MD, 8Merck Re-
search Laboratories, Merck & Co. Inc., Boston, MA, 9Sanford
Burnham Medical Research Institute, La Jolla, CA
562 Expansion Of Circulating T Follicular Helper Cells In CVID
Patients With Autoimmune Cytopenias
Dr. Neil D. Romberg, MD1, Dr. Ida Hsu, MD1, Dr. Christina C.
Price, MD1, Dr. Charlotte Cunningham-Rundles, MD, PhD,
FAAAAI2 and Dr. Eric Meffre, PhD1, 1Yale University School of
Medicine, New Haven, CT, 2Mt. Sinai Medical Center, New
York, NY
563 Treatment Of Murine Chronic Granulomatous Disease (CGD)
With The PPARg Agonist Pioglitazone Enhances Phagocyte Mi-
tochondrial Reactive Oxygen Species (ROS) Production and
Antimicrobial Responses
Dr. Donna Bratton, MD, Dr. S. Courtney Frasch, PhD, Dr. Ken-
neth Malcolm, PhD and Dr. Ruby Fernandez-Boyanapalli, PhD,
National Jewish Health, Denver, CO
564 Patient Specific Targeted Gene Therapy In The Treatment Of
X-Linked Hyper-IgM Syndrome
Caroline Y. Kuo, M.D., Division of Allergy and Immunology, De-
partment of Pediatrics, David Geffen School of Medicine at UCLA,
Los Angeles, CA, Alok Joglekar, PhD, Department of Microbiol-
ogy, Immunology, and Molecular Genetics, University of Califor-
nia, Los Angeles, Los Angeles, CA and Donald B. Kohn, MD,
Department of Pediatrics and Department of Microbiology, Immu-
nology, and Molecular GeneticsUniversity of California, Los An-
geles, Los Angeles, CA
565 Digeorge Syndrome Found By SCID Newborn Screening In
California
Dr. Kiran P. Patel, MD, MS1, Dr. Antonia Kwan, PhD, MRCPCH1,
Mica Muskat, MSN1, Dr. Joseph A. Church, MD, FAAAAI2, Dr.
Morna J. Dorsey, MD MMSc FAAAAI1 and Dr. Jennifer M. Puck,
MD1, 1Department of Pediatrics, University of California San Fran-
cisco and UCSF Benioff Childrens Hospital, San Francisco, CA,
2
Department of Pediatrics, University of Southern California and
Childrens Hospital Los Angeles, Los Angeles, CA
Best of EORD
3803
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
566 Urinary Levels Of Phytoestrogens Are Inversely Associated
With Wheezing, Asthma, and Atopy
Juan-Carlos Cardet, MD, Rheumatology, Immunology, and Al-
lergy, Brigham and Womens Hospital, Boston, MA, Christina
Johns, BA, Brigham and Womens Hospital, Boston, MA and Jes-
sica Rabe Savage, MD , Brigham and Womens Hospital, Division
of Rheumatology, Immunology and Allergy, Boston, MA
567 Vitamin D Treatment Is Protective Of Inhalant Organic Dust-
Induced Bone Loss
Dr. Jill A. Poole, MD, FAAAAI1, Anand Dusad1, Dr. Todd Wyatt,
PhD2, Angela Gleason, MA1, Michael Duryee1, Elizabeth Klein1,
Christopher Bauer1, Dr. Lynell Klassen, MD1, Dr. Ted Mikuls,
MD1, Dr. William West, MD1, Dr. Debra Romberger, MD2 and
Dr. Geoffrey Thiele, PhD1, 1University of Nebraska Medical Cen-
ter, Omaha, NE, 2UNMC, Omaha, NE
568 Antigenic Determinants On Der p 1 Identified By Mutagenesis
Analysis Based On The Structure Of Allergen-Antibody Com-
plexes
Dr. Anna Pomes, PhD FAAAAI1, Ms. Jill Glesner1, Ms. Lisa D.
Vailes1, Dr. Wladek Minor, PhD2, Dr. Maksymilian Chruszcz,
PhD3 and Dr. Martin D. Chapman, PhD FAAAAI1, 1Indoor
Abstracts AB331
Biotechnologies, Inc., Charlottesville, VA, 2University of Virginia,
Charlottesville, VA, 3University of South Carolina, Columbia, SC
569 Development Of IgE Against a Cimex Lectularius Allergen Af-
ter Being Bitten By Bed Bugs Was Common Among Children In
NYC
Adnan Divjan1, Dr. Jason B. Price, MD2, Dr. Luis M. Acosta, MD1,
Prof. Andrew Rundle, DrPH3, Prof. Inge Goldstein, DrPH4, Prof. Ju-
dith Jacobson, DrPH3, Prof. William R. Montfort, PhD5, Prof. Greg
Freyer, PhD6 and Prof. Matthew S. Perzanowski, PhD1, 1Department
of Environmental Health Sciences, Mailman School of Public Health,
Columbia University, New York, NY, 2Division of Pediatrics, Depart-
ment of Medicine, College of Physician & Surgeons, Columbia Uni-
versity, New York, NY, 3Department of Epidemiology, Mailman
School of Public Health, Columbia University, New York, NY, 4De-
partment of Epidemiology, Mailman School of Public Health, Co-
lumbia University, New York, NY, 5Department of Chemistry and
Biochemistry, University of Arizona, Tucson, Arizona, 61Depart-
ment of Environmental Health Sciences, Mailman School of Public
SUNDAY
Health, Columbia University, New York, New York
570 Divergent Effects Of Endotoxin and Mold Exposure On Asthma
Exacerbations In The Childhood Asthma Management Pro-
gram (CAMP)
Dr. Ronina A. Covar, MD1, Mrs. Anna Forssen, MS1, Dr. Stanley
J. Szefler, MD, FAAAAI2,3, David A. Schwartz, MD4 and Andrew
H. Liu, MD1, 1National Jewish Health, Denver, CO, 2University of
Colorado Denver School of Medicine, Denver, CO, 3Childrens
Hospital Colorado, Denver, CO, 4University of Colorado Denver
School of Medicine, Aurora, CO
Best of FADDA
3804
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
571 Inhibition Of Epidermal Tight Junction Function By Histamine
Is Mediated By H1 and H4 Receptors
Lisa A. Beck, MD, FAAAAI1, Takeshi Yoshida, PhD1, Sade
Fridy1, I-Hsin Kuo, PhD1, Donald Y.M. Leung, MD, PhD,
FAAAAI2 and Anna De Benedetto, MD, FAAAAI1, 1University
of Rochester Medical Center, Rochester, NY, 2National Jewish
Health, Denver, CO
572 The Natural History and Clinical Predictors Of Egg Allergy In
The First 2 Years Of Life: A Prospective, Population-Based, Co-
hort Study
Ms. Rachel Peters, MPH1,2, Prof. Shyamali Dharmage, MD,
PhD1,2, Prof. Lyle Gurrin, PhD2, Dr. Jennifer Koplin, PhD1, Prof.
Anne-Louise Ponsonby, PhD1, Dr. Adrian Lowe, PhD2, Prof.
Mimi L. K. Tang, MD, PhD, FAAAAI3, Dr. Dean Tey, MD1,4,
Dr. David Hill, MBBD, FRACP1, Dr. Marnie Robinson, MBBD,
FRACP5, Ms. Helen Czech, B.Nurs1, Ms. Leone Thiele, MNSc1,
Dr. Nicholas Osborne, PhD6 and Prof. Katrina Jane Allen, MD,
PhD, FAAAAI1,4, 1Murdoch Childrens Research Institute, Victoria,
Australia, 2University of Melbourne, Victoria, Australia, 3The Uni-
versity of Melbourne, Melbourne, Australia, 4Royal Childrens
Hospital, Victoria, Australia, 5Royal Childrens Hospital, Parkville,
Australia, 6Royal Cornwall Hospital, Truro, United Kingdom
573 Mendelian Inheritance Of Elevated Tryptase Associated With
Atopy and Connective Tissue Abnormalities
Dr. Jonathan J. Lyons, MD1, Dr. Guangping Sun, MD1, Dr. Kelly
D. Stone, MD, PhD, FAAAAI1, Celeste Nelson, NP1, Laura Wisch,
MSN1, Michelle OBrien, RN, BSN1, Nina Jones, RN, BSN2, Dr.
Andrew W. Lindsley, MD, PhD3, Dr. Hirsh D. Komarow, MD1,
Yun Bai, MS1, Linda M. Scott, MS, CRNP1, Daly Cantave,
MSN4, Dr. Irina Maric, MD5, Dr. J. Pablo Abonia, MD3, Dr.
Marc E. Rothenberg, MD, PhD, FAAAAI3, Dr. Lawrence B.
121
 AB332 Abstracts
Schwartz, MD, PhD, FAAAAI6, Dr. Todd M. Wilson, DO1 and Dr.
Joshua D. Milner, MD1, 1Laboratory of Allergic Diseases, NIAID/
NIH, Bethesda, MD, 2Frederick National Laboratory for Clinical
Research, Frederick, MD, 3Cincinnati Childrens Hospital Medical
Center, Cincinnati, OH, 4Clinical Center, National Institutes of
Health, Bethesda, MD, 5Department of Laboratory Medicine, Na-
tional Institutes of Health, Bethesda, MD, 6Virginia Commonwealth
University, Richmond, VA
574 Expression Of TSLP and TSLP-R In Chronic Idiopathic Urti-
caria
Ms. Patricia M. Sterba, MS1, Allen Myers, Ph.D2 and Dr. Sarbjit
S. Saini, MD, FAAAAI1, 1Johns Hopkins University, Baltimore,
MD, 2Division of Allergy & Clinical Immunology, Johns Hopkins
University School of Medicine, Baltimore, MD
575 Preclinical Study Of Rapidly-Disintegrating Sublingual Tablets
(RDST): Effect Of Epinephrine (E) Incorporated As Nano-
Crystals
Dr. Keith Simons, PhD1, Dr. Ousama Rachid, PhD1, Dr. Mutasem
SUNDAY
Rawas-Qalaji, PhD2, Dr. Belacryst Mendez, PhD3, Ms. Annette Losada3
and Dr. F. Estelle R. Simons, MD, FAAAAI1, 1University of Manitoba,
Winnipeg, MB, Canada, 2Nova Southeastern University, F. Lauderdale,
FL, 3Nova Southeastern University, Ft. Lauderdale, FL
Best of HEDQ
3805
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
576 A 24-Month Randomized, Controlled Trial Of An Automated
Speech Recognition Program To Improve Adherence In Pediat-
ric Asthma
Bruce G. Bender, PhD FAAAAI1, Peter Cvietusa2, Glenn Good-
rich2, C. Ryan Lowe2, Heather Nuanes2, Susan Shetterly2, Cathy
R. Tacinas2, Nicole Wagner2, Frederick S. Wamboldt1, Stan Xu2
and David Magid2, 1National Jewish Health, Denver, CO, 2Kaiser
Permanente Colorado, Denver, CO
577 Asthma Carepartners: A Home-Based Asthma Intervention
Embedded Within Medicaid Managed Care
Ms. Julie Kuhn, MSW1, Ms. Helen Margellos-Anast, MPH1, Ms. Tala
Alhajj Schwindt, MPH1, Ms. Lourdes Reyes2, Ms. Barbara Hay, M.A.2,
Ms. Sheena Freeman, B.A.1 and Ms. Gloria Seals1, 1Sinai Urban Health
Institute, Chicago, IL, 2Family Health Network, Chicago, IL
578 The Osia Platform: An Extensible Tool For Improving Individ-
ual Allergy and Asthma Control and Understanding Environ-
mental Drivers
Dr. Richard W Lucas, PhD1, Mr. Josh Dees2, Mr. Rob Reynolds2,
Mr. Bryn Rhodes3 and Dr. Richard W Hendershot, MD4, 1Swedish
University of Agricultural Sciences, Ume a, Sweden, 2OSIA Medi-
cal, Sandy, UT, Database Consulting Group, Orem, UT, 4Inter-
3
mountain Health Care, Salt Lake City, UT
579 Allergy Immunotherapy Significantly Reduces Outpatient Ser-
vices Use For Allergy and Respiratory Conditions In Patients
With Newly-Diagnosed Allergic Rhinitis
Dr. Cheryl S. Hankin, PhD1, Dr. Linda Cox, MD, FAAAAI2, Dr. Amy
Bronstone, PhD1 and Ms. Zhaohui Wang, M.S.1, 1BioMedEcon, LLC,
Moss Beach, CA, 2Allergy & Asthma Center, Fort Lauderdale, FL
580 Real-Time Asthma Outreach Reduces Excessive Short-Acting
Beta-Agonist (SABA) Canister-Dispensing: A Randomized
Study
Dr. Robert S. Zeiger, MD, PhD, FAAAAI1, Dr. Michael Schatz,
MD, MS, FAAAAI1, Qiaowu Li, M.S.2, Dr. James Zazzali, PhD3
and Wansu Chen, M.S.2, 1Kaiser Permanente Southern California,
San Diego, CA, 2Kaiser Permanente Southern California, Pasadena,
CA, 3Genentech, Inc., South San Francisco, CA
122
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Chronic Rhinosinusitis and Polyps
3806
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
581 Activation Of TLR4 Induces VEGF Expression Via Akt Path-
way In Nasal Polyps
Mrs. Jung-Sun Cho1, Mr. Ju-Hyung Kang1, Ms. In-Hye Han1,
Mrs. Ji-Young Um1, Prof. Il-Ho Park2 and Prof. Heung-Man
Lee2,3, 1Department of Biomedical Sciences, Korea University
Graduate School, Seoul, South Korea, 2Department of Otorhinolar-
yngology-Head and Neck Surgery, Korea University College of
Medicine, Seoul, South Korea, 3Medical Devices Clinical Trial
Center, Guro Hospital, Korea University, Seoul, South Korea
582 Non-Eosinophilic Nasal Polyps In Second-Generation Asian Pa-
tients In The U.S. With Chronic Rhinosinusitis; Evidence For
Genetic Influence On Eosinophilia
Dr. Mahboobeh Mahdavinia, MD, PhD1, Ms. Lydia Suh, BSc2,
Mr. James Norton, MS2, Mr. Roderick Carter, BSc2, Dr. Atsushi
Kato, PhD2, Dr. Anju T. Peters, MD, FAAAAI2, Dr. Rakesh
Chandra, MD3, Dr. Bruce K. Tan, MD4, Dr. David Conley,
MD4, Dr. Robert C. Kern, MD4, Dr. Leslie C. Grammer, MD,
FAAAAI2 and Dr. Robert P. Schleimer, PhD FAAAAI5, 1Depart-
ment of Medicine, Division of Allergy-Immunology, Northwest-
ern University Feinberg School of Medicine, chicago, IL,
2
Department of Medicine, Division of Allergy-Immunology,
Northwestern University Feinberg School of Medicine, Chicago,
IL, 3Northwestern University, Chicago, IL, 4Department of Oto-
laryngology, Northwestern University Feinberg School of Medi-
cine, Chicago, IL, 5Division of Allergy-Immunology,
Department of Medicine, Northwestern University Feinberg
School of Medicine, Chicago, IL
583 Regulation Of Expression Of Pendrin Protein In CRS With Na-
sal Polyps and In Airway Epithelial Cells
Dr. Sudarshan Seshadri, PhD1, Dr. Xiang Lu, MD, PhD1, Mr.
Matthew Purkey, BS1, Dr. Tetsuya Homma, MD1, Mr. Andrew
Choi1, Mr. Roderick Carter, BSc1, Mr. James Norton, MS1, Ms. Ly-
dia Suh, BSc1, Dr. Atsushi Kato, PhD1, Prof. Pedro C. Avila, MD,
FAAAAI1, Dr. Anju T. Peters, MD, FAAAAI1, Dr. David Conley,
MD2, Dr. Rakesh Chandra, MD3, Dr. Bruce K. Tan, MD2, Dr. Leslie
C. Grammer, MD, FAAAAI1, Dr. Robert C. Kern, MD2 and Dr.
Robert P. Schleimer, PhD FAAAAI4, 1Department of Medicine, Di-
vision of Allergy-Immunology, Northwestern University Feinberg
School of Medicine, Chicago, IL, 2Department of Otolaryngology,
Northwestern University Feinberg School of Medicine, Chicago,
IL, 3Northwestern University, Chicago, IL, 4Division of Allergy-
Immunology, Department of Medicine, Northwestern University
Feinberg School of Medicine, Chicago, IL
584 Sex-Specific Differences In Disease Severity In Patients With
Chronic Rhinosinusitis With Nasal Polyps
Dr. Kathryn E. Hulse, PhD1, Dr. Whitney Wyatt Stevens, MD,
PhD2, Dr. Bruce K. Tan, MD3, Mr. James Norton, MS2, Ms. Ly-
dia Suh, BSc2, Dr. Robert C. Kern, MD3, Dr. David Conley,
MD3, Dr. Rakesh Chandra, MD1, Dr. Anju T. Peters, MD,
FAAAAI2, Dr. Leslie C. Grammer, MD, FAAAAI2, Ms. Kathleen
E. Harris, BSc2, Mr. Roderick Carter, BSc2, Dr. Atsushi Kato,
PhD2, Dr. Margrit Urbanek, PhD4 and Dr. Robert P. Schleimer,
PhD FAAAAI5, 1Northwestern University, Chicago, IL, 2Depart-
ment of Medicine, Division of Allergy-Immunology, Northwest-
ern University Feinberg School of Medicine, Chicago, IL,
3
Department of Otolaryngology, Northwestern University Fein-
berg School of Medicine, Chicago, IL, 43Division of Endocrinol-
ogy, Metabolism and Molecular Medicine, Northwestern
University Feinberg School of Medicine, 5Division of Allergy-
Immunology, Department of Medicine, Northwestern University
Feinberg School of Medicine, Chicago, IL
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
585 The Role Of Innate Cytokine In Non-Asthmatic, Non-Eosino-
philic Nasal Polyps: IL-25, IL-33 and TSLP
Dr. Dong-Kyu Kim1, Dr. Hyun-Woo Shin2, Dr. Jong-Wan Park2,
Dr. Min-Suk Yang3 and Dr. Dae Woo Kim3, 1Chuncheon Sacred
Heart Hospital, Hallym University College of Medicine, South Ko-
rea, 2Seoul National University College of Medicine, Pharmacology
and Biomedical Science, Ischemic/Hypoxic Disease Institute, South
Korea, 3Seoul National University Hospital and Boramae Medical
Center, South Korea
The Redwan Moqbel Memorial MAAI Featured
Poster Session
3807
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
586 IL33 and Type 2 Innate Lymphoid Cells (ILC2) But Not Th2
Cells Are Essential For Persistence Of Chronic Experimental
Asthma
Dr. Christina Christianson, PhD, Ms. Chaoyu Irvin, MS, Magda-
lena Gorska, MD, PhD and Rafeul Alam, MD, PhD, FAAAAI, Na-
tional Jewish Health, Denver, CO
587 PGE2 Deficiency Causes a Phenotype Of Aspirin Sensitive
Asthma That Depends On Platelets and Cysteinyl Leukotrienes
Dr. Tao Liu, PhD1,2, Dr. Joshua A. Boyce, MD, FAAAAI1,2, Dr. Tanya
M. Laidlaw, MD, FAAAAI1,2 and Dr. Howard Katz, PhD1,2, 1Brigham
and Womens Hospital, Division of Rheumatology, Immunology and
Allergy, Boston, MA, 2Harvard Medical School, Boston, MA
588 CCR8 Is a Receptor For CCL18 On Human Th2 Cells
Dr. Morris Ling, MD1, Dr. Sabina Islam, MD1,2, Dr. John Leung,
MD3, Wayne G. Shreffler, MD, PhD, FAAAAI1,2 and Dr. Andrew
D. Luster, MD, PhD4,5, 1Massachusetts General Hospital, Boston,
MA, 2Harvard Medical School, Boston, MA, 3Tufts Medical Cen-
ter, Boston, MA, 4Massachusetts General Hospital, Charlestown,
MA, 5Harvard Medical School, Charlestown, MA
589 Increased Frequency Of Dual Positive Th2/Th17 Cells In Bron-
choalveolar Lavage Characterizes a Population Of Severe Asth-
matic Patients
Rafeul Alam, MD, PhD, FAAAAI, Ms. Chaoyu Irvin, MS, Dr.
James Good, MD, Dr. Donald Rollins, MD, Dr. Christina Christian-
son, PhD, Ms. Iram Zafar, MS, Magdalena Gorska, MD, PhD and
Dr. Richard J. Martin, MD, National Jewish Health, Denver, CO
590 Cmrf-35-Like Molecule 1 (CLM-1) Is Required For IL-4-In-
duced Cellular Responses and Development Of Allergic Airway
Inflammation
Mr. Itay Moshkovits1, Mrs. Danielle Karo-Atar1, Mrs. Dana Shik1,
Dr. Alon Hershko, MD, PhD2 and Dr. Ariel Munitz, PhD1, 1Depart-
ment of Clinical Microbiology and Immunology, The Sackler
School of Medicine, Tel-Aviv University, Tel Aviv, Israel, 2Labora-
tory of Allergy and Clinical Immunology, Department of Medici-
ne,The Herbert Center of Mast Cell Disorders, Meir Medical
Center, Kfar Saba, Israel
Allied Health Featured Poster
3811
Sunday, March 2nd, 2014, 4:00 PM - 6:00 PM
591 Quality Of Life Improves In Children Undergoing Peanut Im-
munotherapy
Ms. Shannon Seopaul, BS1, Dr. Satya Narisety, MD2, Corinne
Keet, MD, MS3, Ms. Kim E. Mudd, RN MSN CCRP1, Ms. Sarah
D. Knorr, RN MPH CCRP4 and Robert A. Wood, MD, FAAAAI5,
Abstracts AB333
1
Johns Hopkins University School of Medicine, Baltimore, MD,
2
Johns Hopkins University School of Medicine, 3Pediatrics, Johns
Hopkins University School of Medicine, Baltimore, MD, 4Gei-
singer Community Medical Center., Scranton, PA, 5Johns Hopkins
University Medical Center, Baltimore, MD
Epidemiology: Asthma Control
4201
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
592 Asthma In The Elderly: The Role Of Vitamin D
Dr. Michele Columbo, MD, FAAAAI, Asthma, Allergy and Im-
munology Specialists, Bryn Mawr, PA, Dr. Reynold A. Panettieri
Jr., MD, University of Pennsylvania, Philadelphia, PA and Dr. Al-
bert S. Rohr, MD, FAAAAI, Rohr and Columbo Asthma, Allergy
SUNDAY
and Immunology Specialists, Bryn Mawr, PA
593 A Preliminary Randomized Controlled Trial:Educational Inter-
vention For Treatment Of Hispanic and African American
Adults With Asthma: Allergen Triggers, Peak Flow, and Spi-
rometry
Reenal Patel, MD, UMDNJ, Newark, NJ, Josha Fogel, PhD, Nas-
sau University Medical Center, East Meadow, NY and Marianne
Frieri, MD, PhD, FAAAAI, State University of NY @ Stony brook,
Stony Brook, NY
594 Assessment Of Asthma Education and Teaching Practices
Among Allergists
Natalia Vernon, M.D., Penn State Hershey Medical Center, Her-
shey, PA and Dr. Timothy Craig, D.O., Penn State University, Her-
shey, PA
595 Comparison Of Asthma-Related ED Visits In Public Versus Pri-
vate Hospitals In The Bronx
Dr. Mili Shum, MD, Weill Cornell Medical College, New York,
NY; Montefiore Medical Center, Bronx, NY, Dr. David L. Rose-
nstreich, MD, FAAAAI, Albert Einstein/Montefiore Medical Cen-
ter, Bronx, NY and Dr. Sunit Jariwala, MD, Albert Einstein/
Montefiore Medical Center, New York, NY
596 Comparison Of Pre- and Post-Pubertal Gender Differences In
Markers Of Angiogenesis and Asthma Outcomes
Dr. Amy Thomas, MD1, Mark DeVries2, Mr. Christopher J. Tisler,
MT2, Ms. Victoria Rajamanickam3, Dr. James E. Gern, MD,
FAAAAI2, Dr. Robert F. Lemanske Jr., MD, FAAAAI2 and Dr.
Daniel J. Jackson, MD4, 1University of Wisconsin Hospitals and
Clinics, Madison, WI, 2University of Wisconsin School of Medi-
cine and Public Health, Madison, WI, 3University of Wisconsin
Hospitals and Clinics, 4Pediatrics, University of Wisconsin School
of Medicine and Public Health, Madison, WI
597 Asthma Exacerbation In U.S. Adults: Who Are The Frequent
Utilizers Of The Emergency Department?
Dr. Kohei Hasegawa, MD, MPH1,2, Ashley Sullivan, MPH, MS1,
Stuart Turner, BPharm, MPH3, Susan Massaro, PharmD, MPH4 and
Dr. Carlos Camargo Jr., MD, DrPH1,2, 1Department of Emergency
Medicine, Massachusetts General Hospital, Boston, MA, 2Harvard
Medical School, Boston, MA, 3Novartis Pharmaceuticals Corpora-
tion, East Hanover, NJ, 4Novartis Pharmaceuticals
598 The Relationship Of The Serum Vitamin D Levels With Asth-
matic Severity Responses In Asthmatic Children
Dr. Julio Orellana1, Dr. Telma Varela2, Dr. Ana Romero Boni1, Dr.
Ofelia Mi~no1, Dr. Estela Pautasso1, Dr. Susana Rivolta1, Dr. Ramon
Pogonza3 and Dr. Juan Carlos Muino, MD, PhD, FAAAAI4, 1Nuevo
Hospital de Ni~nos de la Santisima Trinidad Cordoba Argentina,
Cordoba, Argentina, 2Nuevo Hospital de Ni~nos de la Santisima Tri-
nidad Cordoba Argentina, Cordoba, Argentina, 3Nuevo Hospital de
Ni~nos de la Santisima Trinidad Cordoba Argentina - CIU, Cordoba,
Argentina, 4FAC CS MED UNC, Cordoba, Argentina
123
 AB334 Abstracts
599 Newly Diagnosed Asthma In The Elderly: Is It Really Differ-
ent?
Prof. Bilun Gemicioglu, MD, PhD, Istanbul Univ. Cerrahpasa Faculty
of Medicine, Istanbul, Turkey, Prof. Oznur Abadoglu, MD, Cumhur-
iyet Univ. Faculty of Medicine, Sivas, Turkey, Dr. Levent Akyildiz,
MD, Mardin Medical Park Hospital, Mardin, Turkey, Prof. Hasan
Bayram, MD, PhD, University of Gaziantep, Gaziantep, Turkey,
Prof. Aykut Cilli, MD, Akdeniz Univ. Faculty of Medicine, Antalya,
Turkey, Prof. Arif Cimrin, MD, Dokuz Eylul Univ. Faculty of Medi-
cine, Izmir, Turkey, Prof. Hakan Gunen, MD, Sureyyapasa Pulmonary
Diseases Hospital and Research Center, Istanbul, Turkey, Prof. Zeynep
Misirligil, MD, Ankara Univ. Faculty of Medicine, Ankara, Turkey,
Prof. Tevfik Ozlu, MD, Karadeniz Teknik Univ. Faculty of Medicine,
Trabzon, Turkey, Prof. Mecit Suerdem, MD, Selcuk Univ. Faculty of
Medicine, Konya, Turkey and Prof. Esra Uzaslan, MD, Bursa Univ.
Faculty of Medicine, Bursa, Turkey
600 Risk Factors For Acute Asthma In The City Of
Esmeraldas, Ecuador
Dr. Cristina Ardura-Garcia1, Gisela Oviedo2, Maritza Vaca2, Car-
los Sandoval2, Stefanie Menzies2, Lisa J. Workman, BA3, Prof.
Matthew S. Perzanowski, PhD4, Maria Jose Rosa5, Thomas A.E.
Platts-Mills, MD, PhD, FAAAAI3 and Dr. Phil J. Cooper2,6, 1Uni-
versity of Liverpool, Wellcome Trust PhD Fellow, Liverpool,
United Kingdom, 2Laboratorio de FEPIS, Quininde, Esmeraldas
Province, Ecuador, 3Division of Asthma, Allergy & Immunology,
University of Virginia Health System, Charlottesville, VA, 4Depart-
ment of Environmental Health Sciences, Mailman School of Public
Health, Columbia University, New York, NY, 5Columbia Univer-
sity, New York, NY, 6St. Georges University, London, United
Kingdom
601 Serum Vitamin D Levels and Clinical Features Of The Disease
In Children With Asthma Aged 5 To 18 Years Old
Dr. Zeynep Tamay, MD, Associate Professor of Pediatrics, Istan-
bul University, Istanbul School of Medicine, Department of Pediat-
rics, Division of Pediatric Allergy, Istanbul, Turkey, Dr. Nurhan
MONDAY
Ozcan, Ege Medical Faculty, Department of Pediatrics, Prof. Fir-
devs Bas, Istanbul University, Istanbul School of Medicine, Depart-
ment of Pediatrics; Division of Pediatric Endocrinology, Prof. Umit
Turkoglu, Istanbul University, Istanbul School of Medicine, Depart-
ment of Pediatrics, Division of Biochemistry and Prof. Nermin Gu-
ler, MD, Istanbul University, Istanbul School of Medicine,
Department of Pediatrics, Division of Pediatric Allergy, Turkey
602 Effectiveness Of Specific Immunotherapy Against Alternaria
Alternata In Patients With Asthma and Or Allergic Rhinitis
Dr. Silvia Martnez Blanco, MD1, Dr. Ana Anton-Laiseca, MD1,
Dr. R. Mielgo Ballesteros, MD1, Dr. Consuelo Fernandez
Rodrguez, MD, PhD1, Dr. Ruth Barranco Jimenez, MD1 and Dr.
R. Vives Conesa, MD2, 1Hospital Universitario 12 de Octubre,
Spain, 2Hospital Universitario 12 de Octubre, Madrid, Spain
603 Vitamin D Levels As Related To Severity and Ethnicity In Asth-
matics
Dr. Patricia H. Stewart, MD1, Dr. Thomas Pressley, PharmD1, Dr.
Deborah Minor, PharmD1 and Prof. Gailen D. Marshall Jr., MD,
PhD, FAAAAI2, 1University of Mississippi Medical Center, 2Uni-
versity of Mississippi Medical Center, Jackson, MS
604 Real Life Study Of Safety and Efficacy Of Subcutaneous Immu-
notherapy With Cat and Dog Extracts
Ms. Silvia Uriarte and Prof. Joaquin Sastre, MD, PhD, FAAAAI,
Fundacion Jimenez Daz, Madrid, Spain
605 Improvement In Quality Of Life In Parents Of Asthmatic Chil-
dren Aged < 4 Years Receiving Subcutaneous Allergy Immuno-
therapy
Yurydia Jorge1, Yikania Pichardo1, Paola Polanco, MD2, Xin
Zheng, PhD3, Jose Adames, BS3, Dr. Andrew A. Wiznia, MD3,
Dr. David L. Rosenstreich, MD, FAAAAI4 and Dr. Gabriele De
Vos, MD5, 1Jacobi Medical Center, New York, NY, 2Jacobi Medical
Center, 3Albert Einstein College of Medicine, 4Albert Einstein/
124
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Montefiore Medical Center, Bronx, NY, 5Albert Einstein College
of Medicine, Bronx, NY
606 Ashmi Suppresses Neutrophil Pulmonary Inflammation In a
Ragweed Allergic Asthma Model That Is Associated With Mod-
ulation Of Innate and Adaptive Immune Responses
Dr. Kamal D. Srivastava, PhD1, Dr. David Dunkin, MD2, Dr. Nan
Yang, PhD, MS1, Dr. Changda Liu, PhD1, Dr. Rachel L. Miller, MD,
FAAAAI3 and Dr. Xiu-Min Li, MD1, 1Pediatrics, Icahn School of Med-
icine at Mount Sinai, New York, NY, 2Icahn School of Medicine at
Mount Sinai, New York, NY, 3Division of Pulmonary, Allergy and Crit-
ical Care Medicine, Columbia University, New York, NY
607 Longitudinal Characteristics Of Viral and Non-Viral Exacerba-
tions Of Childhood Asthma
Dr. Amaziah Coleman, MD1, Dr. Daniel J. Jackson, MD2, Dr. Ro-
nald E. Gangnon, PhD1, Mr. Michael D. Evans, MS1, Dr. Robert F.
Lemanske Jr., MD, FAAAAI1 and Dr. James E. Gern, MD,
FAAAAI1, 1University of Wisconsin School of Medicine and Public
Health, Madison, WI, 2Pediatrics, University of Wisconsin School
of Medicine and Public Health, Madison, WI
Biomarkers and Asthma Control II
4202
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
608 Bronchial Epithelial Cell Gene Expression In Relation To Ex-
haled Nitric Oxide Identifies New Molecular Asthma Pheno-
types
Dr. Brian D. Modena, MD1, Dr. John Tedrow, MD1, Dr. Jadranka
Milosevic, PhD1, Dr. Naftali Kaminski, MD2 and Sally E. Wenzel,
MD, FAAAAI1, 1University of Pittsburgh Medical Center NW,
Pittsburgh, PA, 2Yale-New Haven Hospital, New Haven, CT
609 How Common Is The Phenotype Reflected By The Atopic
March? Results At Two Years Of Age In a General Risk
Multi-Racial Birth Cohort
Dr. Christine Cole Johnson, PhD MPH FAAAAI1, Ms. Suzanne
Havstad, M.A.1, Dr. Dennis Ownby, M.D. FAAAAI2, Dr. Christine
L.M. Joseph, PhD1, Dr. Haejin Kim, MD3, Kimberley J. Woodcroft,
PhD1, Dr. Edward M. Zoratti, MD, FAAAAI4 and Ganesa We-
gienka, PhD1, 1Department of Public Health Sciences, Henry
Ford Hospital, Detroit, MI, 2Department of Pediatrics Georgia Re-
gents University, Augusta, GA, 3Division of Allergy and Clinical
Immunology, Henry Ford Hospital, Detroit, MI, 4Henry Ford
Health System, Detroit, MI
610 Is Asthma Predictive Index Feasible For A Retrospective
Study?
Dr. Chung I. Wi, MD1, Dr. Miguel A. Park, MD2 and Dr. Young J.
Juhn, MD, MPH1, 1Dept of Pediatric and Adolescent Medicine,
Mayo Clinic, Rochester, MN, 2Department of Internal Medicine:
Division of Allergic Diseases, Mayo Clinic, Rochester, MN
611 Comparison Of Rates Of Prescribing Oral Corticosteroids For
Asthma Exacerbations Between Step-Down Therapy Ap-
proaches Among Initiators Of Inhaled Corticosteroids and
Long-Acting Beta-Agonist Combination Therapy
Ayad K. Ali, PhD1,2, Almut Winterstein, PhD2, Leslie Hendeles,
PharmD2, Xiaomin Lu, PhD3, Richard Segal, PhD2 and Abraham
Hartzema, PhD2, 1Eli Lilly and Company, Indianapolis, IN, 2Col-
lege of Pharmacy, University of Florida, Gainesville, FL, 3College
of Public Health and Health Professions, College of Medicine, Uni-
versity of Florida, Gainesville, FL
612 The Good, The Bad and The Ugly Of The Naepp EPR3 Guide-
lines
Dr. Priyanka Lall, MD, Emory University, Atlanta, Dr. Karen A.
DeMuth, MD, FAAAAI, Emory University, Atlanta, GA and Dr.
Morton Galina, Emory University
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
613 Fibrin Complexes From The Sputum Of Human Asthmatics
Contain Viable Fungi
Dr. Rani Maskatia, MD1, Cameron Landers, B.S1, Dr. Evan Li,
M.D.1, Dr. Roger Rossen, M.D.1,2, Dr. Frank M. Orson, MD,
FAAAAI1,2 and Dr. David B. Corry, MD1, 1Baylor College of Med-
icine, Houston, TX, 2Veterans Affairs Medical Center, Houston, TX
614 Proteomic Identification Of S100A8 As a Potential Effector Pro-
tein Of Acupuncture In Asthma Treatment
Yu-Dong Xu1,2, Yu Wang1, Ying Wei1, Lei-Miao Yin1, Jun Ran1
and Yong-Qing Yang1,2, 1Molecular Biology Laboratory, Shanghai
Research Institute of Acupuncture and Meridian, Shanghai Univer-
sity of Traditional Chinese Medicine, Shanghai, China, 2Yue Yang
Hospital, Shanghai University of Traditional Chinese Medicine,
Shanghai, China
615 Are Asthma Specialists and Non-Specialists Familiar With In-
haled Corticosteroid (ICS) Dosing Recommendations and Side
Effects In Children With Asthma?
Dr. Jonathan Drori, West Penn Allegheny Health System, Pitts-
burgh, PA
616 Medication Remaining In Discarded Metered Dose Inhalers Of
Asthmatic Children
Dr. Wantida Dampanrat, MD, Prince Of Songkla University, Ha-
tyai, Thailand, Dr. Pasuree Sangsupawanich, MD, Prince Songkhla-
nagarind hospital, Hadyai, Thailand and Dr. Araya Yuenyongviwat,
MD, Prince of Songkla University, Songkhla, Thailand
617 Defining Severe Asthma In Childhood: A Descriptive Multicen-
ter Study In Turkey
Bulent Enis Sekerel1, Dr. Ozge Soyer2, Fatih Celmeli3, Yakup
Canitez3, Ozlem Keskin3, Demet Can3, Ferhat Catal3, Mehtap
Kilic3, Burcin Nalbantoglu3, Nail Yologlu3, Suleyman T. Yavuz3,
Belgin Guc3, Fadil Ozturk3, Gulbin Karakoc3, Suna Asilsoy3, Meh-
met Kilic3, Cem Razi3, Dost Zeyrek3, Semanur Kuyucu3, Hasan
Yuksel3, Omer Cevit3, Aysen Bingol3, Mehtap G. Yazicioglu3 and
Ayse Yenigun3, 1Hacettepe University, Pediatric Allergy Unit, An-
kara, Turkey, 2Hacettepe University School of Medicine, Ankara,
Turkey, 3TURPEDAS, Turkey
618 The Pediatric Diagnostic Conundrum Of Chronic Respiratory
Symptoms
Zainab Kagen, MD, University of Tennesee College of Medicine-
Chattanooga, TN, Joel Ledbetter, MD, University of Tennessee Col-
lege of Medicine-Chattanooga, TN, Jennifer Hamm, MD, University
of Tennesee College of Medicine-Chattanooga and Esther Wilson,
MD, University of Tennessee College of Medicine-Chattanooga
IVIG and Other Therapeutics
4203
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
619 Quantification Of The Wear-Off Effect Towards The End Of
The Intravenous Immunoglobulin Infusion Interval: Pooled
Data Analysis
Mr. John-Philip Lawo, CSL Behring GmbH, Marburg, Germany,
Dr. Alphonse Hubsch, CSL Behring AG, Berne, Switzerland and
Dr. Mikhail Rojavin, PhD, Clinical Research and Development,
CSL Behring LLC, King of Prussia, PA
620 Safety and Efficacy Of Biweekly Hizentra Administration In
Patients With Primary Immunodeficiency Diseases: A Retro-
spective Single-Center Study
Clare Malcolmson and Dr. Alison Jones, Great Ormond Street
Hospital, London, United Kingdom
621 Long-Term Tolerability and Safety Of Facilitated-Subcutaneous
Infusion Of Human Immune Globulin G (IgG), 10%, and Re-
combinant Human Hyaluronidase (rHuPH20) (IGHy): A Phase
3 Extension Study In Patients With Primary Immunodefi-
ciencies (PIs)
Abstracts AB335
Dr. Isaac Reuven Melamed, MD1, Dr. Richard L. Wasserman, MD,
PhD, FAAAAI2, Dr. Mark Stein, MD, FAAAAI3, Dr. Arye Rubinstein,
MD, FAAAAI4, Dr. Jennifer M. Puck, MD5, Sudhir Gupta, MD, PhD,
FAAAAI6, Werner Engl7, Dr. Heinz Leibl, PhD7, Dr. Leman Yel, MD,
FAAAAI8 and Dr. Richard I. Schiff, MD, PhD8, 1IMMUNOe Health
Centers, Centennial, CO, 2DallasAllergyImmunology, Dallas, TX,
3
Allergy Associates of the Palm Beaches, North Palm Beach, FL, 4Al-
bert Einstein College of Medicine, Bronx, NY, 5Department of Pediat-
rics, University of California San Francisco and UCSF Benioff
Childrens Hospital, San Francisco, CA, 6University of California, Ir-
vine, Irvine, CA, 7Baxter BioScience, Vienna, Austria, 8Baxter BioSci-
ence, Westlake Village, CA
622 Health-Related Quality Of Life Of Japanese Patients With Pri-
mary Immunodeficiency Diseases Receiving IgPro20, a 20%
Liquid Subcutaneous Immunoglobulin (Hizentra)
Prof. Hirokazu Kanegane, MD, PhD1, Prof. Kohsuke Imai, MD,
PhD2, Prof. Masafumi Yamada, MD, PhD3, Prof. Hidetoshi Takada,
MD, PhD4, Prof. Tadashi Ariga, MD, PhD3, Prof. Ataru Igarashi,
PhD5, Prof. Kiichiro Tsutani, MD, PhD5, Dr. Martin Bexon,
MD6, Dr. Mikhail Rojavin, PhD7, Ms. Midori Kobayashi, BSPharm,
MBA8, Dr. John-Philip Lawo, PhD9, Mr. Art Zbrozek, RPh, MSc,
MBA10, Prof. Shigeaki Nonoyama, MD, PhD11, Prof. Toshiro
Hara, MD, PhD4 and Prof. Toshio Miyawaki, MD, PhD1, 1Depart-
ment of Pediatrics, Graduate School of Medicine and Pharmaceuti-
cal Sciences, University of Toyama, Toyama, Japan, 2Department
of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo
Medical and Dental University, Tokyo, Japan, 3Department of Pedi-
atrics, Hokkaido University Graduate School of Medicine, Sapporo,
Japan, 4Department of Pediatrics, Graduate School of Medical Sci-
ences, Kyushu University, Fukuoka, Japan, 5Department of Drug
Policy and Management, Graduate School of Pharmaceutical Sci-
ences, The University of Tokyo, Tokyo, Japan, 6Clinical Research
and Development, CSL Behring AG, Berne, Switzerland, 7Clinical
Research and Development, CSL Behring LLC, King of Prussia,
PA, 8Research and Development, CSL Behring K.K., Tokyo, Japan,
9
CSL Behring GmbH, Marburg, Germany, 10CSL Behring LLC,
MONDAY
King of Prussia, PA, 11Department of Pediatrics, National Defense
Medical College, Tokorozawa, Japan
623 Efficacy and Tolerability Of Privigen In Clinical Practice
Dr. Morna J. Dorsey, MD MMSc FAAAAI1, Viet Ho2, Dr. Moh-
sen I. Mabudian, MD3, Pere Soler-Palacn4, Nerea Domnguez-Pi-
nilla5, Dr. Robert W. Hellmers, MD, FAAAAI6, Dr. Radha
Gandhi Rishi, MD, FAAAAI6, Rahul Rishi7, Dr. Duane W. Wong,
MD6, Dr. Mikhail Rojavin, PhD8, Dr. Alphonse Hubsch9 and Dr.
Melvin Berger, MD, PhD, FAAAAI8, 1Department of Pediatrics,
University of California, San Francisco, San Francisco, CA, 2Mof-
fitt Cancer Hospital, FL, 3Beaver Medical Group, Inc., Department
of Allergy and Clinical Immunology, Redlands, CA, 44Pediatric In-
fectious Diseases and Immunodeficiencies Unit, Hospital Universi-
tari Vall dHebron, Barcelona, Spain, 55Department of Pediatrics,
Hospital 12 de Octubre, Madrid, Spain, 6Arizona Allergy Associ-
ates, Chandler, AZ, 7Arizona Allergy Associates, Phoenix, AZ,
8
Clinical Research and Development, CSL Behring LLC, King of
Prussia, PA, 9CSL Behring AG, Berne, Switzerland
624 Safety and Tolerability Of An Intravenously Administered Al-
pha1-Proteinase Inhibitor (A1PI) At An Increased Infusion
Rate: A Randomized, Rate Control, Placebo-Masked, Cross-
over Study In Healthy Adults
Adam Haeberle1, Leock Ngo1, Neil Inhaber1, David Gelmont1 and
Dr. Leman Yel, MD, FAAAAI2, 1Baxter BioScience, 2Baxter Bio-
Science, Westlake Village, CA
625 Pharmacokinetic Modeling Predicts Different IgG Exposures
Using Different IVIG-Scig Dose Conversion Factors In Patients
With Primary Immune Deficiency
Dr. Jagdev S. Sidhu, PhD1, Dr. Mikhail Rojavin, PhD2, Dr. Melvin
Berger, MD, PhD, FAAAAI2, Dr. Martin Bexton3 and Dr. Jonathan
M. Edelman, MD2, 1Clinical Pharmacology & Early Development,
125
 AB336 Abstracts
CSL Ltd, Parkville, Australia, 2Clinical Research and Development,
CSL Behring LLC, King of Prussia, PA, 3CSL Behring AG, Berne,
Switzerland
626 Flexible Dosing For Hizentra: Pharmacokinetic Simulations
Of Various Subcutaneous Dosing Regimens and Compliance
In Patients With Primary Immunodeficiency
Dr. Mikhail Rojavin, PhD1, Dr. Jagdev S. Sidhu, PhD2, Dr. Martin
Bexon, MD3 and Dr. Jonathan M. Edelman, MD1, 1Clinical Re-
search and Development, CSL Behring LLC, King of Prussia,
PA, 2Clinical Pharmacology & Early Development, CSL Ltd, Park-
ville, Australia, 3Clinical Research and Development, CSL Behring
AG, Berne, Switzerland
627 Effect Of Synthetic Steroids and Hydroxychloroquine On B-
Cell IgE Production
Dr. Ahila Subramanian, MD, MPH, Yingchun Han and Dr. Fred
H. Hsieh, MD, Cleveland Clinic Foundation, Cleveland, OH
628 Safety, Tolerability, and Efficacy Of Hizentra In Japanese Pa-
tients With Primary Immunodeficiency Over 48 Weeks
Prof. Kohsuke Imai, MD, PhD1, Prof. Hirokazu Kanegane, MD,
PhD2, Prof. Masafumi Yamada, MD, PhD3, Prof. Hidetoshi Takada,
MD, PhD4, Prof. Tadashi Ariga, MD, PhD3, Ms. Midori Kobayashi,
BSPharm, MBA5, Dr. Mikhail Rojavin, PhD6, Dr. Martin Bexon,
MD7, Prof. Shigeaki Nonoyama, MD, PhD8, Prof. Toshiro Hara,
MD, PhD4 and Prof. Toshio Miyawaki, MD, PhD2, 1Department of
Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Med-
ical and Dental University, Tokyo, Japan, 2Department of Pediatrics,
Graduate School of Medicine and Pharmaceutical Sciences, University
of Toyama, Toyama, Japan, 3Department of Pediatrics, Hokkaido Uni-
versity Graduate School of Medicine, Sapporo, Japan, 4Department of
Pediatrics, Graduate School of Medical Sciences, Kyushu University,
Fukuoka, Japan, 5Research and Development, CSL Behring K.K., To-
kyo, Japan, 6Clinical Research and Development, CSL Behring LLC,
King of Prussia, PA, 7Clinical Research and Development, CSL Behr-
ing AG, Berne, Switzerland, 8Department of Pediatrics, National De-
fense Medical College, Tokorozawa, Japan
MONDAY
629 In Vitro Effect Of Intravenous Immunoglobulin (IVIG) On Nat-
ural Antibody Producing Human B1 Cells
Kevin A. Cook, MD1, Sudhanshu Agrawal, MS1 and Sudhir Gupta,
MD, PhD, FAAAAI2, 1University of California, Irvine, 2University
of California, Irvine, Irvine, CA
630 Effect Of A Novel, Oral Histamine H4R Antagonist On Hista-
mine-Induced Pruritus In Healthy Subjects
Dr. Alexa P. Kollmeier, MD1, Paul Dunford, MSc1, Xie Xu, PhD1,
Andrew Greenspan, MD1, Yichuan Xia, PhD2, Bei Zhou, PhD2,
Klaus Francke, MD, PhD3 and Dr. Robin L. Thurmond, PhD1,
1
Janssen Research & Development, LLC, La Jolla, CA, 2Janssen
Research & Development, LLC, Spring House, PA, 3Parexel Inter-
national, London, United Kingdom
631 Decreasing Risk Of Infection and Severity Of Infections Result-
ing In Hospitalizations In Patients With Primary Immunodefi-
ciency Disease Changing From IVIG To Scig Therapy
Mr. Art Zbrozek, RPh, MSc, MBA1, Ms. Sonam Mehta2, Dr.
Dipen A. Patel2 and Mr. Marc Botteman, MSc2, 1CSL Behring
LLC, King of Prussia, PA, 2Pharmerit International, Bethesda, MD
632 A Multicenter Non-Interventional Study On The Efficacy and
Tolerability Of The Polyvalent Intravenous Immunoglobulin
Privigen Allergy & Immunology Cr., Cairo, Egypt, Dr. Marwa Ahmed, Al-
Dr. Rainer Hoffmann, MD1, Dr. Peer Lotichius, PhD2 and Dr. Di-
etmar Pfruender, MD2, 11Praxis fur Neurologie und Psychiatrie,
Berlin, Germany, 2CSL Behring, Hattersheim, Germany
633 The Immunoglobulin Diagnosis, Evaluation, and Key Learnings
(IDEaL) Patient Registry: Analysis Of Ig Dosing, Infection Con-
trol, and Quality-Of-Life Assessments In Our Primary Immu-
nodeficiency Population
Sean Kearns, Ph.D1, Keith Crawford1, Loretta Kristofek, RN1, Rob-
byn Kirylo1 and Dr. Luqman Seidu, MD2, 1Coram Clinical Trials, Den-
ver, CO, 2Allergy and Asthma of Atlanta, LLC, Atlanta, GA
126
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
634 Retrospective Analysis Of The Clinical Utility Of Biweekly Dos-
ing With High-Concentration Subcutaneous Immunoglobulin
In 10 Patients With Primary Immunodeficiency
Dr. Richard L. Wasserman, MD, PhD, FAAAAI1, Dr. Shahnaz
Fatteh2, Dr. Javaid M. Khan, DO2 and Dr. Elie Haddad, MD3,
1
Medical City Childrens Hospital, Dallas, TX, 2Larkin Community
Hospital, South Miami, FL, 3CHU Sainte-Justine, Montreal, QC,
Canada
Autoinflammatory Disorders
4204
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
635 Concomitant FMF and TRAPS Mutation In a Periodic Fever
Patient
Dr. Adrianne C. Netterville, MD1, Dr. Victoria Dimitriades, MD1
and Dr. Paul D. Niolet, MD2, 1Louisiana State University Depart-
ment of Pediatrics, New Orleans, LA, 2Allergy Asthma and Immu-
nology, Ocean Springs, MS
636 Association Of Interleukin-23 Receptor Single Nucleotide Poly-
morphisms With Ulcerative Colitis
Dr. Mona Hedayat, MD, Boston Childrens Hospital, Boston, MA,
Dr. Nasser Ebrahimi Daryani, Department of Gastroenterology and
Hepatology, Tehran University of Medical Sciences, Dr. Farnaz
Najmi Varzaneh, Molecular Immunology Research Center, Depart-
ment of Immunology, Tehran University of Medical Sciences and
Dr. Nima Rezaei, MD, PhD, Research Center for Immunodefi-
ciencies, Childrens Medical Center, Tehran University of Medical
Sciences, Tehran, Tehran, Iran
637 A Novel Immunoablative Regimen Utilized In The Successful
Remission Of Pulmonary Hemorrhage In An Adolescent Fe-
male With Systemic Lupus Erythematosus
Ms. Vivian E. Cino, MSN ARNP-BC PNP1, Alexander Constan-
tinescu, MD2, Kristina Deeter, MD2, Faina Shenderov, PharmD2,
Joan Spiro, PharmD2 and Dr. Gary I. Kleiner, MD, PhD, FAAAAI2,
1
Joe Dimaggio Childrens Hospital, Hollywood, FL, 2Joe Dimaggio
Childrens Hospital
638 Haptoglobin Deficiency and Autoimmune Manifestations; A
Case Series
Dr. Anna Kochin, MD1, Dr. Jenny Shliozberg, MD, FAAAAI1 and
Dr. Arye Rubinstein, MD, FAAAAI2, 1Montefiore Medical Center,
Bronx, NY, 2Albert Einstein College of Medicine, Bronx, NY
639 Immunogenicity Analysis Of Two Anti-TNF (Infliximab vs Eta-
nercept) Therapies In Rheumatologic Patients
Dr. Yvelise Barrios, MD, PhD1, Dr. Victor Matheu, MD2, Dr. An-
dres Franco, MD1, Dr. Esmeralda Delgado, MD3 and Dr. Sagrario
Bustabad, MD3, 1Immunology, Hospital Universitario de Canarias,
LA LAGUNA, Spain, 2Allergy Section, Hospital Ofra, Tenerife,
Spain, 3Rheumatology, Hospital Universitario de Canarias, LA LA-
GUNA, Spain
640 Circulating Endothelial and Platelet Microparticles For Diag-
nosis and Monitoring Vasculitis
Prof. El-Desouki E. Fouda, MD, FAAAAI, Al-Azhar university
azhar Allergy&Immunology Cr., Cairo, Egypt and Prof. Mona Al-
rayes, Al-Azhar Allergy& Immunology Cr.,, Cairo, Egypt
641 Mistaken Identity: Misdiagnosis Based On Auto-Antibodies In
IVIG
Dr. Kristyn E. Anthony, MD, Tulane University, New Orleans, LA
and Dr. Jane M. El-Dahr, MD, Tulane University School of Medi-
cine, New Orleans, LA
642 Th-17 Cytokines In Oral Lichen Planus
Prof. G.N. Drannik1, Prof. A.I. Kurchenko1, Dr. R.A. Rehuretska1,
Dr. A.G. Drannik2 and Prof. Lawrence M. DuBuske, MD,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
FAAAAI3, 1National Medical University, Kiev, Ukraine, 2National
medical University, Kiev, Ukraine, 3George Washington University
School of Medicine, DC
Airborne Allergen Exposures
4205
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
643 A Study On Allergy Sensitization Of Dense Urban Dwellers To
Dog and Cat Allergens Using The Skin Prick Test
Dr. Racquel Joy Y. So, Dr. Florecita Padua and Dr. Shirley Kwong,
Fe Del Mundo Medical Center, Quezon City
644 Rhinix Nasal Filters For The Treatment Of Allergic Rhinitis:
A Randomized, Double-Blinded Placebo-Controlled Crossover
Clinical Trial
Peter Kenney, BSc1, Ole Hilberg, MD, DMSc2, Henrik Pedersen,
PhD3, Ole Bkgaard Nielsen, PhD4 and Torben Sigsgaard, MD,
PhD1, 1Department of Public Health, Aarhus University, Aarhus,
Denmark, 2Department of Respiratory Diseases and Allergology,
Aarhus University Hospital, Aarhus, Denmark, 3Department of
Engineering - Signal Processing, Aarhus University, Aarhus, Den-
mark, 4Department of Biomedicine, Aarhus University, Aarhus
645 Airborne Allergen Exposure As a Quantum Phenomenon
Dr. Gert Doekes, PhD, Institute for Risk Assessment Sciences,
University Utrecht, NL, Utrecht, Netherlands, Dr. Peter S. Thorne,
PhD, University of Iowa, Iowa City, IA, Dr. Ingrid Sander, PhD, In-
stitute for Prevention and Occupational Medicine, Ruhr-University
Bochum, Bochum, Germany, Dr. Inge Wouters, PhD, Institute for
Risk Assessment Sciences, University Utrecht, Utrecht, Nether-
lands, Dr. Wijnand Eduard, PhD, National Institute of Occupational
Health, Oslo, Norway and Dr. Dick Heederik, PhD, Institute for
Risk Assessment Sciences, Utrecht, Netherlands
646 Computer-Aided Design Of An Allergen Challenge Theatre
William H. Yang, MD, Jimmy Yang, MBA, Robert Perrins, P.Eng,
Suzanne Kelly, PhD and Jacob Karsh, MD, Red Maple Trials Inc.,
Ottawa, ON, Canada
647 Evaluation Of a Compact Ionic Capture Device For Airborne
Allergens In Inner City Schools
Dr. Julian Gordon, PhD1, Ms. Prasanthi Gandhi, MBA MPH1, Dr.
Gajendra Shekhawat, PhD2, Ms. Ann Bailey, BA3 and Dr. Wanda
Phipatanakul, MD, MS, FAAAAI4, 1Inspirotec LLC, Chicago, IL,
2
Northwestern University, Evanston, IL, 3Channing Laboratory,
Boston, MA, 4Boston Childrens Hospital, Boston, MA
648 Relevance Of Sensitization To Blomia Tropicalis, Dermatopha-
goides and Tropomyosin- Containing Antigens Among Atopics
Living In a Tropical Region
Dr. Beverly K. Di Giorgi, MD, Dr. Sylvette Nazario, MD, Dr. Fer-
nando J. Lopez, MD and Dr. Javier A. Mendez, MD, University of
Puerto Rico School of Medicine, San Juan, PR
649 Update In The Prevalence Of Atopic Conditions, IgE Levels and
Skin Test Sensitization To Aeroallergens In Northern Puerto
Rico
Dr. Rafael H. Zaragoza, MD, PhD, Doral Bank Center, San Juan,
PR; University of Puerto Rico School of Medicine, San Juan, PR
650 Stability Of Immunoassay Analytes and Test Kits Used For
Monitoring Environmental Allergen Exposure
Bryan Smith, Denise Block, Stephanie Filep, Dr. Martin D. Chap-
man, PhD FAAAAI and Dr. Eva-Maria King, PhD, Indoor Biotech-
nologies, Inc., Charlottesville, VA
651 Factors Affecting Pollen Rupture and Protein Release From Al-
lergenic Pollens
Ms. Umaporn Siriwattanakul, Master of Science Program in Plant
Science, Department of Plant Science, Faculty of Science and De-
partment of Pharmaceutical Botany, Faculty of Pharmacy, Mahidol
Abstracts AB337
University, Bangkok, Thailand and Dr. Wisuwat Songnuan, Depart-
ment of Plant Science, Faculty of Science, Mahidol University,
Bangkok, Thailand
652 Attitudes and Behaviors Among Patients With Confirmed Pet
Allergy
Dr. Timothy J. Campbell, MD, Dr. Asaf Klein, MD, Xiaofeng
Wang, PhD, Qi Zhang, M.S. and Dr. Roxana Siles, MD, Cleveland
Clinic
653 Uniformed Distribution Of Aerosolized Dust Mite Allergen In
The Allergen Biocube (ABC)
Keith Lane, Ora Inc., MA, Paul Gomes, Ora Inc., Endri Angjeli,
Ora, Inc, Andover, MA and Dr. Anne K. Ellis, MD, MSc FAAAAI,
Allergy Research Unit, Kingston General Hospital, Kingston, ON,
Canada; Departments of Medicine and Biomedical & Molecular
Science, Queens University, Kingston, ON, Canada
Infections, Asthma and Allergies
4206
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
654 Cytokine Profiles In Bronchoalveolar Lavage In a Mouse Model
Of Bronchial Asthma During A(H1N1)pdm09 and Seasonal
H1N1 Infection
Dr. Shunji Hasegawa1, Dr. Seigo Okada2, Dr. Hiroyuki Wakiguchi2,
Dr. Hideki Hasegawa3, Dr. Akira Ainai4, Dr. Komei Shirabe5, Dr. Shoi-
chi Toda5, Dr. Ryo Atsuta6, Dr. Akihiro Hasegawa7 and Dr. Takashi
Ichiyama1, 1Department of Pediatrics, Yamaguchi University Graduate
School of Medicine, Ube, Yamaguchi, Japan, 2Department of Pediat-
rics, Yamaguchi University Graduate School of Medicine, 3Depart-
ment of Pathology, National Institute of Infectious Diseases,
4
Influenza Virus Research Center, National Institute of Infectious Dis-
eases, 5Yamaguchi Prefectural Institute of Public Health and Environ-
MONDAY
ment, 6Department of Respiratory Medicine, Juntendo University
School of Medicine, 7Department of Microbiology and Immunology,
Yamaguchi University Graduate School of Medicine
655 In Vitro Tumor Necrotic Factor Alpha Responses To Persistent
Chlamydia Pneumoniae Infection From PBMC Of Asthmatic
Children
Dr. Kobkul Chotikanatis, MD1, Dr. Diana Weaver, MD2, Danielle
Lent3, Eva Estrella3, Dr. Margaret R. Hammerschlag, MD3, Dr.
Rauno O. Joks, MD, FAAAAI1,4 and Dr. Stephan Kohlhoff, MD5,6,
1
SUNY Downstate Medical Center, Center for Allergy and Asthma
Research, Brooklyn, NY, 2Kings County Hospital Center, Brooklyn,
NY, 3SUNY Downstate Medical Center, Brooklyn, NY, 4Department
of Medicine, State University of New York Downstate Medical Cen-
ter, Brooklyn, NY, 5Center for Allergy and Asthma Research, State
University of New York Downstate Medical Center, Brooklyn, NY,
6
Department of Pediatrics, State University of New York Downstate
Medical Center, Brooklyn, NY
656 Human Rhinoviruses/Enteroviruses Associated Wheezing In
Children
Anyarat Wanitchakorn, MD1, Dr. Wiparat Manuyakorn, MD1,
Wasu Kamchaisatian, MD1, Dr. Wasun Chantratita2, Kanjana Pre-
mchaiporn2 and Suwat Benjaponpitak, MD1, 1Division of Pediatric
Allergy/Immunology/Rheumatology, Department of Pediatrics,
Faculty of Medicine Ramathibodi Hospital, Mahidol University,
Bangkok, Thailand, 2Department of Pathology, Faculty of Medicine
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
657 Study Of Montelukast For The Treatment Of Acute and Post
Viral-Induced Wheezing
Sirirak Kanchanateeraphong, MD, Gun Phongsamart, MD, Tas-
salapa Dangsuwan, MD and Mukda Vangveeravong, MD, Queen
Sirikit National Institute of Child Health(Children Hospital), Bang-
kok, Thailand
127
 AB338 Abstracts
658 Prevalence Of Toxocara Infection In Subjects With Suspected
Allergies
Dr. Rosanna M. Qualizza, Istituti Clinici di Perfezionamento, Mi-
lano, Italy, Dr. Cristoforo Incorvaia, Istituti Clinici di perfeziona-
mento, Milano, Italy and Dr. Anna Maraschini, IRCCS
Fondazione CaGranda Policlinico, Milano, Italy
659 The Effects Of Dexamethasone On Community-Acquired Pneu-
monia In Children
Prof. Youn Ho Shin, Department of Pediatrics, CHA Medical Cen-
ter, CHA University School of Medicine, Seoul, Korea, South Ko-
rea, Dr. Jun Hwan Kim, Department of Pediatrics, CHA University
School of Medicine, South Korea, Dr. Jung Won Yoon, Department
of Pediatrics, Myongji Hospital, Gyeonggi-do, South Korea, Prof.
Sun-Hee Choi, MD, PhD, Gangdong Kyung Hee University Hospi-
tal, Seoul, South Korea, Dr. Hyeung Yoon Kim, Department of Pe-
diatrics, Bundang Jaesaeng Hospital, Seongnam, South Korea, Hye
Mi Jee, MD, Department of Pediatrics, CHA University School of
Medicine, Seongnam, Korea, South Korea, Prof. Man-Yong Han,
MD, PhD, Department of Pediatrics, CHA University School of
Medicine, Seongnam, South Korea and Dr. Jin-Tack Kim, MD,
PhD, Department of Pediatrics, Uijeongbu St. Marys Hospital,
The Catholic University of Korea, College of Medicine, Uijeongbu,
Gyeonggi-Do, South Korea
660 The Association Between Strongyloides Stercoralis Infection
and Allergic Skin Diseases
Dr. Lahari Rampur, MD, Albert Einstein/Jacobi medical centre,
Bronx, NY, Dr. Gabriele De Vos, MD, Albert Einstein College of
Medicine, Bronx, NY, Dr. Golda Hudes, MD, PhD, Albert Einstein/
Montefiore Medical Center, New York, NY and Dr. Sunit Jariwala,
MD, Albert Einstein/Montefiore Medical Center, New York, NY
661 Effects Of Human Rhinovirus Species On Cytokine Production
and Cellular Cytotoxicity In Differentiated Sinus Epithelial
Cells
Dr. Kazuyuki Nakagome, MD1,2, Dr. Yury Bochkov, PhD1, Dr.
Shamaila Ashraf, PhD1, Ms. Rebecca Brockman-Schneider, MS1
MONDAY
and Dr. James E. Gern, MD, FAAAAI1, 1University of Wisconsin
School of Medicine and Public Health, Madison, WI, 2Saitama
Medical University, Saitama, Japan
662 Human Rhinovirus Bronchiolitis Predominant In Very Low
Birthweight Infants In Argentina
Dr. Jodell E Linder-Jackson, PhD1, Tatyana E Plachco2, Lucrecia
Bossi3, Gabriela Bauer2, Fernando P Polack4, Romina P Libster5
and Eva K Kathryn Miller, MD, MPH6, 1Vanderbilt, TN, 2Hospital
de Pediatra Garrahan, Argentina, 3Maternidad Sarda, Argentina,
4
Fundacion Infant, Vanderbilt University, Argentina, 5Fundacion
Infant, Argentina, 6Vanderbilt University Medical Center, Nash-
ville, TN
663 Association Of Vitamin D Status With Recurrent Wheezers and
Lower Respiratory Infection In Pre-School Children
Prof. Jin-A Jung, MD, Dong-A University College of Medicine,
Busan, Prof. Ja Hyeong Kim, MD, Ulsan University Hospital, Ul-
san, South Korea and Prof. Ju-Suk Lee, MD, PhD, Sungkyunkwan
university, Changwon, South Korea
Immune Mediated Skin Diseases
4207
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
664 Safety and Efficacy Of Dupilumab Versus Placebo For Moder-
ate-To-Severe Atopic Dermatitis In Patients Using Topical Cor-
ticosteroids (TCS): Greater Efficacy Observed With
Concomitant Therapy Compared To TCS Alone
Dr. Diamant Thaci, MD1, Dr. Margitta Worm, MD2, Dr. Haobo
Ren, PhD3, Dr. Steven Weinstein, MD, PhD4, Dr. Neil Graham,
128
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
MD4, Dr. Gianluca Pirozzi, MD, PhD5, Warren Brooks, PhD4
and Dr. Marius Ardeleanu, MD4, 1Universitat zu Lubeck, Lu-
beck, Germany, 2Charite - Universitatsmedizin Berlin, Berlin,
Germany, 3Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ,
4
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 5Sanofi,
Bridgewater, NJ
665 A Lipid Plant Extract From Chamaecyparis Obtusa Induces
Filaggrin and Human Beta-Defensin -3
Mr. Byung Eui Kim, MD, PhD1, Mr. Gwui Cheol Kim, PhD2, Ms.
Hee Jin Kim2 and Donald Y.M. Leung, MD, PhD, FAAAAI1, 1Na-
tional Jewish Health, Denver, CO, 2Jeonnam Nano Bio Research
Center
666 Identification Of Novel Gene Signatures In Atopic Dermatitis
Complicated By Eczema Herpeticum
Dr. Lianghua Bin, MD, PhD1, Dr. Michael G Edwards2, Dr. Ryan
Heiser, PhD1, Mrs. Joanne Streib, BA1, Ms. Brittany Richers1 and
Donald Y.M. Leung, MD, PhD, FAAAAI1, 1National Jewish
Health, Denver, CO, 2University of Colorado at Denver
667 Topical Application Of Rapamycin Ointment Inhibits Dermato-
phagoides Farinae Body (Dfb) Extract Antigen-Induced Derma-
titis In NC/Nga Mice
Mr. Fei Yang1, Dr. Lingli Yang1, Dr. Mari Tanaka1, Dr. Mari
Wataya-Kaneda1, Ayumi Nakamura2, Shoji Matsumoto2, Dr.
Mostafa Attia3, Dr. Hiroyuki Murota1 and Prof. Ichiro Ka-
tayama1, 1Department of Dermatology, Course of Integrated
Medicine, Graduate School of Medicine, Osaka University,
Osaka, Japan, Osaka, Japan, 2Osaka University Hospital, Depart-
ment of Pharmacy, Osaka, Japan, 3Dermatology, Cairo Univer-
sity, Cairo, Egypt, Cairo, Egypt
668 Therapeutic Effects Of Recombinant Salmonella Typhimurium
Expressing TLR8 miRNA On Atopic Dermatitis
Dr. Wonsuck Yoon, Department of Life Science and Biotechnol-
ogy, Seoul, South Korea, Prof. Ji Tae Choung, MD, Korea Univ.
Medical Center, Seoul and Dr. Young Yoo, MD, PhD, Department
of Pediatrics, College of Medicine, Korea University, Seoul, South
Korea
669 Correlation Between Serum 25-Hydroxyvitamin D Levels and
Severity Of Allergic Atopic Dermatitis In Children
Dr. Sung Soon, BUSAN MARY, BUSAN, South Korea
670 Association Between Prenatal and Early Life Vitamin D Levels
and Allergic Outcome At Age 2 Years
Ganesa Wegienka, PhD1, Ms. Suzanne Havstad, M.A.1, Kimber-
ley J. Woodcroft, PhD1, Dr. Dennis Ownby, M.D. FAAAAI2, Dr.
Edward M. Zoratti, MD, FAAAAI3 and Dr. Christine Cole Johnson,
PhD MPH FAAAAI1, 1Department of Public Health Sciences,
Henry Ford Hospital, Detroit, MI, 2Department of Pediatrics Geor-
gia Regents University, Augusta, GA, 3Henry Ford Health System,
Detroit, MI
671 Association Between Sun Exposure During The First 6 Months
Of Life and The Cumulative Incidence Of Atopic Dermatitis In
Infants
Dr. Miwa Shinohara, MD, PhD, Department of Pediatric Allergy
and Clinical Research, Shimoshizu National Hospital, Yotsukaido,
Japan and Dr. Kenji Matsumoto, MD, PhD, Department of Allergy
and Immunology, National Research Institute for Child Health and
Development, Tokyo, Japan
672 Dampness In The Water-Damaged Homes Affects The Severity
Of Atopic Dermatitis In Children
Prof. Sungchul Seo, The Enviornmental Health Center for Asthma,
Korea University, Seoul, Prof. Ji Tae Choung, MD, Korea Univ.
Medical Center, Seoul, Dr. Young Yoo, MD, PhD, Department of
Pediatrics, College of Medicine, Korea University, Seoul, South
Korea, Dr. Wonsuck Yoon, Department of Life Science and Bio-
technology, Seoul, South Korea, Prof. Kangmo Ahn, MD, PhD, De-
partment of Pediatrics, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, South Korea and Dr. Jihyun
Kim, MD, Samsung Medical Center, Seoul
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
673 Mycotoxin Aggravates Atopic Dermatitis Via TSLP Induced
Th2 Inflammation
Ms. Seung-Hwa Lee1, Ms. Ha-Jung Kim1 and Prof. Soo-Jong
Hong, MD. PhD2,3, 1Asan Institute for Life Sciences, University
of Ulsan College of Medicine, 2Department of Pediatrics, Asan
Medical Center, Childhood Asthma Atopy Center, South Korea,
3
Research Center for Standardization of Allergic Disease, Univer-
sity of Ulsan College of Medicine, Seoul, Korea
674 Early Skin Care By Experienced Mothers May Prevent Sen-
sitization In Infants With Atopic Dermatitis
Dr. Atsushi Yamashita, Dr. Mizuho Nagao, MD, Ms. Kanae Fur-
uya, Dr. Junya Hirayama, Dr. Keigo Kainuma, MD and Dr. Takao
Fujisawa, MD, FAAAAI, Institute for Clinical Research, Mie Na-
tional Hospital
675 Association Of Bathing Habits To Pruritus and Allergic Disease
Dr. Kanwaljit K. Brar, MD1, Dr. Rauno O. Joks, MD, FAAAAI2
and Dr. Hamid Moallem, MD1, 1SUNY Downstate Medical Center,
Brooklyn, NY, 2Center for Allergy and Asthma Research, State
University of New York Downstate Medical Center, Brooklyn, NY
676 A Molecular Mechanism Underlying Atopic Dermatitis In Hy-
per-IgE Syndrome
Masako Saito, PhD, Division of Molecular Medicine, Institute for
Genome Research, The University of Tokushima, Tokushima, Ja-
pan, Dr. Hajime Karasuyama, MD, PhD, Tokyo Medical and Den-
tistry Graduate School, Tokyo, Japan and Dr. Yoshiyuki Minegishi,
MD and PhD, Division of Molecular Medicine, Institute for Ge-
nome Research, The University of Tokushima
677 Racial Differences In The Relationship Of Total and Food-Spe-
cific IgE To Atopic Dermatitis In Childhood
Dr. Gillian Bassirpour, MD1, Dr. Edward M. Zoratti, MD,
FAAAAI2, Ganesa Wegienka, PhD3, Ms. Suzanne Havstad,
M.A.3, Alexandra Sitarik, M.S.3, Dr. Haejin Kim, MD1, Dr. Dennis
Ownby, M.D. FAAAAI4 and Dr. Christine Cole Johnson, PhD MPH
FAAAAI3, 1Division of Allergy and Clinical Immunology, Henry
Ford Hospital, Detroit, MI, 2Henry Ford Health System, Detroit,
MI, 3Department of Public Health Sciences, Henry Ford Hospital,
Detroit, MI, 4Department of Pediatrics Georgia Regents University,
Augusta, GA
678 Major Culprit Allergen Sensitization Patterns According To
Age In Korean Atopic Dermatitis Patients
Hye Jung Park1, Jae-Hyun Lee1,2, Kyung-Yong Jeong2, Kyung-
Hee Park1,2, Yoon-Ju Kim2 and Jung-Won Park1,2, 1Division of Al-
lergy and Clinical Immunology, Department of Internal Medicine,
Yonsei University College of Medicine, Seoul, South Korea, 2Insti-
tute of Allergy, Yonsei University College of Medicine, Seoul,
South Korea
679 Protein Microarray: IgE-Profiling Of Brazilians With Atopic
Dermatitis
Lucila Camargo Lopes de Oliveira1, Roberta Faria Camilo-Ara-
ujo1, Isabel Rugue Genov1, Dr. Renata R. Cocco2, Dr. Marcia Mal-
689
lozi, MD3, Prof. Nelson A. Rosario, MD, PhD, FAAAAI4 and Prof.
Dirceu Sole, MD, PhD5, 1UNIFESP, 2Federal University of S~ao
Paulo, 3Federal University of S~ao Paulo, Brazil, 4Federal University
of Parana, Curitiba, Brazil, 5Federal University of Sao Paulo, Sao
Paulo, Brazil
680 Relationship Between Dietary Food and Nutrient Intakes and
Bone Mineral Density In Childhood Eczema
Dr. Ting Fan Leung, MD FRCPCH FAAAAI, Ms. Flora Yin-ying
Kwok, MPhil, Dr. Yvonne Yi-fong Ho, MPhil, Dr. Susan Shuxin
Wang, PhD, Ms. Patty Pui-pui Tse, MSc, Prof. Gary Wing-kin
Wong, MD, FRCPC and Dr. Kam Lun Ellis Hon, MD, FAAP, De-
partment of Paediatrics, The Chinese University of Hong Kong,
Hong Kong
681 Change Of Caregivers Perception Regarding Atopic Dermati-
tis From 2006 To 2013
Dr. Kyung Suk Lee, MD, PhD1, Prof. Yeong-Ho Rha, MD, PhD1
and Prof. Sun-Hee Choi, MD, PhD2, 1Kyung Hee University
Abstracts AB339
Hospital, 2Gangdong Kyung Hee University Hospital, Seoul, South
Korea
682 Excellent Agreement Between Dermatology and Pediatric Re-
searchers In Severity Scoring Of Atopic Dermatitis (SCORAD)
Index In Children
Dr. Rodrigo Hoyos Bachiloglu, MD1, Dr. Cristian Navarrete,
MD2, Dr. Cristian Vera, MD2, Dr. Sergio Silva, MD2, Dr. Lorena
Cifuentes, MD1, Mrs. Carolina Iturriaga, RN1, Ms. Francisca Cristi,
MSc1 and Dr. Arturo Borzutzky, MD1, 1Division of Pediatrics,
School of Medicine, Pontificia Universidad Catolica de Chile, San-
tiago, Chile, 2Department of Dermatology, School of Medicine,
Pontificia Universidad Catolica de Chile, Santiago, Chile
683 A Case Of Recurrent Severe Poison Ivy Contact Dermatitis,
Treated Successfully With Seasonal Cyclosporine
Dr. Jaron T. Abbott, MD, Dr. Yuriy Zgherea, MD and Dr. Selina
Gierer, DO, University of Kansas Medical Center
684 Allergic Contact Stomatitis From Orthodontic Adhesives
Dr. Priscilla H. Wong, MD1, Dr. Scott D. Dickson, DO2 and Dr.
Christopher A. Coop, MD1, 1Wilford Hall Ambulatory Surgical
Center, Lackland AFB, TX, 256th Medical Group, Luke AFB, AZ
685 Contact Dermatitis Due To Topical Amorolfine
Dr. Ruperto Gonzalez Perez, Mrs. Paloma Poza-Guedes, Mrs. In-
maculada Sanchez Machn and Dr. Victor Matheu, MD, Hospital
del Torax-Ofra, Sta Cruz de Tenerife, Spain
686 Sweets Syndrome By A Show Of Hands
Dr. Syeda Hamadani, Dr. Anita Ravi, Dr. Seth Politano, Dr. Eric
Hsieh and Dr. Gina Rossetti, USC, Los Angeles, CA
687 Mango, Pulp Fiction?
Dr. Alexander S. Kim, MD, University of California San Diego,
La Jolla, CA and Dr. Sandra C. Christiansen, MD, FAAAAI, South-
ern CA Permanente Med Grp, San Diego, CA
688 Preoperative Patch Testing In Patients Undergoing Pectus Ex-
cavatum Repair
Dr. Laura Helfner, MD1, Dr. David Rosenthal, DO1, Dr. Blanka
M. Kaplan, MD, FAAAAI2 and Dr. Punita Ponda, MD, FAAAAI3,
1
MONDAY
Division of Allergy/Immunology, Departments of Medicine and
Pediatrics, Hofstra North Shore-LIJ School of Medicine, Great
Neck, NY, 2Department of Pediatrics, Division of Allergy & Immu-
nology, Hofstra-North Shore-LIJ School of Medicine, Great Neck,
NY, 3Allergy and Immunology, North Shore LIJ Health System,
Great Neck, NY
Food Allergy II
4208
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
Oral Allergy Syndrome - a Spectrum Of Presentations
Dr. Parwinder Gill1, Dr. Gordon L. Sussman, FAAAAI2, Jiayi
Bian1 and Ms. Carly Barron3, 1University of Toronto, Toronto,
ON, Canada, 2University of Toronto, Faculty of Medicine, Toronto,
ON, Canada, 3Gordon Sussman Clinical Research Inc., Toronto,
ON, Canada
690 Allergy To Sheep Milk With Or Without Allergy To Cow Milk
Dr. Fouseena Pazheri1, Dr. Alton Lee Melton Jr., MD2, Dr. Earl
Poptic1 and Dr. Belinda Willard1, 1Cleveland CLinic, Cleveland,
OH, 2Cleveland Clinic, Cleveland, OH
691 Genome-Wide Study Of Interaction Between Season Of Birth
and Peanut Allergy Identifies a Region On Chromosome 3 As
a Genetic Risk Factor
Corinne Keet, MD, MS1, Xiumei Hong, PhD2, Dr. Ingo Ruczinski,
PhD2, Dr. Terri H Beaty, PhD2, Dr. Jacqueline Pongracic, MD,
FAAAAI3 and Dr. Xiaobin Wang, MD, MPH ScD4, 1Pediatrics,
Johns Hopkins University School of Medicine, Baltimore, MD,
2
Johns Hopkins University School of Public Health, Baltimore,
129
 AB340 Abstracts
MD, 3Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi-
cago, IL, 4Center on Early Life Origins of Disease, Department of
Population, Family and Reproductive Health, Johns Hopkins Uni-
versity Bloomberg School of Public Health, Baltimore, MD
692 Orofecal Infections and Risk Of Food Allergy In Children
Dr. Gary Wong, MD1, Dr. Jing Li, MD, MSc2, Dr. Ting Fan Leung,
MD FRCPCH FAAAAI3 and Prof. Nanshan Zhong2, 1Chinese Uni-
versity of Hong Kong, Shatin, Hong Kong, 2The First Affiliated
Hospital of Guangzhou Medical College, State Key Laboratory of
Respiratory Disease, Guangzhou Institute of Respiratory Disease,
Guangzhou, China, 3Department of Paediatrics, The Chinese Uni-
versity of Hong Kong, Hong Kong
693 Peanut, Milk, and Wheat Intake During Pregnancy Is Associ-
ated With Reduced Allergy and Asthma In Children
Dr. Supinda Bunyavanich, MD, MPH1, Ms. Sheryl Rifas-Shiman,
MPH2, Thomas A.E. Platts-Mills, MD, PhD, FAAAAI3, Lisa J.
Workman, BA3, Dr. Joanne Sordillo, ScD4, Dr. Carlos Camargo
Jr., MD, DrPH5, Dr. Matthew Gillman, MD, SM2, Dr. Diane R.
Gold, MD, MPH6 and Dr. Augusto A. Litonjua, MD, MPH4, 1Divi-
sion of Pediatric Allergy & Immunology, Department of Pediatrics,
Icahn School of Medicine at Mount Sinai, New York, NY, 2Depart-
ment of Population Medicine, Harvard Pilgrim Health Care Insti-
tute, Harvard Medical School, Boston, MA, 3Division of Asthma,
Allergy & Immunology, University of Virginia Health System,
Charlottesville, VA, 4Channing Division of Network Medicine,
Brigham & Womens Hospital, Harvard Medical School, Boston,
MA, 5Department of Emergency Medicine, Massachusetts General
Hospital, Harvard Medical School, Boston, MA, 6Channing Labo-
ratory, Brigham and Womens Hospital, Boston, MA
694 The Prevalence Of Food Sensitization and Food Allergy In An
Inner City Birth Cohort
Robert A. Wood, MD, FAAAAI, Johns Hopkins University Med-
ical Center, Baltimore, MD, Dr. Emily C. McGowan, MD, Johns
Hopkins University School of Medicine, Baltimore, MD, Dr. Gor-
don R. Bloomberg, MD, FAAAAI, Campus Box 8116, St. Louis
MONDAY
Childrens Hospital, Saint Louis, MO, Dr. Peter J. Gergen, MD,
MPH, AAIB\DAIT\NIH, Bethesda, MD, Dr. Cynthia Visness,
PhD, Rho Federal Systems Division, Inc., Chapel Hill, NC, Katy
Jaffee, MS, Rho, Inc., Chapel Hill, NC, Dr. George T. OConnor,
MD, Boston University School of Medicine, Boston, MA, Dr.
Meyer Kattan, MD, NewYork-Presbyterian/Columbia, New York,
NY and Dr. James E. Gern, MD, FAAAAI, University of Wisconsin
School of Medicine and Public Health, Madison, WI
695 Food Allergy Prevalence In Parents Of Food-Allergic Children
Based On Self-Report, Serologic Testing and Physician Diagno-
sis
Melanie M. Makhija, MD1,2, Dr. Rachel Glick Robison2,3, Deanna
Caruso, MS4, Miao Cai, MS5, Dr. Xiaobin Wang, MD, MPH ScD4
and Dr. Jacqueline Pongracic, MD, FAAAAI3,6, 1Ann and Robert
H. Lurie Childrens Hospital of Chicago, Chicago, IL, 2Division
of Allergy & Immunology, Department of Pediatrics,Northwestern
University Feinberg School of Medicine, Chicago, IL, 3Ann & Rob-
ert H. Lurie Childrens Hospital of Chicago, Chicago, IL, 4Johns
Hopkins University School of Public Health, Baltimore, MD, 5Di-
vision of Allergy & Immunology, Department of Pediatrics, North-
western University Feinberg School of Medicine, Ann & Robert H.
Lurie Childrens Hospital of Chicago, Chicago, IL, 6Division of Al-
lergy & Immunology, Department of Pediatrics,Northwestern Uni-
versity Feinberg School of Medicine
696 The Effect Of Neighborhood Level Poverty and Urbanization
On The Prevalence Of Food Allergy In The National Health In-
terview Survey (NHIS)
Dr. Emily C. McGowan, MD1, Dr. Meredith C. McCormack,
MD2, Dr. Roger Peng, PhD3, Dr. Elizabeth Matsui, MD2 and Cor-
inne Keet, MD, MS4, 1Johns Hopkins University School of Medi-
cine, Baltimore, MD, 2The Johns Hopkins University School of
Medicine, Baltimore, MD, 3Johns Hopkins School of Public Health,
130
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Baltimore, MD, 4Johns Hopkins University Medical Center, Balti-
more, MD
697 Prevalence Of IgE-Mediated Food Sensitisation and Food Al-
lergy In Unselected 12-36 Month Old South African Children
Dr. Maresa Botha, MBChB, FCPaed1 and Prof. Michael E. Levin,
MBChB, FCPaed, Dip Allergology, MMed(Paeds), PhD, EAACI
allergy exam (UEMS), Certificate Allergology, FAAAAI1,2, 1Uni-
versity of Cape Town, Cape Town, South Africa, 2Red Cross War
Memorial Childrens Hospital, Cape Town, South Africa
698 Evaluation Of Peanut Allergy In a Birth Cohort
Dr. Hiba Bashir, MD1, Mr. Christopher J. Tisler, MT1, Dr. Eliza-
beth L. Anderson1, Dr. Theresa Kang, PhD1, Lisa Salazar, BS1,
Mr. Michael D. Evans, MS1, Dr. Ronald E. Gangnon, PhD1, Dr.
Daniel J. Jackson, MD2, Dr. Robert F. Lemanske Jr., MD, FAAAAI1
and Dr. James E. Gern, MD, FAAAAI1, 1University of Wisconsin
School of Medicine and Public Health, Madison, WI, 2Pediatrics,
University of Wisconsin School of Medicine and Public Health,
Madison, WI
699 Prevalence Of Peanut Allergy: A Systematic Review
Dr. Heather Mackenzie1, Dr. Carina Venter, PhD RD2, Dr. Sally
Kilburn1, Ms. Harriet R. Moonesinghe1, Ms. Kellyn Lee1 and
Prof. Taraneh Dean1,3, 1University of Portsmouth, School of Health
Sci, Portsmouth, United Kingdom, 2The David Hide Asthma and
Allergy Research Center, Isle of Wight, United Kingdom, 3The Da-
vid Hide Asthma and Allergy Centre, Newport
700 Prevalence Of Fish and Shellfish Allergy- A Systematic Review
Ms. Harriet R. Moonesinghe1, Dr. Sally Kilburn1, Dr. Heather
Mackenzie1, Dr. Paul J. Turner, FRACP PhD2, Dr. Carina Venter,
PhD RD3, Ms. Kellyn Lee1 and Prof. Taraneh Dean1, 1University
of Portsmouth, School of Health Sci, Portsmouth, United Kingdom,
2
Imperial College London, United Kingdom, 3The David Hide
Asthma and Allergy Research Center, Isle of Wight, United
Kingdom
701 Prevalence Of Food Allergy To Uncommon Foods Based On
Oral Food Challenges
Dr. Gita Ram1, Christina Gustafson1, Dr. Jonathan M. Spergel,
MD, PhD, FAAAAI2 and Dr. Antonella Cianferoni, MD, PhD3,
1
Childrens Hospital of Philadelphia, Philadelphia, PA, 2The Chil-
drens Hospital of Philadelphia, Philadelphia, PA, 33615 Civic Cen-
ter Boulevard, The Childrens Hospital of Philadelphia,
Philadelphia, PA
702 Prevalence Of Food Allergy In Patients With Irritable Bowel
Syndrome
Erin L. Reigh, MD, MS1, Dr. Javed Sheikh, MD, FAAAAI2 and
Anna Kovalszki, MD1, 1Beth Israel Deaconess Medical Center,
Boston, MA, 2Kaiser Permanente Los Angeles Medical Center,
Los Angeles, CA
703 Clinical Characteristics Of Seafood Allergy In Canadian Chil-
dren
Dr. Victoria Cook, Department of Pediatrics, University of British
Columbia, BC Childrens Hospital, Vancouver, BC, Canada, Dr.
Edmond S. Chan, MD, FAAAAI, Department of Pediatrics, Faculty
of Medicine, University of British Columbia, Dr. Ann Elaine
Clarke, MD, MSc, Division of Allergy and Clinical Immunology,
Department of Medicine, McGill University Health Centre, Mon-
treal, QC, Canada; Division of Clinical Epidemiology, Department
of Medicine, McGill University Health Centre, Montreal, QC, Can-
ada, Mr. Greg Shand, Department of Medicine, Division of Clinical
Epidemiology, McGill University Health Center, Montreal, QC,
Canada and Dr. Moshe Ben-Shoshan, MD, MSc, Division of Paedi-
atric Allergy and Clinical Immunology, Department of Paediatrics,
McGill University Health Center, Montreal, QC, Canada
704 Changes In Total IgE Levels To Predic Food Challenge Test
Outcomes
Dr. Kenta Horimukai, Jikei University Katsushika Medical Cen-
ter, Tokyo, Japan, Dr. Masami Narita, MD, PhD, National Center
for Child Health and Development, Tokyo, Japan, Dr. Ichiro
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Nomura, MD, PhD, National Center for Child Health and Develop-
ment, Setagayaku, Japan, Dr. Kenji Matsumoto, MD, PhD, Depart-
ment of Allergy and Immunology, National Research Institute for
Child Health and Development, Tokyo, Japan and Dr. Yukihiro
Ohya, MD, PhD, Division of Allergy, National Center for Child
Health and Development, Tokyo, Japan
705 Situational and Environmental Factors Associated With a
Childs Willingness To Use An Epinephrine Auto-Injector
Amanda Tantleff, Byram Hills High School and Dr. Anna H.
Nowak-Wegrzyn, MD, FAAAAI, Icahn School of Medicine at
Mount Sinai, New York, NY
706 Possession Of Epinephrine Auto-Injectors (EAI) In a Vulnera-
ble Canadian Population With Food Allergies
Dr. Sabrine Cherkaoui, M.D1, Ms. Lianne Soller, MSc2, Dr.
Moshe Ben-Shoshan, MD, MSc3, Daniel Harrington, MA, PhD4,
Dr. Sebastien La Vieille, MD5, Dr. Joseph Fragapane, MD6, Dr.
Lawrence Joseph, PhD7, Mr. Yvan St-Pierre, MSc8, Prof. Susan El-
liott, PhD9 and Dr. Ann Elaine Clarke, MD, MSc7,10, 1Division of
Internal Medicine, Department of Medicine, University of Mon-
treal, Montreal, QC, Canada, 2Division of Clinical Epidemiology,
Department of Medicine, McGill University Health Center, Mon-
treal, QC, Canada, 3Division of Paediatric Allergy and Clinical Im-
munology, Department of Paediatrics, McGill University Health
Center, Montreal, QC, Canada, 4McMaster University - School of
Geography, Hamilton, ON, Canada, 5Food Directorate, Health Can-
ada, Ottawa, ON, Canada, 6McGill University, Dorval, QC, Canada,
7
Division of Clinical Epidemiology, Department of Medicine,
McGill University Health Centre, Montreal, QC, Canada, 8Division
of Clinical Epidemiology, Department of Medicine, McGill Univer-
sity Health Center, Canada, 9Applied Health Sciences, University of
Waterloo, ON, Canada, 10Division of Allergy and Clinical Immu-
nology, Department of Medicine, McGill University Health Centre,
Montreal, QC, Canada
707 Food Allergy In Daycare Centers: Prevalence, Management,
and Knowledge Of Directors
Dr. Lisanne Newton, M.D. and Dr. Brian Schroer, MD, Cleveland
Clinic, Cleveland, OH
708 Assessment Of Food Insecurity and Health Literacy In a Ter-
tiary Care Pediatric Allergy Population
Dr. Meredith A. Dilley, MD1,2, Ms. G. Lynn Christie, MS RD2,
Ms. Mary Price2, Ms. Connelly Weeks2, Mallikarjuna Rettiganti,
PhD1,2, Maria Melguizo Castro1,2, Dr. Amy M. Scurlock, MD3,4,
Dr. Tamara T. Perry, MD1,2, Dr. Robbie D. Pesek1,2, Dr. Matthew
C. Bell, MD1,2, Joshua L. Kennedy, MD5, Ms. Erin OBrien1,2,
Ms. Sklar McGrath2, Mr. Jared Hogan2, Megan Patterson1, Julia Ar-
onson1, Dr. Patrick Casey, MD1,2 and Stacie M. Jones, MD3,5, 1Uni-
versity of Arkansas for Medical Sciences, Little Rock, AR,
2
Arkansas Childrens Hospital, Little Rock, AR, 3University of Ar-
kansas for Medical Sciences and Arkansas Childrens Hospital, Lit-
tle Rock, AR, 4University of Arkansas for Medical Sciences/
Arkansas Childrens Hospital, Little Rock, AR, 5Arkansas Chil-
drens Hospital Research Institute, Little Rock, AR
709 Environmental and Sociodemographic Factors Associated With
Food Allergy: A Nested Case-Control Study
Dr. Moshe Ben-Shoshan, MD, MSc1,2, Ms. Lianne Soller, MSc3,
Daniel Harrington, MA, PhD4, Ms. Megan Knoll, MSc5, Dr. Sebas-
tian La Vieille, MD6, Dr. Joseph Fragapane, MD7, Dr. Lawrence
Joseph, PhD8,9, Mr. Yvan St. Pierre, MSc10, Dr. Kathi Wilson11,
Prof. Susan Elliott, PhD12 and Dr. Ann Elaine Clarke, MD,
MSc8,13, 1Division of Paediatric Allergy and Clinical Immunology,
Department of Paediatrics, McGill University Health Center, Mon-
treal, QC, Canada, 2Montreal Childrens Hospital, Montreal, Can-
ada, 3Division of Clinical Epidemiology, Department of
Medicine, McGill University Health Center, Montreal, QC, Can-
ada, 4McMaster University - School of Geography, Hamilton,
ON, Canada, 5Division of Clinical Epidemiology, Department of
Medicine, McGill University Health Center, Canada, 6Food
Abstracts AB341
Directorate, Health Canada, Ottawa, ON, Canada, 7McGill Univer-
sity, Dorval, QC, Canada, 8Division of Clinical Epidemiology, De-
partment of Medicine, McGill University Health Centre, Montreal,
QC, Canada, 9McGill University, Montreal, QC, Canada, 10Divi-
sion of Clinical Epidemiology, Department of Medicine, McGill
University Health Center, QC, Canada, 11Department of Geogra-
phy, University of Toronto, Toronto, ON, Canada, ON, Canada,
12
Applied Health Sciences, University of Waterloo, ON, Canada,
13
McGill University Health Centre, Montreal, Canada
710 Differences In Empowerment and Quality Of Life Among
Mothers and Fathers Of Children With Food Allergy
Mr. Christopher Warren, BA1, Dr. Ruchi Gupta, MD, MPH2, Mr.
Namit Lal3, Dr. Min-Woong Sohn, PhD4, Dr. Craig Garfield, MD4,
Dr. Jacqueline Pongracic, MD, FAAAAI2 and Dr. Xiaobin Wang,
MD, MPH ScD5, 1University of Southern California, Los Angeles,
CA, 2Ann & Robert H. Lurie Childrens Hospital of Chicago, Chi-
cago, IL, 3University of Michigan, Ann Arbor, MI, 4Northwestern
University, Chicago, IL, 5Johns Hopkins, Chicago, IL
711 Prevalence Of Misconceptions Regarding Egg Allergy and Mea-
sles Mumos and Rubella Vaccine Contraindications
Dr. Vylma Velazquez, MD, Dr. Carmen Rivera and Dr. Monique
Adorno, Hospital Episcopal San Lucas, Ponce, PR
712 Prenatal and Postnatal Factors Associated With IgE-Mediated
Wheat Allergy In Infants: A Study In Asian Population
Dr. Suparat Sirivimonpan, MD, Chulalongkorn University, Bang-
kok, Thailand
713 Maternal Healthy Diet and Development Of Allergic Disease
Dr. Carina Venter, PhD RD1, Ms. Harriet R. Moonesinghe2, Prof. Ha-
san Arshad3,4, Prof. Taraneh Dean2,5, Mrs. Jane Grundy3, Mrs. Gill
Glasbey3 and Dr. Veeresh Patil3,4, 1The David Hide Asthma and Al-
lergy Research Center, Isle of Wight, United Kingdom, 2University
of Portsmouth, School of Health Sci, Portsmouth, United Kingdom,
3
The David Hide Asthma and Allergy Centre, Newport, United King-
dom, 4University of Southampton, Southampton, United Kingdom,
5
The David Hide Asthma and Allergy Centre, Newport
MONDAY
714 Effect Of Annual Income On Parental/Family Burden Of Food
Allergy
Dr. David A. Petty, DO, University of Tennessee Allergy fellow-
ship program, Memphis, TN, Jay A. Lieberman, MD, University
of Tennessee, Memphis, TN and Nhu Quynh Tran, PhD, University
of Tennessee Department of Preventative Medicine
715 Food Allergy and Anaphylaxis Educational Needs Assessment,
Training Curriculum and Assessment Of Knowledge Of Urban
Child Care Center Workers
Dr. Bruce J. Lanser, MD1, Dr. Ronina A. Covar, MD1, David
Mark Fleischer, MD, FAAAAI1 and Dr. J. Andrew Bird, MD,
FAAAAI2, 1National Jewish Health, Denver, CO, 2UT Southwest-
ern Medical Center, Dallas, TX
716 Food Allergy Survey Among Food Service Workers
Bruce M. Prenner, MD1, John Hollingsworth, PA2, Ron Oliver3
and Linnet Brew, LVN1, 1Allergy Partners of San Diego, San
Diego, CA, 2Scripps Clinic, 3The Marine Room, La Jolla, CA
717 Bullying and Food Allergy Longitudinal Follow-Up
Scott H. Sicherer, MD, FAAAAI1, Melissa Rubes2, Chloe Mullar-
key2, Mordechai Ambrose3, Noga Ravid2, Kelley Chuang3, Rachel
Annunziato2 and Eyal Shemesh3, 1Mount Sinai School of Medicine,
New York, NY, 2Fordham University, NY, 3Icahn School of Medi-
cine at Mount Sinai, NY
718 Prevalence and Characteristics of Consumer-Reported Food
Allergic and Anaphylactic Events in CAERS, 2007-2011
Ms. Taiye M Oladipo, MPH and Dr. Stefano Luccioli, MD,
FAAAAI, Center for Food Safety and Applied Nutrition, Food
and Drug Administration, College Park, MD
719 Impact Of School Peanut-Free Guidelines On Epinephrine Ad-
ministration
Dr. Lisa M. Bartnikas, MD1,2, Dr. Michelle F. Huffaker, MD1,3,
Dr. William J. Sheehan, MD1,2, Dr. Watcharoot Kanchongkittiphon,
131
 AB342 Abstracts
MD, PhD1,2, Mr. Carter Petty, MA2, Ms. Anne Sheetz, RN, BSN,
MPH4, Dr. Robert Leibowitz, PhD4, Dr. Michael C. Young, MD,
FAAAAI1,2 and Dr. Wanda Phipatanakul, MD, MS, FAAAAI1,2,
1
Harvard Medical School, Boston, MA, 2Boston Childrens Hospi-
tal, Boston, MA, 3Brigham and Womens Hospital, Boston, MA,
4
Massachusetts Department of Public Health, Boston, MA
720 Comparison Of Germfree and Conventional Mice For Evaluat-
ing The Potential Allergenicity Of Dietary Proteins Using
Model Allergenic and Non-Allergenic Proteins
Nathan L. Marsteller1,2, Mr. Kwame Andoh-Kumi1, Daniel A. Peter-
son3, Richard E. Goodman1 and Joe L. Baumert1, 1Food Allergy Re-
search and Resource Program, University of Nebraska-Lincoln,
Lincoln, NE, 2School of Biological Sciences, University of Ne-
braska-Lincoln, 3Johns Hopkins School of Medicine, Baltimore, MD
721 The Role Of Lipopolysaccharide In Skewing The Sensitization
Potential Of Purified b-Lactoglobulin In a Mouse Model
Mr. Kwame Andoh-Kumi1, Richard E. Goodman1, Daniel A. Peter-
son2, Joe L. Baumert1 and Nathan L. Marsteller1,3, 1Food Allergy Re-
search and Resource Program, University of Nebraska-Lincoln,
Lincoln, NE, 2Johns Hopkins School of Medicine, Baltimore, MD,
3
School of Biological Sciences, University of Nebraska-Lincoln
722 Oral Co-Administration Of Peanut and Cholera Toxin Subunit
B During Pregnancy and Lactation Blocks Anaphylaxis and In-
duces Epigenetic Modifications In Peanut Allergic Murine
Mothers
Dr. Ying Song, MD1, Dr. ChangDa Liu1, Dr. Kamal D. Srivas-
tava, PhD1, Dr. Jia Chen, ScD1,2, Dr. Rachel L. Miller, MD,
FAAAAI3 and Dr. Xiu-Min Li, MD1, 1Pediatrics, Icahn School
of Medicine at Mount Sinai, New York, NY, 2Prevention, Icahn
School of Medicine at Mount Sinai, NY, 3Division of Pulmonary,
Allergy and Critical Care Medicine, Columbia University, New
York, NY
723 Worsened Reaction Severity In Oral Food Challenges Confirms
Need For In-Office Procedure
Dr. Annie Esquivel, Dr. Girish V. Vitalpur, MD, FAAAAI, Dr.
MONDAY
Kirsten Kloepfer, MD and Dr. Frederick E. Leickly, MD, MPH
FAAAAI, Riley Hospital for Children at Indiana University Health,
Indianapolis, IN
724 Oral Food Challenge Outcome Among Children With a Nega-
tive Skin Prick Test Result
Dr. Wipa Jessadapakorn, MD, Division of Allergy and Immunol-
ogy, Department of Pediatrics, Faculty of Medicine, Prince of
Songkla University, Hat-Yai, Songkhla, Thailand, Dr. Prapasri Ku-
lalert, MD, Prince of Songkla University, Songkla, Thailand, Dr.
Araya Yuenyongviwat, MD, Prince of Songkla University,
Songkhla, Thailand and Dr. Pasuree Sangsupawanich, MD, Prince
Songkhlanagarind hospital, Hadyai, Thailand
725 Abbreviated Oral Food Challenge As a Safe and Effective Alter-
native For Diagnosing Food Allergy In a Pediatric Clinic
April L. Goolsby, BS1, Heather Minto, MD1,2, Amy Perkins, MS1,2
and Kelly M. Maples, MD1,2, 1Eastern Virginia Medical School,
Norfolk, VA, 2Childrens Hospital of The Kings Daughters, Nor-
folk, VA
726 Safety Of Ungraded Oral Food Challenges In Ruling Out Pea-
nut Allergy In Children
Dr. Darlene Kassab Mansoor, MD, MS1, Amit Singal, BS2,
Shweta Bansil, BS2 and Dr. Hemant P. Sharma, MD MHS
FAAAAI1, 1Childrens National Medical Center, 2George Washing-
ton University School of Medicine
727 Safety Of Oral Food Challenges To Extensively Heated Egg In
Children
Dr. Cindy Nguyen, MD1, Shweta Bansil, BS2, Amit Singal, BS2
and Dr. Hemant P. Sharma, MD MHS FAAAAI3, 1Childrens Na-
tional Medical Center, Division of Allergy and Immunology, Wash-
ington, DC, 2George Washington University School of Medicine,
3
Childrens National Medical Center, Division of Allergy and Im-
munology, DC
132
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
728 Banana Allergy In Children Evaluated Using Double Blind Pla-
cebo Controlled Food Challenge
Aysen Bingol, TURPEDAS, Turkey, Dilara Kocacik Uygun, AK-
DENIZ UNIVERSITY MEDICAL FACULTY DEPT OF PEDIAT-
RIC ALLERGY IMMMUNOLOGY, Dr. Serkan Filiz, AKDENIZ
UNIVERSITY MEDICAL FACULTY DEPT OF PEDIATRIC AL-
LERGY IMMUNOLOGY, ANTALYA, Turkey and Olcay Yegin,
AKDENIZ UNIVERSITY MEDICAL FACULTY DEPT OF PEDI-
ATRIC ALLERGY IMMUNOLOGY, Antalya, Turkey
729 Risk Of Oral Food Challenges In Children - a Prospective Mul-
ticenter Study -
Dr. Toshiko Itazawa, MD, PhD1, Dr. Motokazu Nakabayashi, MD,
PhD1, Dr. Yasunori Ito, MD, PhD1, Dr. Yoshie Okabe, MD, PhD1,
Dr. Yoko S Adachi, MD, PhD1, Dr. Yuichi Adachi, MD, PhD1, Dr.
Komei Ito, MD, PhD2 and Motohiro Ebisawa, MD, PhD, FAAAAI3,
1
Department of Pediatrics, University of Toyama, Toyama, Japan,
2
Aichi Childrens Health and Medical Center, Obu, Aichi, Japan,
3
Clinical Research Center for Allergy and Rheumatology, Sagami-
hara National Hospital, Kanagawa, Japan
730 A Double-Blind Randomized Controlled Trial Of A Thickened
Amino-Acid-Based Formula In Children Allergic To Cows
Milk and To Protein Hydrolyzates
Prof. Nicolas Kalach, MD, Ph D1, Dr. Elena Bradatan2, Prof.
Alain Lachaux3, Dr. Francois Payot3, Prof. Frederic de BLAY4,
Dr. Lydie Guenard-Bilbault5,6, Dr. Riad Hatahet7, Dr. Sandra Mu-
lier8 and Prof. Christophe Dupont, MD, PhD9, 1H^opital Saint Vin-
cent de Paul, Groupement des Hospitaux de lInstitut Catholique de
Lille (GH-ICL), Lille, France, 2Department of Pediatrics, Regional
Hospital, Namur, Belgium, 3Gastroenterology, Hepatology and Nu-
trition Unit, University and Pediatric Hospital of Lyon, France,
4
CHRU Strasbourg, France, 5Regional University Hospital, Stras-
bourg, Strasbourg, France, 6Allergologist, Illkirch-Graffenstaden,
France, 7Pediatrician Allergologist, Forbach, France, 8Queen Fa-
biola Childrens, University Hospital, Brussels, Brussels, Belgium,
9
Hopital Necker Enfants Malades, Paris, France
731 Impact Of Formula Containing Docosahexaenoic Acid, Prebi-
otics, and Beta-Glucan On Allergic Manifestations In Young
Children
Dr. Deolinda Scalabrin, MD, PhD1, Suzanne Stolz1, Weihong
Zhuang1, Mariana Pontes2, Angela de Mattos2, Indhira Almeida2,
Carolina Godoy2, Sara Gatto2, Vivian Leal2, Gabriela Cabral2, Ter-
eza Ribeiro2 and Hugo Ribeiro2, 1Mead Johnson Nutrition, Evans-
ville, IN, 2Federal University of Bahia, Brazil
732 Parents Perception Of The Likelihood Of Future Life-Threat-
ening Events In Their Children With Food Allergies
Dr. Peter Arkwright, MD, PhD, FAAAAI1, Ms. Jennifer Ogg1,
Dr. Naomi Davis2 and Dr. Ming Wan1, 1University of Manchester,
Manchester, United Kingdom, 2Royal Manchester Childrens Hos-
pital, United Kingdom
733 Can Training Improve Allergists Ability To Accurately Iden-
tify Anxiety In Children With Food Allergy?
Melissa Rubes1, Anna Podolsky2, Nicole Caso1, Rachel Annun-
ziato1, Dr. Amanda L. Cox, MD2, Dr. Jennifer S. Kim, MD,
FAAAAI2, Dr. Anna H. Nowak-Wegrzyn, MD, FAAAAI2, Dr. Julie
Wang, MD, FAAAAI2, Scott H. Sicherer, MD, FAAAAI3 and Eyal
Shemesh2, 1Fordham University, NY, 2Icahn School of Medicine at
Mount Sinai, NY, 3Mount Sinai School of Medicine, New York, NY
734 Nutritional Status Impairment In Patients With Food Allergies
Dr. Gesmar Segundo, Mrs. Larissa Costa and Mrs. Erica Rezende,
Universidade Federal de Uberlandia, Uberlandia, Brazil
735 Everyday Life Impact On Food Allergy Spanish Children.Car-
egivers Perception
Dr. Elena Alonso-Lebrero, PhD, Hospital Materno Infantil Gre-
gorio Mara~non Pediatric Allergy Section, Madrid, Spain, Mr. Julio
Monleon, MS, Santa Barbara, Madrid, Spain and Alberto Alvarez-
Perea, MD, Hospital Materno Infantil Gregorio Mara~non, Pediatric
Allergy Department, Madrid, Spain
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
736 The First 4 Central American Cases Of Delayed Meat Allergy
With Galactose-Alpha-1,3-Galactose Positivity Clustered
Among Field Biologists In Panama
Dr. Paige G. Wickner, MD, Brigham and Womens Hospital, Di-
vision of Rheumatology, Immunology and Allergy, Chesnut Hill,
MA and Scott P. Commins, MD, PhD, University of Virginia Health
System, Charlottesville, VA
737 Incidence Of New Onset Food Allergy In Renal, Cardiac, and
Hepatic Transplant Recipients and Correlation With Immuno-
suppression Protocol
Francois Graham, MD, MSc1, Frederic Racicot2, Luminita Iuli- 745
ana Jamali, MD2, Marie-Jeanne Lebel, MD2, Hugo Chapdelaine,
MD2, Fernando Alvarez, MD2, Veronique Phan Cong, MD2,
Marie-Josee Raboisson, MD2, Louis P. Paradis, MD FRCPC
FAAAAI2 and Anne M. Des Roches, MD FRCPC FAAAAI2,
1
CHUM, H^ opital Notre-Dame, Montreal, QC, Canada, 2Centre
Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada
738 Late and Secondary Onset Food Allergy
Dr. Liat Nachshon, MD1, Dr. Michael Goldberg, MD, PhD1, Dr.
Arnon Elizur, MD1,2, Dr. Michael B. Levy, MD, FAAAAI1 and
Prof. Yitzhak Katz, MD, FAAAAI1,2, 1Assaf Harofeh, Zerifin, Is-
rael, 2Tel Aviv University, Tel Aviv, Israel
739 Food Allergy Testing Practices Of Primary Care Pediatricians
In Illinois
Hector Rodriguez, MD1,2, Ms. Claudia Lau1, Dr. Ruchi Gupta,
MD, MPH1,2 and Melanie M. Makhija, MD1,3, 1Ann and Robert
H. Lurie Childrens Hospital of Chicago, Chicago, IL, 2Northwest-
ern University Feinberg School of Medicine, Chicago, IL, 3Division
of Allergy & Immunology, Department of Pediatrics,Northwestern
University Feinberg School of Medicine, Chicago, IL
740 Understanding The Role Of Online Resources For Childhood
Food Allergies
David Goese, University of Chicago Pritzker School of Medicine,
Chicago, IL and Ves Dimov, MD, University of Chicago Medicine,
Chicago, IL; Section of Allergy, Asthma and Immunology, Depart-
ment of Pediatrics, Department of Medicine, University of Chicago,
Chicago, IL
741 Clinical Features, Diagnosis, Management and Natural History
Of Food Protein-Induced Enterocolitis Syndrome In a National
Cohort
Dr. Todd David Green, MD, FAAAAI1, Dr. Matthew J. Green-
hawt, MD, MBA, MSc2, Dr. Tammy S. Jacobs, MD, MA1 and Fal-
lon Schultz3, 1Childrens Hospital of Pittsburgh of UPMC,
Pittsburgh, PA, 2Department of Internal Medicine, The University
of Michigan Medical School, Division of Allergy and Clinical Im-
munology, Ann Arbor, MI, 3International Association for Food Pro-
tein Enterocolitis (IAFFPE)
Health Care Delivery
4209
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
742 Health Literacy Is Associated With Medication Adherence In
Adolescents and Young Adults With HIV-1 Infection
Dr. Amrita Khokhar, MD, Department of Medicine, Hofstra North
Shore-LIJ School of Medicine, Dr. Robert Sporter, MD, Division of
Allergy/Immunology, Departments of Medicine and Pediatrics,
Hofstra North Shore-LIJ School of Medicine, Kathryn Kilkenny,
Division of Allergy/Immunology, Departments of Medicine and Pe-
diatrics, Hofstra North Shore-LIJ School of Medicine and Dr. David
Rosenthal, DO, Division of Allergy/Immunology, Departments of
Medicine and Pediatrics, Hofstra North Shore-LIJ School of Med-
icine, Great Neck, NY
Abstracts AB343
743 Variability In Measurement Of Allergen Skin Testing Results
Among Allergy-Immunology Specialists
Dr. Tiffany Jean1, Dr. Kenny Y. Kwong1 and Dr. Nasser Redjal,
MD, FAAAAI2, 1Harbor-UCLA Medical Center, 2Harbor-UCLA
Medical Center, Torrance, CA
744 Serologic Specific IgE (sIgE) Testing In a Closed Healthcare
System
Dr. Daniel A. Steigelman, MD and Dr. Tonya S. Rans, MD, Wil-
ford Hall Ambulatory Surgical Center, Joint Base San Antonio -
Lackland AFB, TX
Outcomes After Implementation Of An Inpatient Antibiotic
Prescribing Pathway For Patients With Penicillin Or Cephalo-
sporin Allergy
Dr. Kimberly Blumenthal, MD, Allergy and Immunology, Divi-
sion of Rheumatology, Allergy, and Immunology, Department of
Medicine, Massachusetts General Hospital, Harvard Medical
School, Boston, MA, Dr. Erica Shenoy, MD, PhD, Division of In-
fectious Disease and Infection Control Unit, Department of Medi-
cine, Massachusetts General Hospital, Harvard Medical School,
Boston, MA, Ms. Christy Varughese, Pharm.D., Department of
Pharmacy, Infection Control Unit, Massachusetts General Hospital,
Boston, MA, Dr. David Hooper, MD, PhD, Division of Infectious
Disease and Infection Control Unit, Department of Medicine, Mas-
sachusetts General Hospital, Boston, MA and Dr. Aleena Banerji,
MD, Division of Rheumatology, Allergy, and Immunology, Depart-
ment of Medicine, Massachusetts General Hospital, Harvard Med-
ical School, Boston, MA
746 The Effect Of Panel Ordering On Utilization Of In Vitro Spe-
cific IgE Testing By Primary Care Physicians In a Large HMO
Dr. Bruce J. Goldberg, MD, PhD, FAAAAI, Kaiser Permanente,
Los Angeles, CA and Dr. John S. Kaptein, PhD, Southern Califor-
nia Permanente Medical Group, Los Angeles, CA
747 Premature Discontinuation Of Allergy Immunotherapy-Inade-
quate Reimbursement By Health Insurers A Major Factor
Dr. Surender K. Vaswani, MD, FAAAAI, Allergy & Asthma
MONDAY
Clinical Center, Columbia, MD, Ravi Vaswani, New York Univer-
sity School of Medicine, Dr. Njideka Udochi, Howard County Gen-
eral Hospital/Johns Hopkins, Rajiv Karani, University of Cincinnati
School of Medicine and Dr. Leena Parikh, St.Agnes Hospital
748 Adherence To Labeling Guidelines Of Inhalant Allergen Immu-
notherapy Practice Parameter 2011 At The University Of Mich-
igan Health Service
Dr. Marilyn Karam, MD1, Kiela Samuels2, Cynthia Hernandez,
RN2, Dr. Christine L. Holland, MD1 and Dr. Matthew J. Greenhawt,
MD, MBA, MSc3, 1The University of Michigan, Division of Al-
lergy and Clinical Immunology, Ann Arbor, MI, 2University of
Michigan Health System, Ann Arbor, MI, 3Department of Internal
Medicine, The University of Michigan Medical School, Division of
Allergy and Clinical Immunology, Ann Arbor, MI
749 The Prevalence Of Allergic Rhinitis Among High- School Male
Military Recruits In Jordan
Dr. Mansour Fuad Karadsheh, MD and Dr. Suleiman Soudi,
Royal Medical Services, Madaba, Jordan
750 Allergen Sensitivity Patterns Among Atopic Individuals At A
Tertiary Allergy Center
Dr. Lukena U. Karkhanis, MD, Dr. Sarena Sawlani, MD and Dr.
Andrew Kau, MD, PhD, Washington University School of Medi-
cine, St. Louis, MO
751 Assessing Quality Of Life In Patients With AERD After Aspirin
Desensitization
Dr. Melissa Iammatteo, MD1, Dr. Autumn Chandler Guyer, MD2,
Dr. Rebecca Saff, MD, PhD3, Dr. Eric Holbrook, MD4, Dr. Stacey
Gray, MD4, Dr. Aidan Long, MD, FAAAAI5 and Dr. Aleena Bane-
rji, MD5, 1Massachusetts General Hospital, Boston, MA, 2Massa-
chusetts General Hospital, Harvard Medical School, Boston, MA,
3
Allergy and Clinical Immunology, Massachusetts General Hospi-
tal, Boston, MA, 4Massachusetts Eye and Ear Infirmary, Boston,
133
 AB344 Abstracts
MA, 5Division of Rheumatology, Allergy, and Immunology, De-
partment of Medicine, Massachusetts General Hospital, Harvard
Medical School, Boston, MA
752 Published Findings On Dust Allergens May Be Inaccurate Due
To Improper Handling Of Values Below The Lower Limit Of
Detection
Henry Lynn, Mr. Agustin Calatroni, MA MS, Katy Jaffee, MS, Re-
becca A. Zabel and Samuel J. Arbes Jr., Rho, Inc., Chapel Hill, NC
753 Patient-Reported Factors That Influence Diphenhydramine Use
In Children and Adults In An Allergy Specialty Practice
Dr. Prakash Navaratnam1, Dr. Robert Anolik, MD, FAAAAI2, Dr.
Howard Friedman, MS, PhD1 and Dr. Eduardo Urdaneta, MD3,
1
DataMed Solutions LLC, New York, NY, 2Allergy and Asthma
Specialists, PC, Blue Bell, PA, 3McNeil Consumer Healthcare,
Fort Washington, PA
Allergen Extracts and Immunotherapy
4210
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
754 The Efficacy and Safety Of The Short Ragweed Sublingual Im-
munotherapy Tablet MK-3641 Is Similar In Asthmatic and
Nonasthmatic Subjects Treated For Allergic Rhinitis With/
Without Conjunctivitis (AR/C)
Dr. Jennifer Maloney, MD1, Dr. David I. Bernstein, MD, FAAAAI2,
Dr. Jacques Hebert, MD3, Dr. Martha White, MD4, Dr. Robert Fisher,
MD5, Dr. Thomas B. Casale, MD, FAAAAI6, Dr. Amarjot Kaur,
PhD1 and Dr. Hendrik Nolte, MD, PhD1, 1Merck, Whitehouse Sta-
tion, NJ, 2Bernstein Allergy Group, Cincinnati, OH, 3Centre de Re-
cherche Appliquee en Allergie de Quebec, Quebec City, QC,
Canada, 4Institute for Asthma & Allergy, Wheaton, MD, 5Allergy
Research & Care, Milwaukee, WI, 6Univeristy Of South Florida
MONDAY
Morsani College Of Medicine, Tampa, FL
755 Compliance With Guidelines In The Use Of Allergen Immuno-
therapy
Dr. Pudupakkam K Vedanthan, MD1, Ms. Christina Cutter, MSc,
BA2, Ms. Phuong Dinh, BS2 and Mr. Peter DeWitt, MS2, 1Univer-
sity of Colorado, Lakewood, CO, 2University of Colorado - An-
schutz Medical Campus, Aurora, CO
756 Efficacy Of Short Ragweed Sublingual Immunotherapy Tablet
(SLIT-T) In Mono-Sensitized and Poly-Sensitized Subjects
Dr. David I. Bernstein, MD, FAAAAI1, Kevin R. Murphy, MD2,
Dr. Hendrik Nolte, MD, PhD3, Dr. Amarjot Kaur, PhD3 and Dr. Jen-
nifer Maloney, MD3, 1Bernstein Allergy Group, Cincinnati, OH,
2
Boys Town National Research Hospital, Boys Town, NE, 3Merck,
Whitehouse Station, NJ
757 Trends In Prescribing Of Specific Immunotherapy For Grass
Pollen Allergy In Germany: 2005-2012
Prof. Ulrich Wahn, Prof Dr Med1, Amanda McDonnell2, Catrina
Richards2, Dr. Felicia C. Allen-Ramey, PhD3, Mr. Jakob N. Andrea-
sen4, Charles Hawes2 and Dirk Demuth2, 1Charite, Berlin, Ger-
many, 2IMSHealth, United Kingdom, 3Merck & Co, Inc, West
Point, PA, 4ALK, Denmark
758 Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In The
Treatment Of Rhinitis Symptoms In Patients With Grass Pol-
len-Induced Allergic Rhinoconjunctivitis
Prof. Claus Bachert, MD, PhD1, Prof. Alain Didier, MD, PhD2,
Ms. Laurence Ambroisine, Msc3, Dr. Kathy Abiteboul, PharmD3
and Dr. Robert K. Zeldin, MD3, 1Universitair Ziekenhuis Gent,
Ghent, Belgium, 2Larrey Hospital, CHU, Toulouse, France, 3Stal-
lergenes S.A., Antony, France
759 Allergen Immunotherapy Safety While Using High Risk
Medication: A Survey Of AAAAI Members
Dr. Matthew A. Rank, MD, FAAAAI, Mayo Clinic, Scottsdale,
134
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
AZ, Dr. David W. Hauswirth, MD, FAAAAI, Nationwide Chil-
drens Hospital, Columbus, OH, Dr. Christopher W. Calabria,
MD, Dilley Allergy and Asthma Specialists, San Antonio, TX,
Dr. Lawrence D. Sher, MD, FAAAAI, Peninsula Research Associ-
ates, Rolling Hills Estates, CA and Dr. Desiree E.S. Larenas Linne-
mann, MD, FAAAAI, Hospital Medica Sur, Mexico D.F., Mexico
760 Venom Immunotherapy Use With Contraindicated Medication:
A Survey Of AAAAI Members Experience
Dr. David W. Hauswirth, MD, FAAAAI, Buckeye Allergy, Co-
lumbus, OH; Nationwide Childrens Hospital, Columbus, OH, Dr.
Matthew A. Rank, MD, FAAAAI, Mayo Clinic, Scottsdale, AZ,
Dr. Desiree E.S. Larenas Linnemann, MD, FAAAAI, Hospital
Medica Sur, Mexico D.F., Mexico, Dr. Lawrence D. Sher, MD,
FAAAAI, Peninsula Research Associates, Rolling Hills Estates,
CA and Dr. Christopher W. Calabria, MD, Dilley Allergy and
Asthma Specialists, San Antonio, TX
761 Simultaneous Measurement Of Multiple Proteins In Blattella
Germanica Extract Using Antibody-Based Multiplex Assay
Dr. Taruna Khurana, PhD1, Ms. Maggie Collison1 and Dr. Jay E.
Slater, MD2, 1CBER FDA, 2FDA/CBER/OVRR/DBPAP, Rockville,
MD
762 Characterization and Protein Composition Of Food Allergen
Extracts
Dr. Greg A. Plunkett, PhD and Dr. Tricia Moore, PhD, ALK-
Abello, Inc, Round Rock, TX
763 Stability and Compatibility Of Cat, Dog, Dust Mite, and Cock-
roach Extracts In Indoor Allergen Mixtures and Dilutions For
Immunotherapy
Dr. Silvia Huebner, MD1, Dr. Satyen Manilal Gada, MD2, Dawn
Hall, BS3 and Dr. Thomas Grier, MD3, 1Evans Army Community
Hospital, Fort Carson, CO, 2Walter Reed National Military Medical
Center, Bethesda, MD, 3Greer Labs
764 Interest Of Mass Spectrometry-Based Quantification Of Rele-
vant Allergens To Improve The Standardization Of Allergen
Extracts
Thierry Batard, PhD1, Emmanuel Nony2, Christel Dayang, PhD2,
Julien Bouley, PhD2, Maxime Le Mignon, PhD2, Christelle Ber-
rouet2, Aurelie Lautrette, PhD2, Marie Naveau, PhD2, Henri Cha-
bre, PhD2 and Dr. Philippe Moingeon, PhD3, 1Stallergenes,
Antony, France, 2Stallergenes, France, 3Stallergenes SA, Antony,
France
Outcome Measures and Challenge Testing with
Immunotherapy
4211
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
765 Baseline Predictors Of Symptom Severity Following Exposure
To House Dust Mite In An Antigen Challenge Chamber (ACC)
Daniel Ramirez, MD1, Robert L. Jacobs, MD1, Cynthia Rather,
CCRC1, Andrew Carrillo, BS2,3, Weijing He, MD2,3, Nathan
Harper, BS2,3, Charles Andrews, MD1 and Sunil K. Ahuja,
MD2,3, 1Biogenics Research Chamber, San Antonio, TX, 2Depart-
ment of Medicine, University of Texas Health Science Center,
San Antonio, TX, 3Veterans Administration Center for Personalized
Medicine, South Texas Veterans Health Care System, San Antonio,
TX
766 Validation Of Biogenics Research Chamber For Elicitation Of
Symptoms To Dust Mite Antigen (Der p1)
Robert L. Jacobs, MD1, Cynthia Rather, CCRC1, Fabio Jimenez,
BS2,3, Hernan Martinez, MD2,3, Weijing He, MD2,3, Daniel Ram-
irez, MD1, Charles Andrews, MD1 and Sunil K. Ahuja, MD2,3, 1Bi-
ogenics Research Chamber, San Antonio, TX, 2Department of
Medicine, University of Texas Health Science Center, San Antonio,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
TX, 3Veterans Administration Center for Personalized Medicine,
South Texas Veterans Health Care System, San Antonio, TX
767 Magnitude Of Changes In Patient Symptom and Medication
Scores In Grass Allergy Immunotherapy Trials: Dependency
On Levels Of Pollen Exposure
Dr. Hendrik Nolte, MD, PhD1, Prof. Stephen R. Durham, MA
MD FRCP2, Dr. Harold S. Nelson, MD, FAAAAI3, Dr. David
I. Bernstein, MD, FAAAAI4, Dr. Peter S. Creticos, MD,
FAAAAI5, Dr. Ziliang Li, PhD1 and Dr. Jens Andersen, PhD6,
1
Merck, Whitehouse Station, NJ, 2Imperial College London, Lon-
don, United Kingdom, 3National Jewish Health, Denver, CO,
4
Bernstein Allergy Group, Cincinnati, OH, 5Johns Hopkins Divi-
sion of Allergy & Clinical Immunology, 6ALK-Abello,
Hrsholm, Denmark
768 Evaluation Of Acoustic Rhinometry In Histamine Nasal Provo-
cation Test In Children and Adolescents
Dr. Fausto Y. Matsumoto, Federal University of S~ao Paulo, S~ao
Paulo, Brazil, Dr. Gustavo Wandalsen, MD, UNIFESP, Sao Paulo,
Brazil, Dr. Aline Mendes, Federal University of S~ao Paulo, Brazil.
and Prof. Dirceu Sole, MD, PhD, Federal University of Sao Paulo,
Sao Paulo, Brazil
769 EQ-5D Health Utility Values In The Treatment Of Seasonal
Grass Pollen Induced Rhinoconjunctivitis
Mr. Jakob N. Andreasen1, Dr. Chris Poole2, Dr. Christian Bannis-
ter3, Dr. Jens Andersen, PhD4 and Mr. Niels Serup-Hansen1, 1ALK,
Denmark, 2Cardiff University, Cardiff, Wales, 3Cardiff University,
4
ALK-Abell o, Hrsholm, Denmark
770 Ex-Vivo Allergen Stimulation In Whole Blood: A Novel Ap-
proach For Evaluating Mechanisms Of Action Of Synthetic
Peptide Immuno-Regulatory Epitopes
Dr. Pascal LC Hickey, BPharm PhD1, Dr. Mark Larche, PhD2, Dr.
Rod Hafner, PhD3, Ms. Kristen Armstrong, M.Sc.4, Ms. Eileen Lee,
BA (Hons)5, Dr. Elaine Lee, PhD5 and Dr. Stephen A. Kilfeather,
PhD5, 1Adiga Life Sciences, Hamilton, Canada, 2McMaster Univer-
sity, Hamilton, ON, Canada, 3Circassia Ltd, Oxford, United King-
dom, 4Adiga Life Sciences Inc., Hamilton, ON, Canada, 5Aeirtec
Limited, Newcastle upon Tyne, United Kingdom
771 Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In Grass
Pollen-Induced Allergic Rhinoconjunctivitis: Pooled Analysis
By Age
Dr. Robert K. Zeldin, MD1, Prof. Ulrich Wahn, Prof Dr Med2,
Prof. Alain Didier, MD, PhD3, Mrs. Armelle Montagut1 and Dr.
Marie-Pierre Furrer, PhD1, 1Stallergenes S.A., Antony, France,
2
Charite, Berlin, Germany, 3Larrey Hospital, CHU, Toulouse,
France
772 Characterization Of Allergic Rhinitis Symptomotology Induced
By a Nasal Allergen Challenge (NAC) Titration In a Dust Mite
Sensitize Population
Mr. Paul Gomes1, Endri Angjeli2, Mr. Keith Lane2 and Dr. Paul H.
Ratner, MD, FAAAAI3, 1ORA. Inc, Andover, MA, 2Ora, Inc, And-
over, MA, 3Sylvana Research, San Antonio, TX
773 Atopic and Non-Atopic Individuals Manifest Partly Concordant
Clinical and Leukocyte Responses Following Exposure To
House Dust Mite In An Antigen Challenge Chamber (ACC)
Weijing He, MD1,2, Nathan Harper, BS1,2, Andrew Carrillo,
BS1,2, Charles Andrews, MD3, Cynthia Rather, CCRC3, Daniel
Ramirez, MD3, Robert L. Jacobs, MD3 and Sunil K. Ahuja,
MD1,2, 1Department of Medicine, University of Texas Health Sci-
ence Center, San Antonio, TX, 2Veterans Administration Center
for Personalized Medicine, South Texas Veterans Health Care Sys-
tem, San Antonio, TX, 3Biogenics Research Chamber, San Anto-
nio, TX
774 The Effects Of Pollen Season On Reactions To Subcutaneous
Immunotherapy
Dr. Devi Jhaveri, DO1, Dr. Julie Abraham, M.D.2, Megan Betteley,
B.S.3, Dr. Mary Ann ORiordan, PhD2, Dr. Theodore H. Sher, MD,
FAAAAI4, Dr. Robert W. Hostoffer, DO4 and Dr. Haig
Abstracts AB345
Tcheurekdjian, MD, FAAAAI4, 1University Hospitals, South Eu-
clid, OH, 2Rainbow Babies and Childrens Hospital, Cleveland,
OH, 3Case Western Reserve University School of Medicine,
Cleveland, OH, 4Allergy/Immunology Associates, Inc., South Eu-
clid, OH
Mechanistic Insight into Pollens and Other
Antigens
4212
Monday, March 3rd, 2014, 9:45 AM - 10:45 AM
775 Protease Inhibitor Reduces Airway Response and Inflammation
In Mouse Model Of Cockroach Allergy
Mr. Sanjay Saw, M.Sc. and Dr. Naveen Arora, Ph.D, CSIR Insti-
tute of Genomics and Integrative Biology, New Delhi, India
776 Aryl Hydrocarbon Receptor (AhR) Modulates Cockroach Al-
lergen Induced TGF Beta 1 Secretion In Fibroblasts
Sarah Mirza1,2, Yufeng Zhou, MD, PhD1, Priya Tripathi, PhD1,
Liang Yuan1, Beverly Plunkett, MS1, Allen Myers, Ph.D1 and Pei-
song Gao, MD, PhD1, 1Division of Allergy & Clinical Immunology,
Johns Hopkins University School of Medicine, Baltimore, MD,
2
Sher-I-Kashmir Institute of Medical Sciences, Jammu and Kash-
mir, India
777 Effect Of Peanut Allergens On Intestinal Barrier Permeability
and Tight Junction Localisation In Caco-2 Cell Cultures
Prof. Cenk Suphioglu, PhD1, Ms. Dwan Price, BSc Hons1, Prof.
Leigh Ackland, PhD2, A. Wesley Burks, MD, FAAAAI3 and Dr.
Matthew Knight, PhD4, 1Deakin University, Australia, 2Deakin
Universisty, Australia, 3University of North Carolina, Chapel Hill,
NC, 4Department of Primary Industries, Australia
778 Synergistic Effect Of Dermatophagoides Pteronyssinus Aller-
gens and Dexamethasone On Expression Of CD163 By Periph-
MONDAY
eral Blood Mononuclear Cells Of Allergic Asthma Patients
Prof. Krzysztof Kowal, MD, PhD1, Pawel Bernatowicz, MD,
PhD2, Prof. Lech Chyczewski, MD, PhD2 and Prof. Anna Bod-
zenta-Lukaszyk, MD, PhD3, 1Medical University of Bialystok, Bia-
lystok, Poland, 2Medical University of Bialystok, 3Medical
University of Bialystok, Poland
779 IgE Antibodies and FceRI Are Critical For Acquired Resistance
Against Honeybee Venom In Mice
Dr. Philipp Starkl, PhD1, Dr. Thomas Marichal, DVM PhD1, Dr.
Laurent L. Reber, PhD1, Dr. Janet Kalesnikoff, PhD1, Dr. Hans C.
Oettgen, MD, PhD, FAAAAI2, Dr. Martin Metz, MD, PhD3 and
Dr. Stephen J. Galli, MD1, 1Stanford University School of Medi-
cine, Stanford, CA, 2Boston Childrens Hospital, Boston, MA,
3
Charite Campus Mitte, Berlin, Germany
780 Ragweed Pollen Proteins Bind TLR4/MD2, and Rapidly Re-
cruit MyD88 and TRAF6 To The Signaling Complex
Dr. Qian Sun, PhD, Dr. Koa Hosoki, MD, PhD, Dr. Leopoldo
Aguilera-Aguirre, PhD, Prof. Istvan Boldogh, PhD and Prof. Sanjiv
Sur, MD, University of Texas Medical Branch, Galveston, TX
781 Sensitization To Silkworm Moth (Bombyx mori) Allergen In
Patients With Respiratory Allergy
Mrs. Laura ML Araujo, Federal University of Parana, Brazil and
Prof. Nelson A. Rosario, MD, PhD, FAAAAI, Federal University of
Parana, Curitiba, Brazil
782 Balsam Of Peru, a Common Contact Dermatitis Allergen, Is a
CD1a Antigen
Sarah Nicolai, MD1,2, Tan-Yun Cheng, PhD1,2, Elvire A. Bour-
geois, PhD1,2, Annemieke de Jong, PhD3 and D. Branch Moody,
MD1,2, 1Brigham and Womens Hospital, Division of Rheumatol-
ogy, Immunology and Allergy, Boston, MA, 2Harvard Medical
School, Boston, MA, 3Columbia University Medical Center, De-
partment of Dermatology, New York, NY
135
 AB346 Abstracts
783 Cellular Infiltrate Induced By Bites From The Tick Ambly-
omma Americanum In Subjects With Or Without IgE To Ga-
lactose-Alpha-1,3-Galactose (Alpha-gal)
Dr. Nikhila Schroeder, MD1, Mr. Jake Eccles2, Erin J. Klaffky,
MD, PhD1 and Thomas A.E. Platts-Mills, MD, PhD, FAAAAI1,
1
Division of Asthma, Allergy & Immunology, University of Vir-
ginia Health System, 2University of Virginia School of Medicine
784 Duox2 and Mitochondria-Induced Antiviral Innate Immune
Response After Influenza A Virus Infection In Human Nasal
Epithelium
Prof. Hyun Jik Kim1,2, Prof. Chang-Hoon Kim3,4, Dr. Sung-Shik
Kim5 and Prof. Joo-Heon Yoon3,6, 1Chung-Ang University College
of Medicine, Seoul, South Korea, 2Airway Mucus Institute, Seoul,
South Korea, 3Department of Otorhinolaryngology, Yonsei Univer-
sity College of Medicine, Seoul, South Korea, 4The Airway Mucus
Institute, Yonsei University College of Medicine, Seoul, South Ko-
rea, 5Koenko Nose Infirmary, Seongnam, South Korea, 6Research
Center for Human Natural Defense System, Yonsei University Col-
lege of Medicine, Seoul, South Korea
785 Persistent Endothelial Damage After Intravenous Immunoglob-
ulin Therapy In Kawasaki Disease
Dr. Yoshihiko Sakurai1,2, Dr. Hideo Takatsuka1, Dr. Mutsuzo Ta-
kada1 and Dr. Masato Nishino1, 1Nara Prefectural Mimuro Hospital,
Sango, Japan, 2Matsubara Tokushukai Hospital, Matsubara, Japan
786 Prevalence Of Toxocariasis In General Population Based On
Serologic Test
Prof. Byung-Jae Lee, MD1, Dr. Jin-Young Lee, MD1, Dr. Mi-Jung
Oh, MD2 and Prof. Dong-Chull Choi, MD1, 1Samsung Medical
Center, 2Bundang Jesaeng General Hospital
787 Vitamin D Levels and Sensitization To Indoor Inhalant Aller-
gens In Korea
Dr. Kyung-Hwan Lim1,2, Dr. Min-Gyu Kang1,2, Dr. Han-Ki Park1,
Prof. So-Hee Lee1, Prof. Min-Suk Yang1,3, Prof. Woo-Jung Song,
M.D.1, Prof. Hye-Ryun Kang1, Prof. Heung-Woo Park, MD,
PhD1, Prof. Sun-Sin Kim1, Prof. Yoon-Seok Chang1,2, Prof. Sang
MONDAY
Heon Cho, MD, PhD1, Prof. Kyung-Up Min, MD, PhD1 and Prof.
Sae-Hoon Kim1,2, 1Department of Internal Medicine, Seoul Na-
tional University College of Medicine, Seoul, South Korea, 2De-
partment of Internal Medicine, Seoul National University
Bundang Hospital, Seongnam, South Korea, 3SMG-SNU Boramae
Medical Center, Seoul, South Korea
788 Measuring Vascular Leak During Respiratory Viral Infections
Dr. Brian T. Kelly, MD, Mrs. Desire Hunter and Dr. Mitchell H. Gray-
son, MD, FAAAAI, Medical College of Wisconsin, Milwaukee, WI
789 Effects Of Rhinovirus (RV) 39 Infection On Airway Hyper-Re-
activity (AHR) To Histamine and Carbachol In Human Airways
Joshua L. Kennedy, MD1, Stacie M. Jones, MD1,2, Ms. Megan
Kurten1,3, Ms. Suzanne House1,3 and Richard Kurten, PhD1,3, 1Ar-
kansas Childrens Hospital Research Institute, Little Rock, AR,
2
University of Arkansas for Medical Sciences and Arkansas Chil-
drens Hospital, Little Rock, AR, 3University of Arkansas for Med-
ical Sciences, Little Rock, AR
Adherence
4601
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
790 Poor Asthma Control In Older Adults Is Associated With Re-
duced Adherence To Controller Therapies and Inability To Af-
ford Medications
Dr. Jessica Tan, MD, MPH1, Dr. David I. Bernstein, MD,
FAAAAI2, Ms. Cheryl Koff Bernstein, RN BSN CCRC3, Dr. Pat-
rick Ryan, PhD4, Dr. Jonathan A. Bernstein, MD, FAAAAI5, Ms.
Banu Kesavalu6, Dr. Manuel S. Villareal, MD, FAAAAI1,7, Dr.
136
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Andrew M. Smith, MD, FAAAAI8, Dr. Peter Lenz9 and Dr. Tolly
Epstein, MD, MS10, 1University of Cincinnati Medical Center, Cin-
cinnati, OH, 2Bernstein Allergy Group, Cincinnati, OH, 3Bernstein
Clinical Research Center, LLC, Cincinnati, OH, 4Cincinnati Chil-
drens Hospital Medical Center, Cincinnati, OH, 5Division of Im-
munology Allergy & Rheumatology, University of Cincinnati
Medical Center, Cincinnati, OH, 6University of Cincinnati, 7Uni-
versity of Cincinnati, Cincinnati, OH, 83255 Eden Ave., HPB
350, University of Cincinnati Medical Center, Cincinnati, OH,
9
The University of Cincinnati Medical Center, 10Allergy Partners
of Central Indiana, Indianapolis, IN
791 Texting Medication Reminders For Better Asthma Control In
Children and Teens
Dr. Humaa M. Bhatti, DO1, Ms. Wafa Alame, RN1, Mr. Joseph
Adams2, Dr. Jenny M. Montejo, MD1, Dr. Milind V. Pansare,
MD, FAAAAI1, Dr. Pavadee Poowuttikul, MD1 and Dr. Elizabeth
A. Secord, MD, FAAAAI2, 1Childrens Hospital of Michigan, De-
troit, MI, 2Wayne State University, Detroit, MI
792 Adherence To Prescribed Controller Therapy and Effects On
Asthma Control In The Hispanic Population Of a Pediatric Dis-
ease Management Program
Dr. Lyne G. Scott, MD1, Tricia Morphew2, Marilyn Li1 and Dr.
Salima A. Thobani, MD1, 1University of Southern California,
2
Morphew Consulting, LLC, CA
793 Correlation Between Emergency Department Visits For
Asthma Exacerbation and No Show Visits To Primary Care
Provider In a Pediatric Population
Dr. Margaret Redmond, M.D. and David R. Stukus, MD,
FAAAAI, Nationwide Childrens Hospital, Columbus, OH
794 Choosing Wisely: Adherence By Allergists To Recommended
Use Of Spirometry In The Diagnosis and Management Of Adult
Asthma
Dr. Kristin C. Sokol, MD, MPH, Dr. Gregg Wilkinson, PhD, Ms.
Karen Pierson, MA and Dr. Randall M. Goldblum, MD, University
of Texas Medical Branch, Galveston, TX
Bone Marrow Transplantation in Primary
Immunodeficiencies
4602
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
795 G Protein-Coupled Receptor Kinase-3 (GRK-3) In Bone Mar-
row Niche Interactions and Transplantation
Jaime M. Brozowski1,2, Roman Timoshchenko2, Jessica Koontz3,
Janet Rubin3,4, Matthew Billard2 and Teresa K. Tarrant2,3, 1Depart-
ment of Microbiology and Immunology, University of North Caro-
lina School of Medicine, Chapel Hill, NC 27599, USA, 2Thurston
Arthritis Research Center and Department of Medicine, Division
of Rheumatology, Allergy, and Immunology, University of North
Carolina, Chapel Hill, NC 27599, USA, 3School of Medicine, Uni-
versity of North Carolina, Chapel Hill, NC 27599, USA, 4Pediatrics
and Pharmacology and Department of Medicine, Division of Endo-
crinology and Metabolism, University of North Carolina, Chapel
Hill, NC 27599, USA
796 Allogeneic Hematopoietic Stem Cell Transplantation For Im-
mune Dysregulation, Polyendocrinopathy, X-Linked (IPEX)
Syndrome Resolves Enteropathy and Autoimmunity: A Single
Institution Experience
Dr. Zeynep Yesim Yesim Kucuk, MD, Dr. Jack J.H. Bleesing,
MD, PhD, Dr. Rebecca A. Marsh, MD, Dr. Kejian Zhang, MD,
Dr. Stella Davies, MBBS, PhD and Dr. Alexandra H. Filipovich,
MD, Cincinnati Childrens Hospital Medical Center,
Cincinnati, OH
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
797 Natural Killer Cell Immunoglobulin Like Receptor (KIR) Ge-
netic Profile Is a Strong Predictor Of Allogeneic Hematopoietic
Cell Transplant Outcomes
Dr. Rehan M. Faridi, PhD1, Taylor Kemp1, Dr. Poonam Dhar-
mani, PhD1, Dr. Victor Lewis, MD2, Dr. Noureddine Berka,
PhD3, Dr. Jan Storek, MD, PhD1 and Dr. Faisal Khan, PhD1, 1Uni-
versity of Calgary, Calgary, AB, Canada, 2Alberta Childrens Hos-
pital, Calgary, AB, Canada, 3Calgary Laboratory Services, Calgary,
AB, Canada
798 Transient Lymphopenia Of Infancy: A Previously Unrecognized
Entity
Dr. Robert Sporter, MD, Division of Allergy/Immunology, De-
partments of Medicine and Pediatrics, Hofstra North Shore-LIJ
School of Medicine, Dr. Catherine Capo, MD, Department of Med-
icine, Hofstra North Shore-LIJ School of Medicine, Manhasset, NY
and Dr. Vincent R. Bonagura, MD, FAAAAI, Division of Allergy/
Immunology, Departments of Medicine and Pediatrics, Hofstra
North Shore-LIJ School of Medicine, Great Neck, NY
Air Pollution/Allergens/Air Quality
4603
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
799 Associations Among Volatile Organic Compounds, Allergic Sen-
sitization, and Respiratory Illness In Children With Asthma
Enrolled In a Study Of Low-Income, Green Eco-Friendly Hous-
ing (The Green Housing Study)
Dr. Joy Hsu, MD, MSCI1, Sandra Chaves, MD, MSc2, Marika
Iwane, PhD, MPH2, Yang Qiu, ScM3, Christopher Schaffer, BS4,
Marty Alvarez-Reeves, MS3, Prof. Tiina Reponen, PhD4, Dr.
Gary Adamkiewicz, PhD3, Dr. Patrick Ryan, PhD5, Doug Brugge,
PhD6, David Turcotte, ScD7, Fuyuen Yip, PhD, MPH8, Kanta Sir-
car, PhD, MPH8, Benjamin Blount, PhD9, K. Udeni Alwis, PhD9,
Connie Sosnoff, MA9, Peter Ashley, DrPH10, Curtis Hedman,
PhD11, Steve Strebel, BS11, Behrooz Behbod, MBChB, MSc,
ScD1, Matthew Lozier, PhD, MPH1 and Dr. Ginger L. Chew,
ScD, MSPH8, 1Epidemic Intelligence Service, Centers for Disease
Control and Prevention, Atlanta, GA, 2National Center for Immuni-
zation and Respiratory Diseases, Centers for Disease Control and
Prevention, Atlanta, GA, 3Harvard School of Public Health, Boston,
MA, 4University of Cincinnati, Cincinnati, OH, 5Cincinnati Chil-
drens Hospital Medical Center, Cincinnati, OH, 6Tufts University
Health Sciences, Boston, MA, 7Center for Family, Work and Com-
munity, University of Massachusetts Lowell, Lowell, MA, 8Air Pol-
lution and Respiratory Health Branch, Division of Environmental
Hazards and Health Effects, National Center for Environmental
Health, Centers for Disease Control and Prevention, Atlanta, GA,
9
Division of Laboratory Sciences, National Center for Environmen-
tal Health, Centers for Disease Control and Prevention, Atlanta,
GA, 10Office of Healthy Homes and Lead Hazard Control, U.S. De-
partment of Housing and Urban Development, Washington, DC,
11
Wisconsin State Lab of Hygiene, Madison, WI
800 A Systematic Analysis Of Pollen Transcriptomes From Plant
Allergens Reveals Conserved Targets Of Immune Responses
Dr. Bjoern Peters1, Dr. Jason Greenbaum1, Dr. Veronique M.
Schulten1, Dr. Denise Baker1, Dr. April Frazier1, Dr. Alessandro
Sette, Dr. Biol. Sci.1, Dr. Michael Wallner 2 and Mrs. Heidi Hofer2,
1
La Jolla Institute for Allergy and Immunology, La Jolla, CA, 2Uni-
versity of Salzburg, Salzburg, Austria
801 Urinary Polycyclic Aromatic Hydrocarbon Metabolites and
Th2 Immunity In Children
Kinjal M. Hew, PhD1, Annett I. Walker, MD1, Arunima Kohli1,
Aleena Syed1, Cameron McDonald-Hyman1, Zheng Li, PhD,
MPH2, Andreas Sjodin, PhD2 and Dr. Kari C. Nadeau, MD, PhD,
Abstracts AB347
FAAAAI3, 1Department of Pediatric Allergy and Immunology,
Stanford University, Stanford, CA, 2Division of Laboratory Sci-
ences, National Center for Environmental Health, Centers for Dis-
ease Control and Prevention, Atlanta, GA, 3Pediatric Allergy
Immunology, Stanford University, Stanford, CA
802 Impact Of BMI On Ozone-Induced IL-1b In The Airways Of
Human Volunteers
Dr. Michelle L. Hernandez, MD1, Dr. Krista Todoric, MD1, Ms.
Katherine Mills, BA2, Dr. Haibo Zhou, PhD3 and Dr. David B. Pe-
den, MD, MS, FAAAAI4, 1University of North Carolina at Chapel
Hill School of Medicine, Chapel Hill, NC, 2University of North
Carolina Chapel Hill School of Medicine, Chapel Hill, NC, 3Uni-
versity of North Carolina at Chapel Hill, School of Public Health,
4
Office #544, Campus Box 7310, University of North Carolina at
Chapel Hill School Medicine, NC
803 Group-2 Innate Lymphoid Cells Promote Air-Pollutant Induced
Airway Inflammation and Hyperresponsiveness (AHR)
Dr. Qi Yang, PhD, Moyar Q. Ge, Blerina Kokalari, Imre G Redai,
Xinxin Wang, Dr. Avinash Bhandoola, MBBS PhD and Dr. Angela
Haczku, MD, PhD, FAAAAI, University of Pennsylvania, Philadel-
phia, PA
Food Allergy
4604
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
804 Peanut T Cell Epitope Discovery: Ara h1 and Ara h3
Dr. Manish Ramesh, MD, PhD1, Madhan Masilamani, PhD2, Dr.
George N. Konstantinou, MD, PhD, MSc3,4, Jay A. Lieberman,
MD5, Hugh A. Sampson, MD, FAAAAI6, Dr. Madhundra Sivaku-
mar1, Dr. Araya Yuenyongviwat, MD7 and Dr. Mariona Pascal,
PhD8, 1Mount Sinai School of Medicine, New York, NY, 2Icahn
MONDAY
School of Medicine at Mount Sinai, New York, NY, 3424 General
Military Training Hospital, Thessaloniki, Greece, 4First Pediatric
Department, Aristotle University of Thessaloniki, Hippokration
General Hospital, Thessaloniki, Greece, 5University of Tennessee,
Memphis, TN, 6Pediatrics, Icahn School of Medicine at Mount Si-
nai, New York, NY, 7Prince of Songkla University, Songkhla, Thai-
land, 8Servei dImmunologia, Centre de Diagnostic Biomedic.
Hospital Clinic., Barcelona, Spain
805 Microparticles Encapsulated With Antigen Protect Against
Sensitization and Reduce Anaphylactic Reactivity In a Food Al-
lergy Model
Dr. Karen B. Chien, PhD, Northwestern University, Chicago, IL
and Dr. Paul Bryce, PhD, Division of Allergy-Immunology, Depart-
ment of Medicine, Feinberg School of Medicine, Northwestern
University, Chicago, IL
806 Over-The-Counter Dietary Supplements Genistein and Iprifla-
vone Suppress Peanut Allergy Symptoms
Ms. Lisa Chang, BS1, Ms. Mohanapriya Kamalakannan, MS1, Mr.
Matthew Stadler1, Hugh A. Sampson, MD, FAAAAI2 and Madhan
Masilamani, PhD1, 1Icahn School of Medicine at Mount Sinai, New
York, NY, 2Pediatrics, Icahn School of Medicine at Mount Sinai,
New York, NY
807 Analyzing Casein-Specific IL-4 and IL-13 Secreting T-Cells: A
Reliable Tool For Diagnosis Of Cows Milk Allergy
Dr. Benedicte Michaud, MD, PhD1,2, Dr. Joseph Aroulandom,
MD3, Mrs. Nour Baz, PhD4, Dr. Flore Amat, MD3, Dr. Rahele
Gouvis-Echraghi, MD3, Dr. Sophie Candon, MD, PhD1,2, Mr.
Remy Couderc, PhD PharmaD5, Prof. Jean-Francois Bach, MD,
PhD1,2, Prof. Lucienne Chatenoud, MD, PhD1,2 and Prof. Jocelyne
Just, MD, PhD3,4, 1Universite Paris Descartes, Sorbonne Paris Cite,
France, 2Institut national de la sante et de la recherche medicale,
Unite U1013, Paris, France, 3Allergology department, Trousseau
137
 AB348 Abstracts
hospital AP-HPUPMC Paris 6, France, 4EPidemiology of Allergic
and Respiratory diseases (EPAR) Department, UMR-S 707 IN-
SERM, UPMC Paris 6, France, 5Service de Biochimie et Biologie
Moleculaire, Trousseau hospital AP-HP, Paris, France
808 Growth Of Children Aged 2-17 With Cows Milk, Peanut, and
Egg Allergy In NHANES
Dr. Karen Robbins, MD1, Robert A. Wood, MD, FAAAAI2
and Corinne Keet, MD, MS2, 1Johns Hopkins University
School of Medicine, 2Johns Hopkins University Medical Center,
Baltimore, MD
Epidemiology
4605
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
809 Allergic Causes Of Death In The United States
Dr. Susan J. Kim, MD, Kaiser Permanente Southern California,
Los Angeles, CA and Dr. Jordan C. Brooks, PhD, MPH, Life Ex-
pectancy Project, San Francisco, CA
810 Death From Anaphylaxis Is a Reassuringly Unusual Outcome
Dr. Larry Borish, MD, FAAAAI1, Dr. Theodore Danoff, MD,
PhD2 and Dr. Liyuan (Larry) Ma, PhD2, 1Asthma and Allergic
Diseases Center, Carter Center for Immunology Research, Uni-
versity of Virginia, Charlottesville, VA, 2Endo Pharmaceuticals
Inc.
811 Allergic Rhinitis, Asthma and Cardiovascular Disease
Dr. Angelina M. Crans Yoon, MD1, Dr. Anne M. Staveren, MD1,
Dr. Michael S. Kaplan, MD, FAAAAI1, Dr. Javed Sheikh, MD,
FAAAAI2 and Dr. Bruce J. Goldberg, MD, PhD, FAAAAI1, 1Kaiser
Permanente, Los Angeles, CA, 2Kaiser Permanente Los Angeles
Medical Center, Los Angeles, CA
812 Pre-Natal and Early Life Predictors Of Atopy In Canadian
Children: Results Of The Family Study
Tahira Batool, MBBS, FRCPC1, Michael M. Cyr, MD, FRCPC1,
MONDAY
Judah Aryeh Denburg, MD, FRCPC, FAAAAI1, Ms. Karleen
Schulze, MMath2, Sonia Anand, MD, FRCPC2, Koon Teo, MD,
FRCPC2 and Family Investigators2, 1Division of Clinical Immunol-
ogy and Allergy, Department of Medicine, McMaster University,
ON, Canada, 2Population Health Research Institute, Department
of Medicine, McMaster University, ON, Canada
813 Association Between Antibiotic Treatment In The First Six
Months Of Life and Clinical Allergic Outcomes At Ages 2 To
3 Years
Kyra Jones, MEd1, Alexandra Sitarik, M.S.1, Ms. Suzanne Hav-
stad, M.A.1, Ganesa Wegienka, PhD1, Dr. Dennis Ownby, M.D.
FAAAAI2, Dr. Edward M. Zoratti, MD, FAAAAI3 and Dr. Chris-
tine Cole Johnson, PhD MPH FAAAAI1, 1Department of Public
Health Sciences, Henry Ford Hospital, Detroit, MI, 2Division of
Allergy-Immunology and Rheumatology, Georgia Health Sci-
ences University, Augusta, GA, 3Henry Ford Health System, De-
troit, MI
Chronic Rhinosinusitis
4606
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
814 The Clinical Significance Of Specific Antibody Deficiency (SAD)
Severity In Chronic Rhinosinusitis (CRS)
Dr. Anjeni Keswani, MD1, Neha Mehrotra, MD2, Dr. Angelica
Manzur3, Dr. Rakesh Chandra, MD4, Dr. David Conley, MD5, Dr.
Bruce K. Tan, MD5, Dr. Leslie C. Grammer, MD, FAAAAI1, Dr.
Robert C. Kern, MD5, Dr. Robert P. Schleimer, PhD FAAAAI6
138
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
and Dr. Anju T. Peters, MD, FAAAAI1, 1Department of Medicine,
Division of Allergy-Immunology, Northwestern University Fein-
berg School of Medicine, Chicago, IL, 2University of Chicago,
IL, 3Department of Medicine, Northwestern University Feinberg
School of Medicine, 4Northwestern University, Chicago, IL, 5De-
partment of Otolaryngology, Northwestern University Feinberg
School of Medicine, Chicago, IL, 6Division of Allergy-Immunol-
ogy, Department of Medicine, Northwestern University Feinberg
School of Medicine, Chicago, IL
815 Meta-Analysis Of Gene Expression Microarrays Reveals Novel
Biomarkers Consistent With Altered Functionality Of Mucosal
Barrier In Patients With Chronic Rhinosinusitis
Dr. Sergejs Berdnikovs, PhD1, Dr. Atsushi Kato, PhD2, Mr. James
Norton, MS2, Ms. Lydia Suh, BSc2, Dr. Robert C. Kern, MD3, Dr.
David Conley, MD3, Dr. Rakesh Chandra, MD4, Dr. Anju T. Peters,
MD, FAAAAI2, Dr. Leslie C. Grammer, MD, FAAAAI2, Ms.
Kathleen E. Harris, BSc2, Dr. Michael Platt, MD5, Dr. Ralph Met-
son, MD6 and Dr. Robert P. Schleimer, PhD FAAAAI7, 1Division of
Allergy-Immunology, Northwestern University Feinberg School of
Medicine, Chicago, IL, 2Department of Medicine, Division of Al-
lergy-Immunology, Northwestern University Feinberg School of
Medicine, Chicago, IL, 3Department of Otolaryngology, Northwest-
ern University Feinberg School of Medicine, Chicago, IL, 4North-
western University, Chicago, IL, 5Department of Otolaryngology,
Boston Medical Center, Boston University, Boston, MA, 6Depart-
ment of Otology and Laryngology, Harvard Medical School, Bos-
ton, MA, 7Division of Allergy-Immunology, Department of
Medicine, Northwestern University Feinberg School of Medicine,
Chicago, IL
816 Evidence For Immunoglobulin D In Patients With Chronic Rhi-
nosinusitis
Dr. Jin Young Min, MD, PhD1, Dr. Robert C. Kern, MD1, Dr.
Kathryn E. Hulse, PhD2, Dr. Rakesh Chandra, MD2, Dr. David
Conley, MD1, Ms. Lydia Suh, BSc3, Mr. Roderick Carter,
BSc3, Mr. James Norton, MS3, Julia H. Huang1, Dr. Atsushi
Kato, PhD3, Dr. Robert P. Schleimer, PhD FAAAAI4 and Dr.
Bruce K. Tan, MD1, 1Department of Otolaryngology, Northwest-
ern University Feinberg School of Medicine, Chicago, IL,
2
Northwestern University, Chicago, IL, 3Department of Medicine,
Division of Allergy-Immunology, Northwestern University Fein-
berg School of Medicine, Chicago, IL, 4Division of Allergy-Im-
munology, Department of Medicine, Northwestern University
Feinberg School of Medicine, Chicago, IL
817 Oncostatin M Is Elevated In Chronic Rhinosinusitis and De-
creases Barrier Function In Human Airway Epithelium
Ms. Kathryn L. Pothoven1,2, Mr. James Norton, MS2, Dr. Christo-
pher Ocampo, MD, PhD2, Ms. Lydia Suh, BSc2, Mr. Roderick
Carter, BSc2, Dr. Kathryn E. Hulse, PhD3, Dr. Sudarshan Seshadri,
PhD2, Dr. Bruce K. Tan, MD4, Dr. Rakesh Chandra, MD3, Dr. Anju
T. Peters, MD, FAAAAI2, Ms. Kathleen E. Harris, BSc2, Dr. David
Conley, MD4, Dr. Leslie C. Grammer, MD, FAAAAI2, Dr. Robert
C. Kern, MD4 and Dr. Robert P. Schleimer, PhD FAAAAI5, 1Dris-
kill Graduate Program, Northwestern University, Chicago, IL, 2De-
partment of Medicine, Division of Allergy-Immunology,
Northwestern University Feinberg School of Medicine, Chicago,
IL, 3Northwestern University, Chicago, IL, 4Department of Otolar-
yngology, Northwestern University Feinberg School of Medicine,
Chicago, IL, 5Division of Allergy-Immunology, Department of
Medicine, Northwestern University Feinberg School of Medicine,
Chicago, IL
818 Immunologic Changes During Chronic Rhinosinusitis Exacer-
bations Compared To Controls
Dr. Shefali Samant, MD1, Dr. Matthew A. Rank, MD, FAAAAI2,
Dr. John B. Hagan, MD, FAAAAI1, Dr. Erin OBrien1, Dr. Devyani
Lal3 and Hirohito Kita, MD1, 1Mayo Clinic, Rochester, MN, 2Mayo
Clinic, Scottsdale, AZ, 3Mayo Clinic, Phoenix, AZ
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Mechanisms of Asthma and Allergic Disease
4607
Monday, March 3rd, 2014, 2:00 PM - 3:15 PM
819 Allergen Challenge Increases Peripheral Blood CD84+ ILC2 In
Allergic Rhinitis
Dr. David R. Scott, M.D.1, Dr. Taylor A. Doherty, MD, FAAAAI2,
Naseem Khorram, M.S.3, Mr. Sean Lund, B.S.3, Ms. Rachel Baum,
B.S.3, Jinny Chang, M.D.4, Mr. Peter Rosenthal, B.S.3, Mr. Andrew
Beppu, B.S.3, Dr. Marina Miller, MD, PhD3 and Dr. David H.
Broide, MB ChB FAAAAI5, 1Allergy and Asthma Center of West-
ern Colorado, 2Medicine, University of California, San Diego, San
Diego, CA, 3University of California San Diego, 4Sansum Clinic,
Santa Barbara, 5Department of Medicine, San Diego, CA
820 Asthma Susceptibility Due To Environmental Programming Of
Innate Immunity In Utero
Sarah Manners, BS1, Rafeul Alam, MD, PhD, FAAAAI1, David
A. Schwartz, MD2 and Magdalena M. Gorska, MD, PhD1, 1Na-
tional Jewish Health, Denver, CO, 2University of Colorado Denver
School of Medicine, Aurora, CO
821 Rhinovirus Challenge Augments Allergen Responsiveness In
Basophils Of Atopic Asthmatics
Rachana Agrawal, PhD, Thomas A.E. Platts-Mills, MD, PhD,
FAAAAI, Peter W. Heymann, MD and Judith A. Woodfolk,
MBChB, PhD, FAAAAI, University of Virginia, Charlottesville,
VA
822 Der p 3 Allergen Activated Ano-1 Channel On Afferent Airway
Nerves Regulates Th2 Cell Responses
Mr. Mayur Patil, MS1, Dr. Edward G. Brooks, MD2, Dr. Michael
Henry, D.D.S, PhD1 and Dr. Armen Akopian, PhD3, 1UTHSCSA,
san antonio, TX, 2Univ. Texas Health Science Center San Antonio,
San Antonio, TX, 3UTHSCSA, San Antonio, TX
823 Increased Serum Soluble ST2 In Asthmatic Children and Re-
current Early Wheezers
Prof. Hai Lee Chung, MD, PhD and Dr. Eun Joo Lee, Catholic
University of Taegu, Taegu, South Korea
The Impact of Environmental Factors on Asthma
5201
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
824 High Traffic Pollution Exposure Is Significantly Associated
With Poorer Asthma-Related Quality Of Life In Older Asth-
matics
Dr. Jennifer A. Kannan1, Dr. David I. Bernstein, MD, FAAAAI2,
Ms. Cheryl Koff Bernstein, RN BSN CCRC3, Dr. Patrick Ryan,
PhD1,4, Dr. Jonathan A. Bernstein, MD, FAAAAI5, Dr. Manuel S.
Villareal, MD, FAAAAI1, Dr. Andrew M. Smith, MD, FAAAAI6,
Dr. Peter Lenz1 and Dr. Tolly Epstein, MD, MS7, 1University of
Cincinnati Medical Center, Cincinnati, OH, 2Bernstein Allergy
Group, Cincinnati, OH, 3Bernstein Clinical Research Center,
LLC, Cincinnati, OH, 4Cincinnati Childrens Hospital Medical
Center, Cincinnati, OH, 5Division of Immunology Allergy & Rheu-
matology, University of Cincinnati Medical Center, Cincinnati, OH,
6
3255 Eden Ave., HPB 350, University of Cincinnati Medical Cen-
ter, Cincinnati, OH, 7Allergy Partners of Central Indiana, Indianap-
olis, IN
825 Effect Of Early Exposure To Traffic Related Air Pollution On
The Asthma Predictive Index and Asthma At Age 7
Dr. Priyal Amin, DO, University of Cincinnati, College of Medi-
cine, Cincinnati, OH, Afghanistan, Prof. Linda Levin, PhD, Univer-
sity of Cincinnati, Cincinnati, OH, Dr. Tolly Epstein, MD, MS,
Allergy Partners of Central Indiana, Indianapolis, IN, Dr. Patrick
Ryan, PhD, Cincinnati Childrens Hospital Medical Center,
Abstracts AB349
Cincinnati, OH and Dr. David I. Bernstein, MD, FAAAAI, Bern-
stein Allergy Group, Cincinnati, OH
826 Twins Increased Risk Of Asthma Compared To Singletons Is
Mediated By Gestational Age
Vilhelmina Ullemar1, Cecilia Lundholm, MSc1 and Prof. Catarina
Almqvist, MD, PhD1,2, 1Department of Medical Epidemiology and
Biostatistics, Karolinska Institutet, Stockholm, Sweden, 2Depart-
ment of Womens and Childrens Health, Astrid Lindgren Chil-
drens Hospital, Karolinska University Hospital, Stockholm,
Sweden
827 Viral Etiology Of Early Life Wheezing Illnesses Differentially
Predict Persistence Of Asthma In High-Risk Children
Dr. Frederick Rubner, MD1, Dr. Daniel J. Jackson, MD2, Mr. Mi-
chael D. Evans, MS1, Dr. James E. Gern, MD, FAAAAI1 and Dr.
Robert F. Lemanske Jr., MD, FAAAAI1, 1University of Wisconsin
School of Medicine and Public Health, Madison, WI, 2Pediatrics,
University of Wisconsin School of Medicine and Public Health,
Madison, WI
828 Prevalence and Severity Of Wheezing In The First Year Of Life
Among Infants With Low Birth Weight
Dr. Nathalia Barroso1, Dr. Leila Borges, MD1, Dr. Gustavo Wan-
dalsen, MD2, Dr. Elaine Prestes3, Prof. Herberto J. Chong Neto,
MD, PhD, FAAAAI4, Prof. Nelson A. Rosario, MD, PhD,
FAAAAI5, Dr. Ana Carolina Dela Bianca6, Dr. Carolina Aranda7,
Dr. Decio Medeiros6, Prof. Emanuel Sarinho, Prof. PHD8, Dr. Lil-
lian SANCHEZ LACERDA Moraes, MD, MSc9, Dr. Javier Mal-
lol10 and Prof. Dirceu Sole, MD, PhD7, 1UNIFESP, Brazil,
2
UNIFESP, Sao Paulo, Brazil, 3State University of Para, 4Federal
University of Parana, Brazil, 5Federal University of Parana, Curi-
tiba, Brazil, 6Federal University of Pernambuco, 7Federal Univer-
sity of Sao Paulo, Sao Paulo, Brazil, 8UFPE, Universidade
Federal de Pernambuco, Brazil, 9Federal University of Mato
Grosso, 10University of Santiago de Chile
829 Interactive Exploration Of Microbial Exposure, Asthma and
Allergy Using a Web-Based Tool
Jeremy Wildfire1, Mr. Agustin Calatroni, MA MS1, Dr. Susan V.
Lynch, PhD2, Dr. Homer A. Boushey Jr., MD, FAAAAI3, Dr. Kei
Fujimura, PhD2, Dr. Marcus Rauch, PhD2 and Henry Lynn1,
1
Rho, Inc., Chapel Hill, NC, 2University of California San Fran-
cisco, San Francisco, CA, 3University of California, San Francisco,
San Francisco, CA
830 Is There a Link Between Uncontrolled Asthma and Sensitiza-
tion To Inhalant Allergens?
Dr. Majdy Qutub, MD1, Prof. Emad Abdulkader Koshak, MD1,
Dr. Moufag Tayeb2 and Dr. Mohammed Alrabea1, 1King Abdul
Aziz University, Jeddah, Saudi Arabia, 2King Abdul Aziz Univer-
sity, Rabigh, Saudi Arabia
831 Allergy To Cockroaches: The Need For Standardization Of Ex-
tracts For Clinical Practice
Prof. Emanuel Sarinho, Prof. PHD, UFPE, Universidade Federal
de Pernambuco, Brazil, Dr. Filipe Wanick Sarinho, Md, IMIP, Bra-
zil, Prof. Dirceu Sole, MD, PhD, Federal University of Sao Paulo,
Sao Paulo, Brazil and Dr. Isabela Londres, UFPE
TUESDAY
832 Are Environmental Factors More Important Than Genetic Fac-
tors In Incident Asthma?
Dr. Efren L. Rael, MD, FAAAAI, Allergy/Immunology, Penn
State University College of Medicine, Hershey, PA
833 Sensitization In Patients With Allergic Difficult-To-Control
Asthma
Dr. Rosana C. Agondi, MD, PhD1, Dr. Bruna Saliba2, Dr. Carla
Bisaccioni, MD1, Dr. Marcelo Vivolo Aun, MD1, Prof. Jorge Kalil,
MD, PhD1 and Prof. Pedro Giavina-Bianchi, MD, PhD,
FAAAAI1,3, 1Clinical Immunology and Allergy Division, Univer-
sity of Sao Paulo, Sao Paulo, Brazil, 2Clinical Immunology and
Allergy Division University of S^ao Paulo, Brazil, Brazil, 3Clinical
Imunnology and Allergy Division, University of Sao Paulo,
Boston, MA
139
 AB350 Abstracts
834 Sensitization To Inhalant Allergens In Elderly Patients Of An
Allergy Clinic In Rio De Janeiro
Dr. Jose Luiz M. Rios, MD, PhD, Dr. Luiz C G Arcanjo, Fabio C
Kuschnir, Joao BM Rios and Ana CS Oliveira, Policlinica Geral do
Rio de Janeiro, Brazil
Diagnostic Modalities of Asthma
5202
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
835 The Evaluation Of Airway Obstruction By Lung Sound Analy-
sis In The Patients With Asthma
Dr. Terufumi Shimoda, MD1, Dr. Yukio Nagasaka, MD2, Dr.
Yasushi Obase, MD3, Dr. Michiyoshi Imaoka, MD1, Dr. Tomoaki
Iwanaga, MD1 and Dr. Reiko T. Kishikawa, MD1, 1Fukuoka Na-
tional Hospital, Fukuoka, Japan, 2Kyoto Respiratory Center,
Otowa Hospital, Kyoto, Japan, 3Kawasaki Medical School, Kur-
ashiki, Japan
836 IOS Is Useful In Younger Children Who Cannot Perform Spi-
rometry
Dr. Shintaro Okazaki, MD, Hiroki Murai, MD, PhD, Hisako Hay-
ashi, MD, Akiko Kawakita, MD, Motoko Yasutomi, MD, PhD, Mit-
sufumi Mayumi, MD, PhD and Yusei Ohshima, MD, PhD,
University of Fukui, Fukui, Japan
837 The Association Of Spirometry With Asthma Control and
Asthma Morbidity In Inner City Schoolchildren With Asthma
Dr. Watcharoot Kanchongkittiphon, MD, PhD1,2, Dr. Jonathan
M. Gaffin, MD, MMSc1,3, Dr. Lianne S. Kopel, MD1,3, Dr. William
J. Sheehan, MD1,3, Dr. Sachin N. Baxi, MD1,3, Dr. Perdita Permaul,
MD3,4, Dr. Diane R. Gold, MD, MPH3,5 and Dr. Wanda Phipatana-
kul, MD, MS, FAAAAI1,3, 1Boston Childrens Hospital, Boston,
MA, 2Ramathibodi Hospital, Mahidol University, Bangkok, Thai-
land, 3Harvard Medical School, Boston, MA, 4Division of Pediatric
Allergy/Immunology, Massachusetts General Hospital, Boston,
MA, 5Channing Laboratory, Brigham and Womens Hospital, Bos-
ton, MA
838 Impulse Oscillometry (IOS) Is Easier Than Spirometry For
Older Asthmatic and Non-Asthmatic Subjects
Dr. Michael C. Balduzzi, MD1, Dr. Adam Updegraff, DO1, Dr.
Kerri Rawson, Ph.D, MS2, Dr. Brice Taylor, MD3, Dr. Monroe J.
King, DO, FAAAAI4 and Dr. Richard F. Lockey, MD5, 1University
of South Florida, Tampa, FL, 2Washington University School of
Medicine of Medicine, St. Louis,, MO, 3Morsani College of Med-
icine, University of South FLorida, Tampa, FL, 4University of
South Florida, Largo, FL, 5Division of Allergy and Immunology,
Department of Internal Medicine, University of South Florida Mor-
sani College of Medicine and James A. Haley Veterans Affairs
Hospital, Tampa, FL
839 Clinical and Spirometric Characteristics In Young Patients
TUESDAY
With Intermittent and Mild Persistent Atopic Asthma
Prof. Vera Tsybulkina1, Dr. N. Kurmaeva1, Dr. Nicolai Tsybulkin1
and Prof. Lawrence M. DuBuske, MD, FAAAAI2, 1Kazan State
Medical University, Russia, 2George Washington University School
of Medicine, DC
840 Clinical Impact Of Molecular Diagnosis In Dog Allergy
Prof. Joaquin Sastre, MD, PhD, FAAAAI and Ms. Silvia Uriarte,
Fundacion Jimenez Daz, Madrid, Spain
841 Asthma As An Unrecognized Risk Factor For Herpes Zoster In
Adults: A Population-Based Case-Control Study
Dr. Young J. Juhn, MD, MPH1, Dr. Hyo-Jin Kwon1, Dr. Duk Won
Bang1, Dr. Eun Na Kim1, Peter Wollan2 and Mr. Brian Lahr2, 1Dept
of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester,
MN, 2Mayo Clinic, Rochester, MN
140
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
842 The Simplified Method For Eucapnic Voluntary Hyperventila-
tion (EVH) May Be Useful To Discriminate Between Hyperven-
tilation and Gastroesophageal Reflux Disease (GERD) Induced
Bronchospasm
Dr. Richard R. Rosenthal, MD1,2, Mr. Harvey Howe, BS3 and Mr.
Paul Knause, BS3, 1Allergy and Clinical Immunology, Johns Hop-
kins University School of Medicine, Baltimore, MD, 2INOVA Fair-
fax Hospital, Fairfax, VA, 3Self
843 A Young Adult With Increased Variability Of FEF25-75 Rela-
tive To FEV1 Post-Bronchial Thermoplasty
Dr. Amy M. CaJacob, MD1, Dr. Mark H. Kalenian, MD,
FAAAAI2, Dr. John T. Anderson, MD1, Dr. Mark Dransfield3 and
Dr. Jennifer Trevor, MD1, 1University of Alabama at Birmingham,
Birmingham, AL, 2Alabama Asthma and Allergy, PC, Dothan, AL,
3
University of Alabama School of Medicine, AL
Basic and Translational Immunology
5203
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
844 Interferon-~a-Release Assay Prevents Unnecessary Tuberculosis
Therapy In Individuals With Positive Tuberculin Skin Test
Dr. Vered Schichter-konfino and Prof. Elias Toubi, Bnai-Zion
Medical Center, Rappaport Faculty of Medicine, Technion, Haifa-
Israel, Haifa, Israel
845 High Dimensional Single-Cell Mass Cytometry Demonstrates
Conserved Human Toll-Like-Receptor Activation Signatures
Dr. Elena Hsieh, MD1, Dr. William OGorman, PhD2, Ms. Erica
Savig2, Dr. Pier Federico Gherardini, PhD2, Prof. Mark Davis,
PhD2 and Prof. Garry Nolan, PhD2, 1Allergy and Immunology,
Stanford University, Stanford, CA, 2Stanford University-Microbiol-
ogy & Immunology, Stanford, CA
846 Heterogenous Nuclear Ribonucleoprotein L Regulates The Se-
lective Expression Of Glucocorticoid Receptor Translational
Isoforms In HL-60 Cells
Newton Li, MD, Ingrid Bender and Nick Lu, PhD, Division of Al-
lergy and Immunology, Department of Medicine, Northwestern
University Feinberg School of Medicine, Chicago, IL
847 Dendrimeric Silica Particle Composites For IgE Determination
In Patients Allergic To Amoxicillin
Dr. Maria Isabel Monta~ nez, PhD1,2, Dr. Yolanda Vida, PhD2,3, Dr.
Adriana Ariza, PhD , Dr. Cristobalina Mayorga, PhD1, Dr. Maria
1
Salas, MD, PhD4, Dr. Miguel Blanca, MD, PhD4, Dr. Ezequiel
Perez-Inestrosa, PhD2,3 and Dr. Mara Jose Torres, MD, PhD4, 1Re-
search Laboratory for Allergic Diseases, Hospital Regional Universi-
tario de Malaga - FIMABIS-IBIMA, Malaga, Spain, 2Andalusian
Centre for Nanomedicine and Biotechnology, BIONAND, Malaga,
Spain, 3Organic Chemistry, University of Malaga, Malaga, Spain,
4
Allergy Service, Carlos Haya Hospital, Malaga, Spain
848 Murine Splenocytes From Peanut-Allergic Donors Transfer
Peanut Allergy To Nave, Irradiated Recipient Mice
Daphne Moutsoglou, BS and Dr. Stephen C. Dreskin, MD, PhD,
FAAAAI, University of Colorado Denver, Aurora, CO
849 Alternaria-Induced Releases Of IL-1 Alpha and IL-1 Beta
From Airway Epithelial Cells Through Syk and PKC Signaling
Pathways
Dr. Yonghan Sun, gil hospital, Incheon, South Korea and Hirohito
Kita, MD, Mayo Clinic Rochester, Rochester, MN
850 Transmaternal Bisphenol A Exposure Accelerates Diabetes
Type 1 Development In NOD Mice
Dr. Johanna Bodin1, Dr. Anette Kocbach Blling1, Dr. Rune
Becher1, Prof. Frieke Kuper2, Prof. Martinus Lovik1 and Dr. Unni
C. Nygaard1, 1Norwegian Institute of Public Health, Oslo, Norway,
2
TNO Nutrition and Food Research, Zeist, Netherlands
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
851 Soluble Type I Interferon Receptor 2 and Soluble Type II Inter-
feron Receptor 1 Are Independently Regulated
Thomas B. Lavoie, PhD, Taher Fatakdawala, Xiao-Hong Lin, Mi-
chael Skawinski, Jonathan Ferriera and Tara Stauffer, PBL Assay
Science
852 Regulation Of Innate Immune Recognition Of Viral Infection
By Epigallocatechin Gallate
Dr. Christina L. Nance, PhD1,2, Melinda Mata, B.S.1, Ashley
McMullen, B.S.1, Sean McMaster, B.S.1 and Dr. William T.
Shearer, MD, PhD, FAAAAI1,2, 1Baylor College of Medicine,
2
Texas Childrens Hospital
853 Prostaglandin I2 (PGI2) Inhibits IL-33-Induced Type 2 Cyto-
kine Responses By Mouse CD4 T Cells
Weisong Zhou, PhD1, Jian Zhang, MS1, Kasia Goleniewska2 and
Dr. R. Stokes Peebles Jr., MD, FAAAAI1, 1Division of Allergy, Pul-
monary and Critical Care Medicine, Vanderbilt University School
of Medicine, Nashville, TN, 2Allergy, Pulmonary, and Critical
Care Medicine, Department of Medicine, Vanderbilt University
School of Medicine, Nashville, TN
854 Sequencing Of The ST2 Gene and The Identification Of Genetic
Determinants Of Serum Total ST2 Levels: Strong Evidence For
Replication Across European and African American Popula-
tions
Dr. Rasika A. Mathias, ScD1, Lili Huang, MPH1, Dr. Candelaria I.
Vergara, MD, PhD1, Dr. Li Gao, MD, PhD1, Nicholas M. Rafaels1,
Joseph Potee1, Mrs. Monica Campbell1, Dr. Hironori Masuko, MD,
PhD1, Justyna Fert-Bober2, James Snider3, Dr. Margaret Taub,
PhD4, Dr. Ingo Ruczinski, PhD4, Dr. Terri H Beaty, PhD4, Dr. Jen-
nifer E. Van Eyk, PhD2 and Dr. Kathleen C. Barnes, PhD
FAAAAI1, 1Division of Allergy and Clinical Immunology, Depart-
ment of Medicine, Johns Hopkins University, Baltimore, MD, 2De-
partment of Medicine, Johns Hopkins University, Baltimore, MD,
3
Critical Diagnostics, San Diego, CA, 4Johns Hopkins Bloomberg
School of Public Health, Johns Hopkins University, Baltimore, MD
855 Salmonella Typhimurium Impedes Innate Immunity With a
Mast Cell-Suppressing Tyrosine Phosphatase Sptp
Hae Woong Choi1, Rhea Brooking, PhD1, Subham Neupane1,
Chul-Jin Lee, PhD1, Dr. Edward Miao, MD, PhD2, Dr. Herman F.
Staats, PhD1 and Dr. Soman N. Abraham, PhD1,3, 1Duke University
Medical Center, Durham, NC, 2University of North Carolina at
Chapel Hill, Chapel Hill, 3Duke-National University of Singapore,
Singapore, Singapore
856 The Role Of Semaphorin 7A In Alternatively Activation Of
Macrophages
Prof. Hye-Ryun Kang, MD, PhD, Dr. Hyun Seung Lee, PhD, Ms.
Da Eun Park, B.A., Ms. Ji Won Lee, B.A., Prof. Woo-Jung Song,
MD, Prof. Heung-Woo Park, MD, PhD, Prof. Sang Heon Cho,
MD, PhD and Prof. Kyung-Up Min, MD, PhD, Department of In-
ternal Medicine, Seoul National University College of Medicine,
Seoul, South Korea
857 Immune Perturbation In Patients With Tgfbeta Pathway De-
fects
Dr. Dat Q. Tran, MD1, Mrs. Ellen Regalado2 and Dr. Dianna Mile-
wicz2, 1University of Texas Medical School at Houston, Houston,
TX, 2UTHealth
858 Chemokine Receptors On Regulatory T Cell Surface, Surrogate
Markers For Intracellular Th1 and Th2 Cytokines
Mr. Satoru Watanabe1,2, Dr. Yoshiyuki Yamada1 and Prof. Hiro-
kazu Murakami2, 1Gunma Childrens Medical Center, Shibukawa,
Gunma, Japan, 2Gunma University Faculty of Medicine School of
Health Science, Maebashi, Gunma, Japan
859 IL-4 Signaling Attenuates gd T Cell IL-17A Protein Expression
Melissa T. Harintho, BS1, Dr. Dawn C. Newcomb Baker, PhD2, Jac-
queline-Yvonne Cephus, BS2, Kasia Goleniewska3 and Dr. R. Stokes
Peebles Jr., MD, FAAAAI2, 1Department of Pathology, Microbiology,
and Immunology, Vanderbilt University School of Medicine, Nash-
ville, TN, 2Division of Allergy, Pulmonary and Critical Care Medicine,
Abstracts AB351
Vanderbilt University School of Medicine, Nashville, TN, 3Allergy,
Pulmonary, and Critical Care Medicine, Department of Medicine, Van-
derbilt University School of Medicine, Nashville, TN
860 Influence Of Dietary Fiber On Cellular Immunity In Experi-
mental Vitamin Deficiency
Dr. Roman Khanferyan, MD, PhD1, Dr. E.N. Trushina2, O.K. Mus-
tafina3, V.M. Kodentzova2 and Prof. Lawrence M. DuBuske, MD,
FAAAAI4, 1Insitute of Nutrition, Russian Academy of medical Sci-
ences, Moscow, Russia, 2Insitute of Nutrition Russian Academy of Sci-
ences, Russia, 3Institute of Nutrition Russian Academy of Sciences,
Russia, 4George Washington University School of Medicine, DC
861 Evaluation Of Cytokine Levels In Patients With Active Pulmo-
nary Tuberculosis Their Household Contacts-A Follow Up
Study
Ms. Ramya Sivangala1, Ms. Meenakshi Ponnana1, Ms. Shruthi
Thada1, Mrs. Lavanya Joshi1, Dr. Vijayalakshmi Valluri1,2 and Dr.
Sumanlatha Gaddam1, 1Bhagwan mahavir medical research center,
Hyderabad, India, 2LEPRA IndiaBlue Peter Public Health & Re-
search Centre, Hyderabad, India
862 Semaphorin 4C Is An Intrinsic Regulator Of Cell-Cell Interac-
tion In Th2 Stimulated Memory-B-Cells
Ms. Marianne Beland1, Dr. Marylin Desjardins, MD1,2, Ms. Di
Xue3 and Dr. Bruce D. Mazer, MD, FAAAAI4,5, 1Meakins-Christie
Laboratories, Montreal, QC, Canada, 2Division of Allergy and Clin-
ical Immunology, Department of Paediatrics, McGill University
Health Centre, Montreal, QC, Canada, 3Mcgill university, Montreal,
QC, Canada, 4Montreal Childrens Hospital, Montreal, QC, Can-
ada, 5Meakins-Christie Laboratories, Research Institute - McGill
University Health Centre, Montreal, QC, Canada
Innate Immunity and Primary
Immunodeficiencies
5204
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
863 A Patient With a Novel Leukocyte Adhesion Deficiency and Py-
oderma Gangrenosum-Like Disease
Dr. Jared I. Darveaux, MD1, Dr. Anna Huttenlocher2, Dr. Daniel
Bennett3, Dr. Judith Smith3, Dr. Christine M. Seroogy, MD,
FAAAAI3 and Dr. James E. Gern, MD, FAAAAI4, 1University of Wi-
soconsin, Madison, WI, 2University of Wisconsin, Madison, Madi-
son, WI, 3University of Wisconsin, Madison, WI, 4University of
Wisconsin School of Medicine and Public Health, Madison, WI
864 Reduced Macrophages IL-12 Production After Stimulation By
BCG/INF-Gamma Suggestive Of Impaired INF-Gamma Path-
way Signalling In a Child With Disseminated Atypical Myco-
bacterial Infection and History Of Chemotherapy For
Langerhans Cell Histiocytosis
Dr. Eliska Furlong, MD, PhD, Dr. Richard K.S. Loh, MD,
FAAAAI, Dr. Grace Wooi Kee Gong, MD and Dr. Andrew
TUESDAY
McLean-Tooke, MBChB, Princess Margaret Hospital for Children,
Perth, Australia
865 Sporadic Case Of Chronic Mucocutaneous Candidiasis (CMC)
Due To a Gain-Of-Function Mutation In STAT1 In a 13 Year
Old Female
Dr. Aimee E. Baer Ellington, MD and Dr. Jennifer A. Shih, MD,
Emory University, Atlanta, GA
866 A Young Boy With a Novel, Autosomal-Dominant Signal Trans-
ducer and Activator Of Transcription 1 (STAT1) Hypermorphic
Mutation Presenting With Pneumocystis Jirovecii Pneumonia
(PJP), Chronic Mucocutaneous Candidiasis (CMC), and Com-
bined Immunodeficiency
Dr. Matthew C. Altman, MD1, Dr. David Hagin, MD1, Dr. David
Buchbinder, MD2, Dr. Suzanne Skoda-Smith, MD3, Dr. Hans D.
141
 AB352 Abstracts
Ochs, MD1 and Dr. Troy R. Torgerson, MD, PhD1, 1University of
Washington, Seattle, WA, 2Childrens of Orange County, 3Seattle
Childrens Hospital, Seattle, WA
867 Infections In Mannose-Binding Lectin Deficiency Patients
Dr. Mary K. Paul, MD1,2, Dr. Christopher Chang, MD, PhD,
FAAAAI2, Dr. Magee DeFelice, MD3, Dr. Gang Ye, PhD4 and
Dr. Sam Soundar, PhD5, 1Thomas Jefferson University Hospital,
Philadelphia, PA, 2Alfred I duPont Hospital for Children, Wilming-
ton, DE, 3Nemours/AI duPont Hospital for Children, Philadelphia,
PA, 4Nemours, Orlando, FL, 5Nemours
868 LRBA Causes Immunodeficiency and Autoimmunity By Dereg-
ulating NFkB-Mediated Multiple Immune Effectors Critical
For B Cell Activation
Dr. Jia-Wang Wang, PhD1, Mrs. Michelle A. Reiser, MS1, Mrs.
Kunyu Li, BS1, Ms. Eileen Rifkin1, Ms. Bangmei Wang1, Dr. Nar-
asaiah Kolliputi, PhD1 and Dr. Richard F. Lockey, MD1,2, 1Division
of Allergy and Immunology, Department of Internal Medicine, Uni-
versity of South Florida, Morsani College of Medicine, Tampa, FL,
2
James A. Haley Veterans Affairs Hospital, Tampa, FL
869 Giscelli Syndrome: A Case Treated With a Hematopoietic
Stems Cells From a Cord Blood
Dr. Marisol Rico-Arroyo, Instituto Mexicano del Seguro Social
870 Fungal Granuloma and Chronic Mucocutaneous Candidiasis
Due To Autosomal Dominant Gain Of Function STAT1 Mutation
Dr. Nauman Salim, MBBS , MD, University of South Florida,
Tampa, FL and Dr. Jennifer Leiding, MD, University of South Flor-
ida, St. Petersburg, FL
871 Impaired T-Independent IgM Responses Due To Irak-4-,
MyD88 Deficiency Or Splenectomy
Dr. Paul J. Maglione, MD, PhD1, Lin Radigan1, Sam Black1, Jes-
sica Overbey1, Dr. Emelia Bagiella1, Dr. Isabelle Meyts2, Prof.
Jean-Laurent Casanova, MD, PhD3,4, Dr. Capucine Picard, MD,
PhD3 and Dr. Charlotte Cunningham-Rundles, MD, PhD,
FAAAAI1, 1Mount Sinai Medical Center, New York, NY, 2Univer-
sity Hospitals Leuven, Belgium, 3Hopital Necker-Enfants Malades,
Paris, France, 4Rockefeller University, New York, NY
872 Intestinal Perforation and Non-Tuberculous Mycobacterial Per-
itonitis In a Patient With Interleukin-1 Receptor Associated Ki-
nase 4 Deficiency
Dr. Hana B. Niebur, MD, Dr. Nathan Tang, MD, FAAAAI and Dr.
Jennifer Leiding, MD, University of South Florida, St. Petersburg,
FL
873 Suspected Non-Infectious Prosthetic Valve Inflammatory Dehis-
cence In X-Linked Chronic Granulomatous Disease
Dr. Monica Bhagat, MD1, Dr. Joshua A. Steinberg, MD2, Dr.
Frank Silvestry, MD3, Dr. Lea Surrey, MD3, Dr. Andrea J. Apter,
MD MA MSc FAAAAI1, Dr. Patricia A. Takach, MD, FAAAAI1
and Dr. Benjamin P. Soule, MD1, 1University of Pennsylvania, Phil-
adelphia, PA, 2Medical College of Wisconsin, Milwaukee, WI,
3
UPENN, Philadelphia, PA
873A The Effects Of Anti-Seizure Medications On Patients With An-
tibody Deficiency Syndrome
Dr. Tatyana Gavrilova, MD and Dr. Harumi Jyonouchi, MD,
TUESDAY
Rutgers University of Medicine and Dentistry, Newark, NJ
Epidemiology and Risk Factors of Asthma
5205
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
874 Risk Factors Associated With The Development Of Asthma
and Allergic Rhinitis Among Adolescents Living In S~ao Paulo
Brazil
Dr. Fernanda Patini Furlan1, Dr. Djanira Andrade2, Danielli
Christinni Bichuete-Silva, MD3, Dr. Tessa Rachel Tranquilini
142
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Goncalves, MD3, Dr. In^es Camelo Nunes2 and Prof. Dirceu Sole,
MD, PhD3, 1Division of Allergy and Clinical Immunology, Dept
of Pediatrics, Escola Paulista de Medicina, Federal University of
S~ao Paulo, S~ao Paulo, Brazil, S~ao Paulo, Brazil, 2Universidade Fed-
eral de S~ao Paulo, S~ao Paulo, Brazil, 3Federal University of Sao
Paulo, Sao Paulo, Brazil
875 Atopic Associations In Asthmatic Patients Readmitted Within
30 Days To The Hospital
Dr. Larisa Buyantseva, MD, MS, Dr. Melissa Rossi, Prof. Jason
Liao, PhD and Dr. Timothy Craig, D.O., Penn State University, Her-
shey, PA
876 Pediatric Asthma Associated With Fungal Exposure
Dr. Cecilia Nguyen, MD1, Dr. Christina E. Ciaccio, MD,
FAAAAI2 and Dr. Charles Barnes, PhD2, 1Childrens Mercy Hospi-
tals and Clinics, 2Childrens Mercy Hospital, Kansas City, MO
877 Assessment Of Factors Associated With PPV23 Vaccine Uptake
Among Young Adults With Asthma In Olmsted County, MN
Maria J. Bachman, Medical Student1, Joshua Gauger, Medical
Student2, Dr. Chriss Derauf, MD3, Dr. Slavica Katusic, MD3, Jen
Rand-Weaver3, YuBin Choi3, Elizabeth Krusemark3 and Dr. Young
J. Juhn, MD, MPH3, 1Mayo Medical School, Rochester, MN,
2
Mayo Medical School, 3Dept of Pediatric and Adolescent Medi-
cine, Mayo Clinic, Rochester, MN
878 Clinical Effectiveness In Allergic Airway Disease Of Oriton IgE
Chemiphar TM: A Rapid Determination System Of Allergen-
Specific IgE
Dr. Tomoyuki Soma, MD1,2, Dr. Ai Masumoto2, Dr. Takehito Ko-
bayashi, MD2, Dr. Atsushi Kamijyo, MD2, Dr. Yoshitaka Uchida1,2,
Prof. Kouichi Hagiwara, MD1, Prof. Minoru Kanazawa, MD1 and
Prof. Makoto Nagata, MD1,2, 1Department of Respiratory Disease,
Saitama Medical University, Japan, 2Allergy Center, Saitama Med-
ical University, Japan
879 Gender Differentially Contributes To Airway Hyperresponsive-
ness In Adult Asthmatics
Dr. Jeong-Hee Choi, MD1, Dr. Cheol-Hong Kim, MD2, Prof. In-Gyu
Hyun, MD3, Dr. Joo-Hee Kim, MD4, Dr. Tae-Rim Shin, MD5 and Dr.
Sang-Myeon Park, MD5, 1Dept. of Pulmonology and Allergy, Hal-
lym University Dongtan Sacred Heart Hospital, Hwaseong, South
Korea, 2Dept. of pulmonology and Allergy, Hallym University Dong-
tan Sacred Heart Hospital, 3Hallym University Dongtan Sacred Heart
Hospital, 4Hallym University School of Medicine, Anyang, 5Hallym
University Kangnam Sacred Heart Hospital
880 Prevalence Of Sleep Disorders In Children With Asthma and
Its Association With The Level Of Control Of The Disease,
Smoking and Obesity
Dr. Lorena Rangel-Garza, MD1, Prof. Sandra N. Gonzalez-Diaz,
MD, PhD, FAAAAI1, Dr. Alejandra Macias-Weinmann, MD2, Prof.
Alfredo Arias-Cruz, MD, FAAAAI1, Dr. Maria Del Carmen Zarate-
Hernandez, MD3, Dr. Idalia V. Yanez-Perez, MD4 and Dr. Hilda
Hernandez-Sanchez, MD4, 1University Hospital Dr. Jose Eleuterio
Gonzalez, UANL, Monterrey, Mexico, 2Hospital Universitario
UANL, Monterrey, N.L., Mexico, 3University Hospital, Monterrey,
Mexico, 4Regional Center of Allergy and Clinical Immunology.
University Hospital Dr. Jose Eleuterio Gonzalez., Monterrey,
Mexico
881 Asthma and Allergic Diseases Of Preschool Children In Korea:
Findings From The Pilot Study For The Korean Surveillance
Survey For Childhood Asthma
Prof. Ji Tae Choung, MD, Korea Univ. Medical Center, Seoul,
Prof. Sungchul Seo, The Enviornmental Health Center for Asthma,
Korea University, Seoul, Dr. YongMin Cho, The environmental
health center for asthma, Dr. Young Yoo, MD, PhD, Department
of Pediatrics, College of Medicine, Korea University, Seoul, South
Korea; Department of Environmental Health Sciences, Mailman
School of Public Health, Columbia University, New York, NY
and Dr. Wonsuck Yoon, Department of Life Science and Biotech-
nology, Seoul, South Korea
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
882 Atopic Characteristics Of Patients With Paroxysmal Vocal
Cord Dysfunction
Casey Curtis, MD1,2, Meagan W. Shepherd, MD1,2, Gary Phillips,
M.A.S.3 and Princess U. Ogbogu, MD, FAAAAI1,2, 1Wexner Med-
ical Center at the Ohio State University, Columbus, OH, 2Nation-
wide Childrens Hospital, Columbus, OH, 3Wexner Medical
Center at The Ohio State University, Columbus, OH
883 Relationship Of Allergen Sensitization and LUNG Function In
Adults Patients With Asthma In Allergy Clinic In Monterrey,
Mexico
Dr. Hilda Hernandez Sanchez, MD, Prof. Sandra N. Gonzalez-
Diaz, MD, PhD, FAAAAI, Prof. Alejandra Macias-Weinmann,
MD, Prof. Alfredo Arias-Cruz, MD, FAAAAI, Dr. Idalia Vanessa
Yanez-Perez, MD and Dr. Lorena Rangel-Garza, MD, University
Hospital Dr. Jose Eleuterio Gonzalez, UANL, Monterrey, Mexico
884 Targeting Patient Eduation: Correlating Fluctuating Pollen
Counts With Patient Online Inquiries Into Asthma and Allergic
Rhinitis
Dr. John M. Kern, D.O.1, Dr. Leonard Bielory, MD, FAAAAI2,3
and Mr. Spencer H. Luster3,4, 1Rutgers University - NJMS, ocean-
port, NJ, 2Robert Wood Johnson University Hospital, New Bruns-
wick, NJ, 3STARx Allergy and Asthma Center, Springfield, NJ,
4
University of Pennsylvania, Philadelphia, PA
Eosinophilic Gastrointestinal Diseases
5206
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
886 Elevated Exhaled Nitric Oxide Levels In Eosinophilic Esophagi-
tis Patients With and Without Atopy
Michael Kagen, M.D.1, Zainab Kagen, MD2, Prof. Steve L. Kagen,
MD, FAAAAI3 and Joe Zondlo, M.D.3, 1University of Tennessee
College of Medicine-Chattanooga, Chattanooga, TN, 2University
of Tennesee College of Medicine-Chattanooga, TN, 3Kagen Allergy
Clinic, Appleton, WI
887 Older Mice Intranasally Sensitized with Aspergillus Fumigatus
Develop Stronger Eosinophilic Esophageal Inflammation Com-
pared to Their Younger Counterparts
Dr. Antonella Cianferoni, MD, PhD1, Simona Barni, MD2, Cara
Smith, BS3, Valsamma Abraham, PhD4, Peng Guan, BS3, Dr. Fran-
cesca Saretta, MD5, Katie Ruyman, BS3, Hamid Bassiri, MD, PhD3,
Dr. Kim E. Nichols, MD6 and Dr. Jonathan M. Spergel, MD, PhD,
FAAAAI3,7, 1The Childrens Hospital of Philadelphia, 2University of
Florence Italy, Italy, 3Childrens Hospital of Philadelphia, 4University
of Pennsylvania, 5Ospedale Di Palmanova, ASS 5 Bassa Friulana, Pag-
nacco, Italy, 6CChildrens Hospital of Philadelphia, Philadelphia, PA,
7
The Childrens Hospital of Philadelphia, Philadelphia, PA
888 Cripto-1 Is Elevated In Pediatric Subjects With Eosinophilic
Esophagitis
Lisa Beppu, BS1, Arjun Andrew Anilkumar, BS2, Richard Kurten,
PhD3, Ranjan Dohil, MD4, David Broide, MB ChB2 and Seema
Sharma Aceves, MD, PhD, FAAAAI5, 1University of California
San Diego, Department of Pediatrics, Division of Allergy and Im-
munology, 2University of California San Diego, Department of
Medicine, Division of Allergy and Immunology, 3University of Ar-
kansas for Medical Sciences, Little Rock, AR, 4University of Cal-
ifornia San Diego, Rady Childrens Hospital, Department of
Pediatrics, Division of Gastroenterology, 5Pediatrics, University
of California San Diego, La Jolla, CA
889 Interleukin-33 and Thymic Stromal Lymphopoietin Are Prefer-
entially Elevated In The Sera Of Infants With Eosinophilic Gas-
troenteritis
Dr. Ichiro Nomura, MD, PhD1,2, Dr. Akio Matsuda, PhD2, Dr.
Tetsuo Shoda, MD2, Dr. Hideaki Morita, MD., PhD.2, Dr. Katsuhiro
Abstracts AB353
Arai, MD3, Dr. Hirotaka Shimizu, MD3, Dr. Yoshiyuki Yamada,
MD, PhD4, Dr. Yukihiro Ohya, MD, PhD1, Dr. Hirohisa Saito,
MD., PhD.2 and Dr. Kenji Matsumoto, MD, PhD2, 1Division of Al-
lergy, National Center for Child Health and Development, Tokyo,
Japan, 2Department of Allergy and Immunology, National Research
Institute for Child Health and Development, Tokyo, Japan, 3Divi-
sion of Gastroenterology, National Center for Child Health and De-
velopment, Tokyo, Japan, 4Gunma Childrens Medical Center,
Shibukawa, Japan
890 Comprehensive Analysis Of Offending Milk Protein Compo-
nents In Non-IgE-Mediated Gastrointestinal Food Allergies
By Antigen-Specific Lymphocyte Proliferation Test
Dr. Tetsuo Shoda, M.D., Dr. Ichiro Nomura, MD, PhD, Dr. Hide-
aki Morita, MD., PhD., Dr. Akio Matsuda, PhD, Dr. Hirohisa Saito,
MD., PhD. and Dr. Kenji Matsumoto, MD, PhD, Department of Al-
lergy and Immunology, National Research Institute for Child
Health and Development, Tokyo, Japan
891 Milk Elimination Diet For Treatment Of Eosinophilic Esopha-
gitis
Elizabeth Erwin, MD1, Patrice Kruszewski2, Dr. John Russo,
M.D.1 and Thomas A.E. Platts-Mills, MD, PhD, FAAAAI3, 1Na-
tionwide Childrens Hospital, Columbus, OH, 2Nationwide Chil-
drens Hospital, 3Division of Asthma, Allergy & Immunology,
University of Virginia Health System, Charlottesville, VA
892 Pediatric Eosinophilic Esophagitis: A 10-Year Experience At a
Canadian Tertiary Care Centre
Dr. Jason A. Ohayon, MD1, Perri R. Tutelman2, Dr. Jefferson
Terry, MD, PhD3 and Dr. Mary E. Sherlock, MB BCh, BAO,
PhD2, 1Department of Pediatrics, McMaster Childrens Hospital,
McMaster University, Hamilton, ON, Canada, 2Department of Pe-
diatric Gastroenterology and Nutrition, McMaster Childrens
Hospital, McMaster University, Hamilton, ON, Canada, 3Depart-
ment of Pathology and Molecular Medicine,
McMaster Childrens Hospital, McMaster University, Hamilton,
ON, Canada
893 Clinical Characteristics Of Eosinophilic Esophagitis - a Case
Series Of 30 Patients
Dr. Susana D. Piedade1, Dr. Diana Silva1,2, Dr. Bruno Sim~oes1,3,
^
Dr. Angela Gaspar1, Dr. Sandra Morgado4, Dr. Filipa Santos5 and
Dr. Mario Morais-Almeida1, 1Immunoallergy Department, Hospital
CUF Descobertas, Lisbon, Portugal, 2Immunoallergy Department,
Hospital S~ao Jo~ao, Oporto, Portugal, 3Pediatrics Department, Hos-
pital Faro, Faro, Portugal, 4Gastroenterology Unit, Hospital CUF
Descobertas, Lisbon, Portugal, 5Pediatrics Department, Hospital
CUF Descobertas, Lisbon, Portugal
894 Characteristics Of Eosinophilic Esophagitis Among Children
Living In Rural, Southern United States
Ms. Erin OBrien1,2, Dr. Troy Gibbons, MD1,2, Dr. Amy M. Scur-
lock, MD3, Dr. Jennifer Olivier, MD1,2, Mallikarjuna Rettiganti,
PhD1,2, Maria Melguizo Castro1,2, Ms. Peggy L. Chandler,
APN1,2, Audrey Fendley, RD2, Dr. Helen Casteel, MD1,2, Dr. Mar-
yelle VonLanthen, MD1,2, Dr. Stephen Fiedorek, MD1,2, Dr. Tamara
T. Perry, MD1,2, Stacie M. Jones, MD3,4 and Dr. Robbie D. Pesek1,2,
TUESDAY
1
University of Arkansas for Medical Sciences, Little Rock, AR,
2
Arkansas Childrens Hospital, Little Rock, AR, 3University of Ar-
kansas for Medical Sciences and Arkansas Childrens Hospital, Lit-
tle Rock, AR, 4Arkansas Childrens Hospital Research Institute,
Little Rock, AR
895 Failure To Thrive In a Pediatric Cohort With Eosinophilic
Esophagitis
Dr. Brenda Paquet, MD, FRCPC1, Dr. Philippe Begin, MD, MSc
FRCPC1, Louis P. Paradis, MD FRCPC FAAAAI2, Dr. Eric Drouin,
MD FRCPC1 and Anne M. Des Roches, MD FRCPC FAAAAI2,
1
Centre Hospitalier Universitaire Ste-Justine, Montreal, QC, Can-
ada, 2Centre Hospitalier Universitaire Sainte-Justine, Montreal,
QC, Canada
143
 AB354 Abstracts
896 Eosinophilic Esophagitis In The Puerto Rican Pediatric Popula-
tion
Dr. Carmen M. Pimentel, MD, Dr. Angel M. Rivera, MD, Dr. Iona
K. Malinow, MD, Dr. Cristina J. Ramos, MD, Dr. Anardi Agosto-
Mujica, MD, Dr. Rita Diaz, MD and Dr. Sylvette Nazario, MD,
University of Puerto Rico School of Medicine, San Juan, PR
897 Challenges With Measurement Of IgE Antibodies To Minor
Components In Food Allergy: Eosinophilic Esophagitis, Peanut
Allergy, and Delayed Anaphylaxis To Mammalian Meat
Anubha Tripathi, MD1, Lisa J. Workman, BA1, Scott Commins,
MD, PhD1, Barrett Barnes, MD2, Prof. Robert G. Hamilton, PhD
D.ABMLI FAAAAI3, Thomas A.E. Platts-Mills, MD, PhD,
FAAAAI1 and Elizabeth Erwin, MD4, 1Division of Asthma, Allergy
& Immunology, University of Virginia Health System, Charlottes-
ville, VA, 2Division of Pediatric Gastroenterology, University of
Virginia Health System, Charlottesville, VA, 3Johns Hopkins Uni-
versity School of Medicine, Baltimore, MD, 4Nationwide Chil-
drens Hospital, Columbus, OH
898 Serum IgE To Allergen Components In Patients With Eosino-
philic Esophagitis
Maria Slack, MD1, Princess U. Ogbogu, MD, FAAAAI2, Anubha
Tripathi, MD3, Lisa J. Workman, BA3, Thomas A.E. Platts-Mills,
MD, PhD, FAAAAI3 and Elizabeth Erwin, MD4, 1Nationwide Chil-
drens Hospital, Columbus, OH, 2Wexner Medical Center at the
Ohio State University, Columbus, OH, 3Division of Asthma, Al-
lergy & Immunology, University of Virginia Health System, Char-
lottesville, VA, 4Nationwide Childrens Hospital
899 Eosinophilic Gastroenteritis Due To Egg Allergy Presenting As
Acute Pancreatitis
Dr. Kevin Tse, MD, UCSD and Dr. Sandra C. Christiansen, MD,
FAAAAI, Southern CA Permanente Med Grp, San Diego, CA
900 Patient Ratings Of Various Eosinophilic Esophagitis Treatment
Options
Dr. Samantha K. Lin, MD, Dr. Neelu Kalra, MD and Dr. Gisoo Ghaf-
fari, MD, FAAAAI, Penn State Hershey Medical Center, Hershey, PA
901 Eosinophilic Esophagitis and Serum Eotaxin-3 Levels: A Non-
Invasive Method To Monitor Disease Activity
Dr. Cristina Jimenez-Aponte1, Dr. Jose Torres-Silva1, Dr. Eric
Gonzalez-Hernandez1, Dr. Liza Gonzalez-Benitez1, Dr. Mairim
Wiscovich-Torres1, Dr. Carlos Camacho1 and Dr. Vylma Velaz-
quez, MD2, 1Hospital Episcopal San Lucas-Ponce, 2Hospital Epis-
copal San Lucas, Ponce, PR
902 Evaluation Of Antigenic Triggers and Etiologies In Eosinophilic
Esophagitis: A Single Center Experience
Dr. Tanvi Patel, University of Florida, Gainesville, FL and Dr. Sa-
rah Glover, University of Florida at Gainesville, Gainesville, FL
903 Eosinophilic Esophagitis and Selective IgA Deficiency. A New
Combined Disorder
Dr. Eric Gonzalez Hernandez1, Dr. Vylma Velazquez, MD2, Dr.
Carlos Camacho3 and Dr. Sheila Capre1, 1Hospital Episcopal San
Lucas, 2Hospital Episcopal San Lucas, Ponce, PR, 3Hospital Epis-
copal San Lucas-Ponce
TUESDAY
Drug Allergy
5207
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
904 Cephalosporin Cross-Reactivity In Skin Test
Dr. Jong-Myung Lee, MD1,2 and Dr. Min-Hye Kim1,3, 1Regional
Pharmacovigilance Center, Kyungpook National University Hospi-
tal, Daegu, South Korea, 2Department of Internal Medicine, Kyung-
pook National University School of Medicine, Daegu, South Korea,
3
Department of Internal Medicine,Kyungpook National University
School of Medicine, Daegu, South Korea
144
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
905 Rituxan Hypersensitivity and Management
Dr. Johnson T. Wong, MD, FAAAAI1, Dr. Aleena Banerji, MD1,
Dr. Timothy P. Lax, MD2, Dr. Aidan Long, MD, FAAAAI1, Dr. Mi-
chael T. Wilson, MD, PhD1 and Dr. Caroline Sokol, MD, PhD3,
1
Division of Rheumatology, Allergy, and Immunology, Department
of Medicine, Massachusetts General Hospital, Harvard Medical
School, Boston, MA, 2Division of Rheumatology, Allergy, and Im-
munology, Department of Medicine, Massachusetts General Hospi-
tal, Harvard Medical School, Boston, MA, Boston, MA,
3
Massachusetts General Hospital
906 Diagnostic Evaluation Of Hypersensitivity Reactions To Beta-
lactam Antibiotics In A Large Population Of Children
Dr. Maria J Torres, MD, PhD1, Dr. Maria Angeles Zambonino2,
Dr. Jose Luis Corzo, MD3, Dr. Candelaria Mu~noz3, Dr. Gloria Re-
quena3, Dr. Adriana Ariza, PhD4, Dr. Cristobalina Mayorga, PhD5,
Dr. Antonio Urda3 and Dr. Miguel Blanca, MD, PhD1, 1Allergy Ser-
vice, Carlos Haya Hospital, Malaga, Spain, 2Allergy Service, Car-
los Haya Hospital, Malaga, Spain, Malaga, Spain, 3Pediatric
Service, Carlos Haya Hospital, Malaga, Spain, 4Research Labora-
tory for Allergic Diseases, Hospital Regional Universitario de Ma-
laga - FIMABIS-IBIMA, Malaga, Spain, 5Research Laboratory for
Allergic Diseases, Hospital Regional Universitario de Malaga -
IBIMA, Malaga, Spain
907 Clinical Presentation and Outcomes Of Children Undergoing
Evaluation For Drug Allergy
Dara Mairiang, MD, Dr. Wiparat Manuyakorn, MD, Wasu Kam-
chaisatian, MD, Soamarat Vilaiyuk, MD and Suwat Benjaponpitak,
MD, Division of Pediatric Allergy/Immunology/Rheumatology,
Department of Pediatrics, Faculty of Medicine Ramathibodi Hospi-
tal, Mahidol University, Bangkok, Thailand
908 Analysis Of Drug Hypersensitivity Reactions In A Large Serie
Of Children
Dr. Maria Angeles Zambonino1, Dr. Candelaria Mu~noz2, Dr. Jose
Luis Corzo, MD2, Dr. Gloria Requena2, Dr. Adriana Ariza, PhD3,
Dr. Cristobalina Mayorga, PhD3, Dr. Antonio Urda2, Dr. Miguel
Blanca, MD, PhD1 and Dr. Maria J Torres, MD, PhD1, 1Allergy Ser-
vice, Carlos Haya Hospital, Malaga, Spain, 2Pediatric Service, Car-
los Haya Hospital, Malaga, Spain, 3Research Laboratory for
Allergic Diseases, Hospital Regional Universitario de Malaga - FI-
MABIS-IBIMA, Malaga, Spain
909 Assessing IgE-Mediated Reactions In Children Presenting To
An Allergy Clinic With a Suspected Antibiotic Allergy
Mr. Christopher Mill, BSc1, Dr. Marie-Noel Primeau, MD2, Dr.
Christine Lejtenyi, MD3, Dr. Elaine J. Medoff3, Ms. Nofar Kimchi4
and Dr. Moshe Ben-Shoshan, MD, MSc5,6, 1Division of Clinical
Epidemiology, Department of Medicine, McGill University Health
Centre, Montreal, QC, Canada, 2McGill University Health Center,
Montreal, QC, Canada, 3Montreal Childrens Hospital, Montreal,
QC, Canada, 4Technion American Medical Students Program, Is-
rael, 5Division of Paediatric Allergy and Clinical Immunology, De-
partment of Paediatrics, McGill University Health Center,
Montreal, QC, Canada, 6Montreal Childrens Hospital, Montreal,
Canada
910 Hypersensitivity Drug Reactions (HDR) In Latin America. Sim-
ilarities and Differences Between Children and Adults
Dr. Ricardo Cardona-Villa, MD1, Dr. Edgardo J. Jares, MD2, Dr.
Maximiliano Gomez3, Dr. Luis Felipe C. Ensina, MD4, Dr. Mario
Sanchez-Borges, MD, FAAAAI5, Dr. Alfredo Arias Cruz6, Dr. Car-
los Serrano7, Dr. Mabel Noemi Cuello, MD8, Ivan Cherrez9, Dr.
Andrea Zanacchi10, Prof. Alicia De Falco11, Dr. Silvana Monsell2,
Dr. Adolfo Salvatierra12, Dr. Susana Barayazarra10, Dr. Susana
Diez-Zuloaga1, Dr. Blanca Maria Morfin-Maciel, MD13, Dr. Paola
Toche Pinaud14, Dr. Sandra Gonzalez Daz6 and Dr. Juan F. Schuhl,
MD, FAAAAI15, 1Universidad de Antioquia, Medellin, Colombia,
2
C.M.P. SA, Buenos Aires, Argentina, 3Hospital San Bernardo,
Salta, Argentina, 4Universidade Federal de S~ao Paulo, S~ao Paulo,
Brazil, 5Clinica El Avila, 6a transversal Altamira, piso 8,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
consultorio 803, Caracas., Caracas, Venezuela, 6Hospital Universi-
tario, Monterrey, Mexico, 7Fundacion Valle del Lili, Cali, Colom-
bia, 8Consultorios San Juan, San Juan, Argentina, 9Respiralab -
Hospital Kennedy, Guayaquil, Ecuador, 10Nuevo Hospital San Ro-
que, C ordoba, Argentina, 11Universidad Nacional de La Plata, La
Plata, Argentina, 12Fundair, San Luis, Argentina, 13Hospital Mocel,
Mexico City, Mexico, 14Clnica Las Condes, Santiago, Chile,
15
British Hospital, Montevideo, Uruguay
911 Copy Number Variations In ALOX5 and PTGER1 Genes Are
Associated With Susceptibility To AERD and Mnsaid-UA
Mrs. Maria Del Carmen Plaza Seron, Bsc.1, Dr. Pedro Ayuso Par-
ejo, PhD1, Dr. Natalia Blanca-Lopez, MD, PhD1, Dr. Inmaculada
Do~ na, MD, PhD2, Dr. Jose A Cornejo-Garcia, PhD3, Dr. Mara
Jose Torres, MD, PhD2, Dr. Javier Fernandez4, Dr. Jose Julio La-
guna, MD, PhD5, Veronique Godineau3, Ms. Miriam Osorio6,
Mrs. Luisa Galindo, RN2, Dr. Gabriela Canto, MD, PhD1 and Dr.
Miguel Blanca, MD, PhD2, 1Allergy Service, Infanta Leonor Hos-
pital, Madrid, Spain, 2Allergy Service, Carlos Haya Hospital,
Malaga, Spain, 3Research Laboratory, Carlos Haya Hospital, Ma-
laga, Spain, 4UMH Alicante G.University Hospital - Allergy
Sect., Alicante, Spain, 5De La Cruz Roja Hospital, Madrid, Spain,
6
Research Laboratory, Carlos Haya Hospital-FIMABIS, Malaga,
Spain
912 Association Study Of Genes Involved In Mast Cell Activation
and Mnsaid-UA
Dr. Pedro Ayuso Parejo, PhD1, Mrs. Maria del Carmen Plaza-
Seron, Bsc1, Dr. Inmaculada Do~na, MD, PhD2, Dr. Natalia
Blanca-L opez, MD, PhD1, Dr. Jose A Cornejo-Garcia, PhD3, Dr.
Maria J Torres, MD, PhD2, Dr. Javier Fernandez4, Dr. Jose Julio La-
guna, MD, PhD5, Ms. Miriam Osorio6, Veronique Godineau3, Mrs.
Luisa Galindo, RN2, Dr. Cristobalina Mayorga, PhD3, Dr. Gabriela
Canto, MD, PhD1 and Dr. Miguel Blanca, MD, PhD2, 1Allergy Ser-
vice, Infanta Leonor Hospital, Madrid, Spain, 2Allergy Service,
Carlos Haya Hospital, Malaga, Spain, 3Research Laboratory, Carlos
Haya Hospital, Malaga, Spain, 4UMH Alicante G.University Hospi-
tal - Allergy Sect., Alicante, Spain, 5De La Cruz Roja Hospital, Ma-
drid, Spain, 6Research Laboratory, Carlos Haya Hospital-
FIMABIS, Malaga, Spain
913 Non-Steroidal Antiinflammatory Drugs (NSAIDs)-Induced
Acute Urticaria: A Genome-Wide Association Study In The
Spanish Population
Dr. Jose A Cornejo-Garcia, PhD1, Dr. Mike Lee2, Dr. Natalia
Blanca-L opez, MD, PhD3, Dr. Lieh-Bang Liou4, Dr. Chien-Hsiun
Chen5, Dr. Inmaculada Do~na, MD, PhD6, Veronique Godineau1,
Dr. Jose Julio Laguna7, Dr. F. Javier Fernandez, MD, PhD8,
Dr. Pedro Ayuso Parejo, PhD3, Mrs. Maria del Carmen Plaza-
Seron, Bsc3, Dr. Gabriela Canto, MD, PhD3 and Dr. Miguel
Blanca, MD, PhD6, 1Research Laboratory, Carlos Haya Hospital,
Malaga, Spain, 2Laboratory for International Alliance on Ge-
nomic Research, RIKEN Center for Integrative Medical Sciences,
Yokohama Kanagawa, Japan, 3Allergy Service, Infanta Leonor
Hospital, Madrid, Spain, 4Division of Rheumatology, Allergy
and Immunology, Chang Gung Memorial Hospital at Lin-kou,
Kwei-san, Tao-yuan, Taiwan, 5Institute of Biomedical Sciences,
Academia Sinica, Taipei, Taiwan, 6Allergy Service, Carlos
Haya Hospital, Malaga, Spain, 7Hospital De La Cruz Roja,, Ma-
drid, Spain, 8UMH Alicante G.University Hospital - Allergy
Sect., Alicante, Spain
914 Tolerance To COX-2 Inhibitors In Children With Multiple Hy-
persensitivity To Non- Steroidal Anti-Inflammatory Drugs
Dr. Jose Luis Corzo Higueras, MD1, Dr. Maria Angeles Zambo-
nino2, Dr. Candelaria Mu~noz1, Dr. Cristobalina Mayorga, PhD3,
Dr. Gloria Requena1, Dr. Antonio Urda1, Dr. Miguel Blanca, MD,
PhD4 and Dr. Maria J Torres, MD, PhD4, 1Pediatric Service, Carlos
Haya Hospital, Malaga, Spain, 2Allergy Service, Carlos Haya Hos-
pital, Malaga, Spain, Malaga, Spain, 3Research Laboratory for Al-
lergic Diseases, Hospital Regional Universitario de Malaga -
Abstracts AB355
FIMABIS-IBIMA, Malaga, Spain, 4Allergy Service, Carlos Haya
Hospital, Malaga, Spain
915 Aspirin Allergy In a High Risk VA Population and Potential
Benefit From Aspirin Desensitization
Bhavisha Patel, MD1,2, Joseph Karls2, Sandra Tompkins2, Dawn
Nyland2, Jo Ann Clough2, Jane Ludwig2 and Sameer K. Mathur,
MD, PhD, FAAAAI1,2, 1University of Wisconsin School of Medi-
cine and Public Health, Madison, WI, 2William S. Middleton Vet-
erans Hospital, Madison, WI
916 Novel Protocol For Successful Aspirin Desensitization In a Pa-
tient With Laryngeal Angioedema To Aspirin
Dr. Nikki Garg, MD, Dr. Pratik Patel, MD and Dr. Sindhura Bandi,
MD, Rush University Medical Center, Chicago, IL
917 Allergy To Beta-Lactams In Patients Consulting Allergology
Center Of The Antioquia University, Colombia
Dr. Elizabeth Lopez1, Dr. Kaddy Juliana Beltran1, Dr. Jorge San-
chez1 and Dr. Ricardo Cardona-Villa, MD2, 1Universidad de Anti-
oquia, Colombia, 2Universidad de Antioquia, Medellin, Colombia
918 Effect Of Penicillin Allergy On Outpatient Antibiotic Prescrip-
tions At VA Hospital
Mark Biagtan, MD1,2, Bryan Babler, BS Pharm RPh2, Sujani Ka-
kumanu, MD1,2 and Sameer K. Mathur, MD, PhD, FAAAAI1,2,
1
University of Wisconsin School of Medicine and Public Health,
Madison, WI, 2William S. Middleton Veterans Hospital, Madison,
WI
919 Value Of Clavulanic Acid In Basophil Activation Test For Eval-
uating Immediate Reactions To The Combination Amoxicillin-
Clavulanic Acid
Dr. Cristobalina Mayorga, PhD1, Dr. Adriana Ariza, PhD2, Dr. In-
maculada Do~na, MD, PhD3, Dr. Maria Angeles Zambonino3, Dr.
Maria Isabel Monta~nez, PhD1, Dr. Maria Salas, MD, PhD3, Ms.
Maria Dolores Ruiz3, Ms. Lidia Melendez, Lab. Tech.1, Mrs. Maria
D Ca~namero3, Dr. Miguel Blanca, MD, PhD3 and Dr. Maria J
Torres, MD, PhD3, 1Research Laboratory for Allergic Diseases,
Hospital Regional Universitario de Malaga - IBIMA, Malaga,
Spain, 2Research Laboratory for Allergic Diseases, Hospital Re-
gional Universitario de Malaga - FIMABIS-IBIMA, Malaga, Spain,
3
Allergy Service, Carlos Haya Hospital, Malaga, Spain
920 Persistence Of Penicillin Allergy Label Despite Documented
Tolerance
Matthew Feldman, MD and Dr. David A. Khan, MD, FAAAAI,
University Texas SW Medical Center, Dallas, TX
921 Allergy To Betalactams In Brazil: Placebo Effect Or Misdiagno-
sis?
Dr. Manoela Crespo-Magalh~aes1, Dr. Marcelo Vivolo Aun, MD1,
Dr. Roberta Almeida-Castro2, Dr. Marisa Rosimeire Ribeiro, MD3,
Dr. Laila Sabino Sabino Garro, MD, PhD3, Prof. Jorge Kalil, MD,
PhD1, Prof. Antonio Ablio Motta, MD, PhD3 and Prof. Pedro Gia-
vina-Bianchi, MD, PhD, FAAAAI1, 1Clinical Immunology and Al-
lergy Division, University of Sao Paulo, Sao Paulo, Brazil, 2Clinical
Imunnology and Allergy Division, University of Sao Paulo, Sao
paulo, Brazil, 3Clinical Imunnology and Allergy Division, Univer-
sity of Sao Paulo, Sao Paulo, Brazil
TUESDAY
922 Prevalence Of Reported Penicillin Allergy In a Tertiary Allergy
Immunology Clinic In The United States
Dr. Sara M. May, MD, Andrew Nickels, MD and Dr. Michael
Park, MD, FAAAAI, Mayo Clinic, Rochester, MN
923 Successful Oxacillin Desensitization With Interrupted Dosing
Versus Continuous Infusion
Dr. Melinda Braskett, MD, UCLA Med Center - Mattel Childrens
Hospital, Los Angeles, CA and Dr. Monika Saeedian, MD, Univer-
sity of California, Los Angeles
924 IgE To Penicillins With Different Specificities Can Be Identified
By a Multiepitope Macromolecule. Bihaptenic Penicillin Struc-
tures and IgE Specificities
Dr. Adriana Ariza, PhD1, Dr. Cristobalina Mayorga, PhD2, Dr.
Maria Jose Jose Torres, MD, PhD3, Dr. Maria Isabel Monta~nez,
145
 AB356 Abstracts
PhD2, Dr. Ezequiel Perez-Inestrosa, PhD4, Dr. Antonio Jesus Ruiz-
Sanchez, PhD5, Dr. Rosa Mara Rodrguez-Gueant, MD, PhD6, Dr.
Taha Fernandez, PhD7, Dr. Jean Louis Gueant6 and Dr. Miguel
Blanca, MD, PhD3, 1Research Laboratory for Allergic Diseases,
Hospital Regional Universitario de Malaga - FIMABIS-IBIMA,
Malaga, Spain, 2Research Laboratory for Allergic Diseases, Hospi-
tal Regional Universitario de Malaga - IBIMA, Malaga, Spain, 3Al-
lergy Service, Carlos Haya Hospital, Malaga, Spain, 4Andalusian
Centre for Nanomedicine and Biotechnology, BIONAND, Malaga,
Spain, 5Andalusian Centre for Nanomedicine and Biotechnology-
BIONAND, and Department of Organic Chemistry, Faculty of Sci-
ences, University of Malaga, Malaga, Spain, 6Laboratory of Cellu-
lar and Molecular Pathology in Nutrition, Faculty of Medicine,
University of Nancy, Nancy, France, 7Research Laboratory - FIMA-
BIS Foundation, Malaga, Spain
925 Cephalosporin Prescribing Habits In Penicillin Allergic Pa-
tients
Dr. Shannon D. Tiedeken, MD, Nemours, A.I. duPont Hospital for
Children, Conshohocken, PA, Dr. Christopher Chang, MD, PhD,
FAAAAI, Alfred I duPont Hospital for Children, Wilmington, DE
and Dr. Gang Ye, PhD, Nemours, Orlando, FL
926 Radiocontrast Media Reactions: Rectifying Misconceptions
About Shellfish Allergy and Iodine Allergy In An Academic
Institution
Dr. Amber N. Pepper, MD1, Dr. Emma Westermann-Clark, MD,
MA1, Dr. Neetu Talreja, MD2 and Dr. Richard F. Lockey, MD2,
1
Department of Internal Medicine, University of South Florida
Morsani College of Medicine, Tampa, FL, 2Division of Allergy
and Immunology, Department of Internal Medicine, University of
South Florida Morsani College of Medicine and James A. Haley
Veterans Affairs Hospital, Tampa, FL
927 Clinical Predictors Of The Outcome Of Medication Challenges
Dr. Farah Khan, DO1,2, Dr. Christopher Chang, MD, PhD,
FAAAAI2 and Dr. Gang Ye, PhD3, 1Thomas Jefferson University
Hospital, Philadelphia, PA, 2Alfred I duPont Hospital for Children,
Wilmington, DE, 3Nemours, Orlando, FL
928 Clinical Experience With Oxaliplatin (O) Desensitization (OD):
A Case Series
Dr. Adam Updegraff, DO, University of South Florida, Tampa, FL
and Dr. Devang R. Doshi, MD, FAAAAI, William Beaumont Hos-
pital, Royal Oak, MI
929 Clinical Value Of a Negative Skin Test To Contrast Radio Me-
dia (CR) In Further Exposures
Dr. Luiz C G Arcanjo, Dr. Tania M T Goncalves, Flavia C Loyola,
Matheus Ribeiro, Alfredo Alves Neto, Tatiana L Carvalho and Dr.
Jose Luiz M. Rios, MD, PhD, Policlinica Geral do Rio de Janeiro, Brazil
930 Perioperative Reactions: Are They So Infrequent?
Dr. Claude M. Urbain, MD1, Dr. Alberto Lafuente, MD2, Dr. Gra-
cia Javaloyes, MD, PhD1, Dr. Paula Cabrera-Freitag, MD, PhD3, Dr.
Juan De La Borbolla Moran, MD4, Dr. M Jose Goikoetxea, Ph.D,
MD4, Dr. Rafael Moncada, MD2, Dr. Maria L Sanz, MD, PhD1,
Dr. Marta M. Ferrer, MD, PhD, FAAAAI4 and Dr. Gabriel Gasta-
minza, MD, PhD1, 1Department of Allergy, Clinica Universidad
TUESDAY
de Navarra, Spain, 2Department of Anesthesia, Clinica Universidad
de Navarra, Spain, 3Department of Allergy, Clinica Universidad de
Navarra, Spain, Pamplona, Spain, 4Department of Allergy, Clinica
Universidad de Navarra, Pamplona, Spain
931 Causes Of Perioperative Allergic Reactions Our Experience
In The Last Two Years
Dr. Lourdes Arochena, MD, Mrs. Deborah Hughes, RN, Dr.
Bryan N. Fernandes, MD, Dr. Marina Tsoumani, MD and Dr. Sus-
ana F. Marinho, MD, PhD, University Hospital of South Manches-
ter NHS Foundation Trust, Manchester, United Kingdom
932 Perianesthetic Hypersensitivity Reactions In Latin America
Dr. Edgardo J. Jares, MD1, Dr. Ricardo Cardona-Villa, MD2, Prof.
Carlos E. Baena-Cagnani, MD3, Dr. Luis Felipe C. Ensina, MD4, Dr.
Juan C. Ivancevich, MD5, Dr. Alfredo Arias Cruz6, Dr. Maximiliano
146
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Gomez7, Dr. Mabel Noemi Cuello, MD8, Dr. Paola Toche Pinaud9,
Dr. Blanca Maria Morfin-Maciel, MD10, Prof. Alicia De Falco11,
Dr. Adolfo Salvatierra12, Dr. Juan F. Schuhl, MD, FAAAAI13, Dr.
Ivan Oswaldo Tinoco Moran, MD14, Dr. Susana Barayazarra15, Dr.
Andrea Zanacchi15, Prof. Ada Castillo Mendez16 and Dr. Mario
Sanchez-Borges, MD, FAAAAI17, 1C.M.P. SA, Buenos Aires, Ar-
gentina, 2Universidad de Antioquia, Medellin, Colombia, 3Catholic
University of Cordoba, Cordoba, Argentina, 4Universidade Federal
de S~ao Paulo, S~ao Paulo, Brazil, 5Division of Immunology, Medical
School, Universidad del Salvador, Buenos Aires. Head of the Divi-
sion of Allergy and Immunology, Clnica Santa Isabel, Buenos Aires,
Argentina, 6Hospital Universitario, Monterrey, Mexico, 7Hospital
San Bernardo, Salta, Argentina, 8Consultorios San Juan, San Juan,
Argentina, 9Clnica Las Condes, Santiago, Chile, 10Hospital Mocel,
Mexico City, Mexico, 11Universidad Nacional de La Plata, La Plata,
Argentina, 12Fundair, San Luis, Argentina, 13British Hospital, Mon-
tevideo, Uruguay, 14Clinica Torre Medica Para La Familia, Machala,
Ecuador, 15Nuevo Hospital San Roque, Cordoba, Argentina, 16Hos-
pital Clinico Quirurugico Dr. Salvador Allende, La Habana, Cuba,
17
Clinica El Avila, 6a transversal Altamira, piso 8, consultorio 803,
Caracas., Caracas, Venezuela
933 A New In Vitro Flow Cytometry Method For Detection Of De-
layed Drug Sensitization To Local Anesthetics. The Lymphocyte
Activation Test (LAT)
Dr. Massimo Caruso, PhD, FIT AAAAI, Dr. Rosalia Emma, Dr.
Raffaella Lizzio and Prof. Riccardo Polosa, MD, PhD, FAAAAI,
University of Catania, Catania, Italy
934 Utility Of ICD-9-CM Codes For Identification Of Allergic Drug
Reactions
Dr. Rebecca Saff, MD, PhD1, Dr. Carlos Camargo Jr., MD,
DrPH1,2, Dr. Susan A. Rudders, MD3, Dr. Sunday Clark, MPH,
ScD4, Dr. Aidan Long, MD, FAAAAI1 and Dr. Aleena Banerji,
MD1, 1Division of Rheumatology, Allergy, and Immunology, De-
partment of Medicine, Massachusetts General Hospital, Harvard
Medical School, Boston, MA, 2Department of Emergency Medi-
cine, Massachusetts General Hospital, Harvard Medical School,
Boston, MA, 3Division of Asthma and Allergy, Department of Pe-
diatrics, Rhode Island Hospital, Alpert School of Medicine at
Brown University, Providence, RI, 4Department of Emergency
Medicine, Weill Cornell Medical College, New York, NY
935 Vancomycin Use and Vancomycin Resistant Enterococcus Are
Increased In Patients With Reported Penicillin Allergy
Dr. Vinitha Reddy, MD, Penn State Hershey Medical Center, Her-
shey, PA and Dr. Faoud T. Ishmael, MD, PhD, FAAAAI, The Penn-
sylvania State University College of Medicine, Hershey, PA
936 Detection Of Causative Drugs Using Measurement Of Inter-
feron-~awith Quantiferon-TB Gold Test In Severe Drug Allergy:
Preliminary Study
Dr. Young-Hee Nam, MD1, Dr. Kyeong-Hee Kim, MD2, Dr. Dong
Sub Jeon, MD3, Dr. Hye-Won Lee, MD3, Hee-Joo Nam4 and Mr.
Soo-Keol Lee, MD5, 1Department of Internal Medicine, College
of Medicine, Dong-A University, Busan, South Korea, 2Department
of Laboratory Medicine, College of Medicine, Dong-A University,
South Korea, 3Department of Internal Medicine, College of Medi-
cine, Dong-A University, South Korea, 4Department of Pharmacy,
Dong-A University Hospital, South Korea, 5Dong-A University
College of Medicine, Pusan, South Korea
937 Successful Rapid Desensitization To Glatiramer Acetate In a
Patient With Multiple Sclerosis
Dr. Ekaterini I. Syrigou, PhD, Department of Allergy, Sotiria
General Hospital, Athens, Greece, Dr. Photis Psarros, Department
of Allergy, Athens Naval Hospital ,Greece and Prof. Konstantinos
Syrigos, Athens School of Medicine, Greece
938 Hypersensitivity Reaction To Denosumab In Patient With Oste-
oporosis: Desensitization Methodology
Dr. Antonio Foncubierta, MD, PhD MPH1,2, Dr. Diego Gutierrez,
MD, PhD3, Dr. Fermin Medina, MD3, Dr. Salvador Fernandez, MD,
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
PhD4, Dr. Maria Jose Fernandez3 and Dr. Juan Luis Anguita, MD5,
1
Servicio Andaluz de Salud: UGC Joaquin Pece, 2Universidad de
Cadiz, 3Hospital Universitario Puerta del Mar, 4Hospital Universi-
tario Carlos Haya, 5Complejo Hospitalario de Jaen
939 Patient With Severe Primary Igf-I Deficit and Mecasermine Al-
lergy: Desensitization Methodology
Dr. Diego Gutierrez, MD, PhD1, Dr. Antonio Foncubierta, MD,
PhD MPH2,3, Alfonso M. Lechuga, MD, PhD1, Dr. Maria Jose Fer-
nandez1, Juan Luis Anguita,MD, PhD4 and Jose Luis Lechuga, MD,
PhD3, 1Hospital Universitario Puerta del Mar, 2Servicio Andaluz de
Salud: UGC Joaquin Pece, 3Universidad de Cadiz, 4Complejo Hos-
pitalario de Jaen
940 Drug-Induced Anaphylaxis: A Five Year Study In a Third Level
Spanish Hospital
Maria Elisa Caralli, M.D.1, Sarah Micozzi, M.D.1, Abdonias
Rodrguez Gamboa, M.D.1, Dasha Roa Medellin, M.D.1, Alberto
Alvarez-Perea, MD2 and Manuel De Barrio, M.D.1, 1Hospital Gen-
eral Universitario Gregorio Mara~ n
on, Allergy Department, Madrid,
Spain, 2Hospital Materno Infantil Gregorio Mara~ n
on, Pediatric Al-
lergy Department, Madrid, Spain
941 Quinolones Allergy In An Allergy Unit. Our Experience In 3
Years
Dr. Tamara Fernandez-Teruel1, Gabriela Zambrano, M.D.2, Celia
Pinto1, Beatriz Ameiro, M.D.2, Dr. Roberto Pelta1 and Manuel De
Barrio1, 1Department of Allergy, Gregorio Mara~ n
on University
Hospital, Madrid, Spain., 2Department of Allergy, Gregorio
Mara~non University Hospital, Madrid, Spain., Spain
942 A Successful Desensitization Protocol For Filgrastim
Brett Hronek, MD, Washington University School of Medicine, St
Louis, MO and Anthony Kulczycki Jr., MD, FAAAAI, Washington
University School of Medicine, St. Louis, MO
943 Are Proton Pump Inhibitors(PPI) Naive? A Case Of Drug Re-
action With Eosinophilia and Systemic Symptom (DRESS) Sec-
ondary To Lansoprazole
Dr. Aditya Uppalapati, MD1, Dr. Sindhura Gogineni, MD1, Dr.
Sravantika Koneru, MBBS2 and Dr. Ghassan Kamel, MD3, 1St.
Louis University, St. Louis, MO, 2Mamata Medical College, 3Saint
Louis University, St. Louis
944 Increased Of PCT and CRP In Dress Syndrome By Two Drugs
Structurally Unrelated Molecular In The Same Pacient
Dr. Rafael A. Perez Arango, Ram on and Cajal University
Hospital,Spain
945 Non-Immediate Skin Reactions Due To Antibiotics
Gabriela Zambrano, M.D.1, Dr. Tamara Fernandez2, Beatriz
Ameiro, M.D.1, Celia Pinto3, Alberto Alvarez-Perea, MD4 and
Manuel De Barrio, M.D.5, 1Department of Allergy, Gregorio
Mara~non University Hospital, Madrid, Spain., Spain, 2Hospital gen-
non, Madrid, Spain, 3Department of
eral universitario gregorio mara~
Allergy, Gregorio Mara~ n
on University Hospital, Madrid, Spain.,
4
Hospital Materno Infantil Gregorio Mara~ n
on, Pediatric Allergy
Department, Madrid, Spain, 5Hospital General Universitario Gre-
gorio Mara~non, Allergy Department, Madrid, Spain
946 Multiple Drug Hypersensitivity Syndrome In Our Allergy Ser-
vice
Dr. Inmaculada Do~ na, MD, PhD, Dr. Maria J Torres, MD, PhD,
Dr. Paloma Campo, MD, PhD, Dr. Francisca G omez, MD, PhD,
Dr. Maria Salas, MD, PhD, Ms. Maria Dolores Ruiz, Ms. Maria
Auxiliadora Guerrero and Dr. Miguel Blanca, MD, PhD, Allergy
Service, Carlos Haya Hospital, Malaga, Spain
947 Desensitization To Anakinra. Case Report
Dr. Miriam Zamora Verduga, Dr. Maria Alicia Urena Tavera,
Mrs. Denisse Angel Pereira, Dr. Ricardo Madrigal-Burgaleta,
MD, Dr. Pilar Berges-Gimeno, PhD and Dr. Emilio Alvarez-Cuesta,
MD, PhD, Ramon y Cajal University Hospital, Madrid, Spain
948 Vitamin K Anaphylaxis Confirmed With Skin Test
Dr. Min-Hye Kim1,2 and Dr. Jong-Myung Lee, MD1,3, 1Regional
Pharmacovigilance Center, Kyungpook National University
Abstracts AB357
Hospital, Daegu, South Korea, 2Department of Internal Medicine,-
Kyungpook National University School of Medicine, Daegu, South
Korea, 3Department of Internal Medicine, Kyungpook National
University School of Medicine, Daegu, South Korea
949 Successful Rapid Induction Of Temporary Drug Tolerance To
Colistimethate Sodium
Dr. Colleen S. Adkins, MD, University of Alabama, Birmingham,
AL and Dr. James Ryan Bonner, MD, FAAAAI, Alabama Allergy
& Asthma Center, Birmingham, AL
950 Anaphylactic Reaction During a Folfox Scheme Administration
Secondary To Calcium Folinate: A Case Report
Dr. Maria Alicia Urena Tavera, MD1, Dr. Miriam Zamora Ver-
duga1, Mrs. Denisse Angel Pereira2, Dr. Ricardo Madrigal-Burga-
leta, MD1, Dr. Pilar Berges, MD. PhD.1 and Dr. Emilio Alvarez-
Cuesta1, 1Ramon y Cajal University Hospital, Spain, 2Ramon y Ca-
jal University Hospital, Madrid, Spain
951 Dual Hypersensitivity To Oxaliplatin Revealed Following Rapid
Drug Desensitization: A History Of Anaphylaxis and New-Onset
Hemolytic Anemia
Dr. Jared Silver, MD, PhD1, Dr. Timothy Kyin, MD1 and Dr. Ma-
riana C. Castells, MD, PhD, FAAAAI2, 1Brigham and Womens
Hospital, Boston, MA, 2Division of Rheumatology, Allergy and Im-
munology, Department of Medicine, Brigham and Womens Hospi-
tal, Harvard Medical School, Boston, MA
952 Oupatient Lenalidomide Desensitization For Delayed Hyper-
sensitivity Reactions In 5 Patients With Multiple Myeloma
Dr. Min Jung Lee, MD1, Dr. Paige G. Wickner, MD2, Dr. Robert
Schlossman, MD3, Dr. Paul Richardson, MD3, Dr. Jacob Laubach,
MD3 and Dr. Mariana C. Castells, MD, PhD, FAAAAI4, 1Brigham
& Womens Hospital, Boston, MA, 2Brigham & Womens Hospital,
Chestnut Hill, MA, 3Dana Farber Cancer Institute, Boston, MA,
4
Division of Rheumatology, Allergy and Immunology, Department
of Medicine, Brigham and Womens Hospital, Harvard Medical
School, Boston, MA
953 An Atypical Case Of Drug Reaction With Eosinophilia and Sys-
temic Symptoms (DRESS) With Well-Formed Non-Necrotizing
Granulomas On Bone Marrow Biopsy
Dr. Katie Miro, MD, Rutgers- New Jersey Medical School, New-
ark, NJ and Dr. Eugenio Capitle, MD, Rutgers-New Jersey Medical
School, Newark, NJ
954 Anaphylactic Reaction To Bacitracin Zinc Topical Antibiotic
Ointment: A Case Report
Dr. Jake D. Lenington, MD, Oregon Health and Science Univer-
sity, Portland, OR, Dr. David R. Scott, MD, Allergy and Asthma
Center of Western Colorado and Dr. Anthony Montanaro, MD,
FAAAAI, Oregon Health Science University, Portland, OR
Ocular Allergy
5208
TUESDAY
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
956 Ocular Surface Disease Index (OSDI) and Pollen Counts (PC)
Mr. Spencer H. Luster, STARx Allergy and Asthma Center, Spring-
field, NJ; University of Pennsylvania, Philadelphia, PA and Dr. Leo-
nard Bielory, MD, FAAAAI, Rutgers University, New Brunswick,
NJ; Robert Wood Johnson University Hospital, New Brunswick, NJ
957 Efficacy and Safety Of a New Olopatadine Hydrochloride,
0.77% Ophthalmic Formulation In Patients With Allergic Con-
junctivitis Using The Conjunctival Allergen Challenge (CAC)
Model (NCT01479374)
Gail Torkildsen, Andover Eye Associates, Andover, MA, Thomas
Macejko, Apex Eye, Fairfield, OH, Abhijit Narvekar, Alcon Labo-
ratories, Inc., Fort Worth, TX and Mark Bergmann, Apex Eye, Cin-
cinnati, OH
147
 AB358 Abstracts
958 Cytokine Secretion Profiles In The Tears Of Patients With
Chronic Allergic Conjunctivitis
Dr. Naoko Okada1, Dr. Hiroshi Fujishima2, Dr. Kazumi Fukagawa3,
Dr. Akio Matsuda, PhD1, Dr. Hirohisa Saito, MD., PhD.1 and Dr.
Kenji Matsumoto, MD, PhD1, 1Department of Allergy and Immunol-
ogy, National Research Institute for Child Health and Development,
Tokyo, Japan, 2Department of Ophthalmology, Tsurumi University,
3
Department of Ophthalmology, Keio University School of Medicine
959 Severity and Frequency Of Allergic Conjunctivitis Symptoms
Dr. Milton M. Hom, OD FAAO, Private Practice, Azusa, CA, Dr.
Dominick Opitz, OD FAAO, Illinois College of Optometry, Chi-
cago, IL, Dr. Justin Kwan, OD FAAO, Marshall B. Ketchum Uni-
versity, Fullerton, CA and Dr. Leonard Bielory, MD, FAAAAI,
Robert Wood Johnson University Hospital, New Brunswick, NJ;
Rutgers University, New Brunswick, NJ
960 Ocular Symptoms Are Proportionally More Bothersome In
Subjects With More Symptoms Of Cat Allergic Rhinoconjunc-
tivitis
Dr. Peter Creticos, Associate Professor of Medicine; Johns Hop-
kins School of Medicine, Johns Hopkins School of Medicine; Di-
vision of Allergy & Clinical Immunology, Crownsville, MD, Dr.
Stephen Durham, co-author, Imperial College, London, Dr. Mar-
garet Maclennan, co-author, InVentiv Health and Dr. Rod Hafner,
PhD, Circassia Ltd, Oxford, United Kingdom
961 Alcaftadine 0.25% Versus Olopatadine 0.2% In Prevention Of
Ocular Itching In Allergic Conjunctivitis
Eugene B. McLaurin, MD, FACS1, Nicholas P. Marsico, MD,
FACS2, Joseph B. Ciolino, MD3, Linda Villanueva, COT4, Julia
M. Williams, MA, BS4 and David A. Hollander, MD, MBA4, 1Total
Eye Care P.A., Memphis, TN, 2East West Eye Institute, Los An-
geles, CA, 3Massachusetts Eye & Ear Infirmary, Harvard Medical
School, Boston, MA, 4Allergan, Inc., Irvine, CA
962 Cetirizine Significantly Relieves Ocular Allergy Symptoms In
Subjects With Seasonal Allergic Rhinitis
Dr. Mitesh Patel, PharmD1, Dr. Eduardo Urdaneta, MD1, Ms.
Kathleen B. Franklin, BSN, RN2, Ms. Xiaoyan Tian, MS3, Dr. Mei-
Miau Wu, Dr PH4 and Ms. Qiong Du, MS3, 1McNeil Consumer
Healthcare, Fort Washington, PA, 2Franklin Consultants, LLC., Phoe-
nixville, PA, 3Johnson & Johnson Consumer Products, China, Shang-
hai, China, 4J & J Consumer Products, US, Morris Plains, NJ
963 Cetirizine Effectively Relieves Both Ocular Allergy Symptoms
and Nasal Allergy Symptoms In Subjects With Seasonal Aller-
gic Rhinitis
Dr. Eduardo Urdaneta, MD1, Ms. Xiaoyan Tian, MS2, Dr. Mei-
Miau Wu, Dr PH3, Ms. Qiong Du, MS2, Ms. Kathleen B. Franklin,
BSN, RN4 and Dr. Mitesh Patel, PharmD1, 1McNeil Consumer
Healthcare, Fort Washington, PA, 2Johnson & Johnson Consumer
Products, China, Shanghai, China, 3J & J Consumer Products, US,
Morris Plains, NJ, 4Franklin Consultants, LLC., Phoenixville, PA
964 Automated Evaluation Of Conjunctival Provocation Tests
Mr. Torsten Sehlinger1, Mr. Jaron Zuberbier2, Dr. Oliver Kueh-
lert1, Mr. Frank Goergen1, Prof. Torsten Zuberbier3 and Prof.
Karl-Christian Bergmann3, 1Bluestone Technology GmbH, Woerr-
TUESDAY
stadt, Germany, 2Evangelic High-School Kleinmachnow, Germany,
3
Allergy-Centre-Charite, Berlin, Germany
Allergen Immunotherapy
5209
Tuesday, March 4th, 2014, 9:45 AM - 10:45 AM
965 Aeroallergen Immunotherapy Reduces Wheal Diameter In Sea-
sonal and Perennial Allergen Intradermal Skin Tests
Mr. Michael Hauk1, Mrs. Barbara A. McGoey, RN1, Mr. Parimal
Patel1, Mrs. Nicole Argenzia, RN1 and Dr. Mary Ann Michelis,
148
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
MD, FAAAAI2, 1Hackensack University Medical Center, Hacken-
sack, NJ, 2Center for Allergy, Asthma and Immune Disorders Hack-
ensack University Medical Center, Hackensack, NJ
966 Nanoparticle Engineering For The Immunomodulation Of Den-
dritic Cells
Dr. Xavier le Guevel, PhD1, Dr. Taha Fernandez, PhD2, Dr. Adri-
ana Ariza, PhD3, Dr. Maria Isabel Monta~ nez, PhD4, Dr. Maria J
Torres, MD, PhD5, Dr. Cristobalina Mayorga, PhD6 and Dr. Miguel
Blanca, MD, PhD5, 1Bionand, Campanillas, Spain, 2Research Lab-
oratory - FIMABIS Foundation, Malaga, Spain, 3Research Labora-
tory for Allergic Diseases, Hospital Regional Universitario de
Malaga - FIMABIS-IBIMA, Malaga, Spain, 4Research Laboratory
for Allergic Diseases, Hospital Regional Universitario de Malaga
- IBIMA, Malaga, Spain, 5Allergy Service, Carlos Haya Hospital,
Malaga, Spain, 6Research Laboratory, Carlos Haya Hospital-FIMA-
BIS, Malaga, Spain
967 Specific Immunotherapy Modified T-Cells Responses In a Span-
ish Population Of Der p Allergic Patients
Dr. Taha Fern andez, PhD1, Dr. Cristobalina Mayorga, PhD2, Dr.
Enrique Gomez3, Mrs. Rosa Garcia4, Mrs. Maria Isabel Sanchez5,
Dr. Ana Aranda, PhD2, Ms. Miriam Osorio2, Dr. Miguel Blanca,
MD, PhD6 and Dr. Mara Jose Torres, MD, PhD6, 1Research Labo-
ratory - FIMABIS Foundation, Malaga, Spain, 2Research Labora-
tory, Carlos Haya Hospital-FIMABIS, Malaga, Spain, 3Research
Laboratory of allergic diseases - Carlos Haya Hospital. FIMABIS
Foundation. Spain, Malaga, Spain, 4Allergy Service- Carlos Haya
hospital. Spain, Malaga, Spain, 5Allergy Service -Carlos Haya Hos-
pital. Spain, 6Allergy Service, Carlos Haya Hospital, Malaga, Spain
968 Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In Grass
Pollen-Associated Allergic Rhinoconjunctivitis: Pooled Analysis
By Level Of Pollen Exposure
Prof. Alain Didier, MD, PhD1, Prof. Ulrich Wahn, Prof Dr Med2,
Mr. Yann Amistani, Msc3 and Dr. Robert K. Zeldin, MD3, 1Larrey
Hospital, CHU, Toulouse, France, 2Charite, Berlin, Germany, 3Stal-
lergenes S.A., Antony, France
969 The Print Survey II: Perceptions Regarding Injection Number
and Technique
Dr. Michael S. Tankersley, MD, FAAAAI1, Dr. Sandy Yip, MD2
and Dr. Christopher A. Coop, MD2, 1Wilford Hall Ambulatory Sur-
gical Center, Joint Base San Antonio, San Antonio, TX, 2Wilford
Hall Ambulatory Surgical Center, Lackland AFB, TX
970 Allergy Immunotherapy: Characteristics and Risk Factors For
Recurrent Systemic Reactions
Kerline Ductan, MD1, Ewa Schafer, MD, FAAAAI2, Rachel E.
Story, MD2, Deeba Masood, MD2, Paul Detjen, MD3 and Ying
Zhou, PhD4, 1Department of Internal Medicine, University of Chi-
cago-NorthShore, Evanston, IL, 2Allergy and Immunology, North-
Shore University HealthSystem (NUHS), IL, 3Kenilworth Medical
Allergy & Immunology, Kenilworth, IL, 4Center for Clinical and
Research Informatics (CCRI), NUHS Research Institute, Evanston,
IL
971 Allergen Specific Immunotherapy In Monosensitized and Poly-
sensitized Allergic Rhinitis Patients
Dr. L. Maslova, Republican Scientific and Practical Center for Ep-
idemiology and Microbiology.Minsk, Belarus, Dr. Leonid P. Titov,
MD, PhD, Republican Scientific and Practical Center for Epidemi-
ology and Microbiology, Minsk, Belarus and Prof. Lawrence M.
DuBuske, MD, FAAAAI, George Washington University School
of Medicine, DC
972 The Effect Of The Ragweed Sublingual Immunotherapy Tablet
MK-3641 On Rescue Medication Use
Dr. Sandra M. Gawchik, DO, FAAAAI1, Dr. Peter S. Creticos, MD,
FAAAAI2, Kevin R. Murphy, MD3, Dr. Gary D. Berman, MD,
FAAAAI4, Dr. David I. Bernstein, MD, FAAAAI5, Dr. Jennifer Ma-
loney, MD6, Dr. Amarjot Kaur, PhD6 and Dr. Hendrik Nolte, MD,
PhD6, 1Asthma and Allergy Associates, Chester, PA, 2Johns Hopkins
Division of Allergy & Clinical Immunology, 3Boys Town National
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
Research Hospital, Boys Town, NE, 4Allergy and Asthma Special-
ists, Minneapolis, MN, 5Bernstein Allergy Group, Cincinnati, OH,
6
Merck, Whitehouse Station, NJ
Asthma Epidemiology and Risk Factors
5601
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
973 Exposures That Alter The Early Life Microbiome and The Risk
Of Asthma
Amy S. Feldman, MD1, Pingsheng Wu, PhD, MS1,2, Kristina
James, MD3, Tebeb Gebretsadik, MPH1,2, Gabriel Escobar,
MD4,5, Kecia N. Carroll, MD6, Sherian Xu Li, MS5, Eileen
Walsh, RN, MPH5, Ed Mitchel, MS1 and Dr. Tina V. Hartert,
MD, MPH7, 1Division of Allergy, Pulmonary, and Critical Care
Medicine, Department of Medicine, and Center for Asthma and
Environmental Sciences Research, Vanderbilt University School
of Medicine, Nashville, TN, 2Department of Biostatistics, Van-
derbilt University School of Medicine, Nashville, TN, 3Peninsula
Allergy & Asthma Center, Soldotna, AK, 4Kaiser Permanente
Medical Care Program, Oakland, CA, 5Kaiser Permanente North-
ern California, Perinatal Research Unit, Division of Research,
6 In Vesicle Trafficking From The Golgi To Cell Membrane and
Department of Pediatrics, Vanderbilt University School of Med-
icine, Nashville, TN, 7Vanderbilt University School of Medicine,
Nashville, TN
974 Ethnic Differences Of Reported Asthma Symptoms In Urban
School-Based Screening Surveys
Dr. Margee Louisias, MD1, Dr. Joanne Sordillo, ScD2,3, Mrs.
Chunxia Fu, MS4,5 and Dr. Wanda Phipatanakul, MD, MS,
FAAAAI3,6, 1Brigham and Womens Hospital, Boston, MA, 2Chan-
ning Division of Network Medicine, Brigham & Womens Hospital,
Harvard Medical School, Boston, MA, 3Harvard Medical School,
Boston, MA, 4Harvard School of Public Health, Boston, MA,
5 Dr. Meera Rani Gupta, M.D., Dr. Deepthi Kolli, PhD, Dr. Anto-
Channing Laboratory, Brigham and Womens Hospital, Boston,
MA, 6Boston Childrens Hospital, Boston, MA
975 Year One Daycare Attendance Predicts Asthma At Age Seven:
The Cincinnati Childhood Allergy and Air Pollution Study
(CCAAPS)
Dr. Gang Cheng, MD, PhD1, Linda Levin, PhD2, Dr. Andrew M.
Smith, MD, FAAAAI3, Dr. Tolly Epstein, MD, MS4, Patrick Ryan,
PhD5, Grace K. LeMasters, PhD2 and Dr. David I. Bernstein, MD,
FAAAAI1, 1Division of Immunology Allergy & Rheumatology,
University of Cincinnati Medical Center, CINCINNATI, OH, 2Uni-
versity of Cincinnati, Cincinnati, OH, 33255 Eden Ave., HPB 350,
University of Cincinnati Medical Center, Cincinnati, OH, 4Allergy
Partners of Central Indiana, Indianapolis, IN, 5Cincinnati Childrens
Hospital, Cincinnati, OH
976 Determining Risk Levels Of The Composite Asthma Severity
Index (CASI)
Rebecca A. Zabel1, Dr. Peter J. Gergen, MD, MPH2, Dr. Christine
A. Sorkness, PharmD3, Jeremy Wildfire1, Mr. Agustin Calatroni,
MA MS1 and Dr. Herman Mitchell, PhD1, 1Rho, Inc., Chapel
Hill, NC, 2AAIB\DAIT\NIH, Bethesda, MD, 3University of Wis-
consin, Madison, WI
977 BMI and Asthma Severity In An Elementary and Middle
School Inner City Population
Dr. Christina G. Kwong, MD1, Ms. Christina Mahl, RN2, Ms. Lisa
D. Henry, PNP-BC2, Dr. Deborah Loman, PhD, CPNP3, Dr. Robert
C. Strunk IV, MD, FAAAAI1, Ms. Lisa A. Meadows, PNP-BC2 and
Dr. Alysa G. Ellis, MD1, 1Washington University School of
Medicine, Saint Louis, MO, 2St. Louis Childrens Hospital,
Saint Louis, MO, 3St. Louis University School of Nursing, Saint
Louis, MO
Abstracts AB359
Basic and Translational Immunology
5602
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
978 Novel NK Cytotoxicity Assay Enables Drug Discovery For He-
mophagocytic Lymphohistiocytosis
Dr. Jinzhu Li, MD, PhD, Ms. Sarah E. Figueira, Ms. Julie Ferrel
and Dr. Kimberly A. Risma, MD, PhD, FAAAAI, Cincinnati Chil-
drens Hospital Medical Center, Cincinnati, OH
979 Exploitation Of The Host Ubiquitin System By Respiratory
Syncytial Virus Nonstructural Protein 2
Jillian N. Whelan1, Kim C. Tran1, Ruan R. Cox Jr.1, Damian B.
van Rossum2, Randen L. Patterson2 and Michael Teng1, 1Division
of Allergy and Immunology, Department of Internal Medicine,
and the Joy McCann Culverhouse Airway Diseases Research Cen-
ter, University of South Florida Morsani College of Medicine,
Tampa, FL, 2The Pennsylvania State University, University
Park, PA
980 Epigenetic Regulation Of Dendritic Cell Migration
Dr. Timothy P. Moran, MD, PhD1, Dr. Hideki Nakano, PhD2, Dr.
Hrisavgi Kondilis-Mangum, PhD2, Dr. Paul Wade, PhD2 and Dr.
Donald Cook, PhD2, 1Duke University Medical Center, Durham,
NC, 2National Institute of Environmental Health Sciences, NIH,
Research Triangle Park, NC
981 LRBA Subcellular Localization: Evidence Of The LRBAs Role
Endocytosis
Mrs. Michelle A. Reiser, MS1, Dr. Jia-Wang Wang, PhD1, Mrs.
Kunyu Li, BS1 and Dr. Richard F. Lockey, MD2, 1Division of Al-
lergy and Immunology, Department of Internal Medicine, Univer-
sity of South Florida, Morsani College of Medicine, Tampa, FL,
2
Division of Allergy and Immunology, Department of Internal
Medicine, University of South Florida Morsani College of Medi-
cine and James A. Haley Veterans Affairs Hospital, Tampa, FL
982 Differential Role Of Dendritic Cell Subsets In Shaping T-Cell
Responses To Respiratory Viruses
nella Casola, M.D. and Dr. Roberto P. Garofalo, MD, University
of Texas Medical Branch, Galveston, TX
Environmental Risk Factors and Diseases
Outcomes
5603
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
983 Effect Of Prenatal Exposure To Indoor PM2.5 and Environ-
mental Tobacco Smoke Affecting Lower Respiratory Tract In-
fection Was Modified By ROS Genes: Cocoa Study
Dr. Song I Yang, MD1, Dr. Eun Lee, MD1, Dr. Young Ho Jung,
TUESDAY
MD1, Kil-Yong Choi2, Mi-Jin Kang, MS2, Ho-Sung Yu2, Cheol
Min Lee3, Prof. Youn Ho Shin, MD, PhD4, Prof. Kangmo Ahn,
MD, PhD5, Prof. Kyung Won Kim, MD, PhD6, Prof. Soo-Jong
Hong, MD, PhD1 and Cocoa study Group7, 1Childhood Asthma At-
opy Center, Department of Pediatrics, Asan Medical Center, Uni-
versity of Ulsan College of Medicine, Seoul, South Korea, 2Asan
Institute for Life Sciences, University of Ulsan College of Medi-
cine, Seoul, South Korea, 3Institute of Environmental and Industrial
Medicine, Hanyang University, Seoul, South Korea, 4Department of
Pediatrics, CHA Medical Center, CHA University College of Med-
icine, Seoul, South Korea, 5Department of Pediatrics, Samsung
Medical Center, Sungkyunkwan University School of Medicine,
Seoul, South Korea, 6Department of Pediatrics, Yonsei University
College of Medicine, Seoul, South Korea, 7COCOA study group
149
 AB360 Abstracts
984 IgE Anti-Respiratory Syncytial Virus Antibodies In Older Asth-
matic Children
Mira Mandal1, Dr. Rauno O. Joks, MD, FAAAAI2, Dr. Kevin Noro-
witz, M.D.3, Dr. Diana Weaver, MD4, Dr. Helen G. Durkin, PhD5, Dr.
Martin H. Bluth, MD, PhD6, Dr. Stephan Kohlhoff, MD5 and Dr. Tamar
A. Smith-Norowitz, PhD7, 1SUNY Downstate Medical Center,
2
SUNY-HSC, Brooklyn, NY, 3SUNY Downstate Medical Center, Cen-
ter for Allergy and Asthma Research, Brooklyn, NY, 4SUNY Down-
state Med. Ctr, Brooklyn, NY, 5Center for Allergy and Asthma
Research, State University of New York Downstate Medical Center,
Brooklyn, NY, 6Wayne State University Medicine, Detroit, MI, 7Center
for Allergy and Asthma Research at SUNY Downstate, Brooklyn, NY
985 Asthma Symptoms and Rhinovirus In A Longitudinal Chil-
drens Cohort
Dr. Euan R. Tovey, PhD1,2, Dr. S. Stelzer-Braid, PhD3,4, Dr. B.G.
Toelle, PhD1, Ms. C.M. Willenborg, BSc3, Dr. H.K Reddel, PhD,
MBBS1,2, Ms. F.L. Garden, MPH1,2, Prof. A. Jaffe, PhD MD4,5, Ms.
R. Strachan5, Dr. B.G. Oliver, PhD1,2, Dr. Y.C. Belessis, MBBS4,5,
Prof. G.B. Marks, PhD, MD1,2 and Prof. W.D. Rawlinson, PhD,
MD3,4, 1Woolcock Institute of Medical Research, Sydney, Australia,
2
University of Sydney, Australia, 3Virology Division, SEALS Micro-
biology, Prince of Wales Hospital, Sydney, Australia, 4University of
NSW, Australia, 5Sydney Childrens Hospital, Randwick Australia
986 Maternal Transfer Of Der p 1 and Blo t 5 Allergens and Their
Respective Specific Antibodies Trough Placenta and Colostrum
Dr. Patricia Macchiaverni, Department of Immunology, Institute
of Biomedical Sciences, University of S~ao Paulo, SP, Brazil, Chris-
tina Arslanian, University of S~ao Paulo, Dr. Valerie Verhasselt, IN-
SERM, Valbonne, France and Prof. Antonio Condino-Neto, MD,
PhD, Institute of Biomedical Sciences, Department of Immunology,
University of S~ao Paulo, Sao Paulo, Brazil
987 Rhinovirus Infection Is Associated With Changes In The Air-
way Microbiome
Dr. Kirsten Kloepfer, MD1, Dr. Valeriy Poroyko, PhD2, Mrs. Rose
Vrtis, BS3, Mrs. Tressa Pappas, BS3, Dr. Theresa Kang, PhD3, Dr.
Wai-Ming Lee, PhD3, Mr. Michael D. Evans, MS3, Dr. Ronald E.
Gangnon, PhD3, Dr. Yury Bochkov, PhD3, Dr. Robert F. Lemanske
Jr., MD, FAAAAI3 and Dr. James E. Gern, MD, FAAAAI3, 1Riley
Hospital for Children at Indiana University Health, Indianapolis,
IN, 2University of Chicago, Chicago, IL, 3University of Wisconsin
School of Medicine and Public Health, Madison, WI
Eosinophilic Gastrointestinal Diseases
5604
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
988 Natural History Of Esophageal Remodeling In Pediatric Eosin-
ophilic Esophagitis Treated For Four Years
Dr. Jessica Rajan, MD1,2, Dr. Robert Newbury, MD3,4, Arjun Andrew
Anilkumar, BS2,5, Ranjan Dohil, MD6,7, Dr. David H. Broide, MB ChB
FAAAAI8 and Seema Sharma Aceves, MD, PhD, FAAAAI9, 1Scripps
TUESDAY
Clinic Medical Group, San Diego, CA, 2Division of Allergy/Immunol-
ogy, 3Department of Pediatrics, 4Division of Pathology, 5Department
of Medicine, 6Department of Pediatrics, Division of Gastroenterology,
7
Division of Gastroenterology, UCSD, Rady Childrens Hospital, San
Diego, 8Department of Medicine, San Diego, CA, 9Pediatrics, Univer-
sity of California San Diego, La Jolla, CA
989 Diagnostic Inaccuracy Of Biopsy Evaluations In Eosinophilic
Esophagitis Underscores The Value Of a Secondary Review
Process
Emily Stucke, BA1, Dr. Katherine E. Clarridge, MD, MSc1,2, Dr.
Margaret Collins, MD1, Dr. Lisa J. Martin, PhD1, Carol J. Hender-
son, PhD RD LD1 and Dr. Marc E. Rothenberg, MD, PhD,
FAAAAI1, 1Cincinnati Childrens Hospital Medical Center, Cincin-
nati, OH, 2University of Cincinnati
150
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
990 Development Of Eosinophilic Esophagitis To Food After Devel-
opment Of IgE Tolerance To The Same Food
Dr. Solrun Melkorka Maggadottir, MD1, Dr. David Hill, MD,
PhD2, Dr. Terri F. Brown-Whitehorn, MD1 and Dr. Jonathan M.
Spergel, MD, PhD, FAAAAI3, 1Childrens Hospital of Philadelphia,
Philadelphia, PA, 2Childrens Hospital of Philadelphia, 3The Chil-
drens Hospital of Philadelphia, Philadelphia, PA
991 Mast Cells, Eosinophils and Eosinophilic Esophagitis
Dr. Jay Jin, MD, PhD, Dr. Jeffrey Alexander, MD, Hirohito Kita,
MD, Ms. Diane Squillace, MS, Dr. Joseph A. Murray, MD, Dr.
Amindra Arora, MD, Dr. Yvonne Romero, MD, Dr. Thomas
Smyrk, MD and Dr. Catherine R. Weiler, MD, PhD, FAAAAI,
Mayo Clinic, Rochester, MN
992 CD3 and CD8 Cells Produce IL-9 In Pediatric Eosinophilic
Esophagitis
Arjun Andrew Anilkumar, BS, Department of Medicine; Division
of Allergy/Immunology, Lisa Beppu, BS, Department of Pediatrics
University of California San Diego; Division of Allergy and Immu-
nology, Richard Kurten, PhD, University of Arkansas for Medical
Sciences, Little Rock, AR; Department of Physiology and Biophys-
ics, Dr. Robert Newbury, MD, Department of Pediatrics; Division of
Pathology, Ranjan Dohil, MD, Department of Pediatrics, Division of
Gastroenterology; Division of Gastroenterology, UCSD, Rady Chil-
drens Hospital, San Diego, David Broide, MB ChB, University of
California San Diego, Department of Medicine, Division of Allergy
and Immunology and Seema Sharma Aceves, MD, PhD, FAAAAI,
Pediatrics, University of California San Diego, La Jolla, CA
Population Health and Food Allergy
5605
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
993 Longitudinal Effect Of Food Allergy Education On Epineph-
rine Availability In Public Schools Dipika Patel, MD1, Gwendo-
lyn Johnson, BSN, RN, MEd2, Danielle Guffey, MS1, Charles
Minard, PhD1 and Carla Davis, MD1, 1Baylor College of Medicine,
Houston, TX, 2Houston Independent School District, Houston, TX
994 Population Response To Change In Infant Feeding Guidelines
For Allergy Prevention
Dr. Dean Tey, MD1,2, Prof. Katrina Jane Allen, MD, PhD,
FAAAAI1,2, Ms. Rachel Peters, MPH2, Dr. Jennifer Koplin, PhD2,
Prof. Mimi L. K. Tang, MD, PhD, FAAAAI3, Prof. Lyle Gurrin,
PhD2,4, Prof. Anne-Louise Ponsonby, PhD2, Dr. Adrian Lowe,
PhD2,4, Prof. Melissa Wake, MD, PhD1,2 and Prof. Shyamali Dhar-
mage, MD, PhD2,4, 1Royal Childrens Hospital, Victoria, Australia,
2
Murdoch Childrens Research Institute, Victoria, Australia, 3The
University of Melbourne, Melbourne, Australia, 4University of
Melbourne, Victoria, Australia
995 Teasing and Bullying Among Adolescents With Food Allergy
Dr. Adora Lin, MD, PhD, National Institute of Allergy and Infec-
tious Diseases, Bethesda, MD and Dr. Hemant P. Sharma, MD MHS
FAAAAI, Childrens National Medical Center, Division of Allergy
and Immunology, Washington, DC
996 Differences In Food Allergy Quality Of Life Between Care-
givers In a Clinic-Based and a Caregiver-Reported Food Aller-
gic Population
Dr. Matthew J. Greenhawt, MD, MBA, MSc, Department of In-
ternal Medicine, The University of Michigan Medical School, Divi-
sion of Allergy and Clinical Immunology, Ann Arbor, MI
997 Food Allergy Management In An Urban Pediatric Population
Dr. Jennifer M. Camacho, MD, Dr. Stephanie Albin, MD, Dr.
Doerthe A. Andreae, MD and Dr. Julie Wang, MD, FAAAAI,
The Icahn School of Medicine at Mount Sinai, New York, NY
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
New Forms of Immunotherapy
5606
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
998 Persistent Treatment Effect Achieved At One Year After Four
Doses Of Der p Derived Synthetic Peptide Immuno-Regulatory
Epitopes In An Exposure Chamber Model Of House Dust Mite
Allergy
Dr. Rod Hafner, PhD1, Dr. Peter Couroux, M.D.2, Ms. Kristen
Armstrong, M.Sc.3, Dr. AnneMarie Salapatek, PhD4, Dr. Deepen
Patel, M.D.2 and Dr. Mark Larche, PhD5, 1Circassia Ltd, Oxford,
United Kingdom, 2Topstone Research, Toronto, ON, Canada,
3
Adiga Life Sciences Inc., Hamilton, ON, Canada, 4Inflamax Re-
search, Mississauga, ON, Canada, 5McMaster University/St. Jo-
sephs Healthcare, Hamilton, ON, Canada
999 Treatment With Synthetic Peptide Immuno-Regulatory Epi-
topes Derived From Grass Allergens Leads To a Substantial Re-
duction In Grass Allergy Symptoms In The Environmental
Exposure Unit
Dr. Anne K. Ellis, MD, MSc FAAAAI1,2, Dr. Charles W. Frankish,
MD3, Ms. Kristen Armstrong, M.Sc.4, Dr. Mark Larche, PhD5, Ms.
Lisa Steacy, BSc1 and Dr. Rod Hafner, PhD6, 1Allergy Research
Unit, Kingston General Hospital, Kingston, ON, Canada, 2Depart-
ments of Medicine and Biomedical & Molecular Science, Queens
University, Kingston, ON, Canada, 3Kanata Allergy Services, Ka-
nata, ON, Canada, 4Adiga Life Sciences Inc., Hamilton, ON, Can-
ada, 5McMaster University/St. Josephs Healthcare, Hamilton, ON,
Canada, 6Circassia, Oxford, United Kingdom
1000 Epicutaneous Immunotherapy Induces Epigenetic Changes In
Sensitized Mice
Lucie Mondoulet, PhD1, Dr. Vincent Dioszeghy, PhD1, Mrs.
Melanie Ligouis1, Mrs. Veronique Dhelft1, Mrs. Emilie Puteaux1,
Mrs. Camille Plaquet1, Prof. Christophe Dupont, MD, PhD2 and
Pierre Henri Benhamou, MD1, 1DBV Technologies, Bagneux,
France, 2Hopital Necker Enfants Malades, Paris, France
1001 Ultra-Fast Hypoallergenic Birch Pollen Allergy Vaccine Allert
Is Efficient and Safe: Results Of a Phase IIb Study
Dr. Francois Spertini, MD1, Prof. Frederic de BLAY2, Dr. Lars
Jacobsen, MD3, Prof. Marek Jutel, MD, PhD4, Dr. Margitta
Worm, MD5, Dr. Gilles Della Corte, MD6, Dr. Alexander Kettner,
PhD7, Dr. Vincent Charlon, PhD6 and Dr. Christophe Reymond7,
1
Division of Immunology and Allergy, CHUV, LAUSANNE,
Switzerland, 2CHRU Strasbourg, France, 3Glostrup University
Hospital, Copenhagen, Denmark, 4Wroclaw Medical University,
Wroclaw, Poland, 5Charite - Universitatsmedizin Berlin, Berlin,
Germany, 6Anergis SA, Epalinges, Switzerland, 7ANERGIS SA,
EPALINGES, Switzerland
1002 Stable Conjugates Between A Novel Toll-Like Receptor 7 Lig-
and and Protein Allergens As Modulators Of Th2 Responses
In Vitro and In Vivo
Dr. Lucia Fil1, Dr. Alessandra Vultaggio1, Dr. Elisa Cardilic-
chia1, Dr. Cinzia Manuelli1, Dr. Andrea Casini2, Dr. Francesca
Nencini1, Dr. Laura Maggi1, Dr. Sara Pratesi1, Dr. Giulia Petroni1,
Dr. Francesca Boscaro3, Prof. Ernesto Giovanni Occhiato2, Prof.
Sergio Romagnani1, Prof. Enrico Maggi1 and Prof. Paola
Abstracts AB361
Parronchi1, 1University of Florence, DENOTHE Center, Florence,
Italy, 2University of Florence, Dept. of Chemistry U. Shiff,
Florence, Italy, 3University of Florence, Mass Spectrometry Cen-
ter (CISM), Florence, Italy
Mechanisms of T Cell-Mediated Allergic Disease
5607
Tuesday, March 4th, 2014, 2:00 PM - 3:15 PM
1003 TSLP Induces Corticosteroid Resistance In Natural Helper
Cells Via STAT5 Pathway
Hiroki Kabata1, Kazuyo Moro2,3, Koichi Fukunaga1, Yusuke Su-
zuki1, Katsunori Masaki1, Tomoko Betsuyaku1, Shigeo Koyasu1,2
and Prof. Koichiro Asano, MD4, 1Keio University School of Med-
icine, Tokyo, Japan, 2RIKEN Center for Integrative Medical Sci-
ences, Kanagawa, Japan, 3PRESTO, JST, Japan, 4Tokai
University School of Medicine, Kanagawa, Japan
1004 Impairment Of IL-27s Differential Effect On CD4+T Cells In
Asthma
Dr. Zhihong Chen1, Shanze Wang2, Xiaopeng Qi2, Prof. Chunxue
Bai1 and Prof. Hua Huang2, 1Zhongshan Hospital, Fudan Univer-
sity, Shanghai, China, 2National Jewish Health, Denver, CO
1005 Profile Of Food Allergen-Specific T Cells In Allergic and Clin-
ically Tolerant Individuals
David Chiang, MS1, Alexander V. Grishin, PhD1, Madhan Masi-
lamani, PhD1, Miriam Merad, MD, PhD1, A. Karolina Palucka,
MD, PhD1,2, Hideki Ueno, MD, PhD2, A. Wesley Burks, MD,
FAAAAI3, Stacie M. Jones, MD4, Andrew H. Liu, MD5, Scott
H. Sicherer, MD, FAAAAI1, Robert A. Wood, MD, FAAAAI6,
Wendy Davidson, PhD7, Hugh A. Sampson, MD, FAAAAI8 and
M. Cecilia Berin, PhD1, 1Icahn School of Medicine at Mount Si-
nai, New York, NY, 2Baylor Institute for Immunology Research,
Dallas, TX, 3University of North Carolina, Chapel Hill, NC, 4Uni-
versity of Arkansas for Medical Sciences and Arkansas Childrens
Hospital, Little Rock, AR, 5National Jewish Health, Denver, CO,
6
Johns Hopkins University Medical Center, Baltimore, MD, 7Na-
tional Institutes of Health, Bethesda, MD, 8Pediatrics, Icahn
School of Medicine at Mount Sinai, New York, NY
1006 Follicular Helper T Cells Mediate IgE Antibody Production
and Allergic Immune Responses in Mice
Takao Kobayashi, PhD1, Koji Iijima, PhD1 and Hirohito Kita,
MD2, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic Rochester, Ro-
chester, MN
1007 Analysis Of Circulating Rhinovirus-Specific CD4+ T Cells Us-
ing Novel MHC Class II Tetramers Reveals Marked Expan-
sion Of Effector Memory Cells In Infected Subjects
Lyndsey Muehling1, Rachana Agrawal, PhD1, Julia Wisniew-
ski, MD1, Paul Wright1, William W. Kwok, PhD2, Ronald
Turner, MD1 and Judith A. Woodfolk, MBChB, PhD, FAAAAI1,
1
TUESDAY
University of Virginia Health System, Charlottesville, VA, (2)-
Benaroya Research Institute at Virginia Mason,
Seattle, WA
151
 AB398 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014

LATE-BREAKING ABSTRACTS
PRESENTED AT SCIENTIFIC SESSIONS
AAAAI ANNUAL MEETING
FEBRUARY 28-MARCH 4, 2014

The following abstracts were accepted for presentation after the deadline for the abstract supplement

L1 Human TNFR2 Exhibits Bi-Directional Control over Regulatory

T Cells
Dr. Denise L. Faustman, MD, PhD1, Limei Wang2, Yoshiaki Okubo2;
only when prolines were hydroxylated. Deletion of the HYP-domain did
not prevent the variant to refold correctly and to display Ara h 2
1 conformational epitopes. The IgE-binding capacity of Ara h 2 was then
Massachusetts General Hospital/Harvard Medical, Charlestown, MA,
2 recapitulated with an equimolar mixture of the deletion variant and the
Massachusetts General Hospital/Harvard Medical.
synthetic HYP-peptide. Surprisingly, the HYP-peptide was also able to
BACKGROUND: The homeostatic functions of CD4+ regulatory T-cells
trigger the degranulation of RBL cells as efficiently as the unfolded Ara h 2,
(Treg) protect against autoimmunity, cancer and infections, but mecha-
which retained an allergenic activity with most of the tested sera.
nisms governing Treg activity are ill-defined. We hypothesized that tumor
CONCLUSIONS: Proline hydroxylation is critical for Ara h 2 allerge-
necrosis factor receptor 2 (TNFR2) may control Treg functions, consid-
nicity and peptides overlapping the HYP-domain, as short as 15 and 27
ering that TNFR2 is highly expressed on human Tregs.
amino acid residues, retain an anaphylactic potential.
METHODS: Effects of TNFR2 monoclonal antibodies (moAbs) on Treg
proliferation, signaling, phenotype, and function were studied by multiple
in vitro assays using isolated fresh human CD4+ and CD25hi coexpressing
T cells from >100 donors. Antibody performance was compared to
L3 Immunocap Cellulose Displays Cross-Reactive Carbohydrate
Epitopes and Can Cause False-Positive Test Results in Patients
with Anti-CCD IgE Antibodies
standard Treg expansion methods and categorized as agonist, antagonist Wolfgang Hemmer, PhD1, Stefan Wohrl, MD, MSc, FAAAAI1, Felix
or neutral in activity. Wantke, MD, FAAAAI1, Friedrich Altmann, PhD2; 1Floridsdorf Allergy
RESULTS: Two antibodies exclusively acted as either a TNFR2 agonist or Center, Vienna, Austria, 2Department of Chemistry, University of Natural
antagonist. In vitro the newly identified TNFR2 agonist induced prolifera- Resources and Life Sciences, Vienna, Austria.
tion of enriched human Tregs into phenotypically homogeneous RATIONALE: Cross-reactive carbohydrate determinants (CCDs) in plant
populations of effector Tregs (FOXP3hiCD45RO+CD25hiHLA- and insect venom extracts are a common cause of false-positive results
DR+CTLA4+,CD127-CXCR3-). Conversely, the TNFR2 antagonist sup- during in vitro allergy diagnosis. We noticed, when using the Phadia
pressed human Treg proliferation. When Tregs were co-incubated with ImmunoCAP system, that some CCD-positive sera deliver multiple posi-
their target CD8+ T-cells, the agonist-treated Tregs suppressed CD8+ tive results even when tested with CCD-free recombinant allergens.
proliferation, whereas the antagonist had negligible effects. The two METHODS: ImmunoCAP IgE binding to selected recombinant allergens
ligands also triggered different downstream intracellular Treg signaling, and to blank ImmunoCAPs (BIC) with no allergens coupled to the
with the agonist upregulating TRAF2, FOXP3 and cIAP2. cellulose sponge was compared in CCD-positive sera before and after
CONCLUSIONS: The findings show that certain TNFR2 ligands can act inhibition with a CCD inhibitor (ProGlycAn, Vienna, Austria).
as antagonists or agonists by exerting opposing actions in human cells RESULTS: 30/45 (67%) CCD-positive sera (MUXF-CCD 1.01-59.6 kU/l)
regarding Treg proliferation, signaling, and target cell activity. TNFR2 has showed IgE-binding to BIC greater than 0.35 kU/l (0.41-6.66 kU/l).
the potential for bidirectional control over Treg homeostatic functions in Among those with anti-CCD IgE levels >7.0 kU/l, 86% (24/28) were
humans, opening new clinical opportunities for Treg expansion or positive. IgE-binding to BIC correlated with IgE-binding to MUXF-CCD
suppression. (r50.66) and was completely abolished by serum pre-incubation with a
CCD inhibitor (n511). Binding scores with a second lot of BIC were lower
L2 Contribution of Sequential and Conformational IgE-Binding
Epitopes to the Allergenicity of Major Peanut Allergen Ara h 2
Stephane Hazebrouck, PhD1, Blanche Guillon, BSc1, Marie-Francoise
but correlated strongly with the first lot (r50.99). IgE-binding of seven
highly CCD-reactive sera (14.0-52.5 kU/l) to the recombinant allergens
rPhl p12, rFel d1, rAra h2, and rPru p3 was positive to all four components
Drumare, BSc1, Evelyne Paty, MD2, Jean-Michel Wal, PhD1, Herve
(up to 1.6 kU/l). Binding correlated strongly with antibody binding to
Bernard, PhD1; 1INRA UR496, Gif-sur-Yvette, France, 2Universite Paris
MUXF-CCD and BIC (r50.92) and could be completely blocked by the
Descartes, H^opital Necker Enfants Malades, Paris, France.
CCD inhibitor. Mass spectroscopic analysis confirmed the presence of
RATIONALE: Protein unfolding reduces significantly the allergenic
MMXF glycans in unprocessed and processed cellulose.
activity of the most potent peanut allergen Ara h 2. This allergen also
CONCLUSIONS: Cellulose used as an allergen carrier in the
contains major sequential IgE-binding epitopes, especially in a flexible
ImmunoCAP system contains varying traces of CCDs itself, which can
region comprising the repetitive post-translationally modified peptide
cause multiple false-positive results even to non-glycosylated recombi-
DPYSPOHS, with a hydroxyproline (HYP). We then investigated the
nant components in patients with elevated levels of anti-CCD IgE
relative contributions of sequential and conformational epitopes to the
antibodies.
allergenic activity of Ara h 2.
METHODS: Peptides overlapping the HYP-domain were synthesized
with or without the prolines hydroxylated. A variant lacking the
HYP-domain was generated by deletion mutagenesis. IgE reactivity of
19 peanut-allergic patients toward synthetic peptides and recombinant Ara
h 2 variants was determined by IgE-binding inhibition assays and by
degranulation tests of rat basophil leukemia (RBL) SX38 cells sensitized
with patients IgE antibodies.
RESULTS: The peptide encompassing the longest HYP-domain exhibited
an inhibitory capacity similar to that of the full-length unfolded Ara h 2, but

152
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
L4 The RNA-Binding Protein Hur Is Required to Control Cytokine
Expression in CD4+ T Cells
Dr. Ulus Atasoy, MD, FAAAAI1, Dr. Patsharaporn Techasintana2,
Dr. Joseph Magee2, Dr. Matt Gubin3, Mr. Joe Rowles2; 1Surgery,
University of MO-Columbia, Columbia, MO, 2University of Missouri,
3
Washington University.
RATIONALE: During T cell activation, up to 50% of changes occur at the
posttranscriptional level, which is mediated by RNA-binding proteins
(RBPs). HuR is a stabilizing RBP which regulates mRNA target expression
via AU-rich elements present in mRNA 3UTRs. It is permissive for Th2
and Th17 differentiation.
METHODS: Previously, we showed HuR regulates GATA-3, IL-4, IL-13
and other Th2 restricted transcripts, as well as IL-17. We hypothesized that
HuR is required for Th2 differentiation and Th2 associated disease such as
asthma. To avoid defects in T cell development, we utilized a HuR KO
mouse model in which HuR is ablated in mature CD4+ T cells, using distal
Lck-Cre-ROSA-HuRfl/fl.
RESULTS: Activated or Th2 polarized HuR KO CD+4 T cells showed
striking increases in IL-2 secretion and an inability to shut off IL-2 expression.
These also mice had profound reductions in Th2 and Th17 cytokine expression.
We used the ova challenge model of airway inflammation to further
investigate HuR KO under antigenic conditions. HuR KO mice had profound
reductions in BAL IL-4 and IL-13, and in pulmonary cellular infiltration
with suppression of neutrophils, lymphocytes and eosinophils. The levels of
cellular infiltration in HuR KO mice resembled un-immunized controls.
CONCLUSIONS: HuR appears to be required for Th2 and Th17 but not
Th1 differentiation and cytokine production. Furthermore, HuR functions
as an off switch for IL-2 expression during T cell activation. These results
may have implications for understanding mechanisms of tolerance under
antigen challenge as well as in allergen driven airway lung inflammation.
L5 Whole-Exome Sequencing Reveals IKBKB As a Cause of
Combined Immunodeficiency
Dr. Talal Mousallem, MD1,2, Dr. Jialong Yang, PhD1, Dr. Thomas J.
Urban, PharmD, PhD2, Mrs. Hongxia Wang, MS1,3, Mrs. Roberta E.
Parrott, BS1, Dr. Joseph L. Roberts, MD, PhD1, Dr. Rebecca H.
Buckley, MD, FAAAAI1, Dr. Xiaoping Zhong, MD, PhD1, Dr. David B.
Goldstein, PhD2; 1Department of Pediatrics, Duke University Medical
Center, Durham, NC, 2Center for Human Genome Variation, Duke
University Medical Center, Durham, NC, 3Laboratory Medicine Center,
Nanfang Hospital, Southern Medical University, Guangzhou, China.
RATIONALE: There is considerable interest in the use of next generation
sequencing to identify molecular defects in patients with primary
immunodeficiency.
METHODS: To identify the cause of Combined Immunodeficiency in 2
patients from 2 different consanguineous Qatari families who had a similar
clinical and immunologic phenotype, we used whole-exome sequencing.
The patients presented at an early age with fungal, viral and bacterial
infections. The patients had hypogammaglobulinemia, normal numbers of
B and T cells (most of which were CD45RA positive) and low numbers of
NK cells. T cell proliferative responses to mitogens were normal, but were
absent to antigens and anti-CD3. We looked for homozygous variants that
were present in the patients but absent in controls and public databases.
Additional studies included IKKb, IKBa, and phospho-IKBa immuno-
blotting, retroviral mediated reconstitution of IKKb, and cell growth in an
immortalized patient B cell line.
RESULTS: We found the same homozygous nonsense mutation in IKBKB
(R286X) in both patients. IKKb acts as part of the IKK complex in NF-kB
activation and phosphorylates the NF-kB inhibitor, IKBa. The mutation
co-segregated with disease in both families. Western blotting showed
absence of detectable IKKb, and retroviral mediated reconstitution with
wild type IKKb corrected cell growth and restored IKBa phosphorylation
and IKBa degradation in an EBV transformed patient B cell line.
CONCLUSION: These data indicate that mutated IKBKB is the likely cause
of immunodeficiency in these two patients. To our knowledge, this is the
first report of combined immunodeficiency caused by a mutation in IKBKB.
Abstracts AB399
L6 Sputum Cytokines and Adult Asthma Endotypes
Dr. Ioana O. Agache1, Dr. Costel Agache2, Mrs. Beate Ruckert3,
Prof. Liliana Rogozea1, Dr. Cristina Ciobanu2, Prof. Cezmi A. Akdis, MD,
FAAAAI4; 1Transylvania University Brasov, Romania, 2Theramed
Medical Center, Romania, 3Swiss Institute of Allergy and Asthma
Research, Switzerland, 4Swiss Institute of Allergy and Asthma Research,
Davos, Switzerland.
RATIONALE: Asthma clusters can be separated according to their
endotype by combining visible properties and sputum cytokines.
METHODS: The Local Ethics Committee approved the study. Induced
sputum sampled outside an exacerbation was processed by dialysis
(D-Tube Dialyzers Midi, Novagen) followed by ultrafiltration (Amicon
Ultra 3K, Millipore, 3000 NMWL). Sputum cytokines were measured with
the 27 Plex Human Cytokine Group I Bioplex (Biorad). Hierarchical
cluster analysis with a wide array of variables was used. Difference
between clusters was assesed by One-way Anova.
RESULTS: 60 adult asthmatics, mean age 44614 years old, 52% females
were included. Three clusters were separated, significantly different for
all sputum cytokines (except RANTES and FGF-b), asthma severity
(GINA), onset of asthma, ACT score, lung function (LF), AHR,
exacerbation frequency, near-fatal asthma (NFA), corticosteroid-resis-
tance, blood eosinophils. Cluster 1 (n527, 67% males) had the lowest
frequency of asthma exacerbations, the best LF, predominant macrophages
and lymphocytes in induced sputum and the highest sputum IL-4, IL-1RA,
VEGF and IL-7. Cluster 2 (n514, 64.3% females) had the longest asthma
duration, the highest AHR and frequency of asthma exacerbations,
corticosteroid-resistance and NFA, the worst LF and ACT score, the
highest sputum and blood eosinophilia and the highest sputum cytokines.
Cluster 3 (n519, 63.2% females), had the shortest asthma duration, the
highest FeNO and total serum IgE, the highest incidence of LF decline
and atopy, sputum neutrophilia and the lowest values for all sputum
cytokines.
CONCLUSION: Deep phenotyping incorporating phenotypic traits,
longitudinal data and biomarkers of inflammation stratifies asthma into
subclasses according to their biological basis.
L7 Omalizumab Therapy Is Associated with Reduced Circulating
Basophil Populations in Asthmatic Children
Dr. David A. Hill, MD, PhD1, Dr. Mark Siracusa, PhD2, Kathryn
Ruymann1, Dr. Elia Tait Wojno, PhD2, Dr. David Artis, PhD2,
Dr. Jonathan M. Spergel, MD, PhD, FAAAAI1; 1The Childrens Hospital
of Philadelphia, Philadelphia, PA, 2University of Pennsylvania,
Philadelphia, PA.
RATIONALE: Basophils have been implicated in promoting the early
development of TH2 cell responses in some murine models of TH2
cytokine-associated inflammation. However, the specific role of basophils
in allergic asthma remains an active area of research. Recent studies in
animal models and human subjects suggest that IgE may regulate the
homeostasis of human basophil populations. Here, we examine basophil
populations in children with severe asthma before and during therapy with
the IgE directed monoclonal antibody omalizumab.
METHODS: Subjects were selected based on age between 5 and 18 years,
body weight and IgE level compatible with the omalizumab dosing table,
and severe asthma. Asthma symptoms assessments were administered
during therapy. Peripheral blood samples were obtained before and during
therapy and basophil frequencies and numbers were monitored using flow
cytometric techniques.
RESULTS: Omalizumab therapy was associated with a significant reduction
in circulating basophil frequencies and numbers (p<0.05, Wilcoxon Signed
Rank Test), a finding that correlated with improved clinical outcomes.
CONCLUSIONS: The observation that circulating basophils are reduced
following omalizumab therapy supports a mechanistic link between
IgE levels and circulating basophil populations and may provide new
insights into one mechanism by which this drug improves asthma
symptoms.
153
 AB400 Abstracts
L8 Elucidating the Basis of Airway Protection By Gastrointestinal
Lactobacillus Johnsonii
Dr. Kaitlyn S. Lucey, PhD1, Dr. Kei Fujimura, PhD1, Dr. Marcus
Rauch, PhD1, Ali Faruqi1, Douglas Fadrosh1, Dr. Tine Demoor, PhD2,
Dr. Christine Cole Cole Johnson, PhD, MPH, FAAAAI3, Dr. Homer A.
Boushey, Jr, MD, FAAAAI1, Dr. Edward M. Zoratti, MD, FAAAAI3,
Dr. Dennis Ownby, MD, FAAAAI4, Dr. Nicholas W. Lukacs, PhD2,
Dr. Susan V. Lynch, PhD1; 1University of California San Francisco, San
Francisco, CA, 2University of Michigan, Ann Arbor, MI, 3Henry Ford
Health System, Detroit, MI, 4Department of Pediatrics Georgia Regents
University, Augusta, GA.
RATIONALE: We recently demonstrated that the gram-positive, facul-
tative anaerobe, L. johnsonii, is significantly enriched in the cecal micro-
biome of mice whose airways are protected against allergen and viral
challenge, and that oral supplementation with this species alone can afford
airway protection. Current studies are aimed at deciphering the basis for
gastrointestinal L. johnsonii protection of the airways.
METHODS: L. johnsonii was isolated from airway protected mice, and its
genome was sequenced using the Illumina MiSeq platform. The gut micro-
biome composition of mice supplemented with L. johnsonii was compared to
unsupplemented animals, and used in conjunction with a metagenome predic-
tive tool, PICRUSt, to compare the functional capacity of these communities.
RESULTS: L. johnsonii preferentially localizes in the terminal ileum and
cecum. While its 16S rRNA is 99% homologous to L. johnsonii NCC 533,
only 85% of the assembled contigs of its 2Mb genome are identical, sug-
gesting that 15% of its genome is distinct from this species. Genes relevant
to colonization, survival, and inter-species competition in the gut are pre-
sent. Oral supplementation of mice with L. johnsonii is associated with sig-
nificant enrichment of specific members of the Bacteroides,
Proteobacteria, Firmicutes, Spirochaetes, Cyanobacteria, and Caldiserica
(Welchs t-test p-value < 0.05, q-value < 0.16) and collectively this com-
munity imparts a myriad of immunomodulatory functions.
CONCLUSION: L. johnsonii is a crucial species of the gut microbial
community that reshapes community composition and function in a
manner that affords airway protection in mice.
L9 IL-13/CD14 Polymorphisms and Prenatal Risk Factors That Shape
Gut Microbiota Influence the Development of Atopic Dermatitis
in Infancy in a Synergistic Manner: A Birth Cohort Study
(COCOA)
Prof. So Yeon Lee, MD, PhD1, Prof. Hae-Ran Lee2, Kang Mo Ahn3,
Prof. Kyung Won Kim, MD, PhD4, Prof. Youn Ho Shin, MD, PhD5,
Gyeong-shin Lee6, Seo Ah Hong7, Dr. Young-Ho Ho Jung, MD8,
Dr. Eun Lee, MD9, Song-Yi Yang10, Dr. Ju-Hee Seo, MD11, Ji-Won
Kwon12, Dr. Byoung-Ju Kim, MD, PhD13,14, Dr. Byoung-Ju Kim, MD,
PhD13,14, Dr. Hyo-Bin Kim, MD, PhD14,15, Prof. Soo-Jong Hong, MD,
PhD16; 1Department of Pediatrics, Hallym University College of Medicine,
Seoul, South Korea, 2Hallym University, South Korea, 3Department of Pe-
diatrics, Samsung Medical Center, Sungkyunkwan University School of
Medicine, Seoul, Korea, South Korea, 4Department of Pediatrics, Severance
Childrens Hospital, College of Medicine, Yonsei University, Seoul, Korea,
Seoul, South Korea, 5Department of Pediatrics, CHA Medical Center, CHA
University College of Medicine, Seoul, South Korea, 6Childhood Asthma
Atopy Center, Asan Medical Center, University of Ulsan College of Medi-
cine, South Korea, 7Research Center for Standardization of Allergic Dis-
eases, Asan Institute for Life Sciences, University of ulsan College of
Medicine, South Korea, 8Childhood Asthma Atopy Center, Department of
Pediatrics, Asan Medical Center, University of Ulsan College of Medicine,
Seoul, South Korea, 9Childhood Asthma Atopy Center, Asan Medical Cen-
ter, University of Ulsan College of Medicine, South Korea, 10Childhood
Asthma Atopy Center, Department of Pediatrics, Asan Medical Center, Uni-
versity of Ulsan College of Medicine, South Korea, 11Department of pediat-
rics, Korea Cancer Center Hospital, South Korea, 12Department of Pediatrics,
Seoul National University Bundang Hospital, South Korea, 13Department of
Pediatrics, Hae-undae Paik Hospital, Inje University College of Medicine,
Busan, South Korea, 14Research Center for Standardization of Allergic
154
J ALLERGY CLIN IMMUNOL
FEBRUARY 2014
Diseases, Seoul, South Korea, South Korea, 15Department of Pediatrics, Inje
University Sanggye Paik Hospital, Seoul, South Korea, 16Department of Pedi-
atrics, Asan Medical Center, Childhood Asthma Atopy Center, South Korea.
RATIONALE: Although cesarean delivery and prenatal exposure to
antibiotics are likely to affect the gut microbiome in infancy, their effect on
the development of atopic dermatitis (AD) in infancy is unclear. The
influence of individual genotypes on these relationships is also unclear. To
evaluate with a prospective birth cohort study whether cesarean section,
prenatal exposure to antibiotics, and susceptible genotypes act synergis-
tically to promote the development of AD in infancy.
METHODS: The study population comprised 412 infants from the Cohort
for Childhood of Asthma and Allergic Diseases (COCOA). Their cord
blood DNA was subjected to IL13 (rs20541) and CD14 (rs2569190)
genotype analysis. Fecal samples were obtained from 11 of the 412 infants
in this study at the age of 6 months and 16s rRNA bacterial gene
sequencing was performed.
RESULTS: The combination of cesarean delivery and prenatal exposure
to antibiotics associated significantly and positively with AD (aOR, 5.70;
95% CI, 1.1927.3). The association between cesarean delivery and AD
was significantly modified by parental history of allergic diseases or risk-
associated IL-13 (rs20541) and CD14 (rs2569190) genotypes. Infants who
were exposed prenatally to antibiotics and were born by cesarean delivery
had lower total microbiota diversity in stool samples at 6 months of age
than the control group. As the number of these risk factors increased, the
AD risk rose (trend p<0.05).
CONCLUSION: Cesarean delivery and prenatal antibiotic exposure may
affect the gut microbiota, which may in turn influence the risk of AD in infants.
These relationships may be shaped by the genetic susceptibility alleles.
L10 The Role of Chitin and TNF-Alpha in Airway Inflammation
Induced By House Dust Mite in Murine Model
Prof. Sang Min Lee, MD1, Mr. Joon Pyo Choi, PhD2, Young Min Kim2,
Seung Jin Choi2, Hyun Taek Park2, Prof. Sang Pyo Lee, MD, PhD3,
Prof. Sang Heon Cho, MD, PhD4,5, Prof. Yoon-Keun Kim, MD, PhD2;
1
Department of Internal Medicine, Gachon University Gil Medical Center, In-
cheon, South Korea, 2Division of Molecular and Life Sciences, Department of
Life Science, Pohang University of Science and Technology (POSTECH),
Pohang, South Korea, 3Department of Internal Medicine, Gachon University
Gil Medical center, Incheon, South Korea, 4Department of Internal Medicine,
Seoul National University College of Medicine, Seoul, South Korea, 5Institute
of Allergy and Clinical Immunology, Seoul National University Medical
Research Center, Seoul, South Korea.
BACKGROUND: Chitin is a potent adjuvant in immune responses of Th2,
Th1 and Th17. In our previous study, tumor necrosis factor alpha (TNF-a) is
a key mediator in the development of Th2 cell response to inhaled allergens.
OBJECTIVE: We investigated the role of chitin in the induction of Th1,
Th2, and Th17 response, sensitizing and challenging mice intranasally with
OVA and chitin in this study. We also evaluated the role of TNF-a and the
size of chitin in the development of Th2 immune response induced by chitin,
using TNF-a-deficient mice and chitinase-treated chitin, respectively.
METHODS: A mouse model was generated via simultaneous intranasal
administration of 75 mg of ovalbumin (OVA) and 100 mg of house dust mite
(HDM)-derived chitin in the presence or absence of chitinase. The effect of
TNF-a on adaptive immune response was also evaluated using TNF-a-
deficient mice.
RESULTS: HDM-derived chitin induced airway inflammation and
increased the expression of all cytokines of Th1, Th2, and Th17 as well
as the serum level of OVA-specific IgE, IgG1, and IgG2a. In the absence of
TNF-a or in the presence of chitinase, the expression of Th2 cytokines and
the serum level of OVA-specific IgE were alleviated, while the expression
of Th1 and Th17 cytokines and the serum level of OVA-specific IgG1 and
IgG2a were preserved or more enhanced.
CONCLUSION: HDM-derived chitin is size-dependent multifaceted
immune adjuvant inducing Th1, Th2, and Th17 immune response, and
TNF-a produced by airway exposure to HDM-derived chitin is a key
mediator in the development of Th2 cell response to inhaled allergens.
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
L11 Platelets Constitutively Express Interleukin-33 Protein
Dr. Tomohiro Takeda, MT, PhD1,2, Dr. Hirotoshi Unno, MD1,
Dr. Hideaki Morita, MD, PhD1, Dr. Hirohisa Saito, MD, PhD1, Dr. Kenji
Matsumoto, MD, PhD1, Dr. Akio Matsuda, PhD1; 1Department of Allergy
and Immunology, National Research Institute for Child Health and
Development, Tokyo, Japan, 2Department of Health Sciences, Kansai
University of Health Sciences, Osaka, Japan.
RATIONALE: Recent studies revealed that platelets are activated during
asthma exacerbation and that depletion of platelets in a mouse model of
asthma improves airway inflammation. However, the precise mechanisms
of how plateletsdespite being devoid of a nucleusregulate allergic
inflammation are not fully understood. IL-33, an IL-1 family cytokine, has
attracted attention as a critical cytokine in the development of allergic
diseases because of its potent ability to induce type 2 immunity and its
strong genetic association with asthma. Objective: To determine whether
platelets express IL-33 protein.
METHODS: IL-33 protein in human platelets and a megakaryocyte cell
line, MEG-01, and in bone marrow-derived mouse megakaryocytes was
detected by Western blot analysis and fluorescent immunostaining. Papain
inhalation (100 mg/day 3 3 days)-induced IL-33-dependent airway
inflammation (Oboki K. et al. PNAS 2010) was compared between
platelet-intact and platelet-depleted (by injection of anti-CD41 mAb) groups.
RESULTS: Human platelets and anucleated fragments of mouse bone-
marrow-derived megakaryocytes expressed full-length IL-33 protein,
which is biologically active. Cytosol, but not nuclear, fractions of MEG-
01 and mouse megakaryocytes also expressed full-length IL-33 protein.
Depletion of platelets resulted in a significant decrease in eosinophilic, but
not neutrophilic, inflammation in papain-treated mouse airways.
CONCLUSIONS: Our novel findings suggest that platelets constitutively
express active IL-33 protein and that activation of platelets plays a pivotal
role in IL-33-dependent type II airway inflammation. Further understand-
ing of the precise molecular mechanisms may lead to platelets becoming
an attractive new target in asthma treatment.
L12 Targeted Resequencing Identified Damaging Rare Variants in
IFNGR1 Associated with Atopic Dermatitis Complicated By
Eczema Herpeticum
Dr. Li Gao, MD, PhD1, Dr. Ryan Heiser, PhD2, Nicholas M. Rafaels1,
Lili Huang, MPH1, Joseph Potee1, Dr. Rasika A. Mathias, ScD1, Lisa A.
Beck, MD, FAAAAI3, Dr. Kathleen C. Barnes, PhD, FAAAAI1, Donald
Y. M. Leung, MD, PhD, FAAAAI2; 1Division of Allergy and Clinical
Immunology, Department of Medicine, Johns Hopkins University,
Baltimore, MD, 2National Jewish Health, Denver, CO, 3Department of
Dermatology, University of Rochester Medical Center, Rochester, NY.
RATIONALE: Genetic variations in IFNGR1 gene have been reported
that abrogate IFN-g signaling leading to enhanced susceptibility to myco-
bacterial infection. However, the causality of IFNGR1 variants in atopic
dermatitis with eczema herpeticum (ADEH+) has not been established.
Utilizing targeted resequencing, we assess the influence of rare functional
variations in IFNGR1 to ADEH+ susceptibility.
METHODS: We performed targeted resequencing in 122 European
American (EA) ADEH+ cases and 107 ADEH- controls followed by
validation genotyping for 3 rare missense variants in the entire cohort
including a total of 411 EA patients (133 ADEH+, 157 ADEH- and 121
non-atopic controls (NA)). Association tests between rare variants and risk
of ADEH+ was performed using SKAT-O. The IFN-g induced CD80
expression on peripheral blood mononuclear cells (PBMC) was examined
in a selected group of patients.
RESULTS: We identified 18 common and 118 rare variants in IFNGR1.
Among the rare variants, 6 were missense with 3 as possibly damaging
(Val14Met, Val61Ile and Tyr397Cys) including one novel variant
(Tyr397Cys). The 3 damaging rare variants conferred greater risk for
ADEH+ (P<0.031) when we compared 133 ADEH+ patients including 5
heterozygous carriers to 278 non-ADEH+ subjects (157 ADEH-, 121
NA). Enhanced signal was observed (P<7.48E-14) when we compared
findings to an unphenotyped control population (4300 EAs) from the
Abstracts AB401
Exome Sequencing Project. In functional studies conducted thus far, we
observed that an 8-year-old boy carrying the Val14Met variant had a blunt-
ed response to IFN-g induced CD80 expression.
CONCLUSIONS: Our novel findings provide evidence that functional
polymorphisms in IFNGR1 contribute to ADEH+ susceptibility.
Additional functional studies are underway.
L13 Grass Pollen Allergoids Coupled to Mannan Are Novel
Vaccines with Enhanced Capacity to be Captured By
Dendritic Cells Promoting Th1 Immune Responses and High
Levels of IL-10
Dr. Oscar Palomares, PhD1, Dr. Sofia Sirvent, PhD1, Dr. Irene
Soria, PhD2, Dr. Barbara Cases, PhD3, Dr. Carmen Dez, PhD4,
Dr. Pedro Reche, PhD4, Dr. Juan Lopez-Rela~no, PhD4, Dr. Eduardo
Martnez-Naves, PhD4, Dr. Enrique Fernandez-Caldas, PhD3, Dr. Jose
Luis Subiza, MD, PhD3; 1Department of Biochemistry and Molecular
Biology, Faculty of Chemistry, Madrid, Spain, 2Hospital Clnico San Car-
los, Madrid, Spain, 3Inmunotek, Madrid, Spain, 4Department of Immu-
nology, School of Medicine, Complutense University, Madrid, Spain.
RATIONALE: The immunogenicity and efficacy of allergen vaccines
depend on the capacity of dendritic cells (DCs) to capture them and to
induce proper immune responses. Herein, we compared the ability of
native grass pollen extracts (N), glutaraldehyde-polymerized allergoids (P)
and glutaraldehyde-polymerized allergoids coupled to mannan (PM) to be
internalized by DCs and to regulate immune responses.
METHODS: N, P and PM Phleum pratense pollen extracts were pro-
duced. Human monocytes from buffy coats were differentiated to DCs
with IL-4/GM-CSF. Allergen uptake was assessed by flow cytometry and
confocal microscopy. Co-culture experiments, real-time quantitative
PCR, ELISA and ELISPOT were performed. Antibody levels in serum
from BALB/c mice immunized with extracts, proliferation of splenocytes
and cytokine production were determined.
RESULTS: PM was captured by human DCs more efficiently than N or P
through mechanisms partially depending on receptor-mediated internali-
zation. DCs stimulated with N, P and PM expressed high levels of HLA-
DR, CD86 and CD83. PM-activated DCs produced higher levels of IL-6
and IL-10 than N- or P-activated DCs. Allogeneic and allergen-specific co-
cultures showed that PM-activated DCs generated T cells producing higher
levels of IFN-gamma and IL-10 and lower levels of IL-5 or IL-4 than N- or
P-activated DCs. Splenocytes from mice immunized with PM showed a
Th1 cytokine-signature and high levels of IL-10 with higher proliferation
than those from mice immunized with N or P.
CONCLUSIONS: Grass pollen hypoallergenic allergoids conjugated to
mannan may represent safer and more effective novel vaccines due to their
enhanced immunogenicity and capacity to promote Th1 mediated T cell
responses to allergens.
155
 AB402 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014

L14 Upregulated Matrix Metalloproteinase 2/9 Activity in Murine

Asthma Detected with Activatable Cell-Penetrating Peptides
Csilla N. Felsen, Elamprakash N. Savariar, Michael Whitney, Roger Y.
Tsien; University of California, San Diego.
RATIONALE: Asthma, an airway inflammatory disease characterized by
intermittent airway obstruction, affects more than 300 million people
worldwide. Matrix metalloproteinase 2 and 9 (MMP2/9) mRNA and
protein levels correlate with asthma pathogenesis; however, the role of
MMP2/9 in asthma is not well understood, particularly because previous
studies have not evaluated protease activity. We report the application of
activatable cell-penetrating peptides (ACPPs), injectable probes that
highlight in vivo protease activity, to assess protease activity in murine
asthma.
METHODS: Asthma mice were sensitized (ovalbumin [OVA] + alum in
saline [PBS]) and then challenged (OVA in PBS). Age-matched control
mice were sensitized but not challenged. The day after the final OVA
challenge, ACPPs (cleavable and uncleavable, n 5 3-6 mice each) were
administered intravenously 6 hr before mice were sacrificed. Lungs were
imaged for Cy5 fluorescence (Maestro, CRi). Lung sections (10 mm, 8
images/mouse) were imaged for Cy5 fluorescence on a confocal micro-
scope (5Live, Zeiss) and stained with hematoxylin and eosin.
RESULTS: MMP2/9 activity was > 2-fold higher in lungs from asthma
mice than controls (p 5 1.831024). The same pattern was observed for ra-
tiometric ACPPs. MMP2/9 activity localized around inflamed airways with
1.6-fold higher ACPP uptake surrounding airways compared to the normal
lung parenchyma (p 5 0.03). MMP2/9 activity detected by ACPPs
co-localized with gelatinase activity measured with in situ DQ gelatin.
CONCLUSIONS: MMP-activated ACPPs allow for real-time detection
of protease activity in a murine asthma model, improving our understand-
ing of protease activation in asthma progression and elucidating novel
therapy targets.
L16 Efficacy and Safety of Lebrikizumab in Severe Uncontrolled
Asthma: Results from the Lute and Verse Phase II
Randomized, Double-Blind, Placebo-Controlled Trials
Nicola A. Hanania, MD1, Michael J. Noonan, MD2, Jonathan
Corren, MD3, Phillip Korenblat, MD, FAAAAI4, Yanan Zheng, PhD5,
Wendy Putnam, PhD5, Elaine Murray, MD5, Connie Abelardo, MD5,
Heleen Scheerens, PhD5, Romeo Maciuca, PhD5, Sarah Gray, PhD5,
Ramona Doyle, MD5, Dana McClintock, MD5, John G.
Matthews, MBBS, MRSCP, PhD5, Karl Yen, MD, MMSc, FAAP5;
1
Baylor College of Medicine, Houston, TX, 2Allergy Associates
Research, Portland, OR, 3Allergy Medical Clinic, Los Angeles, CA,
4
Clinical Research Center LLC, St. Louis, MO, 5Genentech, Inc., South
San Francisco, CA.
RATIONALE: A subset of severe asthma patients are inadequately
controlled despite treatment with inhaled corticosteroids (ICS) and a
second controller. Lebrikizumab is a humanized antibody to IL-13, a key
effector cytokine in asthma pathogenesis. In a previous Phase 2 trial,
lebrikizumab treatment increased forced expiratory volume in 1 sec
(FEV1), particularly in patients with higher blood periostin levels.
METHODS: LUTE and VERSE were replicate, multicenter, double-
blind studies that randomized (1:1:1:1) patients with uncontrolled
asthma despite treatment with ICS and a second controller to receive
lebrikizumab 37.5mg, 125mg, 250mg, or placebo subcutaneously every
4 weeks. The primary endpoint was the rate of exacerbations.
Secondary endpoints included change in FEV1. The trials, initially
Phase 3, were converted to Phase 2b upon identification of a process-
related impurity requiring changes to the lebrikizumab manufacturing
process.
RESULTS: 463 patients were pooled for analysis. The median number
of doses received was 6 (range 112). Compared with placebo (n5116),
the exacerbation rate (95% CI) was reduced by 62% (23%83%;
n5117), 35% (217%65%; n5112), and 11% (254%49%; n5118)

L15 Asthma and Airway Hyperresponsiveness in Children with

Eosinophilic Esophagitis: EGF and FGF-2 As a Link
Dr. Nadia L. Krupp, MD1, Prof. Sarita Sehra, PhD2, Dr. Sandeep K.
in all patients and by 81% (35%97%), 77% (26%95%), and
22% (262%63%) in periostin-high (> _50ng/mL) patients in the
lebrikizumab 37.5mg, 125mg, and 250mg groups, respectively. At
Gupta, MD1, Prof. Mark H. Kaplan, PhD1, Dr. Robert S. Tepper, MD3; Week 12, increases in FEV1 were greater for lebrikizumab versus pla-
1
Indiana University School of Medicine, Indianapolis, IN, 2Indiana cebo, particularly in periostin-high patients. No important safety signals
University School of Medicine, 3Riley Hospital for Children, Indianapo- were observed.
lis, IN. CONCLUSIONS: Lebrikizumab treatment reduced the exacerbation rate
RATIONALE: Asthma is prevalent in children with eosinophilic esoph- and increased FEV1 in patients with uncontrolled asthma on ICS and a sec-
agitis (EoE), previously estimated at 24-42% versus 9% for the general ond controller, particularly those who were periostin-high, confirming the
population. However, studies of pulmonary function and airway hyper- findings from the previous Phase 2 trial.
responsiveness (AHR) in children with EoE are lacking.
METHODS: A cross-sectional study was conducted of children aged 6-18
years with EoE and healthy controls. Methacholine challenge (AHR
defined as provocative concentration of methacholine <8mg/ml), and
exhaled nitric oxide were performed. Peripheral blood was analyzed for
total IgE, eosinophil count, eotaxin, and serum cytokines.
RESULTS: Baseline spirometry was normal and not significantly
different for EoE subjects (n533) and healthy controls (n537). AHR
was present in 33% of children with EoE and 10.8% of healthy controls
(p50.04). 20% of EoE subjects with asthma (n515) had AHR, versus 44%
of EoE subjects without asthma (n518). Overall, 69.7% of EoE subjects
had either asthma or AHR. AHR correlated strongly with serum IgE
(p<0.0001) and exhaled nitric oxide (p50.0002). Epidermal growth factor
(EGF) and fibroblastic growth factor 2 (FGF-2) were elevated in subjects
with EoE and asthma , compared to healthy controls and those with EoE but
no asthma (p<0.05). Subjects with EoE and asthma who were on asthma
controller medications had similar levels of EGF and FGF-2 as healthy
controls. Th2 cytokines and eotaxin did not differ significantly among any
groups.
CONCLUSIONS: Asthma and AHR may be more prevalent than
previously estimated in children with EoE. Serum elevations of EGF and
FGF-2 were seen in EoE subjects with asthma, but not in subjects on
asthma controller medications.

156
J ALLERGY CLIN IMMUNOL
VOLUME 133, NUMBER 2
L17 Dose-Finding Efficacy and Safety Trial of House Dust Mite
Sublingual Immunotherapy Tablet, MK-8237, Using an
Environmental Exposure Chamber
Dr. Hendrik Nolte, MD, PhD1, Dr. Jennifer Maloney, MD1, Dr. Harold S.
Nelson, MD, FAAAAI2, Dr. David I. Bernstein, MD, FAAAAI3,
Dr. Ziliang Li, PhD1, Rene Zieglmayer4, Dr. Petra U. Zieglmayer, MD4,
Dr. Friedrich Horak, MD4; 1Merck, Whitehouse Station, NJ, 2National
Jewish Health, Denver, CO, 3Bernstein Allergy Group, Cincinnati, OH,
4
Vienna Challenge Chamber, Vienna, Austria.
RATIONALE: Sublingual immunotherapy with house dust mite (HDM)
might be beneficial in patients with allergic rhinitis with/without
conjunctivitis (AR/C), although reported effect size is small to moderate
and varies greatly among studies. MK-8237 (Merck/ALK-Abell o) is a
sublingual HDM immunotherapy tablet currently under investigation.
METHODS: In this randomized, double-blind, single-site trial adults with
HDM-induced AR/C with/without asthma (n5124) received daily MK-
8237 12 DU, 6 DU, or placebo for 24 weeks, and underwent exposure
challenges (Vienna Challenge Chamber) at weeks 8, 16, and 24. The
primary objective was to evaluate the dose-related efficacy of MK-8237
versus placebo on total nasal symptom score (TNSS) during chamber
challenge at week 24. TNSS was the sum of 4 nasal symptom scores
(maximum512).
RESULTS: MK-8237 12 DU and 6 DU provided a 48.4% and 26.2%
improvement, respectively, in TNSS at week 24 versus placebo (mean
difference: 23.62, P< .001 and 21.98, P5.003). TNSS improvements
were also observed at weeks 8 (mean difference: 21.37, 20.3%;
P5.007) and 16 (mean difference: 22.08, 30.1%; P<.001) for the 12
DU dose and week 16 (mean difference: 21.23, 17.8%; P5.032) for the
6 DU dose. Total symptom scores (nasal+ocular symptoms) were signifi-
cantly improved by both doses versus placebo at week 24. Both doses of
MK-8237 were well tolerated, with no systemic allergic reactions or reac-
tions requiring epinephrine.
CONCLUSIONS: MK-8237 appears promising, with potential for high
and clinically meaningful (>20% reduction in symptoms) effect to be
further evaluated in field trials. A dose-dependent effect was observed,
with the 12 DU dose exhibiting the best benefit/risk ratio.
L18 Long-Lasting Egg Consumption in Egg Allergic Children
Treated with Oral Immunotherapy (OIT): Follow-up from the
Consortium of Food Allergy Research (CoFAR) Study
Stacie M. Jones, MD1, A. Wesley Burks, MD, FAAAAI2, Robert A.
Wood, MD, FAAAAI3, David Mark Fleischer, MD, FAAAAI4, Scott H.
Sicherer, MD, FAAAAI5, Alice Henning, MS6, Robert Lindblad, MD7,
Peter Dawson, PhD6, Brian P. Vickery, MD, FAAAAI2, Corinne
Keet, MD, MS3, Andrew H. Liu, MD4, Dr. Amy M. Scurlock, MD1,
Hugh A. Sampson, MD, FAAAAI5; 1University of Arkansas for Medical
Sciences and Arkansas Childrens Hospital, Little Rock, AR, 2University
of North Carolina, Chapel Hill, NC, 3Johns Hopkins University Medical
Center, Baltimore, MD, 4National Jewish Health, Denver, CO, 5Mount
Sinai School of Medicine, New York, NY, 6The EMMES Corporation,
Rockville, MD, 7The EMMES Corporation, Ro, MD.
RATIONALE: Egg OIT results in sustained unresponsiveness (SU) in a
subset of egg-allergic children; however, long-term treatment effects off-
therapy are not established.
METHODS: Egg-allergic children (5-18 y/o) received egg OIT (n540),
maximum 4 years, or placebo (n515), maximum 1 year. Through year 4,
subjects were assessed as SU (passed OFC after 4-6 weeks off OIT) or
desensitized (D) (passed OFC on therapy only). SU subjects were
instructed to add unbaked egg ad libitum; other subjects added egg
independent of physician instruction. Long-term, follow-up questionnaires
(LFQ) were administered at a median of 61.6 months from enrollment to
assess unbaked (lightly cooked) vs. baked (heat-denatured) egg consump-
tion in current diet and symptoms.
RESULTS: Of 40 egg OIT-treated subjects, 22/40(55%) were SU by year
4 (versus 27.5% at year 2). Of 8,925 egg OIT doses in years 2-4, 95% were
symptom-free. 45/55 (81.8%) subjects completed the LFQ. More egg OIT
Abstracts AB403
subjects [23/34(67.6%)] consumed unbaked and baked egg vs. placebo
subjects [2/11(18.2%)] (p50.006). 20/20 (100%) OIT-SU subjects were
consuming all forms of egg in their diet. 7/8 (87.5%) OIT-D subjects were
consuming some egg; 3 unbaked and 4 only baked egg. 1/6 (16.7%) OIT-
not-desensitized subjects were consuming only baked egg. 4/11 (36.4%)
placebos were consuming some egg; 2 unbaked and 2 only baked egg.
CONCLUSIONS: Findings suggest sustainability of long-term egg
consumption among subjects demonstrating SU after completion of egg
OIT. Future work is needed to identify individuals who will benefit from
egg OIT.
L19 A Randomized, Double-Blind, Placebo-Controlled Trial of
Omalizumab Combined with Oral Immunotherapy (OIT) in
the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing
Dr. Jennifer S. Kim, MD, FAAAAI1, Robert A. Wood, MD, FAAAAI2,
Robert Lindblad, MD3, Ms. Sally A. Noone, RN, MSN, CCRC1,
Ms. Melissa N. Paterakis, RN, BSN2, Alice Henning, MS3, Dr. Kari C.
Nadeau, MD, PhD, FAAAAI4, Kyrsten Spann4, Hugh A. Sampson, MD,
FAAAAI1; 1Icahn School of Medicine at Mount Sinai, New York, NY,
2
Johns Hopkins University Medical Center, Baltimore, MD, 3The
EMMES Corporation, Rockville, MD, 4Stanford University, Stanford,
CA.
RATIONALE: Determine whether the addition of omalizumab reduces
dosing-related side-effects in subjects with CMA undergoing milk OIT.
METHODS: Fifty-seven milk-allergic subjects (7-32 y/o) confirmed by
DBPCFC with a milk-specific IgE >0.35 kUA/L and/or positive PST were
randomized 1:1 to receive blinded omalizumab or placebo for 16 months.
Open-label milk OIT dosing was initiated after Month 4 of omalizumab/
placebo with an escalation to maintenance over 22-40 weeks; goal - 3.84 g
milk protein/day.
RESULTS: At enrollment, there were no statistically significant differ-
ences between the omalizumab/placebo treatment arms for age, milk
specific-IgE (39.4 vs. 42.0 kUA/L), milk PST wheal (10.0 vs. 8.0 mm) or
OFC dose at first symptom (20 vs. 20 mg). Three subjects withdrew prior to
OIT dosing. Significant differences between the omalizumab (n526) and
placebo (n528) groups were seen for dose-related symptoms per subject
during dose escalation and maintenance therapy through 16 months
(median: 5.0 vs. 47.5; p50.0001), dosing reactions requiring treatment
(median: 1.0 vs. 12.0; p50.0003), and need for epinephrine (1 time in 1
omalizumab subject vs. 17 times in 9 placebo subjects). Significantly fewer
doses were required to achieve maintenance dosing in the omalizumab
group (median: 198.0 vs. 224.5; p50.01) resulting in a shorter escalation
phase with omalizumab (25.9 vs. 30.8 weeks; p50.01).
CONCLUSIONS: This is the first randomized, double-blinded, placebo-
controlled OIT trial demonstrating that omalizumab significantly reduces
the dosing symptoms and treatment requirements, including epinephrine,
of OIT-related side-effects and reduces the time to achieve maintenance
dosing. Future DBPCFCs will determine whether omalizumab improves
the induction rate of desensitization and tolerance.
157
 AB404 Abstracts J ALLERGY CLIN IMMUNOL
FEBRUARY 2014

L20 Dupilumab Monotherapy in Adults with Moderate-to-Severe

Atopic Dermatitis: A 12-Week, Randomized, Double-Blind,
Placebo-Controlled Study
Prof. Thomas R. M. Bieber, MD, PhD, FAAAAI1, Dr. Diamant
Thaci, MD2, Dr. Neil Graham, MD3, Dr. Gianluca Pirozzi, MD, PhD4,
Dr. Ariel Teper, MD4, Dr. Haobo Ren, PhD5, Dr. Allen Radin, MD3;
1
Friedrich-Wilhelms University of Bonn, Bonn, Germany, 2Universitat
zu L ubeck, Lubeck, Germany, 3Regeneron Pharmaceuticals, Inc.,
Tarrytown, NY, 4Sanofi, Bridgewater, NJ, 5Regeneron Pharmaceuticals,
Inc., Basking Ridge, NJ.
RATIONALE: Dupilumab, a human monoclonal antibody targeting the
IL-4Ra subunit, blocks IL-4/IL-13 signaling.
METHODS: This European trial randomized adults with moderate-to-
severe atopic dermatitis poorly controlled by topical agents to 12 weekly
subcutaneous doses of placebo (n554) or dupilumab 300 mg (n555);
topical agents were not permitted. Primary efficacy endpoint was percent
change in Eczema Area and Severity Index (EASI) score from baseline to
week 12. Secondary endpoints included changes from baseline in EASI,
body surface area, SCORAD, pruritus numerical rating scale, and 5-D
Pruritus Scale; proportions of patients achieving EASI reduction > _50%
(EASI-50), Investigators Global Assessment (IGA) 0 or 1, and safety were
assessed.
RESULTS: Baseline characteristics were similar between groups (EASI
mean 6SD: 23.12612.35 on dupilumab and 24.10612.70 on placebo).
Percent change from baseline in EASI showed improvements that
significantly favored dupilumab relative to placebo, -74.0% and -23.3%,
respectively (P<0.0001). EASI-50 responder rate was 85.5% with dupilu-
mab and 35.2% with placebo (P<0.0001). Other measures of disease activ-
ity (SCORAD and IGA) and pruritus scores significantly favored
dupilumab (P<0.0001). Eleven SAEs were reported in the placebo group
compared to 1 in the dupilumab group. Skin infections were also reported
less often in dupilumab group (2[4%] vs 14[26%]). Treatment-emergent
adverse events (TEAEs) were 74.5% with dupilumab and 77.8% with pla-
cebo. Frequent TEAEs reported more often with dupilumab were injection
site reactions and nasopharyngitis.
CONCLUSIONS: In this study, 12 weeks of dupilumab monotherapy was
associated with rapid, marked improvements in measures of disease
activity and pruritus, fewer SAEs, less infections compared to placebo,
and was generally well-tolerated.

158
 ACGME ComPETENCY INDEX

To contribute to the development of our members as lifelong learners Professionalism

and to enhance the effectiveness of the CME activities it provides, the
AAAAI uses the six competencies defined by the Accreditation Council
for Graduate Medical Education (ACGME) to guide its educational
programming decisions. The six competencies are:
Patient Care
Medical Knowledge
Practice-Based Learning and Improvement
Interpersonal and Communication Skills
Professionalism
Systems-Based Practice
All sessions at the Annual Meeting address the competencies of
Patient Care and Medical Knowledge. Below is a list of sessions that
address the other competencies:
Interpersonal and Communication Skills
0001, 1101, 1112, 1203, 1209, 1209AD, 1301, 1302, 1501, 1603,
1609, 1611, 1802, 1805, 2004, 2007, 2011, 2013, 2023, 2025, 2251,
2305, 2306, 2307, 2507, 2524, 2526, 2625, 2701, 2803, 2804, 2813,
2814, 2815, 2816, 2823, 2824, 3002, 3004, 3006, 3008, 3010, 3014,
3015, 3043, 3044, 3304, 3306, 3308, 3312, 3314, 3315, 3521, 3526,
3551, 4001, 4002, 4006, 4015, 4303, 4304, 4803, 4812, 4813, 5001,
5002, 5003, 5004, 5007, 5008, 5054, 5304, 5311, 5312, 5801, 5807,
5808, 5809
1102, 1112, 1201, 1203, 1209, 1209AD, 1210, 1301, 1401, 1501,
1601, 1603, 1608, 1609BC, 1611, 1621, 1701, 1805, 2004, 2011,
2012, 2013, 2251, 2301, 2311, 2316, 2510, 2521, 2526, 2623, 2811,
2812, 2814, 2823, 2825, 3004, 3008, 3010, 3013, 3014, 3015, 3302,
3304, 3305, 3306, 3312, 3313, 3520, 3524, 3525, 3526, 3551, 4001,
4006, 4015, 4805, 4807, 5001, 5007, 5008, 5053, 5054, 5304, 5311
System-based Practice
1011, 1203, 1207, 1209AD, 1209BC, 1605, 1607, 1609AD, 1609BC,
1610, 1611, 1613, 1802, 1803, 1901, 1903, 1904, 2001, 2002, 2004,
2009, 2010, 2011, 2304, 2305, 2306, 2307, 2314, 2315, 2316, 2501,
2502, 2503, 2504, 2506, 2507, 2508, 2509, 2510, 2512, 2515, 2521,
2522, 2525, 2526, 2611, 2623, 2701, 2801, 2802, 2804, 2805, 2807,
2808, 2809, 2813, 2814, 2815, 2816, 3001, 3002, 3004, 3009, 3010,
3011, 3012, 3013, 3014, 3301, 3303, 3306, 3307, 3315, 3521, 3522,
3523, 3524, 3525, 4001, 4002, 4004, 4005, 4007, 4010, 4012, 4015,
4051, 4101, 4301, 4302, 4303, 4305, 4803, 4804, 4805, 4806, 4809,
4811, 4812, 4813, 4814, 4815, 4823, 4824, 5001, 5002, 5006, 5009,
5052, 5053, 5101, 5302, 5311, 5313, 5314, 5503, 5505, 5506, 5522,
5523, 5801, 5807, 5808
For more information about the ACGMEs physician competencies, visit
http://www.acgme.org.

Practice-based Learning and Improvement

1011, 1101, 1101A, 1101B, 1101C, 1101D, 1201, 1202, 1204, 1205,
1206, 1207, 1208, 1209, 1209BC, 1210, 1301, 1402, 1501, 1601,
1602, 1604, 1605, 1606, 1607, 1608, 1609, 1609AD, 1609BC, 1610,
1612, 1613, 1701, 1801, 1802, 1803, 1804, 1901, 1902, 1903, 1904,
1905, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2012, 2013,
2014, 2015, 2021, 2022, 2023, 2024, 2025, 2026, 2101, 2252, 2301,
2302, 2303, 2304, 2305, 2306, 2308, 2311, 2312, 2313, 2314, 2315,
2501, 2502, 2503, 2504, 2505, 2506, 2507, 2508, 2511, 2513, 2514,
2521, 2522, 2523, 2524, 2525, 2526, 2527, 2611, 2621, 2622, 2624,
2625, 2801, 2802, 2803, 2804, 2805, 2806, 2809, 2810, 2812, 2814,
2815, 2816, 2821, 2822, 2824, 3001, 3002, 3003, 3004, 3005, 3006,
3007, 3008, 3009, 3010, 3011, 3012, 3015, 3041, 3042, 3043, 3101,
3301, 3302, 3303, 3304, 3307, 3311, 3312, 3313, 3314, 3315, 3521,
3522, 3523, 3524, 3526, 3527, 4001, 4002, 4003, 4005, 4007, 4008,
4009, 4010, 4011, 4012, 4013, 4014, 4101, 4301, 4302, 4303, 4304,
4305, 4306, 4307, 4701, 4801, 4802, 4803

160
 exhibits

Abbott Nutrition Alcon Laboratories, Inc.

3300 Stelzer Road 6201 South Freeway
Columbus, OH 43219 Fort Worth, TX 76134
Phone: (614) 624-7677 Phone: (817) 551-4067
www.abbottnutrition.com www.alcon.com
Booth #320 Booth #401
Abbott Nutrition is one of the worlds leading authorities in science- As a global leader in eye care, Alcons mission is to provide innovative
based nutrition for all stages of life. As your nutrition partner, we invite products that enhance quality of life by helping people see better. We
you to visit us and explore our portfolio of products, including EleCare, are committed to making significant contributions to preserve, restore
PediaSure Peptide, and PediSure to help your patients grow and and enhance vision by working to address the worlds most pressing
achieve greater well-being. eye care needs.

Accredo ALK
1640 Century Center 1700 Royston Lane
Memphis, TN 38134 Round Rock, TX 78664
Phone: (877) 222-7336 Phone: (866) 255-7722
www.accredo.com www.alk.net/us
Booth #110 Booth #1005
ALK is a research driven, global pharmaceutical company focusing
AD RescueWear on allergy treatment, prevention and diagnosis. As the world leader
3801 S. Grape Street in allergy immunotherapy, a treatment given to increase immunity to
Denver, CO 80237 substances causing allergic symptoms, ALK is devoted to improving
Phone: (303) 953-4137 the quality of life for people with allergies by creating products that
www.ADRescueWear.com treat the cause of allergies. ALK is also committed to supporting the
Booth #724 business of allergy by providing diagnostic tools, automation software
AD RescueWear is the 1st and only U.S. company to manufacture and and customized business, technical and clinical consulting services.
sell wet wrap therapy products for the treatment of childhood atopic
dermatitis/eczema. These products are a breakthrough for parents, Allergan
doctors and nurses who have struggled with wet wrapping children 2525 Dupont Drive
with atopic dermatitis/eczema. Parents and caregivers can now do a Irvine, CA 92612
full body wet wrap treatment in under 2 minutes with our ultra soft Phone: (714) 246-4500
fabric that absorbs 50% more moisture than cotton. 6% Spandex www.allergan.com
keeps the fabric close to the childs skin for fast, easy and extremely Booth #815
effective wet wrap therapy. The Wrap-E-Soothe products are also great Recently celebrating its 60th anniversary, Allergan is a global leader
worn dry for dry wrapping eczema and are excellent as a protection in discovering and developing therapeutic agents to advance patient
layer for healing skin. Machine washable makes AD RescueWear care. Allergan is also one of the fastest-growing eye care companies
products more cost effective than traditional gauze. worldwide. Eye care professionals and patients rely on Allergan
products to treat a variety of eye conditions. Visit www.allergan.com for
Aerocrine more information.
5151 McCrimmon Parkway
Suite 260
Morrisville, NC 27560
Phone: (919) 518-3073
www.aerocrine.com
Booth #425
Aerocrine AB is a medical technology company focused on the
improved management and care of patients with inflammatory airway
diseases. As the pioneer and leader in the technology to monitor and
manage airway inflammation, Aerocrine markets NIOX Flex and NIOX
MINO. Both products enable fast and reliable management of airway
inflammation and may therefore play a critical role in more effective
diagnosis, treatment and follow-up of patients with inflammatory
airway diseases such as asthma. Aerocrine is based in Sweden with
subsidiaries in the US, Germany and the UK. Aerocrine shares were
listed on the Stockholm Stock Exchange on June 15 2007.

161
 exhibits

Allergy & Asthma Network Allergy Guardian

8229 Boone Blvd, Suite 260 7422 Carmel Executive Park, #310B
Vienna, VA 22182 Charlotte, NC 28226
Phone: (800) 878-4403 Phone: (704) 910-8075
http://www.aanma.org www.allergyguardian.com
Booth #1042 Booth #423
Allergy & Asthma Network is the leading patient advocacy organization
dedicated to ending the needless death and suffering due to asthma, Allergy Laboratories, Inc.
allergies and related conditions through outreach, education and 1005 SW 2nd Street
advocacy. Oklahoma City, OK 73109
Phone: (405) 235-1451
Allergy and Asthma Proceedings www.allergylabs.com
95 Pitman Street Booth #621
Providence, RI 02906 Established in 1929, Allergy Laboratories, Inc. is proud to be the only
Phone: (401) 331-2510 American owned allergenic extract manufacturer. We produce a full
www.allergyandasthmaproceedings.com range of diagnostic and therapeutic allergens, as well as sterile empty
Booth #520 vials and pre-filled vials of allergenic extract diluting solutions. We
The primary focus of Allergy & Asthma Proceedings is directed to the invite your inquires.
publication of articles with the highest degree of clinical relevance
for the practicing allergist/immunologist. Additionally the Proceedings American Express OPEN
is committed to medical education, having recently published the
200 Vesey Street
teaching tool, Northwestern University A-I Syllabus for Medical Students
New York, NY 10285
& Residents. Academically, the Proceedings has established a 34 year
Phone: (212) 640-2000
reputation as a National Library of Medicine/PubMed indexed journal
www.open.com
with circulation at 5000 and impact factor of 2.19.
Booth #820
Allergy Control Products American Latex Allergy Association (ALAA)
1620 Satellite Boulevard, Suite D
PO Box 198
Duluth, GA 30097
Slinger, WI 53086
Phone: (800) 255-3749
Phone: (608) 874-4044
www.AllergyControl.com
www.latexallergyresources.org
Booth #525
Booth #933
For over 30 years, Allergy Control Products has been a trusted source
Latex allergy educational resources.
for helpful allergen avoidance information and effective allergy relief
products. We value our relationship with AAAAI Physicians and look American Partnership for Eosinophilic Disorders
forward to seeing physicians who have supported us throughout the
P.O. Box 29545
years and to meeting new physicians who wish to learn more about
Atlanta, GA 30359
environmental controls and how they can benefit patents.
Phone: (713) 493-7749
www.apfed.org
Booth #943
The American Partnership for Eosinophilic Disorders (APFED) is a
nonprofit patient advocacy group dedicated to improving the lives of
those with eosinophil associated diseases. Our mission is education,
awareness, support and research.

162
 exhibits

Asthma and Allergy Foundation of America Baxter Healthcare

(AAFA) One Baxter Parkway
8201 Corporate Drive, Suite 1000 Deerfield, IL 60015
Landover, MD 20785 Phone: (224) 948-2000
Phone: 1-800-7ASTHMA www.baxter.com
www.aafa.org Booth #607
Booth #735 Baxter Healthcare Corporation, along with its subsidiaries, develops,
The Asthma and Allergy Foundation of American (AAFA) is dedicated manufactures and markets healthcare products that save and sustain
to improving the quality of life for people with asthma and allergies by the lives of people with hemophilia, immune disorders, infectious
providing free patient education, advocating on behalf of patients, and diseases, kidney disease, trauma, and other chronic and acute medical
supporting ongoing medical research. Kids with Food Allergies, a divi- conditions. As a global, diversified healthcare company, Baxter applies
sion of AAFA, provides support for families with food allergies. Please a unique combination of expertise in medical devices, pharmaceuticals
visit www.aafa.org for more information. and biotechnology to create healthcare products that advance patient
care worldwide. Come visit Baxters BioTherapeutics booth, where
Axelacare Health Solutions our specialists will be available to answer your questions about
9801 Renner Blvd, Ste 275 Baxter products and our commitment to the fields of immunology and
Lenexa, KS 66215 neurology. For more information on Baxters products and services,
Phone: (913) 747-3703 please visit www.baxter.com.
www.axelacare.com
Booth #527 Baxter Healthcare, Global Medical Affairs
AxelaCare specializes in the administration of Immune Globulin IVIG One Baxter Parkway
and other infusible medications. CareExchange is our proprietary Deerfield, IL 60015
clinical outcomes measurement system using validated data that is Phone: (224) 948-2000
collected and presented in simple graphical display via secure web www.baxter.com
access to clinicians to determine optimal care based on dose vs. time Booth #722
and collected outcomes.
Bio Products Laboratoy
Baby Healthcare Inc 4445 N A1A, Suite 225
2192 Dupoint Drive, Suite 108 Vero Beach, FL 32963
Irvine, CA 92612 Phone: (772) 453-9084
Phone: (949) 333-1299 www.gammaplex.com
www.babyhealthcare.us Booth #1003
Booth #726 Gammaplex Immune Globulin Intravenous (Human) 5% Liquid with
Baby Health Care, Inc. has been specializing in providing high quality FDA approval for Primary Humoral Immunodeficiency (PI ) and is also
health care devices for babies. As a pioneer for the home-use nasal indicated for the treatment of chronic immune thrombocytopenic
aspirator, we are applying innovative technology and sophisticated purpura (ITP).
design to all of our products to keep our devices reliable and enjoyable.

163
 exhibits

Biogenics Research Chamber Boston Scientific

8299 Fredericksburg Road 100 Boston Scientific Way
San Antonio, TX 78229 Marlborough, MA 01752
Phone: (210) 614-2564 Phone: (877) 810-6060
www.biogenicschamber.com www.BTforAsthma.com
Booth #432 Booth #821
Biogenics Research Chamber is a United States based allergen Boston Scientific has developed the first device to treat adult patients
challenge chamber designed to conduct allergic rhinoconjunctivitis with severe asthma. Bronchial Thermoplasty (BT) delivered by the Alair
studies in a controlled environment. We have the experience and System is a safe outpatient procedure clinically proven to provide long-
expertise to accomplish the goals of each clinical trial conducted at lasting reduction in exacerbations and a 79% significant improvement
Biogenics. in patients asthma related quality of life. For more information, please
visit www.BTforAsthma.com Prescription only.
Biomed Pharmaceuticals
950 Calcon Hook Rd, Suite 15 Burkard Manufacturing
Sharon Hill, PA 19079 Woodcock Hill Industrial Estate, Unit 7
Phone: (888) 244-2340 Harefield Road
www.biomed-rx.com Rickmansworth, WD3 1PJ
Booth #240 United Kingdom
Biomed is a leading pharmacy provider of intravenous, injectable and Phone: +44-1923-773134
oral medications for patients with complex and chronic conditions. We www.burkard.co.uk
strive to provide comprehensive patient-specific services and efficient Booth #433
coordination of care with physicians and their staff to achieve optimal Burkard will be exhibiting a new multi-vial cyclone sampler using DNA,
therapeutic outcomes. We are dedicated to delivering superior care ELISA or real time analysis. Also, laboratory and field instruments using
through our strategically located pharmacies and highly-qualified the new cyclone techniques together with personal air monitors for
infusion nurses nationwide. Programs include bleeding disorder sampling directly into microtitre wells. Many of the instruments will be
management, immune globulin therapies, transplant, acute and more. displayed under power.
As part of each, education and training is provided to patients and
caregivers from clinical staff who are committed to improving patient Buzzy Personal Pain Solutions
lives. MMJ Labs, LLC
322 Sutherland Place NE
Biotest Pharmaceuticals Corporation Atlanta, GA 30307
5800 Park of Commerce Blvd NW Phone: (877) 805-2899
Boca Raton, FL 33487 www.buzzy4shots.com
Phone: (561) 989-5800 Booth #227
www.biotestpharma.com Buzzy is a handheld medical device that uses vibration and cold to
Booth #926 confuse the nerves and deliver powerful pain blocking right where its
Biotest Pharmaceuticals researches and manufactures biotherapeutic needed.
products with a specialization in immunology and hematology. Biotest
Pharmaceuticals is a leader in the collection of source plasma and is Carestream
currently involved in the development of plasma protein products in 1765 The Exchange
the field of Primary Immune Deficiency (PID) and various hyperimmune Atlanta, GA 30339
(IG) products which are antibody specific to high titer for treatment of Phone: (888) 477-4359
modality. www.carestream.com/ent-allergy
Booth #534
For fast and accurate CT images, choose the CARESTREAM CS 9300:
the point-of-care CT system that is easy to implement and afford.
Featuring a range of fields of view and resolutions, the unit is ideal for
visualizing temporal bone and sinus structuresand all with much less
radiation than conventional multi-slice CT exams.

164
 exhibits

Clinical Immunology Society Crowell Systems

555 East Wells Street, Suite 1100
Milwaukee, WI 53202
Phone: (414) 224-8095
www.clinimmsoc.org
Booth #1027
The Clinical Immunology Society (CIS) is devoted to fostering
developments in the science and practice of clinical immunology. CIS
is an international professional organization which includes more than
600 clinicians, investigators, and trainees. The mission of CIS is to
facilitate education, translational research, and novel approaches to
therapy in clinical immunology to promote excellence in the care of
patients with immunologic/inflammatory disorders.
Corpus Christi Allergy & Asthma Center
2502 Morgan Avenue
Corpus Christi, TX 78405
Phone: (361) 888-6782
www.asthmaandallergy.com
Booth #236
The Corpus Christi Allergy Asthma Dermatology Clinic is currently
seeking a Physician to join the practice. This is an outstanding
opportunity for a BC/BE allergist to join one of the largest most
prestigious solo Allergy Asthma Immunology practice in the country.
Hospitals are dangerous places for asthmatics. The Corpus Christi
Allergy & Asthma Center is committed to keeping asthmatics, of
all ages, well and out of the hospital. It is our belief that, The Best
Allergist Uses The Fewest Medicines, and thus avoids their Phone: (800) 238-7828
dangerous side effects.
4235 South Stream Blvd., Suite 100
Charlotte, NC 28217
Phone: (704) 665-2000
www.crowellsystems.com
Booth #328
You are invited to see Medformix Vue The Fastest New Visual
Interface Easiest to Use System Available It Will Save You Money It Will
Increase Your Efficiency Comprehensive Allergy Software EMR & PM &
Shots & Extract See the System Practices Everywhere are Raving About
CSL Behring
1020 1st Avenue
King of Prussia, PA 19406-0901
Phone: (610) 878-4000
www.cslbehring-us.com
Booth #507
CSL Behring is a leader in the plasma protein therapeutics industry.
The company manufactures and markets plasma-derived and
recombinant therapies worldwide. CSL Behring therapies are used
around the world to treat coagulation disorders, primary immune
deficiencies, hereditary angioedema and inherited respiratory disease,
and neurological disorders in certain markets.
CVS Caremark Specialty Pharmacy
3424 William Penn Highway, Suite 250
Pittsburgh, PA 15235
http://www.cvscaremarkspecialtyrx.com/
Booth #434
Personalized Specialty Pharmacy Services
Our commitment to helping patients and their physicians manage
complex drug therapies by delivering individualized care with expertise,
compassion and dedication has made us one of the leading specialty
pharmacies in the country. To learn more or to enroll patients, call
1-800-238-7828.

165
 exhibits

Dyax Corp European Academy of Allergy and Clinical

55 Network Drive Immunology
Burlington, MA 01803 Hagenholzstrasse 111
Phone: (617) 225-2500 Zurich, 8050
dyax.com/index.html Switzerland
Booth #533 Phone: +41 44 205 55 33
Dyax is a fully integrated biopharmaceutical company focused on the www.eaaci.org
discovery, development and commercialization of novel biotherapeutics Booth #927
for unmet medical needs. Since February 2010, the Company has been The European Academy of Allergy and Clinical Immunology (EAACI) is a
selling KALBITOR (ecallantide) in the United States for the treatment non-profit organization active in the field of allergic and immunologic
of acute attacks of hereditary angioedema (HAE). diseases such as asthma, rhinitis, eczema, occupational allergy, food
and drug allergy and anaphylaxis. EAACI was founded in 1956 in
Edge Pharmaceuticals, LLC Florence and has become the largest medical association in Europe
7264 NW 63rd Terrace in the field of allergy and clinical immunology. It includes nearly
Parkland, FL 33067 8,000 members from 121 countries, as well as 42 National Allergy
Phone: (877) 580-3343 Societies. EAACIs mission is to promote basic and clinical research; to
Booth #622 collect, assess and diffuse scientific information; to act as a scientific
We specialize in Sublingual (SLIT) and Nasal Metered Dose Delivery reference body for other scientific, health and political organizations;
Systems; allergy testing and treatment materials; specialty pharmacy to encourage and provide training and continuous education, and to
compounding services and products such as: sublingual treatment collaborate with patients and lay organizations. The Academy aims to
material, compounded capsules. We look forward to meeting with you. provide the most efficient platform for scientific communication and
Please stop by our booth to see us education in the field of allergy and immunology, ultimately striving to
ease patients lives.
Elsevier
1600 JFK Blvd., Suite 1800 Federation of Clinical Immunology Societies
Philadelphia, PA 19103 11950 W. Lake Park Drive, Suite 320
Phone: (215) 239-3491 Milwaukee, WI 53051
www.elsevierhealth.com Phone: (414) 359-1670
Booth #827 www.focisnet.org
ELSEVIER is a leading publisher of health science publications, Booth #935
advancing medicine by delivering superior reference information The Federation of Clinical Immunology Societies (FOCIS) exists
and decision support tools to doctors, nurses, health practitioners to improve human health through immunology by fostering
and students. With an extensive media spectrum print, online and interdisciplinary approaches to both understand and treat immune-
handheld, we are able to supply the information you need in the most based diseases. The federation provides a voice for clinical
convenient format. immunologists and ultimately strives to improve patient care.

166
 exhibits

Food Allergy Research and Education (FARE) GlaxoSmithKline

7925 Jones Branch Drive, Suite 1100 Five Moore Drive
McLean, VA 22102 Research Triangle Park, NC 27709
Phone: (800) 929-4040 Phone: (888) 825-5249
www.foodallergy.org www.gsk.com
Booth #941 Booth #633
The mission of Food Allergy Research & Education (FARE) is to ensure
the safety and inclusion of individuals with food allergies while GlaxoSmithKline
relentlessly seeking a cure. FARE is the leading national organization Five Moore Drive
dedicated to food allergy research, education, advocacy, and Research Triangle Park, NC 27709
awareness. For more information, please visit: www.foodallergy.org. Phone: (888) 825-5246
www.gsk.com
Forest Pharmaceuticals, Inc. Booth #435
13600 Shoreline Drive
St. Louis, MO 63045 Global Allergy and Asthma Organization
Phone: (800) 678-1605 Altgasse 8-10
www.forestpharm.com Vienna, 1130
Booth #428 Austria
Forests longstanding global partnerships and track record developing Phone: +49 171 7616923
and marketing pharmaceutical products in the United States have www.ga2p2.org
yielded its well-established central nervous system and cardiovascular Booth #1034
franchises and innovations in anti-infective, respiratory and GAAPP - The Global allergy and asthma platform is an association of
gastrointestinal medicine. organizations from all continents supporting patients by protecting
their rights and insisting on the duties of governments, health-care
Fraunhofer ITEM professional organizations, and the general public. We assist the
Nikolai-Fuchs-Str. 1 founding of patient organizations in emerging contries. www.ga2p2.org
Hannover, 30625
Germany Greer Laboratories, Inc.
Phone: +49 (0) 511-5350-262 639 Nuway Circle
Booth #130 Lenoir, NC 28645
Fraunhofer ITEM offers preclinical and clinical contract research in Phone: (828) 754-5327
the field of respiratory diseases. Clinical proof of concept studies www.greerlabs.com
are performed with a variety of challenge models, in particular, the Booth #413
Fraunhofer environmental challenge chamber. Clinical trials (phase I-IV) GREER is devoted to furthering the specialty of allergy
for asthma, allergic rhinitis or COPD are conducted with state-of-the- immunotherapy. We provide allergy professionals with allergenic
art clinical and immunological read-out parameters. extracts, sterile empty vials, sterile diluting fluids, skin testing devices,
and a full line of ancillary products needed to successfully test and
Genentech/Novartis treat allergic patients.
1 DNA Way
MS #69
South San Francisco, CA 94080-4990
Phone: (650) 467-1251
www.gene.com
Booth #800
Founded more than 35 years ago, Genentech is a leading
biotechnology company that discovers, develops, manufactures and
commercializes medicines to treat patients with serious or life-
threatening medical conditions. The company, a member of the Roche
Group, has headquarters in South San Francisco, California.

167
 exhibits

HAE: Learn About It, Talk About It Immune Epitope Database & Analysis Resource
730 Stockton Dr (IEDB)
Exton, PA 19335 9420 Athena Circle
www.letstalkHAE.com La Jolla, CA 92037
Booth #740 www.ledb.org
Booth #1036
HollisterStier Allergy The IEDB is an NIH-supported, freely available resource that provides
3525 N Regal Street access to published data related to antibody and T cell epitopes, as
Spokane, WA 99207 well as online tools for prediction and further analysis of immune
Phone: (800) 992-1120 epitopes. The IEDB has data for infectious and autoimmune diseases,
www.hsallergy.com allergens, and alloantigens.
Booth #215
HollisterStier Allergy manufactures a full line of products for allergy Indoor Biotechnologies, Inc.
practices. Our line includes allergenic extracts for diagnostic testing 1216 Harris Street
and immunotherapy, complete skin testing systems, latex-free vials/ Charlottesville, VA 22903
diluents, and other ancillary supplies. Phone: (434) 984-2304
www.inbio.com
Hycor Biomedical Booth #126
7272 Chapman Avenue Indoor Biotechnologies specializes in products and services in
Garden Grove, CA 92841 environmental sciences, allergy and asthma, configured for research
Phone: (800) 382-2527 or for consumer use. We serve academic and government researchers,
www.hycorbiomedical.com Fortune 500 companies, the indoor air quality industry, allergy vaccine
Booth #321 manufacturers and the biopharmaceutical industry. Our mission is
HYCOR Biomedical is a manufacturer and supplier of high-quality to improve patient care through research, education and developing
diagnostic instrumentation and in-vitro diagnostics for allergy and cutting edge technologies that serve our clients and customers
autoimmune testing. The HYTEC 288 Plus Automated Immunoassay worldwide.
System yields rapid, accurate results and represents an automated,
cost-effective platform for clinical laboratories, hospitals and Inflamax Research Inc.
physician office testing. The HYTEC 288 Plus offers a broad allergy 1310 Fewster Drive
and autoimmune testing menu optimized on a single platform. For Mississauga, ON L4W 1A4
moderate to higher-volume labs, HYCOR offers the Ultra- Sensitive EIA Canada
System which combines the precision and accuracy of fully automated Phone: (905) 282-1808
robotic reagent dispensing with a newly formulated high-sensitivity www.inflamaxresearch.com
assay design, resulting in superior test performance. HYCORs mission Booth #624
is to drive new products, technologies and medical education materials Inflamax Research is a full-service Contract Research Organization
designed to improve patient care and advance healthcare globally. that specializes in allergy, asthma, COPD and dermatology with
extensive experience in design and conduct of clinical trials Phase I-IV.
Immune Deficiency Foundation Inflamax offers proprietary Natural Environmental Exposure Chamber
40 West Chesapeake Avenue, Suite 308 models, available for clinical research studies. Allergy models have
Towson, MD 21204 been validated for Ragweed, Grass, Tree, House Dust Mite and Cat.
Phone: (800) 296-4433 Inflamax has a unique, patented mobile EEC model which can be
www.primaryimmune.org located anywhere worldwide for use in multicenter trials. Inflamax is
Booth #1029 developing a consortium of specialized investigators and have access
The Immune Deficiency Foundation is the national patient organization to specific patient populations. For more information, please contact
dedicated to improving the diagnosis, treatment and quality of life of Cynthia OBrien at 507-252-1749 or cobrien@inflamaxresearch.com.
persons with primary immunodeficiency diseases through advocacy,
education and research.

168
 exhibits

International Association for Food Protein Kirkman Group, Inc.

Entercolitis (IAFFPE) 10639 Professional Circle
2372 U.S. Highway 9 South Reno, NV 89521
Howell, NJ 07731 Phone: (503) 694-1600
Phone: (908) 910-4419 www.kirkmandocs.com
www.iaffpe.org; www.fpies.org Booth #828
Booth #932 Kirkman is the leading manufacturer of hypoallergenic nutritional
supplements for sensitive individuals. Every ingredient in every product
International Asthma Services (IAS) manufactured by Kirkman* is tested for more than 950 environmental
7700 W. Virginia Ave, Suite B contaminants. No other supplement company in the world offers this
Lakewood, CO 80226 degree of purity testing. For more than 60 years, customers have relied
Phone: (720) 987-5925 on Kirkman for pure and effective products that meet their special
www.globalchestinitiatives.org health needs. *Except lotions, creams and oils
Booth #936
IAS is involved for the past 25 years in promoting allergy asthma Lincoln Diagnostics, Inc.
awareness in developing contries. IAS conducts several CMEs for P.O. Box 1128
physicians, public forums as well as set up Respiratory centers. Active Decatur, IL 62525
in India, Myanmar, Kenya, Fiji, Saratov Russia as well as in USA. Phone: (800) 537-1336
www.lincolndiagnostics.com
International Eosinophil Society, Inc. Booth #112
555 E. Wells Street, Suite 1100 Lincoln Diagnostics is displaying state-of-the-art, safety-engineered
Milwaukee, WI 53202 skin testing devices that meet all current OSHA requirements- Multi-
Phone: (414) 276-6445 Test PC (Pain Control), Multi-Test II, Multi-Test, Duotip-Test II, Duotip-
www.eosinophil-society.org Test, and the new UniTest PC. Please visit our exhibit to learn about the
Booth #937 economic value of using Lincolns devices and why they are the most
The International Eosinophil Society, Inc. (IES) has been established widely used and most extremely published on devices available.
to bring together scientists around the world who are engaged in
research in the field of eosinophil biology and eosinophil disorders Lineage Therapeutics
with a view to facilitating exchange of ideas and information about this 2 Walnut Grove Drive, Suite 190
fascinating inflammatory cell type and its role in disease. Horsham, PA 19044-7707
Phone: (215) 259-3579
Karger Publishers www.epinephrineautoinject.com
26 West Avon Rd Booth #733
PO Box 529 About Lineage Therapeutics: Lineage Therapeutics is committed to
Unionville, CT 06085 patient education and as such, we are providing product trainers
Phone: (860) 675-7834 at no cost to health care professionals and patients so they can
www.karger.com become familiar with the epinephrine auto-injector. In addition,
Booth #620 www.epinephrineautoinject.com provides the information necessary
Publications include the book series Chemical Immunology and for patients to learn more about their risk of anaphylaxis and their
Allergy, Current Directions in Autoimmunity, and Progress in epinephrine auto-injector. Injection training videos, product expiration
Respiratory Research; and the journals Dermatology, International reminder programs and other resources are also available to patients
Archives of Allergy and Immunology, Journal of Innate Immunity, on the website.
Neuroimmunomodulation, and Respiration.
McNeil Consumer Healthcare
Kaz, Inc / Honeywell 7050 Camphill Road
250 Tumpike Road Fort Washington, PA 19034
Southborough, MA 01772 Phone: (800) 962-5357
Phone: (508) 490-7214 Booth #1011
www.kaz.com Zyrtec
Booth #125
Honeywell is the market leader in portable air purification products,
offering True Hepa permanent filtration providing your patients with
superior air cleaning products for over 25 years!

169
 exhibits

Meda Pharmaceuticals Merck

265 Davidson Avenue One Merck Drive
Somerset, NJ 08873 Whitehouse Station, NJ 08889
Phone: (732) 564-2200 Phone: (908) 423-1000
www.meda.us www.merck.com
Booth #901 Booth #601
Todays Merck is working to help the world be well. Through our
Medical College of Wisconsin medicines, vaccines, biologic therapies, and consumer and animal
8701 Watertown Plank Rd products, we work with customers and operate in more than 140
Wauwatosa, WI 53226 countries to deliver innovative health solutions.
Phone: (414) 955-7495
www.mcw.edu/cirl Merck Childhood Asthma Network, Inc.
Booth #322 1400 K. Street, NW, Suite 750
The Clinical Immunodiagnostic & Research Laboratory (CIRL) at MCW Washington, DC 20005
offers diagnostic flow cytometry for Primary Immunodeficiency (PID) Phone: (202) 326-5200
diseases. CIRL and CHWs PID Clinics function as Jeffrey Modell www.mcanonline.org
Diagnostic & Patient Referral Center in Wisconsin since 2007. IDC Booth #1041
is first in USA to pioneer statewide newborn screening for Severe The Merck Childhood Asthma Network, Inc. (MCAN) is a non-profit,
Combined Immunodeficiency. 501(c)(3) organization. Its mission is to support and advance evidence-
based programs that improve the quality of life for children with
Meditab Software, Inc. asthma and their families, and to reduce, through the dissemination of
333 Hegenberger Rd., Suite 800 effective interventions, the burden of the disease on them and society.
Oakland, CA 94621
Phone: (510) 632-8021 Methapharm
www.meditab.com 81 Sinclair Boulevard
Booth #220 Brantford, ON N3S 7X6
Meditab Software develops and supports AllergyEHR - Black Books #1 Canada
ranked EHR for Allergy and Immunology. This allergy-specific solution Phone: (519) 751-3602
provides affordable Practice Management and EHR - including an www.metharpharm.com
integrated Shot Lab - a Patient Portal and Reporting, to practices of Booth #226
all sizes. This multi-certified solution can help you maximize workflow Provocholine (methacholine chloride). The Provocholine Challenge
efficiencies, enhance the care you provide to patients, and reduce is a direct challenge test and provides a generally accurate diagnosis
your operational costs. Headquartered in Oakland, California, with of bronchial hyperreactivity as well as determining the severity of
offices across the US, Meditab supports tens-of-thousands of clients asthma. Methacholine challenge is the gold standard for ruling out a
nationwide. As our customers can attest, Meditab takes tremendous diagnosis of asthma. The Provocholine Challenge can also be used to
pride in providing comprehensive, user-friendly solutions for each confirm occupational asthma. 2.0 CRCE hours No Charge. Visit www.
practices unique needs. www.meditab.com / 866-99-Go-EMR. provocholine.com/ssm and review the educational information on
methacholine challenge tests and complete the evaluation.
Merck
One Merck Drive Micro Direct, Inc.
Whitehouse Station, NJ 08889 803 Webster Street
Phone: (908) 423-1000 Lewiston, ME 04240
www.merck.com Phone: (207) 786-7808
Booth #201 www.micro-direct.com
Todays Merck is working to help the world be well. Through our Booth #421
medicines, vaccines, biologic therapies, and consumer and animal Micro Direct is pleased to offer Total Spirometry Solutions with seven
products, we work with customers and operate in more than 140 models priced from $650 to $2,495, all designed to meet your needs;
countries to deliver innovative health solutions. and each with your choice of inexpensive cardboard mouthpieces,
one-way mouthpieces or full protection pulmonary filters. Micro Direct
also offers inexpensive screening spirometers and peak flow meters
for office and home use. At Micro Direct our mission is clear to provide
innovative products at a fair price and the support and great service
you expect.

170
 exhibits

Mission Pharmacal Company Morrow Brown Allergy Diagnostics

P.O. Box 786099 P.O. Box 306
San Antonio, TX 78278 Oakhurst, NJ 07755-0306
Phone: (210) 696-8400 Phone: (732) 531-7830
www.missionpharmacal.com www.morrowbrown.com
Booth #137 Booth #128
Mission Pharmacal is a privately held Pharmaceutical company based Alkaline Corporation now in our 33rd year manufactures Anti-Allergen
in San Antonio, Texas. For sixty-five years, the company has been Cleaning products for the home and Morrow Brown Allergy Testing
dedicated to identifying unmet health needs in the marketplace and Diagnostic Products. Allersearch Products are medically proven
developing innovative prescription and over-the-counter products to effective for allergen removal and allergen control using our proprietary
meet them. tannic acid formulations. Allersearch Laboratories is proud to introduce
skin care products specifically formulated for Eczema, Dermatitis
Mission: Allergy and other Allergy Skin conditions. Visit our booth to see both product
28 Hawleyville Road lines and find out more ways to help your patients enjoy a clean and
Hawleyville, CT 06440 allergen free environment. Morrow Brown Allergy Diagnostics product
Phone: (203) 364-1570 x 2000 encompass our standardized allergy testing needles which offer
www.missionallergy.com greater patient comfort and a more accurate skin testing. Stop by our
Booth #207 booth to pick up a complimentary Skin Testing Caliper and needle
Leading allergists and allergy divisions recommend Mission: Allergy by samples.
for its scientific accuracy and its highest quality microfiber pillow and
mattress encasings and other products for allergen avoidance. Please Mother To Baby Pregnancy Studies Conducted
stop by our booth to request your free supply of our informative Allergy by the Organization of Teratology Information
Self-Help Guide for patients, and to view an unusual display of live Dust Specialists
Mites in High-Definition!
9500 Gilman Dr.
Mailcode 0828
ModuleMD
La Jolla, CA 92093
8359 Office Park Drive
Phone: (877) 311-8972
Grand Blanc, MI 48439
www.pregnancystudies.org
Phone: (248) 434-0444
Booth #1033
www.modulemd.com
Booth #829 Mylan, Inc.
For over 15 years, ModuleMD has been a leader in EHR Cloud
1500 Corporate Drive
Technology solutions to Allergists. As an ONC-ATCB certified integrated
Canonsburg, PA 15317
EHR system, Module MD delivers peak clinical, operational and
Phone: (724) 514-1800
financial performance to Allergy Practices. Our focus is simple - the
www.mylan.com
client comes first. At ModuleMD, we are solutions...not just software.
Booth #712
Mylan is a leading genetics & specialty pharmaceutical company
focused on providing the world with access to high quality medicine.
The company operates one of the worlds largest active pharmaceutical
ingredient manufacturers and currently markets a growing portfolio
of more than 1,100 products in approximately 150 countries and
territories.

171
 exhibits

National Allergy Supply NeilMed Pharmaceuticals Inc.

1620-D Satellite Blvd 601 Aviation Blvd.
Duluth, GA 30097 Santa Rosa, CA 95404
Phone: (800) 522-1448 Phone: (707) 525-3784
www.NationalAllergy.com www.neilmed.com
Booth #623 Booth #109
Just like you, National Allergy believes that avoiding airborne allergens The mission of the company is to create and maintain safe, affordable
can help improve patient outcomes. We are firmly established as and effective products to sustain long-term growth and create drug
the leader in the allergen avoidance products market having sold to free and effective nasal/sinus care devices for millions of consumers
hundreds of thousands of customers through the referrals of thousands worldwide. Please visit the website www.neilmed.com for more details.
of doctors since our start in 1988. Our colorful patient flyers are super
easy to use as compared to bulky catalogs and offer your patients
Nestle
a Special Discount on their first order with us. Our BedCare barrier 12 Vreeland Road
encasings are Made In The USA and set the standard for comfort, Florham Park, NJ 07932
quality, and affordable allergen protection. See for yourself by visiting Phone: (800) 828-BABY
our booth and well be happy to give you a FREE Standard Size Pillow www.medical.gerber.com
Encasing. Booth #224
Nutritional products
National Eczema Association
4460 Redwood Hwy, Ste 16D
New York Times
San Rafael, CA 94903 613 South Avenue
Phone: (415) 499-3474 New York, NY
www.nationaleczema.org www.nytimes.com
Booth #934 Booth #728
The National Eczema Association (NEA) improves the health and Visit The New York Times booth for reduced rate home delivery and
quality of life of individuals with eczema through research, support, receive a free gift with your new order. The New York Times newspaper
and education. NEA provides and distributes educational materials is distributed internationally and is the largest metropolitan newspaper
for health professionals and the public, related to the treatment and in the U.S. Although nicknamed the Gray Lady for its staid appearance
management of patients suffering from atopic dermatitis/eczema. and style, it is frequently relied upon as the official and authoritative
reference for modern events. Founded in 1851, the newspaper has
ndd Medical Technologies won 112 Pulitzer prizes, winning its first in 1918 for its World War I
Two Dundee Park, Suite 301 reporting. Subscribe Today!
Andover, MA 01810
Phone: (978) 470-0923
Novartis Pharmaceuticals Corp
www.nddmed.com One Health Plaza
Booth #720 East Hanover, NJ 07936
ndd Medical Technologies is committed to setting new standards in Phone: (862) 778-8300
pulmonary function testing by offering innovative, easy to use products www.novartis.com
and excellent customer support. Our newest product, The EasyOne Booth #515
Pro LAB offers all the benefits of the EasyOne ProSingle Breath CO Novartis Pharmaceuticals is dedicated to discovering, developing,
Diffusion in one square foot - with Multiple-Breath Nitrogen Washout manufacturing and marketing prescription drugs that help meet our
for the measurement of FRC and LCI. The EasyOne Plus series of customers medical needs and improve their quality of life. Please visit
spirometers are based on the best technology, packed with features the Novartis exhibit where our sales representatives will be available to
and easy to use; while the Easy on-PC offers real time curves and discuss our products.
pediatric incentives. Please visit our booth to determine which product
is right for you.

172
 exhibits

nSpire Health Panatrex, Inc.

1830 Lefthand Circle 1648 Sierra Madre Circle
Longmont, CO 80501 Placentia, CA 92870
Phone: (800) 574-7374 Phone: (714) 630-5582
www.nspirehealth.com www.panatrex.com
Booth #221 Booth #721
nSpire Health develops and manufactures respiratory care products Quanti-test system provides depth control ensures reproducible result
and provides related services. The Company is focused on pulmonary make accurate. The well will wipe out the excessive allergens.
diagnostics, respiratory core lab services, and disease management
solutions. nSpire Health is the exclusive provider of premier HD4000 Perrigo Company
digital whole body Plethymography, PC and Desktop KoKo Spirometry, 515 Eastern Avenue
Piko Lung Home Health Monitoring, Asthma and Allergy products. Allegan, MI 49010
Phone: (269) 673-8451
NUTRICIA www.perrigo.com
P.O. Box 117 Booth #325
Gaithersburg, MD 20884 Perrigo is the largest manufacturer of store-brand over-the-counter
Phone: (301) 795-2300 medicines for the nations leading retailers, grocers, club stores and
www.nutricia-na.com pharmacy chains. The company produces store-brand over-the-counter
Booth #104 medications, nutritional supplements and infant formula that compare
Nutricia is a global leader in advanced medical nutrition for specialized to leading national-brands. Perrigos store-brand medicines meet or
care. Neocate, brought to you by Nutricia, is an age specific range exceed FDA quality standards.
of amino-acid based nutrition proven effective in the nutritional
management of multiple GI disorders and food-allergy related Precision Medical Products, Inc.
conditions, such as SBS, CMA, MFPI, EoE and GERD. 44 Denver Road
Denver, PA 17517
Ora, Inc. Phone: (717) 335-3700
300 Brickstone Square www.pmp.net
Andover, MA 01810 Booth #422
Phone: (978) 685-8900 Allergy Testing Needles, contract medical device manufacturing and
www.oraclinical.com contract packaging.
Booth #235
Ora is the worlds leading independent, full-service allergy CRO and Protein Sciences Corporation
product development firm with offices in the United States and Japan. 1000 Research Parkway
Over the past 30 years, we helped our clients earn 34 FDA approvals. Meriden, CT 06450
We support a wide array of organizations, from start-ups to global Phone: (203) 686-0800
pharmaceutical and device companies, to efficiently and successfully www.proteinsciences.com
bring their new products from concept to market. Oras clinical models Booth #532
and unique methodologies, including The Boston Chamber and Nasal Flublok is the first and only highly purified influenza vaccine on the
and Conjunctival Allergen Challenges, and regulatory strategies market. It is made using modern recombinant technology without the
have been refined across thousands of projects both in the US and use of eggs, live influenza viruses and antibiotics. It also contains no
internationally. We bring together an extensive and experienced preservatives. In addition to a designation by ACIP for egg allergic
network of allergy experts to maximize the value of new product people regardless of severity it is particularly attractive to pregnant
initiatives. women and young people - 18-49 years.

Osia Medical PuraCap Pharmaceutical LLC

9789 Stone Cliff Dr 1001 Durham Avenue, Ste 300
Sandy, UT 84092 South Plainfield, NJ 07080
Phone: (801) 432-7545 Phone: (908) 941-5456
Booth #522 Booth #108
AllergyTrackr is a platform for physicians and patients to collaboratively EpiCeram Skin Barrier Emulsion is a ceramide-dominant topical cream
manage allergies and asthma. By collecting patient input data and that is steroid-free, fragrance-free and paraben-free.
combining it with environmental data, AllergyTrackr helps to identify
an individuals triggers and trends that might have otherwise lead to a
hospitalization.

173
 exhibits

Quest Diagnostics Red River Commodities

3 Giralda Farms 501 42nd St. N.
Madison, NJ 07940 Fargo, ND 58102
Phone: 1-800-MY-QUEST Phone: (877) 873-4501
www.questdiagnostics.com www.sunbutter.com
Booth #141 Booth #123
Quest Diagnostics, the worlds leading provider of diagnostic testing, SunButter Sunflower Seed Spread, the leading alternative to peanut
information and services, offers a comprehensive test menu including and other nut butters. Manufactured in a completely dedicated peanut
toxicology, immunology, endocrinology, oncology, rheumatology and & tree-nut free facility. Great for those diagnosed with peanut/nut
genetics. Beyond our comprehensive menu of laboratory testing allergies.
services, we offer a variety of resources to help you manage your
patients, run your office and stay current with the latest medical Rosch Visionary Systems, Inc.
advances. Visit QuestDiagnostics.com. 501 Howard Avenue, Suite A204
Altoona, PA 16601
Rabbit Air Phone: (800) 307-3320
125 N. Raymond Ave., Suite 308 www.roschvisionary.com
Pasadena, CA Booth #723
Phone: (888) 866-8862 Rosch Immunotherapy is the leading allergy shot room automation
www.RabbitAir.com software, designed to safely and effectively manage your allergy
Booth #228 testing, mixing, and treatment activities. Multiple safety features
Founded in 2004, Pasadena, California-based Rabbit Air has dedicated include bar-coding of patient vials as well as bulk antigen inventory.
its time, energy, and resources to perfecting a product that improves Our allergy tracker smart phone app sends patient notifications for
quality of life: the air purifier. Rabbit Airs undivided attention and upcoming and/or overdue shots, increasing patient compliance. Come
dedication to air purification is the reason it has become one of the see our brand new skin testing module, designed by leading allergists
fastest growing companies in the U.S., ranked as such from 2009 to in the US, and discover why at Rosch Visionary Systems, were your
2012 by INC. magazine. Rabbit Air aims to redefine the industry through allergy technology specialists!
its innovative approach to design, product development, and customer
service. Our air purifiers are respectful of the environment; they remove Sanofi
pollutants and give back nothing but clean air in return. 55 Corporate Drive
Bridgewater, NJ 08807
Red Maple Trials Phone: (908) 243-1699
2935 Conroy Road, Unit 110 www.sanofi.com
2935 Conroy Road Booth #301
Ottawa, ON K1G 6C6 Sanofi, a global and diversified healthcare leader, discovers, develops
Canada and distributes therapeutic solutions focused on patients needs.
Phone: (613) 368-4320 Sanofi has core strengths in the field of healthcare with seven growth
www.redmapletrials.com/ platforms: diabetes solutions, human vaccines, innovative drugs,
Booth #523 consumer healthcare, emerging markets, animal health and the new
Red Maple Trials provides specialty services in allergy, asthma and Genzyme
immunology clinical research, highlighted by our next generation
Allergen Challenge Theatre (environmental exposure chamber) and Sanofi
our Phase I infrastructure. Our clinical trial facilities are capable of 55 Corporate Drive
executing on Phase I through IV studies, and our experienced team Bridgewater, NJ 08807
provides site management services in order to fulfill the challenging Phone: (908) 243-1699
demands of our biopharmaceutical partners. www.sanofi.com
Booth #408
Chattem Inc is part of Sanofi Group. Sanofi US is an affliate Sanofi a
leading global pharmaceutical that discovers, develops, and distributes
therapeutic solutions to improve the lives of everyone.

174
 exhibits

Santarus, Inc. Solutionreach

3611 Valley Centre Drive, Suite 400 2912 Executive Pkwy, Suite 300
San Diego, CA 92130 Lehi, UT 84043
Phone: (858) 314-5700 Phone: (866) 605-6867
santarus.com www.solutionreach.com
Booth #524 Booth #629
Santarus is please to present an Educational Exhibit discussing a Solutionreach is a patient engagement software service designed to
current perspective on the diagnosis and management of Hereditary maintain and retain existing patients while identifying and acquiring
Angioedema. new patients. Utilizing the latest automated text/e-mail messaging
technologies and social media tools, Solutionreach helps you to
Shire increase productivity and grow your practice, while you focus on your
300 Shire Way patients.
Lexington, MA 02421
Phone: (617) 349-0200 Sunovion Pharmaceuticals
www.shire.com 84 Waterford Drive
Booth #115 Marlborough, MA 01752
As one of the worlds leading specialty biopharmaceutical companies, Booth #501
Shire has emerged as a company fully focused on a single purpose:
to enable people with life-altering conditions to lead better lives. Teva Respiratory
Through our Rare Diseases Business Unit, we pursue opportunities to 41 Moores Rd
develop therapies on behalf of patients and families living with orphan Frazer, PA 19355
diseases. Phone: (888) 483-9522
www.tevarespiratory.com
Shire Medical Affairs Booth #101
300 Shire Way Stop by our booth to learn more about Qvar (beclomethasone
Lexington, MA 02421 dipropionate HFA) & ProAir HFA (albuterol sulfate) . Information,
Phone: (617) 349-0200 educational materials, and resources to benefit your practice will be
www.shire.com available.
Booth #121
As one of the worlds leading specialty biopharmaceutical companies, The American Board of Allergy and Immunology
Shire has emerged as a company fully focused on a single purpose: 111 South Independence Mall East, Suite 701
to enable people with life-altering conditions to lead better lives. Philadelphia, PA 19106
Through our Rare Diseases Business Unit, we pursue opportunities to Phone: (215) 592-9466
develop therapies on behalf of patients and families living with orphan www.abai.org
diseases. Booth #1028
The ABAI was established in 1971 as a Conjoint Board of the ABIM
SmartPractice and ABP. The internal medicine subspecialty existed from 1036-1971
3400 E. McDowell Road and the pediatric subspecialty existed from 1955-1971. The ABAI is
Phoenix, AZ 85008 committed to working closely with its parent boards to maintain the
Phone: (800) 878-3837 highest educational and clinical standards in the specialty of allergy/
http://www.smartpractice.com immunology.
Booth #225
SmartPractice Manufactures and Markets Patch Testing Products for The JAMA Network
the diagnosis of allergic contact dermatitis. 330 N. Wabash Avenue, Ste. 39300
Chicago, IL 60611
Sol Millennium Medical Inc Phone: (312) 464-5000
5415 Sugarloaf Parkway, Suite 2203 www.jamanetwork.com
Lawrenceville, GA 30019 Booth #133
Phone: (770) 331-0617 Building on a tradition of editorial excellence, The JAMA Network brings
www.sol-millenniumna.com JAMA together with nine specialty journals to offer enhanced access
Booth #424 to the research, viewpoints, and medical news shaping medicine today
Sol Millennium Medical is the manufacturer of the Sol Care line of and into the future. JAMA is one of the most widely circulated, peer-
safety syringes and needles. We are introducing our newest line of reviewed, general medical journals in the world.
syringes with safety needles for the AAAAI.

175
 exhibits

The Mastocytosis Society US Hereditary Angioedema Association

PO Box 129 Seven Waterfront Plaza
Hastings, NE 68902 500 Ala Moana Boulevard
Phone: (952) 905-6778 Honolulu, HI 96813
www.tmsforacure.org Phone: (866) 798-598
Booth #1032 www.haea.org
Booth #929
Thermo Fisher Scientific The US Hereditary Angioedema Association (HAEA) provides a wide
4169 Commercial Avenue range of patient services, patient advocacy programs and clinical
Portage, MI 49002 research for this rare genetic blood disease. We display information
Phone: (800) 346-4364 on HAE diagnosis and treatment as well as on our Scientific Registry -
www.thermoscientific.com/phadia Patient Driven Research for a Cure. We also have important information
Booth #626 on the new US HAEA Angioedema Center at UCSD established in 2013.
As the immunodiagnostic experts within Thermo Fisher Scientific, we
work to dramatically improve the management of allergy, asthma and USIDNET
autoimmune diseases. We do this by providing healthcare professionals 40 Chesapeake Ave, Suite 308
with innovative diagnostic technologies and clinical expertise. This Towson, MD 21204
results in better healthcare and quality of life for millions of patients Phone: (800) 296-4433
and their families. The following diagnostic technologies are marketed www.usidnet.org
under the Thermo Scientific brand: ImmunoCAP specific IgE blood Booth #1031
test, Phadia Laboratory Systems, and EliA Autoimmune Assays. The United States Immunodeficiency Network (USIDNET) is a research
consortium established to advance scientific research in the field of
Ursatec-Verpackung GmbH primary immunodeficiency diseases.
Schillerstr. 4
St. Wendel, 66606 Vasculitis Foundation
Germany P.O. Box 28660
Phone: +49 6851 80 26 0 Kansas City, MO 64188
www.ursatec.de Phone: (816) 436-8211
Booth #140 www.vasculitisfoundation.org
URSATEC stands for innovative developments in preservative-free Booth #1039
pharmaceutical, cosmetic and medical products such as oral and nasal The Vasculitis Foundation supports and empowers our community
sprays. Safe protection against contamination by microorganisms, through education, awareness, and research.
even after the opening of a package, is guaranteed by the dual
microbiological protection of the patented dosing systems 3K and Vidara Therapeutics Inc.
COMFORT. From the product idea to the selection of raw materials, 1000 Holcomb Woods Parkway #270
parts manufacturing, aseptic filling (GMP-compliant), microbiological Roswell, GA 30076
safety testing through to assistance with permits and preparation of Phone: (407) 6973424
dossiers, URSATEC covers every step with their partners. www.vidararx.com
Booth #928
US Bioservices Specialty Pharmacy ACTIMMUNE is a bioengineered form of interferon gamma-1b, a
3101 Gaylord Pkwy protein that acts as a biologic response modifier through stimulation
Frisco, TX 75034 of the human immune system. It is approved by the US Food and
Phone: (888) 518-7246 Drug Administration (FDA) for use in children and adults with Chronic
www.usbioservices.com Granulomatous Disease (CGD) and severe, malignant osteopetrosis.
Booth #229
US Bioservices delivers nationwide specialty pharmacy and home
infusion nursing services. Through our Pathpoint Ig program, we
provide access to all available brands of Immune Globulin, verify
each patients insurance benefits, coordinate comprehensive nursing
services for every infusion and deliver scheduled status reports to the
physician.

176
 exhibits

Viracor-IBT Laboratories Wiley

1001 NW Technology Drive 350 Main Street
Lees Summit, MO 64086 Malden, MA 02148
Phone: (816) 554-5171 Phone: (781) 388-8200
www.ViracorIBT.com www.wiley.com
Booth #908 Booth #426
With 30 years of specialized expertise in allergy, immunology and Wiley is the leading society publisher. We publish on behalf of more
infectious disease testing, Viracor-IBT is committed to helping societies and membership associations than anybody else, and offer
medical professionals, national and regional reference labs and libraries and individuals 1250 online journals, thousands of books and
biopharmaceutical companies solve challenging and often life- e-books, reviews, reference works, databases, and more. For more
threatening problems. Viracor-IBT is passionate about delivering information, visit www.wiley.com, or our online resource: onlinelibrary.
value to its clients by providing timely, actionable information, never wiley.com.
losing sight of the connection between the testing it performs and the
patients it ultimately serves. To learn more about our menu and testing World Allergy Organization
services, visit www.viracoribt.com. 555 East Wells Street, Suite 1100
Milwaukee, WI 53202
ViroPharma, Inc. Phone: (414) 276-1791
730 Stockton Drive www.worldallergy.org
Exton, PA 19341 Booth #1026
Phone: (610) 458-7300 The World Allergy Organization (WAO) is an international umbrella
www.viropharma.com organization whose members consist of 92 regional and national
Booth #315 Allergology and clinical immunology societies from around the world.
By collaborating with member societies, WAO is a global resource and
Vitalograph, Inc. advocate in the field of allergy; visit our booth to learn more.
13310 W.99th Street
Lenexa, KS 66215 World Immunopathology Organization (WIPO)
Phone: (913) 888-4221 4 Ostrovityanova Street
www.vitalograph.com Moscow 117513
Booth #521 Russia
Vitalograph is a global leader in pulmonary diagnostic device Phone: +7 495 735 1414
manufacturing and clinical trial professional services. Our extensive www.wipocis.org
respiratory range includes a variety of world class spirometers, Booth #1040
asthma monitors, COPD screeners, peak flow meters, e-diaries and World Immunopathology Organization (WIPO) is non-profit organization.
inhaler trainers. As we celebrate our 50th anniversary we are proud to The WIPO global mission is to promote through education and research
introduce the latest version of Spirotrac PC-based Spirometry Software activities worldwide basic and clinical research in Allergy, Asthma and
and the new Compact comprehensive desktop medical workstation, Clinical Immunology.
offering advanced spirometry, pulse oximetry, ambulatory blood
pressure, ECG and more. Xoran Technologies
5210 South State Rd.
Walgreens Infusion Services Ann Arbor, MI 48108
2050 S Finley Road Phone: (800) 709-6726
Lombard, IL 60148-4837 www.xorantech.com
Phone: (630) 495-2899 Booth #420
www.walgreensheath.com Xoran Technologies is the innovator and market leader in compact,
Booth #324 specialized medical CT scanners for Allergists. The Xoran MiniCAT is a
Walgreens provides IVIG and SubQIG therapies as well as therapies compact, upright in-office CT scanner designed for high-resolution, low
for HAE. We have over 200 offices nationwide and service 90% of the radiation dose bone window imaging of the sinuses, temporal bones
United States with home infusion as well as infusion centers. and skull base. MiniCAT provides immediate access to images at the
patients point-of-care resulting in a faster diagnosis and treatment.
Well Amy, LLC
60 Lakeview Avenue
Short Hills, NJ 07078
Phone: (973) 218-6152
www.wellamy.com
Booth #233
We are an online market specializing in allergen-free products.

177
 exhibits

Xtract Solutions
9495 SW Locust St, Suite E
Portland, OR 97223
Phone: (503) 379-0110
www.xtractsolutions.com
Booth #129
Discover the NEW STANDARD OF CARE in Allergy Immunotherapy.
Xtract Solutions is a team of physicians and engineers that looked
at the process of serum formulation from the beginning to end and
analyzed the causes of inefficiency and uncertainty. We took these
liabilities and developed solutions that ensure every step is performed
correctly in a quantifiable, verifiable, and reproducible way. The
Complete Allergen Preparation System (CAPS) is the culmination of
these efforts and a new standard in allergy immunotherapy.

Yodle
50 West 23rd Street, Ste 401
New York, NY 10010
Phone: (877) 276-5104
www.yodle.com
Booth #429
Yodle, a leader in local online marketing, connects thousands of local
businesses with consumers in a process so simple and cost-effective
that business owners cant imagine any other way to advertise.
Yodle has developed an integrated approach to signing up and serving
local businesses that are transitioning their marketing budgets online

178
 exhibits
Allergenic Extracts
ALK. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1005
Allergy Laboratories, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 621
HollisterStier Allergy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
Clinical Research Organizations
Biogenics Research Chamber. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fraunhofer ITEM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inflamax Research Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ora, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Red Maple Trials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Computer Hardware/Software
Crowell Systems. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meditab Software, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ModuleMD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Osia Medical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rosch Visionary Systems, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Solutionreach. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Xtract Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diagnostic Equipment
Carestream. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ndd Medical Technologies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SmartPractice. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Xoran Technologies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diagnostic Testing
Aerocrine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hycor Biomedical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Indoor Biotechnologies, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lincoln Diagnostics, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Medical College of Wisconsin. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Methapharm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Morrow Brown Allergy Diagnostics. . . . . . . . . . . . . . . . . . . . . . . . .
Quest Diagnostics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thermo Fisher Scientific. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Viracor-IBT Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Environmental Products
Allergy Control Products. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Burkard Manufacturing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Kaz, Inc / Honeywell. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mission: Allergy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
National Allergy Supply. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rabbit Air. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Equipment/Supplies
Buzzy Personal Pain Solutions. . . . . . . . . . . . . . . . . . . . . . . . . . .
Panatrex, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Precision Medical Products, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . .
Sol Millennium Medical Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health/Body Care
AD RescueWear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 724
Baby Healthcare Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 726
Well Amy, LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
Immunotherapy
432 Baxter Healthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 607
130 Baxter Healthcare, Global Medical Affairs . . . . . . . . . . . . . . . . . . . . 722
624 Bio Products Laboratoy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1003
235 Dyax Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 533
523 Edge Pharmaceuticals, LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 622
Greer Laboratories, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 413
328 Walgreens Infusion Services. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324
220 Other
829 Abbott Nutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320
522 Accredo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
723 American Express OPEN. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820
629 Axelacare Health Solutions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 527
129 Biomed Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240
Boston Scientific. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 821
534 Forest Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 428
720 Immune Epitope Database & Analysis Resource. . . . . . . . . . . . . . 1036
225 Kirkman Group, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 828
420 McNeil Consumer Healthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1011
Nestle. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
NUTRICIA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
425 World Allergy Organization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1026
321 World Immunopathology Organization. . . . . . . . . . . . . . . . . . . . . . 1040
126 Yodle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 429
112
322 Patient/Public Education
226 Allergy & Asthma Network . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1042
128 American Latex Allergy Association. . . . . . . . . . . . . . . . . . . . . . . . . 933
141 American Partnership for Eosinophilic Disorders. . . . . . . . . . . . . . . 943
626 Asthma and Allergy Foundation of America (AAFA). . . . . . . . . . . . . 735
908 Food Allergy Research and Education. . . . . . . . . . . . . . . . . . . . . . . 941
Global Allergy and Asthma Organization . . . . . . . . . . . . . . . . . . . . 1034
Immune Deficiency Foundation. . . . . . . . . . . . . . . . . . . . . . . . . . . 1029
525 International Association for Food Protein Entercolitis. . . . . . . . . . . 932
433 International Asthma Services. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 936
125 Kaz, Inc / Honeywell. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
207 Merck Childhood Asthma Network, Inc.. . . . . . . . . . . . . . . . . . . . . 1041
623 Mother To Baby Pregnancy Studies Conducted by the Organization of
228 Teratology Information Specialists. . . . . . . . . . . . . . . . . . . . . . . . . 1033
National Eczema Association . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 934
227 Red River Commodities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
721 US Hereditary Angioedema Association. . . . . . . . . . . . . . . . . . . . . . 929
422 Vasculitis Foundation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1039
424
179
 exhibits

Pharmaceuticals Physician Recruitment

Alcon Laboratories, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 401 Corpus Christi Allergy & Asthma Center. . . . . . . . . . . . . . . . . . . . . . 236
Allergan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 815
Publications
Biotest Pharmaceuticals Corporation. . . . . . . . . . . . . . . . . . . . . . . . 926
Allergy and Asthma Proceedings. . . . . . . . . . . . . . . . . . . . . . . . . . . 520
CSL Behring. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 507
Elsevier. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 827
CVS Caremark Specialty Pharmacy. . . . . . . . . . . . . . . . . . . . . . . . . 434
Karger Publishers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 620
Genentech/Novartis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800
New York Times . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 728
GlaxoSmithKline. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 633
The JAMA Network. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
GlaxoSmithKline. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 435
Wiley . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 426
Lineage Therapeutics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 733
Meda Pharmaceuticals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 901 Spirometry
Merck. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201 Micro Direct, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 421
Merck. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 601 nSpire Health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221
Mission Pharmacal Company. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137 Vitalograph, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 521
Mylan, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 712
NeilMed Pharmaceuticals Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
Novartis Pharmaceuticals Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . 515
Perrigo Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 325
Protein Sciences Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 532
PuraCap Pharmaceutical LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
Sanofi. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 301
Sanofi. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 408
Santarus, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 524
Shire. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
Shire. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
Sunovion Pharmaceuticals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 501
Teva Respiratory. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
Ursatec-Verpackung GmbH. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
US Bioservices Specialty Pharmacy. . . . . . . . . . . . . . . . . . . . . . . . 229
Vidara Therapeutics Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 928
ViroPharma, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315

Physician Education
Allergy Guardian. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 423
Clinical Immunology Society. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1027
European Academy of Allergy and Clinical Immunology. . . . . . . . . . 927
Federation of Clinical Immunology Societies. . . . . . . . . . . . . . . . . . 935
HAE: Learn About It, Talk About It. . . . . . . . . . . . . . . . . . . . . . . . . . . 740
International Eosinophil Society, Inc . . . . . . . . . . . . . . . . . . . . . . . . 937
The American Board of Allergy and Immunology. . . . . . . . . . . . . . 1028
The Mastocytosis Society. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1032
USIDNET. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1031

180
 Exhibit Hall Floor Plan

ALK
McNeil
MCAN Vasculitis
Foundation OTIS USIDNET IDF CIS Consumer
Bio
Products
1051 1049 1047 1045 1043 1041 1039 1033 1031 1029 1027 CONCESSION C Healthcare 1011 1005 1003

9'-5"
25' x 45' 9'-5"
1054 1052 1050 1048 1046 1044 1042 1040 1036 1034 1032 1028 1026

AANMA WIPO IEDB GA2P2 TMS ABAI WAO Meda

955 953 951 949 947 945
APFED
943
FARE
941
IES
937
FOCIS
935
ALERT
933
HAEA
929
EAACI
927
Pharmaceuticals
901

10' 10' 10'

908
954 952 950 948 946 944 942 940 936 934 932 928 926
Viracor-IBT
IAS NEA IAFFPE Vidara Biotest
Boston Laboratories
Scientific Allergan 800

ModuleMD Elsevier
Corporation
855 853 851 849 847 845 843 841 829 827 821 815
FE FE
Genentech
10' FH 10' FH 10'
USA
12 11
854 852 850 848 846 844 842 840 Kirkman
828 826 824 822 American
820

Group, Express
Inc. Open

712

AAFA
Regeneron
Lineage
Therapeutics
Pharmaceuticals,
Rosch Panatrex,
Inc.

Mylan
755 753 751 749 747 745 743 741 733 Inc. 721
735 727 723

10' 10' 10'

754 752 750 748 746 744 742 740 New728 Baby726 724
Baxter
722 720 Inc.
HAE York Health
AD
Medical
ndd

GSK
RescueWear Medical
Care Affairs
Times
10'-1" 10'
National Allergy
10' Baxter Merck 10'
Solutionreach Allergy Laboratories,
Supply Inc.
655 653 651 649 647 645 643 641 633 629 627 625 623 621 607 601

10' 10' 10'

626
654 652 650 648 646 644 642 640
Dyax
Thermo 624 622 620
Inflamax

CSL
Karger
Fisher
Edge
Research Pharmaceuticals Publishers

Scientific
Inc. Novartis
Sunovion
Pharmaceuticals

Corp Behring
Axelacare Red Pharmaceuticals
Allergy Corp
Vitalograph,
Health Control Maple

Hall C
Inc.
Products
555 553 551 549 547 545 543 541 533 Solutions 527 525 Trials523 521 515 507 501

10' 10' 10'

554 552 550 548 546 544 542 540
Carestream
534
Protein
Sciences
532

Santarus
524
Osia
522

Medical
Allergy520
and
Asthma Greer
Alcon
Laboratories
Proceedings

Laboratories,
GSK
Micro
Burkard Yodle Aerocrine
Allergy
Direct, Inc.
Inc.
Guardian
Inc.
455 453 451 449 447 445 443 441 435 433 429 425 423 421 413 401

10' 10' 10'

408
454 452 450 448 446 444 442 440 436 CVS 434 432 428 426
Sol
424 422
Precision 420

Sanofi
Biogenics
Caremark Wiley- Millennium Medical Xoran
Specialty
Research Forest Blackwell Medical Products, Technologies
Chamber
ViroPharma,
Sanofi
Pharmacy Inc Inc.

Perrigo Hycor
Inc.

355 353 351 349 347 345 343 341 Company 325
Biomedical
321 315 301
6 5
10' FH FE
10' FH FE
10'
354 352 350 348 346 344 342 340 328 326 324
Walgreens
Medical322 320
Crowell College Abbott
Infusion
Systems Services
of Nutrition
Wisconsin Hollister-Stier
Laboratories Merck
Ora nSpire Mission:
Well LLC
US Buzzy4
Amy, SmartPractice

Health Allergy
Bioservices shots.com
255 253 251 249 247 245 243 241 235 LLC233 229 227 225 221 215 207 201

10' 10' 10'

232 220
254 252 250 248 246 244 242 240 236
Kedrion
228 226 224 Meditab
Corpus Rabbit
Software,
Biomed
Methapharm Nestle
Teva
Pharmaceuticals
Christi Air
Biopharma Inc.
Shire NeilMed

Respiratory
Pharmaceuticals
Quest Mission The
Red
Honeywell
Xtract
Pharmacal JAMA Shire
Diagnostics
Solutions
Company Network River
155 153 151 149 147 145 141 137 135 133 129 125 123 121 115 109 101

10' 10' 10'

154 152 150 140 138 136 134 UpTo
132 130 128
Indoor
126
Lincoln 112 110
Accredo
108 104

Ursatec Fraunhofer Alkaline Health PuraCap Nutricia

Date Biotech
Diagnostics Group

C3 C2 C1
FE TL FE
FIRST AED # 7 TL
13'6"

AID HP HP HP HP
10'
WF WF WF WF

181
 San Diego Convention Center

Upper Level:

Mezzanine Level:

Ground Level:

182
San Diego Convention Center

Press
Speaker Room
Resource
Room

Posters
General
Session
Exhibit Registration
Hall

183
 San Diego Marriott Marquis
& Marina Hotel
Lobby Level:

TO BAYSIDE CABANAS
& (LEVEL 1)
ROYS
RESTAURANT
PRESIDIO
ROOMS
RANCHO SANTA FE
SAN DIEGO BAY ROOMS

PRIVATE DINING ROOMS

THE THE
DINING PORCH THE
ROOM KITCHEN
TABLE POOL DECK
MARINA KITCHEN
THE DEN THE NOOK

THE
BA

CELLAR MEDIA
R

ROOM TORREY PINES

THE PANTRY LOUNGE ROOMS

E
IV

R
DR

YE
TEQUILA

FO
LL
BAR & GRILLE

HA

LL
EXCHANGE

HA
T
OT
(LEVEL 1)

TT
RI

IO
AR

R
AR
M

M
BUSINESS
CENTER/
UPS STORE

S
Level 1 Lobby Level
MARCH 2012
Level 1:

CABANAS

Speaker
VISTA
Resource
Room
TEQUILA
BAR & GRILLE

Hospitality
Suite

184
 San Diego Marriott Marquis
& Marina Hotel
South Tower: Level 3

South Tower - Level 4

MARCH 2012

South Tower: Level 4

LA JOLLA

LA MESA

CATALINA

LA COSTA

DANA POINT

MALIBU

185
 Keyword Index
This index lists all Annual Meeting sessions by the relevant keyword
from the ABAIs topic outline.
ABPA / AFS: 4811, 5503
Acquired (Secondary) Immunodeficiencies: Non-HIV/AIDs-related:
2005, 2806
Adverse Event Reporting: 4012
Aerobiology: 1201, 1601, 1803, 2007, 2305, 2314, 3006, 5053, 5101
Air Quality: 2507
Allergen Avoidance: 1210, 2021, 3523, 3551, 5002, 5053, 5802
Allergen immunotherapy: 1209BC, 1609AD, 1609BC, 1905, 2013,
2301, 2510, 2512, 2812, 2821, 3011, 3313, 4012, 5009
Anaphylaxis (including Idiopathic, Exercise, Latex): 1101B, 1605,
2014, 2252, 2302, 2311, 2526, 2809, 2816, 2821, 3009, 3011, 3044,
4008, 4012, 4801, 4826, 4827, 5007, 5807
Anti-inflammatory Agents (including COX-1 & 2): 2815, 4809, 4815,
5302
Antibody-Mediated Immune Regulation: 4305, 5306
Anticholinergics: 3001
Antigens / Antigen Presentation/Superantigens: 5051
Asthma: Adults: 1111, 1202, 1302, 1613, 1802, 1901, 2001, 2002,
2304, 2308, 2314, 2506, 2507, 2510, 2522, 2524, 2801, 2804, 2809,
2810, 2815, 3001, 3002, 3010, 3041, 3101, 3301, 3308, 3312, 3521,
3525, 4001, 4002, 4007, 4015, 4301, 4303, 4305, 4307, 4805, 4808,
4811, 4812, 4813, 4822, 4824, 4825, 5001, 5006, 5301, 5312, 5313,
5503, 5504, 5805
Asthma: Children: 1202, 1302, 1802, 1804, 2002, 2008, 2251, 2304,
2306, 2307, 2314, 2501, 2506, 2507, 2521, 2524, 2801, 2805, 3001,
3010, 3015, 3304, 3314, 4301, 4304, 4805, 4812, 4813, 4822, 5001,
5002, 5006, 5301, 5312, 5801, 5804
Billing and Coding: 1209BC, 1603, 1805, 2011, 2315, 2623, 2808,
4828
Bronchial Provocation: 2002
CD4+ Cells (TH1, TH2) and T regulatory cells: 2515, 4015, 5305
Cell Surface Markers and Receptors (Flow Cytometry): 5051
Chronic Cough: 1101A, 5004
Congenital (Primary) Immunodeficiencies: B Cell / Antibody
Deficiencies: 1206, 1607, 2003, 2303, 2527, 2806, 4302, 4804, 4829,
5803
Congenital (Primary) Immunodeficiencies: Complement
Deficiencies: 2527, 4829, 5521
Congenital (Primary) Immunodeficiencies: Neutrophil Deficiencies:
1206, 2006, 2303, 2505, 2527, 4302, 5307
Congenital (Primary) Immunodeficiencies: T Cell Deficiencies:
1206, 1604, 1607, 2005, 2303, 2505, 4302, 4806
Conjunctivitis: 5052
Contact Hypersensitivity: 1208, 1604, 3303, 3523
186
Controversial Tests / Misuse of Standard Tests: 2824
Controversial Treatments: 2301, 3005, 3043, 4823
COPD: 1101D, 1604, 1613, 4001, 5504
Cough: 1101A, 5004
Cytokine and Cytokine Receptor-Mediated Therapy (IFNs, CSFs,
ILs): 2015, 3002, 3101, 5305, 5307
Cytokines: 2001, 2506, 3013, 3014, 5005, 5502
Cytokines / Chemokines and Their Receptors: 2813, 4015, 4810,
5805
Data Analysis and Biostatistics: 1610, 2624, 4006
Dermatologic and Ophthalmic Treatments: 1208, 4821, 4830, 5052
Drug Reactions: 1207, 2009, 2022, 2302, 2508, 2807, 4101, 4803,
4821, 5522, 5807
Eczema / Atopic Dermatitis: 0001, 2023, 2312, 2803, 3315, 3524,
5003, 5303
Effect of Mediators on Target Organs: 2515
EHR/EMR: 1203, 1701, 2004, 2011, 2504, 2802, 4004
Endothelial / Epithelial / Smooth Muscle / Fibroblasts: 2813, 2815,
4303
Environmental Controls: 1210, 2007, 5101
Environmental Issues: 2823, 3006
Eosinophilic Esophagitis: 2010, 5802
Eosinophils: 1904, 2525, 3003, 3008, 4307, 4808, 4810
Epidemiology: 3525
Evidence-based/Clinical Practice Guidelines: 1610, 2026, 2502,
2824, 3012, 3524, 4803, 4807, 5314
Experimental Design: 2811
Food Allergy: 1101, 1111, 1205, 1301, 1402, 1804, 1903, 2010,
2021, 2024, 2025, 2301, 2302, 2312, 2509, 2514, 2523, 2622, 2803,
2805, 2825, 3008, 3044, 3305, 3311, 3315, 3520, 3551, 4008, 4009,
4011, 4807, 5003, 5008, 5524, 5802, 5806
Food Challenge: 1402, 2024, 2509, 2523, 3311, 4807, 4826, 5524
Foods: 1402, 2509, 3551
Gastrointestinal System: 2021, 2525, 2825, 4009
Gene Transfer: 4823
Glucocorticoids: 5314
Health Informatics: 1203, 1401, 1701, 2004, 2316, 2701, 3004,
4004, 4802
Health Literacy: 1101C, 2521, 3004
Healthcare Disparities: 2307, 3308, 4825, 5804
Hereditary and Acquired Angioedema: 2503, 5304, 5506
Histamine Antagonists: 3302
Hypereosinophilic Syndromes: 1904, 2015, 2525
 Keyword Index
Ig Measurement / Total & Specific: 2012, 2523, 3042
IgE Receptor / Allergen Binding: 5311
IgE-Mediated Biochemical Events: 5005
Immune Complexes: 3522
Immunogenetics / Molecular Biology: 1610, 4003
Immunoglobulin Replacement Therapy: 2313, 2806, 4051, 4804,
5803
Immunoglobulins (including IgE): 1902, 2514, 3306, 5311
Immunohematologic Diseases: 4306
Immunologic Eye Diseases: 5052
Immunologic Skin Diseases: 4003, 5523, 5809
Immunomodulators / Suppressives (including anti-IgE, DNA,CpG
ODNs): 1901, 2524, 3304, 5523
Immunoprophylaxis Vaccine: 4304
Immunoregulation / Tolerance: 1804, 1905, 2514, 3015, 3527, 5051
Immunotherapy: 1011, 1209, 1609, 1901, 1905, 2013, 2101, 2611,
2621, 2821, 3005, 3313, 3526, 5009, 5505
Indoor Allergens: 1608, 2013, 3007, 5002
Infectious Agents: 2008, 3015, 3304, 3306, 4304, 4805, 5313
Inflammatory Gastrointestinal Diseases: 3008
Innate Immunity/TLRs: 1801, 2306, 2308, 3307, 4014, 4306, 4809,
5305, 5307, 5805
Insurance Issues (e.g. contracts, appeals): 1102, 1401, 1603, 1805,
2011
Leukotriene Pathway Modulators: 4301
Lipid Mediators: 2515, 2810, 3013, 3527, 4809
Lymphocyte Function: Proliferation, Cytotoxicity: 4005
Lymphocytes: T cells/B cells/NK cells/LAK cells: 1602, 3042, 4005,
4014, 4051, 5311, 5502, 5808
Lymphoid System & Organs: 4005
Mast Cell Stabilizers: 1605
Mast Cells / Basophils: 2014, 2526, 3013, 3014, 3306, 4801, 4810,
4827, 5005
Mastocytosis: 1605, 2526, 3009, 4801
Mediator Measurement: 2513, 5807
Microbiome: 2008, 3007, 3521
Modulation of Mediator Release: 2001
Molds and Fungi: 1210, 1601, 1803, 2007, 2012, 2305, 3006, 4811,
5503
Molecular Biology Technology including TRECs. RTPCR, in situ
hybridization, cell purification, gene chips: 2701, 4701
Monocytes / Macrophages / Dendritic Cells (i.e., Antigen-
Presenting Cells): 5301
Mucosal Immunity: 2306, 3307, 4014, 5306
Nasal Provocation: 2513, 2811
Neutrophils: 2014
NK / NKT Cells: 3307, 5502, 5806
Non-invasive diagnostic measures: 4824, 5006
Occupational Diseases: 2305, 2809, 3041, 3303, 4007, 4824, 5101
Patch testing: 3303, 3523, 5303
Patient Education: 1203, 1207, 1301, 1302, 1603, 1802, 1805, 2316,
2625, 2823, 2824, 3043, 3308, 3312, 3314, 4011, 4051, 4802, 5003,
5054
Platelets: 2810
Pollens: 1201, 2012, 3305, 5053
Pollutants: 1803, 2801
Practice Management: 1501, 2315, 2316, 2504, 2621, 2623, 2802,
2808, 2822, 2823, 3044, 4004
Pulmonary Function Tests: 1613, 2502, 3041
Quality and Outcomes: 1102, 1112, 1611, 1621, 2004, 2307, 2313,
2504, 2510, 2521, 2621, 2808, 2814, 3010, 3302, 3314, 3525, 4001,
4010, 4303, 4803, 4812, 4825, 5054, 5312, 5801, 5804
Rhinitis: 1204, 1612, 1903, 2513, 2811, 3011, 4808
Rhinoscopy: 1204, 1612
Serologic Tests for Autoimmunity: 2003
Serologic Tests: ELISA, Western Blot: 3042
Sinusitis: 1204, 1612, 2308, 2511, 3012, 3101, 4013, 4305, 4814,
4815, 5302, 5306, 5525
Skin: 1208, 2023, 2312, 2803, 4007, 4830, 5303
Skin Testing: Scratch and Intradermal: 1207, 1209AD, 1903, 2508,
2807
Skin tests (Immunoassay for Total and Specific IgE): 1209
Spirometry: 2502
Standardization of Antigens: 1209AD
Stinging Insect Allergy: 3305
Surgical Intervention with Sinuses / Middle Ear: 4814
Systemic Autoimmune Disease: RA/SLE/Vasculitis/Other
Disorders: 1606, 5808
T and B Cell Ligand-Receptor Interactions and Signal Transduction
/ Cell Activation / Anergy: 3014
Upper Airway, Nose, Sinuses, Middle Ear: 3012, 4013, 5302, 5525
Urticaria: 0001, 3302, 3524, 4008, 4827, 5304, 5523, 5809
Vaccine (Principles and Reactions): 1607, 2005, 4306, 4701, 5808
Venoms: 1209, 2816
187
 faculty index
A Beigelman, Avraham, MD MSCI, St. Louis, MO - 3304
Aaronson, Donald W., MD FAAAAI, Chicago, IL - 1209BC, 1609AD,
2621, 2808
Abonia, Juan Pablo, MD, Cincinnati, OH - 2010, 5802
Abraham, Soman N., PhD, Durham, NC - 3306
Abramson, Stuart L., MD PhD FAAAAI, San Angelo, TX - 2701
Aceves, Seema Sharma, MD PhD FAAAAI, La Jolla, CA - 2021, 5802
Ackerman, Steven J., PhD, Chicago, IL - 2015
Adams, Karla E., MD, San Antonio, TX - 0001
Adelman, Daniel C., MD FAAAAI, Redwood City, CA - 1111
Adinoff, Allen D., MD FAAAAI, Denver, CO - 1612
Ahuja, Sunil K., MD, San Antonio, TX - 1602
Akdis, Cezmi A., MD FAAAAI, Davos, Switzerland - 2101, 3301
Akdis, Mubeccel, MD PhD, Davos, Switzerland - 3301, 4012, 4305
Akin, Cem, MD PhD FAAAAI, Boston, MA - 1205, 1605, 4801
Allakhverdi, Zoulfia, PhD FAAAAI, Montreal, QC, Canada - 5305
Allen, Katrina Jane, MD PhD FAAAAI, Victoria, Australia - 1804, 2525,
5802
Allison, Beth A., NP, Portland, OR - 2026, 3312
Aloe, Charles, MPH, Baltimore, MD - 2624
Ananos, Diane, G., RN, New York, NY - 2625
Anderson, James J., MLT, London, ON, Canada - 3006
Andreakos, Evangelos, PhD, Athens, Greece - 3301
Anolik, Robert, MD FAAAAI, Blue Bell, PA - 2802
Apter, Andrea J., MD MA MSc FAAAAI, Philadelphia, PA - 1611, 5314,
5804
Arnold, Jeanette L., MSN RN C-FNP, Jackson, MS - 1101A, 2824
Arruda, Luisa Karla P., MD PhD FAAAAI, Ribeirao Preto, Brazil - 2013,
3015
Asano, Koichiro, MD, Kanagawa, Japan - 3013
Askenazi, Noga, MD FAAAAI, Crystal Lake, IL - 4828
Assaad, Amal H., MD FAAAAI, Cincinnati, OH - 4810, 5801
Atkins, Dan, MD FAAAAI, Denver, CO - 5802
Atkinson, Katie J., RN CFNP, New York, NY - 2021, 2622
Avila, Pedro C., MD FAAAAI, Chicago, IL - 4805
Azzi, Helena, DNP FNP-BC AE-C, Jupiter, FL - 2625
B Bukstein, Don A., MD, Madison, WI - 5809
Bacharier, Leonard B., MD FAAAAI, Saint Louis, MO - 2304, 2501, 3304
Bachert, Claus, MD PhD, Ghent, Belgium - 2511, 5302
Bahna, Sami L., MD DrPH FAAAAI, Shreveport, LA - 1903
Bajowala, Sakina S., MD FAAAAI, North Aurora, IL - 1805, 3004
Baker, James R., Jr., MD FAAAAI, Ann Arbor, MI - 3522, 4701
Balcer-Whaley, Susan L., MPH, Baltimore, MD - 2314
Ballow, Mark, MD FAAAAI, St. Petersburg, FL - 1206, 4804
Bandino, Michelle, MD, San Antonio, TX - 0001
Banerji, Aleena, MD, Boston, MA - 2807, 5304
Banks, Taylor A., MD, Bethesda, MD - 1011
Bansal, Priya J., MD FAAAAI, Bloomingdale, IL - 2011, 2504
Baptist, Alan P., MD MPH FAAAAI, Ann Arbor, MI - 3308, 4001, 4825
Barnes, Charles S., PhD, Kansas City, MO - 5053
Barnes, Kathleen C., PhD FAAAAI, Baltimore, MD - 1611, 3522
Barney, Neal P., MD, Madison, WI - 5052
Baroody, Fuad M., MD FAAAAI, Chicago, IL - 2811, 4814
Barrett, Nora A., MD FAAAAI, Boston, MA - 1611, 4006, 5301
Beck, Lisa A., MD FAAAAI, Rochester, NY - 1604
188
Bell, Matthew C., MD, Madison, WI - 1604
Bender, Bruce G., PhD FAAAAI, Denver, CO - 3010, 3525, 5312, 5804
Berin, Cecilia, PhD, New York, NY - 5306
Bernstein, Cheryl Koff, RN BSN CCRC, Cincinnati, OH - 1102, 1401,
3313
Bernstein, David I., MD FAAAAI, Cincinnati, OH - 1401, 2812, 3303
Bernstein, Jonathan A., MD FAAAAI, Cincinnati, OH - 3524, 5053
Beyer, Kirsten, MD, Berlin, Germany - 3305, 4807
Bhakta, Nirav, MD PhD, San Francisco, CA - 5805
Bird, J. Andrew, MD FAAAAI, Dallas, TX - 2301
Bisgaard, Hans, MD DMSci, Gentofte, Denmark - 5313
Blaiss, Michael S., MD FAAAAI, Memphis, TN - 1011, 1609AD, 3526
Bleesing, Jack J.H., MD PhD, Cincinnati, OH - 4005
Blessing-Moore, Joann C., MD FAAAAI, Palo Alto, CA - 1011
Blouin, William R., ARNP, North Miami, FL - 2023, 2311, 4051
Bochner, Bruce S., MD FAAAAI, Chicago, IL - 3014, 5051
Bock, S. Allan, MD FAAAAI, Boulder, CO - 2509
Boguniewicz, Mark, MD FAAAAI, Rochester, NY - 2803, 5303
Boisson-Dupuis, Stephanie, MD, New York, NY - 1607
Bollinger, Mary E., DO, Baltimore, MD - 2307
Bonadonna, Patrizia, MD PhD, Padora, Italy - 1605
Bonagura, Vincent R., MD FAAAAI, Great Neck, NY - 1206, 2527, 5803
Bonilla, Francisco A., MD PhD FAAAAI, Boston, MA - 1206, 2005, 3522
Bonini, Matteo, MD, Rome, Italy - 3001
Booker, Jeanette, Asheville, NC - 2822
Boonpiyathad, Tadech, MD, MSc, Bangkok, Thailand - 0001
Borgmeyer, Anne E., MSN RN CPNP AE-C, Saint Louis, MO - 1302, 3314
Borish, Larry, MD FAAAAI, Charlottesville, VA - 2810, 3307, 3527, 5502
Borrelli, Belinda, PhD, Boston, MA - 5312
Boushey, Homer A., MD FAAAAI, San Francisco, CA - 2524, 3521
Boyce, Joshua A., MD FAAAAI, Boston, MA - 1611, 4006, 5301
Brennan, Patrick J., MD PhD, Boston, MA - 1611, 5806
Broide, David H., MB ChB FAAAAI, San Diego, CA - 4810
Brown, David A., MD, Skyland, NC - 1209BC
Bruner, Karen Elizaeth, MD, San Antonio, TX - 0001
Buehring, Bjoern, MD, Madison, WI - 5314
Burks, A. Wesley, MD FAAAAI, Chapel Hill, NC - 1111
Busse, Paula L., MD FAAAAI, New York, NY - 4001, 4303
Busse, William W., MD FAAAAI, Madison, WI - 1604, 2013, 2304, 3521
Butterfield, Joseph H., MD FAAAAI, Rochester, MN - 3009
C
Calabria, Christopher W., MD, San Antonio, TX - 2812
Calatroni, Agustin, MA MS, Chapel Hill, NC - 1608
Caldwell, Jason W., DO FAAAAI, Winston Salem, NC - 1604
Calhoun, William J., MD FAAAAI, Galveston, TX - 2522
Canalis, Ernesto, MD, Hartford, CT - 5314
Candotti, Fabio, MD, Bethesda, MD - 4302, 4823
Carlisle, Suzanne K., RN BSN CCRP, Little Rock, AR - 2024
Carter, Melody C., MD, Bethesda, MD - 3009, 4801
Cartier, Andr, MD FAAAAI, Montreal, QC, Canada - 2809, 4824
Casale, Thomas B., MD FAAAAI, Tampa, FL - 1901, 2611, 2815, 3302
Castells, Mariana C., MD PhD FAAAAI, Boston, MA - 1112, 1605, 2526,
4101
 faculty index
Castro, Mario, MD MPH, St. Louis, MO - 1101, 2304, 2522
Caubet, Jean-Christoph, MD, Geneva, Switzerland - 4009
Celedon, Juan C., MD, DrPH, FAAAAI, Pittsburgh, PA - 1802
Cerutti, Andrea, MD, New York, NY - 5306
Chambers, Christina, PhD MPH, San Diego, CA - 2804
Chandra, Rakesh, MD, Chicago, IL - 3012
Chang, Christopher, MD PhD FAAAAI, Wilmington, DE - 1102
Chaudhry, Sofia, MD, Silver Spring, MD - 4808
Chehade, Mirna, MD MPH, New York, NY - 2010, 2525
Cheung, Dorothy S., MD FAAAAI, Milwaukee, WI - 2306, 3306
Chipps, Bradley E., MD FAAAAI, Sacramento, CA - 2501
Chiu, Asriani M., MD FAAAAI, Milwaukee, WI - 1112, 5054
Choo, Eugene M., MD FAAAAI FACAAI, Houston, TX - 1205
Chou, Janet S., MD, Boston, MA - 4302
Chowdhury, Badrul A., MD PhD FAAAAI, Potomac, MD - 4808
Christiani, David C., MD, Boston, MA - 5101
Christie, G. Lynn, MS RD, Little Rock, AR - 2825, 3551
Ciaccio, Christina E., MD FAAAAI, Kansas City, MO - 1210, 3007
Cianferoni, Antonella, MD PhD, Philadelphia, PA - 1610
Cicardi, Marco, MD PhD, Milan, Italy - 5304, 5506
Cockcroft, Donald W., MD FAAAAI, Saskatoon, SK, Canada - 1613, 2002
Cohn, John R., MD FAAAAI, Philadelphia, PA - 5053
Collins, Limone C., Jr., MD, Falls Church, VA - 0001
Commins, Scott P., MD PhD, Charlottesville, VA - 4008
Condino-Neto, Antonio, MD PhD, Sao Paulo, Brazil - 1607
Corazalla, Edward O., MS RPFT, Minneapolis, MN - 1101D, 3041
Corren, Jonathan, MD, Los Angeles, CA - 1901, 3002, 4002
Covar, Ronina A., MD, Denver, CO - 5313
Cox, Linda, MD FAAAAI, Fort Lauderdale, FL - 1011, 1111, 2101, 2302,
2611, 5505
Cox-Ganser, Jean M., PhD, Morgantown, WV - 5101
Craig, Timothy J., DO FAAAAI, Hershey, PA - 1802, 3521
Crain, Maria G., CPNP AE-C, Dallas, TX - 2622
Crameri, Reto, PhD, Davos, Switzerland - 2012
Crawford, William W., MD, Harbor City, CA - 3525
Creticos, Peter S., MD FAAAAI, Crownsville, MD - 1209AD, 2512
Crotty, Shane, PhD, La Jolla, CA - 5808
Cunningham-Rundles, Charlotte, MD PhD FAAAAI, New York, NY - 2003
Curtin-Brosnan, Jean, MA, Baltimore, MD - 2624
Cush, John J., MD, Dallas, TX - 1606
D Gleich, Gerald J., MD FAAAAI, Salt Lake City, UT - 4307
Darr, Jennifer M., MSW LCSW, Denver, CO - 1301
Davies, Donna, BSc PhD, Southampton, United Kingdom - 3101
Davis, Ray S., MD FAAAAI, St. Louis, MO - 2816
De Benedetto, Anna, MD, Rochester, NY - 5303
De Jong, Nicolette, PhD, Rotterdam, Netherlands - 1101
De La Morena, M. Teresa, MD, Dallas, TX - 1206, 2303
Demain, Jeffrey G., MD FAAAAI, Anchorage, AK - 3523, 5503
Derrico, Thomas J., Albany, NY - 2823
Dimov, Ves, MD, Chicago, IL - 1203, 2802, 4802
Dinakar, Chitra, MD FAAAAI, Kansas City, MO - 2805, 4010, 4813, 5006
Dioun, Anahita F., MD FAAAAI, Boston, MA - 1207, 2009
Dixit, Anupma B., PhD, St. Louis, MO - 2007
Doherty, Taylor A., MD FAAAAI, San Diego, CA - 1611, 3307
Dooley, Mary Anne, MD, Chapel Hill, NC - 1606
Dowling, Paul J., MD FAAAAI, Kansas City, MO - 1210
Dreyfus, David H., MD PhD FAAAAI, Waterbury, CT - 5523
Duff, Carla M., CPNP MSN, St Petersburg, FL - 2023, 4051
Durban, Raquel Z., MS RD LDN, Charlotte, NC - 2625
Durham, Stephen R., MA MD FRCP, London, United Kingdom - 1602,
2101, 2611
Dykewicz, Mark S., MD FAAAAI, St. Louis, MO - 2503
E
Ebisawa, Motohiro, MD PhD FAAAAI, Kanagawa, Japan - 1607, 2302
Eichenfield, Lawrence F., MD, San Diego, CA - 1208
Ellis, Anne K., MD MSc FAAAAI, Kingston, ON, Canada - 2513, 2811
Elverson, Wendy, RD LDN, Boston, MA - 3315
Epland, Kristin, NP, Plymouth, MN - 2313, 4051
Epstein, Tolly, MD MS, Indianapolis, IN - 1802, 3011
Escribano, Luis, MD PhD FAAAAI, Salamanca, Spain - 1605
Espinosa-Rosales, Francisco J., MD, Naucalpan de Juarez, Mexico -
4829
F
Fanning, Laura B., MD, Boston, MA - 1611
Farrar, J. David, PhD, Dallas, TX - 5305
Fasano, Mary Beth, MD FAAAAI, Iowa City, IA - 1011, 1112
Feldweg, Anna M., MD, Boston, MA - 4826
Fineman, Stanley M., MD MBA FAAAAI, Marietta, GA - 1603, 1805,
2803
Finkelman, Fred D., MD, Cincinnati, OH - 2302
Fleischer, David Mark, MD FAAAAI, Denver, CO - 4807
Fleisher, Thomas A., MD FAAAAI, Bethesda, MD - 1111, 2805
Fonacier, Luz S., MD FAAAAI, Mineola, NY - 1208, 1604, 3303
Frank, Michael M., MD FAAAAI, Durham, NC - 5304
Freeman, Alexandra F., MD, Bethesda, MD - 1902, 2006
Fritz, Patricia Mason, Albany, NY - 2507
Fuleihan, Ramsay L., MD, Chicago, IL - 2806
G
Galli, Stephen J., MD, Stanford, CA - 4810
Gelfand, Erwin W., MD FAAAAI, Denver, CO - 5502
Geller, Mario, MD FAAAAI, Rio de Janeiro, Brazil - 4827
Georas, Steve N., MD, Rochester, NY - 3101, 5805
George, Maureen, PhD RN AE-C, Philadelphia, PA - 1101, 1302, 3043
Gergen, Peter J., MD MPH, Bethesda, MD - 1608
Gern, James E., MD FAAAAI, Madison, WI - 1611, 2008, 5313
Goldberg, Pinkus, MD FAAAAI, Indianapolis, IN - 1402
Goldblum, Randall M., MD, Galveston, TX - 2801
Golden, David B.K., MD FAAAAI, Baltimore, MD - 1011, 2816
Goleva, Elena, PhD, Denver, CO - 5001
Goronzy, Jorg, MD PhD, Stanford, CA - 4306
Gould, Hannah J., PhD, London, United Kingdom - 5005, 5311
Graham, Barney S., MD PhD, Bethesda, MD - 4304
Grammer, Leslie C., MD FAAAAI, Chicago, IL - 2801, 4007, 4811, 5101
Grayson, Mitchell H., MD FAAAAI, Milwaukee, WI - 1611, 2306, 3306,
3527, 5311
Green, Brett J., PhD, Morgantown, WV - 3007
Green, Linda D., MD FAAAAI, Havertown, PA - 1203
Greenberger, Paul A., MD FAAAAI, Chicago, IL - 1605, 2526
Gregory, Karen L., DNP APRN-BC RRT AE-C, Edmond, OK - 1101D,
2312, 2821
189
 faculty index
Grimshaw, Kathryn E., PhD RD, Southampton, United Kingdom - 2825,
3551
Grodofsky, Marshall P., MD FAAAAI, West Hartford, CT - 1603, 2011
Groetch, Marion E., MS RD, New York, NY - 2021, 3551
Gronert, Karsten, PhD, Berkeley, CA - 3527
Gross, Gary N., MD FAAAAI, Dallas, TX - 1209BC, 2808, 4828
Gruchalla, Rebecca S., MD PhD FAAAAI, Dallas, TX - 1207, 2807
H Joseph, Christine L.M., PhD, Detroit, MI - 4825
Haczku, Angela, MD PhD FAAAAI, Philadelphia, PA - 2813, 4014, 4809
Hagan, John B., MD FAAAAI, Rochester, MN - 4813
Hague, Angela R., PA-C, Dallas, TX - 2625
Hamilos, Daniel L., MD, Boston, MA - 1204, 2511, 4814, 5503
Hamilton, Robert G., PhD D.ABMLI FAAAAI, Baltimore, MD - 1011, 3305
Han, Joseph K., MD, Norfolk, VA - 5525
Hanania, Nicola A., MD, Houston, TX - 5504
Hanifin, Jon M., MD FAAAAI, Portland, OR - 4830
Hankin, Cheryl S., PhD, Moss Beach, CA - 1609
Hansel, Trevor Thomas, MD PhD, Paddington, United Kingdom - 2308
Hanson, I. Celine, MD FAAAAI, Houston, TX - 1206
Hare, Nathaniel D., MD FAAAAI, Lewisburg, PA - 2802, 3004, 4802
Harrison, Rayn, Philadelphia, PA - 2814
Hartert, Tina V., MD MPH, Nashville, TN - 4304, 4805
Hartman, Joel M., MD, Winston Salem, NC - 1205
Hauswirth, David W., MD FAAAAI, Columbus, OH - 1205, 4814
Hawkins, Joan E., Worcester, MA - 1501, 2315, 2623, 2823
Hernandez-Trujillo, Vivian P., MD FAAAAI, Miami, FL - 1101B, 2311,
4804
Herzog, Ronit, MD FAAAAI, New York, NY - 4003
Heymann, Peter W., MD, Charlottesville, VA - 5313
Hiegel, Anne M., RN CRC, Little Rock, AR - 2024
Hoffman, Hal M., MD FAAAAI, La Jolla, CA - 5307
Hogan, Mary Beth, MD FAAAAI, Reno, NV - 2014
Holbreich, Mark, MD FAAAAI, Indianapolis, IN - 3008
Holbrook, Teri, RN CRNP, Baltimore, MD - 3311
Holtzman, Michael J., MD FAAAAI, St. Louis, MO - 2306
Holzhauer, Robert J., MD MBA FAAAAI, San Luis Obispo, CA - 1805
Honsinger, Richard W., MD MACP FAAAAI, Los Alamos, NM - 2521,
2808
Horner, Anthony A., MD FAAAAI, San Diego, CA - 1803, 4809
Horner, W. Elliott, PhD LEED AP FAAAAI, Marietta, GA - 1601
Horowitz, Edward, M., BA, Baltimore, MD - 2625
Hossny, Elham M., MD PhD FAAAAI, Cairo, Egypt - 1607
Hsu Blatman, Karen S., MD, Brookline, MA - 4827, 5807
Huang, Yvonne, MD, San Francisco, CA - 2001
Hulse, Kathryn E., PhD, Chicago, IL - 4305, 5306
Huston, David P., MD FAAAAI, Houston, TX - 1606
I Land, Michael H., MD FAAAAI, San Diego, CA - 1604
Idzko, Marco, MD, Freiburg, Germany - 5301
Irish, Jonathan M., PhD, Nashville, TN - 1610
Ishmael, Faoud T., MD PhD FAAAAI, Hershey, PA - 4002, 5001
J Larenas Linnemann, Dsire E.S., MD FAAAAI, Mexico D.F., Mexico -
Jackson, Daniel J., MD, Madison, WI - 2308, 3304, 5313
Janevic, Mary, MPH PhD, Ann Arbor, MI - 3308
Jardetzky, Theodore S., PhD, Stanford, CA - 5311
190
Jariwala, Sunit, MD, New York, NY - 2314
Jarvinen-Seppo, Kirsi M., MD PhD, Albany, NY - 4826
Jerath, Maya R., MD PhD, Chapel Hill, NC - 4008
Johnson, Kimberly S., MD, Abilene, TX - 0001
Johnson, Sarah, Philadelphia, PA - 2814
Johnston, Sebastian L., MD PhD, London, United Kingdom - 4304
Jones, Stacie M., MD, Little Rock, AR - 2523
K
Kabourek, Jamie L., MS RD, Lincoln, NE - 3551
Kamilaris, Janet S., RN, Charlotte, NC - 1621
Kaplan, Allen P., MD FAAAAI, Charleston, SC - 5809
Kaplan, Michael R., DO FAAAAI, Jacksonville, FL - 0001
Kastner, Daniel L., MD, Bethesda, MD - 5307
Katial, Rohit, MD FAAAAI, Denver, CO - 1111, 1609BC
Kato, Atsushi, PhD, Chicago, IL - 5306
Kavanaugh, Arthur, MD FAAAAI, San Diego, CA - 1606
Keating, Richard, MD, San Diego, CA - 1606
Kelso, John M., MD FAAAAI, San Diego, CA - 4306, 4805
Kennedy, Josh L., MD, Little Rock, AR - 2506
Kennedy, Kevin, MPH CIEC, Kansas City, MO - 1210
Kern, Robert C., MD, Chicago, IL - 1204
Khan, David A., MD FAAAAI, Dallas, TX - 0001, 1011, 2807, 3524, 4101
Khoury, Paneez, MD, Bethesda, MD - 1111, 3003
Kidon, Mona I., MD FAAAAI, Rishon, Israel - 1607
Kiley, James P., PhD, Bethesda, MD - 2304
Kim, Haejin, MD, Detroit, MI - 1604
Kim, Jennifer S., MD FAAAAI, New York, NY - 4821
King, Eva-Maria, PhD, Charlottesville, VA - 1608, 1803
Kingdom, Todd T., MD, Aurora, CO - 1204, 2527
Kita, Hirohito, MD, Rochester, MN - 2813, 5502
Kleine-Tebbe, Joerg R., MD FAAAAI, Berlin, Germany - 1209, 2523, 3305
Klion, Amy D., MD, Bethesda, MD - 1205, 1904
Kloepfer, Kirsten, MD, Indianapolis, IN - 2008
Knight, Adina Kay, MD FAAAAI, Rockville, MD - 1111, 5521
Kobrynski, Lisa J., MD MPH FAAAAI, Atlanta, GA - 1206
Koepke, Jerald W., MD FAAAAI, Littleton, CO - 1612
Korenblat-Hanin, Melissa T., ACSW LCSW, Saint Louis, MO - 1301
Kosisky, Susan E., BS MHA, Burtonsville, MD - 0001, 1609AD
Kraft, Monica, MD, Durham, NC - 4303
Kuhn, Julie, A., MSW, Chicago, IL - 2625
Kumararatne, Dinakantha, MD PhD, Cambridge, United Kingdom - 1801
L
LaBelle, Ginger S., CPNP, Cary, NC - 2313
LaForce, Craig F., MD FAAAAI, Raleigh, NC - 1401
Laidlaw, Tanya M., MD FAAAAI, Boston, MA - 1611, 2810
Lang, David M., MD FAAAAI, Cleveland, OH - 3302
Lanz, Miguel J., MD FAAAAI, Coral Gables, FL - 4812
Larche, Mark, PhD, Hamilton, ON, Canada - 4012
2611, 2812, 3526
Lawrence, Monica G., MD, Bethesda, MD - 1604, 5307
 faculty index
Le, Tao T., MD MHS FAAAAI, Elizabethtown, KY - 1203, 1603, 1805,
2004, 2521, 2802
LeBovidge, Jennifer S., PhD, Reading, MA - 3315
Ledford, Dennis K., MD FAAAAI, Tampa, FL - 1205
Lee, Gerald B., MD FAAAAI, Louisville, KY - 1205, 4802
Lee, Rachel Umi, MD, San Diego, CA - 0001
Legge, Kevin, PhD, Iowa City, IA - 2306
Lenehan, Patrick J., Baltimore, MD - 2624
Leo, Harvey L., MD FAAAAI, Ann Arbor, MI - 2521
Leung, Donald Y.M., MD PhD FAAAAI, Denver, CO - 1111
Levetin, Estelle, PhD FAAAAI, Tulsa, OK - 1201, 1601, 5053
Levi-Schaffer, Francesca, PhD FAAAAI, Jerusalem, Israel - 3014
Levinson, Arnold I., MD FAAAAI, Philadelphia, PA - 1606
Li, H. Henry, MD PhD, Chevy Chase, MD - 3303
Lieberman, Jay A., MD, Memphis, TN - 1209AD
Lieberman, Phillip L., MD FAAAAI, Germantown, TN - 1205, 2526
Lim, Kaiser G., MD FAAAAI, Rochester, MN - 4010
Lima, John, MD, Jacksonville, FL - 4301
Limb, Susan Lee, MD FAAAAI, Silver Spring, MD - 4808
Ling, Morris, MD, Boston, MA - 5805
Lio, Peter A., MD, Chicago, IL - 1208, 4821
Lipworth, Brian J., MD, United Kingdom - 2815
Lloyd, Clare M., PhD, London, United Kingdom - 5305
Lund, Frances E., PhD, Birmingham, AL - 5311
Lundberg, Cory A., DO, Bethesda, MD - 0001
Luong, Amber U., MD PhD, Houston, TX - 4013, 5525
Luster, Andrew D., MD PhD, Charlestown, MA - 1602, 4810
Lynch, Susan V., PhD, San Francisco, CA - 2810
M Newcomb Baker, Dawn C., PhD, Nashville, TN - 4015, 5301
MacGinnitie, Andrew J., MD PhD, Boston, MA - 2503
Macy, Eric M., MD FAAAAI, San Diego, CA - 2508
Mahr, Todd A., MD FAAAAI, La Crosse, WI - 2805
Maleki, Soheila J., PhD, New Orleans, LA - 5524
Mallam, Dee, RN AE-C, Mercerville, NJ - 2821
Mancia, Sonia C., RN, Fairfax, VA - 3044
Manning, Michael E., MD FAAAAI, Scottsdale, AZ - 5504
Markert, M. Louise, MD PhD FAAAAI, Durham, NC - 2005, 2303, 4051
Marsh, Rebecca A., MD, Cincinnati, OH - 2505
Martin, Bryan L., DO FAAAAI, Columbus, OH - 1609BC
Martin, Richard J., MD, Denver, CO - 2815
Martinez, Fernando D., MD, Tucson, AZ - 3304, 4813
Mathur, Sameer K., MD PhD FAAAAI, Madison, WI - 2015, 4306
Mathuria, Adhuna C., MD, Chantilly, VA - 1805
Matsui, Elizabeth, MD, Baltimore, MD - 5002
McClimon, Brad, J., MD, Dubuque, IA - 2510
McCormack, Meredith C., MD, Baltimore, MD - 1613
McCormick, Margaret J., MS RN, Baltimore, MD - 2625
McDowell, Karen, MD, Cleveland, OH - 5801
McGeady, Stephen J., MD FAAAAI, Philadelphia, PA - 2625, 3314
McHeyzer-Williams, Michael G., PhD, La Jolla, CA - 5808
McKnight, A. Sean, MD FAAAAI, Henderson, NV - 1203, 2504, 2802
Meadows, J. Allen, MD FAAAAI, Montgomery, AL - 2808
Meffre, Eric, PhD, New Haven, CT - 5808
Mehta, Vinay, MD FAAAAI, Lincoln, NE - 1805
Melton, Alton Lee, MD, Cleveland, OH - 4011
Metz, Gregory M., MD, Edmond, OK - 2312, 2821
Meyerson, Karen L., MSN FNP-C AE-C, Grand Rapids, MI - 2625
Midoro-Horiuti, Terumi, MD PhD FAAAAI, Galveston, TX - 2801
Mikita, Cecilia, MD MPH FAAAAI, Bethesda, MD - 1609AD
Milewski, John D., Med. Admin., Denver, CO - 1501, 2316, 2621, 2822
Miller, Eva K., MD, Nashville, TN - 2506, 5313
Miller, Rachel L., MD FAAAAI, New York, NY - 1202, 2305, 2801
Milligan, Ki Lee, MD, Bethesda, MD - 0001
Milner, Joshua D., MD, Bethesda, MD - 1610
Mitchell, Allen A., MD, Boston, MA - 2804
Mitchell, Herman, PhD, Chapel Hill, NC - 1608
Modell, Fred, New York, NY - 1607
Mosnaim, Giselle, MD MS FAAAAI, Chicago, IL - 2307, 3525, 5804
Moss, Mark H., MD, Madison, WI - 5054
Mudd, Kim E., RN MSN CCRP, Baltimore, MD - 1621, 2022, 3311
Mullol, Joaquim, MD PhD FAAAAI, Barcelona, Spain - 5302
Munitz, Ariel, PhD, Tel Aviv, Israel - 3013
Murphy, Kevin R., MD, Boys Town, NE - 1612
Mustillo, Peter J., MD FAAAAI, Columbus, OH - 2006
N
Naclerio, Robert M., MD FAAAAI, Chicago, IL - 2811
Nadeau, Kari C., MD PhD FAAAAI, Stanford, CA - 1202, 2301, 5806
Nagler, Cathryn R., PhD, Chicago, IL - 2514
Nair, Parameswaran K., MD PhD FRCP, Hamilton, ON, Canada - 4307
Namazy, Jennifer A., MD FAAAAI, San Diego, CA - 2804
Nelson, Harold S., MD FAAAAI, Denver, CO - 1609, 2815, 4812
Nelson, Michael R., MD PhD FAAAAI, Bethesda, MD - 0001, 1011,
1112, 1609, 1609AD, 3313
Noone, Sally A., RN MSN CCRC, New York, NY - 1701, 2023
Nowak-Wegrzyn, Anna H., MD FAAAAI, New York, NY - 1903, 2523, 4009
Nyenhuis, Sharmilee M., MD FAAAAI, Chicago, IL - 4306
O
OByrne, Paul M., MD FAAAAI, Hamilton, ON, Canada - 4813
Ober, Carole, PhD, Chicago, IL - 1202
Ochs, Hans D., MD, Seattle, WA - 1902
Odom, Laura, MSN FNP, Knoxville, TN - 2625
Ogbogu, Princess U., MD FAAAAI, Columbus, OH - 1205, 3003
Ollert, Markus W., MD, Munich, Germany - 3305
Olson, Grant C., MD, Denver, CO - 1612
Oppenheimer, John, MD FAAAAI, Denville, NJ - 1209AD, 5505
Ortiz, Gabriel, MPAS PA-C, El Paso, TX - 1101B, 2311
Ostrov, David A., PhD, Gainesville, FL - 4101
Owens, Tiffany J., MD, San Antonio, TX - 0001
P
Pacheco, Karin A., MD MSPH FAAAAI, Denver, CO - 2305, 3303, 3523
Pajno, Giovanni B., MD FAAAAI, Messina, Italy - 2301
Palmer, James, MD, Philadelphia, PA - 2308
Panettieri, Reynold A., MD, Philadelphia, PA - 4303
Papadopoulos, Nikolaos G., MD FAAAAI, Athens, Greece - 3301
Park, Miguel A., MD, Rochester, MN - 2022, 2508
Pashley, Catherine A., PhD, Leicester, United Kingdom - 4811
Passalacqua, Giovanni, MD, Genoa, Italy - 1905, 3526, 5009
Patel, Minal R., PhD MPH, Ann Arbor, MI - 2307
191
 faculty index
Patterson, David L., MD MS MBA FAAAAI, Noblesville, IN - 1603
Paulson, James C., PhD, La Jolla, CA - 5051
Peebles, R. Stokes, Jr., MD FAAAAI, Nashville, TN - 2524, 4015, 4304
Perez, Elena E., MD PhD FAAAAI, Miami, FL - 2505, 4302, 4804
Perry, Tamara T., MD, Little Rock, AR - 2307
Perzanowski, Matthew S., PhD, New York, NY - 2314
Peters, Anju T., MD FAAAAI, Chicago, IL - 1204, 4305, 5302
Peters, Stephen P., MD PhD FAAAAI, Winston Salem, NC - 4301, 5504
Phipatanakul, Wanda, MD MS FAAAAI, Boston, MA - 1210, 2305
Pichler, Werner J., MD, Bern, Switzerland - 4101
Pien, Lily, MD FAAAAI, Cleveland, OH - 5054
Pityn, Peter J., PhD, London, Canada - 3006
Platts-Mills, Thomas A.E., MD PhD FAAAAI, Charlottesville, VA - 2524,
3015
Plaut, Marshall, MD FAAAAI, Bethesda, MD - 1602
Polosa, Riccardo, MD PhD FAAAAI, Catania, Italy - 1613, 4822
Pongdee, Thanai, MD FAAAAI, Jacksonville, FL - 1112
Poole, Jill A., MD FAAAAI, Omaha, NE - 2305, 5101
Porteus, Matthew, MD PhD, Stanford, CA - 4823
Portnoy, Jay M., MD FAAAAI, Kansas City, MO - 1210, 1803, 4803
Price, Christina C., MD, New Haven, CT - 2806
Prograis, Lawrence J., MD, Bethesda, MD - 4006
Prussin, Calman, MD FAAAAI, Bethesda, MD - 3307
Puck, Jennifer M., MD, San Francisco, CA - 4302, 4806
Pulver, Donald W., MD FAAAAI, Rochester, NY - 1612
Q Sharma, Hemant P., MD MHS FAAAAI, Elkridge, MD - 3311
Quinn, James M., MD FAAAAI, San Antonio, TX - 2502
Quirce, Santiago, MD PhD, Madrid, Spain - 2809, 4007
R Shulan, David J., MD FAAAAI, Albany, NY - 1203, 4004
Raby, Benjamin A., MD MPH, Boston, MA - 1202
Rachid, Rima A., MD FAAAAI, Boston, MA - 2003, 4804
Rance, Karen S., DNP RN CPNP AE-C, Indianapolis, IN - 1402
Rand, Cynthia S., PhD, Baltimore, MD - 5312, 5804
Rank, Matthew A., MD FAAAAI, Scottsdale, AZ - 1209, 2510, 2812
Rao, V. Koneti U., MD, Bethesda, MD - 4005
Rathkopf, Melinda M., MD FAAAAI, Anchorage, AK - 1203, 2004, 2802,
4802
Ray, Prabir, PhD, Pittsburgh, PA - 5311
Reijula, Kari E., MD PhD FAAAAI, Helsinki, Finland - 1803
Ren, Bing, PhD, San Diego, CA - 1202
Renz, Harald E., MD, Marburg, Germany - 4809
Ricketti, Anthony J., MD, Trenton, NJ - 1101C
Riedl, Marc A., MD MS, Los Angeles, CA - 5304, 5506
Ring, Johannes, MD PhD FAAAAI, Munich, Germany - 5003
Risma, Kimberly A., MD PhD FAAAAI, Cincinnati, OH - 1111
Roberts, Joseph L., MD PhD, Durham, NC - 3042
Robinson, Humaira, BSN RN, Washington, DC - 3044
Romano, Antonino G., MD, Rome, Italy - 1207
Rosenstreich, David L., MD FAAAAI, Bronx, NY - 2314
Rosenwasser, Lanny J., MD FAAAAI, Kansas City, MO - 2302
Ross, Jaime, RN, New York, NY - 1621
Routes, John M., MD FAAAAI, Milwaukee, WI - 2527, 3005, 4806
S Sprunger, Anna C., PA-C, Washington, DC - 2625
Salo, Paivi M., PhD, Research Triangle Park, NC - 1608
192
Sampson, Hugh A., MD FAAAAI, New York, NY - 2301, 4807
Sanak, Marek, MD, Krakow, Poland - 3301
Sanders, Georgiana M., MD MS FAAAAI, Ann Arbor, MI - 3308
Sands, Mark F., MD FAAAAI, Buffalo, NY - 1613, 2522, 4822
Santos, Alexandra F., MD MSc, London, United Kingdom - 1602
Sastre, Joaquin, MD PhD FAAAAI, Madrid, Spain - 2809
Savage, Jessica R., MD, Baltimore, MD - 5806
Schatz, Michael, MD MS FAAAAI, San Diego, CA - 2804, 3525
Schleimer, Robert P., PhD FAAAAI, Chicago, IL - 2810, 3101
Schlosser, Rodney J., MD, Charleston, SC - 4013
Schmid-Grendelmeier, Peter, MD PhD, Zuerich, Switzerland - 2012,
5303
Schnaar, Ronald L., PhD, Baltimore, MD - 5051
Schneider, Lynda C., MD FAAAAI, Boston, MA - 1208, 3524, 5303
Schultz, Fallon, MSW LCSW CAM, Howell, NJ - 2625
Schwartz, David A., MD, Aurora, CO - 1202
Schwartz, Lawrence B., MD PhD FAAAAI, Richmond, VA - 1112, 4801
Scott, James, PhD, Toronto, ON, Canada - 1601
Sears, Malcolm R., MD FAAAAI, Hamilton, ON, Canada - 5313
Secord, Elizabeth A., MD FAAAAI, Detroit, MI - 1112
Sedlak, Debra A., MSN CPNP, Durham, NC - 1101, 2021, 2311, 3042,
4051
Shaker, Marcus S., MD MS FAAAAI, Lebanon, NH - 4803, 5312
Shamji, Mohamed H., BSc MSc PhD, South Kensington, United Kingdom
- 1905, 2512
Sheikh, Javed, MD FAAAAI, Los Angeles, CA - 3008, 3302
Sher, Mandel R., MD FAAAAI, Largo, FL - 5004
Shreffler, Wayne G., MD PhD FAAAAI, Boston, MA - 1602
Sicherer, Scott H., MD FAAAAI, New York, NY - 4807
Silvers, William S., MD FAAAAI, Denver, CO - 1804, 3043
Silviu-Dan, Fanny, MD FAAAAI, Montreal, Canada - 1112
Simon, Dagmar, MD, Bern, Switzerland - 4830
Simons, F. Estelle R., MD FAAAAI, Winnipeg, MB, Canada - 2302, 4808
Singh, Anne Marie, MD, Chicago, IL - 1604
Skoner, David P., MD, Pittsburgh, PA - 5009
Skripak, Justin M., MD, Hoboken, NJ - 2509
Skypala, Isabel J., PhD, London, United Kingdom - 2025, 3551
Slavin, Raymond G., MD MS FAAAAI, Saint Louis, MO - 3012, 4811
Sloane, David E., MD, Boston, MA - 1207, 5807
Smart, Brian A., MD FAAAAI, Long Grove, IL - 1603
Smith, Alisa M., PhD FAAAAI, Washington, DC - 2507
Smith, Andrew M., MD FAAAAI, Cincinnati, OH - 5052
Smith, Lewis J., MD, Chicago, IL - 4301
Sokol, Caroline L., MD PhD, Boston, MA - 3306
Solensky, Roland, MD FAAAAI, Corvallis, OR - 2807, 5522
Somech, Raz, MD PhD, Ramat Gan, Israel - 1607
Soong, Weily, MD FAAAAI, Birmingham, AL - 1805
Spahn, Joseph D., MD, Denver, CO - 1802, 4812, 5801
Spencer, Lisa A., PhD FAAAAI, Boston, MA - 4307
Spergel, Jonathan M., MD PhD FAAAAI - 2525
Sperling, Anne, PhD, Chicago, IL 2813, 4014, 5805
Stadtmauer, Gary J., MD FAAAAI, New York, NY - 5004
Steele, Pamela H., MSN CPNP AE-C, Chapel Hill, NC - 2622
 faculty index
Steigelman, Daniel A., MD, San Antonio, TX - 0001
Stein, Mark R., MD FAAAAI, North Palm Beach, FL - 5803
Steinberg, Joshua A., MD, Milwaukee, WI - 5314
Steinke, John W., PhD FAAAAI, Charlottesville, VA - 5307, 5808
Stevenson, Donald D., MD FAAAAI, San Diego, CA - 4815
Stieb, Elisabeth S., RN BSN AE-C, Boston, MA - 2024, 3311
Stokes, Jeffrey R., MD FAAAAI, Omaha, NE - 1112
Storms, William W., MD FAAAAI, Colorado Springs, CO - 3001
Straight, Timothy, MD PhD, San Antonio, TX - 0001
Strand, Vibeke, MD, Portola Valley, CA - 2806
Strong, Beth D., RN CCRC, New York, NY - 1101
Stukus, David R., MD FAAAAI, Columbus, OH - 2316, 2824
Sublett, James L., MD FAAAAI, Louisville, KY - 1210
Sullivan, Kathleen E., MD PhD FAAAAI, Philadelphia, PA - 1111, 2303,
3005, 4806
Sullivan, Timothy J., MD, Ogden, UT - 5807
Sutton, Brian, MA DPhil, London, United Kingdom - 5311
Szefler, Stanley J., MD FAAAAI, Denver, CO - 1610, 4303, 4812, 5006
T Weinberger, Miles M., MD FAAAAI, Iowa City, IA - 5801
Takach, Patricia A., MD FAAAAI, Philadelphia, PA - 4305
Tang, Mimi L. K., MD PhD FAAAAI, Melbourne, Australia - 1804
Tankersley, Michael S., MD FAAAAI, San Antonio, TX - 1609BC, 2611,
3011, 3312
Tantisira, Kelan, MD MPH, Boston, MA - 5314
Tarlo, Susan M., MBBS FAAAAI, Toronto, ON, Canada - 2809, 4824
Tashkin, Donald P., MD, Los Angeles, CA - 1613
Taylor, James S., MD, Cleveland, OH - 3523
Teuber, Suzanne S., MD FAAAAI, Davis, CA - 5524
Thompson, Larry, Garden Ridge, TX - 1701
Thompson, Teresa, CPC CMSCS CCC, Carlsborg, WA - 1501, 2315, 2623
Thorne, Peter S., PhD, Iowa City, IA - 1608
Tichenor, Wellington S., MD FAAAAI, New York, NY - 1204
Tilles, Stephen A., MD FAAAAI, Seattle, WA - 5054
Timmons, Karol G., RN MS CPNP, Boston, MA - 1101, 2023, 3315
Tobin, Mary C., MD FAAAAI, Chicago, IL - 5314
Togias, Alkis, MD FAAAAI, Bethesda, MD - 1202
Topol, Eric J., MD, La Jolla, CA - 2701
Torgerson, Troy R., MD PhD, Seattle, WA - 2303
Tovey, Euan R., PhD, Sydney, Australia - 5002
Tracy, James M., DO FAAAAI, Omaha, NE - 2814
Trikha, Anita, MD, Denver, CO - 1209AD
U Zhou, Weisong, PhD, Nashville, TN - 2515
Umetsu, Dale T., MD PhD FAAAAI, South San Francisco, CA - 3307
Unkle, David Wayne, MSN FCCM, Trenton, NJ - 1101C
Uzel, Gulbu, MD, Bethesda, MD - 1604, 4829
V 1101A
Van De Water, Peter, PhD, Fresno, CA - 1201
Varshney, Pooja, MD, Austin, TX - 2312
Venter, Carina, PhD RD, Isle of Wight, United Kingdom - 2825, 3314,
3551
Vickery, Brian P., MD FAAAAI, Chapel Hill, NC - 1611, 2805
Vlieg-Boerstra, Berber, PhD RD, Brummen, Netherlands - 2025, 3551
Voelker, Dennis R., PhD, Denver, CO - 4809
Volcheck, Gerald W., MD FAAAAI, Rochester, MN - 5007
W
Wagenmann, Martin, MD FAAAAI, Dsseldorf, Germany - 2308,
2513, 2811, 4814
Wallace, Dana V., MD FAAAAI, Fort Lauderdale, FL - 2802, 5505
Walter, Jolan E., MD PhD, Boston, MA - 4806
Wambre, Erik R., PhD, Seattle, WA - 1602
Wang, Julie, MD FAAAAI, New York, NY - 1804, 5008
Wardlaw, Andrew J., MD PhD, Leicester, United Kingdom - 4811,
5503
Wasserman, Richard L., MD PhD FAAAAI, Dallas, TX - 1801, 2802,
4004
Wasserman, Stephen I., MD FAAAAI, San Diego, CA - 1011, 2814
Weber, Richard W., MD FAAAAI, Denver, CO - 1201, 4815
Wechsler, Michael E., MD, Denver, CO - 2304
Wedner, H. James, MD FAAAAI, St. Louis, MO - 2007
Weiler, Catherine R., MD PhD FAAAAI, Rochester, MN - 1904, 2009,
4801
Weiler, John M., MD FAAAAI, Iowa City, IA - 1613, 2002
Weinstein, Andrew G., MD FAAAAI, Wilmington, DE - 5312
Weiss, Scott T., MD MS, Boston, MA - 1610
Weldon, David R., MD FAAAAI, College Station, TX - 3302
Wenzel, Sally E., MD FAAAAI, Pittsburgh, PA - 3002, 3101
Wesemann, Duane R., MD PhD, Boston, MA - 2514, 5806
Westley, C. Ross, MD FAAAAI, Arvada, CO - 1612
White, Kevin M., MD, San Antonio, TX 0001, 2502
Williams, L. Keoki, MD MPH FAAAAI, Detroit, MI - 3010
Williams, Paul V., MD FAAAAI, Mount Vernon, WA - 4701
Wilson, Sandra R., PhD, Palo Alto, CA - 5312
Windom, Hugh H., MD FAAAAI, Sarasota, FL - 2802
Woessner, Katharine M., MD FAAAAI, San Diego, CA - 5302, 5807
Wood, Robert A., MD FAAAAI, Baltimore, MD - 1209
Y
Yao, Lu, MD, Phoenix, AZ - 4003
Young, Michael C., MD FAAAAI, South Weymouth, MA - 4011, 5008
Younger, M. Elizabeth M., CRNP PhD, Baltimore, MD - 2313, 4051
Yu, Joyce E., MD, New York, NY - 1205, 5521
Yusin, Joseph S., MD FAAAAI, Los Angeles, CA - 0001
Z
Zeldin, Darryl C., MD, Research Triangle Park, NC - 1608, 2515
Zhao, Wei, MD PhD FAAAAI, Richmond, VA - 2014
Zhu, Jinfang, PhD, Bethesda, MD - 5311
Ziegler, Steven, PhD, Seattle, WA - 2813
Zimmermann, Nina A., MSN RN ANP-BC AE-C, Arnold, MO - 1101,
Zimmermann, Nives, MD FAAAAI, Cincinnati, OH - 4307, 5051
Zinreich, S. James, MD, Baltimore, MD - 1204
Zuraw, Bruce L., MD, San Diego, CA - 5506
193
 AAAAI Staff

Executive Office Support Staff

555 East Wells Street, Suite 1100
Milwaukee, WI 53202-3823
Tel: (414) 272-6071
Fax: (414) 272-6070
E-mail: annualmeeting@aaaai.org
annualmeeting.aaaai.org
AAAAI Staff
Thomas B. Casale, MD FAAAAI, Executive Vice President
Kay Whalen, MBA CAE, Executive Director
Bert Slivensky, CAE, Associate Executive Director
Josh de Beer, Administrative Manager to the Board of Directors
Rachel McCormick, Executive Assistant
Daniel A. Nemec, MBA CAE, Director of Finance
Communications & Membership Team
Shauna Barnes, Senior Membership Development Manager
John Augustyniak, Constituency Groups Manager
Megan Brown, Senior Media & Member Communications Manager
Laura Plizka, Online Communications Manager
Kate Rudolph, Communications & Membership Coordinator
Education & Meetings Team
Steven Folstein, MFA MEd, Director of Education and Meetings
Brian Balistreri, MS, Program Manager
Amanda Buckley, MBA, Program Manager
Marlene DeMaster, Meetings Manager
Kathy Murphy-Ott, Meetings Coordinator
Gail Radecki, Education Coordinator
Jaime Sattler, MSW, Program Manager
Katy Tomczak, Program Manager
Jaimee Acevedo, Information Services Specialist
David Baumann, Chief Operating Officer
Kesha Brooks, Systems Administrator
Amanda Darkow, Human Resources Coordinator
Scott Daveley, Software Architect
James Degnan, Operations Assistant
Shawn Dimmer, Director of Web Services
Gerald Dugan, Web Designer/Developer
Dan Ellenberger, Accountant
Peggy Goetsch, Graphic Designer
Jennifer Gubbin, Graphic Designer
Debbie Kucharski, Receptionist
Carrie La Barr, Information Services Specialist
Laura Ludwig, Director of Creative Services
Christy Madore, Accountant
Louis Nguyen, Web Designer/Developer
Kathy Olejnik, Executive Assistant
Wendy Ramm, Office Assistant
Celeste Rom, Associate Director of Corporate and Human Resources
Paul Rushizky, Director of Information Services
Paula Schulze, Web Designer/Developer
Joriah Siemann, Systems Administrator II
Annette Strini, Receptionist
Patrick Sullivan, Associate Director of Information Services
Lee Szymczak, Mail Services and Operations Manager
Anna Torres-Garcia, Information Services Specialist
Adam Woznicki, Associate Director of Finance
Mark Zbikowski, Director of Technology Services

Journal, Research & Training Team

Justin Byrne, Managing Editor, JACI and JACI: In Practice
Mari Durn, Program Manager
John Galati, JACI Senior Editorial Assistant
Craig Reinbold, JACI Editorial Assistant
Jerome Schultz, Program Manager, Manager AAAAI Awards

Practice & Policy Team

Sheila Heitzig, JD MNM CAE, Director of Practice & Policy
Shazia Ali, Program Manager
Lauri Sweetman, Program Manager

Allergy, Asthma & Immunology Education and

Research Trust (ARTrusttm)
Tara Withington, CAE, Director of Development
Bianca Costanzo, Development Manager
Charlotte Surmer, Development Coordinator

194
 Notes

___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________

195
 Notes

___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________

196
 ANNUALMEETING.AAAAI.ORG

SAN DIEGO
AAAAI Executive Office
555 East Wells Street, Suite 1100
Milwaukee, WI 53202-3823
Tel: (414) 272-6071
Fax: (414) 272-6070
Email: annualmeeting@aaaai.org